data_2kg2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kg2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.4 p -91.06 129.16 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.28 151.54 51.33 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.741 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.95 152.18 18.57 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.742 0.306 . . . . 0.0 110.548 -172.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -129.58 154.61 40.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -141.12 102.12 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.306 0.574 . . . . 0.0 110.35 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.42 127.01 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -99.63 148.67 24.08 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HB2' HD11 ' A' ' 27' ' ' LEU . 22.5 pttm -39.18 123.36 1.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.472 HD21 ' HD2' ' A' ' 65' ' ' PRO . 49.4 tp -117.67 122.08 42.58 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.559 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -92.81 109.71 21.15 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -107.41 109.14 20.79 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.57 -110.77 3.69 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.72 17.74 12.71 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.194 0.521 . . . . 0.0 111.479 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.67 166.81 12.29 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 20' ' ' LYS . 58.4 tp -112.85 126.59 55.61 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.82 163.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 97' ' ' LEU . 9.9 mp -88.4 2.3 52.94 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.051 0.929 . . . . 0.0 109.419 175.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.9 -47.26 2.04 Favored Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 115.264 -0.88 . . . . 0.0 114.362 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.421 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 39.9 p90 -90.63 166.11 13.35 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.8 m -123.96 163.62 20.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.508 1.523 . . . . 0.0 109.497 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.513 HD11 HD13 ' A' ' 55' ' ' ILE . 7.9 pt -125.17 166.15 21.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 122.75 0.42 . . . . 0.0 110.615 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.24 -22.42 6.83 Favored Glycine 0 CA--C 1.487 -1.675 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.311 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.525 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 123.58 163.54 11.78 Favored Glycine 0 C--O 1.196 -2.238 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.613 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.88 -117.3 3.45 Favored Glycine 0 N--CA 1.432 -1.588 0 O-C-N 124.583 0.814 . . . . 0.0 112.345 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.62 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.05 -17.58 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 122.101 0.953 . . . . 0.0 112.869 -174.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.496 ' HB2' HG23 ' A' ' 89' ' ' THR . 19.5 t70 -75.2 -9.19 58.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.421 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.6 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 24.9 mm-40 -107.55 162.86 13.57 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.097 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -105.21 108.63 61.82 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -58.44 -19.79 45.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 123.794 2.996 . . . . 0.0 113.402 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -75.34 -5.58 45.51 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.586 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.15 29.29 0.89 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.523 0.329 . . . . 0.0 111.155 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -107.22 145.5 31.32 Favored Pre-proline 0 CA--C 1.495 -1.14 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.36 -40.83 10.09 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 C-N-CA 123.204 2.603 . . . . 0.0 113.057 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.63 4.41 10.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.262 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.242 179.157 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.62 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 53.1 mttp . . . . . 0 CA--C 1.552 1.047 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.93 159.41 8.28 Favored Glycine 0 C--O 1.191 -2.555 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.513 HD13 HD11 ' A' ' 33' ' ' ILE . 20.1 mm -77.88 128.11 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 117.657 0.728 . . . . 0.0 109.538 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.406 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 3.1 p90 -131.09 157.77 42.18 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.951 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.5 t -80.57 134.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 O-C-N 124.748 1.28 . . . . 0.0 110.469 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 p -106.15 -23.03 12.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.618 0.723 . . . . 0.0 110.519 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -155.19 142.51 19.47 Favored 'General case' 0 CA--C 1.473 -1.992 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 16.3 m -107.73 -172.03 0.4 Allowed 'Isoleucine or valine' 1 N--CA 1.339 -6.02 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 p -64.51 131.32 46.77 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.59 -21.42 26.68 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 123.181 0.592 . . . . 0.0 112.146 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.99 52.72 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.6 -161.23 10.45 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-N 114.905 -0.648 . . . . 0.0 112.771 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HD2' HD21 ' A' ' 21' ' ' LEU . 38.2 Cg_endo -63.27 -32.68 72.94 Favored 'Trans proline' 0 C--O 1.211 -0.872 0 C-N-CA 123.541 2.827 . . . . 0.0 112.543 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.06 -61.1 2.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -70.79 -30.67 67.2 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.329 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 mm -63.69 -42.69 96.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.783 0.325 . . . . 0.0 111.316 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.74 -55.2 5.7 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.169 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.98 29.4 0.05 OUTLIER Glycine 0 C--N 1.312 -0.78 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.056 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HB2' HG12 ' A' ' 16' ' ' VAL . 6.5 tp -100.33 120.93 40.69 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.457 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 28.7 mm-40 -116.33 153.31 32.21 Favored 'General case' 0 N--CA 1.425 -1.693 0 O-C-N 123.964 0.79 . . . . 0.0 110.959 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.43 131.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.68 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.96 -27.45 20.34 Favored Glycine 0 C--O 1.252 1.244 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.956 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 53.2 m-20 -72.53 125.28 27.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.762 0.792 . . . . 0.0 111.02 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 63.2 mttp -82.87 128.82 34.78 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.139 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.414 HG13 HG13 ' A' ' 109' ' ' VAL . 2.8 mp -92.72 124.57 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.3 mmt -109.41 -11.44 14.83 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.533 0.683 . . . . 0.0 110.918 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -148.43 124.74 10.88 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.498 HG22 HD23 ' A' ' 107' ' ' LEU . 44.6 t -136.68 118.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 53.07 39.16 29.08 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.607 1.163 . . . . 0.0 112.997 170.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.413 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 65.08 27.42 72.28 Favored Glycine 0 N--CA 1.462 0.408 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.715 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -10.04 13.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 55.69 111.47 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.468 1.107 . . . . 0.0 113.717 -169.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.617 ' SD ' HG12 ' A' ' 88' ' ' VAL . 62.7 tpp -95.92 1.52 52.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.201 1.001 . . . . 0.0 109.353 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -71.33 135.55 47.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttp 55.48 74.61 0.36 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.327 1.051 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.617 HG12 ' SD ' ' A' ' 85' ' ' MET . 11.3 p -149.9 150.16 13.95 Favored 'Isoleucine or valine' 0 C--O 1.261 1.691 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 38' ' ' ASP . 15.6 p -73.31 157.66 36.59 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.6 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 13.7 t60 -53.58 -42.93 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.336 175.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.75 -46.66 84.32 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.789 0.681 . . . . 0.0 110.825 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -32.89 67.42 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.816 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.88 -45.13 75.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.314 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.463 ' CZ ' HG23 ' A' ' 98' ' ' THR . 13.5 mmm180 -55.18 -40.76 71.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.661 0.743 . . . . 0.0 110.291 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.502 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -85.93 32.69 0.6 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.893 -176.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.455 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.1 tpt180 -148.88 -48.66 0.15 Allowed 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.014 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -92.32 -20.72 20.81 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.489 ' N ' HD11 ' A' ' 97' ' ' LEU . 14.6 t -118.21 10.12 12.79 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 117.666 -1.613 . . . . 0.0 110.837 175.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -66.28 154.96 38.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -103.67 6.24 36.88 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.0 t -79.28 -37.93 36.64 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -92.96 147.9 22.45 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.449 ' HG3' HG11 ' A' ' 104' ' ' VAL . 11.7 pt-20 -101.48 -63.9 1.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.794 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -117.85 133.26 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-O 122.002 0.905 . . . . 0.0 112.347 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.65 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.631 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -100.57 112.82 25.25 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.498 HD23 HG22 ' A' ' 80' ' ' VAL . 14.8 mt -112.86 162.9 15.27 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.1 mp -139.74 123.66 17.61 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 123.421 0.689 . . . . 0.0 109.273 174.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 77' ' ' ILE . 34.7 m -115.71 151.49 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 CA-C-O 121.16 0.505 . . . . 0.0 110.101 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.401 -2.913 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 173.96 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.33 146.3 14.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.538 HE22 ' HB ' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -153.78 155.15 35.31 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 122.195 -0.316 . . . . 0.0 110.451 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.64 142.65 27.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.538 ' HB ' HE22 ' A' ' 14' ' ' GLN . 8.1 p -134.68 154.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.99 107.72 4.46 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.485 0.659 . . . . 0.0 111.26 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.424 HG23 ' CG ' ' A' ' 65' ' ' PRO . 2.0 mp -97.26 126.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.15 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -93.25 145.24 24.58 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.814 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HB2' HD11 ' A' ' 27' ' ' LEU . 20.2 pttp -37.6 115.95 0.45 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.695 1.198 . . . . 0.0 113.805 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.02 123.85 44.45 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.303 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.51 126.94 35.79 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.193 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -120.67 106.32 11.61 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.39 -100.52 1.07 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -125.56 14.89 8.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.269 0.557 . . . . 0.0 110.348 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.436 ' HA ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.5 169.46 11.39 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 20' ' ' LYS . 14.3 tp -116.45 119.17 34.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.15 163.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 97' ' ' LEU . 2.9 mm? -95.83 9.35 40.81 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-O 123.446 1.593 . . . . 0.0 108.659 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.98 -48.69 3.69 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.603 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.35 170.65 11.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.098 0.475 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 48.8 m -132.85 163.49 28.97 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 123.66 0.784 . . . . 0.0 110.485 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.513 HD13 HD13 ' A' ' 55' ' ' ILE . 6.1 pt -121.18 166.96 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 122.777 0.431 . . . . 0.0 110.42 -174.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.33 -21.58 6.87 Favored Glycine 0 CA--C 1.486 -1.741 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.595 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.581 ' C ' HD12 ' A' ' 55' ' ' ILE . . . 124.54 169.51 13.04 Favored Glycine 0 N--CA 1.416 -2.672 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.909 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -119.4 -117.95 2.7 Favored Glycine 0 C--O 1.209 -1.435 0 O-C-N 124.158 0.563 . . . . 0.0 112.24 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -19.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.051 0.453 . . . . 0.0 111.757 -176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.508 ' HB2' HG23 ' A' ' 89' ' ' THR . 35.8 t70 -76.17 -8.8 57.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.226 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.586 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 26.4 mm-40 -107.11 165.8 11.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.5 t70 -107.83 119.99 48.53 Favored Pre-proline 0 C--N 1.315 -0.905 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.244 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -56.07 -29.0 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.335 2.69 . . . . 0.0 113.379 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -67.87 -26.45 66.03 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -117.43 9.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.0 111.747 -176.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 5.9 m-80 -101.36 150.9 37.59 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.14 -49.88 0.6 Allowed 'Trans proline' 0 C--O 1.217 -0.549 0 C-N-CA 123.207 2.605 . . . . 0.0 113.49 -175.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.44 7.64 24.98 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.735 0.779 . . . . 0.0 110.333 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 9.2 t . . . . . 0 N--CA 1.427 -1.622 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.716 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm . . . . . 0 N--CA 1.429 -1.518 0 CA-C-O 121.382 0.61 . . . . 0.0 109.442 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.51 154.54 6.21 Favored Glycine 0 C--O 1.174 -3.649 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.606 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 29.5 mm -73.49 120.15 21.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 118.112 0.956 . . . . 0.0 109.776 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.8 p90 -117.42 151.25 37.44 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.53 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 71' ' ' LEU . 93.7 t -82.12 130.3 36.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 124.02 0.825 . . . . 0.0 109.853 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -103.13 -27.19 12.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.58 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 85.4 mtt180 -144.12 138.44 28.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.082 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 HG11 ' CB ' ' A' ' 66' ' ' ALA . 4.9 t -116.28 144.71 23.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.523 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 2.8 t -45.52 113.69 0.63 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.927 1.392 . . . . 0.0 109.102 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.46 -17.69 14.59 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.513 1.525 . . . . 0.0 114.421 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.3 46.52 0.19 Allowed Glycine 0 CA--C 1.469 -2.806 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.523 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -131.65 -165.71 11.46 Favored Glycine 0 N--CA 1.413 -2.899 0 CA-C-N 114.172 -1.014 . . . . 0.0 112.721 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.424 ' CG ' HG23 ' A' ' 18' ' ' ILE . 41.9 Cg_endo -65.2 -29.6 55.47 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 123.706 2.937 . . . . 0.0 112.4 -170.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.407 ' CB ' HG11 ' A' ' 60' ' ' VAL . . . -60.73 -59.14 5.86 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.433 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.0 pt-20 -67.8 -32.62 73.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.649 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 64' ' ' GLY . 23.1 mm -58.55 -47.26 88.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.015 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.96 -40.89 64.97 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.494 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.1 20.62 0.82 Allowed Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.153 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 57' ' ' VAL . 1.9 tp -79.58 125.81 30.08 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.419 ' N ' HD11 ' A' ' 71' ' ' LEU . 21.3 mm-40 -114.27 150.88 33.73 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.839 0.828 . . . . 0.0 109.733 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.4 mt -68.63 132.68 32.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.9 175.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.31 58.57 Favored Glycine 0 C--O 1.248 0.984 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.429 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 15.4 m-20 -84.74 126.22 33.22 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -86.88 117.35 25.55 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 mt -83.15 141.48 14.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.651 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.3 mmt -119.96 -20.6 7.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.438 0.637 . . . . 0.0 109.351 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.43 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -143.59 138.61 29.18 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.459 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 34.4 t -142.37 119.68 7.14 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 124.045 0.938 . . . . 0.0 108.752 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.3 t-20 43.86 57.22 4.21 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.736 1.614 . . . . 0.0 112.127 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.43 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 47.44 30.15 5.88 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 117.07 1.588 . . . . 0.0 117.07 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.459 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -109.72 -12.47 14.62 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -175.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.95 93.55 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 127.258 2.223 . . . . 0.0 107.973 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.606 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 4.3 ttp -89.02 -12.51 41.17 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -170.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.1 t -53.93 127.84 27.84 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 120.93 0.395 . . . . 0.0 110.357 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.3 ttm 63.4 90.27 0.08 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.446 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.49 155.64 4.41 Favored 'Isoleucine or valine' 0 C--O 1.263 1.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 38' ' ' ASP . 9.4 p -75.09 159.72 31.34 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 120.98 0.419 . . . . 0.0 110.167 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.586 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 14.1 t60 -55.33 -46.9 76.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.634 174.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.8 -50.56 72.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.987 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.4 67.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.957 -176.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.677 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -73.81 -42.54 60.8 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.489 ' CZ ' HG21 ' A' ' 98' ' ' THR . 12.9 mmm180 -50.19 -44.17 52.85 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 123.92 0.888 . . . . 0.0 111.031 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -84.26 29.25 0.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.056 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.47 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 5.3 tpt180 -142.91 -42.61 0.31 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.84 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -95.27 -17.52 21.61 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.489 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 11.9 t -124.75 13.78 8.62 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.692 174.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.6 ptpt -70.17 178.29 2.87 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.315 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.436 ' NH1' ' HA ' ' A' ' 26' ' ' ASN . 13.9 ptm180 -131.65 6.08 4.36 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.556 -176.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.449 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 20.2 m -74.93 -41.77 59.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.37 0.605 . . . . 0.0 109.497 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.31 139.73 32.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.411 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.96 -63.81 1.24 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.0 t -98.8 122.38 50.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 120.81 0.338 . . . . 0.0 110.141 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.41 ' HA ' ' ND2' ' A' ' 81' ' ' ASN . 33.4 m -113.96 145.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -125.64 115.98 20.98 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.455 HD11 HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -117.61 153.15 33.77 Favored 'General case' 0 N--CA 1.397 -3.123 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -172.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.3 mp -118.0 121.18 39.96 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -116.8 154.08 18.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.7 p . . . . . 0 N--CA 1.399 -3.0 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.778 176.844 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -112.28 147.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.59 152.08 43.72 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -94.43 149.26 21.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.887 0.375 . . . . 0.0 110.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.66 159.16 37.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.49 106.47 4.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.43 0.633 . . . . 0.0 111.326 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -93.95 128.61 45.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.736 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -96.65 151.98 19.09 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 11.0 ptpp? -43.34 128.38 4.8 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.406 HD23 ' HD2' ' A' ' 65' ' ' PRO . 51.2 tp -122.48 123.85 42.23 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.189 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -88.5 116.38 26.7 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -113.3 103.33 11.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.19 -102.47 0.94 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.86 6.19 10.43 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.268 0.556 . . . . 0.0 111.317 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.85 163.11 12.98 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -117.89 108.92 15.9 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.48 163.55 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.62 9.96 32.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.95 0.881 . . . . 0.0 110.984 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.23 -41.69 3.07 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.68 -0.691 . . . . 0.0 114.341 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CD1' HD23 ' A' ' 71' ' ' LEU . 49.3 p90 -99.0 172.54 7.33 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.7 m -136.26 170.44 16.02 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.306 1.042 . . . . 0.0 109.364 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 HD13 HD13 ' A' ' 55' ' ' ILE . 7.0 pt -127.93 167.22 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 117.868 0.304 . . . . 0.0 111.169 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.39 -27.68 4.64 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.18 165.25 12.29 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.344 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -117.85 -110.17 2.5 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.203 0.59 . . . . 0.0 113.13 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.533 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.76 -26.19 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -173.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 15.2 t70 -66.32 -19.82 65.92 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.685 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 27.5 mm-40 -96.38 -177.76 4.07 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 3.9 t70 -132.39 120.49 16.95 Favored Pre-proline 0 CA--C 1.498 -1.029 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.12 -23.25 35.17 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.197 2.598 . . . . 0.0 113.771 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -69.9 -28.87 65.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -116.03 7.48 14.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.552 0.691 . . . . 0.0 110.725 -175.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -98.89 146.5 31.76 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.32 -44.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.948 3.098 . . . . 0.0 114.458 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -109.1 12.09 25.31 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.674 0.75 . . . . 0.0 110.427 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.432 -1.364 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.49 179.578 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 67.1 mttt . . . . . 0 C--O 1.238 0.495 0 CA-C-O 121.799 0.809 . . . . 0.0 113.144 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.91 159.88 8.09 Favored Glycine 0 C--O 1.192 -2.528 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.526 HD13 HD13 ' A' ' 33' ' ' ILE . 29.0 mm -74.56 120.19 23.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 117.868 0.834 . . . . 0.0 110.296 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -120.6 157.77 28.8 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.927 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.463 HG21 HD11 ' A' ' 71' ' ' LEU . 98.5 t -84.23 132.57 31.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 O-C-N 124.713 1.258 . . . . 0.0 110.71 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -108.26 -19.66 13.4 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.462 0.649 . . . . 0.0 111.362 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -142.09 142.17 32.79 Favored 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 66' ' ' ALA . 25.5 t -140.4 132.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.571 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -49.82 126.97 15.14 Favored 'General case' 0 N--CA 1.413 -2.301 0 O-C-N 124.372 1.045 . . . . 0.0 112.521 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.69 -16.17 64.03 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.06 0.944 . . . . 0.0 111.802 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.96 46.7 0.39 Allowed Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.16 -174.87 14.06 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.701 -0.749 . . . . 0.0 111.499 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.406 ' HD2' HD23 ' A' ' 21' ' ' LEU . 35.0 Cg_endo -62.54 -29.1 78.01 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 C-N-CA 124.106 3.204 . . . . 0.0 111.965 -171.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.448 ' CB ' HG12 ' A' ' 60' ' ' VAL . . . -59.7 -61.96 2.23 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.752 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 61' ' ' SER . 2.4 pt-20 -70.09 -31.2 68.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.763 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.44 -41.39 84.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.33 -44.25 30.19 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.588 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.78 27.35 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.245 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 57' ' ' VAL . 5.1 tp -89.45 123.69 33.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.456 ' N ' HD13 ' A' ' 71' ' ' LEU . 28.0 mm-40 -110.2 162.92 14.12 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 122.301 1.048 . . . . 0.0 110.62 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.63 134.61 29.48 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.88 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.21 18.72 71.11 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.051 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.502 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 3.6 m-20 -77.01 -2.08 32.09 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 43.07 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.421 HD12 ' CG2' ' A' ' 57' ' ' VAL . 9.9 mt -84.51 124.93 40.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.519 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.477 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 18.2 mmt -112.18 -10.63 13.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.257 0.551 . . . . 0.0 110.527 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 7.8 tp60 -156.47 127.33 6.83 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.731 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 107' ' ' LEU . 22.3 t -132.79 121.59 44.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.213 0 C-N-CA 124.175 0.99 . . . . 0.0 109.212 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.85 30.83 12.06 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.44 6.11 86.32 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 115.835 -0.62 . . . . 0.0 114.49 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.493 ' CZ2' HG22 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -99.1 -2.47 36.93 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 68.69 127.04 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 124.386 1.074 . . . . 0.0 111.222 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 tpt -123.58 -4.38 8.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 110.348 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -68.36 -16.19 63.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.778 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.66 98.39 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.493 HG22 ' CZ2' ' A' ' 83' ' ' TRP . 9.2 p -163.93 146.58 2.73 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.429 HG21 ' HB2' ' A' ' 38' ' ' ASP . 3.1 p -73.19 155.46 39.58 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.463 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.584 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 11.1 t60 -53.5 -45.4 69.66 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.975 0.797 . . . . 0.0 109.393 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.87 -42.47 97.51 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.386 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.87 -32.31 61.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.618 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.522 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.12 -43.56 74.17 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.102 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.45 ' C ' ' H ' ' A' ' 96' ' ' ARG . 9.6 mmm180 -55.75 -40.31 72.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.009 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.14 29.53 0.41 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.146 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.511 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.6 tpt180 -142.11 -43.45 0.34 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.989 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -101.31 -20.46 15.2 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.458 ' N ' HD12 ' A' ' 97' ' ' LEU . 10.3 t -115.55 11.74 15.96 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.014 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -63.04 143.65 57.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -103.27 6.83 38.32 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.835 0.826 . . . . 0.0 110.453 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.795 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.94 165.71 12.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.472 ' HG3' HG11 ' A' ' 104' ' ' VAL . 8.8 pt-20 -118.53 -63.57 1.39 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.7 p -121.49 131.06 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-O 121.687 0.756 . . . . 0.0 112.679 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.49 171.87 17.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.645 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -123.33 114.43 20.18 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -116.97 148.24 41.59 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -176.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.2 mp -116.02 121.91 43.65 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-O 121.349 0.595 . . . . 0.0 109.5 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 27.6 m -117.49 150.2 19.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.293 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 N--CA 1.413 -2.284 0 CA-C-O 121.625 0.726 . . . . 0.0 110.342 -178.222 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 120.629 0.252 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.443 HG21 HG23 ' A' ' 110' ' ' THR . 41.6 t -91.5 120.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.488 ' NE2' HG21 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -138.01 156.73 47.53 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.458 0.474 . . . . 0.0 110.046 -174.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -103.32 144.71 30.99 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.409 ' HB ' HE22 ' A' ' 14' ' ' GLN . 10.0 p -126.78 156.15 37.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.95 104.07 5.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.667 0.746 . . . . 0.0 111.271 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.402 HD12 HD23 ' A' ' 107' ' ' LEU . 1.5 mp -92.31 129.02 43.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.053 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -93.15 159.97 15.05 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.741 0.651 . . . . 0.0 109.359 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -50.72 124.79 11.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -128.67 131.72 48.03 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.382 0.673 . . . . 0.0 110.27 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.2 106.02 8.05 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.95 -109.17 2.71 Favored Glycine 0 N--CA 1.428 -1.868 0 O-C-N 124.051 0.844 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -116.54 17.74 15.27 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.99 172.59 11.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -120.0 115.34 23.56 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.49 163.77 33.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.408 ' CD2' HG21 ' A' ' 105' ' ' VAL . 7.5 mp -82.28 2.76 30.48 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.991 0.901 . . . . 0.0 109.892 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.56 -44.89 3.06 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.816 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -89.17 164.69 14.89 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.605 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 85.0 p -114.74 -173.2 2.26 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.048 0.939 . . . . 0.0 109.616 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.507 HD13 HD12 ' A' ' 55' ' ' ILE . 7.3 pt -138.16 164.78 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.275 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.14 -33.79 2.68 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.32 151.62 8.59 Favored Glycine 0 C--O 1.2 -2.022 0 C-N-CA 118.581 -1.771 . . . . 0.0 113.798 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.66 -115.64 4.09 Favored Glycine 0 C--O 1.205 -1.682 0 C-N-CA 121.071 -0.585 . . . . 0.0 114.16 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.502 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.09 -9.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.039 0.923 . . . . 0.0 112.203 -175.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.503 ' HB2' HG23 ' A' ' 89' ' ' THR . 24.0 t70 -81.67 -13.36 57.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.579 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.603 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 17.6 mm-40 -113.8 -178.12 3.3 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 13.3 t70 -122.16 124.63 26.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.6 Cg_endo -56.44 -28.48 73.44 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.537 -176.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -76.32 -19.86 57.84 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.488 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -120.89 12.64 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.844 0.83 . . . . 0.0 110.104 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.411 HD22 ' HB3' ' A' ' 39' ' ' GLN . 0.8 OUTLIER -103.0 144.03 27.79 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.048 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.54 -49.41 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.936 2.424 . . . . 0.0 113.526 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 63.8 m-85 -111.89 16.32 20.42 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.411 1.101 . . . . 0.0 109.982 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' A' ' 41' ' ' PRO . 8.0 t . . . . . 0 N--CA 1.424 -1.757 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.74 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.502 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 47.2 mttp . . . . . 0 N--CA 1.427 -1.585 0 CA-C-O 121.102 0.477 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.94 166.51 10.92 Favored Glycine 0 CA--C 1.475 -2.417 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.507 HD12 HD13 ' A' ' 33' ' ' ILE . 32.7 mm -81.08 132.53 31.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 18.3 p90 -141.76 161.3 38.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.683 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 32' ' ' SER . 59.6 t -84.92 130.6 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.355 0 O-C-N 124.717 1.26 . . . . 0.0 110.447 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.7 p -102.24 -23.08 14.05 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.878 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.605 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 27.1 mmt180 -149.28 129.6 13.77 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 123.97 0.908 . . . . 0.0 109.202 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -104.37 177.29 0.89 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.033 0 CA-C-N 119.217 0.917 . . . . 0.0 109.3 174.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.553 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.2 t -79.7 116.21 19.75 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.73 -2.21 2.36 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.382 1.473 . . . . 0.0 114.336 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.5 33.76 0.16 Allowed Glycine 0 C--N 1.273 -2.921 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -121.51 -168.49 13.44 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.43 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.96 -28.8 57.83 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 123.323 2.682 . . . . 0.0 111.661 -170.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.67 -64.27 0.99 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.124 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.3 pt-20 -71.48 -29.95 65.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.54 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.7 mm -56.2 -47.31 81.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 O-C-N 123.287 0.367 . . . . 0.0 110.73 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.44 -47.55 32.94 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.28 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.31 14.94 0.44 Allowed Glycine 0 C--N 1.312 -0.772 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.63 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tp -79.63 118.52 21.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -119.35 140.09 50.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.59 139.97 10.8 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 O-C-N 124.64 1.213 . . . . 0.0 110.303 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.48 34.67 19.14 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 119.601 -1.285 . . . . 0.0 111.436 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.557 ' OD2' HG13 ' A' ' 77' ' ' ILE . 10.0 p-10 -94.47 -161.4 0.85 Allowed 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 113.54 -1.33 . . . . 0.0 107.875 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 73.8 mmtt -150.36 96.42 2.4 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.557 HG13 ' OD2' ' A' ' 75' ' ' ASP . 22.8 mt -73.12 113.31 10.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.282 1.039 . . . . 0.0 110.459 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.8 mmt -105.06 -10.21 17.33 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.182 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 1.1 tm0? -163.14 134.13 4.76 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 121.861 -0.525 . . . . 0.0 110.023 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.453 HG13 HD12 ' A' ' 107' ' ' LEU . 22.8 t -134.31 115.4 20.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 48.07 55.79 8.21 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 124.509 1.124 . . . . 0.0 112.395 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.412 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 62.0 2.35 3.72 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-N 113.662 -1.608 . . . . 0.0 116.582 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.461 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -87.33 -14.17 41.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.457 ' OD1' HG22 ' A' ' 86' ' ' THR . 7.3 t0 65.15 120.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.06 1.744 . . . . 0.0 111.602 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.466 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 41.7 ttm -119.36 8.54 11.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.209 1.004 . . . . 0.0 110.926 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.457 HG22 ' OD1' ' A' ' 84' ' ' ASP . 10.5 t -46.12 -28.43 1.21 Allowed 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 125.793 1.637 . . . . 0.0 114.743 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 ttp -159.86 92.39 1.02 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.466 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.1 p -148.5 151.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 38' ' ' ASP . 18.4 p -70.28 157.06 38.39 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.308 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.603 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.4 t60 -57.59 -43.56 84.72 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -58.9 -47.3 85.49 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.954 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -36.8 64.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.631 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.14 -40.67 94.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.711 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 7.9 mmm180 -53.45 -39.77 64.7 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.597 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.406 ' HB3' ' HZ3' ' A' ' 95' ' ' LYS . 2.8 mmmp? -81.19 13.93 2.61 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.383 -176.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 22.9 tpt180 -131.37 -35.8 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.865 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -98.86 -27.78 13.76 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.619 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 t -113.53 13.05 18.73 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.048 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HD2' ' HG2' ' A' ' 102' ' ' GLU . 14.4 ptpt -67.64 157.36 34.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 165.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -112.91 8.92 18.77 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.418 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -81.18 -31.28 34.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.465 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 18.6 mm-40 -87.15 146.12 26.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -94.18 -75.41 0.51 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.566 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.453 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 2.0 p -109.73 133.86 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-O 121.141 0.496 . . . . 0.0 110.012 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.408 HG21 ' CD2' ' A' ' 29' ' ' LEU . 16.7 m -132.3 162.99 38.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.511 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.415 ' C ' HD11 ' A' ' 107' ' ' LEU . 97.7 mtt180 -123.91 117.57 25.12 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.453 HD12 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -119.61 152.34 37.21 Favored 'General case' 0 N--CA 1.397 -3.122 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -175.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.9 mp -116.92 131.07 57.05 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.488 HG21 ' NE2' ' A' ' 14' ' ' GLN . 20.8 m -131.91 153.96 39.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 123.976 0.797 . . . . 0.0 109.889 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.443 HG23 HG21 ' A' ' 13' ' ' VAL . 36.9 p . . . . . 0 N--CA 1.419 -1.984 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.435 -1.214 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.05 142.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.521 HE22 ' HB ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -144.84 153.85 42.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -99.27 138.47 36.32 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.521 ' HB ' HE22 ' A' ' 14' ' ' GLN . 7.4 p -122.6 157.13 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.6 106.27 5.36 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.478 0.656 . . . . 0.0 110.959 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -93.59 127.44 45.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.914 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.412 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 43.9 m170 -95.92 160.09 14.64 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 124.159 0.912 . . . . 0.0 109.311 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 17.6 ptpt -43.13 110.15 0.18 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.504 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 33.2 tp -107.96 115.4 30.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -104.73 103.0 12.55 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.61 -174.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -104.24 108.57 20.01 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.35 -106.34 1.31 Allowed Glycine 0 C--N 1.311 -0.825 0 O-C-N 123.635 0.584 . . . . 0.0 112.846 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.09 6.63 20.98 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.771 0.319 . . . . 0.0 111.47 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.69 170.82 8.3 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.544 0.688 . . . . 0.0 109.294 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.44 121.73 35.69 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -129.5 155.81 41.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 40.6 mt -86.25 5.0 36.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.777 0.798 . . . . 0.0 109.331 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . 90.36 -46.97 3.04 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 114.388 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.417 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 46.1 p90 -86.93 161.6 18.16 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 43.6 m -115.62 165.9 12.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.116 1.366 . . . . 0.0 108.705 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.487 HD13 HD13 ' A' ' 55' ' ' ILE . 8.9 pt -126.18 165.35 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.678 0.217 . . . . 0.0 110.491 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.11 -32.61 3.45 Favored Glycine 0 CA--C 1.484 -1.893 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.512 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.44 154.02 8.87 Favored Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.325 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.522 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -100.32 -122.83 4.97 Favored Glycine 0 N--CA 1.418 -2.506 0 O-C-N 124.298 0.646 . . . . 0.0 113.478 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -22.93 31.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 16.8 t70 -66.99 -19.4 65.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.818 0.818 . . . . 0.0 110.424 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.618 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 15.5 mm-40 -96.26 -169.55 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.068 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -136.17 125.5 15.85 Favored Pre-proline 0 CA--C 1.493 -1.216 0 CA-C-O 118.855 -0.593 . . . . 0.0 109.809 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 20.9 Cg_endo -58.9 -24.5 72.92 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.739 2.293 . . . . 0.0 113.683 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.1 t -73.25 -32.46 64.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.216 0.531 . . . . 0.0 109.829 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.93 16.33 20.38 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.01 0.434 . . . . 0.0 111.246 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.487 HD22 ' HB3' ' A' ' 39' ' ' GLN . 3.6 m120 -102.4 140.12 20.84 Favored Pre-proline 0 CA--C 1.485 -1.538 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.412 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.03 -46.15 2.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.434 2.09 . . . . 0.0 113.38 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -120.61 31.52 6.41 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.584 ' HA ' ' NZ ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.312 -1.064 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.011 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 55.8 mtmt . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 121.001 0.429 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 153.65 156.54 7.67 Favored Glycine 0 C--O 1.183 -3.067 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 36' ' ' GLY . 31.4 mm -71.91 129.06 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.215 1.008 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.43 160.59 38.29 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' SER . 87.1 t -86.01 132.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 O-C-N 125.205 1.566 . . . . 0.0 109.872 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 p -104.54 -27.14 12.06 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.798 0.808 . . . . 0.0 111.026 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -144.42 133.28 22.52 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.417 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 33.8 m -97.72 -175.5 0.37 Allowed 'Isoleucine or valine' 1 N--CA 1.347 -5.602 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.465 ' OG ' ' HA3' ' A' ' 30' ' ' GLY . 0.9 OUTLIER -68.09 126.37 29.29 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.34 -25.14 1.45 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.838 1.255 . . . . 0.0 112.981 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.71 57.96 0.1 Allowed Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -139.83 -168.69 11.4 Favored Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.594 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.95 -34.49 95.12 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 124.35 3.367 . . . . 0.0 113.095 -170.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.76 11.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -75.48 -21.51 58.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.933 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 64' ' ' GLY . 28.1 mm -67.56 -42.07 86.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.467 0.651 . . . . 0.0 109.651 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.46 -42.82 21.95 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.297 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.29 20.75 0.89 Allowed Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.398 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.94 117.21 17.42 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.583 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 24.5 mm-40 -111.9 135.7 52.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.242 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.1 mt -53.69 143.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 124.199 1.0 . . . . 0.0 111.246 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.64 36.66 58.3 Favored Glycine 0 N--CA 1.48 1.576 0 CA-C-O 122.725 1.181 . . . . 0.0 111.485 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.608 ' HB2' ' HB ' ' A' ' 109' ' ' VAL . 22.2 p-10 -84.92 -52.44 6.0 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 126.183 1.793 . . . . 0.0 114.492 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.584 ' NZ ' ' HA ' ' A' ' 47' ' ' SER . 55.7 mttm 70.46 100.77 0.06 Allowed 'General case' 0 C--O 1.249 1.043 0 C-N-CA 124.624 1.17 . . . . 0.0 108.01 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.0 mt -83.87 130.47 35.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.006 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.463 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 3.4 mmt -109.97 -22.83 11.64 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.376 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.54 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -143.25 134.19 25.5 Favored 'General case' 0 C--O 1.199 -1.58 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -175.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.486 HG22 HD22 ' A' ' 107' ' ' LEU . 40.2 t -140.19 115.11 7.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 48.14 50.15 16.54 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 125.668 1.587 . . . . 0.0 112.806 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.54 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 66.31 -11.84 0.5 Allowed Glycine 0 CA--C 1.565 3.17 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -21.67 58.27 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.235 1.018 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t0 72.92 113.93 0.06 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 125.301 1.44 . . . . 0.0 109.137 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 tpt -94.2 -8.45 39.28 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.997 -167.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -49.89 125.56 12.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.763 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.9 ttt 53.89 80.87 0.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.91 1.284 . . . . 0.0 113.373 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.15 147.9 18.33 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.7 p -69.33 156.83 38.14 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.987 0.515 . . . . 0.0 110.992 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.618 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.5 t60 -56.48 -41.44 76.59 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.564 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 23.2 t70 -60.16 -53.73 54.3 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 124.045 0.84 . . . . 0.0 111.183 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -31.02 70.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.156 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.679 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.64 -48.23 67.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.462 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.508 ' CZ ' HG23 ' A' ' 98' ' ' THR . 20.3 mmm180 -56.62 -44.13 80.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.801 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 30.0 mmtp -80.83 28.4 0.35 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.385 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -144.61 -45.85 0.24 Allowed 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.4 pp -92.43 -35.2 13.8 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.563 ' N ' HD13 ' A' ' 97' ' ' LEU . 12.1 t -103.08 9.2 38.59 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.334 -1.346 . . . . 0.0 109.235 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -62.91 148.86 46.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -96.0 15.09 21.55 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.832 0.825 . . . . 0.0 110.974 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.429 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 67.7 m -93.66 -25.96 17.26 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.947 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -77.12 -178.62 5.12 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.774 0.797 . . . . 0.0 113.086 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 10.1 pt-20 -146.64 -73.27 0.22 Allowed 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.019 169.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.6 p -119.51 134.37 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.454 ' CG2' HD23 ' A' ' 107' ' ' LEU . 16.8 m -140.01 149.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.088 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -104.39 127.29 52.04 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.486 HD22 HG22 ' A' ' 80' ' ' VAL . 3.3 mt -122.46 147.51 46.25 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.517 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 6.9 mp -113.54 124.13 51.64 Favored 'General case' 0 CA--C 1.452 -2.801 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 75' ' ' ASP . 35.8 m -124.79 153.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.543 -177.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.0 p . . . . . 0 C--N 1.276 -2.597 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 176.235 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 110' ' ' THR . 59.4 t . . . . . 0 N--CA 1.423 -1.785 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 12.3 p -99.65 133.65 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.5 154.08 40.31 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.872 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.69 148.29 22.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.94 0.4 . . . . 0.0 109.961 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -129.14 157.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 38.1 tt0 -150.31 106.38 3.45 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.579 0.704 . . . . 0.0 109.809 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -94.69 130.14 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.3 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -101.57 141.16 34.85 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.916 0.76 . . . . 0.0 109.111 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 103' ' ' GLU . 18.0 ptpt -29.59 112.24 0.07 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.98 1.712 . . . . 0.0 115.401 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 38.0 tp -113.67 121.02 42.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.1 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -97.91 112.47 24.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -114.34 106.22 14.07 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.14 -108.69 2.28 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 123.732 0.645 . . . . 0.0 112.425 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.74 16.67 18.48 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.42 168.98 13.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.82 118.5 28.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -126.89 158.13 37.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.085 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' A' ' 105' ' ' VAL . 9.2 mp -86.43 -1.53 57.65 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.763 0.792 . . . . 0.0 109.744 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.98 3.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.38 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -96.5 171.61 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.582 0.691 . . . . 0.0 112.19 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.455 ' O ' HG21 ' A' ' 57' ' ' VAL . 47.1 m -138.71 169.17 18.28 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.863 1.265 . . . . 0.0 110.404 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.519 HD12 HD13 ' A' ' 55' ' ' ILE . 7.1 pt -126.82 169.45 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.129 -0.357 . . . . 0.0 110.762 -170.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.92 -24.76 5.65 Favored Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.565 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 120.4 163.2 12.05 Favored Glycine 0 C--O 1.195 -2.331 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.632 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.551 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -114.97 -115.03 3.02 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.888 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.81 -24.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.251 0.548 . . . . 0.0 111.996 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HB2' HG21 ' A' ' 89' ' ' THR . 32.8 t70 -72.54 -17.75 61.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.89 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.565 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 28.3 mm-40 -104.18 166.75 10.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -106.43 121.23 45.97 Favored Pre-proline 0 CA--C 1.492 -1.256 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.257 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -57.2 -30.02 85.73 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.88 2.387 . . . . 0.0 113.298 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.9 m -65.75 -27.24 68.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.999 0.428 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.42 11.91 15.06 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.391 0.615 . . . . 0.0 110.465 -175.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -103.97 146.04 31.78 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.44 -44.13 6.96 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 123.68 2.92 . . . . 0.0 113.753 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.46 14.45 21.45 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.215 0.531 . . . . 0.0 110.115 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.4 t . . . . . 0 N--CA 1.426 -1.661 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.502 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.528 0.68 . . . . 0.0 109.283 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.451 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 145.01 159.63 8.17 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 36' ' ' GLY . 36.1 mm -77.92 122.16 32.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-N 118.126 0.963 . . . . 0.0 109.502 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.4 p90 -122.31 151.9 40.66 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.363 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 32' ' ' SER . 8.7 p -80.82 132.35 31.83 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 O-C-N 124.769 1.293 . . . . 0.0 110.69 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 p -106.75 -27.25 10.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.435 0.636 . . . . 0.0 110.686 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -138.13 131.46 30.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.05 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 71' ' ' LEU . 64.8 t -118.9 140.6 42.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 174.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.71 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.5 t -63.66 116.91 6.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 pt-20 -77.27 2.99 14.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.837 0.827 . . . . 0.0 112.024 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.63 29.94 0.94 Allowed Glycine 0 C--N 1.267 -3.265 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -128.14 -177.88 15.08 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.075 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.55 -29.01 70.3 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 124.366 3.377 . . . . 0.0 112.791 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.77 -59.19 5.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.477 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.71 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.6 pt-20 -74.06 -31.88 63.05 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.387 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 64' ' ' GLY . 26.3 mm -55.11 -41.37 59.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 O-C-N 123.737 0.648 . . . . 0.0 110.471 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.05 -55.92 5.15 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.319 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.54 28.69 0.04 OUTLIER Glycine 0 C--N 1.317 -0.501 0 C-N-CA 119.768 -1.206 . . . . 0.0 113.239 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.489 ' HB2' HG13 ' A' ' 16' ' ' VAL . 2.5 tp -94.55 117.56 30.32 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -115.39 143.81 44.73 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.419 ' HA ' HG12 ' A' ' 57' ' ' VAL . 65.6 mt -54.89 129.67 16.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.004 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.02 -3.95 45.03 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.706 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 84.0 m-20 -80.94 130.23 34.92 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.909 0.355 . . . . 0.0 110.571 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.46 116.11 22.92 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.411 HG13 HG12 ' A' ' 109' ' ' VAL . 3.0 mp -86.27 124.34 40.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.5 mmt -102.27 -19.88 14.86 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.313 0.577 . . . . 0.0 111.116 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 50.2 tp60 -148.47 134.84 19.52 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.91 -171.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.492 HG22 HD23 ' A' ' 107' ' ' LEU . 54.8 t -142.62 108.84 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.0 0.52 . . . . 0.0 111.974 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.4 t-20 55.18 39.43 31.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.297 1.439 . . . . 0.0 112.715 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.32 4.79 83.34 Favored Glycine 0 C--N 1.294 -1.771 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.23 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.486 ' NE1' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -116.7 148.32 41.17 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.94 122.76 28.69 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 40.2 ttm -108.98 -0.92 19.34 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.044 0.926 . . . . 0.0 110.515 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t -58.79 -34.63 71.69 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.657 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.1 ttt -140.72 95.36 2.85 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.437 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 9.7 p -160.1 151.15 5.77 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.449 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.465 HG21 ' HB2' ' A' ' 38' ' ' ASP . 10.4 p -71.41 158.33 36.5 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.542 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 22.2 t60 -56.11 -43.6 78.3 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.124 175.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.15 -49.54 76.8 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.96 0.788 . . . . 0.0 111.399 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -31.77 68.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.421 ' O ' HD11 ' A' ' 97' ' ' LEU . . . -75.21 -40.62 59.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.509 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 15.9 mmt180 -53.04 -47.34 68.47 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.681 0.613 . . . . 0.0 111.023 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.412 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 63.1 tttm -86.24 39.14 0.8 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.666 1.222 . . . . 0.0 108.921 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.486 ' HG2' ' NE1' ' A' ' 83' ' ' TRP . 30.7 tpt180 -145.76 -45.99 0.21 Allowed 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.147 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.509 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -92.45 -26.95 17.75 Favored 'General case' 0 C--O 1.208 -1.104 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.326 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.0 t -117.43 14.79 14.7 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.455 ' CD ' ' HB2' ' A' ' 101' ' ' SER . 13.6 ptpt -74.08 171.06 14.22 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -113.8 -0.36 14.23 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.034 0.445 . . . . 0.0 111.897 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.455 ' HB2' ' CD ' ' A' ' 99' ' ' LYS . 69.8 m -76.72 -28.46 55.82 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.442 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 33.9 mm-40 -81.84 179.19 7.92 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.117 0.484 . . . . 0.0 110.696 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.431 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 7.6 pt-20 -146.42 -70.14 0.25 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 44.0 t -105.99 126.63 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 30.6 m -128.49 134.68 64.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 123.626 0.579 . . . . 0.0 111.014 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -103.56 116.52 32.52 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.492 HD23 HG22 ' A' ' 80' ' ' VAL . 5.9 mt -114.39 161.43 17.95 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -134.77 121.61 20.95 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 32.7 m -113.39 156.27 14.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.662 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.5 p . . . . . 1 N--CA 1.371 -4.414 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.424 -1.774 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.0 p -93.33 126.31 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.511 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -130.52 154.41 47.83 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.98 -174.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.424 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 3.1 ppt_? -97.06 145.57 25.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 71' ' ' LEU . 7.9 p -133.97 149.03 30.13 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.94 103.06 5.87 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.548 0.689 . . . . 0.0 111.291 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -91.72 126.79 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.482 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -96.26 150.51 20.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HB2' HD23 ' A' ' 27' ' ' LEU . 21.5 pttm -43.37 121.72 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.6 tp -122.59 123.91 42.28 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.566 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.9 126.84 33.83 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.418 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 21.8 mt-30 -128.4 111.4 13.28 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 175.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.55 -105.81 1.69 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -122.73 15.24 10.17 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.39 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.81 171.16 7.66 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 20' ' ' LYS . 1.9 tm? -122.84 109.42 14.16 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.05 164.35 19.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.2 mp -88.08 3.69 48.1 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.056 0.931 . . . . 0.0 109.62 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 87.64 -42.2 3.11 Favored Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.676 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -90.4 166.48 13.26 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 20.3 m -120.5 167.82 11.98 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.404 1.481 . . . . 0.0 108.894 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.513 HD13 HD11 ' A' ' 55' ' ' ILE . 11.4 pt -127.4 167.13 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 110.988 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.95 -27.1 5.0 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.99 157.97 10.17 Favored Glycine 0 C--O 1.196 -2.274 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.856 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.02 -115.9 4.1 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.577 0.81 . . . . 0.0 113.486 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.597 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.74 -26.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -173.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.73 -18.39 65.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.752 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.508 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 24.4 mm-40 -98.58 164.83 12.09 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.806 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -119.8 118.91 31.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 10.2 Cg_endo -54.0 -26.04 39.02 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.732 2.955 . . . . 0.0 113.731 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 t -66.32 -26.79 67.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.05 4.37 10.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.26 0.553 . . . . 0.0 111.431 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.422 HD21 ' HA ' ' A' ' 44' ' ' ASN . 5.9 m120 -90.62 149.57 40.9 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 -50.52 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 123.439 2.759 . . . . 0.0 113.131 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.12 -3.48 19.88 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.692 0.758 . . . . 0.0 111.52 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 6.1 t . . . . . 0 C--N 1.291 -1.976 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.758 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.597 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 56.4 mttm . . . . . 0 N--CA 1.447 -0.611 0 CA-C-O 121.362 0.601 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.4 156.17 7.19 Favored Glycine 0 C--O 1.191 -2.548 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.513 HD11 HD13 ' A' ' 33' ' ' ILE . 18.5 mm -74.41 129.21 36.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 118.207 1.003 . . . . 0.0 110.332 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -130.71 154.06 48.35 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.197 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.438 HG21 HD11 ' A' ' 71' ' ' LEU . 90.8 t -77.22 135.54 26.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 124.591 1.182 . . . . 0.0 110.369 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 p -111.02 -19.93 12.59 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.22 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.438 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 20.4 mtm180 -152.73 138.19 17.65 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 71' ' ' LEU . 15.5 m -106.22 -173.3 0.42 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.046 0 CA-C-N 119.252 0.933 . . . . 0.0 108.632 172.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.604 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.8 t -87.74 118.0 26.95 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.26 -14.59 27.39 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.69 33.41 0.63 Allowed Glycine 0 C--N 1.286 -2.219 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.496 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -118.92 -169.76 14.51 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.521 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.93 -29.6 67.13 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.761 2.974 . . . . 0.0 112.373 -170.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.03 -64.87 0.73 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.611 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.2 pt-20 -72.19 -31.89 66.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.506 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 mm -57.08 -39.86 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.335 0.397 . . . . 0.0 110.997 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.91 16.02 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.851 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.59 17.75 0.2 Allowed Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.402 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.47 ' HB2' HG22 ' A' ' 16' ' ' VAL . 5.5 tp -89.46 124.05 34.13 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -115.37 157.99 23.09 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 122.197 0.998 . . . . 0.0 111.175 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.5 mt -61.84 128.3 23.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.914 172.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.97 4.8 56.63 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -82.55 121.82 27.29 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.204 0.526 . . . . 0.0 111.661 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -83.56 99.98 10.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.876 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 mt -79.28 128.24 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.423 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 1.1 mmt -112.17 -18.91 12.45 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.47 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -148.47 137.97 22.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.461 HG23 HD23 ' A' ' 107' ' ' LEU . 37.8 t -139.73 120.88 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 50.44 40.13 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.24 1.416 . . . . 0.0 112.471 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.47 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 62.98 16.21 57.03 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 114.226 -1.352 . . . . 0.0 114.783 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.419 ' HE1' ' HE1' ' A' ' 85' ' ' MET 0.307 0.0 OUTLIER -91.17 -82.89 0.28 Allowed 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 118.742 -0.646 . . . . 0.0 112.255 -179.797 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.4 t70 168.41 127.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.457 ' HG3' ' HB ' ' A' ' 55' ' ' ILE . 47.3 tpp -128.3 1.0 5.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 122.709 1.242 . . . . 0.0 109.907 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 t -80.73 -29.5 36.34 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.629 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.6 ttp -133.01 75.25 1.61 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.78 -0.575 . . . . 0.0 110.409 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.403 HG11 ' SD ' ' A' ' 85' ' ' MET . 9.1 p -151.52 150.51 13.13 Favored 'Isoleucine or valine' 0 C--O 1.259 1.574 0 CA-C-O 121.252 0.549 . . . . 0.0 110.232 -176.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 p -73.29 157.85 36.25 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.999 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.508 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.3 t60 -56.74 -43.11 80.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.655 174.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.88 -50.72 72.94 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 124.357 1.063 . . . . 0.0 111.996 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -39.4 76.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.958 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.663 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.071 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.426 ' CZ ' HG22 ' A' ' 98' ' ' THR . 15.6 mmm180 -55.53 -38.7 69.59 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.238 0.542 . . . . 0.0 110.469 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -86.98 24.44 1.52 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.515 0.674 . . . . 0.0 109.215 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 19.1 mmt180 -137.23 -48.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.751 0.82 . . . . 0.0 110.984 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -96.76 -20.49 18.18 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.509 ' N ' HD11 ' A' ' 97' ' ' LEU . 15.1 t -117.94 12.7 13.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.854 -1.538 . . . . 0.0 110.586 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.8 ptpt -68.49 -173.63 0.45 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -133.4 6.55 3.83 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.587 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 10.4 m -80.24 -40.48 26.93 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.131 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.06 152.28 22.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 104' ' ' VAL . 9.7 pt-20 -104.06 -63.42 1.2 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.932 0.396 . . . . 0.0 110.678 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.0 p -118.81 132.5 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 CA-C-O 121.323 0.582 . . . . 0.0 110.929 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.426 ' CG2' HD21 ' A' ' 107' ' ' LEU . 19.6 m -135.51 155.17 36.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.507 -174.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.51 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 3.3 mpt_? -107.2 126.29 52.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.461 HD23 HG23 ' A' ' 80' ' ' VAL . 5.2 mt -119.91 146.84 45.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.17 122.56 46.44 Favored 'General case' 0 C--N 1.265 -3.09 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.511 HG22 ' NE2' ' A' ' 14' ' ' GLN . 11.1 m -123.25 152.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.661 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p . . . . . 0 C--N 1.28 -2.442 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.438 HG22 HG22 ' A' ' 110' ' ' THR . 21.9 t -95.48 117.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 156.02 43.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -173.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -94.52 151.79 19.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.945 0.402 . . . . 0.0 111.057 -174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 71' ' ' LEU . 3.1 t -131.51 151.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 174.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -147.11 104.16 3.65 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.546 0.688 . . . . 0.0 109.784 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -88.08 127.12 41.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.093 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.1 m170 -108.81 111.64 23.48 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.852 0.72 . . . . 0.0 110.918 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 13.9 ptpt 25.81 97.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 165.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.57 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 41.9 tp -112.25 118.88 36.52 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.617 -0.677 . . . . 0.0 109.765 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -102.55 102.92 13.22 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.361 0.6 . . . . 0.0 110.019 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -108.7 112.65 25.06 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.96 -103.51 0.65 Allowed Glycine 0 C--N 1.303 -1.263 0 O-C-N 124.262 0.976 . . . . 0.0 112.272 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -118.45 20.49 13.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 123.319 0.648 . . . . 0.0 110.538 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.52 177.12 7.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.449 0.642 . . . . 0.0 110.175 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -124.77 121.38 34.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.57 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -128.55 164.37 30.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.1 mp -93.75 0.92 56.59 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.724 0.774 . . . . 0.0 110.13 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.78 -35.68 3.9 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 115.152 0.821 . . . . 0.0 115.152 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -102.95 165.47 11.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 23.0 m -133.26 168.36 18.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.305 1.442 . . . . 0.0 110.24 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.493 HD12 HD11 ' A' ' 55' ' ' ILE . 6.4 pt -126.75 172.73 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-O 120.525 0.203 . . . . 0.0 111.488 -168.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.32 -5.6 12.8 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.612 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 107.57 -178.98 21.92 Favored Glycine 1 N--CA 1.393 -4.181 0 CA-C-N 114.546 -0.827 . . . . 0.0 111.904 -177.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.629 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -131.58 -79.09 0.17 Allowed Glycine 0 N--CA 1.405 -3.411 0 O-C-N 124.886 0.991 . . . . 0.0 114.293 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.496 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -101.57 -25.85 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.469 ' HB2' HG22 ' A' ' 89' ' ' THR . 10.7 t70 -71.99 -20.69 61.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.35 1.071 . . . . 0.0 109.636 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.539 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -105.88 142.71 35.14 Favored 'General case' 0 N--CA 1.393 -3.319 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.786 -173.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.9 t70 -88.53 125.61 62.78 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.9 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.408 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.2 Cg_endo -56.28 -31.3 83.97 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.93 2.42 . . . . 0.0 113.486 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -68.89 -29.34 67.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.249 0.547 . . . . 0.0 111.075 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.534 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.4 pt20 -109.42 8.0 25.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.673 0.749 . . . . 0.0 111.293 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.54 149.31 35.76 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.788 -177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.65 -52.75 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.115 2.544 . . . . 0.0 113.156 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -107.87 21.93 16.69 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.1 t . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.363 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 83.9 mttt . . . . . 0 C--O 1.24 0.564 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.5 139.91 4.86 Favored Glycine 0 C--O 1.183 -3.084 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.629 HD13 ' N ' ' A' ' 36' ' ' GLY . 28.7 mm -55.08 130.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -170.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.481 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -125.7 149.86 48.14 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.188 177.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.455 HG22 HD11 ' A' ' 71' ' ' LEU . 95.9 t -83.22 132.99 30.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 124.36 1.037 . . . . 0.0 110.805 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.0 p -112.66 -20.26 11.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.34 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 4.3 mmm180 -140.43 132.84 28.46 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.426 HG12 ' CB ' ' A' ' 66' ' ' ALA . 53.4 t -127.22 142.8 42.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.669 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.4 m -62.1 105.3 0.57 Allowed 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 123.892 0.745 . . . . 0.0 112.363 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.41 -28.28 0.34 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 129.168 2.987 . . . . 0.0 113.545 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.2 29.52 2.05 Favored Glycine 0 C--N 1.296 -1.643 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -113.06 -175.47 19.36 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.051 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 45.7 Cg_endo -64.6 -27.0 61.28 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.01 3.14 . . . . 0.0 111.767 -171.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' CB ' HG12 ' A' ' 60' ' ' VAL . . . -58.15 -59.89 4.6 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.842 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.5 pt-20 -82.63 -20.7 35.82 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.746 -1.582 . . . . 0.0 113.107 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 64' ' ' GLY . 24.5 mm -61.12 -35.59 66.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.68 -54.7 5.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.373 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 151.71 25.63 0.05 OUTLIER Glycine 0 C--O 1.225 -0.422 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.608 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.503 ' HB2' HG13 ' A' ' 16' ' ' VAL . 5.2 tp -95.95 125.41 40.48 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.462 ' N ' HD13 ' A' ' 71' ' ' LEU . 22.6 mm-40 -113.66 165.18 12.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 122.043 0.925 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.3 mt -75.37 125.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.4 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.19 0.62 41.22 Favored Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.197 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 72' ' ' GLN . 14.0 m-20 -79.97 123.86 28.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.481 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 35.1 mtmt -93.04 125.36 37.59 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.445 HD13 ' CG2' ' A' ' 57' ' ' VAL . 2.5 mp -96.45 131.81 42.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -171.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.441 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 9.0 mmt -107.12 -25.92 11.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.123 0.487 . . . . 0.0 110.649 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 19.6 tp60 -140.82 128.67 21.78 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.467 HG22 HD21 ' A' ' 107' ' ' LEU . 53.3 t -140.78 113.92 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 C-N-CA 123.382 0.673 . . . . 0.0 110.159 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 55.69 43.54 27.86 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.234 1.014 . . . . 0.0 112.564 171.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.19 -4.18 55.61 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.962 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.496 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -104.33 146.92 28.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -81.36 112.88 19.05 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.837 0.827 . . . . 0.0 111.056 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.496 ' HE2' ' HE1' ' A' ' 83' ' ' TRP . 61.7 tpp -89.05 -8.2 54.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.531 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -70.42 137.3 50.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.6 ttt 53.98 75.06 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.871 0.868 . . . . 0.0 112.849 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.79 149.95 12.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -70.39 154.99 41.29 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 123.269 0.628 . . . . 0.0 112.204 -178.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -56.8 -44.28 81.77 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.715 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.14 -52.59 64.68 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.869 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.33 -32.12 73.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.942 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.599 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -78.21 -37.26 45.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.843 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.465 ' CZ ' HG23 ' A' ' 98' ' ' THR . 16.6 mmm180 -53.98 -44.11 70.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.407 0.622 . . . . 0.0 110.546 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -85.14 32.56 0.54 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.878 0.847 . . . . 0.0 110.473 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.524 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.3 tpp180 -143.21 -43.3 0.29 Allowed 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.604 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -101.69 -20.94 14.78 Favored 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.465 HG23 ' CZ ' ' A' ' 94' ' ' ARG . 13.7 t -116.44 15.38 15.71 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.683 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.1 ptpt -62.61 158.67 17.67 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.074 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -114.06 6.28 16.36 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.647 0.737 . . . . 0.0 110.531 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.413 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 19.8 m -79.4 -34.39 41.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.339 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.6 144.19 31.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.471 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -100.55 -53.43 3.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.192 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.0 p -121.04 128.58 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.705 0.764 . . . . 0.0 112.565 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.6 m -126.99 146.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.741 -174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -100.46 115.22 29.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.467 HD21 HG22 ' A' ' 80' ' ' VAL . 12.5 mt -114.52 159.95 19.79 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.2 mp -137.56 123.57 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.59 159.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.538 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.438 HG22 HG22 ' A' ' 13' ' ' VAL . 76.2 p . . . . . 0 N--CA 1.425 -1.713 0 CA-C-O 121.298 0.57 . . . . 0.0 111.495 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.3 141.02 19.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.4 148.96 31.85 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.49 28.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -126.24 152.89 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.43 101.4 4.1 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.41 0.624 . . . . 0.0 109.88 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -85.54 122.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.317 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 46.2 m170 -94.46 145.84 24.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 124.123 0.889 . . . . 0.0 109.549 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -31.64 113.18 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 115.035 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.434 HD21 ' CD ' ' A' ' 65' ' ' PRO . 50.1 tp -120.51 117.73 28.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.879 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -96.27 116.97 29.87 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -109.77 106.86 16.64 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.62 -105.31 1.27 Allowed Glycine 0 N--CA 1.432 -1.604 0 O-C-N 123.842 0.714 . . . . 0.0 111.319 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -109.6 -3.58 16.79 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.94 167.81 9.96 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -172.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.92 122.26 44.79 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -133.79 155.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.27 1.36 37.08 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.107 0.956 . . . . 0.0 109.792 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 89.35 -43.58 3.04 Favored Glycine 0 N--CA 1.42 -2.381 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.708 176.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 41.5 p90 -91.35 164.7 13.75 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.6 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 87.2 p -113.83 179.93 3.82 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.344 1.057 . . . . 0.0 109.676 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.547 HD11 HD12 ' A' ' 55' ' ' ILE . 6.6 pt -138.32 166.73 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.19 -23.01 6.25 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.554 ' C ' HD11 ' A' ' 55' ' ' ILE . . . 126.9 171.24 13.03 Favored Glycine 0 CA--C 1.476 -2.382 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.16 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -119.92 -117.52 2.63 Favored Glycine 0 C--O 1.208 -1.482 0 O-C-N 124.445 0.732 . . . . 0.0 112.841 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -65.33 -25.68 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.99 -16.77 63.81 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.329 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.545 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 28.4 mm-40 -98.94 163.3 12.65 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.893 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 1.3 m-20 -91.47 107.52 22.45 Favored Pre-proline 0 CA--C 1.489 -1.376 0 C-N-CA 124.507 1.123 . . . . 0.0 111.787 175.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 25.9 Cg_endo -64.16 -20.9 67.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.589 2.192 . . . . 0.0 110.442 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m -63.52 -32.44 73.9 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 113.921 -1.491 . . . . 0.0 110.222 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -122.8 4.98 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.792 0.806 . . . . 0.0 112.876 -170.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -95.38 144.81 28.43 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.09 -40.23 11.98 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.794 2.996 . . . . 0.0 113.756 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.404 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 41.3 m-85 -119.59 21.29 12.13 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.969 0.89 . . . . 0.0 108.991 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.423 -1.787 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.649 177.413 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.3 mtmm . . . . . 0 N--CA 1.422 -1.843 0 CA-C-O 121.562 0.696 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.9 163.31 11.03 Favored Glycine 0 C--O 1.181 -3.174 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.554 HD11 ' C ' ' A' ' 35' ' ' GLY . 36.4 mm -72.0 127.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 118.767 1.283 . . . . 0.0 110.634 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -127.64 151.77 48.52 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.41 HG22 HD13 ' A' ' 71' ' ' LEU . 85.9 t -79.89 133.34 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 124.426 1.079 . . . . 0.0 110.369 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.404 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 9.3 p -106.11 -22.38 12.88 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.285 0.564 . . . . 0.0 110.75 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.6 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.7 mmt180 -155.13 140.25 17.47 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.193 1.397 . . . . 0.0 107.73 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.429 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 20.6 m -106.88 -176.41 0.57 Allowed 'Isoleucine or valine' 1 N--CA 1.346 -5.657 0 CA-C-N 118.985 0.811 . . . . 0.0 109.714 173.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.493 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 2.8 t -75.82 114.78 14.81 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 173.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.82 -30.26 44.38 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.939 0.775 . . . . 0.0 112.614 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.39 48.13 0.55 Allowed Glycine 0 CA--C 1.484 -1.884 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.493 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -129.3 -165.64 11.74 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.634 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.434 ' CD ' HD21 ' A' ' 21' ' ' LEU . 42.4 Cg_endo -64.9 -28.45 58.49 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.4 2.733 . . . . 0.0 112.177 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.39 -62.37 1.82 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.66 -30.43 67.04 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.173 0.296 . . . . 0.0 111.418 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.0 mm -64.73 -39.07 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.357 0.598 . . . . 0.0 111.299 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.89 -47.65 16.1 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.61 14.14 0.24 Allowed Glycine 0 C--N 1.311 -0.832 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.846 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.521 ' HB2' HG13 ' A' ' 16' ' ' VAL . 8.1 tp -86.44 124.43 32.76 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -116.87 159.29 22.61 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 122.146 0.974 . . . . 0.0 111.029 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.97 125.44 21.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.902 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.83 35.11 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.206 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.43 124.11 23.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-O 120.817 0.341 . . . . 0.0 110.544 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -86.63 119.36 26.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.54 122.85 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.406 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 25.5 mmt -101.8 -13.25 17.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.44 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -161.53 132.46 5.23 Favored 'General case' 0 C--O 1.2 -1.551 0 O-C-N 121.989 -0.445 . . . . 0.0 110.007 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.501 HG22 HD21 ' A' ' 107' ' ' LEU . 50.5 t -131.92 125.5 55.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.601 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 49.3 43.26 22.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.79 1.236 . . . . 0.0 112.269 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.412 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 63.72 12.57 48.03 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 114.15 -1.386 . . . . 0.0 114.977 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.421 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -97.12 -8.64 29.69 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 71.77 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.861 0.864 . . . . 0.0 110.637 -173.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 tpt -120.73 -0.92 10.08 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.563 0.697 . . . . 0.0 109.689 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 t -66.63 -15.98 63.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.842 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.5 ttt -150.28 93.94 2.06 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.042 0.448 . . . . 0.0 110.394 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.96 149.51 12.24 Favored 'Isoleucine or valine' 0 C--O 1.259 1.561 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.3 p -72.33 155.75 39.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 122.632 0.373 . . . . 0.0 110.652 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.527 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 17.7 t60 -53.58 -44.25 69.19 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.859 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.59 -43.96 92.18 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.126 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -35.23 68.18 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.209 0.528 . . . . 0.0 111.423 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -68.59 -42.88 77.57 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.432 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -55.7 -38.61 69.93 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.619 0.723 . . . . 0.0 109.092 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.419 ' O ' ' HE3' ' A' ' 99' ' ' LYS . 47.2 tttp -81.15 18.29 1.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.972 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.524 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 34.1 mtt-85 -137.74 -37.19 0.61 Allowed 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -102.12 -23.13 14.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.474 ' N ' HD11 ' A' ' 97' ' ' LEU . 13.9 t -111.66 12.0 21.13 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.398 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.3 ptpt -69.97 176.95 3.4 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.527 169.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -119.88 -0.13 10.72 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.552 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.8 m -82.81 -36.95 25.13 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.81 115.19 27.19 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.643 0.735 . . . . 0.0 110.491 -174.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -75.16 -68.11 0.59 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.725 -173.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.1 p -121.28 125.5 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.421 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.44 147.13 32.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.909 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -97.93 116.72 30.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.054 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.501 HD21 HG22 ' A' ' 80' ' ' VAL . 11.9 mt -112.76 152.41 29.15 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.97 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mp -126.38 126.0 43.14 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 122.661 0.384 . . . . 0.0 110.146 174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 m -122.05 149.64 25.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 p . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.585 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.465 0.298 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.458 HG23 HG23 ' A' ' 110' ' ' THR . 11.7 t -97.19 137.0 26.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.415 ' NE2' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -138.48 151.18 47.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 5.0 ppt_? -96.24 155.1 16.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.036 0.446 . . . . 0.0 111.111 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -133.71 154.5 38.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -150.53 105.63 3.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.125 0.488 . . . . 0.0 109.781 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -90.94 127.61 43.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.393 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -96.24 134.44 39.34 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HB2' HD22 ' A' ' 27' ' ' LEU . 23.3 pttm -29.34 121.8 0.15 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -120.79 125.85 48.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.899 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -91.15 125.79 36.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.416 ' NE2' HD11 ' A' ' 28' ' ' ILE . 33.1 mt-30 -130.37 105.67 8.04 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.29 -115.82 6.67 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.16 -0.82 49.54 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.469 0.308 . . . . 0.0 110.297 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.78 174.81 5.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.869 0.842 . . . . 0.0 111.08 -169.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -126.51 113.0 16.22 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 HD11 ' NE2' ' A' ' 23' ' ' GLN . 0.9 OUTLIER -125.65 164.21 25.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 97' ' ' LEU . 49.4 mt -91.93 8.51 37.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.854 0.835 . . . . 0.0 109.984 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.0 -46.92 2.68 Favored Glycine 0 N--CA 1.416 -2.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.53 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 30.6 p90 -93.4 172.39 8.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.3 m -136.44 169.28 17.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.12 1.768 . . . . 0.0 110.222 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.532 HD12 HD12 ' A' ' 55' ' ' ILE . 5.5 pt -124.81 172.54 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 C-N-CA 122.608 0.363 . . . . 0.0 111.477 -170.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.17 -12.37 8.33 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.626 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 114.33 170.49 16.85 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 119.537 -1.316 . . . . 0.0 113.066 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.447 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -123.68 -114.71 2.14 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 124.083 0.52 . . . . 0.0 112.109 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -29.31 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.34 -17.87 65.02 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.852 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.533 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 19.6 mm-40 -101.24 153.54 19.53 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.0 t70 -99.98 115.69 65.31 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -51.37 -30.01 32.68 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.773 2.982 . . . . 0.0 113.018 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.2 t -66.17 -25.99 67.2 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.331 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.403 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -121.85 15.68 10.92 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.583 0.706 . . . . 0.0 111.032 -177.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.512 HD22 ' HB2' ' A' ' 39' ' ' GLN . 87.7 m-20 -93.49 155.3 40.89 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.57 -55.91 0.08 OUTLIER 'Trans proline' 0 C--O 1.198 -1.524 0 C-N-CA 122.746 2.298 . . . . 0.0 113.003 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -105.8 27.7 8.24 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.88 0.848 . . . . 0.0 110.602 -175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.3 t . . . . . 0 C--O 1.204 -1.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 121.327 0.584 . . . . 0.0 109.949 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.68 140.86 7.69 Favored Glycine 0 C--O 1.186 -2.892 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.661 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 27.9 mm -60.73 128.83 22.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.248 0.547 . . . . 0.0 111.012 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.3 151.86 48.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.748 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 97.8 t -79.23 134.23 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 123.959 0.787 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -110.92 -21.93 11.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -148.73 135.63 19.9 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.443 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 71' ' ' LEU . 27.5 m -117.63 173.15 4.72 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.9 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 172.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.16 126.24 29.29 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -73.24 -19.16 61.13 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.771 0.67 . . . . 0.0 110.548 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.34 43.8 0.91 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.29 -170.82 12.83 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.314 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.95 -31.6 66.6 Favored 'Trans proline' 0 N--CA 1.474 0.327 0 C-N-CA 123.742 2.961 . . . . 0.0 112.297 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.83 -63.52 1.15 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.103 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.7 -28.04 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.003 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.16 -49.76 79.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.339 0.4 . . . . 0.0 110.364 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -52.13 43.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.269 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.96 22.8 0.08 OUTLIER Glycine 0 C--N 1.305 -1.151 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.724 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.514 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.2 tp -90.19 106.97 18.84 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -124.49 124.13 41.62 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.1 mt -35.98 122.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 125.777 1.923 . . . . 0.0 112.801 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.06 14.7 23.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.457 ' OD1' ' HB ' ' A' ' 57' ' ' VAL . 5.6 p-10 -87.32 139.0 31.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.523 ' HB3' ' HZ3' ' A' ' 76' ' ' LYS . 7.5 mtpm? -104.5 107.43 18.36 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.437 ' HB ' ' HE3' ' A' ' 85' ' ' MET . 9.6 mt -74.78 142.77 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.05 -172.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.8 mmt -122.15 -20.19 6.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.619 0.723 . . . . 0.0 109.891 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.498 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -144.44 134.82 24.47 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.462 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 62.6 t -140.51 120.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 53.75 39.55 30.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.867 0.867 . . . . 0.0 111.891 170.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.498 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 57.8 21.89 45.49 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.462 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -102.77 -0.13 31.96 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.362 3.8 p30 49.83 99.28 0.01 OUTLIER 'General case' 0 C--N 1.342 0.273 0 CA-C-O 123.462 1.601 . . . . 0.0 113.635 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.661 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 ttp -97.95 -10.04 25.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.303 -169.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.2 t -33.19 -36.31 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 126.445 1.898 . . . . 0.0 115.727 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.9 ttm -139.26 93.63 2.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.92 151.89 10.04 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.0 p -73.64 157.34 36.8 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.372 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.51 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 8.8 t60 -54.58 -46.31 73.71 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.967 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.55 -44.83 95.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.281 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -37.61 68.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.872 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.93 87.95 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.761 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -52.61 -34.98 53.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.638 0.775 . . . . 0.0 111.943 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -88.29 13.5 11.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.351 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.531 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 15.3 tpt180 -133.21 -39.66 0.93 Allowed 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.482 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.53 ' O ' HD11 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -103.05 -11.88 17.81 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.964 -176.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -125.93 14.23 7.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.978 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 13.4 ptpt -67.13 -168.94 0.08 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.27 170.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -132.52 3.22 3.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.12 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.428 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 34.9 m -73.27 -40.3 64.71 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.437 -177.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.16 134.32 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.1 pm0 -81.45 -61.04 2.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.594 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -120.34 129.18 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 C-N-CA 123.049 0.54 . . . . 0.0 110.842 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.78 146.53 30.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.595 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -98.93 117.69 34.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 108' ' ' LEU . 19.0 mt -112.09 155.35 24.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.875 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 107' ' ' LEU . 4.7 mp -133.42 126.3 30.91 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.415 HG21 ' NE2' ' A' ' 14' ' ' GLN . 17.0 m -123.45 158.93 28.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 123.682 0.614 . . . . 0.0 109.84 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.458 HG23 HG23 ' A' ' 13' ' ' VAL . 37.9 p . . . . . 0 N--CA 1.41 -2.453 0 CA-C-O 121.25 0.548 . . . . 0.0 110.249 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.7 t . . . . . 0 N--CA 1.426 -1.635 0 CA-C-O 121.062 0.458 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 8.6 p -112.14 126.53 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.608 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' NE2' HG21 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -137.65 152.52 49.4 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -176.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -93.81 150.44 20.38 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -125.71 156.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -141.86 105.72 4.73 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.618 0.723 . . . . 0.0 110.761 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.7 mp -96.99 128.2 48.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.189 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -97.67 137.54 36.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -36.09 121.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -177.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 tp -124.52 128.54 49.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.649 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -96.09 132.9 41.0 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.153 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.534 ' NE2' ' HA2' ' A' ' 30' ' ' GLY . 66.4 mt-30 -123.68 108.06 12.15 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.33 -103.86 1.25 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -119.92 12.7 12.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.26 167.44 14.87 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -113.73 118.41 34.25 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.48 154.14 36.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 63.8 mt -79.36 2.31 22.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.8 0.809 . . . . 0.0 109.596 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.534 ' HA2' ' NE2' ' A' ' 23' ' ' GLN . . . 95.64 -44.73 2.06 Favored Glycine 0 N--CA 1.408 -3.176 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.921 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 37.7 p90 -90.65 164.56 14.12 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 m -115.01 164.84 13.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 125.027 1.331 . . . . 0.0 109.135 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.497 HD11 HD13 ' A' ' 55' ' ' ILE . 6.5 pt -126.06 166.62 21.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.0 -31.03 3.46 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.488 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.38 154.02 9.13 Favored Glycine 0 C--O 1.2 -1.996 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.298 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.451 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -102.57 -117.67 4.33 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.335 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -23.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.469 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 18.5 t70 -68.94 -20.47 64.2 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.761 0.791 . . . . 0.0 109.887 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 21.9 mm-40 -100.97 156.96 17.1 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 5.0 t70 -101.32 114.66 65.71 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.17 -25.66 23.95 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 123.859 3.04 . . . . 0.0 113.682 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 m -76.02 -8.59 57.33 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.235 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -135.22 13.09 3.56 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.905 0.859 . . . . 0.0 110.348 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.527 HD22 ' HB2' ' A' ' 39' ' ' GLN . 95.5 m-20 -97.86 150.43 36.75 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.495 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.09 -45.7 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.037 0 C-N-CA 122.993 2.462 . . . . 0.0 114.31 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -114.02 9.53 17.36 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 121.354 -0.842 . . . . 0.0 110.931 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 9.6 t . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.407 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 138.48 157.99 7.59 Favored Glycine 0 C--O 1.204 -1.765 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.497 HD13 HD11 ' A' ' 33' ' ' ILE . 30.7 mm -80.95 118.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 117.685 0.743 . . . . 0.0 109.555 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -120.71 155.69 33.36 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.072 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.58 131.56 33.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 O-C-N 124.733 1.271 . . . . 0.0 110.36 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 p -106.57 -19.04 13.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.556 0.693 . . . . 0.0 111.319 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -154.73 135.92 13.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.424 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 30.3 m -100.57 -177.44 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.351 -5.416 0 CA-C-N 119.592 1.087 . . . . 0.0 108.186 173.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.439 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 5.2 t -76.26 122.41 24.36 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.67 -18.5 31.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.275 0.984 . . . . 0.0 113.09 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.56 46.32 0.23 Allowed Glycine 0 CA--C 1.482 -1.975 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -132.78 -168.34 11.95 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.967 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.45 -31.88 88.32 Favored 'Trans proline' 0 C--O 1.216 -0.576 0 C-N-CA 123.987 3.125 . . . . 0.0 112.552 -169.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HB2' ' H ' ' A' ' 61' ' ' SER . . . -56.63 -60.26 3.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.31 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -71.17 -30.14 66.07 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.245 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 64' ' ' GLY . 32.4 mm -62.6 -41.1 90.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 122.983 0.513 . . . . 0.0 111.147 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.94 -56.78 4.21 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.498 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.14 22.53 0.05 OUTLIER Glycine 0 C--N 1.314 -0.64 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.029 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.52 ' HB2' HG11 ' A' ' 16' ' ' VAL . 3.2 tp -87.94 119.61 28.46 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -115.27 140.98 48.64 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.62 0.575 . . . . 0.0 109.494 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.8 mt -49.52 126.53 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 123.316 0.385 . . . . 0.0 111.521 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.71 50.79 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.104 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -80.62 131.91 35.55 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -94.3 108.2 20.11 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 109' ' ' VAL . 3.3 mp -78.9 125.72 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.4 mmt -112.84 -8.82 13.71 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.85 0.357 . . . . 0.0 111.821 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -156.55 136.13 12.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.476 HG21 HD12 ' A' ' 107' ' ' LEU . 39.2 t -142.61 115.04 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.546 1.138 . . . . 0.0 109.972 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.617 HD21 ' HA ' ' A' ' 105' ' ' VAL . 2.8 t-20 50.5 57.8 6.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.622 1.169 . . . . 0.0 111.784 176.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.61 -17.89 1.93 Allowed Glycine 0 C--N 1.289 -2.082 0 CA-C-N 114.029 -1.441 . . . . 0.0 115.293 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.433 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -90.88 157.01 17.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.87 134.33 34.54 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.417 0.627 . . . . 0.0 109.897 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.526 ' SD ' HG13 ' A' ' 88' ' ' VAL . 63.4 tpp -113.15 1.59 15.33 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.235 1.017 . . . . 0.0 108.881 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.566 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.6 t -61.16 -35.7 77.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.133 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.4 ttm -139.47 91.25 2.47 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.526 HG13 ' SD ' ' A' ' 85' ' ' MET . 9.3 p -157.13 151.05 8.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.422 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 38' ' ' ASP . 2.3 p -71.13 157.19 38.61 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.51 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.577 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 13.0 t60 -53.92 -45.19 71.12 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.189 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.65 -48.36 81.21 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.733 0.645 . . . . 0.0 111.537 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.49 -30.38 67.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.409 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.624 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.86 -42.86 66.4 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 176.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.458 ' C ' ' H ' ' A' ' 96' ' ' ARG . 11.1 mmm180 -56.08 -42.8 77.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.537 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -80.32 27.33 0.34 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 109.123 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.531 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 tpt180 -139.77 -43.27 0.44 Allowed 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 1.5 pp -100.03 -28.85 12.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.466 ' N ' HD13 ' A' ' 97' ' ' LEU . 14.9 t -108.19 15.88 23.75 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.945 -1.502 . . . . 0.0 109.614 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.551 ' HD2' ' CB ' ' A' ' 102' ' ' GLU . 16.3 ptpt -65.78 176.2 1.66 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.535 170.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -127.41 12.29 6.97 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.698 0.761 . . . . 0.0 111.261 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 m -94.64 -32.71 13.27 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.95 0.881 . . . . 0.0 111.731 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.551 ' CB ' ' HD2' ' A' ' 99' ' ' LYS . 14.7 tt0 -108.79 119.28 39.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.496 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -80.52 -71.54 0.46 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.463 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 31.3 t -98.88 136.07 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.617 ' HA ' HD21 ' A' ' 81' ' ' ASN . 19.6 m -129.62 152.78 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 CA-C-O 121.32 0.581 . . . . 0.0 111.778 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -127.14 112.32 15.02 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.33 162.58 16.92 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.703 -171.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.7 mp -130.95 127.39 38.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 21.7 m -119.14 150.27 21.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.1 p . . . . . 0 N--CA 1.42 -1.958 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.932 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 110' ' ' THR . 15.5 t -97.04 127.5 49.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.32 150.88 50.08 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -97.14 143.85 27.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -176.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 8.5 p -132.75 154.29 39.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -137.14 108.54 6.89 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.284 0.564 . . . . 0.0 111.689 -174.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.402 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -98.83 133.31 41.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.777 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -99.32 147.71 24.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 41.9 pttt -38.32 116.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 52.3 tp -117.6 125.45 50.81 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.124 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -95.48 126.28 40.66 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -122.93 99.6 6.47 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.74 -104.12 1.65 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.0 -1.32 15.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.12 171.22 7.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.316 0.579 . . . . 0.0 109.979 -172.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -122.07 108.42 13.34 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 1.3 mt -121.51 156.04 25.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 68.6 mt -84.03 3.35 34.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.628 0.728 . . . . 0.0 109.871 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -34.43 3.97 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.519 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -99.07 170.99 8.31 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.343 0.571 . . . . 0.0 111.55 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.539 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 82.4 p -124.13 -173.7 2.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.09 0.556 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' HG ' ' A' ' 97' ' ' LEU . 8.4 pt -135.42 164.98 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.73 -17.39 7.49 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.543 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 121.6 166.34 12.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.261 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -115.95 -108.16 2.61 Favored Glycine 0 N--CA 1.409 -3.148 0 O-C-N 124.459 0.741 . . . . 0.0 113.322 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.531 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -80.83 -21.14 11.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.194 0.521 . . . . 0.0 111.43 -174.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 89' ' ' THR . 7.3 p-10 -86.39 3.85 41.91 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 110.309 -174.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.521 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 60.6 mm-40 -99.34 178.06 5.0 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.474 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -132.12 121.6 17.82 Favored Pre-proline 0 CA--C 1.479 -1.786 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.4 -24.76 44.82 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.477 2.118 . . . . 0.0 113.496 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m -66.73 -30.08 70.21 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.859 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.13 21.05 9.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.283 0.563 . . . . 0.0 111.221 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' A' ' 39' ' ' GLN . 5.8 m120 -115.08 143.76 30.82 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.62 -50.97 1.07 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.667 2.911 . . . . 0.0 114.008 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -104.8 17.78 23.52 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.497 0.665 . . . . 0.0 110.469 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.4 t . . . . . 0 N--CA 1.418 -2.05 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.149 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 37' ' ' ILE . 8.6 mtmp? . . . . . 0 CA--C 1.547 0.864 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.441 ' C ' ' HA2' ' A' ' 36' ' ' GLY . . . 129.21 146.85 6.2 Favored Glycine 0 C--O 1.177 -3.416 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.543 HD13 ' C ' ' A' ' 35' ' ' GLY . 31.6 mm -58.81 117.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 118.811 1.305 . . . . 0.0 112.402 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -119.25 153.94 34.22 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.106 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.28 135.39 25.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 124.567 1.167 . . . . 0.0 110.207 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 p -109.65 -23.57 11.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.268 0.556 . . . . 0.0 111.863 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.539 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 40.7 mtt-85 -142.56 138.22 30.68 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' A' ' 66' ' ' ALA . 54.3 t -124.87 135.76 62.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.2 t -54.44 118.76 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 124.469 1.106 . . . . 0.0 109.801 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.74 -5.85 9.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.598 1.559 . . . . 0.0 112.659 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.28 38.47 0.33 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.401 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -124.01 -174.08 14.05 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.37 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.92 -29.89 76.5 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 124.018 3.145 . . . . 0.0 111.934 -172.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 60' ' ' VAL . . . -57.94 -60.91 2.99 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.626 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.5 pt-20 -75.61 -23.94 56.47 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.9 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.2 mm -59.24 -43.69 90.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -50.72 19.24 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.024 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.85 21.81 0.24 Allowed Glycine 0 C--N 1.321 -0.277 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.884 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.13 126.63 31.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -116.66 147.18 42.18 Favored 'General case' 0 C--O 1.205 -1.247 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.6 mt -61.59 132.35 27.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.808 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.41 -0.34 55.72 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 73.1 m-20 -75.86 119.94 20.54 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -83.47 114.53 21.54 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.1 mt -86.63 123.79 39.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.835 -173.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.3 mmt -107.66 -17.91 13.97 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.228 0.537 . . . . 0.0 110.192 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.474 HE22 ' CA ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -147.13 137.69 23.55 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 107' ' ' LEU . 18.4 t -139.89 115.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 123.276 0.63 . . . . 0.0 109.326 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER 53.12 35.76 20.57 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.802 1.241 . . . . 0.0 111.313 173.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.474 ' CA ' HE22 ' A' ' 79' ' ' GLN . . . 73.73 7.35 74.56 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 114.584 -1.189 . . . . 0.0 115.443 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.574 ' CZ2' ' HG3' ' A' ' 96' ' ' ARG 0.325 0.1 OUTLIER -81.39 -86.12 0.09 Allowed 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 118.21 1.005 . . . . 0.0 112.762 -179.965 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 162.99 111.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 126.404 1.881 . . . . 0.0 107.161 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -113.0 -1.88 14.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.884 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -72.41 -33.97 67.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.933 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.531 ' SD ' HG21 ' A' ' 37' ' ' ILE . 16.4 tpt -128.54 85.83 2.38 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 HG13 ' A' ' 55' ' ' ILE . 7.2 p -161.06 147.53 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.891 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 38' ' ' ASP . 8.7 p -69.8 159.55 33.38 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.995 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.488 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 7.9 t60 -57.64 -41.74 82.03 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.616 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.45 -51.14 70.76 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.486 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.517 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -72.06 -34.67 68.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.17 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -33.06 65.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' A' ' 96' ' ' ARG . 12.8 mmm180 -52.74 -48.72 66.53 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -83.72 26.68 0.68 Allowed 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.649 0.737 . . . . 0.0 110.885 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 24.3 mmt180 -131.56 -29.03 1.79 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.004 176.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -106.72 -27.6 10.69 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.288 174.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.404 ' N ' HD13 ' A' ' 97' ' ' LEU . 8.7 t -112.47 16.8 19.72 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.754 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.3 ptpt -64.8 165.08 11.11 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.172 168.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -122.91 4.74 9.38 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.946 0.879 . . . . 0.0 109.374 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -45.44 94.78 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.744 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -107.69 179.91 4.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.412 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 8.3 pt-20 -132.35 -62.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.4 t -95.99 126.16 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.491 ' HA ' ' ND2' ' A' ' 81' ' ' ASN . 28.0 m -127.04 153.02 35.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.088 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 92.5 mtt180 -124.47 116.52 22.64 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.451 HD11 HG23 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.87 147.57 40.92 Favored 'General case' 0 N--CA 1.395 -3.218 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -174.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.402 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 6.9 mp -111.98 121.5 45.17 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 35.5 m -117.2 147.35 20.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.002 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.465 HG23 HG22 ' A' ' 13' ' ' VAL . 47.1 p . . . . . 0 N--CA 1.411 -2.42 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.764 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -84.32 119.8 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.27 152.81 49.29 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.34 146.2 24.95 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.898 -174.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -125.87 158.01 35.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.7 103.78 3.68 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.531 0.681 . . . . 0.0 110.777 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.58 126.57 44.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.978 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 55.6 m170 -96.94 161.95 13.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 124.232 0.957 . . . . 0.0 109.902 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HG3' HD11 ' A' ' 27' ' ' LEU . 39.6 ttmt -40.68 125.88 2.31 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.237 1.415 . . . . 0.0 113.705 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.451 HD22 ' CD ' ' A' ' 65' ' ' PRO . 42.8 tp -139.71 131.43 27.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.037 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -99.96 137.07 38.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -128.49 104.21 7.56 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.96 -108.55 2.52 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -111.85 9.59 20.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.267 0.556 . . . . 0.0 110.679 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.65 172.03 7.28 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.418 HD11 ' HG3' ' A' ' 20' ' ' LYS . 14.3 tp -122.77 115.74 22.53 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.17 153.62 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.574 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 97' ' ' LEU . 9.3 mp -78.59 0.16 27.41 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.667 0.746 . . . . 0.0 111.423 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.54 -37.81 3.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.927 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 34.3 p90 -100.64 178.21 4.78 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -143.57 168.04 20.8 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 124.274 1.03 . . . . 0.0 110.053 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.556 HD12 HD12 ' A' ' 55' ' ' ILE . 11.1 pt -127.43 167.7 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 117.944 0.338 . . . . 0.0 111.87 -171.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.07 -29.89 4.13 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 127.24 161.82 10.96 Favored Glycine 0 N--CA 1.42 -2.406 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.376 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.518 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -108.19 -119.41 4.34 Favored Glycine 0 N--CA 1.428 -1.899 0 O-C-N 124.16 0.565 . . . . 0.0 112.652 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -24.27 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.153 0.502 . . . . 0.0 111.759 -175.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.464 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.8 t70 -66.63 -13.03 60.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.773 1.229 . . . . 0.0 111.014 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.614 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 30.0 mm-40 -104.61 169.63 8.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.899 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -114.19 128.08 26.17 Favored Pre-proline 0 CA--C 1.486 -1.502 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.408 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.0 Cg_endo -57.08 -32.11 92.27 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.023 1.815 . . . . 0.0 113.731 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.2 t -65.75 -32.18 73.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.94 13.69 29.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.534 0.683 . . . . 0.0 110.784 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 39' ' ' GLN . 13.0 m-80 -112.26 146.05 34.1 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -64.94 -53.47 0.89 Allowed 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 123.271 2.647 . . . . 0.0 113.349 -171.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -101.24 0.86 38.19 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.602 0.715 . . . . 0.0 110.624 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 t . . . . . 0 N--CA 1.415 -2.193 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.69 -179.102 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 58.9 mtmt . . . . . 0 N--CA 1.431 -1.42 0 CA-C-O 121.811 0.815 . . . . 0.0 112.388 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.2 153.1 5.79 Favored Glycine 0 C--O 1.185 -2.935 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.556 HD12 HD12 ' A' ' 33' ' ' ILE . 29.1 mm -64.25 127.94 25.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 118.708 1.254 . . . . 0.0 111.584 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -129.88 155.5 45.92 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.85 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.483 HG22 HD11 ' A' ' 71' ' ' LEU . 95.2 t -85.02 130.45 36.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 O-C-N 124.441 1.088 . . . . 0.0 111.028 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -107.35 -20.02 13.4 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 41.2 ttt-85 -142.74 143.29 32.18 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.417 HG11 ' CB ' ' A' ' 66' ' ' ALA . 45.9 t -128.38 144.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t -59.32 126.5 27.9 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.68 -26.48 68.68 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.626 1.17 . . . . 0.0 110.834 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.97 52.44 0.53 Allowed Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.766 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.41 -172.51 12.97 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.878 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.451 ' CD ' HD22 ' A' ' 21' ' ' LEU . 36.9 Cg_endo -64.52 -28.12 61.84 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 124.326 3.35 . . . . 0.0 111.619 -173.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.417 ' CB ' HG11 ' A' ' 60' ' ' VAL . . . -60.44 -58.86 6.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.958 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -69.17 -31.27 69.79 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.535 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.8 mm -59.79 -49.45 83.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.043 0.449 . . . . 0.0 110.546 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.86 53.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.891 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.61 22.6 0.18 Allowed Glycine 0 C--N 1.302 -1.308 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.647 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' HB2' HG13 ' A' ' 16' ' ' VAL . 2.4 tp -85.88 122.92 30.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.424 ' N ' HD13 ' A' ' 71' ' ' LEU . 24.5 mm-40 -115.43 154.09 29.89 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 121.779 0.8 . . . . 0.0 109.098 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.5 mt -65.33 124.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.147 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -15.36 23.54 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.402 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 64.6 m-20 -67.63 130.75 44.0 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.056 0.455 . . . . 0.0 110.533 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -92.37 127.15 37.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.424 HG13 HG12 ' A' ' 109' ' ' VAL . 2.9 mp -94.92 127.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -175.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.8 mmt -103.53 -20.55 13.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.987 0.423 . . . . 0.0 110.689 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 14.6 tp60 -152.48 129.55 11.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.066 -172.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.415 HG21 HD13 ' A' ' 107' ' ' LEU . 38.8 t -137.16 115.71 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.822 0.849 . . . . 0.0 110.329 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 53.04 41.75 32.18 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.243 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.68 90.14 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.112 -0.949 . . . . 0.0 115.062 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.482 ' N ' HE22 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -114.0 150.09 34.39 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.16 136.81 36.58 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.781 0.718 . . . . 0.0 109.884 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 tpt -116.63 -7.06 11.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.229 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.1 t -58.63 -34.91 71.7 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.084 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.0 ttp -137.99 91.07 2.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.24 151.55 10.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.029 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 38' ' ' ASP . 11.8 p -75.39 159.59 31.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.493 0.187 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.614 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 11.4 t60 -55.45 -42.77 74.7 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.55 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 39.2 t70 -59.3 -54.0 51.86 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.756 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -30.17 69.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.866 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.76 -44.59 63.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.164 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 96' ' ' ARG . 8.7 mmm180 -57.92 -43.28 86.16 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.673 0.749 . . . . 0.0 109.471 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.4 40.34 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.405 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 94' ' ' ARG . 11.2 tpt180 -150.02 -45.63 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.243 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.474 HD11 ' N ' ' A' ' 98' ' ' THR . 1.0 OUTLIER -99.16 -26.15 14.29 Favored 'General case' 0 C--O 1.196 -1.722 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.474 ' N ' HD11 ' A' ' 97' ' ' LEU . 12.4 t -111.91 17.09 20.04 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 118.22 -1.392 . . . . 0.0 109.601 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 16.0 ptpt -72.14 161.49 30.81 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -114.43 9.69 16.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.752 0.787 . . . . 0.0 110.373 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.508 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 36.5 m -80.57 -30.44 37.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.851 -177.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -110.11 156.73 20.19 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -110.51 -67.71 0.98 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.865 0.364 . . . . 0.0 111.869 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -103.96 125.11 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-O 122.106 0.955 . . . . 0.0 112.578 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.443 ' C ' ' HD2' ' A' ' 106' ' ' ARG . 15.6 m -126.18 168.48 19.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.453 -175.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.443 ' HD2' ' C ' ' A' ' 105' ' ' VAL . 5.1 mpt_? -127.06 116.29 20.49 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -118.9 153.34 34.72 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.1 mp -125.4 123.6 39.67 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.424 HG12 HG13 ' A' ' 77' ' ' ILE . 30.2 m -124.09 155.44 31.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.6 -176.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 N--CA 1.383 -3.821 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.482 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.24 127.35 53.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.459 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -131.97 154.72 49.02 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.372 -176.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -95.12 145.47 24.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.093 0.473 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 107' ' ' LEU . 9.6 p -129.95 150.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.81 107.34 6.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 122.138 0.971 . . . . 0.0 111.036 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -96.49 125.78 49.32 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.114 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -94.68 165.5 12.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -48.65 129.49 16.55 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 42.6 tp -120.68 122.65 40.92 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 111.98 22.88 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -119.05 102.86 9.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.33 -109.03 2.47 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.28 16.73 21.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.308 0.575 . . . . 0.0 110.822 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.04 167.98 10.67 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -127.24 105.88 8.85 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 102.472 -3.158 . . . . 0.0 102.472 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -122.16 163.93 19.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.046 -174.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.4 mp -89.93 0.57 57.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.135 0.969 . . . . 0.0 110.245 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' CA ' ' HB2' ' A' ' 61' ' ' SER . . . 91.46 -41.31 2.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.239 -0.892 . . . . 0.0 115.095 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 42.3 p90 -96.18 170.58 9.16 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 117.448 0.624 . . . . 0.0 112.615 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.7 m -130.44 165.84 21.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.259 1.023 . . . . 0.0 109.702 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 55' ' ' ILE . 7.7 pt -124.74 168.95 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 120.461 0.172 . . . . 0.0 110.673 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.45 -23.98 6.08 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.576 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 125.01 172.29 13.46 Favored Glycine 0 N--CA 1.414 -2.805 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.366 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . -119.56 -113.71 2.47 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 124.525 0.779 . . . . 0.0 112.5 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -69.61 -24.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.415 ' HB2' HG21 ' A' ' 89' ' ' THR . 27.3 t70 -70.62 -12.53 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.98 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.543 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 19.0 mm-40 -106.23 157.92 17.23 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 8.0 t70 -97.38 123.43 52.59 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -61.86 -26.49 79.3 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.426 2.084 . . . . 0.0 113.523 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -72.35 -23.21 61.1 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -122.12 20.49 10.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.415 0.626 . . . . 0.0 111.006 -178.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -111.82 140.88 23.8 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.36 -39.99 34.24 Favored 'Trans proline' 0 C--O 1.222 -0.284 0 C-N-CA 123.663 2.909 . . . . 0.0 113.632 -170.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CD1' ' HA2' ' A' ' 74' ' ' GLY . 53.5 m-85 -119.72 22.19 11.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.762 0.792 . . . . 0.0 109.693 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 4.6 t . . . . . 0 N--CA 1.433 -1.281 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 36.4 mtmm . . . . . 0 N--CA 1.432 -1.344 0 CA-C-O 121.586 0.708 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.511 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 139.87 169.08 11.53 Favored Glycine 0 CA--C 1.472 -2.626 0 N-CA-C 106.218 -2.753 . . . . 0.0 106.218 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.576 HD13 ' C ' ' A' ' 35' ' ' GLY . 24.2 mm -76.69 131.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 118.779 1.29 . . . . 0.0 109.839 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.2 p90 -128.61 149.01 50.82 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 71' ' ' LEU . 95.6 t -78.48 130.88 35.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 124.459 1.1 . . . . 0.0 111.657 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -106.88 -20.4 13.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.103 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 6.9 ttm180 -144.31 143.44 30.99 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.432 HG12 ' CB ' ' A' ' 66' ' ' ALA . 38.4 t -126.53 136.79 59.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.4 t -55.14 119.76 5.97 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.545 1.153 . . . . 0.0 110.062 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.62 2.59 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 111.471 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.19 41.49 0.27 Allowed Glycine 0 C--N 1.273 -2.954 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.73 -173.09 12.83 Favored Glycine 0 N--CA 1.414 -2.821 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.784 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.78 -28.23 51.54 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 124.847 3.698 . . . . 0.0 112.237 -173.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.432 ' CB ' HG12 ' A' ' 60' ' ' VAL . . . -58.74 -59.17 5.84 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 61' ' ' SER . 5.5 pt-20 -72.32 -27.86 62.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.577 178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -61.19 -40.95 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.013 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.79 -47.64 18.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.02 16.89 0.41 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.422 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.487 HD11 HG22 ' A' ' 57' ' ' VAL . 1.8 tp -74.57 127.79 33.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -113.73 148.49 36.35 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.3 0.571 . . . . 0.0 110.179 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.49 123.3 19.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 46' ' ' PHE . . . 112.99 -15.18 23.59 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.784 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -63.78 127.2 30.31 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.684 0.284 . . . . 0.0 111.021 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' A' ' 78' ' ' MET . 65.3 mttm -89.7 123.29 33.6 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.415 HD13 ' CG2' ' A' ' 57' ' ' VAL . 3.7 mp -90.58 126.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -112.26 -7.7 14.0 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.034 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -159.96 136.5 9.01 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 107' ' ' LEU . 34.0 t -142.49 119.7 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.749 1.219 . . . . 0.0 109.168 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 46.08 57.84 4.91 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 124.533 1.133 . . . . 0.0 112.176 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.1 -17.47 2.96 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 113.644 -1.616 . . . . 0.0 115.37 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.453 ' HE1' ' HE1' ' A' ' 85' ' ' MET . 0.0 OUTLIER -92.49 156.92 16.84 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -94.91 127.32 40.86 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.453 ' HE1' ' HE1' ' A' ' 83' ' ' TRP . 29.1 ttm -105.82 3.54 28.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.313 1.054 . . . . 0.0 110.695 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.479 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.6 t -61.14 -23.04 65.25 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.374 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.558 ' SD ' HG21 ' A' ' 37' ' ' ILE . 52.0 tpp -140.94 90.14 2.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.9 p -160.33 150.03 5.82 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.415 HG21 ' HB2' ' A' ' 38' ' ' ASP . 17.9 p -76.23 159.98 30.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.061 0.458 . . . . 0.0 110.414 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.474 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.1 t60 -54.58 -41.43 69.84 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.379 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.92 -47.59 85.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.752 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.14 -37.35 69.44 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.431 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.85 -45.49 85.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.749 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -53.63 -39.05 64.65 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 122.828 0.451 . . . . 0.0 111.488 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.73 24.41 0.88 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.947 0.403 . . . . 0.0 111.153 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.489 ' HA ' ' CE ' ' A' ' 99' ' ' LYS . 20.6 ttm180 -145.22 -37.98 0.27 Allowed 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -97.51 -17.05 19.83 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.474 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.1 t -122.7 14.18 10.09 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.846 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.489 ' CE ' ' HA ' ' A' ' 96' ' ' ARG . 16.2 ptpt -62.28 161.6 11.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.921 173.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -124.94 19.07 8.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.016 0.912 . . . . 0.0 110.338 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.422 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 47.4 m -84.15 -27.51 28.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.073 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -125.02 159.86 30.35 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.379 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -97.64 -70.47 0.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -109.69 128.55 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.415 ' CG2' HD21 ' A' ' 107' ' ' LEU . 24.1 m -132.67 148.81 31.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.171 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -100.28 124.61 45.94 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.427 ' CD2' HG12 ' A' ' 80' ' ' VAL . 3.9 mt -119.71 154.3 34.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.5 mp -120.08 125.57 48.63 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-O 121.015 0.436 . . . . 0.0 110.389 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.459 HG22 ' NE2' ' A' ' 14' ' ' GLN . 22.1 m -119.8 150.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.223 -177.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 N--CA 1.423 -1.812 0 CA-C-O 121.469 0.652 . . . . 0.0 111.429 -178.364 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -107.61 138.5 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.508 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -135.32 153.34 51.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 139.8 38.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.499 ' CG1' ' HB2' ' A' ' 107' ' ' LEU . 8.5 p -128.66 158.31 41.06 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.21 101.99 4.4 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.386 0.612 . . . . 0.0 110.245 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -93.52 127.87 45.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.027 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -93.07 156.79 16.65 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -49.54 125.89 12.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 45.2 tp -119.05 119.01 32.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.203 175.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -101.67 118.65 37.38 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -121.8 105.23 10.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 -112.46 5.03 Favored Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.869 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.24 3.09 51.51 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.137 0.494 . . . . 0.0 109.721 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.64 161.69 20.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-O 122.128 0.966 . . . . 0.0 110.59 -171.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -122.75 113.97 19.92 Favored 'General case' 0 C--N 1.256 -3.459 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 171.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.449 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -126.38 157.92 36.63 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.919 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 98' ' ' THR . 3.2 mm? -94.65 6.34 49.17 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 123.337 1.541 . . . . 0.0 108.588 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.37 -46.9 2.59 Favored Glycine 0 C--N 1.294 -1.764 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.161 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -89.13 166.36 13.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 55.2 m -120.65 168.13 11.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.702 1.201 . . . . 0.0 109.73 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.516 HD12 HD12 ' A' ' 55' ' ' ILE . 5.9 pt -125.77 164.39 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 120.857 0.36 . . . . 0.0 110.298 -177.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.73 -20.99 7.75 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.304 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.638 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 123.17 171.37 13.64 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . -122.15 -117.44 2.44 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 124.388 0.699 . . . . 0.0 112.6 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -22.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.94 -15.01 60.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.26 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.638 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 6.6 mm-40 -100.17 167.37 10.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -108.0 111.95 61.88 Favored Pre-proline 0 CA--C 1.497 -1.08 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.31 -24.69 35.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.582 2.855 . . . . 0.0 113.314 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -66.15 -33.45 75.79 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.217 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.49 15.39 20.18 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.933 0.873 . . . . 0.0 110.632 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -102.11 142.0 23.69 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.998 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.55 -45.02 7.48 Favored 'Trans proline' 0 C--O 1.221 -0.36 0 C-N-CA 123.507 2.805 . . . . 0.0 113.171 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 67.8 m-85 -113.2 17.95 18.28 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.659 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.285 -2.222 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 -179.1 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm . . . . . 0 N--CA 1.432 -1.369 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.455 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 96.98 154.18 29.88 Favored Glycine 0 C--O 1.178 -3.355 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.526 HD11 ' C ' ' A' ' 35' ' ' GLY . 21.4 mm -76.95 126.25 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 118.26 1.03 . . . . 0.0 110.779 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.08 148.96 44.22 Favored 'General case' 0 CA--C 1.486 -1.498 0 O-C-N 122.107 -0.37 . . . . 0.0 111.353 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.436 ' CG2' HD13 ' A' ' 77' ' ' ILE . 95.8 t -74.46 130.92 35.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 124.423 1.077 . . . . 0.0 110.273 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.498 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.3 p -105.99 -22.21 12.95 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.353 0.596 . . . . 0.0 110.466 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -154.59 142.07 19.71 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.0 m -109.12 -179.91 0.9 Allowed 'Isoleucine or valine' 1 N--CA 1.352 -5.368 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 30.3 t -79.55 126.82 31.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.22 -16.19 1.17 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.645 1.578 . . . . 0.0 114.321 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.91 43.46 0.2 Allowed Glycine 0 CA--C 1.483 -1.943 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.29 -168.31 13.69 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.725 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.433 ' HB2' HG23 ' A' ' 18' ' ' ILE . 33.8 Cg_endo -64.06 -30.66 66.1 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 123.433 2.755 . . . . 0.0 111.939 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.26 -64.77 0.74 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.4 pt-20 -70.9 -31.89 68.67 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.557 -0.857 . . . . 0.0 112.146 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.6 mm -59.77 -40.11 81.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.0 -38.64 27.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.95 17.62 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.712 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.434 HD12 HG21 ' A' ' 57' ' ' VAL . 4.9 tp -83.18 127.24 33.44 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.523 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 23.8 mm-40 -115.5 151.29 35.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 111.08 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.85 130.23 33.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.006 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.02 4.3 55.5 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.172 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 13.4 m-20 -102.27 128.76 48.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.151 0.5 . . . . 0.0 111.873 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 78' ' ' MET . 64.1 mttm -79.72 119.28 22.43 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.242 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.436 HD13 ' CG2' ' A' ' 57' ' ' VAL . 19.5 mt -84.62 121.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.308 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.48 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.3 mmt -111.56 -6.85 14.35 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.649 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.509 ' CB ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.21 134.65 13.43 Favored 'General case' 0 C--O 1.203 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 82' ' ' GLY . 46.4 t -136.96 122.81 27.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.58 -34.99 0.31 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 127.338 2.255 . . . . 0.0 113.004 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 134.95 15.32 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.413 ' HE1' ' HE3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -99.49 -15.69 18.6 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -175.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.55 109.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.326 1.451 . . . . 0.0 111.568 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.471 ' SD ' HD12 ' A' ' 97' ' ' LEU . 32.0 ttm -111.87 7.6 20.13 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.765 0.793 . . . . 0.0 111.366 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.48 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 5.2 t -56.1 -27.41 53.7 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 ttm -143.82 96.1 2.84 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.461 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.0 p -157.09 151.76 8.24 Favored 'Isoleucine or valine' 0 C--O 1.257 1.479 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.7 p -74.33 155.57 38.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -51.41 -43.81 62.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -61.89 -46.71 88.19 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.989 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -31.25 57.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.179 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 -42.11 68.24 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -51.14 -43.25 61.17 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -92.81 50.87 1.62 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.343 1.068 . . . . 0.0 109.568 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -157.85 -50.57 0.07 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.238 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.492 HD11 ' CG2' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -93.95 -20.48 19.96 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.331 -1.348 . . . . 0.0 112.969 -174.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.441 ' HA ' HD22 ' A' ' 29' ' ' LEU . 10.7 t -123.08 13.43 9.72 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.809 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -71.58 173.69 7.7 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 175.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -107.88 -0.48 21.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.8 t -78.02 -23.03 48.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.671 0.748 . . . . 0.0 109.443 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.03 160.09 19.41 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.328 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -120.58 -77.94 0.59 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.552 174.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.509 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -110.61 133.24 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 C-N-CA 123.534 0.734 . . . . 0.0 109.206 176.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.474 ' CG2' HD23 ' A' ' 107' ' ' LEU . 14.6 m -126.73 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.66 108.01 19.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.58 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.499 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . 5.6 mt -116.17 149.16 39.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.427 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.509 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 7.8 mp -122.37 129.15 51.83 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.508 HG22 ' NE2' ' A' ' 14' ' ' GLN . 23.6 m -121.36 148.6 24.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 O-C-N 123.997 0.811 . . . . 0.0 110.481 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.418 -2.032 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.897 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.55 144.65 14.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 149.74 36.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -93.5 145.42 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.848 0.356 . . . . 0.0 110.584 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.485 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -120.67 153.37 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -139.42 104.43 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.0 mp -94.6 133.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.743 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -104.32 128.86 52.19 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.974 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 27' ' ' LEU . 39.8 pttt -20.62 103.96 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.4 HD21 ' HD2' ' A' ' 65' ' ' PRO . 50.6 tp -102.4 123.83 46.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.981 0.419 . . . . 0.0 110.31 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -92.57 118.12 30.67 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.425 ' NE2' HD11 ' A' ' 28' ' ' ILE . 16.7 mt-30 -126.86 109.02 11.53 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.95 -98.89 0.65 Allowed Glycine 0 C--N 1.307 -1.03 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.994 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -116.65 5.32 13.21 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.35 160.44 39.82 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.713 0.768 . . . . 0.0 110.816 -169.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 20' ' ' LYS . 26.4 tp -104.84 127.45 52.65 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.425 HD11 ' NE2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -133.88 169.32 21.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.652 -178.464 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 47.1 mt -92.75 -1.85 56.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.86 -36.6 3.8 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.56 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -100.56 167.63 10.23 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.807 -0.819 . . . . 0.0 112.913 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.9 m -129.25 168.35 16.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.292 1.437 . . . . 0.0 109.339 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.443 HD13 HD12 ' A' ' 55' ' ' ILE . 6.5 pt -124.06 169.88 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.02 0.438 . . . . 0.0 111.355 -172.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.99 -21.24 5.71 Favored Glycine 0 CA--C 1.479 -2.2 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.525 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 121.85 170.9 13.92 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.757 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.454 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -124.24 -105.26 1.64 Allowed Glycine 0 N--CA 1.408 -3.201 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.705 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -23.85 13.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.528 0.68 . . . . 0.0 110.947 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 90' ' ' HIS . 14.7 p-10 -86.11 3.65 41.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.183 -174.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.525 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 44.2 mm-40 -107.55 156.12 19.35 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.089 173.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -99.34 118.65 62.01 Favored Pre-proline 0 CA--C 1.496 -1.11 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.435 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.6 Cg_endo -55.89 -25.2 51.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.16 2.573 . . . . 0.0 113.484 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 -17.16 62.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.85 28.8 4.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.126 0.489 . . . . 0.0 111.437 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 93.0 m-20 -106.25 147.0 34.08 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 122.175 -0.328 . . . . 0.0 111.067 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.55 -50.91 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.949 2.433 . . . . 0.0 112.613 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.41 4.88 28.93 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 0.0 111.447 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 2.2 t . . . . . 0 C--N 1.305 -1.36 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.578 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 37.6 mtmm . . . . . 0 N--CA 1.445 -0.722 0 CA-C-O 121.381 0.61 . . . . 0.0 112.335 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.05 138.38 4.87 Favored Glycine 0 C--O 1.191 -2.576 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.507 ' HB ' ' CG ' ' A' ' 85' ' ' MET . 24.5 mm -50.48 124.81 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.622 1.169 . . . . 0.0 112.546 -174.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -126.59 156.54 40.74 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.287 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.484 HG13 ' CG2' ' A' ' 60' ' ' VAL . 81.7 t -82.24 137.26 21.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 O-C-N 124.591 1.182 . . . . 0.0 110.43 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 p -110.89 -22.46 11.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.479 0.657 . . . . 0.0 111.172 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 19.3 mmt180 -143.68 135.92 26.83 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.484 ' CG2' HG13 ' A' ' 57' ' ' VAL . 71.9 t -128.22 139.72 51.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.63 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.7 m -57.55 112.54 1.46 Allowed 'General case' 0 N--CA 1.42 -1.961 0 O-C-N 124.103 0.877 . . . . 0.0 111.281 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.82 -11.81 49.26 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.051 0.844 . . . . 0.0 112.752 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 22.91 2.71 Favored Glycine 0 C--N 1.285 -2.252 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . -111.93 -179.95 19.75 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.32 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HD2' HD21 ' A' ' 21' ' ' LEU . 38.6 Cg_endo -63.75 -27.54 68.21 Favored 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 124.537 3.491 . . . . 0.0 111.764 -171.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.86 -60.53 3.43 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.0 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.2 pt-20 -87.1 -17.27 33.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.754 -1.578 . . . . 0.0 112.761 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.9 mm -60.68 -34.3 58.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.69 3.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.431 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 155.67 22.71 0.04 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 119.558 -1.306 . . . . 0.0 114.121 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.485 ' HB2' HG11 ' A' ' 16' ' ' VAL . 4.0 tp -88.95 121.3 31.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.152 0.501 . . . . 0.0 110.844 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.55 164.48 12.67 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-O 121.859 0.837 . . . . 0.0 108.789 177.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.62 133.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.641 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.46 14.02 74.79 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 116.415 -0.357 . . . . 0.0 112.386 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.553 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 12.9 m-20 -71.0 1.4 5.72 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt 48.23 87.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.4 mt -83.15 123.83 39.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.408 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 8.1 mmt -106.63 -19.66 13.59 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.197 0.522 . . . . 0.0 109.868 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 16.4 tp60 -154.0 131.35 11.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.172 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 107' ' ' LEU . 60.7 t -134.57 113.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 C-N-CA 123.732 0.813 . . . . 0.0 110.215 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 50.58 29.09 3.83 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.612 1.565 . . . . 0.0 113.381 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.36 64.22 Favored Glycine 0 C--O 1.217 -0.95 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.562 ' HE1' ' HE3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -107.75 -2.83 19.67 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -175.197 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.28 129.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 119.536 1.062 . . . . 0.0 111.779 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.562 ' HE3' ' HE1' ' A' ' 83' ' ' TRP . 26.5 ttm -129.77 1.29 4.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.998 0.904 . . . . 0.0 111.382 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -72.62 -19.17 61.51 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.834 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.0 ttp -139.29 89.15 2.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.511 HG23 ' CZ2' ' A' ' 83' ' ' TRP . 10.0 p -161.29 143.01 3.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.513 HG23 ' HB3' ' A' ' 38' ' ' ASP . 11.4 p -69.82 154.59 41.76 Favored 'General case' 0 N--CA 1.425 -1.721 0 O-C-N 123.539 0.524 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.517 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 8.8 t60 -53.85 -43.44 69.52 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.544 173.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.13 -44.05 95.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.895 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.18 -33.02 50.38 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.824 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.616 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.18 -40.08 71.44 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.04 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.55 ' CZ ' HG23 ' A' ' 98' ' ' THR . 13.7 mmm180 -53.79 -46.21 70.96 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 123.567 0.542 . . . . 0.0 110.434 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -86.7 36.84 0.72 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.855 0.836 . . . . 0.0 110.736 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.538 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.5 tpt180 -141.43 -46.92 0.38 Allowed 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.858 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.4 pp -96.05 -26.16 15.63 Favored 'General case' 0 C--O 1.203 -1.361 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.55 HG23 ' CZ ' ' A' ' 94' ' ' ARG . 15.3 t -110.81 10.94 22.52 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.543 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.2 ptpt -68.84 162.36 26.62 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -115.46 8.43 15.24 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.086 0.47 . . . . 0.0 111.953 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -79.54 -30.57 41.83 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.287 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -112.73 171.87 7.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.022 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.494 ' CB ' ' HB3' ' A' ' 20' ' ' LYS . 7.8 pt-20 -130.43 -71.56 0.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.5 t -91.63 129.83 41.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 122.03 -0.418 . . . . 0.0 109.962 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.05 150.5 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.9 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 -109.32 101.65 10.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 80' ' ' VAL . 21.0 mt -102.55 149.66 24.19 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.4 mp -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.266 -3.035 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 35.9 m -117.42 159.1 17.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.548 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.278 -2.516 0 CA-C-O 121.331 0.586 . . . . 0.0 110.144 -178.392 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.526 HG22 HG22 ' A' ' 110' ' ' THR . 17.9 t -83.45 115.18 25.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.413 ' NE2' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -128.4 153.37 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -94.27 145.25 24.87 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.141 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 71' ' ' LEU . 2.4 t -121.68 156.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 38.8 tt0 -143.92 104.69 4.19 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.98 0.895 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -99.13 129.38 49.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.877 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -100.23 144.63 29.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.467 ' HB3' ' CB ' ' A' ' 103' ' ' GLU . 22.3 pttm -40.39 127.2 2.34 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 tp -124.81 126.03 44.96 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.83 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -91.83 116.3 28.79 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.458 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 20.0 mt-30 -111.08 101.27 9.82 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.75 -117.49 8.19 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.52 9.26 42.81 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.99 166.89 13.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.124 0.488 . . . . 0.0 109.733 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.6 tm? -117.68 107.73 14.56 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.8 163.31 27.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 97' ' ' LEU . 9.0 mp -87.06 7.23 28.72 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.681 0.753 . . . . 0.0 110.598 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA2' ' OE1' ' A' ' 23' ' ' GLN . . . 90.44 -41.12 2.96 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.64 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 38.9 p90 -97.51 175.65 6.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.4 m -140.66 168.92 18.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.493 1.117 . . . . 0.0 109.314 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 55' ' ' ILE . 8.7 pt -125.8 167.02 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 117.916 0.326 . . . . 0.0 111.282 -173.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.49 -28.47 4.84 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.542 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 127.46 165.79 11.96 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.052 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.75 -116.16 3.26 Favored Glycine 0 N--CA 1.423 -2.175 0 O-C-N 124.238 0.611 . . . . 0.0 112.173 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.519 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.04 -23.71 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HB2' HG22 ' A' ' 89' ' ' THR . 24.7 t70 -67.93 -15.71 63.74 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.812 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.542 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 9.8 mm-40 -108.87 150.19 28.04 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.507 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.3 t70 -93.11 122.65 62.97 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.68 -24.94 65.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.706 2.271 . . . . 0.0 113.41 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -70.81 -25.4 62.84 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.343 0.592 . . . . 0.0 110.128 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -121.24 12.24 10.96 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.059 -176.449 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -88.7 147.3 39.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.2 -47.94 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.398 2.066 . . . . 0.0 113.74 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -113.67 24.11 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.866 0.841 . . . . 0.0 110.356 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.528 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.307 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 71.9 mttt . . . . . 0 C--O 1.226 -0.159 0 CA-C-O 120.76 0.314 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.29 157.7 7.52 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 33' ' ' ILE . 22.3 mm -76.71 131.84 34.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 118.066 0.933 . . . . 0.0 110.057 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.461 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 4.7 p90 -133.84 156.78 47.44 Favored 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.523 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 73' ' ' ILE . 8.2 p -84.24 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 O-C-N 125.035 1.46 . . . . 0.0 110.966 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.3 p -110.45 -23.29 11.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 29.8 ttm180 -136.29 146.41 46.63 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -135.91 150.99 28.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 66' ' ' ALA . 18.7 p -52.91 127.66 24.4 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 124.047 0.842 . . . . 0.0 109.644 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.61 -19.65 66.0 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 124.048 0.842 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.88 50.23 0.2 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -129.49 -165.57 11.7 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.464 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.4 -34.33 66.45 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.488 2.792 . . . . 0.0 113.21 -169.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -60.27 -56.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.562 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.72 -27.7 61.33 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.564 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.6 mm -58.61 -44.36 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 17' ' ' GLU . . . -76.34 -55.65 5.36 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.834 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.47 33.81 0.05 OUTLIER Glycine 0 CA--C 1.499 -0.916 0 C-N-CA 119.479 -1.343 . . . . 0.0 113.018 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.497 ' HB2' HG12 ' A' ' 16' ' ' VAL . 2.1 tp -92.17 115.75 28.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -111.3 141.48 44.78 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.411 ' HA ' HG11 ' A' ' 57' ' ' VAL . 70.7 mt -56.59 126.76 14.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 123.603 0.565 . . . . 0.0 109.92 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.79 -3.25 34.01 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.341 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 8.5 m-20 -86.2 131.88 34.13 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 120.986 0.422 . . . . 0.0 111.436 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.461 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 47.5 mtpt -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.22 122.3 43.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.464 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.4 mmt -105.8 -15.78 14.85 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.347 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -153.56 136.52 15.45 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.448 HG13 ' CD2' ' A' ' 107' ' ' LEU . 72.6 t -140.85 118.47 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.795 0.838 . . . . 0.0 110.919 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.406 HD21 ' HA ' ' A' ' 81' ' ' ASN . 1.1 t-20 61.98 14.48 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.271 1.429 . . . . 0.0 113.157 171.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.61 -15.88 19.43 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.958 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.64 149.91 21.91 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -97.08 113.59 25.17 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.444 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 21.3 ttm -77.84 -60.3 2.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.118 -174.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.464 ' HA ' ' SD ' ' A' ' 78' ' ' MET 0.279 9.8 t 23.26 -76.5 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 127.603 2.361 . . . . 0.0 116.775 -176.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.7 ttt -113.97 93.66 4.47 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.444 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 9.5 p -148.7 153.25 11.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.346 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 38' ' ' ASP . 4.7 p -70.28 152.9 43.67 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.526 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.5 t60 -50.75 -46.22 59.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.008 176.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 38.6 t70 -57.83 -48.95 78.28 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.535 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -35.9 70.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.67 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -66.09 -40.99 91.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.451 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 8.4 mmm180 -55.36 -38.79 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.802 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 38.6 mttm -83.3 30.74 0.46 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 94' ' ' ARG . 7.7 tpm_? -148.66 -43.7 0.15 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.507 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.1 pp -102.05 -16.16 16.52 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.438 ' N ' HD13 ' A' ' 97' ' ' LEU . 15.0 t -121.62 10.66 10.42 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.848 174.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.458 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 15.8 ptpt -68.59 171.41 7.63 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 173.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -123.99 13.01 9.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.211 0.529 . . . . 0.0 111.317 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 31.3 t -76.83 -41.1 45.53 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.243 0.544 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.26 167.09 10.37 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.467 ' CB ' ' HB3' ' A' ' 20' ' ' LYS . 7.6 pt-20 -120.34 -64.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 12.5 t -91.54 123.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 29' ' ' LEU . 25.2 m -125.28 136.73 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.236 0.541 . . . . 0.0 112.056 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -95.9 110.24 22.47 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 172.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.448 ' CD2' HG13 ' A' ' 80' ' ' VAL . 14.8 mt -109.23 156.2 20.19 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.4 mp -130.03 123.02 29.52 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -117.36 157.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.584 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.526 HG22 HG22 ' A' ' 13' ' ' VAL . 39.9 p . . . . . 0 N--CA 1.402 -2.86 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.139 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.37 135.3 33.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.408 ' NE2' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -148.97 154.77 39.86 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -178.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.62 150.2 20.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.635 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -135.61 162.81 36.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -154.24 114.23 3.85 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.258 0.551 . . . . 0.0 110.818 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -97.38 134.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.31 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -105.04 134.28 48.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HD3' ' HB2' ' A' ' 103' ' ' GLU . 43.7 pttt -28.12 118.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.9 tp -121.8 130.45 53.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.141 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.85 127.85 44.07 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -121.01 92.87 3.86 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.99 -111.83 3.36 Favored Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -109.88 15.98 22.29 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.332 0.587 . . . . 0.0 110.255 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.83 163.92 21.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -117.56 112.55 20.73 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.87 160.79 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 54.0 mt -86.48 0.41 54.27 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.56 -37.68 3.34 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.319 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -95.84 171.47 8.62 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.8 m -130.68 169.5 15.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.679 1.192 . . . . 0.0 109.975 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 55' ' ' ILE . 6.8 pt -128.49 165.33 28.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 117.701 0.228 . . . . 0.0 110.671 -172.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.44 -31.4 3.76 Favored Glycine 0 CA--C 1.488 -1.616 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.513 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 124.11 154.74 8.98 Favored Glycine 0 C--O 1.199 -2.077 0 C-N-CA 119.416 -1.373 . . . . 0.0 113.187 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -102.18 -119.17 4.51 Favored Glycine 0 N--CA 1.424 -2.115 0 O-C-N 124.157 0.563 . . . . 0.0 112.85 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.544 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.71 -22.6 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.164 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.411 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 31.7 t70 -70.9 -18.05 62.69 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.819 0.818 . . . . 0.0 110.163 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.523 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 11.0 mm-40 -105.87 147.07 29.13 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 4.8 t70 -94.12 127.15 46.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -175.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -20.86 44.46 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.37 2.714 . . . . 0.0 113.322 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 m -76.91 -16.07 59.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.75 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -132.14 19.76 4.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.965 0.888 . . . . 0.0 109.946 -177.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.487 HD22 ' HB2' ' A' ' 39' ' ' GLN . 93.3 m-20 -104.55 144.29 28.41 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.171 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.51 -51.74 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.692 2.261 . . . . 0.0 113.668 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -112.12 22.46 14.77 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.329 0.585 . . . . 0.0 110.639 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 8.5 t . . . . . 0 C--N 1.304 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 68.8 mttt . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 121.057 0.456 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.75 156.27 10.57 Favored Glycine 0 C--O 1.201 -1.963 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.502 HD12 HD13 ' A' ' 33' ' ' ILE . 30.4 mm -78.27 126.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 117.813 0.806 . . . . 0.0 108.874 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.9 p90 -129.52 160.0 34.56 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.787 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.461 HG22 HD12 ' A' ' 71' ' ' LEU . 58.8 t -87.47 128.46 39.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 124.73 1.269 . . . . 0.0 110.917 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 p -104.8 -20.43 13.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.441 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 135.94 23.41 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.405 HG23 HG11 ' A' ' 57' ' ' VAL . 64.6 t -123.59 148.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.443 ' OG ' ' HB1' ' A' ' 66' ' ' ALA . 37.7 p -51.82 126.33 17.7 Favored 'General case' 0 N--CA 1.401 -2.901 0 O-C-N 124.328 1.017 . . . . 0.0 108.563 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -71.32 -28.21 63.93 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-O 121.596 0.712 . . . . 0.0 109.868 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.52 55.57 0.5 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.606 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -139.28 -169.41 11.57 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.61 -30.71 51.19 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 123.677 2.918 . . . . 0.0 113.047 -171.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.443 ' HB1' ' OG ' ' A' ' 61' ' ' SER . . . -61.96 -53.8 50.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.914 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.3 pp20? -69.84 -30.62 68.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.551 0.215 . . . . 0.0 111.28 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.26 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.638 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.23 -48.14 45.07 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.03 21.51 0.41 Allowed Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.069 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.49 ' HB2' HG13 ' A' ' 16' ' ' VAL . 3.4 tp -83.03 125.46 31.47 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.445 ' N ' HD11 ' A' ' 71' ' ' LEU . 20.9 mm-40 -116.8 158.08 24.5 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.715 0.769 . . . . 0.0 109.614 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.38 135.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.898 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.82 -10.95 57.54 Favored Glycine 0 C--O 1.245 0.796 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -74.99 114.69 13.76 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 18.7 ptpt -91.62 122.31 34.08 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.483 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.427 HG13 HG13 ' A' ' 109' ' ' VAL . 2.9 mp -86.53 134.14 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.194 -172.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . 0.608 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -114.83 -14.07 11.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.565 0.697 . . . . 0.0 110.869 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 23.0 tp60 -147.06 129.76 16.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.564 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.498 HG23 HD13 ' A' ' 107' ' ' LEU . 46.2 t -135.38 116.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 5.3 t-20 37.6 59.15 1.28 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.269 1.827 . . . . 0.0 113.465 176.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.24 4.82 38.63 Favored Glycine 0 C--N 1.3 -1.461 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.408 ' CD1' ' HB ' ' A' ' 80' ' ' VAL 0.385 0.0 OUTLIER -90.27 -100.02 0.1 Allowed 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 118.635 1.218 . . . . 0.0 112.603 178.52 . . . . . . . . 4 4 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 173.66 116.96 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -115.14 -2.77 12.66 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.015 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.608 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.5 t -64.87 -28.3 69.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.541 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttm -146.72 87.53 1.71 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.38 0.609 . . . . 0.0 109.579 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.414 HG11 HG13 ' A' ' 55' ' ' ILE . 7.5 p -149.37 149.63 14.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.913 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 38' ' ' ASP . 4.3 p -71.22 155.86 40.23 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 123.3 0.64 . . . . 0.0 110.428 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.523 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.5 t60 -55.6 -43.83 76.4 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.787 176.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.16 -48.89 79.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.684 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -32.52 70.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.11 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.73 -42.64 73.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.05 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 11.2 mmm180 -60.6 -37.03 80.02 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.83 0.824 . . . . 0.0 108.849 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.91 21.16 1.07 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.052 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.518 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 17.7 mmt180 -134.69 -42.53 0.76 Allowed 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.316 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 1.3 pp -100.62 -28.82 12.66 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.48 ' N ' HD11 ' A' ' 97' ' ' LEU . 9.3 t -106.97 14.8 26.06 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.872 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 14.4 ptpt -73.67 175.48 7.12 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.466 169.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -122.81 6.88 9.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.3 t -75.26 -38.45 60.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.493 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -87.97 174.15 8.48 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.529 178.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.444 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 8.6 pt-20 -137.77 -58.72 0.67 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.587 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 59.0 t -104.07 127.2 58.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.465 HG22 HD11 ' A' ' 29' ' ' LEU . 15.0 m -122.16 148.62 25.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.385 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -119.23 103.96 9.98 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.498 HD13 HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -110.17 151.85 26.78 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.963 -171.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.3 mp -125.31 119.37 28.2 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.427 HG13 HG13 ' A' ' 77' ' ' ILE . 27.1 m -112.58 147.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.184 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.7 p . . . . . 0 N--CA 1.408 -2.57 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.842 178.055 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.427 -1.602 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.448 HG23 HG22 ' A' ' 110' ' ' THR . 12.7 t -80.45 126.35 39.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.41 ' NE2' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -144.74 153.1 41.33 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.425 -175.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -90.12 148.17 23.16 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.51 HG12 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -128.29 152.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -135.24 104.36 5.87 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.075 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.8 129.74 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.942 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -99.35 144.8 28.05 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 20.0 pttm -35.26 127.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.0 tp -125.14 118.26 25.71 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.227 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -88.38 111.86 22.23 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.729 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -117.99 110.38 17.62 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.93 -109.73 3.04 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -113.95 13.31 18.26 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -112.57 171.64 7.4 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.873 0.844 . . . . 0.0 109.837 -174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 20' ' ' LYS . 2.3 tm? -126.53 111.82 14.82 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 172.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.97 164.5 23.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 38.1 mt -87.66 -4.24 58.94 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.964 0.888 . . . . 0.0 108.629 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 92.67 -46.02 2.53 Favored Glycine 0 N--CA 1.424 -2.154 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.949 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -84.33 166.46 17.41 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.193 0.521 . . . . 0.0 112.218 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 29.2 m -122.36 166.85 14.05 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.656 1.182 . . . . 0.0 109.961 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 55' ' ' ILE . 3.7 pt -125.14 164.4 24.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.07 -16.23 7.39 Favored Glycine 0 CA--C 1.487 -1.685 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.328 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.584 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 125.04 169.35 12.93 Favored Glycine 0 CA--C 1.473 -2.54 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.168 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.448 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -122.2 -116.3 2.36 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.367 0.686 . . . . 0.0 111.57 175.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . 0.468 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.45 -15.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.151 0.977 . . . . 0.0 110.777 -177.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.487 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 15.2 t0 -70.95 -19.91 62.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.085 -177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.584 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 16.4 mm-40 -113.37 155.25 25.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 10.0 t70 -98.32 129.37 30.73 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 118.612 0.642 . . . . 0.0 109.431 -176.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.53 -21.3 45.35 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 122.768 2.312 . . . . 0.0 113.198 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -77.36 -11.13 59.8 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.015 0.436 . . . . 0.0 110.625 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -130.15 11.58 5.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.415 0.626 . . . . 0.0 110.75 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.471 HD22 ' HB2' ' A' ' 39' ' ' GLN . 97.4 m-20 -99.91 143.32 26.27 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.76 -52.98 0.47 Allowed 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.201 2.601 . . . . 0.0 113.118 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.38 18.11 20.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.575 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.0 t . . . . . 0 C--N 1.31 -1.133 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 53.4 mttt . . . . . 0 C--O 1.224 -0.241 0 CA-C-O 121.206 0.526 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.56 153.36 5.85 Favored Glycine 0 C--O 1.18 -3.273 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.535 HD11 ' C ' ' A' ' 35' ' ' GLY . 30.5 mm -68.27 125.33 25.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 118.009 0.904 . . . . 0.0 109.774 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -124.98 155.9 38.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.188 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.435 HG22 HD13 ' A' ' 71' ' ' LEU . 87.7 t -81.46 129.92 36.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 124.455 1.097 . . . . 0.0 110.619 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -106.08 -19.7 13.64 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.279 0.561 . . . . 0.0 111.068 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -154.46 138.97 16.84 Favored 'General case' 0 C--O 1.204 -1.309 0 C-N-CA 124.124 0.97 . . . . 0.0 108.519 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.515 HG11 ' O ' ' A' ' 71' ' ' LEU . 18.9 m -109.87 174.83 1.75 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.194 0 CA-C-N 119.688 1.131 . . . . 0.0 109.222 172.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.622 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.3 t -77.93 116.23 18.26 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -52.85 -16.34 0.99 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.997 1.719 . . . . 0.0 114.68 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.35 30.41 0.42 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.17 -171.46 19.33 Favored Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.8 -27.07 67.71 Favored 'Trans proline' 0 C--O 1.208 -0.986 0 C-N-CA 123.468 2.778 . . . . 0.0 111.634 -171.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.51 -66.71 0.42 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.796 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.7 pt-20 -75.43 -22.74 57.12 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.592 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -62.93 -41.03 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.03 -45.51 26.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.074 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.1 2.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 119.644 -1.265 . . . . 0.0 114.08 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.515 ' O ' HG11 ' A' ' 60' ' ' VAL . 7.6 tp -74.8 126.51 31.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 122.767 -0.255 . . . . 0.0 110.638 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -120.3 160.82 22.24 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.134 0.896 . . . . 0.0 109.936 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.98 128.72 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.491 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.12 -9.47 54.51 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.341 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 74.1 m-20 -77.78 119.13 20.85 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -88.9 124.12 33.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.431 HG13 HG11 ' A' ' 109' ' ' VAL . 3.0 mp -88.29 135.96 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -174.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.1 mmt -107.77 -26.1 10.95 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.389 0.614 . . . . 0.0 109.839 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -151.63 133.73 15.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.496 HG22 HD21 ' A' ' 107' ' ' LEU . 49.9 t -136.98 117.57 17.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 C-N-CA 123.663 0.785 . . . . 0.0 110.037 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 49.6 49.98 19.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.153 0.981 . . . . 0.0 111.625 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . 0.462 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 69.93 8.06 60.39 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CD2' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -115.26 158.87 21.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 117.681 0.74 . . . . 0.0 110.346 176.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 123.299 0.64 . . . . 0.0 110.509 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.51 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 20.2 ttm -117.47 -4.5 11.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.92 0.867 . . . . 0.0 110.737 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t -68.11 -25.46 65.32 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.779 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 ttt -135.95 85.51 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.91 0.386 . . . . 0.0 110.519 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 p -154.79 148.4 12.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 38' ' ' ASP . 7.9 p -73.05 156.54 38.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.552 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.1 t60 -55.42 -47.33 76.11 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 33.8 t70 -58.93 -47.46 84.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.331 -176.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -72.1 -39.46 68.91 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.202 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.94 -41.7 99.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.303 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.48 ' CZ ' HG21 ' A' ' 98' ' ' THR . 18.2 mmm180 -58.16 -26.03 62.22 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.485 0.659 . . . . 0.0 112.119 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 45.1 mmtm -95.0 8.19 43.68 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.493 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 24.7 ttm180 -136.79 -30.96 0.87 Allowed 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.686 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -92.98 -40.6 10.47 Favored 'General case' 0 C--O 1.19 -2.062 0 C-N-CA 116.646 -2.021 . . . . 0.0 111.132 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.48 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 8.8 t -102.15 14.71 31.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 109.406 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.8 ptpt -66.49 -176.06 0.42 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.951 170.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -122.07 -3.74 9.06 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -67.24 -40.41 86.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 175.51 5.62 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.943 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -134.79 -62.26 0.74 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.53 112.46 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 m -110.41 131.86 60.33 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.206 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -99.8 107.49 19.55 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.496 HD21 HG22 ' A' ' 80' ' ' VAL . 13.9 mt -108.65 151.42 26.17 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.5 mp -122.34 118.62 28.89 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.431 HG11 HG13 ' A' ' 77' ' ' ILE . 31.7 m -117.85 165.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.09 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.448 HG22 HG23 ' A' ' 13' ' ' VAL . 23.8 p . . . . . 0 N--CA 1.407 -2.584 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.307 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.427 -1.614 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.463 HG21 HG21 ' A' ' 110' ' ' THR . 25.3 t -108.77 125.98 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.43 151.17 46.04 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.317 -176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 149.52 23.2 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.78 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -129.65 157.77 42.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -144.92 107.84 4.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.334 0.587 . . . . 0.0 110.771 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -97.46 132.17 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -98.45 152.65 19.28 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 123.819 0.699 . . . . 0.0 110.232 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -40.93 113.17 0.36 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 125.508 1.523 . . . . 0.0 114.48 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.473 HD22 ' CD ' ' A' ' 65' ' ' PRO . 26.7 tp -127.94 137.43 52.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.065 0.546 . . . . 0.0 111.513 177.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -104.62 131.44 52.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -122.47 107.36 11.95 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.15 -113.56 5.24 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -108.79 16.91 22.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.752 0.787 . . . . 0.0 110.539 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -120.63 176.72 5.37 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 1.3 tm? -128.13 112.09 14.18 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mt -129.22 159.01 41.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 61.0 mt -79.61 2.69 21.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.759 0.79 . . . . 0.0 109.844 175.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.28 4.57 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.917 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -98.76 167.33 10.84 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.7 m -121.49 164.15 17.66 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.441 1.096 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.485 HD12 HD13 ' A' ' 55' ' ' ILE . 6.2 pt -124.34 163.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -173.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.21 -24.36 6.56 Favored Glycine 0 CA--C 1.484 -1.886 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.462 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.533 ' C ' HD12 ' A' ' 55' ' ' ILE . . . 124.75 167.67 12.67 Favored Glycine 0 N--CA 1.407 -3.25 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.848 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.57 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -113.8 -121.79 3.73 Favored Glycine 0 N--CA 1.427 -1.904 0 O-C-N 124.507 0.769 . . . . 0.0 112.591 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -19.51 25.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.036 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 27.0 mm-40 -96.01 -173.9 2.96 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -132.98 124.96 18.86 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.943 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.457 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 10.0 Cg_endo -57.63 -26.69 73.82 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.074 2.516 . . . . 0.0 113.132 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -68.87 -32.64 72.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.228 0.537 . . . . 0.0 110.373 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.74 8.51 18.93 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.522 0.677 . . . . 0.0 110.729 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.13 142.19 24.14 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.85 -51.57 0.64 Allowed 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 123.378 2.719 . . . . 0.0 112.843 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -109.18 26.5 10.56 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.029 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 13.8 t . . . . . 0 C--N 1.301 -1.512 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.0 mtmm . . . . . 0 N--CA 1.427 -1.601 0 CA-C-O 121.843 0.83 . . . . 0.0 111.997 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.401 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 144.71 167.36 12.06 Favored Glycine 0 C--O 1.17 -3.877 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 36' ' ' GLY . 35.5 mm -73.9 115.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 120.26 2.03 . . . . 0.0 110.433 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 0.4 OUTLIER -114.9 151.73 33.5 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.059 178.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 71' ' ' LEU . 87.6 t -82.77 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.31 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p -106.66 -15.04 14.87 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.625 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -152.23 145.32 24.56 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' CG2' HG13 ' A' ' 57' ' ' VAL . 39.5 t -133.79 148.72 30.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 13.3 p -52.95 128.54 27.52 Favored 'General case' 0 N--CA 1.406 -2.648 0 O-C-N 124.289 0.993 . . . . 0.0 109.635 176.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.92 -13.6 61.69 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 123.629 0.581 . . . . 0.0 111.553 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.46 41.53 0.31 Allowed Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -120.46 -169.49 13.96 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.194 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.473 ' CD ' HD22 ' A' ' 21' ' ' LEU . 39.2 Cg_endo -64.18 -32.28 63.2 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 123.614 2.876 . . . . 0.0 112.391 -171.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.408 ' HB2' ' OG ' ' A' ' 61' ' ' SER . . . -59.08 -57.22 14.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.202 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 61' ' ' SER . 4.5 pt-20 -75.88 -24.45 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.48 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 64' ' ' GLY . 21.2 mm -63.61 -39.74 86.46 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 121.206 0.527 . . . . 0.0 109.903 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.7 -56.87 4.27 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.842 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.13 24.74 0.05 OUTLIER Glycine 0 C--O 1.224 -0.501 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.292 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 16' ' ' VAL . 4.6 tp -91.96 124.65 36.23 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.439 ' N ' HD13 ' A' ' 71' ' ' LEU . 20.8 mm-40 -116.61 157.34 25.49 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.0 137.15 25.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.865 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.34 -0.25 59.93 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.941 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.13 123.24 24.88 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 120.773 0.321 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -89.0 110.81 21.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 57' ' ' VAL . 12.3 mt -82.94 129.03 38.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.352 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.1 mmt -105.63 -26.26 11.92 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.478 0.656 . . . . 0.0 110.589 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 11.9 tp60 -152.46 133.11 13.92 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.88 -169.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.504 HG21 HD11 ' A' ' 107' ' ' LEU . 55.0 t -136.53 111.86 11.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 C-N-CA 124.27 1.028 . . . . 0.0 111.431 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.2 t-20 52.25 34.93 15.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.724 1.61 . . . . 0.0 112.92 173.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.65 -9.4 68.8 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.435 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.44 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -104.44 150.09 24.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.707 0.403 . . . . 0.0 110.207 178.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.91 132.76 41.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 123.839 0.855 . . . . 0.0 110.343 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.457 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 24.5 ttm -123.28 -0.48 8.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.211 1.005 . . . . 0.0 110.943 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 t -70.16 -25.06 63.27 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.259 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.9 ttt -141.41 86.29 2.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.245 0.545 . . . . 0.0 109.903 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.36 151.95 11.29 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.8 p -75.0 157.11 35.46 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.176 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.585 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.9 t60 -53.84 -45.44 70.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.72 -51.22 69.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.435 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -30.3 63.6 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.072 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.556 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -76.66 -36.0 57.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.141 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -51.49 -45.65 62.9 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.931 0.77 . . . . 0.0 111.424 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.357 0.0 OUTLIER -93.06 59.71 3.16 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-O 122.904 1.335 . . . . 0.0 110.813 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.477 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tpt180 -154.38 -48.1 0.09 Allowed 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 112.151 -2.295 . . . . 0.0 106.698 171.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 1.4 pp -94.88 -25.46 16.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.451 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.7 t -114.23 14.06 18.04 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.476 174.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.501 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 17.5 ptpt -77.23 168.05 20.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.432 172.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.402 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 9.7 ptp85 -113.74 0.39 14.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.822 -175.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.501 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 40.9 m -76.1 -34.02 59.5 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.804 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.409 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 10.2 pt-20 -111.78 172.18 7.05 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.695 -178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -132.85 -87.35 0.44 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 17.9 t -73.37 114.11 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-O 121.625 0.726 . . . . 0.0 109.816 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.455 HG22 HD11 ' A' ' 29' ' ' LEU . 11.4 m -110.36 153.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.761 -177.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -120.94 100.28 6.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -109.28 160.65 15.95 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.548 -171.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.7 mp -132.34 122.58 25.31 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.44 156.99 23.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.027 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.463 HG21 HG21 ' A' ' 13' ' ' VAL . 66.3 p . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 121.27 0.557 . . . . 0.0 110.696 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.856 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m -84.68 98.7 10.36 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.501 0.667 . . . . 0.0 110.355 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.481 ' CE1' ' HD2' ' A' ' 5' ' ' PRO . 10.3 t80 -84.27 127.24 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.423 ' CG2' ' HD3' ' A' ' 5' ' ' PRO 0.328 7.9 tp -92.26 -43.96 0.35 Allowed Pre-proline 0 CA--C 1.575 1.919 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.6 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.481 ' HD2' ' CE1' ' A' ' 3' ' ' TYR . 7.5 Cg_exo -65.46 -177.3 0.65 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 CA-C-N 121.442 1.551 . . . . 0.0 113.932 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -119.98 39.0 2.59 Favored Glycine 0 C--N 1.288 -2.133 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.474 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.43 126.6 47.43 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.498 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 61.8 Cg_endo -82.8 -87.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.067 0 C-N-CA 122.419 2.079 . . . . 0.0 111.275 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 m -142.92 -51.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 122.526 0.331 . . . . 0.0 111.751 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -90.24 -44.86 9.45 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.657 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.498 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . -88.41 144.79 26.16 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.26 128.77 73.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.4 p -91.06 129.16 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.28 151.54 51.33 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.741 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.95 152.18 18.57 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.742 0.306 . . . . 0.0 110.548 -172.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -129.58 154.61 40.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -141.12 102.12 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.306 0.574 . . . . 0.0 110.35 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.42 127.01 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -99.63 148.67 24.08 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.456 ' HB2' HD11 ' A' ' 27' ' ' LEU . 22.5 pttm -39.18 123.36 1.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.472 HD21 ' HD2' ' A' ' 65' ' ' PRO . 49.4 tp -117.67 122.08 42.58 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.559 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -92.81 109.71 21.15 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -107.41 109.14 20.79 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.57 -110.77 3.69 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.72 17.74 12.71 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.194 0.521 . . . . 0.0 111.479 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.67 166.81 12.29 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.456 HD11 ' HB2' ' A' ' 20' ' ' LYS . 58.4 tp -112.85 126.59 55.61 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -136.82 163.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.402 HD23 ' O ' ' A' ' 97' ' ' LEU . 9.9 mp -88.4 2.3 52.94 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.051 0.929 . . . . 0.0 109.419 175.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.9 -47.26 2.04 Favored Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 115.264 -0.88 . . . . 0.0 114.362 175.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.421 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 39.9 p90 -90.63 166.11 13.35 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.8 m -123.96 163.62 20.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.508 1.523 . . . . 0.0 109.497 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.513 HD11 HD13 ' A' ' 55' ' ' ILE . 7.9 pt -125.17 166.15 21.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 122.75 0.42 . . . . 0.0 110.615 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.24 -22.42 6.83 Favored Glycine 0 CA--C 1.487 -1.675 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.311 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 123.58 163.54 11.78 Favored Glycine 0 C--O 1.196 -2.238 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.613 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -112.88 -117.3 3.45 Favored Glycine 0 N--CA 1.432 -1.588 0 O-C-N 124.583 0.814 . . . . 0.0 112.345 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.62 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.05 -17.58 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 122.101 0.953 . . . . 0.0 112.869 -174.828 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.496 ' HB2' HG23 ' A' ' 89' ' ' THR . 19.5 t70 -75.2 -9.19 58.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.421 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.6 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 24.9 mm-40 -107.55 162.86 13.57 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.097 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -105.21 108.63 61.82 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -58.44 -19.79 45.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 123.794 2.996 . . . . 0.0 113.402 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -75.34 -5.58 45.51 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.586 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.15 29.29 0.89 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.523 0.329 . . . . 0.0 111.155 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -107.22 145.5 31.32 Favored Pre-proline 0 CA--C 1.495 -1.14 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.36 -40.83 10.09 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 C-N-CA 123.204 2.603 . . . . 0.0 113.057 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.63 4.41 10.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.262 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.1 t -104.22 1.23 30.33 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.242 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.06 -20.4 65.82 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.365 1.078 . . . . 0.0 108.508 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.517 ' OD2' ' HG2' ' A' ' 50' ' ' LYS . 3.0 t70 -69.53 -60.79 2.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.208 175.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.517 ' HG2' ' OD2' ' A' ' 49' ' ' ASP . 45.7 mmtm -122.5 130.32 52.92 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.521 0.677 . . . . 0.0 110.973 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 p -83.67 -0.19 49.65 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.079 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.45 -5.61 56.85 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 123.022 1.392 . . . . 0.0 110.154 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.62 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 53.1 mttp 49.93 -176.63 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 111.354 -2.657 . . . . 0.0 113.535 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.93 159.41 8.28 Favored Glycine 0 C--O 1.191 -2.555 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.513 HD13 HD11 ' A' ' 33' ' ' ILE . 20.1 mm -77.88 128.11 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 117.657 0.728 . . . . 0.0 109.538 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.406 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 3.1 p90 -131.09 157.77 42.18 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.951 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.5 t -80.57 134.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 O-C-N 124.748 1.28 . . . . 0.0 110.469 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 p -106.15 -23.03 12.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.618 0.723 . . . . 0.0 110.519 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -155.19 142.51 19.47 Favored 'General case' 0 CA--C 1.473 -1.992 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 16.3 m -107.73 -172.03 0.4 Allowed 'Isoleucine or valine' 1 N--CA 1.339 -6.02 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.5 p -64.51 131.32 46.77 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.59 -21.42 26.68 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 123.181 0.592 . . . . 0.0 112.146 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.99 52.72 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.6 -161.23 10.45 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-N 114.905 -0.648 . . . . 0.0 112.771 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.472 ' HD2' HD21 ' A' ' 21' ' ' LEU . 38.2 Cg_endo -63.27 -32.68 72.94 Favored 'Trans proline' 0 C--O 1.211 -0.872 0 C-N-CA 123.541 2.827 . . . . 0.0 112.543 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.06 -61.1 2.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -70.79 -30.67 67.2 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.329 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 mm -63.69 -42.69 96.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.783 0.325 . . . . 0.0 111.316 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.74 -55.2 5.7 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.169 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.98 29.4 0.05 OUTLIER Glycine 0 C--N 1.312 -0.78 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.056 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.502 ' HB2' HG12 ' A' ' 16' ' ' VAL . 6.5 tp -100.33 120.93 40.69 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.457 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 28.7 mm-40 -116.33 153.31 32.21 Favored 'General case' 0 N--CA 1.425 -1.693 0 O-C-N 123.964 0.79 . . . . 0.0 110.959 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.43 131.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.68 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.96 -27.45 20.34 Favored Glycine 0 C--O 1.252 1.244 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.956 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.589 ' OD1' ' HA ' ' A' ' 111' ' ' ARG . 53.2 m-20 -72.53 125.28 27.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.762 0.792 . . . . 0.0 111.02 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.406 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 63.2 mttp -82.87 128.82 34.78 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.139 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.414 HG13 HG13 ' A' ' 109' ' ' VAL . 2.8 mp -92.72 124.57 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.3 mmt -109.41 -11.44 14.83 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.533 0.683 . . . . 0.0 110.918 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -148.43 124.74 10.88 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.498 HG22 HD23 ' A' ' 107' ' ' LEU . 44.6 t -136.68 118.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 53.07 39.16 29.08 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.607 1.163 . . . . 0.0 112.997 170.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.413 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 65.08 27.42 72.28 Favored Glycine 0 N--CA 1.462 0.408 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.715 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -10.04 13.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 55.69 111.47 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.468 1.107 . . . . 0.0 113.717 -169.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.617 ' SD ' HG12 ' A' ' 88' ' ' VAL . 62.7 tpp -95.92 1.52 52.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.201 1.001 . . . . 0.0 109.353 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -71.33 135.55 47.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttp 55.48 74.61 0.36 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.327 1.051 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.617 HG12 ' SD ' ' A' ' 85' ' ' MET . 11.3 p -149.9 150.16 13.95 Favored 'Isoleucine or valine' 0 C--O 1.261 1.691 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 38' ' ' ASP . 15.6 p -73.31 157.66 36.59 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.6 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 13.7 t60 -53.58 -42.93 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.336 175.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.75 -46.66 84.32 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.789 0.681 . . . . 0.0 110.825 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -32.89 67.42 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.816 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.64 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.88 -45.13 75.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.314 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.463 ' CZ ' HG23 ' A' ' 98' ' ' THR . 13.5 mmm180 -55.18 -40.76 71.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.661 0.743 . . . . 0.0 110.291 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.502 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -85.93 32.69 0.6 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.893 -176.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.455 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.1 tpt180 -148.88 -48.66 0.15 Allowed 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.014 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.64 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -92.32 -20.72 20.81 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.489 ' N ' HD11 ' A' ' 97' ' ' LEU . 14.6 t -118.21 10.12 12.79 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 117.666 -1.613 . . . . 0.0 110.837 175.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -66.28 154.96 38.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -103.67 6.24 36.88 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.0 t -79.28 -37.93 36.64 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -92.96 147.9 22.45 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.449 ' HG3' HG11 ' A' ' 104' ' ' VAL . 11.7 pt-20 -101.48 -63.9 1.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.794 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -117.85 133.26 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-O 122.002 0.905 . . . . 0.0 112.347 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.3 m -129.65 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.631 -174.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -100.57 112.82 25.25 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.498 HD23 HG22 ' A' ' 80' ' ' VAL . 14.8 mt -112.86 162.9 15.27 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.1 mp -139.74 123.66 17.61 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 123.421 0.689 . . . . 0.0 109.273 174.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.414 HG13 HG13 ' A' ' 77' ' ' ILE . 34.7 m -115.71 151.49 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 CA-C-O 121.16 0.505 . . . . 0.0 110.101 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.6 p -102.71 122.63 44.84 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.589 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 68.7 mtp180 -69.08 114.23 7.16 Favored 'General case' 0 N--CA 1.42 -1.929 0 O-C-N 123.968 0.793 . . . . 0.0 110.143 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.518 ' C ' ' H ' ' A' ' 114' ' ' LEU . 27.9 mm-40 -108.79 3.99 23.15 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.8 p -77.24 34.84 0.16 Allowed 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 125.821 1.648 . . . . 0.0 110.518 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 112' ' ' GLN . 6.9 mp -88.43 -173.48 4.2 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 125.29 1.436 . . . . 0.0 112.245 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.555 ' C ' ' H ' ' A' ' 117' ' ' ALA . 26.6 mm-40 -129.99 163.51 26.3 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 172.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp 74.91 -29.92 0.2 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 124.753 1.221 . . . . 0.0 110.632 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.555 ' H ' ' C ' ' A' ' 115' ' ' GLN . . . -101.43 166.55 10.67 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 172.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.5 t 70.8 89.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.132 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -54.27 140.79 31.93 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.512 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . 0.429 ' HB2' ' OXT' ' A' ' 124' ' ' SER . 4.3 pt20 -44.97 -38.12 4.49 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -171.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.3 m 56.32 26.9 11.12 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.471 0.708 . . . . 0.0 111.167 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 92.6 mmm 64.12 6.62 2.99 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.252 1.421 . . . . 0.0 112.98 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.0 -29.4 15.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.419 0.628 . . . . 0.0 109.636 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.429 ' OXT' ' HB2' ' A' ' 120' ' ' GLN . 60.1 m . . . . . 0 N--CA 1.42 -1.952 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.122 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m -87.15 156.95 19.48 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -144.99 123.0 12.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mm -121.62 103.65 40.59 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -83.09 -179.98 4.77 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.455 2.103 . . . . 0.0 112.208 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.4 40.26 2.97 Favored Glycine 0 C--N 1.306 -1.13 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.759 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.87 138.63 27.72 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.87 -90.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.032 1.821 . . . . 0.0 113.239 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -141.13 -42.04 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-O 121.088 0.47 . . . . 0.0 111.795 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -109.78 -37.0 5.77 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.85 149.55 26.49 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.16 124.89 44.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.024 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.33 146.3 14.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.538 HE22 ' HB ' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -153.78 155.15 35.31 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 122.195 -0.316 . . . . 0.0 110.451 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.64 142.65 27.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.538 ' HB ' HE22 ' A' ' 14' ' ' GLN . 8.1 p -134.68 154.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -144.99 107.72 4.46 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.485 0.659 . . . . 0.0 111.26 -173.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.424 HG23 ' CG ' ' A' ' 65' ' ' PRO . 2.0 mp -97.26 126.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.15 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -93.25 145.24 24.58 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.814 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HB2' HD11 ' A' ' 27' ' ' LEU . 20.2 pttp -37.6 115.95 0.45 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.695 1.198 . . . . 0.0 113.805 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.02 123.85 44.45 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.303 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.51 126.94 35.79 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.193 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -120.67 106.32 11.61 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.39 -100.52 1.07 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -125.56 14.89 8.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.269 0.557 . . . . 0.0 110.348 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.436 ' HA ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.5 169.46 11.39 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.478 HD11 ' HB2' ' A' ' 20' ' ' LYS . 14.3 tp -116.45 119.17 34.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.15 163.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.432 HD21 ' O ' ' A' ' 97' ' ' LEU . 2.9 mm? -95.83 9.35 40.81 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-O 123.446 1.593 . . . . 0.0 108.659 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.98 -48.69 3.69 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.603 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.35 170.65 11.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.098 0.475 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.427 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 48.8 m -132.85 163.49 28.97 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 123.66 0.784 . . . . 0.0 110.485 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.513 HD13 HD13 ' A' ' 55' ' ' ILE . 6.1 pt -121.18 166.96 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 122.777 0.431 . . . . 0.0 110.42 -174.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.33 -21.58 6.87 Favored Glycine 0 CA--C 1.486 -1.741 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.595 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.581 ' C ' HD12 ' A' ' 55' ' ' ILE . . . 124.54 169.51 13.04 Favored Glycine 0 N--CA 1.416 -2.672 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.909 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -119.4 -117.95 2.7 Favored Glycine 0 C--O 1.209 -1.435 0 O-C-N 124.158 0.563 . . . . 0.0 112.24 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.15 -19.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.051 0.453 . . . . 0.0 111.757 -176.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.508 ' HB2' HG23 ' A' ' 89' ' ' THR . 35.8 t70 -76.17 -8.8 57.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.226 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.586 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 26.4 mm-40 -107.11 165.8 11.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.5 t70 -107.83 119.99 48.53 Favored Pre-proline 0 C--N 1.315 -0.905 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.244 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -56.07 -29.0 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.335 2.69 . . . . 0.0 113.379 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -67.87 -26.45 66.03 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -117.43 9.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.0 111.747 -176.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 5.9 m-80 -101.36 150.9 37.59 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.458 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 56.4 Cg_endo -69.14 -49.88 0.6 Allowed 'Trans proline' 0 C--O 1.217 -0.549 0 C-N-CA 123.207 2.605 . . . . 0.0 113.49 -175.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.44 7.64 24.98 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.735 0.779 . . . . 0.0 110.333 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 9.2 t -106.43 -11.11 16.04 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.716 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 9.4 pt-20 -69.15 -9.7 54.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.284 1.04 . . . . 0.0 110.048 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.76 -51.05 54.02 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 126.395 1.878 . . . . 0.0 111.468 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -152.25 -161.14 1.25 Allowed 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.3 p -102.14 6.25 40.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.281 172.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.31 128.62 36.19 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.928 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 30.5 mmtm -97.14 172.16 8.0 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.442 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.51 154.54 6.21 Favored Glycine 0 C--O 1.174 -3.649 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.606 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 29.5 mm -73.49 120.15 21.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 118.112 0.956 . . . . 0.0 109.776 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.432 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.8 p90 -117.42 151.25 37.44 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.53 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 71' ' ' LEU . 93.7 t -82.12 130.3 36.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 124.02 0.825 . . . . 0.0 109.853 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -103.13 -27.19 12.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.58 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 85.4 mtt180 -144.12 138.44 28.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.082 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 HG11 ' CB ' ' A' ' 66' ' ' ALA . 4.9 t -116.28 144.71 23.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.523 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 2.8 t -45.52 113.69 0.63 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.927 1.392 . . . . 0.0 109.102 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.46 -17.69 14.59 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.513 1.525 . . . . 0.0 114.421 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.3 46.52 0.19 Allowed Glycine 0 CA--C 1.469 -2.806 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.523 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -131.65 -165.71 11.46 Favored Glycine 0 N--CA 1.413 -2.899 0 CA-C-N 114.172 -1.014 . . . . 0.0 112.721 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.424 ' CG ' HG23 ' A' ' 18' ' ' ILE . 41.9 Cg_endo -65.2 -29.6 55.47 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 123.706 2.937 . . . . 0.0 112.4 -170.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.407 ' CB ' HG11 ' A' ' 60' ' ' VAL . . . -60.73 -59.14 5.86 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.433 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.513 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.0 pt-20 -67.8 -32.62 73.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.649 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 64' ' ' GLY . 23.1 mm -58.55 -47.26 88.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.015 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.96 -40.89 64.97 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.494 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.1 20.62 0.82 Allowed Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.153 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 57' ' ' VAL . 1.9 tp -79.58 125.81 30.08 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.419 ' N ' HD11 ' A' ' 71' ' ' LEU . 21.3 mm-40 -114.27 150.88 33.73 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.839 0.828 . . . . 0.0 109.733 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.4 mt -68.63 132.68 32.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.9 175.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.31 58.57 Favored Glycine 0 C--O 1.248 0.984 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.429 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.465 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 15.4 m-20 -84.74 126.22 33.22 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.414 ' HZ2' ' HG3' ' A' ' 112' ' ' GLN . 47.2 mttp -86.88 117.35 25.55 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.7 mt -83.15 141.48 14.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.651 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.3 mmt -119.96 -20.6 7.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.438 0.637 . . . . 0.0 109.351 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.43 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -143.59 138.61 29.18 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.459 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 34.4 t -142.37 119.68 7.14 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 124.045 0.938 . . . . 0.0 108.752 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.3 t-20 43.86 57.22 4.21 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.736 1.614 . . . . 0.0 112.127 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.43 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 47.44 30.15 5.88 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 117.07 1.588 . . . . 0.0 117.07 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.459 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.1 OUTLIER -109.72 -12.47 14.62 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -175.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.95 93.55 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 127.258 2.223 . . . . 0.0 107.973 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.606 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 4.3 ttp -89.02 -12.51 41.17 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -170.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.1 t -53.93 127.84 27.84 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 120.93 0.395 . . . . 0.0 110.357 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.3 ttm 63.4 90.27 0.08 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.446 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.8 p -158.49 155.64 4.41 Favored 'Isoleucine or valine' 0 C--O 1.263 1.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.508 HG23 ' HB2' ' A' ' 38' ' ' ASP . 9.4 p -75.09 159.72 31.34 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 120.98 0.419 . . . . 0.0 110.167 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.586 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 14.1 t60 -55.33 -46.9 76.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.634 174.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.8 -50.56 72.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.987 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.4 67.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.957 -176.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.677 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -73.81 -42.54 60.8 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.489 ' CZ ' HG21 ' A' ' 98' ' ' THR . 12.9 mmm180 -50.19 -44.17 52.85 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 123.92 0.888 . . . . 0.0 111.031 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -84.26 29.25 0.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.056 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.47 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 5.3 tpt180 -142.91 -42.61 0.31 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.84 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.677 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -95.27 -17.52 21.61 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.489 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 11.9 t -124.75 13.78 8.62 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.692 174.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.47 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.6 ptpt -70.17 178.29 2.87 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.315 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.436 ' NH1' ' HA ' ' A' ' 26' ' ' ASN . 13.9 ptm180 -131.65 6.08 4.36 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.556 -176.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.449 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 20.2 m -74.93 -41.77 59.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.37 0.605 . . . . 0.0 109.497 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.31 139.73 32.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.411 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.96 -63.81 1.24 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.0 t -98.8 122.38 50.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 120.81 0.338 . . . . 0.0 110.141 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.41 ' HA ' ' ND2' ' A' ' 81' ' ' ASN . 33.4 m -113.96 145.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -125.64 115.98 20.98 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.455 HD11 HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -117.61 153.15 33.77 Favored 'General case' 0 N--CA 1.397 -3.123 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -172.216 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.3 mp -118.0 121.18 39.96 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -116.8 154.08 18.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.7 p -124.8 130.83 53.15 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.778 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.451 ' HB3' ' OD1' ' A' ' 75' ' ' ASP 0.314 0.0 OUTLIER -100.52 98.94 9.48 Favored 'General case' 0 N--CA 1.41 -2.439 0 C-N-CA 119.041 -1.063 . . . . 0.0 112.013 179.917 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.414 ' HG3' ' HZ2' ' A' ' 76' ' ' LYS . 19.6 mm-40 -84.54 -49.85 8.24 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.425 -175.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.6 m -86.21 15.69 5.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.54 -172.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -109.45 87.99 2.63 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -96.87 -39.41 9.42 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.968 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 53.96 78.67 0.15 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 125.014 1.326 . . . . 0.0 113.057 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.37 -60.01 2.08 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.3 t 49.82 68.34 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 124.521 1.128 . . . . 0.0 111.299 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -103.92 -14.5 15.96 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.611 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -131.2 91.92 3.11 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.6 t -85.13 -36.96 20.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.076 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptp -172.73 169.39 4.95 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.241 0.543 . . . . 0.0 110.839 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.3 tp -114.56 163.41 15.43 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.421 -1.876 0 CA-C-O 119.169 -0.443 . . . . 0.0 110.047 177.597 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.287 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -77.73 -60.58 2.31 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -81.21 160.79 24.21 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.152 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.12 107.77 54.12 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -76.03 176.77 9.6 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.446 2.097 . . . . 0.0 112.967 -177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 43.55 3.25 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -74.4 130.5 82.0 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.557 ' O ' HG12 ' A' ' 9' ' ' VAL . 18.8 Cg_endo -63.72 -68.74 0.04 OUTLIER 'Trans proline' 0 C--O 1.21 -0.891 0 C-N-CA 122.083 1.855 . . . . 0.0 111.281 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.557 HG12 ' O ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 169.24 -49.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 127.964 2.505 . . . . 0.0 108.887 178.085 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -79.96 -23.91 41.34 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.37 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.78 164.7 16.2 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.214 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -104.13 158.43 5.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -112.28 147.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -141.59 152.08 43.72 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -94.43 149.26 21.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.887 0.375 . . . . 0.0 110.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 9.8 p -136.66 159.16 37.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.49 106.47 4.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.43 0.633 . . . . 0.0 111.326 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.487 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -93.95 128.61 45.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.736 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 54.6 m170 -96.65 151.98 19.09 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 11.0 ptpp? -43.34 128.38 4.8 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.406 HD23 ' HD2' ' A' ' 65' ' ' PRO . 51.2 tp -122.48 123.85 42.23 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.189 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -88.5 116.38 26.7 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -113.3 103.33 11.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.19 -102.47 0.94 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.86 6.19 10.43 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.268 0.556 . . . . 0.0 111.317 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.85 163.11 12.98 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.427 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -117.89 108.92 15.9 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.48 163.55 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 10.9 mp -92.62 9.96 32.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.95 0.881 . . . . 0.0 110.984 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.23 -41.69 3.07 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.68 -0.691 . . . . 0.0 114.341 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.41 ' CD1' HD23 ' A' ' 71' ' ' LEU . 49.3 p90 -99.0 172.54 7.33 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.7 m -136.26 170.44 16.02 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.306 1.042 . . . . 0.0 109.364 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 HD13 HD13 ' A' ' 55' ' ' ILE . 7.0 pt -127.93 167.22 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 117.868 0.304 . . . . 0.0 111.169 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.39 -27.68 4.64 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.18 165.25 12.29 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.344 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.509 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -117.85 -110.17 2.5 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.203 0.59 . . . . 0.0 113.13 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.533 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.76 -26.19 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -173.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 15.2 t70 -66.32 -19.82 65.92 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.685 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.584 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 27.5 mm-40 -96.38 -177.76 4.07 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 3.9 t70 -132.39 120.49 16.95 Favored Pre-proline 0 CA--C 1.498 -1.029 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.12 -23.25 35.17 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.197 2.598 . . . . 0.0 113.771 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -69.9 -28.87 65.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -116.03 7.48 14.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.552 0.691 . . . . 0.0 110.725 -175.534 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -98.89 146.5 31.76 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 72.0 Cg_endo -72.32 -44.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.948 3.098 . . . . 0.0 114.458 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -109.1 12.09 25.31 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.674 0.75 . . . . 0.0 110.427 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 4.5 t -119.81 3.81 11.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.49 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 8.8 pt-20 -77.22 -28.31 53.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.616 0.722 . . . . 0.0 110.469 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.54 -46.25 33.19 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.179 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -132.5 135.12 45.8 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.8 p -80.29 6.3 12.36 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.297 0.57 . . . . 0.0 112.22 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.47 108.59 5.63 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.771 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 67.1 mttt -74.63 172.02 12.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.799 0.809 . . . . 0.0 113.144 -175.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.91 159.88 8.09 Favored Glycine 0 C--O 1.192 -2.528 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.526 HD13 HD13 ' A' ' 33' ' ' ILE . 29.0 mm -74.56 120.19 23.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 117.868 0.834 . . . . 0.0 110.296 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -120.6 157.77 28.8 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.927 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.463 HG21 HD11 ' A' ' 71' ' ' LEU . 98.5 t -84.23 132.57 31.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 O-C-N 124.713 1.258 . . . . 0.0 110.71 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -108.26 -19.66 13.4 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.462 0.649 . . . . 0.0 111.362 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -142.09 142.17 32.79 Favored 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.448 HG12 ' CB ' ' A' ' 66' ' ' ALA . 25.5 t -140.4 132.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.571 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -49.82 126.97 15.14 Favored 'General case' 0 N--CA 1.413 -2.301 0 O-C-N 124.372 1.045 . . . . 0.0 112.521 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.69 -16.17 64.03 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.06 0.944 . . . . 0.0 111.802 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.96 46.7 0.39 Allowed Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.16 -174.87 14.06 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.701 -0.749 . . . . 0.0 111.499 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.406 ' HD2' HD23 ' A' ' 21' ' ' LEU . 35.0 Cg_endo -62.54 -29.1 78.01 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 C-N-CA 124.106 3.204 . . . . 0.0 111.965 -171.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.448 ' CB ' HG12 ' A' ' 60' ' ' VAL . . . -59.7 -61.96 2.23 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.752 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.571 ' HG2' ' O ' ' A' ' 61' ' ' SER . 2.4 pt-20 -70.09 -31.2 68.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.763 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.44 -41.39 84.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.33 -44.25 30.19 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.588 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.78 27.35 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.245 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.463 HD11 HG21 ' A' ' 57' ' ' VAL . 5.1 tp -89.45 123.69 33.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.456 ' N ' HD13 ' A' ' 71' ' ' LEU . 28.0 mm-40 -110.2 162.92 14.12 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 122.301 1.048 . . . . 0.0 110.62 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.63 134.61 29.48 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.88 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.21 18.72 71.11 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.051 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 3.6 m-20 -77.01 -2.08 32.09 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 43.07 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.421 HD12 ' CG2' ' A' ' 57' ' ' VAL . 9.9 mt -84.51 124.93 40.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.519 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.477 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 18.2 mmt -112.18 -10.63 13.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.257 0.551 . . . . 0.0 110.527 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.483 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 7.8 tp60 -156.47 127.33 6.83 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.731 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.435 HG13 HD11 ' A' ' 107' ' ' LEU . 22.3 t -132.79 121.59 44.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.213 0 C-N-CA 124.175 0.99 . . . . 0.0 109.212 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.85 30.83 12.06 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.44 6.11 86.32 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 115.835 -0.62 . . . . 0.0 114.49 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.493 ' CZ2' HG22 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -99.1 -2.47 36.93 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 68.69 127.04 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 124.386 1.074 . . . . 0.0 111.222 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 8.1 tpt -123.58 -4.38 8.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 110.348 -175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -68.36 -16.19 63.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.778 -177.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.66 98.39 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.493 HG22 ' CZ2' ' A' ' 83' ' ' TRP . 9.2 p -163.93 146.58 2.73 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.429 HG21 ' HB2' ' A' ' 38' ' ' ASP . 3.1 p -73.19 155.46 39.58 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.463 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.584 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 11.1 t60 -53.5 -45.4 69.66 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.975 0.797 . . . . 0.0 109.393 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.87 -42.47 97.51 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.386 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.87 -32.31 61.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.618 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.522 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.12 -43.56 74.17 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.102 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.45 ' C ' ' H ' ' A' ' 96' ' ' ARG . 9.6 mmm180 -55.75 -40.31 72.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.009 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.14 29.53 0.41 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.146 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.511 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.6 tpt180 -142.11 -43.45 0.34 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.989 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -101.31 -20.46 15.2 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.458 ' N ' HD12 ' A' ' 97' ' ' LEU . 10.3 t -115.55 11.74 15.96 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.014 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -63.04 143.65 57.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -103.27 6.83 38.32 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.835 0.826 . . . . 0.0 110.453 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.795 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.94 165.71 12.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.472 ' HG3' HG11 ' A' ' 104' ' ' VAL . 8.8 pt-20 -118.53 -63.57 1.39 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.487 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.7 p -121.49 131.06 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-O 121.687 0.756 . . . . 0.0 112.679 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.9 m -134.49 171.87 17.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.645 -175.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -123.33 114.43 20.18 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.435 HD11 HG13 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -116.97 148.24 41.59 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -176.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.2 mp -116.02 121.91 43.65 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-O 121.349 0.595 . . . . 0.0 109.5 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.502 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 27.6 m -117.49 150.2 19.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.293 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 33.6 p -107.84 124.66 50.42 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 121.625 0.726 . . . . 0.0 110.342 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -74.29 84.62 1.91 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.151 0.977 . . . . 0.0 113.407 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -81.84 -36.42 28.31 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.286 31.3 p 58.54 69.48 0.73 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.344 -1.753 . . . . 0.0 112.859 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.28 -38.71 71.81 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.441 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -106.82 127.26 53.25 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HZ3' ' HB3' ' A' ' 116' ' ' LYS . 0.6 OUTLIER -93.45 83.64 4.58 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.207 1.003 . . . . 0.0 110.625 -178.127 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.22 147.91 23.27 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.475 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.0 t -103.54 45.47 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 123.302 1.525 . . . . 0.0 108.29 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -87.87 -31.97 19.23 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.604 -1.634 . . . . 0.0 106.83 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -107.24 134.78 49.83 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.27 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 t -73.52 117.07 14.85 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.1 mtt -66.86 -19.85 65.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.61 -173.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.33 -71.17 0.62 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--N 1.314 -0.964 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.098 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.587 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -79.88 -62.45 1.68 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -164.84 126.82 2.17 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.6 109.45 50.74 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.56 157.37 52.75 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.464 2.109 . . . . 0.0 112.436 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.73 43.09 2.1 Favored Glycine 0 C--N 1.302 -1.308 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.235 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -77.0 121.37 84.63 Favored Pre-proline 0 N--CA 1.431 -1.377 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.66 -98.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.332 2.022 . . . . 0.0 110.503 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 m -149.18 -43.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 C-N-CA 123.058 0.543 . . . . 0.0 111.35 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 t -81.91 -23.51 36.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.044 0.449 . . . . 0.0 111.319 -175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.26 143.62 46.43 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.8 t -104.7 106.46 20.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 123.411 0.444 . . . . 0.0 110.661 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.443 HG21 HG23 ' A' ' 110' ' ' THR . 41.6 t -91.5 120.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.488 ' NE2' HG21 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -138.01 156.73 47.53 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.458 0.474 . . . . 0.0 110.046 -174.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -103.32 144.71 30.99 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.409 ' HB ' HE22 ' A' ' 14' ' ' GLN . 10.0 p -126.78 156.15 37.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.95 104.07 5.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.667 0.746 . . . . 0.0 111.271 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.402 HD12 HD23 ' A' ' 107' ' ' LEU . 1.5 mp -92.31 129.02 43.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.053 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -93.15 159.97 15.05 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.741 0.651 . . . . 0.0 109.359 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 17.3 pttp -50.72 124.79 11.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 48.1 tp -128.67 131.72 48.03 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.382 0.673 . . . . 0.0 110.27 176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -131.2 106.02 8.05 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.95 -109.17 2.71 Favored Glycine 0 N--CA 1.428 -1.868 0 O-C-N 124.051 0.844 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -116.54 17.74 15.27 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.99 172.59 11.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -120.0 115.34 23.56 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 175.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.49 163.77 33.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.408 ' CD2' HG21 ' A' ' 105' ' ' VAL . 7.5 mp -82.28 2.76 30.48 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.991 0.901 . . . . 0.0 109.892 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.56 -44.89 3.06 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.816 177.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -89.17 164.69 14.89 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.605 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 85.0 p -114.74 -173.2 2.26 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.048 0.939 . . . . 0.0 109.616 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.507 HD13 HD12 ' A' ' 55' ' ' ILE . 7.3 pt -138.16 164.78 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.275 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.14 -33.79 2.68 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.501 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.32 151.62 8.59 Favored Glycine 0 C--O 1.2 -2.022 0 C-N-CA 118.581 -1.771 . . . . 0.0 113.798 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.66 -115.64 4.09 Favored Glycine 0 C--O 1.205 -1.682 0 C-N-CA 121.071 -0.585 . . . . 0.0 114.16 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.502 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.09 -9.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.039 0.923 . . . . 0.0 112.203 -175.097 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.503 ' HB2' HG23 ' A' ' 89' ' ' THR . 24.0 t70 -81.67 -13.36 57.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.579 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.603 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 17.6 mm-40 -113.8 -178.12 3.3 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.488 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 13.3 t70 -122.16 124.63 26.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.6 Cg_endo -56.44 -28.48 73.44 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.537 -176.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -76.32 -19.86 57.84 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.488 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -120.89 12.64 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.844 0.83 . . . . 0.0 110.104 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.411 HD22 ' HB3' ' A' ' 39' ' ' GLN . 0.8 OUTLIER -103.0 144.03 27.79 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.048 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.54 -49.41 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.936 2.424 . . . . 0.0 113.526 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 63.8 m-85 -111.89 16.32 20.42 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.411 1.101 . . . . 0.0 109.982 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.439 ' HB3' ' HA ' ' A' ' 41' ' ' PRO . 8.0 t -111.21 -12.41 14.12 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.74 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.6 -9.38 58.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.727 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -53.38 -42.9 67.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.478 0.656 . . . . 0.0 109.806 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -137.24 -120.93 0.14 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 t -145.66 24.99 1.35 Allowed 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -81.3 100.53 9.24 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 113.006 -1.906 . . . . 0.0 108.815 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.502 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 47.2 mttp -83.06 173.07 12.07 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.065 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.94 166.51 10.92 Favored Glycine 0 CA--C 1.475 -2.417 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.507 HD12 HD13 ' A' ' 33' ' ' ILE . 32.7 mm -81.08 132.53 31.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 18.3 p90 -141.76 161.3 38.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.683 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 32' ' ' SER . 59.6 t -84.92 130.6 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.355 0 O-C-N 124.717 1.26 . . . . 0.0 110.447 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.7 p -102.24 -23.08 14.05 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.878 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.605 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 27.1 mmt180 -149.28 129.6 13.77 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 123.97 0.908 . . . . 0.0 109.202 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 30.0 m -104.37 177.29 0.89 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.033 0 CA-C-N 119.217 0.917 . . . . 0.0 109.3 174.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.553 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.2 t -79.7 116.21 19.75 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.73 -2.21 2.36 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.382 1.473 . . . . 0.0 114.336 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.5 33.76 0.16 Allowed Glycine 0 C--N 1.273 -2.921 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -121.51 -168.49 13.44 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.43 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.96 -28.8 57.83 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 123.323 2.682 . . . . 0.0 111.661 -170.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.67 -64.27 0.99 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.124 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.553 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.3 pt-20 -71.48 -29.95 65.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.54 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.7 mm -56.2 -47.31 81.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 O-C-N 123.287 0.367 . . . . 0.0 110.73 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.44 -47.55 32.94 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.28 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.31 14.94 0.44 Allowed Glycine 0 C--N 1.312 -0.772 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.63 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tp -79.63 118.52 21.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -119.35 140.09 50.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.59 139.97 10.8 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 O-C-N 124.64 1.213 . . . . 0.0 110.303 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.48 34.67 19.14 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 119.601 -1.285 . . . . 0.0 111.436 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.557 ' OD2' HG13 ' A' ' 77' ' ' ILE . 10.0 p-10 -94.47 -161.4 0.85 Allowed 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 113.54 -1.33 . . . . 0.0 107.875 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 73.8 mmtt -150.36 96.42 2.4 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.557 HG13 ' OD2' ' A' ' 75' ' ' ASP . 22.8 mt -73.12 113.31 10.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.282 1.039 . . . . 0.0 110.459 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 15.8 mmt -105.06 -10.21 17.33 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.182 -176.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 1.1 tm0? -163.14 134.13 4.76 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 121.861 -0.525 . . . . 0.0 110.023 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.453 HG13 HD12 ' A' ' 107' ' ' LEU . 22.8 t -134.31 115.4 20.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 48.07 55.79 8.21 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 124.509 1.124 . . . . 0.0 112.395 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.412 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 62.0 2.35 3.72 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-N 113.662 -1.608 . . . . 0.0 116.582 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.461 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -87.33 -14.17 41.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.457 ' OD1' HG22 ' A' ' 86' ' ' THR . 7.3 t0 65.15 120.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.06 1.744 . . . . 0.0 111.602 -176.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.466 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 41.7 ttm -119.36 8.54 11.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.209 1.004 . . . . 0.0 110.926 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.457 HG22 ' OD1' ' A' ' 84' ' ' ASP . 10.5 t -46.12 -28.43 1.21 Allowed 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 125.793 1.637 . . . . 0.0 114.743 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 ttp -159.86 92.39 1.02 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.466 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.1 p -148.5 151.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.503 HG23 ' HB2' ' A' ' 38' ' ' ASP . 18.4 p -70.28 157.06 38.39 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.308 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.603 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.4 t60 -57.59 -43.56 84.72 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -58.9 -47.3 85.49 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.954 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -36.8 64.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.631 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.14 -40.67 94.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.711 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.417 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 7.9 mmm180 -53.45 -39.77 64.7 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.597 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.406 ' HB3' ' HZ3' ' A' ' 95' ' ' LYS . 2.8 mmmp? -81.19 13.93 2.61 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.383 -176.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 22.9 tpt180 -131.37 -35.8 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.865 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.417 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -98.86 -27.78 13.76 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.619 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.0 t -113.53 13.05 18.73 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.048 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HD2' ' HG2' ' A' ' 102' ' ' GLU . 14.4 ptpt -67.64 157.36 34.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 165.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -112.91 8.92 18.77 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.418 -173.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -81.18 -31.28 34.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.465 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 18.6 mm-40 -87.15 146.12 26.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.453 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -94.18 -75.41 0.51 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.566 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.453 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 2.0 p -109.73 133.86 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-O 121.141 0.496 . . . . 0.0 110.012 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.408 HG21 ' CD2' ' A' ' 29' ' ' LEU . 16.7 m -132.3 162.99 38.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.511 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.415 ' C ' HD11 ' A' ' 107' ' ' LEU . 97.7 mtt180 -123.91 117.57 25.12 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.453 HD12 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -119.61 152.34 37.21 Favored 'General case' 0 N--CA 1.397 -3.122 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -175.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.538 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.9 mp -116.92 131.07 57.05 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.488 HG21 ' NE2' ' A' ' 14' ' ' GLN . 20.8 m -131.91 153.96 39.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 123.976 0.797 . . . . 0.0 109.889 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.443 HG23 HG21 ' A' ' 13' ' ' VAL . 36.9 p -110.1 145.34 37.31 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 173.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -97.85 110.06 22.7 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.42 ' C ' ' H ' ' A' ' 114' ' ' LEU . 80.7 mm-40 -105.48 15.03 27.77 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.1 p -77.28 13.08 1.25 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.007 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.42 ' H ' ' C ' ' A' ' 112' ' ' GLN . 41.1 tp 68.5 141.22 0.04 OUTLIER 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.564 1.546 . . . . 0.0 112.616 177.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -81.14 132.7 35.37 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -83.71 145.51 28.71 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -167.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 66.82 -75.7 0.06 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.159 1.784 . . . . 0.0 112.919 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.3 t 54.91 71.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 122.479 1.133 . . . . 0.0 110.812 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -117.19 5.45 12.71 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.845 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -77.53 3.13 14.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.441 -1.709 . . . . 0.0 110.115 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -72.74 -19.19 61.43 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.313 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.0 mmm -92.71 92.46 7.98 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.709 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.1 mt -113.53 -23.47 9.78 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.955 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.434 -1.248 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.237 178.327 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.626 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 m 74.47 -31.53 0.22 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -79.04 -56.51 4.32 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 63.8 mt 61.31 92.8 0.06 OUTLIER Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 124.307 1.043 . . . . 0.0 111.007 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.16 153.64 36.54 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 121.901 1.734 . . . . 0.0 112.156 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.88 42.7 1.98 Allowed Glycine 0 C--N 1.292 -1.866 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -93.58 138.95 22.71 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 123.538 0.735 . . . . 0.0 110.478 -173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -84.03 -107.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.837 0 C-N-CA 122.03 1.82 . . . . 0.0 108.93 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.92 -48.94 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 t -76.79 -20.62 56.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 110.998 -174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.403 ' HB3' HE21 ' A' ' 115' ' ' GLN . . . -126.92 145.18 50.77 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.091 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t -95.11 138.02 21.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.847 175.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -114.05 142.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.521 HE22 ' HB ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -144.84 153.85 42.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -99.27 138.47 36.32 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.521 ' HB ' HE22 ' A' ' 14' ' ' GLN . 7.4 p -122.6 157.13 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.6 106.27 5.36 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.478 0.656 . . . . 0.0 110.959 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.607 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -93.59 127.44 45.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.914 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.412 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 43.9 m170 -95.92 160.09 14.64 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 124.159 0.912 . . . . 0.0 109.311 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.434 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 17.6 ptpt -43.13 110.15 0.18 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.504 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 33.2 tp -107.96 115.4 30.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -104.73 103.0 12.55 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.61 -174.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -104.24 108.57 20.01 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.35 -106.34 1.31 Allowed Glycine 0 C--N 1.311 -0.825 0 O-C-N 123.635 0.584 . . . . 0.0 112.846 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.09 6.63 20.98 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.771 0.319 . . . . 0.0 111.47 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.69 170.82 8.3 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.544 0.688 . . . . 0.0 109.294 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.44 121.73 35.69 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -129.5 155.81 41.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.577 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 40.6 mt -86.25 5.0 36.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.777 0.798 . . . . 0.0 109.331 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . 90.36 -46.97 3.04 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 114.388 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.417 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 46.1 p90 -86.93 161.6 18.16 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 43.6 m -115.62 165.9 12.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.116 1.366 . . . . 0.0 108.705 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.487 HD13 HD13 ' A' ' 55' ' ' ILE . 8.9 pt -126.18 165.35 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.678 0.217 . . . . 0.0 110.491 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.11 -32.61 3.45 Favored Glycine 0 CA--C 1.484 -1.893 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.512 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.44 154.02 8.87 Favored Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.325 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.522 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -100.32 -122.83 4.97 Favored Glycine 0 N--CA 1.418 -2.506 0 O-C-N 124.298 0.646 . . . . 0.0 113.478 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -22.93 31.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.518 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 16.8 t70 -66.99 -19.4 65.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.818 0.818 . . . . 0.0 110.424 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.618 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 15.5 mm-40 -96.26 -169.55 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.068 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -136.17 125.5 15.85 Favored Pre-proline 0 CA--C 1.493 -1.216 0 CA-C-O 118.855 -0.593 . . . . 0.0 109.809 -179.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 20.9 Cg_endo -58.9 -24.5 72.92 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.739 2.293 . . . . 0.0 113.683 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.1 t -73.25 -32.46 64.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.216 0.531 . . . . 0.0 109.829 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.93 16.33 20.38 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.01 0.434 . . . . 0.0 111.246 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.487 HD22 ' HB3' ' A' ' 39' ' ' GLN . 3.6 m120 -102.4 140.12 20.84 Favored Pre-proline 0 CA--C 1.485 -1.538 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.412 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.03 -46.15 2.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.434 2.09 . . . . 0.0 113.38 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -120.61 31.52 6.41 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.584 ' HA ' ' NZ ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -128.92 6.94 5.53 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.011 177.007 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -87.56 2.45 50.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.539 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.73 -46.42 74.25 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.328 1.451 . . . . 0.0 108.858 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 34.1 mmtp -144.22 -159.34 0.98 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.1 p -93.2 7.42 44.37 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -82.67 112.7 19.78 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.72 -173.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 55.8 mtmt -95.63 173.45 7.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.544 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 153.65 156.54 7.67 Favored Glycine 0 C--O 1.183 -3.067 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 36' ' ' GLY . 31.4 mm -71.91 129.06 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.215 1.008 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.43 160.59 38.29 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 32' ' ' SER . 87.1 t -86.01 132.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 O-C-N 125.205 1.566 . . . . 0.0 109.872 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 p -104.54 -27.14 12.06 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.798 0.808 . . . . 0.0 111.026 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -144.42 133.28 22.52 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.417 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 33.8 m -97.72 -175.5 0.37 Allowed 'Isoleucine or valine' 1 N--CA 1.347 -5.602 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.465 ' OG ' ' HA3' ' A' ' 30' ' ' GLY . 0.9 OUTLIER -68.09 126.37 29.29 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.34 -25.14 1.45 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.838 1.255 . . . . 0.0 112.981 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.71 57.96 0.1 Allowed Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -139.83 -168.69 11.4 Favored Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.594 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -59.95 -34.49 95.12 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 124.35 3.367 . . . . 0.0 113.095 -170.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.53 -57.76 11.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -75.48 -21.51 58.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.933 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 64' ' ' GLY . 28.1 mm -67.56 -42.07 86.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.467 0.651 . . . . 0.0 109.651 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.46 -42.82 21.95 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.297 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.29 20.75 0.89 Allowed Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.398 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.94 117.21 17.42 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.583 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 24.5 mm-40 -111.9 135.7 52.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.242 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.1 mt -53.69 143.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 124.199 1.0 . . . . 0.0 111.246 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.64 36.66 58.3 Favored Glycine 0 N--CA 1.48 1.576 0 CA-C-O 122.725 1.181 . . . . 0.0 111.485 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.608 ' HB2' ' HB ' ' A' ' 109' ' ' VAL . 22.2 p-10 -84.92 -52.44 6.0 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 126.183 1.793 . . . . 0.0 114.492 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.584 ' NZ ' ' HA ' ' A' ' 47' ' ' SER . 55.7 mttm 70.46 100.77 0.06 Allowed 'General case' 0 C--O 1.249 1.043 0 C-N-CA 124.624 1.17 . . . . 0.0 108.01 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.0 mt -83.87 130.47 35.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.006 -175.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.463 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 3.4 mmt -109.97 -22.83 11.64 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.376 -176.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.54 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -143.25 134.19 25.5 Favored 'General case' 0 C--O 1.199 -1.58 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -175.702 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.486 HG22 HD22 ' A' ' 107' ' ' LEU . 40.2 t -140.19 115.11 7.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 48.14 50.15 16.54 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 125.668 1.587 . . . . 0.0 112.806 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.54 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 66.31 -11.84 0.5 Allowed Glycine 0 CA--C 1.565 3.17 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -21.67 58.27 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.235 1.018 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t0 72.92 113.93 0.06 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 125.301 1.44 . . . . 0.0 109.137 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 tpt -94.2 -8.45 39.28 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.997 -167.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -49.89 125.56 12.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.763 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.9 ttt 53.89 80.87 0.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.91 1.284 . . . . 0.0 113.373 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.4 p -145.15 147.9 18.33 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.7 p -69.33 156.83 38.14 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.987 0.515 . . . . 0.0 110.992 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.618 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.5 t60 -56.48 -41.44 76.59 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.564 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 23.2 t70 -60.16 -53.73 54.3 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 124.045 0.84 . . . . 0.0 111.183 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -31.02 70.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.156 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.679 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.64 -48.23 67.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.462 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.508 ' CZ ' HG23 ' A' ' 98' ' ' THR . 20.3 mmm180 -56.62 -44.13 80.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.801 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.564 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 30.0 mmtp -80.83 28.4 0.35 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.385 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -144.61 -45.85 0.24 Allowed 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.679 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.4 pp -92.43 -35.2 13.8 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.563 ' N ' HD13 ' A' ' 97' ' ' LEU . 12.1 t -103.08 9.2 38.59 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.334 -1.346 . . . . 0.0 109.235 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -62.91 148.86 46.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -96.0 15.09 21.55 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.832 0.825 . . . . 0.0 110.974 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.429 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 67.7 m -93.66 -25.96 17.26 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.947 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -77.12 -178.62 5.12 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.774 0.797 . . . . 0.0 113.086 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.434 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 10.1 pt-20 -146.64 -73.27 0.22 Allowed 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.019 169.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.6 p -119.51 134.37 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.454 ' CG2' HD23 ' A' ' 107' ' ' LEU . 16.8 m -140.01 149.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.088 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -104.39 127.29 52.04 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.486 HD22 HG22 ' A' ' 80' ' ' VAL . 3.3 mt -122.46 147.51 46.25 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.517 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 6.9 mp -113.54 124.13 51.64 Favored 'General case' 0 CA--C 1.452 -2.801 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.608 ' HB ' ' HB2' ' A' ' 75' ' ' ASP . 35.8 m -124.79 153.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.543 -177.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 39.0 p -106.44 168.7 8.98 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 176.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -114.03 102.41 10.15 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 -84.06 -55.69 4.07 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.771 -178.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 t 51.2 35.11 12.61 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 124.633 1.208 . . . . 0.0 109.788 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.1 mp 61.26 90.64 0.07 Allowed 'General case' 0 C--N 1.354 0.763 0 CA-C-O 122.031 0.92 . . . . 0.0 109.95 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 11' ' ' ALA . 99.2 mt-30 -63.89 -22.11 66.77 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.4 mptt 71.03 178.0 0.26 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.802 0.689 . . . . 0.0 109.635 -168.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.48 141.97 50.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.047 0.451 . . . . 0.0 109.818 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.68 47.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 123.701 1.715 . . . . 0.0 108.636 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -107.51 140.81 39.92 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.933 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 56.24 33.52 22.33 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.819 1.248 . . . . 0.0 111.932 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.5 p 52.47 83.63 0.06 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.527 1.531 . . . . 0.0 112.915 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.7 mmm -88.95 92.66 9.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.583 0.706 . . . . 0.0 112.28 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.76 -72.34 0.66 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.421 -1.888 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.169 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.733 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 p -127.26 164.44 21.71 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -89.75 163.46 15.07 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 tp -118.82 107.92 41.68 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -69.38 171.59 13.78 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.21 1.94 . . . . 0.0 111.543 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.77 42.1 3.05 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 49.2 tt0 -74.72 122.38 87.37 Favored Pre-proline 0 N--CA 1.436 -1.129 0 C-N-CA 123.254 0.621 . . . . 0.0 110.594 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 74.3 Cg_endo -78.2 -92.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.341 2.027 . . . . 0.0 110.364 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.9 m -138.72 -55.55 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t -81.65 -25.4 35.63 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.981 0.896 . . . . 0.0 110.567 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.628 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -101.15 125.68 47.79 Favored 'General case' 0 CA--C 1.466 -2.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.64 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.427 ' O ' ' HA ' ' A' ' 110' ' ' THR . 59.4 t -98.59 105.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 12.3 p -99.65 133.65 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.5 154.08 40.31 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.872 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.69 148.29 22.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.94 0.4 . . . . 0.0 109.961 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.489 HG13 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -129.14 157.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.524 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 38.1 tt0 -150.31 106.38 3.45 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.579 0.704 . . . . 0.0 109.809 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.518 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -94.69 130.14 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.3 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.3 m170 -101.57 141.16 34.85 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.916 0.76 . . . . 0.0 109.111 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 103' ' ' GLU . 18.0 ptpt -29.59 112.24 0.07 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.98 1.712 . . . . 0.0 115.401 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 38.0 tp -113.67 121.02 42.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.1 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -97.91 112.47 24.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -114.34 106.22 14.07 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.14 -108.69 2.28 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 123.732 0.645 . . . . 0.0 112.425 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.74 16.67 18.48 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.42 168.98 13.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.82 118.5 28.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.467 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -126.89 158.13 37.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.085 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.42 ' CD2' HG22 ' A' ' 105' ' ' VAL . 9.2 mp -86.43 -1.53 57.65 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.763 0.792 . . . . 0.0 109.744 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.98 3.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.38 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -96.5 171.61 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.582 0.691 . . . . 0.0 112.19 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.455 ' O ' HG21 ' A' ' 57' ' ' VAL . 47.1 m -138.71 169.17 18.28 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.863 1.265 . . . . 0.0 110.404 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.519 HD12 HD13 ' A' ' 55' ' ' ILE . 7.1 pt -126.82 169.45 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.129 -0.357 . . . . 0.0 110.762 -170.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.92 -24.76 5.65 Favored Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.565 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 120.4 163.2 12.05 Favored Glycine 0 C--O 1.195 -2.331 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.632 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.551 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -114.97 -115.03 3.02 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.888 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.81 -24.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.251 0.548 . . . . 0.0 111.996 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HB2' HG21 ' A' ' 89' ' ' THR . 32.8 t70 -72.54 -17.75 61.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.89 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.565 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 28.3 mm-40 -104.18 166.75 10.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -106.43 121.23 45.97 Favored Pre-proline 0 CA--C 1.492 -1.256 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.257 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -57.2 -30.02 85.73 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.88 2.387 . . . . 0.0 113.298 -178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.9 m -65.75 -27.24 68.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.999 0.428 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -116.42 11.91 15.06 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.391 0.615 . . . . 0.0 110.465 -175.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -103.97 146.04 31.78 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.44 -44.13 6.96 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 123.68 2.92 . . . . 0.0 113.753 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.46 14.45 21.45 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.215 0.531 . . . . 0.0 110.115 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.4 t -122.24 -3.57 8.97 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.502 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.48 -2.72 14.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -71.17 -51.6 23.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.007 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -152.13 -168.08 2.96 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 123.919 0.888 . . . . 0.0 109.518 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 p -87.28 23.11 1.93 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.6 0.714 . . . . 0.0 110.613 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.98 105.74 8.24 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.031 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.2 mmtm -91.4 166.04 13.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.283 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.451 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 145.01 159.63 8.17 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.551 HD12 ' N ' ' A' ' 36' ' ' GLY . 36.1 mm -77.92 122.16 32.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-N 118.126 0.963 . . . . 0.0 109.502 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.4 p90 -122.31 151.9 40.66 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.363 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 32' ' ' SER . 8.7 p -80.82 132.35 31.83 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 O-C-N 124.769 1.293 . . . . 0.0 110.69 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 p -106.75 -27.25 10.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.435 0.636 . . . . 0.0 110.686 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -138.13 131.46 30.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.05 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.425 HG11 ' O ' ' A' ' 71' ' ' LEU . 64.8 t -118.9 140.6 42.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 174.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.71 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.5 t -63.66 116.91 6.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 pt-20 -77.27 2.99 14.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.837 0.827 . . . . 0.0 112.024 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.63 29.94 0.94 Allowed Glycine 0 C--N 1.267 -3.265 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.406 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -128.14 -177.88 15.08 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.075 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.55 -29.01 70.3 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 124.366 3.377 . . . . 0.0 112.791 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.77 -59.19 5.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.477 -179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.71 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.6 pt-20 -74.06 -31.88 63.05 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.387 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 64' ' ' GLY . 26.3 mm -55.11 -41.37 59.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 O-C-N 123.737 0.648 . . . . 0.0 110.471 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.05 -55.92 5.15 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.319 177.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.54 28.69 0.04 OUTLIER Glycine 0 C--N 1.317 -0.501 0 C-N-CA 119.768 -1.206 . . . . 0.0 113.239 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.489 ' HB2' HG13 ' A' ' 16' ' ' VAL . 2.5 tp -94.55 117.56 30.32 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -115.39 143.81 44.73 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.419 ' HA ' HG12 ' A' ' 57' ' ' VAL . 65.6 mt -54.89 129.67 16.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.004 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.02 -3.95 45.03 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.706 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 84.0 m-20 -80.94 130.23 34.92 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.909 0.355 . . . . 0.0 110.571 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.46 116.11 22.92 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.411 HG13 HG12 ' A' ' 109' ' ' VAL . 3.0 mp -86.27 124.34 40.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 30.5 mmt -102.27 -19.88 14.86 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.313 0.577 . . . . 0.0 111.116 -178.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 50.2 tp60 -148.47 134.84 19.52 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.91 -171.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.492 HG22 HD23 ' A' ' 107' ' ' LEU . 54.8 t -142.62 108.84 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.0 0.52 . . . . 0.0 111.974 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.482 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.4 t-20 55.18 39.43 31.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.297 1.439 . . . . 0.0 112.715 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.32 4.79 83.34 Favored Glycine 0 C--N 1.294 -1.771 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.23 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.486 ' NE1' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -116.7 148.32 41.17 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.629 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.94 122.76 28.69 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 40.2 ttm -108.98 -0.92 19.34 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.044 0.926 . . . . 0.0 110.515 177.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.8 t -58.79 -34.63 71.69 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.657 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.1 ttt -140.72 95.36 2.85 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.437 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 9.7 p -160.1 151.15 5.77 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.449 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.465 HG21 ' HB2' ' A' ' 38' ' ' ASP . 10.4 p -71.41 158.33 36.5 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.542 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 22.2 t60 -56.11 -43.6 78.3 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.124 175.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.15 -49.54 76.8 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.96 0.788 . . . . 0.0 111.399 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -31.77 68.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.421 ' O ' HD11 ' A' ' 97' ' ' LEU . . . -75.21 -40.62 59.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.509 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 15.9 mmt180 -53.04 -47.34 68.47 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.681 0.613 . . . . 0.0 111.023 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.412 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 63.1 tttm -86.24 39.14 0.8 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.666 1.222 . . . . 0.0 108.921 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.486 ' HG2' ' NE1' ' A' ' 83' ' ' TRP . 30.7 tpt180 -145.76 -45.99 0.21 Allowed 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.147 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.509 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -92.45 -26.95 17.75 Favored 'General case' 0 C--O 1.208 -1.104 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.326 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.0 t -117.43 14.79 14.7 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.455 ' CD ' ' HB2' ' A' ' 101' ' ' SER . 13.6 ptpt -74.08 171.06 14.22 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -113.8 -0.36 14.23 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.034 0.445 . . . . 0.0 111.897 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.455 ' HB2' ' CD ' ' A' ' 99' ' ' LYS . 69.8 m -76.72 -28.46 55.82 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.442 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 33.9 mm-40 -81.84 179.19 7.92 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.117 0.484 . . . . 0.0 110.696 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.431 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 7.6 pt-20 -146.42 -70.14 0.25 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.518 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 44.0 t -105.99 126.63 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.524 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 30.6 m -128.49 134.68 64.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 123.626 0.579 . . . . 0.0 111.014 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -103.56 116.52 32.52 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.492 HD23 HG22 ' A' ' 80' ' ' VAL . 5.9 mt -114.39 161.43 17.95 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -134.77 121.61 20.95 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 32.7 m -113.39 156.27 14.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.662 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.5 p -131.1 133.03 45.25 Favored 'General case' 1 N--CA 1.371 -4.414 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -78.24 -62.38 1.7 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.014 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 60.93 68.53 0.74 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.26 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 t -151.71 28.38 0.62 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.628 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.02 6.57 45.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.79 133.56 54.36 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.56 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.31 133.79 34.14 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.023 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.14 134.63 33.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.84 47.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-O 122.57 1.176 . . . . 0.0 110.491 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -139.47 120.7 14.82 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.876 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -88.33 -6.62 57.63 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.0 m 70.83 82.92 0.15 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.496 1.518 . . . . 0.0 111.708 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 168.74 -65.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.002 1.721 . . . . 0.0 107.698 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.2 tp 57.96 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.326 1.45 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.213 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.452 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 m -79.76 -27.83 40.44 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 122.147 0.975 . . . . 0.0 110.542 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -109.21 -158.29 0.64 Allowed 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.407 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -65.53 -61.16 6.24 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 118.498 0.59 . . . . 0.0 111.216 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' HB3' ' CG1' ' A' ' 13' ' ' VAL . 6.2 Cg_endo -61.63 175.3 1.74 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 N-CA-C 116.02 1.508 . . . . 0.0 116.02 172.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.97 14.9 6.26 Favored Glycine 0 C--N 1.304 -1.199 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 175.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -123.3 137.95 29.21 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -82.58 -104.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.571 0 C-N-CA 122.528 2.152 . . . . 0.0 116.558 -169.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.16 -34.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -74.0 -18.17 60.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.831 1.3 . . . . 0.0 108.442 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.48 139.19 25.31 Favored 'General case' 0 N--CA 1.388 -3.569 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 172.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -137.33 145.87 28.82 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.413 ' CG1' ' HB3' ' A' ' 5' ' ' PRO . 14.0 p -93.33 126.31 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.511 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -130.52 154.41 47.83 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.98 -174.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.424 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 3.1 ppt_? -97.06 145.57 25.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 71' ' ' LEU . 7.9 p -133.97 149.03 30.13 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.94 103.06 5.87 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.548 0.689 . . . . 0.0 111.291 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -91.72 126.79 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.482 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -96.26 150.51 20.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.46 ' HB2' HD23 ' A' ' 27' ' ' LEU . 21.5 pttm -43.37 121.72 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 52.6 tp -122.59 123.91 42.28 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.566 176.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.9 126.84 33.83 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.418 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 21.8 mt-30 -128.4 111.4 13.28 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 175.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.55 -105.81 1.69 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -122.73 15.24 10.17 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.39 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.81 171.16 7.66 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.46 HD23 ' HB2' ' A' ' 20' ' ' LYS . 1.9 tm? -122.84 109.42 14.16 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.05 164.35 19.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 9.2 mp -88.08 3.69 48.1 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.056 0.931 . . . . 0.0 109.62 177.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 87.64 -42.2 3.11 Favored Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.676 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -90.4 166.48 13.26 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -175.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.438 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 20.3 m -120.5 167.82 11.98 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.404 1.481 . . . . 0.0 108.894 178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.513 HD13 HD11 ' A' ' 55' ' ' ILE . 11.4 pt -127.4 167.13 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 110.988 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.95 -27.1 5.0 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.484 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.99 157.97 10.17 Favored Glycine 0 C--O 1.196 -2.274 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.856 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -106.02 -115.9 4.1 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.577 0.81 . . . . 0.0 113.486 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.597 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.74 -26.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -173.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.73 -18.39 65.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.752 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.508 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 24.4 mm-40 -98.58 164.83 12.09 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.806 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -119.8 118.91 31.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -176.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.409 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 10.2 Cg_endo -54.0 -26.04 39.02 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.732 2.955 . . . . 0.0 113.731 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 t -66.32 -26.79 67.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -121.05 4.37 10.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.26 0.553 . . . . 0.0 111.431 -175.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.422 HD21 ' HA ' ' A' ' 44' ' ' ASN . 5.9 m120 -90.62 149.57 40.9 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 -50.52 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 123.439 2.759 . . . . 0.0 113.131 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.12 -3.48 19.88 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.692 0.758 . . . . 0.0 111.52 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.413 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 6.1 t -97.36 1.0 48.85 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.758 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.17 -23.72 47.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.19 -58.08 3.31 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.015 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.446 ' HE3' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -110.39 125.32 53.09 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.811 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -89.7 6.78 39.94 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.628 0.728 . . . . 0.0 112.249 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.58 119.89 25.72 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.597 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 56.4 mttm -70.98 168.01 17.93 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.362 0.601 . . . . 0.0 111.138 -174.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.4 156.17 7.19 Favored Glycine 0 C--O 1.191 -2.548 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.513 HD11 HD13 ' A' ' 33' ' ' ILE . 18.5 mm -74.41 129.21 36.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 118.207 1.003 . . . . 0.0 110.332 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -130.71 154.06 48.35 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.197 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG21 HD11 ' A' ' 71' ' ' LEU . 90.8 t -77.22 135.54 26.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 124.591 1.182 . . . . 0.0 110.369 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 p -111.02 -19.93 12.59 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.22 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.438 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 20.4 mtm180 -152.73 138.19 17.65 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG12 ' O ' ' A' ' 71' ' ' LEU . 15.5 m -106.22 -173.3 0.42 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.046 0 CA-C-N 119.252 0.933 . . . . 0.0 108.632 172.161 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.604 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.8 t -87.74 118.0 26.95 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.26 -14.59 27.39 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.69 33.41 0.63 Allowed Glycine 0 C--N 1.286 -2.219 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.496 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -118.92 -169.76 14.51 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.521 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -63.93 -29.6 67.13 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.761 2.974 . . . . 0.0 112.373 -170.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.03 -64.87 0.73 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.611 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.604 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.2 pt-20 -72.19 -31.89 66.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.506 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 mm -57.08 -39.86 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.335 0.397 . . . . 0.0 110.997 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.91 16.02 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.851 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.59 17.75 0.2 Allowed Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.402 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.47 ' HB2' HG22 ' A' ' 16' ' ' VAL . 5.5 tp -89.46 124.05 34.13 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -115.37 157.99 23.09 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 122.197 0.998 . . . . 0.0 111.175 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.5 mt -61.84 128.3 23.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.914 172.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.97 4.8 56.63 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -82.55 121.82 27.29 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.204 0.526 . . . . 0.0 111.661 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -83.56 99.98 10.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.876 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 mt -79.28 128.24 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 -174.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.423 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 1.1 mmt -112.17 -18.91 12.45 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.47 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -148.47 137.97 22.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.461 HG23 HD23 ' A' ' 107' ' ' LEU . 37.8 t -139.73 120.88 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 50.44 40.13 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.24 1.416 . . . . 0.0 112.471 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.47 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 62.98 16.21 57.03 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 114.226 -1.352 . . . . 0.0 114.783 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.419 ' HE1' ' HE1' ' A' ' 85' ' ' MET 0.307 0.0 OUTLIER -91.17 -82.89 0.28 Allowed 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 118.742 -0.646 . . . . 0.0 112.255 -179.797 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.4 t70 168.41 127.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.457 ' HG3' ' HB ' ' A' ' 55' ' ' ILE . 47.3 tpp -128.3 1.0 5.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 122.709 1.242 . . . . 0.0 109.907 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 t -80.73 -29.5 36.34 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.629 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.6 ttp -133.01 75.25 1.61 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.78 -0.575 . . . . 0.0 110.409 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.403 HG11 ' SD ' ' A' ' 85' ' ' MET . 9.1 p -151.52 150.51 13.13 Favored 'Isoleucine or valine' 0 C--O 1.259 1.574 0 CA-C-O 121.252 0.549 . . . . 0.0 110.232 -176.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.9 p -73.29 157.85 36.25 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.999 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.508 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.3 t60 -56.74 -43.11 80.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.655 174.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.88 -50.72 72.94 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 124.357 1.063 . . . . 0.0 111.996 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -39.4 76.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.958 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.663 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.071 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.426 ' CZ ' HG22 ' A' ' 98' ' ' THR . 15.6 mmm180 -55.53 -38.7 69.59 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.238 0.542 . . . . 0.0 110.469 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -86.98 24.44 1.52 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.515 0.674 . . . . 0.0 109.215 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.519 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 19.1 mmt180 -137.23 -48.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.751 0.82 . . . . 0.0 110.984 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.663 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -96.76 -20.49 18.18 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.509 ' N ' HD11 ' A' ' 97' ' ' LEU . 15.1 t -117.94 12.7 13.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.854 -1.538 . . . . 0.0 110.586 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.8 ptpt -68.49 -173.63 0.45 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -133.4 6.55 3.83 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.587 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.418 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 10.4 m -80.24 -40.48 26.93 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.131 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.06 152.28 22.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.443 ' HG3' HG13 ' A' ' 104' ' ' VAL . 9.7 pt-20 -104.06 -63.42 1.2 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.932 0.396 . . . . 0.0 110.678 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.0 p -118.81 132.5 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 CA-C-O 121.323 0.582 . . . . 0.0 110.929 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.426 ' CG2' HD21 ' A' ' 107' ' ' LEU . 19.6 m -135.51 155.17 36.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.507 -174.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.51 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 3.3 mpt_? -107.2 126.29 52.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.461 HD23 HG23 ' A' ' 80' ' ' VAL . 5.2 mt -119.91 146.84 45.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.17 122.56 46.44 Favored 'General case' 0 C--N 1.265 -3.09 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.511 HG22 ' NE2' ' A' ' 14' ' ' GLN . 11.1 m -123.25 152.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.661 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p -106.9 129.05 54.79 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -87.88 93.54 9.5 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.424 0.63 . . . . 0.0 109.74 -177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -100.41 -33.4 10.38 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.75 -176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 t -101.69 2.14 38.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.013 0.911 . . . . 0.0 111.005 -173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 42.5 tp -147.35 106.02 3.82 Favored 'General case' 0 C--N 1.274 -2.681 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.087 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -88.89 -78.24 0.35 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.552 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 49.89 39.94 19.61 Favored 'General case' 0 C--O 1.26 1.632 0 C-N-CA 123.75 0.82 . . . . 0.0 108.987 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.66 140.66 56.24 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 113.765 -1.561 . . . . 0.0 112.342 -173.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.255 9.8 p 46.43 38.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.111 1.764 . . . . 0.0 112.302 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -138.8 -62.92 0.54 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.554 -1.657 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -75.62 -19.86 58.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.896 0.855 . . . . 0.0 109.963 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.8 t -156.46 134.4 11.13 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.36 170.08 8.36 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 47.5 tp -87.25 86.13 7.24 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.51 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.887 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -86.96 0.36 55.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.114 0.483 . . . . 0.0 110.39 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.401 ' OH ' ' HA ' ' A' ' 14' ' ' GLN . 24.5 p90 -146.35 178.26 8.39 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.04 98.02 49.32 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -75.02 169.61 22.24 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.093 1.862 . . . . 0.0 112.433 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.56 59.48 0.61 Allowed Glycine 0 C--N 1.3 -1.427 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.545 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 27.3 tt0 -79.95 132.11 61.43 Favored Pre-proline 0 C--N 1.318 -0.802 0 C-N-CA 123.073 0.549 . . . . 0.0 111.531 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.53 -72.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 121.255 1.303 . . . . 0.0 108.999 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 m -153.19 -60.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.571 1.149 . . . . 0.0 110.577 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.463 ' OG1' ' HA ' ' A' ' 115' ' ' GLN . 11.7 t -83.0 -46.43 12.87 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -174.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -70.06 137.27 51.1 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 120.876 0.37 . . . . 0.0 110.392 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.47 120.54 58.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.438 HG22 HG22 ' A' ' 110' ' ' THR . 21.9 t -95.48 117.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.401 ' HA ' ' OH ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -128.52 156.02 43.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -173.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -94.52 151.79 19.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.945 0.402 . . . . 0.0 111.057 -174.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 71' ' ' LEU . 3.1 t -131.51 151.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 174.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -147.11 104.16 3.65 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.546 0.688 . . . . 0.0 109.784 179.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.588 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -88.08 127.12 41.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.093 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.1 m170 -108.81 111.64 23.48 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.852 0.72 . . . . 0.0 110.918 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.452 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 13.9 ptpt 25.81 97.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 165.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.57 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 41.9 tp -112.25 118.88 36.52 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.617 -0.677 . . . . 0.0 109.765 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -102.55 102.92 13.22 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.361 0.6 . . . . 0.0 110.019 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -108.7 112.65 25.06 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.96 -103.51 0.65 Allowed Glycine 0 C--N 1.303 -1.263 0 O-C-N 124.262 0.976 . . . . 0.0 112.272 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -118.45 20.49 13.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 123.319 0.648 . . . . 0.0 110.538 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.52 177.12 7.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.449 0.642 . . . . 0.0 110.175 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -124.77 121.38 34.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.57 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -128.55 164.37 30.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.488 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.1 mp -93.75 0.92 56.59 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.724 0.774 . . . . 0.0 110.13 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.78 -35.68 3.9 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 115.152 0.821 . . . . 0.0 115.152 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 50.9 p90 -102.95 165.47 11.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 23.0 m -133.26 168.36 18.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.305 1.442 . . . . 0.0 110.24 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.493 HD12 HD11 ' A' ' 55' ' ' ILE . 6.4 pt -126.75 172.73 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-O 120.525 0.203 . . . . 0.0 111.488 -168.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.32 -5.6 12.8 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.612 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 107.57 -178.98 21.92 Favored Glycine 1 N--CA 1.393 -4.181 0 CA-C-N 114.546 -0.827 . . . . 0.0 111.904 -177.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.629 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -131.58 -79.09 0.17 Allowed Glycine 0 N--CA 1.405 -3.411 0 O-C-N 124.886 0.991 . . . . 0.0 114.293 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.496 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -101.57 -25.85 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' HB2' HG22 ' A' ' 89' ' ' THR . 10.7 t70 -71.99 -20.69 61.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.35 1.071 . . . . 0.0 109.636 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.539 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -105.88 142.71 35.14 Favored 'General case' 0 N--CA 1.393 -3.319 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.786 -173.761 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.9 t70 -88.53 125.61 62.78 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.9 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.408 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.2 Cg_endo -56.28 -31.3 83.97 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.93 2.42 . . . . 0.0 113.486 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -68.89 -29.34 67.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.249 0.547 . . . . 0.0 111.075 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.534 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.4 pt20 -109.42 8.0 25.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.673 0.749 . . . . 0.0 111.293 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -99.54 149.31 35.76 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.788 -177.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.65 -52.75 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.115 2.544 . . . . 0.0 113.156 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -107.87 21.93 16.69 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.1 t -125.54 -3.05 7.33 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.363 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.82 -35.59 38.18 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.328 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.96 -57.36 5.11 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.669 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -110.92 109.56 19.76 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.5 p -87.31 7.61 27.94 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 124.273 0.983 . . . . 0.0 113.057 -167.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -72.59 115.21 11.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 83.9 mttt -62.09 167.92 3.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.5 139.91 4.86 Favored Glycine 0 C--O 1.183 -3.084 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.629 HD13 ' N ' ' A' ' 36' ' ' GLY . 28.7 mm -55.08 130.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -170.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.481 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -125.7 149.86 48.14 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.188 177.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.455 HG22 HD11 ' A' ' 71' ' ' LEU . 95.9 t -83.22 132.99 30.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 124.36 1.037 . . . . 0.0 110.805 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.0 p -112.66 -20.26 11.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.34 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 4.3 mmm180 -140.43 132.84 28.46 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.426 HG12 ' CB ' ' A' ' 66' ' ' ALA . 53.4 t -127.22 142.8 42.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.669 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.4 m -62.1 105.3 0.57 Allowed 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 123.892 0.745 . . . . 0.0 112.363 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.41 -28.28 0.34 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 129.168 2.987 . . . . 0.0 113.545 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.2 29.52 2.05 Favored Glycine 0 C--N 1.296 -1.643 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.411 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -113.06 -175.47 19.36 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.051 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.408 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 45.7 Cg_endo -64.6 -27.0 61.28 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.01 3.14 . . . . 0.0 111.767 -171.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.426 ' CB ' HG12 ' A' ' 60' ' ' VAL . . . -58.15 -59.89 4.6 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.842 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.669 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.5 pt-20 -82.63 -20.7 35.82 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.746 -1.582 . . . . 0.0 113.107 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 64' ' ' GLY . 24.5 mm -61.12 -35.59 66.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.68 -54.7 5.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.373 176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 151.71 25.63 0.05 OUTLIER Glycine 0 C--O 1.225 -0.422 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.608 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.503 ' HB2' HG13 ' A' ' 16' ' ' VAL . 5.2 tp -95.95 125.41 40.48 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.462 ' N ' HD13 ' A' ' 71' ' ' LEU . 22.6 mm-40 -113.66 165.18 12.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 122.043 0.925 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.3 mt -75.37 125.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.4 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.19 0.62 41.22 Favored Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.197 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.432 ' OD1' ' HB2' ' A' ' 72' ' ' GLN . 14.0 m-20 -79.97 123.86 28.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.481 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 35.1 mtmt -93.04 125.36 37.59 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.445 HD13 ' CG2' ' A' ' 57' ' ' VAL . 2.5 mp -96.45 131.81 42.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -171.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.441 ' HE3' ' HA ' ' A' ' 78' ' ' MET . 9.0 mmt -107.12 -25.92 11.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.123 0.487 . . . . 0.0 110.649 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 19.6 tp60 -140.82 128.67 21.78 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.467 HG22 HD21 ' A' ' 107' ' ' LEU . 53.3 t -140.78 113.92 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 C-N-CA 123.382 0.673 . . . . 0.0 110.159 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 55.69 43.54 27.86 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.234 1.014 . . . . 0.0 112.564 171.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.19 -4.18 55.61 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.962 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.496 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -104.33 146.92 28.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -81.36 112.88 19.05 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.837 0.827 . . . . 0.0 111.056 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.496 ' HE2' ' HE1' ' A' ' 83' ' ' TRP . 61.7 tpp -89.05 -8.2 54.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.531 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -70.42 137.3 50.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.6 ttt 53.98 75.06 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.871 0.868 . . . . 0.0 112.849 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.79 149.95 12.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.469 HG22 ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -70.39 154.99 41.29 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 123.269 0.628 . . . . 0.0 112.204 -178.157 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -56.8 -44.28 81.77 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.715 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.14 -52.59 64.68 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.869 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.33 -32.12 73.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.942 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.599 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -78.21 -37.26 45.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.843 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.465 ' CZ ' HG23 ' A' ' 98' ' ' THR . 16.6 mmm180 -53.98 -44.11 70.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.407 0.622 . . . . 0.0 110.546 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -85.14 32.56 0.54 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.878 0.847 . . . . 0.0 110.473 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.524 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.3 tpp180 -143.21 -43.3 0.29 Allowed 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.604 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -101.69 -20.94 14.78 Favored 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.465 HG23 ' CZ ' ' A' ' 94' ' ' ARG . 13.7 t -116.44 15.38 15.71 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.683 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.1 ptpt -62.61 158.67 17.67 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.074 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -114.06 6.28 16.36 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.647 0.737 . . . . 0.0 110.531 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.413 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 19.8 m -79.4 -34.39 41.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.339 -178.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.6 144.19 31.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.471 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.452 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -100.55 -53.43 3.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.192 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.0 p -121.04 128.58 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.705 0.764 . . . . 0.0 112.565 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.6 m -126.99 146.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.741 -174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -100.46 115.22 29.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.467 HD21 HG22 ' A' ' 80' ' ' VAL . 12.5 mt -114.52 159.95 19.79 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.2 mp -137.56 123.57 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.59 159.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.538 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.438 HG22 HG22 ' A' ' 13' ' ' VAL . 76.2 p -112.74 136.58 52.18 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.298 0.57 . . . . 0.0 111.495 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.404 HH12 ' CG ' ' A' ' 75' ' ' ASP . 11.8 mmt180 -80.53 97.29 7.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.404 ' HG3' ' HE2' ' A' ' 76' ' ' LYS . 29.9 mm-40 -94.39 -13.59 26.15 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.522 0.677 . . . . 0.0 110.596 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.9 p -86.33 22.65 1.76 Allowed 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.205 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.5 tp -139.36 81.67 1.85 Allowed 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.265 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.463 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 9.6 pt20 -148.54 -40.02 0.16 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.519 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.477 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 8.7 mtmp? 78.42 -178.44 0.11 Allowed 'General case' 0 C--O 1.251 1.134 0 C-N-CA 126.463 1.905 . . . . 0.0 110.261 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -124.75 175.31 7.32 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t -139.56 73.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.47 89.08 5.03 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.278 1.037 . . . . 0.0 109.931 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -18.9 64.37 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.987 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.9 m -69.05 -57.81 4.93 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.364 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.9 tpt 68.61 -12.8 0.34 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.239 1.415 . . . . 0.0 112.991 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.95 1.62 50.58 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 121.644 -0.66 . . . . 0.0 110.657 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.1 t . . . . . 0 N--CA 1.424 -1.742 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.221 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.276 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -122.21 -3.1 9.01 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.1 t80 68.02 -69.11 0.15 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 124.819 1.247 . . . . 0.0 111.475 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.3 mt 64.18 99.84 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.563 1.145 . . . . 0.0 110.503 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -70.25 152.66 66.9 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.663 1.575 . . . . 0.0 111.69 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.39 40.79 2.96 Favored Glycine 0 C--N 1.298 -1.565 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.63 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -82.91 128.16 66.74 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.482 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 66.3 Cg_endo -80.71 -88.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.145 1.897 . . . . 0.0 110.897 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.08 -58.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 123.129 0.572 . . . . 0.0 110.626 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.4 HG21 ' N ' ' A' ' 11' ' ' ALA . 3.5 t -89.67 -51.12 5.68 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 120.769 0.319 . . . . 0.0 111.74 -177.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.482 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . -67.83 141.56 56.43 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.198 -174.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.03 132.44 55.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.261 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.3 141.02 19.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.4 148.96 31.85 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.49 28.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -126.24 152.89 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.43 101.4 4.1 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.41 0.624 . . . . 0.0 109.88 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.465 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -85.54 122.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.317 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 46.2 m170 -94.46 145.84 24.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 124.123 0.889 . . . . 0.0 109.549 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.525 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -31.64 113.18 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 115.035 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.434 HD21 ' CD ' ' A' ' 65' ' ' PRO . 50.1 tp -120.51 117.73 28.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.879 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -96.27 116.97 29.87 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.5 mt-30 -109.77 106.86 16.64 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.62 -105.31 1.27 Allowed Glycine 0 N--CA 1.432 -1.604 0 O-C-N 123.842 0.714 . . . . 0.0 111.319 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -109.6 -3.58 16.79 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.94 167.81 9.96 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -172.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.92 122.26 44.79 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -133.79 155.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.6 mp -82.27 1.36 37.08 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.107 0.956 . . . . 0.0 109.792 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 89.35 -43.58 3.04 Favored Glycine 0 N--CA 1.42 -2.381 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.708 176.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.429 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 41.5 p90 -91.35 164.7 13.75 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.6 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 87.2 p -113.83 179.93 3.82 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.344 1.057 . . . . 0.0 109.676 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.547 HD11 HD12 ' A' ' 55' ' ' ILE . 6.6 pt -138.32 166.73 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.19 -23.01 6.25 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.554 ' C ' HD11 ' A' ' 55' ' ' ILE . . . 126.9 171.24 13.03 Favored Glycine 0 CA--C 1.476 -2.382 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.16 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -119.92 -117.52 2.63 Favored Glycine 0 C--O 1.208 -1.482 0 O-C-N 124.445 0.732 . . . . 0.0 112.841 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.432 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -65.33 -25.68 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.99 -16.77 63.81 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.329 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.545 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 28.4 mm-40 -98.94 163.3 12.65 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.893 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 1.3 m-20 -91.47 107.52 22.45 Favored Pre-proline 0 CA--C 1.489 -1.376 0 C-N-CA 124.507 1.123 . . . . 0.0 111.787 175.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.48 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 25.9 Cg_endo -64.16 -20.9 67.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.589 2.192 . . . . 0.0 110.442 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.7 m -63.52 -32.44 73.9 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 113.921 -1.491 . . . . 0.0 110.222 176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -122.8 4.98 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.792 0.806 . . . . 0.0 112.876 -170.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -95.38 144.81 28.43 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.09 -40.23 11.98 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.794 2.996 . . . . 0.0 113.756 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.404 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 41.3 m-85 -119.59 21.29 12.13 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.969 0.89 . . . . 0.0 108.991 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.6 t -128.22 5.1 5.8 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.649 177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.7 -1.07 53.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.928 0.871 . . . . 0.0 110.937 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -77.85 -42.0 35.06 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.853 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -141.72 -170.58 3.15 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.5 p -99.06 -3.86 33.77 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.31 110.96 5.56 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.157 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.48 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.3 mtmm -96.02 174.12 7.08 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.112 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.9 163.31 11.03 Favored Glycine 0 C--O 1.181 -3.174 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -175.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.554 HD11 ' C ' ' A' ' 35' ' ' GLY . 36.4 mm -72.0 127.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 118.767 1.283 . . . . 0.0 110.634 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -127.64 151.77 48.52 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.41 HG22 HD13 ' A' ' 71' ' ' LEU . 85.9 t -79.89 133.34 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 124.426 1.079 . . . . 0.0 110.369 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.404 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 9.3 p -106.11 -22.38 12.88 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.285 0.564 . . . . 0.0 110.75 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.6 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.7 mmt180 -155.13 140.25 17.47 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.193 1.397 . . . . 0.0 107.73 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.429 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 20.6 m -106.88 -176.41 0.57 Allowed 'Isoleucine or valine' 1 N--CA 1.346 -5.657 0 CA-C-N 118.985 0.811 . . . . 0.0 109.714 173.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.493 ' OG ' ' HA3' ' A' ' 64' ' ' GLY . 2.8 t -75.82 114.78 14.81 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 173.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.82 -30.26 44.38 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.939 0.775 . . . . 0.0 112.614 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.39 48.13 0.55 Allowed Glycine 0 CA--C 1.484 -1.884 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.493 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -129.3 -165.64 11.74 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.634 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.434 ' CD ' HD21 ' A' ' 21' ' ' LEU . 42.4 Cg_endo -64.9 -28.45 58.49 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.4 2.733 . . . . 0.0 112.177 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.39 -62.37 1.82 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.66 -30.43 67.04 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.173 0.296 . . . . 0.0 111.418 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.401 ' HA ' HD23 ' A' ' 123' ' ' LEU . 26.0 mm -64.73 -39.07 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.357 0.598 . . . . 0.0 111.299 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.89 -47.65 16.1 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.61 14.14 0.24 Allowed Glycine 0 C--N 1.311 -0.832 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.846 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.521 ' HB2' HG13 ' A' ' 16' ' ' VAL . 8.1 tp -86.44 124.43 32.76 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -116.87 159.29 22.61 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 122.146 0.974 . . . . 0.0 111.029 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.97 125.44 21.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.902 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.83 35.11 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.206 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.43 124.11 23.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-O 120.817 0.341 . . . . 0.0 110.544 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -86.63 119.36 26.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.54 122.85 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.406 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 25.5 mmt -101.8 -13.25 17.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.44 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.412 ' NE2' ' H ' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -161.53 132.46 5.23 Favored 'General case' 0 C--O 1.2 -1.551 0 O-C-N 121.989 -0.445 . . . . 0.0 110.007 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.501 HG22 HD21 ' A' ' 107' ' ' LEU . 50.5 t -131.92 125.5 55.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.601 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 49.3 43.26 22.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.79 1.236 . . . . 0.0 112.269 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.412 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 63.72 12.57 48.03 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 114.15 -1.386 . . . . 0.0 114.977 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.421 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -97.12 -8.64 29.69 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.139 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 71.77 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.861 0.864 . . . . 0.0 110.637 -173.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.4 tpt -120.73 -0.92 10.08 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.563 0.697 . . . . 0.0 109.689 -176.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.7 t -66.63 -15.98 63.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.842 -174.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.5 ttt -150.28 93.94 2.06 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.042 0.448 . . . . 0.0 110.394 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.96 149.51 12.24 Favored 'Isoleucine or valine' 0 C--O 1.259 1.561 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 9.3 p -72.33 155.75 39.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 122.632 0.373 . . . . 0.0 110.652 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.527 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 17.7 t60 -53.58 -44.25 69.19 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.859 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.59 -43.96 92.18 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.126 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -35.23 68.18 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.209 0.528 . . . . 0.0 111.423 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.571 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -68.59 -42.88 77.57 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.432 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 18.5 mmt180 -55.7 -38.61 69.93 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.619 0.723 . . . . 0.0 109.092 177.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.419 ' O ' ' HE3' ' A' ' 99' ' ' LYS . 47.2 tttp -81.15 18.29 1.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.972 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.524 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 34.1 mtt-85 -137.74 -37.19 0.61 Allowed 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -102.12 -23.13 14.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.474 ' N ' HD11 ' A' ' 97' ' ' LEU . 13.9 t -111.66 12.0 21.13 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.398 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.524 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.3 ptpt -69.97 176.95 3.4 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.527 169.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -119.88 -0.13 10.72 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.552 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.8 m -82.81 -36.95 25.13 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.81 115.19 27.19 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.643 0.735 . . . . 0.0 110.491 -174.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.525 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -75.16 -68.11 0.59 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.725 -173.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.1 p -121.28 125.5 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.421 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 25.4 m -131.44 147.13 32.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.909 -175.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -97.93 116.72 30.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.054 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.501 HD21 HG22 ' A' ' 80' ' ' VAL . 11.9 mt -112.76 152.41 29.15 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.97 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.9 mp -126.38 126.0 43.14 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 122.661 0.384 . . . . 0.0 110.146 174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 m -122.05 149.64 25.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 p -119.23 133.07 55.96 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -93.93 87.06 5.24 Favored 'General case' 0 N--CA 1.416 -2.174 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.288 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -84.48 -47.95 10.1 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.466 -1.697 . . . . 0.0 106.949 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 m -91.1 6.23 45.78 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.36 -170.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.8 mt -140.04 75.54 1.51 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.3 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.426 ' O ' ' HB3' ' A' ' 116' ' ' LYS . 12.1 pt20 -93.9 132.47 38.3 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 174.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 115' ' ' GLN . 62.0 tttp 76.12 150.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.264 0.977 . . . . 0.0 109.54 -173.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 75.72 158.77 0.21 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.596 1.158 . . . . 0.0 112.781 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.0 t 69.26 70.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.593 -177.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.69 109.88 19.66 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 172.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -70.25 98.4 1.36 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.604 0.716 . . . . 0.0 110.29 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.4 m -144.04 -6.39 0.76 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.552 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 21.6 mmt -102.19 -38.09 7.84 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.401 HD23 ' HA ' ' A' ' 68' ' ' ILE . 51.7 tp -76.31 106.48 7.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.84 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--N 1.29 -1.999 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.672 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.052 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 m -128.67 102.01 6.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -121.53 121.21 36.97 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.193 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.8 tt -108.13 111.57 61.85 Favored Pre-proline 0 C--N 1.296 -1.749 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -74.14 164.65 33.81 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.159 1.906 . . . . 0.0 112.64 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.2 50.68 0.99 Allowed Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -67.78 123.76 87.74 Favored Pre-proline 0 C--O 1.243 0.731 0 CA-C-O 120.946 0.403 . . . . 0.0 111.835 -178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -87.69 -106.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 122.94 2.427 . . . . 0.0 112.058 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 m -141.21 -38.85 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.202 0.525 . . . . 0.0 111.5 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -76.23 -12.97 60.18 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.776 0.83 . . . . 0.0 111.067 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.55 148.27 52.33 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.753 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t -126.75 139.8 50.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.458 HG23 HG23 ' A' ' 110' ' ' THR . 11.7 t -97.19 137.0 26.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.415 ' NE2' HG21 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -138.48 151.18 47.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 5.0 ppt_? -96.24 155.1 16.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.036 0.446 . . . . 0.0 111.111 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -133.71 154.5 38.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -150.53 105.63 3.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.125 0.488 . . . . 0.0 109.781 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -90.94 127.61 43.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.393 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -96.24 134.44 39.34 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.413 ' HB2' HD22 ' A' ' 27' ' ' LEU . 23.3 pttm -29.34 121.8 0.15 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 42.7 tp -120.79 125.85 48.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.899 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -91.15 125.79 36.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.416 ' NE2' HD11 ' A' ' 28' ' ' ILE . 33.1 mt-30 -130.37 105.67 8.04 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.29 -115.82 6.67 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.16 -0.82 49.54 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.469 0.308 . . . . 0.0 110.297 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.78 174.81 5.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.869 0.842 . . . . 0.0 111.08 -169.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.413 HD22 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -126.51 113.0 16.22 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 HD11 ' NE2' ' A' ' 23' ' ' GLN . 0.9 OUTLIER -125.65 164.21 25.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.616 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 97' ' ' LEU . 49.4 mt -91.93 8.51 37.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.854 0.835 . . . . 0.0 109.984 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.0 -46.92 2.68 Favored Glycine 0 N--CA 1.416 -2.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.53 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.445 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 30.6 p90 -93.4 172.39 8.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.3 m -136.44 169.28 17.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.12 1.768 . . . . 0.0 110.222 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.532 HD12 HD12 ' A' ' 55' ' ' ILE . 5.5 pt -124.81 172.54 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 C-N-CA 122.608 0.363 . . . . 0.0 111.477 -170.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.17 -12.37 8.33 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.626 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 114.33 170.49 16.85 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 119.537 -1.316 . . . . 0.0 113.066 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.447 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -123.68 -114.71 2.14 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 124.083 0.52 . . . . 0.0 112.109 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -29.31 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -66.34 -17.87 65.02 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.852 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.533 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 19.6 mm-40 -101.24 153.54 19.53 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.0 t70 -99.98 115.69 65.31 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -51.37 -30.01 32.68 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.773 2.982 . . . . 0.0 113.018 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.2 t -66.17 -25.99 67.2 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.331 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.403 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -121.85 15.68 10.92 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.583 0.706 . . . . 0.0 111.032 -177.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.512 HD22 ' HB2' ' A' ' 39' ' ' GLN . 87.7 m-20 -93.49 155.3 40.89 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 56.7 Cg_endo -74.57 -55.91 0.08 OUTLIER 'Trans proline' 0 C--O 1.198 -1.524 0 C-N-CA 122.746 2.298 . . . . 0.0 113.003 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -105.8 27.7 8.24 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.88 0.848 . . . . 0.0 110.602 -175.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.504 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.3 t -138.74 21.74 2.68 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 8.4 pt-20 -89.0 -26.11 21.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.795 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.41 ' OD2' ' HG2' ' A' ' 50' ' ' LYS . 8.2 p-10 -77.71 -30.13 51.65 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.417 0.627 . . . . 0.0 110.917 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HG2' ' OD2' ' A' ' 49' ' ' ASP . 59.3 pttt -154.31 163.95 39.35 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.532 176.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -81.34 19.89 0.92 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.748 1.219 . . . . 0.0 112.298 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 50' ' ' LYS . 37.2 t70 -77.48 110.13 11.99 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.703 -176.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -78.8 -169.11 1.63 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.949 -177.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.68 140.86 7.69 Favored Glycine 0 C--O 1.186 -2.892 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.661 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 27.9 mm -60.73 128.83 22.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.248 0.547 . . . . 0.0 111.012 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.3 151.86 48.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.748 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' HB ' ' OD1' ' A' ' 75' ' ' ASP . 97.8 t -79.23 134.23 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 123.959 0.787 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -110.92 -21.93 11.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -148.73 135.63 19.9 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.443 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 71' ' ' LEU . 27.5 m -117.63 173.15 4.72 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.9 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 172.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -72.16 126.24 29.29 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -73.24 -19.16 61.13 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.771 0.67 . . . . 0.0 110.548 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.34 43.8 0.91 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.29 -170.82 12.83 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.314 -178.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.95 -31.6 66.6 Favored 'Trans proline' 0 N--CA 1.474 0.327 0 C-N-CA 123.742 2.961 . . . . 0.0 112.297 -172.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.83 -63.52 1.15 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.103 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.7 -28.04 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.003 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.16 -49.76 79.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.339 0.4 . . . . 0.0 110.364 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -52.13 43.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.269 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.96 22.8 0.08 OUTLIER Glycine 0 C--N 1.305 -1.151 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.724 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.514 ' O ' HG12 ' A' ' 60' ' ' VAL . 4.2 tp -90.19 106.97 18.84 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.556 ' HB2' ' NH2' ' A' ' 111' ' ' ARG . 22.1 mm-40 -124.49 124.13 41.62 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.1 mt -35.98 122.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 125.777 1.923 . . . . 0.0 112.801 -175.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.06 14.7 23.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.457 ' OD1' ' HB ' ' A' ' 57' ' ' VAL . 5.6 p-10 -87.32 139.0 31.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.523 ' HB3' ' HZ3' ' A' ' 76' ' ' LYS . 7.5 mtpm? -104.5 107.43 18.36 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.437 ' HB ' ' HE3' ' A' ' 85' ' ' MET . 9.6 mt -74.78 142.77 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.05 -172.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 27.8 mmt -122.15 -20.19 6.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.619 0.723 . . . . 0.0 109.891 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.498 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -144.44 134.82 24.47 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.462 ' O ' ' HD1' ' A' ' 83' ' ' TRP . 62.6 t -140.51 120.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 53.75 39.55 30.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.867 0.867 . . . . 0.0 111.891 170.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.498 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 57.8 21.89 45.49 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.462 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -102.77 -0.13 31.96 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.362 3.8 p30 49.83 99.28 0.01 OUTLIER 'General case' 0 C--N 1.342 0.273 0 CA-C-O 123.462 1.601 . . . . 0.0 113.635 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.661 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 ttp -97.95 -10.04 25.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.303 -169.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 6.2 t -33.19 -36.31 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 126.445 1.898 . . . . 0.0 115.727 -177.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.9 ttm -139.26 93.63 2.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.92 151.89 10.04 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 14.0 p -73.64 157.34 36.8 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.372 178.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.51 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 8.8 t60 -54.58 -46.31 73.71 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.967 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.55 -44.83 95.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.281 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -37.61 68.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.872 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.93 87.95 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.761 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -52.61 -34.98 53.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.638 0.775 . . . . 0.0 111.943 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -88.29 13.5 11.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.351 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.531 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 15.3 tpt180 -133.21 -39.66 0.93 Allowed 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.482 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.53 ' O ' HD11 ' A' ' 29' ' ' LEU . 0.6 OUTLIER -103.05 -11.88 17.81 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.964 -176.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -125.93 14.23 7.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.978 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.531 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 13.4 ptpt -67.13 -168.94 0.08 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.27 170.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -132.52 3.22 3.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.12 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.428 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 34.9 m -73.27 -40.3 64.71 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.437 -177.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.16 134.32 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.431 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.1 pm0 -81.45 -61.04 2.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.594 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -120.34 129.18 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 C-N-CA 123.049 0.54 . . . . 0.0 110.842 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.78 146.53 30.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.595 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -98.93 117.69 34.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.437 ' O ' HD12 ' A' ' 108' ' ' LEU . 19.0 mt -112.09 155.35 24.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.875 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 107' ' ' LEU . 4.7 mp -133.42 126.3 30.91 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.415 HG21 ' NE2' ' A' ' 14' ' ' GLN . 17.0 m -123.45 158.93 28.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 123.682 0.614 . . . . 0.0 109.84 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.458 HG23 HG23 ' A' ' 13' ' ' VAL . 37.9 p -112.27 137.43 50.4 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-O 121.25 0.548 . . . . 0.0 110.249 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.556 ' NH2' ' HB2' ' A' ' 72' ' ' GLN . 18.5 mmt180 -100.11 116.24 31.68 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.475 ' C ' ' H ' ' A' ' 114' ' ' LEU . 22.7 mm-40 -96.02 14.92 22.1 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 m -72.83 14.7 0.25 Allowed 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 124.681 1.192 . . . . 0.0 112.822 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.475 ' H ' ' C ' ' A' ' 112' ' ' GLN . 6.3 mp -117.56 18.38 14.26 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.908 0.861 . . . . 0.0 109.024 178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -79.55 150.19 31.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.992 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -155.3 138.98 16.07 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.55 142.84 50.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t 65.31 71.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.453 1.12 . . . . 0.0 110.357 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -152.31 -63.09 0.17 Allowed 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 53.27 99.53 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 m -67.68 -30.38 69.9 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 tpt -165.78 -64.73 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.385 -1.734 . . . . 0.0 106.327 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.5 mt -115.1 -33.39 5.39 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.307 -1.259 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.663 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.764 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 p -149.68 162.12 40.86 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.872 0.336 . . . . 0.0 110.427 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -93.17 108.68 20.24 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.9 mm -102.47 105.62 44.68 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.71 171.78 14.84 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.467 2.111 . . . . 0.0 113.898 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.72 39.29 3.11 Favored Glycine 0 C--N 1.32 -0.334 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.425 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 8.3 tt0 -78.42 128.7 77.02 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.48 -64.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.538 1.492 . . . . 0.0 109.929 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -160.48 -41.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 125.047 1.339 . . . . 0.0 109.439 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 t -116.26 -51.46 2.62 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -175.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -61.71 132.75 54.23 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 118.027 0.376 . . . . 0.0 110.463 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.7 t -101.62 128.86 53.62 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.069 -173.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.441 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 8.6 p -112.14 126.53 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.608 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' NE2' HG21 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -137.65 152.52 49.4 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -176.32 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -93.81 150.44 20.38 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.52 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -125.71 156.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -141.86 105.72 4.73 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.618 0.723 . . . . 0.0 110.761 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.418 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.7 mp -96.99 128.2 48.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.189 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 58.5 m170 -97.67 137.54 36.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -36.09 121.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -177.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 tp -124.52 128.54 49.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.649 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -96.09 132.9 41.0 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.153 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.534 ' NE2' ' HA2' ' A' ' 30' ' ' GLY . 66.4 mt-30 -123.68 108.06 12.15 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.33 -103.86 1.25 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -119.92 12.7 12.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.26 167.44 14.87 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -113.73 118.41 34.25 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.48 154.14 36.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 63.8 mt -79.36 2.31 22.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.8 0.809 . . . . 0.0 109.596 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.534 ' HA2' ' NE2' ' A' ' 23' ' ' GLN . . . 95.64 -44.73 2.06 Favored Glycine 0 N--CA 1.408 -3.176 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.921 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 37.7 p90 -90.65 164.56 14.12 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 m -115.01 164.84 13.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 125.027 1.331 . . . . 0.0 109.135 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.497 HD11 HD13 ' A' ' 55' ' ' ILE . 6.5 pt -126.06 166.62 21.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.0 -31.03 3.46 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.488 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.38 154.02 9.13 Favored Glycine 0 C--O 1.2 -1.996 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.298 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -102.57 -117.67 4.33 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.335 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -23.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.469 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 18.5 t70 -68.94 -20.47 64.2 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.761 0.791 . . . . 0.0 109.887 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.577 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 21.9 mm-40 -100.97 156.96 17.1 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 5.0 t70 -101.32 114.66 65.71 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.17 -25.66 23.95 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 123.859 3.04 . . . . 0.0 113.682 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 m -76.02 -8.59 57.33 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.235 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.429 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -135.22 13.09 3.56 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.905 0.859 . . . . 0.0 110.348 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.527 HD22 ' HB2' ' A' ' 39' ' ' GLN . 95.5 m-20 -97.86 150.43 36.75 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.495 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.09 -45.7 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.037 0 C-N-CA 122.993 2.462 . . . . 0.0 114.31 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -114.02 9.53 17.36 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 121.354 -0.842 . . . . 0.0 110.931 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.494 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 9.6 t -104.95 -4.8 21.67 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.55 2.83 31.15 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.929 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.459 ' CG ' ' HZ2' ' A' ' 50' ' ' LYS . 8.8 t0 -58.32 -37.39 74.99 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.541 1.136 . . . . 0.0 108.367 177.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.459 ' HZ2' ' CG ' ' A' ' 49' ' ' ASP 0.265 0.0 OUTLIER -154.02 -111.85 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.222 168.669 . . . . . . . . 4 4 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.0 p -134.41 19.29 3.65 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -87.13 135.84 33.15 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.2 -171.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -94.44 176.3 6.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.467 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.407 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 138.48 157.99 7.59 Favored Glycine 0 C--O 1.204 -1.765 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.497 HD13 HD11 ' A' ' 33' ' ' ILE . 30.7 mm -80.95 118.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 117.685 0.743 . . . . 0.0 109.555 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -120.71 155.69 33.36 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.072 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.6 p -81.58 131.56 33.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 O-C-N 124.733 1.271 . . . . 0.0 110.36 -179.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 p -106.57 -19.04 13.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.556 0.693 . . . . 0.0 111.319 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -154.73 135.92 13.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.424 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 30.3 m -100.57 -177.44 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.351 -5.416 0 CA-C-N 119.592 1.087 . . . . 0.0 108.186 173.606 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.439 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 5.2 t -76.26 122.41 24.36 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.67 -18.5 31.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.275 0.984 . . . . 0.0 113.09 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.56 46.32 0.23 Allowed Glycine 0 CA--C 1.482 -1.975 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.474 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -132.78 -168.34 11.95 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.967 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -61.45 -31.88 88.32 Favored 'Trans proline' 0 C--O 1.216 -0.576 0 C-N-CA 123.987 3.125 . . . . 0.0 112.552 -169.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.419 ' HB2' ' H ' ' A' ' 61' ' ' SER . . . -56.63 -60.26 3.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.31 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -71.17 -30.14 66.07 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.245 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.474 HG12 ' O ' ' A' ' 64' ' ' GLY . 32.4 mm -62.6 -41.1 90.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 122.983 0.513 . . . . 0.0 111.147 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.94 -56.78 4.21 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.498 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.14 22.53 0.05 OUTLIER Glycine 0 C--N 1.314 -0.64 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.029 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.52 ' HB2' HG11 ' A' ' 16' ' ' VAL . 3.2 tp -87.94 119.61 28.46 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -115.27 140.98 48.64 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.62 0.575 . . . . 0.0 109.494 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.8 mt -49.52 126.53 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 123.316 0.385 . . . . 0.0 111.521 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.71 50.79 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.104 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -80.62 131.91 35.55 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -94.3 108.2 20.11 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.408 HG13 HG12 ' A' ' 109' ' ' VAL . 3.3 mp -78.9 125.72 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.566 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.4 mmt -112.84 -8.82 13.71 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.85 0.357 . . . . 0.0 111.821 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.562 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -156.55 136.13 12.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.476 HG21 HD12 ' A' ' 107' ' ' LEU . 39.2 t -142.61 115.04 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.546 1.138 . . . . 0.0 109.972 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.617 HD21 ' HA ' ' A' ' 105' ' ' VAL . 2.8 t-20 50.5 57.8 6.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.622 1.169 . . . . 0.0 111.784 176.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.61 -17.89 1.93 Allowed Glycine 0 C--N 1.289 -2.082 0 CA-C-N 114.029 -1.441 . . . . 0.0 115.293 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.433 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -90.88 157.01 17.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.817 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.87 134.33 34.54 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.417 0.627 . . . . 0.0 109.897 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.526 ' SD ' HG13 ' A' ' 88' ' ' VAL . 63.4 tpp -113.15 1.59 15.33 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.235 1.017 . . . . 0.0 108.881 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.566 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.6 t -61.16 -35.7 77.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.133 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.4 ttm -139.47 91.25 2.47 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.526 HG13 ' SD ' ' A' ' 85' ' ' MET . 9.3 p -157.13 151.05 8.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.422 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.447 HG23 ' HB2' ' A' ' 38' ' ' ASP . 2.3 p -71.13 157.19 38.61 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.51 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.577 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 13.0 t60 -53.92 -45.19 71.12 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.189 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.65 -48.36 81.21 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.733 0.645 . . . . 0.0 111.537 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.49 -30.38 67.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.409 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.624 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.86 -42.86 66.4 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 176.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.458 ' C ' ' H ' ' A' ' 96' ' ' ARG . 11.1 mmm180 -56.08 -42.8 77.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.537 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -80.32 27.33 0.34 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 109.123 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.531 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 tpt180 -139.77 -43.27 0.44 Allowed 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.634 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 1.5 pp -100.03 -28.85 12.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.466 ' N ' HD13 ' A' ' 97' ' ' LEU . 14.9 t -108.19 15.88 23.75 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.945 -1.502 . . . . 0.0 109.614 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.551 ' HD2' ' CB ' ' A' ' 102' ' ' GLU . 16.3 ptpt -65.78 176.2 1.66 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.535 170.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -127.41 12.29 6.97 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.698 0.761 . . . . 0.0 111.261 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 m -94.64 -32.71 13.27 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.95 0.881 . . . . 0.0 111.731 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.551 ' CB ' ' HD2' ' A' ' 99' ' ' LYS . 14.7 tt0 -108.79 119.28 39.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.496 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 0.7 OUTLIER -80.52 -71.54 0.46 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.135 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.463 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 31.3 t -98.88 136.07 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.617 ' HA ' HD21 ' A' ' 81' ' ' ASN . 19.6 m -129.62 152.78 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 CA-C-O 121.32 0.581 . . . . 0.0 111.778 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -127.14 112.32 15.02 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.476 HD12 HG21 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.33 162.58 16.92 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.703 -171.778 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.7 mp -130.95 127.39 38.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.441 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 21.7 m -119.14 150.27 21.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 75.1 p -118.93 146.98 44.51 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -114.67 96.43 5.73 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -85.02 -11.19 55.98 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.905 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.4 p -81.71 5.51 18.2 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.421 1.105 . . . . 0.0 110.579 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 59.4 tp -109.06 85.08 2.03 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.309 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -95.58 -73.5 0.59 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.87 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm 57.98 19.04 5.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.754 0.822 . . . . 0.0 110.984 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.09 -179.09 7.71 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.8 p -163.51 95.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-O 122.321 1.058 . . . . 0.0 109.69 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -51.31 118.69 3.44 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.378 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -112.11 16.22 20.26 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.239 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.0 m 68.59 16.62 9.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 110.344 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 56.9 ttp -177.73 95.0 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 126.047 1.739 . . . . 0.0 106.794 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.4 tp -111.02 87.35 2.52 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.416 -2.172 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -177.12 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.4 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 p -115.02 104.03 11.49 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 117.346 0.573 . . . . 0.0 109.847 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.532 ' HE1' ' C ' ' A' ' 5' ' ' PRO . 11.7 t80 -80.62 120.21 24.26 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.41 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 44.8 mm -83.35 -58.25 0.41 Allowed Pre-proline 0 CA--C 1.568 1.666 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' C ' ' HE1' ' A' ' 3' ' ' TYR . 51.3 Cg_endo -70.32 -158.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.558 2.172 . . . . 0.0 116.358 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.53 50.64 0.34 Allowed Glycine 0 CA--C 1.493 -1.332 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -77.36 127.13 83.79 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.627 -0.786 . . . . 0.0 113.062 -174.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.21 -106.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 123.025 2.483 . . . . 0.0 109.793 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.79 -50.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 121.961 -0.462 . . . . 0.0 111.701 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -73.89 -24.0 59.65 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.782 0.801 . . . . 0.0 110.675 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.87 142.44 46.93 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.976 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.44 130.91 71.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 110' ' ' THR . 15.5 t -97.04 127.5 49.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -135.32 150.88 50.08 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -97.14 143.85 27.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -176.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 8.5 p -132.75 154.29 39.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -137.14 108.54 6.89 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.284 0.564 . . . . 0.0 111.689 -174.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.402 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -98.83 133.31 41.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.777 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.6 m170 -99.32 147.71 24.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 41.9 pttt -38.32 116.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.4 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 52.3 tp -117.6 125.45 50.81 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.124 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -95.48 126.28 40.66 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -122.93 99.6 6.47 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.74 -104.12 1.65 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.0 -1.32 15.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.12 171.22 7.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.316 0.579 . . . . 0.0 109.979 -172.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -122.07 108.42 13.34 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 177.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 1.3 mt -121.51 156.04 25.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 68.6 mt -84.03 3.35 34.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.628 0.728 . . . . 0.0 109.871 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -34.43 3.97 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.519 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -99.07 170.99 8.31 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.343 0.571 . . . . 0.0 111.55 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.539 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 82.4 p -124.13 -173.7 2.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.09 0.556 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CG2' ' HG ' ' A' ' 97' ' ' LEU . 8.4 pt -135.42 164.98 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.73 -17.39 7.49 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.543 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 121.6 166.34 12.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.261 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -115.95 -108.16 2.61 Favored Glycine 0 N--CA 1.409 -3.148 0 O-C-N 124.459 0.741 . . . . 0.0 113.322 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.531 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -80.83 -21.14 11.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.194 0.521 . . . . 0.0 111.43 -174.468 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.492 ' HB3' HG21 ' A' ' 89' ' ' THR . 7.3 p-10 -86.39 3.85 41.91 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 110.309 -174.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.521 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 60.6 mm-40 -99.34 178.06 5.0 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.474 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -132.12 121.6 17.82 Favored Pre-proline 0 CA--C 1.479 -1.786 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.4 -24.76 44.82 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.477 2.118 . . . . 0.0 113.496 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m -66.73 -30.08 70.21 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.859 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.13 21.05 9.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.283 0.563 . . . . 0.0 111.221 -175.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' A' ' 39' ' ' GLN . 5.8 m120 -115.08 143.76 30.82 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.62 -50.97 1.07 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.667 2.911 . . . . 0.0 114.008 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -104.8 17.78 23.52 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.497 0.665 . . . . 0.0 110.469 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 5.4 t -123.66 2.89 8.92 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -86.32 -14.23 44.23 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.46 -53.85 12.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.392 0.615 . . . . 0.0 109.582 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' C ' ' H ' ' A' ' 52' ' ' ASP . 37.4 mtmm -138.42 154.36 48.89 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.024 176.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.1 p -78.92 21.62 0.42 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 124.957 1.303 . . . . 0.0 113.438 -167.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 50' ' ' LYS . 31.2 t70 -87.77 111.96 21.92 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.205 -177.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 37' ' ' ILE . 8.6 mtmp? -92.03 -176.98 4.57 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.441 ' C ' ' HA2' ' A' ' 36' ' ' GLY . . . 129.21 146.85 6.2 Favored Glycine 0 C--O 1.177 -3.416 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.543 HD13 ' C ' ' A' ' 35' ' ' GLY . 31.6 mm -58.81 117.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 118.811 1.305 . . . . 0.0 112.402 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -119.25 153.94 34.22 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.106 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.28 135.39 25.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 124.567 1.167 . . . . 0.0 110.207 178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 p -109.65 -23.57 11.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.268 0.556 . . . . 0.0 111.863 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.539 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 40.7 mtt-85 -142.56 138.22 30.68 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.423 HG12 ' CB ' ' A' ' 66' ' ' ALA . 54.3 t -124.87 135.76 62.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.2 t -54.44 118.76 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 124.469 1.106 . . . . 0.0 109.801 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.74 -5.85 9.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.598 1.559 . . . . 0.0 112.659 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.28 38.47 0.33 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.401 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -124.01 -174.08 14.05 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.37 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.92 -29.89 76.5 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 124.018 3.145 . . . . 0.0 111.934 -172.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.423 ' CB ' HG12 ' A' ' 60' ' ' VAL . . . -57.94 -60.91 2.99 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.626 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.5 pt-20 -75.61 -23.94 56.47 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.9 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.2 mm -59.24 -43.69 90.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -50.72 19.24 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.024 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.85 21.81 0.24 Allowed Glycine 0 C--N 1.321 -0.277 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.884 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tp -80.13 126.63 31.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -116.66 147.18 42.18 Favored 'General case' 0 C--O 1.205 -1.247 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.6 mt -61.59 132.35 27.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.808 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.41 -0.34 55.72 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 73.1 m-20 -75.86 119.94 20.54 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -83.47 114.53 21.54 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.1 mt -86.63 123.79 39.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.835 -173.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 31.3 mmt -107.66 -17.91 13.97 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.228 0.537 . . . . 0.0 110.192 -176.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.474 HE22 ' CA ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -147.13 137.69 23.55 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.451 HG23 HD11 ' A' ' 107' ' ' LEU . 18.4 t -139.89 115.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 123.276 0.63 . . . . 0.0 109.326 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.491 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER 53.12 35.76 20.57 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.802 1.241 . . . . 0.0 111.313 173.816 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.474 ' CA ' HE22 ' A' ' 79' ' ' GLN . . . 73.73 7.35 74.56 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 114.584 -1.189 . . . . 0.0 115.443 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.574 ' CZ2' ' HG3' ' A' ' 96' ' ' ARG 0.325 0.1 OUTLIER -81.39 -86.12 0.09 Allowed 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 118.21 1.005 . . . . 0.0 112.762 -179.965 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 162.99 111.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 126.404 1.881 . . . . 0.0 107.161 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.1 tpt -113.0 -1.88 14.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.884 -174.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.9 t -72.41 -33.97 67.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.933 -175.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.531 ' SD ' HG21 ' A' ' 37' ' ' ILE . 16.4 tpt -128.54 85.83 2.38 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 HG13 ' A' ' 55' ' ' ILE . 7.2 p -161.06 147.53 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.891 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.492 HG21 ' HB3' ' A' ' 38' ' ' ASP . 8.7 p -69.8 159.55 33.38 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.995 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.488 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 7.9 t60 -57.64 -41.74 82.03 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.616 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.45 -51.14 70.76 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.486 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.517 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -72.06 -34.67 68.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.17 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -33.06 65.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.4 ' C ' ' H ' ' A' ' 96' ' ' ARG . 12.8 mmm180 -52.74 -48.72 66.53 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -83.72 26.68 0.68 Allowed 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.649 0.737 . . . . 0.0 110.885 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.574 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 24.3 mmt180 -131.56 -29.03 1.79 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.004 176.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -106.72 -27.6 10.69 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.288 174.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.404 ' N ' HD13 ' A' ' 97' ' ' LEU . 8.7 t -112.47 16.8 19.72 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.754 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.507 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.3 ptpt -64.8 165.08 11.11 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.172 168.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -122.91 4.74 9.38 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.946 0.879 . . . . 0.0 109.374 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -45.44 94.78 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.744 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -107.69 179.91 4.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.412 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 8.3 pt-20 -132.35 -62.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.4 t -95.99 126.16 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.491 ' HA ' ' ND2' ' A' ' 81' ' ' ASN . 28.0 m -127.04 153.02 35.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.088 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.45 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 92.5 mtt180 -124.47 116.52 22.64 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.451 HD11 HG23 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.87 147.57 40.92 Favored 'General case' 0 N--CA 1.395 -3.218 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -174.442 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.402 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 6.9 mp -111.98 121.5 45.17 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 35.5 m -117.2 147.35 20.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.002 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.465 HG23 HG22 ' A' ' 13' ' ' VAL . 47.1 p -117.81 127.18 53.64 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.764 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 114' ' ' LEU . 85.6 mtt180 -97.5 97.24 8.92 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.521 0.677 . . . . 0.0 110.595 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -80.99 -44.56 17.95 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.802 -1.544 . . . . 0.0 111.195 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.6 t -141.98 20.12 2.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.43 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 3.7 mm? -129.0 40.9 3.56 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -75.99 -22.19 56.1 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.11 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 71.06 177.37 0.27 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.13 1.372 . . . . 0.0 111.01 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.75 164.98 33.81 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t 64.04 75.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-O 122.551 1.167 . . . . 0.0 109.714 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -87.25 2.53 49.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.79 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -75.68 71.06 2.54 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.958 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 t -130.86 8.41 4.84 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -160.42 178.82 9.19 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 tp 57.53 71.61 0.57 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.559 1.143 . . . . 0.0 111.249 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.3 m . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.717 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.967 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -104.36 -30.61 9.99 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 117.116 0.458 . . . . 0.0 110.368 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.8 t80 68.29 91.47 0.09 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.148 0.975 . . . . 0.0 112.264 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 mm -114.22 93.38 30.67 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -69.63 167.3 24.67 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.109 1.873 . . . . 0.0 112.748 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.23 50.69 4.41 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 7.7 tt0 -63.63 124.63 85.34 Favored Pre-proline 0 N--CA 1.438 -1.034 0 C-N-CA 123.302 0.641 . . . . 0.0 110.975 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 9' ' ' VAL . 18.6 Cg_endo -64.66 -63.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.154 1.903 . . . . 0.0 110.218 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.499 HG12 ' O ' ' A' ' 8' ' ' PRO . 1.2 m 157.59 -42.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 129.121 2.969 . . . . 0.0 109.014 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.515 ' O ' ' HB2' ' A' ' 113' ' ' SER . 13.9 t -78.74 -15.15 58.8 Favored 'General case' 0 C--O 1.208 -1.103 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.49 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -132.58 136.56 46.64 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.58 117.66 42.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -84.32 119.8 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -130.27 152.81 49.29 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.34 146.2 24.95 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.898 -174.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.495 HG13 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -125.87 158.01 35.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -146.7 103.78 3.68 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.531 0.681 . . . . 0.0 110.777 179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.58 126.57 44.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.978 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 55.6 m170 -96.94 161.95 13.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 124.232 0.957 . . . . 0.0 109.902 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.418 ' HG3' HD11 ' A' ' 27' ' ' LEU . 39.6 ttmt -40.68 125.88 2.31 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.237 1.415 . . . . 0.0 113.705 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.451 HD22 ' CD ' ' A' ' 65' ' ' PRO . 42.8 tp -139.71 131.43 27.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.037 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -99.96 137.07 38.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -128.49 104.21 7.56 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.96 -108.55 2.52 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -111.85 9.59 20.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.267 0.556 . . . . 0.0 110.679 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.65 172.03 7.28 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.418 HD11 ' HG3' ' A' ' 20' ' ' LYS . 14.3 tp -122.77 115.74 22.53 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.17 153.62 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.574 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 97' ' ' LEU . 9.3 mp -78.59 0.16 27.41 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.667 0.746 . . . . 0.0 111.423 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.54 -37.81 3.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.927 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.414 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 34.3 p90 -100.64 178.21 4.78 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -143.57 168.04 20.8 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 124.274 1.03 . . . . 0.0 110.053 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.556 HD12 HD12 ' A' ' 55' ' ' ILE . 11.1 pt -127.43 167.7 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 117.944 0.338 . . . . 0.0 111.87 -171.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.07 -29.89 4.13 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.532 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 127.24 161.82 10.96 Favored Glycine 0 N--CA 1.42 -2.406 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.376 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.518 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -108.19 -119.41 4.34 Favored Glycine 0 N--CA 1.428 -1.899 0 O-C-N 124.16 0.565 . . . . 0.0 112.652 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -24.27 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.153 0.502 . . . . 0.0 111.759 -175.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.464 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.8 t70 -66.63 -13.03 60.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.773 1.229 . . . . 0.0 111.014 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.614 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 30.0 mm-40 -104.61 169.63 8.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.899 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -114.19 128.08 26.17 Favored Pre-proline 0 CA--C 1.486 -1.502 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.408 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.0 Cg_endo -57.08 -32.11 92.27 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.023 1.815 . . . . 0.0 113.731 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.2 t -65.75 -32.18 73.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.94 13.69 29.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.534 0.683 . . . . 0.0 110.784 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' ND2' ' HB3' ' A' ' 39' ' ' GLN . 13.0 m-80 -112.26 146.05 34.1 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 46.5 Cg_endo -64.94 -53.47 0.89 Allowed 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 123.271 2.647 . . . . 0.0 113.349 -171.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -101.24 0.86 38.19 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.602 0.715 . . . . 0.0 110.624 -176.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 6.2 t -102.47 -10.76 19.1 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.69 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 10.7 pt-20 -71.5 -30.04 65.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.295 1.045 . . . . 0.0 108.828 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -82.89 -38.43 22.9 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.768 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -128.42 117.1 20.79 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.6 p -83.71 8.2 15.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -172.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.72 105.74 13.99 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.408 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 58.9 mtmt -74.55 159.99 31.47 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.811 0.815 . . . . 0.0 112.388 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.2 153.1 5.79 Favored Glycine 0 C--O 1.185 -2.935 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.556 HD12 HD12 ' A' ' 33' ' ' ILE . 29.1 mm -64.25 127.94 25.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 118.708 1.254 . . . . 0.0 111.584 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -129.88 155.5 45.92 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.85 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.483 HG22 HD11 ' A' ' 71' ' ' LEU . 95.2 t -85.02 130.45 36.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 O-C-N 124.441 1.088 . . . . 0.0 111.028 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -107.35 -20.02 13.4 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 41.2 ttt-85 -142.74 143.29 32.18 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.417 HG11 ' CB ' ' A' ' 66' ' ' ALA . 45.9 t -128.38 144.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t -59.32 126.5 27.9 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.68 -26.48 68.68 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.626 1.17 . . . . 0.0 110.834 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.97 52.44 0.53 Allowed Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.766 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.41 -172.51 12.97 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.878 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.451 ' CD ' HD22 ' A' ' 21' ' ' LEU . 36.9 Cg_endo -64.52 -28.12 61.84 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 124.326 3.35 . . . . 0.0 111.619 -173.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.417 ' CB ' HG11 ' A' ' 60' ' ' VAL . . . -60.44 -58.86 6.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.958 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -69.17 -31.27 69.79 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.535 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.8 mm -59.79 -49.45 83.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.043 0.449 . . . . 0.0 110.546 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -71.43 -47.86 53.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.891 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.61 22.6 0.18 Allowed Glycine 0 C--N 1.302 -1.308 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.647 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' HB2' HG13 ' A' ' 16' ' ' VAL . 2.4 tp -85.88 122.92 30.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.424 ' N ' HD13 ' A' ' 71' ' ' LEU . 24.5 mm-40 -115.43 154.09 29.89 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 121.779 0.8 . . . . 0.0 109.098 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.5 mt -65.33 124.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.147 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -15.36 23.54 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.402 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 64.6 m-20 -67.63 130.75 44.0 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.056 0.455 . . . . 0.0 110.533 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -92.37 127.15 37.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.424 HG13 HG12 ' A' ' 109' ' ' VAL . 2.9 mp -94.92 127.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -175.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 28.8 mmt -103.53 -20.55 13.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.987 0.423 . . . . 0.0 110.689 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 14.6 tp60 -152.48 129.55 11.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.066 -172.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.415 HG21 HD13 ' A' ' 107' ' ' LEU . 38.8 t -137.16 115.71 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.822 0.849 . . . . 0.0 110.329 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 53.04 41.75 32.18 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.243 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.68 90.14 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.112 -0.949 . . . . 0.0 115.062 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.482 ' N ' HE22 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -114.0 150.09 34.39 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.16 136.81 36.58 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.781 0.718 . . . . 0.0 109.884 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.5 tpt -116.63 -7.06 11.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.229 -175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 8.1 t -58.63 -34.91 71.7 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.084 -178.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.0 ttp -137.99 91.07 2.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.24 151.55 10.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.029 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.464 HG22 ' HB2' ' A' ' 38' ' ' ASP . 11.8 p -75.39 159.59 31.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.493 0.187 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.614 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 11.4 t60 -55.45 -42.77 74.7 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.55 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 39.2 t70 -59.3 -54.0 51.86 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.756 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -30.17 69.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.866 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.76 -44.59 63.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.164 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.436 ' C ' ' H ' ' A' ' 96' ' ' ARG . 8.7 mmm180 -57.92 -43.28 86.16 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.673 0.749 . . . . 0.0 109.471 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.4 40.34 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.405 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.436 ' H ' ' C ' ' A' ' 94' ' ' ARG . 11.2 tpt180 -150.02 -45.63 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.243 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.474 HD11 ' N ' ' A' ' 98' ' ' THR . 1.0 OUTLIER -99.16 -26.15 14.29 Favored 'General case' 0 C--O 1.196 -1.722 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.474 ' N ' HD11 ' A' ' 97' ' ' LEU . 12.4 t -111.91 17.09 20.04 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 118.22 -1.392 . . . . 0.0 109.601 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.508 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 16.0 ptpt -72.14 161.49 30.81 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -114.43 9.69 16.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.752 0.787 . . . . 0.0 110.373 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.508 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 36.5 m -80.57 -30.44 37.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.851 -177.137 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -110.11 156.73 20.19 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -110.51 -67.71 0.98 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.865 0.364 . . . . 0.0 111.869 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -103.96 125.11 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-O 122.106 0.955 . . . . 0.0 112.578 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.443 ' C ' ' HD2' ' A' ' 106' ' ' ARG . 15.6 m -126.18 168.48 19.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.453 -175.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.443 ' HD2' ' C ' ' A' ' 105' ' ' VAL . 5.1 mpt_? -127.06 116.29 20.49 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.415 HD13 HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -118.9 153.34 34.72 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.1 mp -125.4 123.6 39.67 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.424 HG12 HG13 ' A' ' 77' ' ' ILE . 30.2 m -124.09 155.44 31.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.6 -176.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 11.4 p -98.69 124.32 43.44 Favored 'General case' 0 N--CA 1.383 -3.821 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -65.58 -15.68 62.96 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.645 1.578 . . . . 0.0 111.693 -168.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 64.62 72.9 0.44 Allowed 'General case' 0 CA--C 1.457 -2.618 0 CA-C-O 123.373 1.559 . . . . 0.0 112.211 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 10' ' ' THR . 3.0 m -92.52 -3.24 55.41 Favored 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 111.805 -2.452 . . . . 0.0 108.306 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.6 tp -90.15 92.88 9.14 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -122.15 -170.95 2.16 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.709 -174.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -88.55 168.41 12.6 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.25 149.16 21.43 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.81 60.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 123.526 1.631 . . . . 0.0 109.076 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -76.86 -29.53 55.89 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.543 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.6 149.69 48.87 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.047 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.1 m -138.17 107.9 6.26 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 74.5 mtm -85.12 103.57 14.23 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.327 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -106.04 89.35 3.04 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 C--N 1.314 -0.954 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.62 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.898 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 m -75.76 114.02 13.89 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -58.26 -57.32 13.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.399 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm 54.1 92.31 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 123.701 0.8 . . . . 0.0 110.949 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.25 150.97 81.65 Favored 'Trans proline' 0 CA--C 1.506 -0.902 0 C-N-CA 122.288 1.992 . . . . 0.0 113.475 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.58 36.86 3.63 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -138.74 146.99 52.71 Favored Pre-proline 0 N--CA 1.413 -2.306 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.01 -99.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 121.676 1.584 . . . . 0.0 115.289 -170.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.24 -51.89 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 121.532 0.682 . . . . 0.0 110.99 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -74.69 -13.35 60.61 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.699 -175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.98 139.33 50.36 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.948 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t -114.37 127.6 71.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.225 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.24 127.35 53.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.459 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -131.97 154.72 49.02 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.372 -176.045 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -95.12 145.47 24.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.093 0.473 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' A' ' 107' ' ' LEU . 9.6 p -129.95 150.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.81 107.34 6.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 122.138 0.971 . . . . 0.0 111.036 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -96.49 125.78 49.32 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.114 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 55.2 m170 -94.68 165.5 12.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -48.65 129.49 16.55 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 176.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 42.6 tp -120.68 122.65 40.92 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 111.98 22.88 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -119.05 102.86 9.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.33 -109.03 2.47 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.28 16.73 21.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.308 0.575 . . . . 0.0 110.822 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.04 167.98 10.67 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -127.24 105.88 8.85 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 102.472 -3.158 . . . . 0.0 102.472 174.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.486 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -122.16 163.93 19.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.046 -174.642 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.455 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.4 mp -89.93 0.57 57.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.135 0.969 . . . . 0.0 110.245 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' CA ' ' HB2' ' A' ' 61' ' ' SER . . . 91.46 -41.31 2.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.239 -0.892 . . . . 0.0 115.095 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 42.3 p90 -96.18 170.58 9.16 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 117.448 0.624 . . . . 0.0 112.615 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.7 m -130.44 165.84 21.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.259 1.023 . . . . 0.0 109.702 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.514 HD13 HD11 ' A' ' 55' ' ' ILE . 7.7 pt -124.74 168.95 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 120.461 0.172 . . . . 0.0 110.673 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.45 -23.98 6.08 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.576 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 125.01 172.29 13.46 Favored Glycine 0 N--CA 1.414 -2.805 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.366 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.511 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . -119.56 -113.71 2.47 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 124.525 0.779 . . . . 0.0 112.5 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.558 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -69.61 -24.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.415 ' HB2' HG21 ' A' ' 89' ' ' THR . 27.3 t70 -70.62 -12.53 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.98 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.543 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 19.0 mm-40 -106.23 157.92 17.23 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 8.0 t70 -97.38 123.43 52.59 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -61.86 -26.49 79.3 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.426 2.084 . . . . 0.0 113.523 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -72.35 -23.21 61.1 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.451 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -122.12 20.49 10.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.415 0.626 . . . . 0.0 111.006 -178.013 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -111.82 140.88 23.8 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.36 -39.99 34.24 Favored 'Trans proline' 0 C--O 1.222 -0.284 0 C-N-CA 123.663 2.909 . . . . 0.0 113.632 -170.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CD1' ' HA2' ' A' ' 74' ' ' GLY . 53.5 m-85 -119.72 22.19 11.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.762 0.792 . . . . 0.0 109.693 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 4.6 t -125.77 1.0 7.43 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -81.78 -6.66 59.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.012 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -69.4 -42.65 74.8 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.36 -177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.428 ' C ' ' H ' ' A' ' 52' ' ' ASP . 22.0 pttp -166.25 171.16 12.47 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 123.667 0.787 . . . . 0.0 109.073 176.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 p -79.44 19.52 0.61 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.802 0.81 . . . . 0.0 112.823 -173.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.428 ' H ' ' C ' ' A' ' 50' ' ' LYS . 30.5 t70 -92.23 99.52 12.29 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.154 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.479 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 36.4 mtmm -87.11 -179.48 6.47 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.56 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.511 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 139.87 169.08 11.53 Favored Glycine 0 CA--C 1.472 -2.626 0 N-CA-C 106.218 -2.753 . . . . 0.0 106.218 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.576 HD13 ' C ' ' A' ' 35' ' ' GLY . 24.2 mm -76.69 131.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 118.779 1.29 . . . . 0.0 109.839 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.2 p90 -128.61 149.01 50.82 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.487 HG22 HD11 ' A' ' 71' ' ' LEU . 95.6 t -78.48 130.88 35.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 124.459 1.1 . . . . 0.0 111.657 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -106.88 -20.4 13.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.103 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.423 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 6.9 ttm180 -144.31 143.44 30.99 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.432 HG12 ' CB ' ' A' ' 66' ' ' ALA . 38.4 t -126.53 136.79 59.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.621 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.4 t -55.14 119.76 5.97 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.545 1.153 . . . . 0.0 110.062 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.62 2.59 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 111.471 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.19 41.49 0.27 Allowed Glycine 0 C--N 1.273 -2.954 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.73 -173.09 12.83 Favored Glycine 0 N--CA 1.414 -2.821 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.784 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -65.78 -28.23 51.54 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 124.847 3.698 . . . . 0.0 112.237 -173.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' CB ' HG12 ' A' ' 60' ' ' VAL . . . -58.74 -59.17 5.84 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 61' ' ' SER . 5.5 pt-20 -72.32 -27.86 62.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.577 178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -61.19 -40.95 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.013 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.79 -47.64 18.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.02 16.89 0.41 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.422 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.487 HD11 HG22 ' A' ' 57' ' ' VAL . 1.8 tp -74.57 127.79 33.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.4 mm-40 -113.73 148.49 36.35 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.3 0.571 . . . . 0.0 110.179 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.49 123.3 19.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.426 ' HA2' ' CD1' ' A' ' 46' ' ' PHE . . . 112.99 -15.18 23.59 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.784 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -63.78 127.2 30.31 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.684 0.284 . . . . 0.0 111.021 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HB3' ' HE3' ' A' ' 78' ' ' MET . 65.3 mttm -89.7 123.29 33.6 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.415 HD13 ' CG2' ' A' ' 57' ' ' VAL . 3.7 mp -90.58 126.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -112.26 -7.7 14.0 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.034 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.515 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -159.96 136.5 9.01 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.427 HG12 ' CD2' ' A' ' 107' ' ' LEU . 34.0 t -142.49 119.7 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.749 1.219 . . . . 0.0 109.168 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 46.08 57.84 4.91 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 124.533 1.133 . . . . 0.0 112.176 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.1 -17.47 2.96 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 113.644 -1.616 . . . . 0.0 115.37 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.453 ' HE1' ' HE1' ' A' ' 85' ' ' MET . 0.0 OUTLIER -92.49 156.92 16.84 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -94.91 127.32 40.86 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.453 ' HE1' ' HE1' ' A' ' 83' ' ' TRP . 29.1 ttm -105.82 3.54 28.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.313 1.054 . . . . 0.0 110.695 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.479 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.6 t -61.14 -23.04 65.25 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.374 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.558 ' SD ' HG21 ' A' ' 37' ' ' ILE . 52.0 tpp -140.94 90.14 2.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 8.9 p -160.33 150.03 5.82 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.415 HG21 ' HB2' ' A' ' 38' ' ' ASP . 17.9 p -76.23 159.98 30.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.061 0.458 . . . . 0.0 110.414 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.474 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.1 t60 -54.58 -41.43 69.84 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.379 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.92 -47.59 85.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.752 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.14 -37.35 69.44 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.431 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.646 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.85 -45.49 85.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.749 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.0 mmm180 -53.63 -39.05 64.65 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 122.828 0.451 . . . . 0.0 111.488 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.73 24.41 0.88 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.947 0.403 . . . . 0.0 111.153 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.489 ' HA ' ' CE ' ' A' ' 99' ' ' LYS . 20.6 ttm180 -145.22 -37.98 0.27 Allowed 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -97.51 -17.05 19.83 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.474 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.1 t -122.7 14.18 10.09 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.846 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.489 ' CE ' ' HA ' ' A' ' 96' ' ' ARG . 16.2 ptpt -62.28 161.6 11.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.921 173.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -124.94 19.07 8.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.016 0.912 . . . . 0.0 110.338 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.422 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 47.4 m -84.15 -27.51 28.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.073 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -125.02 159.86 30.35 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.379 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -97.64 -70.47 0.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -109.69 128.55 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.415 ' CG2' HD21 ' A' ' 107' ' ' LEU . 24.1 m -132.67 148.81 31.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.171 -177.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -100.28 124.61 45.94 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.427 ' CD2' HG12 ' A' ' 80' ' ' VAL . 3.9 mt -119.71 154.3 34.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.515 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.5 mp -120.08 125.57 48.63 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-O 121.015 0.436 . . . . 0.0 110.389 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.459 HG22 ' NE2' ' A' ' 14' ' ' GLN . 22.1 m -119.8 150.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.223 -177.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.8 p -114.12 128.96 56.61 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.469 0.652 . . . . 0.0 111.429 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -94.35 100.41 12.44 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -80.92 -39.25 26.54 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m 51.18 27.34 3.4 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.967 1.707 . . . . 0.0 114.215 173.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 mt 47.63 91.09 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -97.67 -60.73 1.51 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -137.57 114.97 11.07 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.221 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.19 170.11 9.62 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.9 t 58.93 66.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 122.796 1.284 . . . . 0.0 110.229 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -138.77 102.79 4.66 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -115.35 110.99 20.18 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.077 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.4 m 62.25 22.86 13.46 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.514 1.126 . . . . 0.0 112.54 176.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 55.1 ttm -127.71 140.62 51.96 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -90.9 163.89 14.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.42 -1.954 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -177.874 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.005 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -117.07 111.27 19.29 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -82.11 -65.79 0.97 Allowed 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.507 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp 61.88 100.04 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.244 1.018 . . . . 0.0 111.782 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.17 -169.74 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.979 2.453 . . . . 0.0 111.802 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.14 50.35 0.37 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -93.8 121.64 64.0 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.665 -0.268 . . . . 0.0 111.415 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.52 ' O ' HG11 ' A' ' 9' ' ' VAL . 24.2 Cg_endo -69.19 -70.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.318 2.012 . . . . 0.0 110.671 174.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.52 HG11 ' O ' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 178.42 -50.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 127.326 2.251 . . . . 0.0 109.99 177.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -78.92 -32.43 45.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.954 0.883 . . . . 0.0 110.372 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.32 142.28 40.45 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.28 136.67 55.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -107.61 138.5 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.508 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -135.32 153.34 51.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 139.8 38.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.499 ' CG1' ' HB2' ' A' ' 107' ' ' LEU . 8.5 p -128.66 158.31 41.06 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.21 101.99 4.4 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.386 0.612 . . . . 0.0 110.245 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -93.52 127.87 45.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.027 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -93.07 156.79 16.65 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -49.54 125.89 12.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.449 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 45.2 tp -119.05 119.01 32.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.203 175.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -101.67 118.65 37.38 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -121.8 105.23 10.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 -112.46 5.03 Favored Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.869 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.24 3.09 51.51 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.137 0.494 . . . . 0.0 109.721 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.64 161.69 20.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-O 122.128 0.966 . . . . 0.0 110.59 -171.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -122.75 113.97 19.92 Favored 'General case' 0 C--N 1.256 -3.459 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 171.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.449 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -126.38 157.92 36.63 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.919 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.441 HD22 ' HA ' ' A' ' 98' ' ' THR . 3.2 mm? -94.65 6.34 49.17 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 123.337 1.541 . . . . 0.0 108.588 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.37 -46.9 2.59 Favored Glycine 0 C--N 1.294 -1.764 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.161 172.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -89.13 166.36 13.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -175.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 55.2 m -120.65 168.13 11.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.702 1.201 . . . . 0.0 109.73 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.516 HD12 HD12 ' A' ' 55' ' ' ILE . 5.9 pt -125.77 164.39 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 120.857 0.36 . . . . 0.0 110.298 -177.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.73 -20.99 7.75 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.304 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.638 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 123.17 171.37 13.64 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 54' ' ' GLY . . . -122.15 -117.44 2.44 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 124.388 0.699 . . . . 0.0 112.6 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -22.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -74.94 -15.01 60.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.26 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.638 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 6.6 mm-40 -100.17 167.37 10.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -108.0 111.95 61.88 Favored Pre-proline 0 CA--C 1.497 -1.08 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -54.31 -24.69 35.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.582 2.855 . . . . 0.0 113.314 -175.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -66.15 -33.45 75.79 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.217 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.49 15.39 20.18 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.933 0.873 . . . . 0.0 110.632 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -102.11 142.0 23.69 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.998 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.55 -45.02 7.48 Favored 'Trans proline' 0 C--O 1.221 -0.36 0 C-N-CA 123.507 2.805 . . . . 0.0 113.171 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.498 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 67.8 m-85 -113.2 17.95 18.28 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.659 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 1.8 t -123.03 -10.78 8.14 Favored 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.98 -11.07 60.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.023 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.02 -30.52 71.08 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.155 0.982 . . . . 0.0 109.92 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -134.96 -170.38 2.56 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.017 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -116.8 8.47 13.66 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -80.04 146.29 32.04 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.543 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -95.76 -146.48 0.28 Allowed 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 123.105 0.562 . . . . 0.0 109.513 -176.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.455 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 96.98 154.18 29.88 Favored Glycine 0 C--O 1.178 -3.355 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.526 HD11 ' C ' ' A' ' 35' ' ' GLY . 21.4 mm -76.95 126.25 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 118.26 1.03 . . . . 0.0 110.779 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.08 148.96 44.22 Favored 'General case' 0 CA--C 1.486 -1.498 0 O-C-N 122.107 -0.37 . . . . 0.0 111.353 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.436 ' CG2' HD13 ' A' ' 77' ' ' ILE . 95.8 t -74.46 130.92 35.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 124.423 1.077 . . . . 0.0 110.273 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.498 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.3 p -105.99 -22.21 12.95 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.353 0.596 . . . . 0.0 110.466 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -154.59 142.07 19.71 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.0 m -109.12 -179.91 0.9 Allowed 'Isoleucine or valine' 1 N--CA 1.352 -5.368 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.46 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 30.3 t -79.55 126.82 31.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.22 -16.19 1.17 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.645 1.578 . . . . 0.0 114.321 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.91 43.46 0.2 Allowed Glycine 0 CA--C 1.483 -1.943 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.29 -168.31 13.69 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.725 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.433 ' HB2' HG23 ' A' ' 18' ' ' ILE . 33.8 Cg_endo -64.06 -30.66 66.1 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 123.433 2.755 . . . . 0.0 111.939 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.26 -64.77 0.74 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.4 pt-20 -70.9 -31.89 68.67 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.557 -0.857 . . . . 0.0 112.146 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.6 mm -59.77 -40.11 81.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.0 -38.64 27.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.95 17.62 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.712 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.434 HD12 HG21 ' A' ' 57' ' ' VAL . 4.9 tp -83.18 127.24 33.44 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.523 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 23.8 mm-40 -115.5 151.29 35.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 111.08 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.85 130.23 33.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.006 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.02 4.3 55.5 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.172 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 13.4 m-20 -102.27 128.76 48.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.151 0.5 . . . . 0.0 111.873 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HB3' ' HE2' ' A' ' 78' ' ' MET . 64.1 mttm -79.72 119.28 22.43 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.242 -178.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.436 HD13 ' CG2' ' A' ' 57' ' ' VAL . 19.5 mt -84.62 121.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.308 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.48 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.3 mmt -111.56 -6.85 14.35 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.649 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.509 ' CB ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.21 134.65 13.43 Favored 'General case' 0 C--O 1.203 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.482 ' C ' ' H ' ' A' ' 82' ' ' GLY . 46.4 t -136.96 122.81 27.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 72.58 -34.99 0.31 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 127.338 2.255 . . . . 0.0 113.004 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.482 ' H ' ' C ' ' A' ' 80' ' ' VAL . . . 134.95 15.32 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.413 ' HE1' ' HE3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -99.49 -15.69 18.6 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -175.101 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.55 109.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.326 1.451 . . . . 0.0 111.568 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.471 ' SD ' HD12 ' A' ' 97' ' ' LEU . 32.0 ttm -111.87 7.6 20.13 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.765 0.793 . . . . 0.0 111.366 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.48 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 5.2 t -56.1 -27.41 53.7 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 ttm -143.82 96.1 2.84 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.461 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.0 p -157.09 151.76 8.24 Favored 'Isoleucine or valine' 0 C--O 1.257 1.479 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.7 p -74.33 155.57 38.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -51.41 -43.81 62.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -61.89 -46.71 88.19 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.989 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -31.25 57.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.179 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 -42.11 68.24 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -51.14 -43.25 61.17 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -92.81 50.87 1.62 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.343 1.068 . . . . 0.0 109.568 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -157.85 -50.57 0.07 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.238 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.492 HD11 ' CG2' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -93.95 -20.48 19.96 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.331 -1.348 . . . . 0.0 112.969 -174.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.441 ' HA ' HD22 ' A' ' 29' ' ' LEU . 10.7 t -123.08 13.43 9.72 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.809 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.2 ptpt -71.58 173.69 7.7 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 175.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -107.88 -0.48 21.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 25.8 t -78.02 -23.03 48.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.671 0.748 . . . . 0.0 109.443 178.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.03 160.09 19.41 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.328 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.509 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -120.58 -77.94 0.59 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.552 174.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.509 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -110.61 133.24 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 C-N-CA 123.534 0.734 . . . . 0.0 109.206 176.507 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.474 ' CG2' HD23 ' A' ' 107' ' ' LEU . 14.6 m -126.73 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.66 108.01 19.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.58 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.499 ' HB2' ' CG1' ' A' ' 16' ' ' VAL . 5.6 mt -116.17 149.16 39.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.427 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.509 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 7.8 mp -122.37 129.15 51.83 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.508 HG22 ' NE2' ' A' ' 14' ' ' GLN . 23.6 m -121.36 148.6 24.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 O-C-N 123.997 0.811 . . . . 0.0 110.481 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 p -112.36 127.5 56.03 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -90.71 115.71 28.01 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -174.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -97.12 -44.56 6.91 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.957 -174.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.6 m -85.56 18.38 2.82 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.539 0.685 . . . . 0.0 111.85 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 49.3 tp -80.82 -40.58 24.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.765 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -151.53 178.44 9.31 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -86.54 144.76 27.07 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.09 -179.14 5.61 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.813 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t 66.82 84.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 122.272 1.034 . . . . 0.0 109.676 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -109.97 -25.26 10.36 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.672 -1.149 . . . . 0.0 113.293 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -133.99 137.06 44.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.7 m -96.17 109.2 21.7 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.1 mtt -64.85 -64.77 0.79 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.52 -67.65 0.91 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.165 0.507 . . . . 0.0 109.73 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.264 1.851 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.008 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.146 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 66.14 27.98 10.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.217 1.007 . . . . 0.0 111.285 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -94.62 -12.35 27.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.01 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.0 mt 70.65 98.92 0.04 OUTLIER Pre-proline 0 C--O 1.241 0.652 0 C-N-CA 123.742 0.817 . . . . 0.0 110.311 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.04 172.44 16.26 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.756 2.304 . . . . 0.0 113.044 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.2 52.96 0.67 Allowed Glycine 0 N--CA 1.435 -1.389 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -77.59 130.51 73.7 Favored Pre-proline 0 CA--C 1.506 -0.715 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -71.73 -73.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 121.344 1.363 . . . . 0.0 110.4 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 m -154.98 -53.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 124.45 1.1 . . . . 0.0 109.774 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -99.9 -42.59 6.73 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -75.59 140.49 42.68 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.426 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.3 t -86.15 115.57 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.55 144.65 14.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -144.39 149.74 36.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.2 ppt_? -93.5 145.42 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.848 0.356 . . . . 0.0 110.584 -176.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.485 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -120.67 153.37 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -139.42 104.43 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.0 mp -94.6 133.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.743 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -104.32 128.86 52.19 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.974 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 27' ' ' LEU . 39.8 pttt -20.62 103.96 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.4 HD21 ' HD2' ' A' ' 65' ' ' PRO . 50.6 tp -102.4 123.83 46.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.981 0.419 . . . . 0.0 110.31 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -92.57 118.12 30.67 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.425 ' NE2' HD11 ' A' ' 28' ' ' ILE . 16.7 mt-30 -126.86 109.02 11.53 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.423 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.95 -98.89 0.65 Allowed Glycine 0 C--N 1.307 -1.03 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.994 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -116.65 5.32 13.21 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.35 160.44 39.82 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.713 0.768 . . . . 0.0 110.816 -169.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.506 HD11 ' HB2' ' A' ' 20' ' ' LYS . 26.4 tp -104.84 127.45 52.65 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.425 HD11 ' NE2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -133.88 169.32 21.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.652 -178.464 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 47.1 mt -92.75 -1.85 56.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.86 -36.6 3.8 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.56 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -100.56 167.63 10.23 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.807 -0.819 . . . . 0.0 112.913 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.415 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.9 m -129.25 168.35 16.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.292 1.437 . . . . 0.0 109.339 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.443 HD13 HD12 ' A' ' 55' ' ' ILE . 6.5 pt -124.06 169.88 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.02 0.438 . . . . 0.0 111.355 -172.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.99 -21.24 5.71 Favored Glycine 0 CA--C 1.479 -2.2 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.525 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 121.85 170.9 13.92 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.757 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.454 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -124.24 -105.26 1.64 Allowed Glycine 0 N--CA 1.408 -3.201 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.705 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -23.85 13.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.528 0.68 . . . . 0.0 110.947 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' CG ' ' H ' ' A' ' 90' ' ' HIS . 14.7 p-10 -86.11 3.65 41.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.183 -174.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.525 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 44.2 mm-40 -107.55 156.12 19.35 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.089 173.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -99.34 118.65 62.01 Favored Pre-proline 0 CA--C 1.496 -1.11 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.435 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.6 Cg_endo -55.89 -25.2 51.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.16 2.573 . . . . 0.0 113.484 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 -17.16 62.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.85 28.8 4.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.126 0.489 . . . . 0.0 111.437 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.5 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 93.0 m-20 -106.25 147.0 34.08 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 122.175 -0.328 . . . . 0.0 111.067 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.55 -50.91 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.949 2.433 . . . . 0.0 112.613 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.41 4.88 28.93 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 0.0 111.447 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 2.2 t -114.35 1.96 14.58 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.578 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.13 -22.4 45.17 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.43 -37.96 24.7 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.679 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -137.99 130.79 29.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.9 p -83.99 2.42 39.02 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.387 0.613 . . . . 0.0 112.488 -172.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.21 114.15 14.57 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.435 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 37.6 mtmm -82.4 -178.27 6.99 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.381 0.61 . . . . 0.0 112.335 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.05 138.38 4.87 Favored Glycine 0 C--O 1.191 -2.576 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.507 ' HB ' ' CG ' ' A' ' 85' ' ' MET . 24.5 mm -50.48 124.81 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.622 1.169 . . . . 0.0 112.546 -174.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -126.59 156.54 40.74 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.287 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.484 HG13 ' CG2' ' A' ' 60' ' ' VAL . 81.7 t -82.24 137.26 21.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 O-C-N 124.591 1.182 . . . . 0.0 110.43 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 p -110.89 -22.46 11.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.479 0.657 . . . . 0.0 111.172 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.415 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 19.3 mmt180 -143.68 135.92 26.83 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.484 ' CG2' HG13 ' A' ' 57' ' ' VAL . 71.9 t -128.22 139.72 51.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.63 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.7 m -57.55 112.54 1.46 Allowed 'General case' 0 N--CA 1.42 -1.961 0 O-C-N 124.103 0.877 . . . . 0.0 111.281 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.82 -11.81 49.26 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.051 0.844 . . . . 0.0 112.752 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 22.91 2.71 Favored Glycine 0 C--N 1.285 -2.252 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . -111.93 -179.95 19.75 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.32 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HD2' HD21 ' A' ' 21' ' ' LEU . 38.6 Cg_endo -63.75 -27.54 68.21 Favored 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 124.537 3.491 . . . . 0.0 111.764 -171.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.86 -60.53 3.43 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.0 -178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.63 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.2 pt-20 -87.1 -17.27 33.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.754 -1.578 . . . . 0.0 112.761 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 12.9 mm -60.68 -34.3 58.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.69 3.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.431 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 155.67 22.71 0.04 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 119.558 -1.306 . . . . 0.0 114.121 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.485 ' HB2' HG11 ' A' ' 16' ' ' VAL . 4.0 tp -88.95 121.3 31.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.152 0.501 . . . . 0.0 110.844 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.55 164.48 12.67 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-O 121.859 0.837 . . . . 0.0 108.789 177.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.62 133.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.641 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.46 14.02 74.79 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 116.415 -0.357 . . . . 0.0 112.386 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.553 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 12.9 m-20 -71.0 1.4 5.72 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 21.5 mmmt 48.23 87.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.4 mt -83.15 123.83 39.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.408 ' HA ' ' HE1' ' A' ' 78' ' ' MET . 8.1 mmt -106.63 -19.66 13.59 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.197 0.522 . . . . 0.0 109.868 -176.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.487 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 16.4 tp60 -154.0 131.35 11.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.172 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.465 HG21 HD21 ' A' ' 107' ' ' LEU . 60.7 t -134.57 113.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 C-N-CA 123.732 0.813 . . . . 0.0 110.215 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 50.58 29.09 3.83 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.612 1.565 . . . . 0.0 113.381 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.36 64.22 Favored Glycine 0 C--O 1.217 -0.95 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.562 ' HE1' ' HE3' ' A' ' 85' ' ' MET . 0.0 OUTLIER -107.75 -2.83 19.67 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -175.197 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.28 129.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 119.536 1.062 . . . . 0.0 111.779 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.562 ' HE3' ' HE1' ' A' ' 83' ' ' TRP . 26.5 ttm -129.77 1.29 4.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.998 0.904 . . . . 0.0 111.382 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -72.62 -19.17 61.51 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.834 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.0 ttp -139.29 89.15 2.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.511 HG23 ' CZ2' ' A' ' 83' ' ' TRP . 10.0 p -161.29 143.01 3.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.513 HG23 ' HB3' ' A' ' 38' ' ' ASP . 11.4 p -69.82 154.59 41.76 Favored 'General case' 0 N--CA 1.425 -1.721 0 O-C-N 123.539 0.524 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.517 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 8.8 t60 -53.85 -43.44 69.52 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.544 173.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.13 -44.05 95.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.895 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.18 -33.02 50.38 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.824 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.616 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.18 -40.08 71.44 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.04 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.55 ' CZ ' HG23 ' A' ' 98' ' ' THR . 13.7 mmm180 -53.79 -46.21 70.96 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 123.567 0.542 . . . . 0.0 110.434 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -86.7 36.84 0.72 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.855 0.836 . . . . 0.0 110.736 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.538 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.5 tpt180 -141.43 -46.92 0.38 Allowed 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.858 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.4 pp -96.05 -26.16 15.63 Favored 'General case' 0 C--O 1.203 -1.361 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.55 HG23 ' CZ ' ' A' ' 94' ' ' ARG . 15.3 t -110.81 10.94 22.52 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.543 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.2 ptpt -68.84 162.36 26.62 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -115.46 8.43 15.24 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.086 0.47 . . . . 0.0 111.953 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -79.54 -30.57 41.83 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.287 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -112.73 171.87 7.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.022 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.494 ' CB ' ' HB3' ' A' ' 20' ' ' LYS . 7.8 pt-20 -130.43 -71.56 0.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.44 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.5 t -91.63 129.83 41.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 122.03 -0.418 . . . . 0.0 109.962 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.9 m -126.05 150.5 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.9 -179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 -109.32 101.65 10.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.465 HD21 HG21 ' A' ' 80' ' ' VAL . 21.0 mt -102.55 149.66 24.19 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.487 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.4 mp -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.266 -3.035 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 35.9 m -117.42 159.1 17.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.548 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.423 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 18.8 p -117.17 129.93 56.27 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-O 121.331 0.586 . . . . 0.0 110.144 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.5 mtp85 -78.57 -6.43 55.52 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -166.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.485 ' C ' ' H ' ' A' ' 114' ' ' LEU . 25.4 mm-40 62.96 8.58 3.25 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.283 1.433 . . . . 0.0 113.727 174.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 p -75.85 24.49 0.12 Allowed 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 125.591 1.557 . . . . 0.0 111.516 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.485 ' H ' ' C ' ' A' ' 112' ' ' GLN . 2.1 pp -84.79 -6.5 59.35 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.53 1.132 . . . . 0.0 112.575 -175.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -159.41 -46.71 0.05 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.504 0.669 . . . . 0.0 109.604 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -101.19 56.35 0.85 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.292 -175.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -120.13 -61.54 1.58 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.6 t -111.9 56.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -159.28 92.16 1.05 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.174 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -130.15 39.64 3.64 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.4 p -63.34 -172.08 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.849 1.66 . . . . 0.0 113.483 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.9 tpt 78.6 -45.13 0.39 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.178 1.391 . . . . 0.0 110.729 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.23 113.98 6.32 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.664 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.394 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.017 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t 74.25 161.94 0.25 Allowed 'General case' 0 C--O 1.25 1.097 0 C-N-CA 124.213 1.005 . . . . 0.0 111.214 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -85.33 115.72 23.25 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.27 108.89 56.85 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.97 172.46 14.59 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.492 2.128 . . . . 0.0 112.457 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.18 45.12 3.15 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 176.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.419 ' HA ' ' CG2' ' A' ' 13' ' ' VAL . 7.8 tt0 -70.57 130.38 89.03 Favored Pre-proline 0 N--CA 1.436 -1.127 0 C-N-CA 123.034 0.533 . . . . 0.0 110.479 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.67 -95.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.27 1.98 . . . . 0.0 111.55 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 m -155.84 -46.31 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.428 1.091 . . . . 0.0 110.873 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 t -78.9 -23.0 45.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.565 0.698 . . . . 0.0 111.233 -174.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.53 136.27 54.85 Favored 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.07 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 59.3 t -96.77 104.92 16.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.526 HG22 HG22 ' A' ' 110' ' ' THR . 17.9 t -83.45 115.18 25.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.413 ' NE2' HG23 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -128.4 153.37 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.344 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -94.27 145.25 24.87 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.141 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.497 HG12 ' HB2' ' A' ' 71' ' ' LEU . 2.4 t -121.68 156.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.418 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 38.8 tt0 -143.92 104.69 4.19 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.98 0.895 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.564 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -99.13 129.38 49.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.877 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.2 m170 -100.23 144.63 29.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.467 ' HB3' ' CB ' ' A' ' 103' ' ' GLU . 22.3 pttm -40.39 127.2 2.34 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 tp -124.81 126.03 44.96 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.83 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -91.83 116.3 28.79 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.458 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 20.0 mt-30 -111.08 101.27 9.82 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.75 -117.49 8.19 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.52 9.26 42.81 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.99 166.89 13.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.124 0.488 . . . . 0.0 109.733 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.411 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.6 tm? -117.68 107.73 14.56 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.8 163.31 27.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.475 HD23 ' O ' ' A' ' 97' ' ' LEU . 9.0 mp -87.06 7.23 28.72 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.681 0.753 . . . . 0.0 110.598 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.458 ' HA2' ' OE1' ' A' ' 23' ' ' GLN . . . 90.44 -41.12 2.96 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.64 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.435 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 38.9 p90 -97.51 175.65 6.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.4 m -140.66 168.92 18.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.493 1.117 . . . . 0.0 109.314 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 55' ' ' ILE . 8.7 pt -125.8 167.02 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 117.916 0.326 . . . . 0.0 111.282 -173.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.49 -28.47 4.84 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.542 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 127.46 165.79 11.96 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.052 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -113.75 -116.16 3.26 Favored Glycine 0 N--CA 1.423 -2.175 0 O-C-N 124.238 0.611 . . . . 0.0 112.173 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.519 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.04 -23.71 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' HB2' HG22 ' A' ' 89' ' ' THR . 24.7 t70 -67.93 -15.71 63.74 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.812 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.542 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 9.8 mm-40 -108.87 150.19 28.04 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.507 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.3 t70 -93.11 122.65 62.97 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.68 -24.94 65.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.706 2.271 . . . . 0.0 113.41 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -70.81 -25.4 62.84 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.343 0.592 . . . . 0.0 110.128 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.507 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -121.24 12.24 10.96 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.059 -176.449 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -88.7 147.3 39.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.2 -47.94 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.398 2.066 . . . . 0.0 113.74 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -113.67 24.11 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.866 0.841 . . . . 0.0 110.356 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.16 15.83 3.49 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.307 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.4 3.78 54.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.835 0.35 . . . . 0.0 111.782 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -61.08 -58.86 6.63 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.202 1.001 . . . . 0.0 108.72 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -140.81 -177.86 5.27 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 p -84.84 23.56 1.17 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.894 0.854 . . . . 0.0 112.133 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -87.62 117.03 26.15 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.806 -176.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 71.9 mttt -88.72 178.15 6.55 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.373 0.669 . . . . 0.0 110.911 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.29 157.7 7.52 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.528 HD12 HD12 ' A' ' 33' ' ' ILE . 22.3 mm -76.71 131.84 34.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 118.066 0.933 . . . . 0.0 110.057 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.461 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 4.7 p90 -133.84 156.78 47.44 Favored 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.523 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 73' ' ' ILE . 8.2 p -84.24 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 O-C-N 125.035 1.46 . . . . 0.0 110.966 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.3 p -110.45 -23.29 11.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.435 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 29.8 ttm180 -136.29 146.41 46.63 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 18.1 t -135.91 150.99 28.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 66' ' ' ALA . 18.7 p -52.91 127.66 24.4 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 124.047 0.842 . . . . 0.0 109.644 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.61 -19.65 66.0 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 124.048 0.842 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.88 50.23 0.2 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.466 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -129.49 -165.57 11.7 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.464 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -63.4 -34.33 66.45 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.488 2.792 . . . . 0.0 113.21 -169.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -60.27 -56.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.562 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.72 -27.7 61.33 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.564 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.6 mm -58.61 -44.36 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 17' ' ' GLU . . . -76.34 -55.65 5.36 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.834 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.47 33.81 0.05 OUTLIER Glycine 0 CA--C 1.499 -0.916 0 C-N-CA 119.479 -1.343 . . . . 0.0 113.018 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.497 ' HB2' HG12 ' A' ' 16' ' ' VAL . 2.1 tp -92.17 115.75 28.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -111.3 141.48 44.78 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.411 ' HA ' HG11 ' A' ' 57' ' ' VAL . 70.7 mt -56.59 126.76 14.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 123.603 0.565 . . . . 0.0 109.92 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.79 -3.25 34.01 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.341 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.435 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 8.5 m-20 -86.2 131.88 34.13 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 120.986 0.422 . . . . 0.0 111.436 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.461 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 47.5 mtpt -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 3.2 mp -92.22 122.3 43.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -174.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.464 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.4 mmt -105.8 -15.78 14.85 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.347 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.53 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -153.56 136.52 15.45 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.448 HG13 ' CD2' ' A' ' 107' ' ' LEU . 72.6 t -140.85 118.47 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.795 0.838 . . . . 0.0 110.919 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.406 HD21 ' HA ' ' A' ' 81' ' ' ASN . 1.1 t-20 61.98 14.48 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.271 1.429 . . . . 0.0 113.157 171.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.61 -15.88 19.43 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.958 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.64 149.91 21.91 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -97.08 113.59 25.17 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.444 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 21.3 ttm -77.84 -60.3 2.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.118 -174.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.464 ' HA ' ' SD ' ' A' ' 78' ' ' MET 0.279 9.8 t 23.26 -76.5 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 127.603 2.361 . . . . 0.0 116.775 -176.541 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.7 ttt -113.97 93.66 4.47 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.444 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 9.5 p -148.7 153.25 11.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.346 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.443 HG22 ' HB2' ' A' ' 38' ' ' ASP . 4.7 p -70.28 152.9 43.67 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.526 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.5 t60 -50.75 -46.22 59.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.008 176.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.542 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 38.6 t70 -57.83 -48.95 78.28 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.535 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -35.9 70.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.67 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.538 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -66.09 -40.99 91.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.451 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 8.4 mmm180 -55.36 -38.79 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.802 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.542 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 38.6 mttm -83.3 30.74 0.46 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.447 ' H ' ' C ' ' A' ' 94' ' ' ARG . 7.7 tpm_? -148.66 -43.7 0.15 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.507 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.1 pp -102.05 -16.16 16.52 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.438 ' N ' HD13 ' A' ' 97' ' ' LEU . 15.0 t -121.62 10.66 10.42 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.848 174.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.458 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 15.8 ptpt -68.59 171.41 7.63 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 173.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -123.99 13.01 9.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.211 0.529 . . . . 0.0 111.317 -179.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.458 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 31.3 t -76.83 -41.1 45.53 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.243 0.544 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.26 167.09 10.37 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.467 ' CB ' ' HB3' ' A' ' 20' ' ' LYS . 7.6 pt-20 -120.34 -64.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 12.5 t -91.54 123.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.418 HG23 ' CD2' ' A' ' 29' ' ' LEU . 25.2 m -125.28 136.73 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.236 0.541 . . . . 0.0 112.056 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -95.9 110.24 22.47 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 172.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.448 ' CD2' HG13 ' A' ' 80' ' ' VAL . 14.8 mt -109.23 156.2 20.19 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.53 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.4 mp -130.03 123.02 29.52 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -117.36 157.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.584 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.526 HG22 HG22 ' A' ' 13' ' ' VAL . 39.9 p -115.28 118.62 33.78 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.139 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.439 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 2.1 mmp_? -73.51 112.52 9.67 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -85.3 -46.62 10.82 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.868 -175.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 m 51.15 41.18 27.39 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.181 0.925 . . . . 0.0 110.194 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.1 tp 70.98 84.9 0.13 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 108.281 -172.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -69.34 155.09 41.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.447 -174.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -116.53 147.16 42.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -113.56 -166.87 1.13 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.194 0.521 . . . . 0.0 111.146 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.9 m -86.1 69.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-O 123.484 1.611 . . . . 0.0 108.901 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 91.42 -79.46 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 110.282 -3.144 . . . . 0.0 109.398 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -163.69 97.34 0.86 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.8 m 65.3 118.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.397 1.079 . . . . 0.0 113.819 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 22.5 ptp -90.0 -2.25 58.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.982 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.14 127.72 33.28 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.812 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.435 -1.18 0 C-N-CA 124.46 1.104 . . . . 0.0 108.707 178.696 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.821 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -164.67 118.82 1.35 Allowed 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -145.49 114.13 6.79 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.5 mt -106.1 115.58 60.94 Favored Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.85 -175.67 2.79 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.302 2.001 . . . . 0.0 111.986 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.76 58.01 0.6 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.86 120.33 77.36 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.65 -88.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 123.517 2.811 . . . . 0.0 113.148 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 m -147.06 -47.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.368 0.667 . . . . 0.0 111.29 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -98.1 -7.6 29.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.52 143.24 33.3 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.313 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t -112.21 115.7 50.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.37 135.3 33.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.408 ' NE2' HG21 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -148.97 154.77 39.86 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -178.074 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.62 150.2 20.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.635 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.49 HG13 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -135.61 162.81 36.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.007 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -154.24 114.23 3.85 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.258 0.551 . . . . 0.0 110.818 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -97.38 134.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.31 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 42.5 m170 -105.04 134.28 48.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.444 ' HD3' ' HB2' ' A' ' 103' ' ' GLU . 43.7 pttt -28.12 118.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 45.9 tp -121.8 130.45 53.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.141 176.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.85 127.85 44.07 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -121.01 92.87 3.86 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.99 -111.83 3.36 Favored Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -109.88 15.98 22.29 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.332 0.587 . . . . 0.0 110.255 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -125.83 163.92 21.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -117.56 112.55 20.73 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.87 160.79 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.57 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 54.0 mt -86.48 0.41 54.27 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.56 -37.68 3.34 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.319 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -95.84 171.47 8.62 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.8 m -130.68 169.5 15.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.679 1.192 . . . . 0.0 109.975 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 55' ' ' ILE . 6.8 pt -128.49 165.33 28.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 117.701 0.228 . . . . 0.0 110.671 -172.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.44 -31.4 3.76 Favored Glycine 0 CA--C 1.488 -1.616 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.513 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 124.11 154.74 8.98 Favored Glycine 0 C--O 1.199 -2.077 0 C-N-CA 119.416 -1.373 . . . . 0.0 113.187 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -102.18 -119.17 4.51 Favored Glycine 0 N--CA 1.424 -2.115 0 O-C-N 124.157 0.563 . . . . 0.0 112.85 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.544 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.71 -22.6 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.164 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.411 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 31.7 t70 -70.9 -18.05 62.69 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.819 0.818 . . . . 0.0 110.163 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.523 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 11.0 mm-40 -105.87 147.07 29.13 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 4.8 t70 -94.12 127.15 46.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -175.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -20.86 44.46 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.37 2.714 . . . . 0.0 113.322 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 m -76.91 -16.07 59.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.75 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -132.14 19.76 4.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.965 0.888 . . . . 0.0 109.946 -177.534 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.487 HD22 ' HB2' ' A' ' 39' ' ' GLN . 93.3 m-20 -104.55 144.29 28.41 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.171 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.51 -51.74 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.692 2.261 . . . . 0.0 113.668 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -112.12 22.46 14.77 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.329 0.585 . . . . 0.0 110.639 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.437 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 8.5 t -117.58 2.06 12.32 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.81 14.2 5.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.976 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.537 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 12.4 m-20 -61.55 -36.34 80.33 Favored 'General case' 0 C--O 1.186 -2.277 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.229 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 1.2 mptt -166.1 -144.7 0.07 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 101.215 -3.624 . . . . 0.0 101.215 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.7 p -92.26 28.62 1.87 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 50' ' ' LYS . 15.6 t0 -86.74 101.66 13.52 Favored 'General case' 0 C--O 1.251 1.137 0 C-N-CA 126.113 1.765 . . . . 0.0 112.18 -172.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.544 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 68.8 mttt -81.41 -160.07 0.31 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.089 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.75 156.27 10.57 Favored Glycine 0 C--O 1.201 -1.963 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.502 HD12 HD13 ' A' ' 33' ' ' ILE . 30.4 mm -78.27 126.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 117.813 0.806 . . . . 0.0 108.874 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.9 p90 -129.52 160.0 34.56 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.787 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.461 HG22 HD12 ' A' ' 71' ' ' LEU . 58.8 t -87.47 128.46 39.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 124.73 1.269 . . . . 0.0 110.917 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 p -104.8 -20.43 13.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.441 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 135.94 23.41 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.405 HG23 HG11 ' A' ' 57' ' ' VAL . 64.6 t -123.59 148.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.443 ' OG ' ' HB1' ' A' ' 66' ' ' ALA . 37.7 p -51.82 126.33 17.7 Favored 'General case' 0 N--CA 1.401 -2.901 0 O-C-N 124.328 1.017 . . . . 0.0 108.563 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -71.32 -28.21 63.93 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-O 121.596 0.712 . . . . 0.0 109.868 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.52 55.57 0.5 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.606 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.438 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -139.28 -169.41 11.57 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.61 -30.71 51.19 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 123.677 2.918 . . . . 0.0 113.047 -171.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.443 ' HB1' ' OG ' ' A' ' 61' ' ' SER . . . -61.96 -53.8 50.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.914 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.438 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.3 pp20? -69.84 -30.62 68.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.551 0.215 . . . . 0.0 111.28 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.26 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.638 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.23 -48.14 45.07 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.03 21.51 0.41 Allowed Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.069 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.49 ' HB2' HG13 ' A' ' 16' ' ' VAL . 3.4 tp -83.03 125.46 31.47 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.445 ' N ' HD11 ' A' ' 71' ' ' LEU . 20.9 mm-40 -116.8 158.08 24.5 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.715 0.769 . . . . 0.0 109.614 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.38 135.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.898 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.82 -10.95 57.54 Favored Glycine 0 C--O 1.245 0.796 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -74.99 114.69 13.76 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 18.7 ptpt -91.62 122.31 34.08 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.483 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.427 HG13 HG13 ' A' ' 109' ' ' VAL . 2.9 mp -86.53 134.14 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.194 -172.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.608 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -114.83 -14.07 11.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.565 0.697 . . . . 0.0 110.869 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.504 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 23.0 tp60 -147.06 129.76 16.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.564 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.498 HG23 HD13 ' A' ' 107' ' ' LEU . 46.2 t -135.38 116.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.441 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 5.3 t-20 37.6 59.15 1.28 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.269 1.827 . . . . 0.0 113.465 176.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.24 4.82 38.63 Favored Glycine 0 C--N 1.3 -1.461 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.408 ' CD1' ' HB ' ' A' ' 80' ' ' VAL 0.385 0.0 OUTLIER -90.27 -100.02 0.1 Allowed 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 118.635 1.218 . . . . 0.0 112.603 178.52 . . . . . . . . 4 4 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 173.66 116.96 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 tpt -115.14 -2.77 12.66 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.015 -175.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.608 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.5 t -64.87 -28.3 69.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.541 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttm -146.72 87.53 1.71 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.38 0.609 . . . . 0.0 109.579 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.414 HG11 HG13 ' A' ' 55' ' ' ILE . 7.5 p -149.37 149.63 14.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.913 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.4 HG21 ' HB2' ' A' ' 38' ' ' ASP . 4.3 p -71.22 155.86 40.23 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 123.3 0.64 . . . . 0.0 110.428 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.523 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.5 t60 -55.6 -43.83 76.4 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.787 176.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.16 -48.89 79.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.684 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -32.52 70.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.11 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.486 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.73 -42.64 73.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.05 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 11.2 mmm180 -60.6 -37.03 80.02 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.83 0.824 . . . . 0.0 108.849 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.91 21.16 1.07 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.052 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.518 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 17.7 mmt180 -134.69 -42.53 0.76 Allowed 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.316 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.57 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 1.3 pp -100.62 -28.82 12.66 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.48 ' N ' HD11 ' A' ' 97' ' ' LEU . 9.3 t -106.97 14.8 26.06 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.872 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 14.4 ptpt -73.67 175.48 7.12 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.466 169.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -122.81 6.88 9.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.3 t -75.26 -38.45 60.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 179.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.493 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -87.97 174.15 8.48 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.529 178.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.444 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 8.6 pt-20 -137.77 -58.72 0.67 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.587 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 59.0 t -104.07 127.2 58.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.465 HG22 HD11 ' A' ' 29' ' ' LEU . 15.0 m -122.16 148.62 25.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.385 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -119.23 103.96 9.98 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.498 HD13 HG23 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -110.17 151.85 26.78 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.963 -171.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.3 mp -125.31 119.37 28.2 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.427 HG13 HG13 ' A' ' 77' ' ' ILE . 27.1 m -112.58 147.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.184 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.7 p -116.09 128.73 55.91 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.842 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -104.9 108.9 20.65 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -82.79 -54.93 4.73 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.5 m 48.86 37.68 10.51 Favored 'General case' 0 C--O 1.248 1.006 0 O-C-N 124.309 1.006 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 49' ' ' ASP . 32.0 tp -72.25 147.62 46.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.29 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -48.41 -61.05 2.21 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.298 1.439 . . . . 0.0 114.115 -176.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -145.62 176.38 9.66 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.42 -84.73 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.627 1.205 . . . . 0.0 113.138 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p -163.95 78.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-O 122.391 1.091 . . . . 0.0 113.401 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -3.17 9.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.463 1.125 . . . . 0.0 108.207 169.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.18 150.55 51.09 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 175.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.1 m 61.09 35.34 18.74 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.613 0.721 . . . . 0.0 109.979 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.5 mtp -68.77 116.07 8.84 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.164 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.96 -43.71 70.97 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.9 m . . . . . 0 N--CA 1.421 -1.923 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.465 177.17 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.87 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -86.6 97.34 10.48 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 117.037 0.419 . . . . 0.0 111.156 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -139.01 132.33 30.01 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.42 HD11 ' HD2' ' A' ' 5' ' ' PRO . 6.4 tp -123.84 115.87 27.8 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' HD2' HD11 ' A' ' 4' ' ' ILE . 15.5 Cg_endo -65.49 167.75 16.21 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.73 2.287 . . . . 0.0 114.242 -177.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.78 54.33 1.67 Allowed Glycine 0 N--CA 1.426 -2.002 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.554 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.17 129.2 90.47 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 123.021 0.529 . . . . 0.0 110.467 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 58.7 Cg_endo -79.69 -84.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.04 1.827 . . . . 0.0 111.705 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.01 -52.28 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 120.735 0.303 . . . . 0.0 111.236 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.405 HG22 ' N ' ' A' ' 11' ' ' ALA . 7.2 t -99.13 -48.3 4.9 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -177.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.459 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . -69.08 135.85 51.41 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.5 0.666 . . . . 0.0 111.371 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.17 106.01 19.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.448 HG23 HG22 ' A' ' 110' ' ' THR . 12.7 t -80.45 126.35 39.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.41 ' NE2' HG21 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -144.74 153.1 41.33 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.425 -175.1 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -90.12 148.17 23.16 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.51 HG12 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -128.29 152.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.129 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -135.24 104.36 5.87 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.075 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 1.7 mp -92.8 129.74 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.942 -178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -99.35 144.8 28.05 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 20.0 pttm -35.26 127.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 44.0 tp -125.14 118.26 25.71 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.227 174.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -88.38 111.86 22.23 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.729 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -117.99 110.38 17.62 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.93 -109.73 3.04 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -113.95 13.31 18.26 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -112.57 171.64 7.4 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.873 0.844 . . . . 0.0 109.837 -174.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.431 HD23 ' HB2' ' A' ' 20' ' ' LYS . 2.3 tm? -126.53 111.82 14.82 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 172.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.97 164.5 23.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 38.1 mt -87.66 -4.24 58.94 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.964 0.888 . . . . 0.0 108.629 174.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 92.67 -46.02 2.53 Favored Glycine 0 N--CA 1.424 -2.154 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.949 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -84.33 166.46 17.41 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.193 0.521 . . . . 0.0 112.218 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.415 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 29.2 m -122.36 166.85 14.05 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.656 1.182 . . . . 0.0 109.961 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 55' ' ' ILE . 3.7 pt -125.14 164.4 24.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.07 -16.23 7.39 Favored Glycine 0 CA--C 1.487 -1.685 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.328 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.584 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 125.04 169.35 12.93 Favored Glycine 0 CA--C 1.473 -2.54 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.168 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.448 ' N ' HD11 ' A' ' 55' ' ' ILE . . . -122.2 -116.3 2.36 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.367 0.686 . . . . 0.0 111.57 175.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . 0.468 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.45 -15.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.151 0.977 . . . . 0.0 110.777 -177.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.487 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 15.2 t0 -70.95 -19.91 62.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.085 -177.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.584 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 16.4 mm-40 -113.37 155.25 25.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.503 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 10.0 t70 -98.32 129.37 30.73 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 118.612 0.642 . . . . 0.0 109.431 -176.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.53 -21.3 45.35 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 122.768 2.312 . . . . 0.0 113.198 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -77.36 -11.13 59.8 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.015 0.436 . . . . 0.0 110.625 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -130.15 11.58 5.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.415 0.626 . . . . 0.0 110.75 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.471 HD22 ' HB2' ' A' ' 39' ' ' GLN . 97.4 m-20 -99.91 143.32 26.27 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.76 -52.98 0.47 Allowed 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.201 2.601 . . . . 0.0 113.118 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.38 18.11 20.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.575 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.439 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.0 t -123.25 -2.37 8.58 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -83.55 -4.33 58.45 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.12 -38.59 89.5 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.705 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -145.81 -168.55 3.01 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.0 p -96.48 0.63 50.59 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.55 0.69 . . . . 0.0 109.659 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.09 99.85 4.77 Favored 'General case' 0 C--O 1.256 1.421 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.276 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 53.4 mttt -74.88 178.4 5.57 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.387 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.56 153.36 5.85 Favored Glycine 0 C--O 1.18 -3.273 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.535 HD11 ' C ' ' A' ' 35' ' ' GLY . 30.5 mm -68.27 125.33 25.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 118.009 0.904 . . . . 0.0 109.774 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -124.98 155.9 38.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.188 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.435 HG22 HD13 ' A' ' 71' ' ' LEU . 87.7 t -81.46 129.92 36.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 124.455 1.097 . . . . 0.0 110.619 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -106.08 -19.7 13.64 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.279 0.561 . . . . 0.0 111.068 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -154.46 138.97 16.84 Favored 'General case' 0 C--O 1.204 -1.309 0 C-N-CA 124.124 0.97 . . . . 0.0 108.519 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.515 HG11 ' O ' ' A' ' 71' ' ' LEU . 18.9 m -109.87 174.83 1.75 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.194 0 CA-C-N 119.688 1.131 . . . . 0.0 109.222 172.025 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.622 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.3 t -77.93 116.23 18.26 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -52.85 -16.34 0.99 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.997 1.719 . . . . 0.0 114.68 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.35 30.41 0.42 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.17 -171.46 19.33 Favored Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.8 -27.07 67.71 Favored 'Trans proline' 0 C--O 1.208 -0.986 0 C-N-CA 123.468 2.778 . . . . 0.0 111.634 -171.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.51 -66.71 0.42 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.796 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.622 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.7 pt-20 -75.43 -22.74 57.12 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.592 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -62.93 -41.03 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.03 -45.51 26.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.074 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.1 2.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 119.644 -1.265 . . . . 0.0 114.08 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.515 ' O ' HG11 ' A' ' 60' ' ' VAL . 7.6 tp -74.8 126.51 31.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 122.767 -0.255 . . . . 0.0 110.638 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -120.3 160.82 22.24 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.134 0.896 . . . . 0.0 109.936 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.98 128.72 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.491 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.12 -9.47 54.51 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.341 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.416 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 74.1 m-20 -77.78 119.13 20.85 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -88.9 124.12 33.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.431 HG13 HG11 ' A' ' 109' ' ' VAL . 3.0 mp -88.29 135.96 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -174.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.1 mmt -107.77 -26.1 10.95 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.389 0.614 . . . . 0.0 109.839 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.507 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -151.63 133.73 15.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.741 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.496 HG22 HD21 ' A' ' 107' ' ' LEU . 49.9 t -136.98 117.57 17.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 C-N-CA 123.663 0.785 . . . . 0.0 110.037 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 49.6 49.98 19.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.153 0.981 . . . . 0.0 111.625 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . 0.462 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 69.93 8.06 60.39 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CD2' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -115.26 158.87 21.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 117.681 0.74 . . . . 0.0 110.346 176.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 123.299 0.64 . . . . 0.0 110.509 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.51 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 20.2 ttm -117.47 -4.5 11.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.92 0.867 . . . . 0.0 110.737 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t -68.11 -25.46 65.32 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.779 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 ttt -135.95 85.51 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.91 0.386 . . . . 0.0 110.519 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 11.2 p -154.79 148.4 12.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.464 HG21 ' HB2' ' A' ' 38' ' ' ASP . 7.9 p -73.05 156.54 38.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.552 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.1 t60 -55.42 -47.33 76.11 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.544 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 33.8 t70 -58.93 -47.46 84.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.331 -176.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.442 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -72.1 -39.46 68.91 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.202 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.94 -41.7 99.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.303 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.48 ' CZ ' HG21 ' A' ' 98' ' ' THR . 18.2 mmm180 -58.16 -26.03 62.22 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.485 0.659 . . . . 0.0 112.119 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.544 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 45.1 mmtm -95.0 8.19 43.68 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.493 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 24.7 ttm180 -136.79 -30.96 0.87 Allowed 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.686 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -92.98 -40.6 10.47 Favored 'General case' 0 C--O 1.19 -2.062 0 C-N-CA 116.646 -2.021 . . . . 0.0 111.132 174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.48 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 8.8 t -102.15 14.71 31.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 109.406 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.8 ptpt -66.49 -176.06 0.42 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.951 170.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -122.07 -3.74 9.06 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -67.24 -40.41 86.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 175.51 5.62 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.943 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -134.79 -62.26 0.74 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.53 112.46 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.0 m -110.41 131.86 60.33 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.206 -177.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -99.8 107.49 19.55 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.496 HD21 HG22 ' A' ' 80' ' ' VAL . 13.9 mt -108.65 151.42 26.17 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.507 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.5 mp -122.34 118.62 28.89 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.431 HG11 HG13 ' A' ' 77' ' ' ILE . 31.7 m -117.85 165.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.09 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.448 HG22 HG23 ' A' ' 13' ' ' VAL . 23.8 p -117.67 124.48 48.67 Favored 'General case' 0 N--CA 1.407 -2.584 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.307 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -81.01 125.65 30.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -93.0 -12.94 29.44 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.937 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.9 t 61.53 22.8 13.19 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 124.532 1.133 . . . . 0.0 112.139 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 92.9 mt 63.28 -52.56 0.2 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.933 1.693 . . . . 0.0 113.308 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -119.04 137.23 53.69 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -87.41 -4.71 59.03 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.949 0.404 . . . . 0.0 111.499 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.81 135.87 50.68 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.778 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.5 m -151.1 44.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 125.318 1.447 . . . . 0.0 107.763 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.24 74.72 7.06 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.046 -1.434 . . . . 0.0 112.866 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -139.35 13.04 2.58 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 122.722 1.248 . . . . 0.0 108.188 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 t -125.28 105.27 8.99 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 69.4 mtm -73.63 -59.03 2.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -133.09 -36.0 1.03 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 172.059 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.176 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -147.82 163.19 37.51 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.2 p90 -99.09 -2.54 36.82 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.294 16.1 tt 42.09 90.69 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.517 1.927 . . . . 0.0 114.151 -178.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -76.01 -173.72 1.78 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.454 2.103 . . . . 0.0 112.941 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.45 47.63 1.17 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 7.4 tt0 -84.95 127.94 62.51 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 115.089 -0.556 . . . . 0.0 110.444 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -81.08 -87.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.805 1.67 . . . . 0.0 109.707 174.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -140.58 -47.23 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.268 -0.27 . . . . 0.0 111.33 171.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 t -94.28 -29.19 15.19 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -76.9 135.07 38.8 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.37 122.45 58.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.463 HG21 HG21 ' A' ' 110' ' ' THR . 25.3 t -108.77 125.98 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.43 151.17 46.04 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.317 -176.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 149.52 23.2 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.78 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -129.65 157.77 42.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -144.92 107.84 4.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.334 0.587 . . . . 0.0 110.771 178.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.522 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -97.46 132.17 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -98.45 152.65 19.28 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 123.819 0.699 . . . . 0.0 110.232 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.4 ttmm -40.93 113.17 0.36 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 125.508 1.523 . . . . 0.0 114.48 -178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.473 HD22 ' CD ' ' A' ' 65' ' ' PRO . 26.7 tp -127.94 137.43 52.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.065 0.546 . . . . 0.0 111.513 177.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -104.62 131.44 52.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -122.47 107.36 11.95 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.15 -113.56 5.24 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -108.79 16.91 22.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.752 0.787 . . . . 0.0 110.539 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -120.63 176.72 5.37 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.402 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 1.3 tm? -128.13 112.09 14.18 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mt -129.22 159.01 41.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 61.0 mt -79.61 2.69 21.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.759 0.79 . . . . 0.0 109.844 175.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.28 4.57 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.917 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -98.76 167.33 10.84 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.7 m -121.49 164.15 17.66 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.441 1.096 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.485 HD12 HD13 ' A' ' 55' ' ' ILE . 6.2 pt -124.34 163.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -173.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.21 -24.36 6.56 Favored Glycine 0 CA--C 1.484 -1.886 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.462 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.533 ' C ' HD12 ' A' ' 55' ' ' ILE . . . 124.75 167.67 12.67 Favored Glycine 0 N--CA 1.407 -3.25 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.848 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.57 ' N ' HD12 ' A' ' 55' ' ' ILE . . . -113.8 -121.79 3.73 Favored Glycine 0 N--CA 1.427 -1.904 0 O-C-N 124.507 0.769 . . . . 0.0 112.591 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.26 -19.51 25.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.036 -179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 27.0 mm-40 -96.01 -173.9 2.96 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -132.98 124.96 18.86 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.943 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.457 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 10.0 Cg_endo -57.63 -26.69 73.82 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.074 2.516 . . . . 0.0 113.132 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -68.87 -32.64 72.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.228 0.537 . . . . 0.0 110.373 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.74 8.51 18.93 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.522 0.677 . . . . 0.0 110.729 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.13 142.19 24.14 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.85 -51.57 0.64 Allowed 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 123.378 2.719 . . . . 0.0 112.843 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -109.18 26.5 10.56 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.029 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 13.8 t -124.31 -6.76 7.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.57 -4.98 45.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.303 -171.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.71 -52.62 17.74 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.934 1.693 . . . . 0.0 109.327 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.441 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 37.0 mtmm -148.48 -147.11 0.21 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 p -99.31 21.41 12.03 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.993 1.378 . . . . 0.0 107.887 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.441 ' HB2' ' HE2' ' A' ' 50' ' ' LYS . 50.7 t0 -73.48 106.83 5.43 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 112.352 -2.204 . . . . 0.0 111.417 -173.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.457 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.0 mtmm -110.03 171.03 7.69 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.843 0.83 . . . . 0.0 111.997 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.401 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 144.71 167.36 12.06 Favored Glycine 0 C--O 1.17 -3.877 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.57 HD12 ' N ' ' A' ' 36' ' ' GLY . 35.5 mm -73.9 115.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 120.26 2.03 . . . . 0.0 110.433 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 0.4 OUTLIER -114.9 151.73 33.5 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.059 178.867 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 71' ' ' LEU . 87.6 t -82.77 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.31 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p -106.66 -15.04 14.87 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.625 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -152.23 145.32 24.56 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' CG2' HG13 ' A' ' 57' ' ' VAL . 39.5 t -133.79 148.72 30.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.476 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 13.3 p -52.95 128.54 27.52 Favored 'General case' 0 N--CA 1.406 -2.648 0 O-C-N 124.289 0.993 . . . . 0.0 109.635 176.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.92 -13.6 61.69 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 123.629 0.581 . . . . 0.0 111.553 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.46 41.53 0.31 Allowed Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.4 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -120.46 -169.49 13.96 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.194 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.473 ' CD ' HD22 ' A' ' 21' ' ' LEU . 39.2 Cg_endo -64.18 -32.28 63.2 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 123.614 2.876 . . . . 0.0 112.391 -171.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.408 ' HB2' ' OG ' ' A' ' 61' ' ' SER . . . -59.08 -57.22 14.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.202 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 61' ' ' SER . 4.5 pt-20 -75.88 -24.45 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.48 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 64' ' ' GLY . 21.2 mm -63.61 -39.74 86.46 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 121.206 0.527 . . . . 0.0 109.903 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.7 -56.87 4.27 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.842 176.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.13 24.74 0.05 OUTLIER Glycine 0 C--O 1.224 -0.501 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.292 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.505 ' HB2' HG13 ' A' ' 16' ' ' VAL . 4.6 tp -91.96 124.65 36.23 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.439 ' N ' HD13 ' A' ' 71' ' ' LEU . 20.8 mm-40 -116.61 157.34 25.49 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.0 137.15 25.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.865 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.34 -0.25 59.93 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.941 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.13 123.24 24.88 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 120.773 0.321 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -89.0 110.81 21.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.46 HD11 ' CG2' ' A' ' 57' ' ' VAL . 12.3 mt -82.94 129.03 38.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.352 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 21.1 mmt -105.63 -26.26 11.92 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.478 0.656 . . . . 0.0 110.589 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 11.9 tp60 -152.46 133.11 13.92 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.88 -169.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.504 HG21 HD11 ' A' ' 107' ' ' LEU . 55.0 t -136.53 111.86 11.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 C-N-CA 124.27 1.028 . . . . 0.0 111.431 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . 0.415 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.2 t-20 52.25 34.93 15.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.724 1.61 . . . . 0.0 112.92 173.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.65 -9.4 68.8 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.435 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.44 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -104.44 150.09 24.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.707 0.403 . . . . 0.0 110.207 178.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.91 132.76 41.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 123.839 0.855 . . . . 0.0 110.343 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.457 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 24.5 ttm -123.28 -0.48 8.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.211 1.005 . . . . 0.0 110.943 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 2.1 t -70.16 -25.06 63.27 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.259 -178.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.9 ttt -141.41 86.29 2.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.245 0.545 . . . . 0.0 109.903 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.36 151.95 11.29 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.8 p -75.0 157.11 35.46 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.176 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.585 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.9 t60 -53.84 -45.44 70.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.72 -51.22 69.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.435 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -30.3 63.6 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.072 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.556 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -76.66 -36.0 57.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.141 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.1 mmm180 -51.49 -45.65 62.9 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.931 0.77 . . . . 0.0 111.424 178.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.357 0.0 OUTLIER -93.06 59.71 3.16 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-O 122.904 1.335 . . . . 0.0 110.813 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.477 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tpt180 -154.38 -48.1 0.09 Allowed 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 112.151 -2.295 . . . . 0.0 106.698 171.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.584 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 1.4 pp -94.88 -25.46 16.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.451 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.7 t -114.23 14.06 18.04 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.476 174.22 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.501 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 17.5 ptpt -77.23 168.05 20.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.432 172.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.402 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 9.7 ptp85 -113.74 0.39 14.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.822 -175.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.501 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 40.9 m -76.1 -34.02 59.5 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.804 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.409 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 10.2 pt-20 -111.78 172.18 7.05 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.695 -178.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -132.85 -87.35 0.44 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 17.9 t -73.37 114.11 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-O 121.625 0.726 . . . . 0.0 109.816 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.455 HG22 HD11 ' A' ' 29' ' ' LEU . 11.4 m -110.36 153.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.761 -177.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -120.94 100.28 6.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.504 HD11 HG21 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -109.28 160.65 15.95 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.548 -171.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.481 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.7 mp -132.34 122.58 25.31 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.44 156.99 23.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.027 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.463 HG21 HG21 ' A' ' 13' ' ' VAL . 66.3 p -129.98 146.29 51.66 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.27 0.557 . . . . 0.0 110.696 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -100.17 84.91 2.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLN . . . . . 0.448 ' C ' ' H ' ' A' ' 114' ' ' LEU . 27.1 mm-40 -89.72 -6.44 56.05 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.823 -175.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -81.46 20.61 0.86 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.448 ' H ' ' C ' ' A' ' 112' ' ' GLN . 9.0 mp 55.34 77.28 0.23 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.488 1.115 . . . . 0.0 112.311 -176.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -134.75 149.83 50.49 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -127.02 92.93 3.63 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -94.52 163.33 13.44 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.672 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.3 t 68.64 78.38 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 124.416 1.072 . . . . 0.0 111.28 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -151.7 89.02 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.301 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -90.82 85.99 6.19 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 m -86.93 -27.3 23.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.027 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.6 mtt 71.05 -70.67 0.15 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.757 1.223 . . . . 0.0 109.871 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.7 tp -92.5 79.61 4.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.262 1.734 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.79 -176.144 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.4 p -91.06 129.16 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.28 151.54 51.33 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.741 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.95 152.18 18.57 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.742 0.306 . . . . 0.0 110.548 -172.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -129.58 154.61 40.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -141.12 102.12 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.306 0.574 . . . . 0.0 110.35 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.42 127.01 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -99.63 148.67 24.08 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HB2' HD11 ' A' ' 27' ' ' LEU . 22.5 pttm -39.18 123.36 1.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.577 HD22 ' HD2' ' A' ' 65' ' ' PRO . 49.4 tp -117.67 122.08 42.58 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.559 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -92.81 109.71 21.15 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HG3' HD12 ' A' ' 28' ' ' ILE . 16.1 mm100 -107.41 109.14 20.79 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.57 -110.77 3.69 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.72 17.74 12.71 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.194 0.521 . . . . 0.0 111.479 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.67 166.81 12.29 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 20' ' ' LYS . 58.4 tp -112.85 126.59 55.61 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 23' ' ' GLN . 0.9 OUTLIER -136.82 163.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.9 mp -88.4 2.3 52.94 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.051 0.929 . . . . 0.0 109.419 175.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . 94.9 -47.26 2.04 Favored Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 115.264 -0.88 . . . . 0.0 114.362 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 39.9 p90 -90.63 166.11 13.35 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.8 m -123.96 163.62 20.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.508 1.523 . . . . 0.0 109.497 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 55' ' ' ILE . 7.9 pt -125.17 166.15 21.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 122.75 0.42 . . . . 0.0 110.615 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.24 -22.42 6.83 Favored Glycine 0 CA--C 1.487 -1.675 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.311 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.543 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 123.58 163.54 11.78 Favored Glycine 0 C--O 1.196 -2.238 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.613 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.546 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -112.88 -117.3 3.45 Favored Glycine 0 N--CA 1.432 -1.588 0 O-C-N 124.583 0.814 . . . . 0.0 112.345 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.646 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.05 -17.58 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 122.101 0.953 . . . . 0.0 112.869 -174.828 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.61 ' HB2' HG22 ' A' ' 89' ' ' THR . 19.5 t70 -75.2 -9.19 58.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.421 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.513 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.0 mm100 -107.55 162.86 13.57 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.097 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 2.8 m-20 -105.21 108.63 61.82 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.484 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -58.44 -19.79 45.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 123.794 2.996 . . . . 0.0 113.402 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -75.34 -5.58 45.51 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.586 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -148.15 29.29 0.89 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.523 0.329 . . . . 0.0 111.155 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 7.4 m120 -107.22 145.5 31.32 Favored Pre-proline 0 CA--C 1.495 -1.14 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.36 -40.83 10.09 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 C-N-CA 123.204 2.603 . . . . 0.0 113.057 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.63 4.41 10.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.262 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 1.1 t . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.242 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.646 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 53.1 mttp . . . . . 0 CA--C 1.552 1.047 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.93 159.41 8.28 Favored Glycine 0 C--O 1.191 -2.555 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 33' ' ' ILE . 20.1 mm -77.88 128.11 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 117.657 0.728 . . . . 0.0 109.538 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 3.1 p90 -131.09 157.77 42.18 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.951 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 71' ' ' LEU . 94.5 t -80.57 134.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 O-C-N 124.748 1.28 . . . . 0.0 110.469 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 p -106.15 -23.03 12.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.618 0.723 . . . . 0.0 110.519 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -155.19 142.51 19.47 Favored 'General case' 0 CA--C 1.473 -1.992 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 16.3 m -107.73 -172.03 0.4 Allowed 'Isoleucine or valine' 1 N--CA 1.339 -6.02 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.406 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 22.5 p -64.51 131.32 46.77 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.59 -21.42 26.68 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 123.181 0.592 . . . . 0.0 112.146 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.99 52.72 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.6 -161.23 10.45 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-N 114.905 -0.648 . . . . 0.0 112.771 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.577 ' HD2' HD22 ' A' ' 21' ' ' LEU . 38.2 Cg_endo -63.27 -32.68 72.94 Favored 'Trans proline' 0 C--O 1.211 -0.872 0 C-N-CA 123.541 2.827 . . . . 0.0 112.543 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.403 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -59.06 -61.1 2.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -70.79 -30.67 67.2 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.329 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 mm -63.69 -42.69 96.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.783 0.325 . . . . 0.0 111.316 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.74 -55.2 5.7 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.169 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.98 29.4 0.05 OUTLIER Glycine 0 C--N 1.312 -0.78 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.056 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.802 ' HB2' HG11 ' A' ' 16' ' ' VAL . 6.5 tp -100.33 120.93 40.69 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.471 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 14.4 mm100 -116.33 153.31 32.21 Favored 'General case' 0 N--CA 1.425 -1.693 0 O-C-N 123.964 0.79 . . . . 0.0 110.959 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.43 131.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.68 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.96 -27.45 20.34 Favored Glycine 0 C--O 1.252 1.244 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.956 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 53.2 m-20 -72.53 125.28 27.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.762 0.792 . . . . 0.0 111.02 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 63.2 mttp -82.87 128.82 34.78 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.139 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.555 HD11 HG23 ' A' ' 57' ' ' VAL . 2.8 mp -92.72 124.57 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.3 mmt -109.41 -11.44 14.83 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.533 0.683 . . . . 0.0 110.918 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.686 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -148.43 124.74 10.88 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.557 HG22 HD22 ' A' ' 107' ' ' LEU . 44.6 t -136.68 118.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 53.07 39.16 29.08 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.607 1.163 . . . . 0.0 112.997 170.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.466 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 65.08 27.42 72.28 Favored Glycine 0 N--CA 1.462 0.408 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.715 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -10.04 13.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 55.69 111.47 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.468 1.107 . . . . 0.0 113.717 -169.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.613 ' SD ' HG11 ' A' ' 88' ' ' VAL . 62.7 tpp -95.92 1.52 52.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.201 1.001 . . . . 0.0 109.353 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -71.33 135.55 47.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttp 55.48 74.61 0.36 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.327 1.051 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.613 HG11 ' SD ' ' A' ' 85' ' ' MET . 11.3 p -149.9 150.16 13.95 Favored 'Isoleucine or valine' 0 C--O 1.261 1.691 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.61 HG22 ' HB2' ' A' ' 38' ' ' ASP . 15.6 p -73.31 157.66 36.59 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.494 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 13.7 t60 -53.58 -42.93 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.336 175.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.75 -46.66 84.32 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.789 0.681 . . . . 0.0 110.825 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -32.89 67.42 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.816 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.657 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.88 -45.13 75.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.314 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.471 ' CZ ' HG21 ' A' ' 98' ' ' THR . 13.5 mmm180 -55.18 -40.76 71.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.661 0.743 . . . . 0.0 110.291 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -85.93 32.69 0.6 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.893 -176.546 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.1 tpt180 -148.88 -48.66 0.15 Allowed 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.014 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -92.32 -20.72 20.81 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.484 ' N ' HD12 ' A' ' 97' ' ' LEU . 14.6 t -118.21 10.12 12.79 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 117.666 -1.613 . . . . 0.0 110.837 175.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -66.28 154.96 38.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -103.67 6.24 36.88 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.0 t -79.28 -37.93 36.64 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -92.96 147.9 22.45 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 11.7 pt-20 -101.48 -63.9 1.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.794 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -117.85 133.26 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-O 122.002 0.905 . . . . 0.0 112.347 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.401 ' CG2' HD21 ' A' ' 107' ' ' LEU . 15.3 m -129.65 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.631 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -100.57 112.82 25.25 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.557 HD22 HG22 ' A' ' 80' ' ' VAL . 14.8 mt -112.86 162.9 15.27 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.686 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.1 mp -139.74 123.66 17.61 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 123.421 0.689 . . . . 0.0 109.273 174.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.502 HG12 HG13 ' A' ' 77' ' ' ILE . 34.7 m -115.71 151.49 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 CA-C-O 121.16 0.505 . . . . 0.0 110.101 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.401 -2.913 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 173.96 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.33 146.3 14.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.78 155.15 35.31 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 122.195 -0.316 . . . . 0.0 110.451 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.64 142.65 27.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 71' ' ' LEU . 8.1 p -134.68 154.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 42.2 tt0 -144.99 107.72 4.46 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.485 0.659 . . . . 0.0 111.26 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 29' ' ' LEU . 2.0 mp -97.26 126.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.15 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -93.25 145.24 24.58 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.814 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.61 ' HB2' HD11 ' A' ' 27' ' ' LEU . 20.2 pttp -37.6 115.95 0.45 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.695 1.198 . . . . 0.0 113.805 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.02 123.85 44.45 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.303 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.51 126.94 35.79 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.193 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -120.67 106.32 11.61 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.39 -100.52 1.07 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -125.56 14.89 8.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.269 0.557 . . . . 0.0 110.348 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HA ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.5 169.46 11.39 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 20' ' ' LYS . 14.3 tp -116.45 119.17 34.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.15 163.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 18' ' ' ILE . 2.9 mm? -95.83 9.35 40.81 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-O 123.446 1.593 . . . . 0.0 108.659 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.98 -48.69 3.69 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.603 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.35 170.65 11.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.098 0.475 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 48.8 m -132.85 163.49 28.97 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 123.66 0.784 . . . . 0.0 110.485 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 55' ' ' ILE . 6.1 pt -121.18 166.96 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 122.777 0.431 . . . . 0.0 110.42 -174.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.33 -21.58 6.87 Favored Glycine 0 CA--C 1.486 -1.741 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.595 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.593 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 124.54 169.51 13.04 Favored Glycine 0 N--CA 1.416 -2.672 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.909 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.53 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.4 -117.95 2.7 Favored Glycine 0 C--O 1.209 -1.435 0 O-C-N 124.158 0.563 . . . . 0.0 112.24 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER -67.15 -19.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.051 0.453 . . . . 0.0 111.757 -176.152 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.568 ' HB2' HG22 ' A' ' 89' ' ' THR . 35.8 t70 -76.17 -8.8 57.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.226 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.548 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.2 mm100 -107.11 165.8 11.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.459 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.5 t70 -107.83 119.99 48.53 Favored Pre-proline 0 C--N 1.315 -0.905 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.244 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD3' ' HE3' ' A' ' 53' ' ' LYS . 6.7 Cg_endo -56.07 -29.0 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.335 2.69 . . . . 0.0 113.379 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -67.87 -26.45 66.03 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.5 pt20 -117.43 9.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.0 111.747 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 5.9 m-80 -101.36 150.9 37.59 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.14 -49.88 0.6 Allowed 'Trans proline' 0 C--O 1.217 -0.549 0 C-N-CA 123.207 2.605 . . . . 0.0 113.49 -175.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.44 7.64 24.98 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.735 0.779 . . . . 0.0 110.333 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 9.2 t . . . . . 0 N--CA 1.427 -1.622 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.716 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.465 ' HE3' ' HD3' ' A' ' 41' ' ' PRO . 30.5 mmtm . . . . . 0 N--CA 1.429 -1.518 0 CA-C-O 121.382 0.61 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.51 154.54 6.21 Favored Glycine 0 C--O 1.174 -3.649 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 33' ' ' ILE . 29.5 mm -73.49 120.15 21.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 118.112 0.956 . . . . 0.0 109.776 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.8 p90 -117.42 151.25 37.44 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.53 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.783 HG21 HD11 ' A' ' 71' ' ' LEU . 93.7 t -82.12 130.3 36.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 124.02 0.825 . . . . 0.0 109.853 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -103.13 -27.19 12.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.58 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 85.4 mtt180 -144.12 138.44 28.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.082 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 66' ' ' ALA . 4.9 t -116.28 144.71 23.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.8 t -45.52 113.69 0.63 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.927 1.392 . . . . 0.0 109.102 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.46 -17.69 14.59 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.513 1.525 . . . . 0.0 114.421 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.3 46.52 0.19 Allowed Glycine 0 CA--C 1.469 -2.806 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -131.65 -165.71 11.46 Favored Glycine 0 N--CA 1.413 -2.899 0 CA-C-N 114.172 -1.014 . . . . 0.0 112.721 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.454 ' CG ' HG23 ' A' ' 18' ' ' ILE . 41.9 Cg_endo -65.2 -29.6 55.47 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 123.706 2.937 . . . . 0.0 112.4 -170.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -60.73 -59.14 5.86 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.433 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.0 pt-20 -67.8 -32.62 73.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.649 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 64' ' ' GLY . 23.1 mm -58.55 -47.26 88.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.015 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -72.96 -40.89 64.97 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.494 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.1 20.62 0.82 Allowed Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.153 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.783 HD11 HG21 ' A' ' 57' ' ' VAL . 1.9 tp -79.58 125.81 30.08 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.439 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.9 mm100 -114.27 150.88 33.73 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.839 0.828 . . . . 0.0 109.733 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.4 mt -68.63 132.68 32.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.9 175.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.31 58.57 Favored Glycine 0 C--O 1.248 0.984 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.429 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 15.4 m-20 -84.74 126.22 33.22 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -86.88 117.35 25.55 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.517 HD11 HG23 ' A' ' 57' ' ' VAL . 10.7 mt -83.15 141.48 14.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.651 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.3 mmt -119.96 -20.6 7.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.438 0.637 . . . . 0.0 109.351 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.538 HE22 ' H ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -143.59 138.61 29.18 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.528 HG13 HD12 ' A' ' 107' ' ' LEU . 34.4 t -142.37 119.68 7.14 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 124.045 0.938 . . . . 0.0 108.752 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.3 t-20 43.86 57.22 4.21 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.736 1.614 . . . . 0.0 112.127 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.538 ' H ' HE22 ' A' ' 79' ' ' GLN . . . 47.44 30.15 5.88 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 117.07 1.588 . . . . 0.0 117.07 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.448 ' HE1' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -109.72 -12.47 14.62 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -175.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.95 93.55 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 127.258 2.223 . . . . 0.0 107.973 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.615 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 4.3 ttp -89.02 -12.51 41.17 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -170.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.1 t -53.93 127.84 27.84 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 120.93 0.395 . . . . 0.0 110.357 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.3 ttm 63.4 90.27 0.08 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.446 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' A' ' 85' ' ' MET . 14.8 p -158.49 155.64 4.41 Favored 'Isoleucine or valine' 0 C--O 1.263 1.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.568 HG22 ' HB2' ' A' ' 38' ' ' ASP . 9.4 p -75.09 159.72 31.34 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 120.98 0.419 . . . . 0.0 110.167 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.47 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 14.1 t60 -55.33 -46.9 76.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.634 174.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.8 -50.56 72.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.987 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.4 67.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.957 -176.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.69 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -73.81 -42.54 60.8 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.498 ' CZ ' HG21 ' A' ' 98' ' ' THR . 12.9 mmm180 -50.19 -44.17 52.85 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 123.92 0.888 . . . . 0.0 111.031 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -84.26 29.25 0.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.056 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.506 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 5.3 tpt180 -142.91 -42.61 0.31 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.84 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -95.27 -17.52 21.61 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.498 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 11.9 t -124.75 13.78 8.62 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.692 174.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.6 ptpt -70.17 178.29 2.87 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.315 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.447 ' NH1' ' HA ' ' A' ' 26' ' ' ASN . 13.9 ptm180 -131.65 6.08 4.36 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.556 -176.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.446 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 20.2 m -74.93 -41.77 59.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.37 0.605 . . . . 0.0 109.497 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.31 139.73 32.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.411 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.96 -63.81 1.24 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.0 t -98.8 122.38 50.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 120.81 0.338 . . . . 0.0 110.141 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.499 HG23 HD21 ' A' ' 107' ' ' LEU . 33.4 m -113.96 145.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -125.64 115.98 20.98 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -117.61 153.15 33.77 Favored 'General case' 0 N--CA 1.397 -3.123 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -172.216 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.3 mp -118.0 121.18 39.96 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -116.8 154.08 18.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.7 p . . . . . 0 N--CA 1.399 -3.0 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.778 176.844 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -112.28 147.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 152.08 43.72 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -94.43 149.26 21.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.887 0.375 . . . . 0.0 110.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 71' ' ' LEU . 9.8 p -136.66 159.16 37.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.49 106.47 4.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.43 0.633 . . . . 0.0 111.326 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -93.95 128.61 45.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.736 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 4.0 m-70 -96.65 151.98 19.09 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 11.0 ptpp? -43.34 128.38 4.8 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.556 HD22 ' HD2' ' A' ' 65' ' ' PRO . 51.2 tp -122.48 123.85 42.23 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.189 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -88.5 116.38 26.7 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -113.3 103.33 11.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.19 -102.47 0.94 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.86 6.19 10.43 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.268 0.556 . . . . 0.0 111.317 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.85 163.11 12.98 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -117.89 108.92 15.9 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.48 163.55 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' HG21 ' A' ' 18' ' ' ILE . 10.9 mp -92.62 9.96 32.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.95 0.881 . . . . 0.0 110.984 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.23 -41.69 3.07 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.68 -0.691 . . . . 0.0 114.341 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 71' ' ' LEU . 49.3 p90 -99.0 172.54 7.33 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.7 m -136.26 170.44 16.02 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.306 1.042 . . . . 0.0 109.364 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 55' ' ' ILE . 7.0 pt -127.93 167.22 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 117.868 0.304 . . . . 0.0 111.169 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.39 -27.68 4.64 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.521 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.18 165.25 12.29 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.344 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.548 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -117.85 -110.17 2.5 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.203 0.59 . . . . 0.0 113.13 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.607 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.76 -26.19 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -173.45 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' HB2' HG22 ' A' ' 89' ' ' THR . 15.2 t70 -66.32 -19.82 65.92 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.685 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 7.1 mm100 -96.38 -177.76 4.07 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 3.9 t70 -132.39 120.49 16.95 Favored Pre-proline 0 CA--C 1.498 -1.029 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.12 -23.25 35.17 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.197 2.598 . . . . 0.0 113.771 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -69.9 -28.87 65.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 pt20 -116.03 7.48 14.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.552 0.691 . . . . 0.0 110.725 -175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 7.4 m120 -98.89 146.5 31.76 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.32 -44.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.948 3.098 . . . . 0.0 114.458 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -109.1 12.09 25.31 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.674 0.75 . . . . 0.0 110.427 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.5 t . . . . . 0 N--CA 1.432 -1.364 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.49 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.607 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 67.1 mttt . . . . . 0 C--O 1.238 0.495 0 CA-C-O 121.799 0.809 . . . . 0.0 113.144 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.91 159.88 8.09 Favored Glycine 0 C--O 1.192 -2.528 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 33' ' ' ILE . 29.0 mm -74.56 120.19 23.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 117.868 0.834 . . . . 0.0 110.296 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -120.6 157.77 28.8 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.927 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.712 HG21 HD11 ' A' ' 71' ' ' LEU . 98.5 t -84.23 132.57 31.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 O-C-N 124.713 1.258 . . . . 0.0 110.71 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -108.26 -19.66 13.4 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.462 0.649 . . . . 0.0 111.362 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -142.09 142.17 32.79 Favored 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.465 HG13 ' CB ' ' A' ' 66' ' ' ALA . 25.5 t -140.4 132.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.568 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -49.82 126.97 15.14 Favored 'General case' 0 N--CA 1.413 -2.301 0 O-C-N 124.372 1.045 . . . . 0.0 112.521 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.69 -16.17 64.03 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.06 0.944 . . . . 0.0 111.802 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.96 46.7 0.39 Allowed Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.16 -174.87 14.06 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.701 -0.749 . . . . 0.0 111.499 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.556 ' HD2' HD22 ' A' ' 21' ' ' LEU . 35.0 Cg_endo -62.54 -29.1 78.01 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 C-N-CA 124.106 3.204 . . . . 0.0 111.965 -171.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.465 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -59.7 -61.96 2.23 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.752 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 61' ' ' SER . 2.4 pt-20 -70.09 -31.2 68.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.763 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.44 -41.39 84.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.33 -44.25 30.19 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.588 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.78 27.35 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.245 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.712 HD11 HG21 ' A' ' 57' ' ' VAL . 5.1 tp -89.45 123.69 33.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.463 ' N ' HD12 ' A' ' 71' ' ' LEU . 13.7 mm100 -110.2 162.92 14.12 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 122.301 1.048 . . . . 0.0 110.62 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.63 134.61 29.48 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.88 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.21 18.72 71.11 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.051 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.511 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 3.6 m-20 -77.01 -2.08 32.09 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 43.07 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 57' ' ' VAL . 9.9 mt -84.51 124.93 40.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.519 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.833 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 18.2 mmt -112.18 -10.63 13.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.257 0.551 . . . . 0.0 110.527 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.644 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 5.7 tp-100 -156.47 127.33 6.83 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.731 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.554 HG13 HD12 ' A' ' 107' ' ' LEU . 22.3 t -132.79 121.59 44.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.213 0 C-N-CA 124.175 0.99 . . . . 0.0 109.212 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.85 30.83 12.06 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.44 6.11 86.32 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 115.835 -0.62 . . . . 0.0 114.49 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.509 ' CZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -99.1 -2.47 36.93 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.16 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 68.69 127.04 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 124.386 1.074 . . . . 0.0 111.222 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.442 ' HE3' ' HB1' ' A' ' 93' ' ' ALA . 8.1 tpt -123.58 -4.38 8.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 110.348 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.833 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 5.0 t -68.36 -16.19 63.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.778 -177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.66 98.39 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.509 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 9.2 p -163.93 146.58 2.73 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.504 HG22 ' HB2' ' A' ' 38' ' ' ASP . 3.1 p -73.19 155.46 39.58 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.463 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 11.1 t60 -53.5 -45.4 69.66 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.975 0.797 . . . . 0.0 109.393 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.87 -42.47 97.51 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.386 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.87 -32.31 61.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.618 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.543 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.12 -43.56 74.17 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.102 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.44 ' HG2' HD11 ' A' ' 33' ' ' ILE . 9.6 mmm180 -55.75 -40.31 72.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.009 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.14 29.53 0.41 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.146 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.6 tpt180 -142.11 -43.45 0.34 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.989 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -101.31 -20.46 15.2 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.452 ' N ' HD12 ' A' ' 97' ' ' LEU . 10.3 t -115.55 11.74 15.96 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.014 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -63.04 143.65 57.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -103.27 6.83 38.32 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.835 0.826 . . . . 0.0 110.453 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.795 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.94 165.71 12.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 8.8 pt-20 -118.53 -63.57 1.39 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.517 HG12 ' HG3' ' A' ' 103' ' ' GLU . 2.7 p -121.49 131.06 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-O 121.687 0.756 . . . . 0.0 112.679 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.427 HG23 HD21 ' A' ' 107' ' ' LEU . 14.9 m -134.49 171.87 17.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.645 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.445 ' C ' HD13 ' A' ' 107' ' ' LEU . 8.8 mmt180 -123.33 114.43 20.18 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.554 HD12 HG13 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -116.97 148.24 41.59 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -176.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.2 mp -116.02 121.91 43.65 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-O 121.349 0.595 . . . . 0.0 109.5 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 27.6 m -117.49 150.2 19.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.293 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 N--CA 1.413 -2.284 0 CA-C-O 121.625 0.726 . . . . 0.0 110.342 -178.222 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 120.629 0.252 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 110' ' ' THR . 41.6 t -91.5 120.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.01 156.73 47.53 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.458 0.474 . . . . 0.0 110.046 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -103.32 144.71 30.99 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 71' ' ' LEU . 10.0 p -126.78 156.15 37.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.95 104.07 5.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.667 0.746 . . . . 0.0 111.271 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.504 HD13 HD23 ' A' ' 107' ' ' LEU . 1.5 mp -92.31 129.02 43.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.053 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -93.15 159.97 15.05 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.741 0.651 . . . . 0.0 109.359 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HB2' HD21 ' A' ' 27' ' ' LEU . 17.3 pttp -50.72 124.79 11.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.513 HD22 ' HD2' ' A' ' 65' ' ' PRO . 48.1 tp -128.67 131.72 48.03 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.382 0.673 . . . . 0.0 110.27 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -131.2 106.02 8.05 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.95 -109.17 2.71 Favored Glycine 0 N--CA 1.428 -1.868 0 O-C-N 124.051 0.844 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -116.54 17.74 15.27 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.99 172.59 11.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.1 tm? -120.0 115.34 23.56 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.49 163.77 33.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 105' ' ' VAL . 7.5 mp -82.28 2.76 30.48 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.991 0.901 . . . . 0.0 109.892 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 89.56 -44.89 3.06 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.816 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 57' ' ' VAL . 45.6 p90 -89.17 164.69 14.89 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 85.0 p -114.74 -173.2 2.26 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.048 0.939 . . . . 0.0 109.616 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 55' ' ' ILE . 7.3 pt -138.16 164.78 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.275 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.14 -33.79 2.68 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 121.32 151.62 8.59 Favored Glycine 0 C--O 1.2 -2.022 0 C-N-CA 118.581 -1.771 . . . . 0.0 113.798 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA2' ' H ' ' A' ' 54' ' ' GLY . . . -105.66 -115.64 4.09 Favored Glycine 0 C--O 1.205 -1.682 0 C-N-CA 121.071 -0.585 . . . . 0.0 114.16 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.524 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.09 -9.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.039 0.923 . . . . 0.0 112.203 -175.097 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.612 ' HB2' HG22 ' A' ' 89' ' ' THR . 24.0 t70 -81.67 -13.36 57.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.579 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.502 ' OE1' ' HB2' ' A' ' 90' ' ' HIS . 5.6 mm100 -113.8 -178.12 3.3 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.51 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 13.3 t70 -122.16 124.63 26.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.6 Cg_endo -56.44 -28.48 73.44 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.537 -176.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -76.32 -19.86 57.84 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.51 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.3 pt20 -120.89 12.64 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.844 0.83 . . . . 0.0 110.104 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.484 HD21 ' HB3' ' A' ' 39' ' ' GLN . 0.8 OUTLIER -103.0 144.03 27.79 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.048 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.54 -49.41 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.936 2.424 . . . . 0.0 113.526 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 63.8 m-85 -111.89 16.32 20.42 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.411 1.101 . . . . 0.0 109.982 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 8.0 t . . . . . 0 N--CA 1.424 -1.757 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.74 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.524 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 47.2 mttp . . . . . 0 N--CA 1.427 -1.585 0 CA-C-O 121.102 0.477 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.479 ' H ' ' HA2' ' A' ' 36' ' ' GLY . . . 141.94 166.51 10.92 Favored Glycine 0 CA--C 1.475 -2.417 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 33' ' ' ILE . 32.7 mm -81.08 132.53 31.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 18.3 p90 -141.76 161.3 38.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.683 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.485 HG11 HG12 ' A' ' 60' ' ' VAL . 59.6 t -84.92 130.6 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.355 0 O-C-N 124.717 1.26 . . . . 0.0 110.447 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.7 p -102.24 -23.08 14.05 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.878 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 27.1 mmt180 -149.28 129.6 13.77 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 123.97 0.908 . . . . 0.0 109.202 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.485 HG12 HG11 ' A' ' 57' ' ' VAL . 30.0 m -104.37 177.29 0.89 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.033 0 CA-C-N 119.217 0.917 . . . . 0.0 109.3 174.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.539 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.2 t -79.7 116.21 19.75 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.73 -2.21 2.36 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.382 1.473 . . . . 0.0 114.336 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.5 33.76 0.16 Allowed Glycine 0 C--N 1.273 -2.921 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -121.51 -168.49 13.44 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.43 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.513 ' HD2' HD22 ' A' ' 21' ' ' LEU . 42.0 Cg_endo -64.96 -28.8 57.83 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 123.323 2.682 . . . . 0.0 111.661 -170.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.67 -64.27 0.99 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.124 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.3 pt-20 -71.48 -29.95 65.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.54 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.7 mm -56.2 -47.31 81.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 O-C-N 123.287 0.367 . . . . 0.0 110.73 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.44 -47.55 32.94 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.28 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.31 14.94 0.44 Allowed Glycine 0 C--N 1.312 -0.772 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.63 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.425 HD11 HG21 ' A' ' 57' ' ' VAL . 2.1 tp -79.63 118.52 21.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -119.35 140.09 50.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.59 139.97 10.8 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 O-C-N 124.64 1.213 . . . . 0.0 110.303 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.48 34.67 19.14 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 119.601 -1.285 . . . . 0.0 111.436 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' OD2' HG13 ' A' ' 77' ' ' ILE . 10.0 p-10 -94.47 -161.4 0.85 Allowed 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 113.54 -1.33 . . . . 0.0 107.875 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 73.8 mmtt -150.36 96.42 2.4 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.566 HG13 ' OD2' ' A' ' 75' ' ' ASP . 22.8 mt -73.12 113.31 10.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.282 1.039 . . . . 0.0 110.459 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 15.8 mmt -105.06 -10.21 17.33 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.182 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -163.14 134.13 4.76 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 121.861 -0.525 . . . . 0.0 110.023 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.556 HG13 HD12 ' A' ' 107' ' ' LEU . 22.8 t -134.31 115.4 20.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.3 t30 48.07 55.79 8.21 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 124.509 1.124 . . . . 0.0 112.395 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.0 2.35 3.72 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-N 113.662 -1.608 . . . . 0.0 116.582 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -87.33 -14.17 41.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.671 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t0 65.15 120.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.06 1.744 . . . . 0.0 111.602 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.479 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 41.7 ttm -119.36 8.54 11.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.209 1.004 . . . . 0.0 110.926 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.437 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 10.5 t -46.12 -28.43 1.21 Allowed 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 125.793 1.637 . . . . 0.0 114.743 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 ttp -159.86 92.39 1.02 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.479 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.1 p -148.5 151.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.612 HG22 ' HB2' ' A' ' 38' ' ' ASP . 18.4 p -70.28 157.06 38.39 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.308 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.502 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 10.4 t60 -57.59 -43.56 84.72 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -58.9 -47.3 85.49 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.954 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -36.8 64.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.631 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' HG13 ' A' ' 55' ' ' ILE . . . -65.14 -40.67 94.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.711 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.424 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 7.9 mmm180 -53.45 -39.77 64.7 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.597 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -81.19 13.93 2.61 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.383 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 22.9 tpt180 -131.37 -35.8 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.865 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -98.86 -27.78 13.76 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.619 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.402 ' N ' HD13 ' A' ' 97' ' ' LEU . 9.0 t -113.53 13.05 18.73 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.048 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HD2' ' HG2' ' A' ' 102' ' ' GLU . 14.4 ptpt -67.64 157.36 34.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 165.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 13.6 ptt180 -112.91 8.92 18.77 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.418 -173.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -81.18 -31.28 34.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.623 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 18.6 mm-40 -87.15 146.12 26.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -94.18 -75.41 0.51 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.566 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.491 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 2.0 p -109.73 133.86 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-O 121.141 0.496 . . . . 0.0 110.012 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 29' ' ' LEU . 16.7 m -132.3 162.99 38.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.511 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.438 ' C ' HD13 ' A' ' 107' ' ' LEU . 97.7 mtt180 -123.91 117.57 25.12 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.556 HD12 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -119.61 152.34 37.21 Favored 'General case' 0 N--CA 1.397 -3.122 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -175.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.9 mp -116.92 131.07 57.05 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 75' ' ' ASP . 20.8 m -131.91 153.96 39.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 123.976 0.797 . . . . 0.0 109.889 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.609 HG22 HG22 ' A' ' 13' ' ' VAL . 36.9 p . . . . . 0 N--CA 1.419 -1.984 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.435 -1.214 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 7.6 p -114.05 142.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.84 153.85 42.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -99.27 138.47 36.32 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.455 HG12 ' HB2' ' A' ' 107' ' ' LEU . 7.4 p -122.6 157.13 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.6 106.27 5.36 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.478 0.656 . . . . 0.0 110.959 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -93.59 127.44 45.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.914 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.454 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 5.1 m-70 -95.92 160.09 14.64 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 124.159 0.912 . . . . 0.0 109.311 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 17.6 ptpt -43.13 110.15 0.18 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 33.2 tp -107.96 115.4 30.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.73 103.0 12.55 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.61 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -104.24 108.57 20.01 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.35 -106.34 1.31 Allowed Glycine 0 C--N 1.311 -0.825 0 O-C-N 123.635 0.584 . . . . 0.0 112.846 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.09 6.63 20.98 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.771 0.319 . . . . 0.0 111.47 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.69 170.82 8.3 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.544 0.688 . . . . 0.0 109.294 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.44 121.73 35.69 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.515 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -129.5 155.81 41.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 40.6 mt -86.25 5.0 36.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.777 0.798 . . . . 0.0 109.331 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . 90.36 -46.97 3.04 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 114.388 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 57' ' ' VAL . 46.1 p90 -86.93 161.6 18.16 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 43.6 m -115.62 165.9 12.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.116 1.366 . . . . 0.0 108.705 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.684 HG21 HD21 ' A' ' 97' ' ' LEU . 8.9 pt -126.18 165.35 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.678 0.217 . . . . 0.0 110.491 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.11 -32.61 3.45 Favored Glycine 0 CA--C 1.484 -1.893 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.44 154.02 8.87 Favored Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.325 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.58 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -100.32 -122.83 4.97 Favored Glycine 0 N--CA 1.418 -2.506 0 O-C-N 124.298 0.646 . . . . 0.0 113.478 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -22.93 31.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 89' ' ' THR . 16.8 t70 -66.99 -19.4 65.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.818 0.818 . . . . 0.0 110.424 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.581 ' HB3' HD21 ' A' ' 44' ' ' ASN . 5.1 mm100 -96.26 -169.55 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.068 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 8.9 t70 -136.17 125.5 15.85 Favored Pre-proline 0 CA--C 1.493 -1.216 0 CA-C-O 118.855 -0.593 . . . . 0.0 109.809 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 20.9 Cg_endo -58.9 -24.5 72.92 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.739 2.293 . . . . 0.0 113.683 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.1 t -73.25 -32.46 64.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.216 0.531 . . . . 0.0 109.829 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.426 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 8.3 pm0 -111.93 16.33 20.38 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.01 0.434 . . . . 0.0 111.246 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.581 HD21 ' HB3' ' A' ' 39' ' ' GLN . 3.6 m120 -102.4 140.12 20.84 Favored Pre-proline 0 CA--C 1.485 -1.538 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.412 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.03 -46.15 2.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.434 2.09 . . . . 0.0 113.38 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -120.61 31.52 6.41 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.595 ' HA ' ' NZ ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.312 -1.064 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.011 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 55.8 mtmt . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 121.001 0.429 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.406 ' C ' ' HA2' ' A' ' 36' ' ' GLY . . . 153.65 156.54 7.67 Favored Glycine 0 C--O 1.183 -3.067 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -176.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.612 HD12 HD12 ' A' ' 33' ' ' ILE . 31.4 mm -71.91 129.06 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.215 1.008 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.43 160.59 38.29 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.57 HG21 HD11 ' A' ' 71' ' ' LEU . 87.1 t -86.01 132.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 O-C-N 125.205 1.566 . . . . 0.0 109.872 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 p -104.54 -27.14 12.06 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.798 0.808 . . . . 0.0 111.026 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -144.42 133.28 22.52 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG12 HG11 ' A' ' 57' ' ' VAL . 33.8 m -97.72 -175.5 0.37 Allowed 'Isoleucine or valine' 1 N--CA 1.347 -5.602 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.443 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.465 ' OG ' ' HA3' ' A' ' 30' ' ' GLY . 0.9 OUTLIER -68.09 126.37 29.29 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.34 -25.14 1.45 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.838 1.255 . . . . 0.0 112.981 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.71 57.96 0.1 Allowed Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -139.83 -168.69 11.4 Favored Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.594 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.412 ' HB2' HG23 ' A' ' 18' ' ' ILE . 28.7 Cg_endo -59.95 -34.49 95.12 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 124.35 3.367 . . . . 0.0 113.095 -170.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 61' ' ' SER . . . -57.53 -57.76 11.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -75.48 -21.51 58.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.933 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 64' ' ' GLY . 28.1 mm -67.56 -42.07 86.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.467 0.651 . . . . 0.0 109.651 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.46 -42.82 21.95 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.297 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.29 20.75 0.89 Allowed Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.398 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.57 HD11 HG21 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -75.94 117.21 17.42 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.092 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.573 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 13.0 mm100 -111.9 135.7 52.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.242 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.1 mt -53.69 143.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 124.199 1.0 . . . . 0.0 111.246 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.64 36.66 58.3 Favored Glycine 0 N--CA 1.48 1.576 0 CA-C-O 122.725 1.181 . . . . 0.0 111.485 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.668 ' HB2' ' HB ' ' A' ' 109' ' ' VAL . 22.2 p-10 -84.92 -52.44 6.0 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 126.183 1.793 . . . . 0.0 114.492 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.595 ' NZ ' ' HA ' ' A' ' 47' ' ' SER . 55.7 mttm 70.46 100.77 0.06 Allowed 'General case' 0 C--O 1.249 1.043 0 C-N-CA 124.624 1.17 . . . . 0.0 108.01 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 57' ' ' VAL . 11.0 mt -83.87 130.47 35.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.006 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.4 mmt -109.97 -22.83 11.64 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.376 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -143.25 134.19 25.5 Favored 'General case' 0 C--O 1.199 -1.58 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -175.702 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.594 HG22 HD22 ' A' ' 107' ' ' LEU . 40.2 t -140.19 115.11 7.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 48.14 50.15 16.54 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 125.668 1.587 . . . . 0.0 112.806 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.31 -11.84 0.5 Allowed Glycine 0 CA--C 1.565 3.17 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -21.67 58.27 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.235 1.018 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t0 72.92 113.93 0.06 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 125.301 1.44 . . . . 0.0 109.137 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 tpt -94.2 -8.45 39.28 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.997 -167.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -49.89 125.56 12.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.763 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.9 ttt 53.89 80.87 0.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.91 1.284 . . . . 0.0 113.373 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.404 HG13 HG13 ' A' ' 55' ' ' ILE . 8.4 p -145.15 147.9 18.33 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 38' ' ' ASP . 5.7 p -69.33 156.83 38.14 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.987 0.515 . . . . 0.0 110.992 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.508 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 9.5 t60 -56.48 -41.44 76.59 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.58 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 23.2 t70 -60.16 -53.73 54.3 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 124.045 0.84 . . . . 0.0 111.183 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -31.02 70.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.156 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.687 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.64 -48.23 67.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.462 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.519 ' CZ ' HG21 ' A' ' 98' ' ' THR . 20.3 mmm180 -56.62 -44.13 80.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.801 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 30.0 mmtp -80.83 28.4 0.35 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.385 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -144.61 -45.85 0.24 Allowed 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.4 pp -92.43 -35.2 13.8 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.1 t -103.08 9.2 38.59 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.334 -1.346 . . . . 0.0 109.235 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -62.91 148.86 46.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -96.0 15.09 21.55 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.832 0.825 . . . . 0.0 110.974 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.493 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 67.7 m -93.66 -25.96 17.26 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.947 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -77.12 -178.62 5.12 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.774 0.797 . . . . 0.0 113.086 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 10.1 pt-20 -146.64 -73.27 0.22 Allowed 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.019 169.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.6 p -119.51 134.37 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' CG2' HD21 ' A' ' 107' ' ' LEU . 16.8 m -140.01 149.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.088 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.559 HH21 ' NE2' ' A' ' 79' ' ' GLN . 57.7 ttp180 -104.39 127.29 52.04 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 HG22 ' A' ' 80' ' ' VAL . 3.3 mt -122.46 147.51 46.25 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.9 mp -113.54 124.13 51.64 Favored 'General case' 0 CA--C 1.452 -2.801 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.042 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.668 ' HB ' ' HB2' ' A' ' 75' ' ' ASP . 35.8 m -124.79 153.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.543 -177.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 39.0 p . . . . . 0 C--N 1.276 -2.597 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 110' ' ' THR . 59.4 t . . . . . 0 N--CA 1.423 -1.785 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 12.3 p -99.65 133.65 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.5 154.08 40.31 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.872 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.69 148.29 22.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.94 0.4 . . . . 0.0 109.961 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.641 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -129.14 157.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 38.1 tt0 -150.31 106.38 3.45 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.579 0.704 . . . . 0.0 109.809 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -94.69 130.14 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.3 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -101.57 141.16 34.85 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.916 0.76 . . . . 0.0 109.111 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HE2' ' HB2' ' A' ' 103' ' ' GLU . 18.0 ptpt -29.59 112.24 0.07 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.98 1.712 . . . . 0.0 115.401 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 38.0 tp -113.67 121.02 42.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.1 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -97.91 112.47 24.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -114.34 106.22 14.07 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.14 -108.69 2.28 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 123.732 0.645 . . . . 0.0 112.425 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.74 16.67 18.48 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.42 168.98 13.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.82 118.5 28.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -126.89 158.13 37.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.085 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.454 ' CD2' HG21 ' A' ' 105' ' ' VAL . 9.2 mp -86.43 -1.53 57.65 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.763 0.792 . . . . 0.0 109.744 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.98 3.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.38 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -96.5 171.61 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.582 0.691 . . . . 0.0 112.19 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 m -138.71 169.17 18.28 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.863 1.265 . . . . 0.0 110.404 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 55' ' ' ILE . 7.1 pt -126.82 169.45 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.129 -0.357 . . . . 0.0 110.762 -170.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.92 -24.76 5.65 Favored Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 120.4 163.2 12.05 Favored Glycine 0 C--O 1.195 -2.331 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.632 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.52 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -114.97 -115.03 3.02 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.888 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.81 -24.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.251 0.548 . . . . 0.0 111.996 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.537 ' HB2' HG22 ' A' ' 89' ' ' THR . 32.8 t70 -72.54 -17.75 61.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.89 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.563 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.2 mm100 -104.18 166.75 10.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -106.43 121.23 45.97 Favored Pre-proline 0 CA--C 1.492 -1.256 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.257 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HD3' ' HE3' ' A' ' 53' ' ' LYS . 10.1 Cg_endo -57.2 -30.02 85.73 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.88 2.387 . . . . 0.0 113.298 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.9 m -65.75 -27.24 68.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.999 0.428 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -116.42 11.91 15.06 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.391 0.615 . . . . 0.0 110.465 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -103.97 146.04 31.78 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.44 -44.13 6.96 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 123.68 2.92 . . . . 0.0 113.753 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.46 14.45 21.45 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.215 0.531 . . . . 0.0 110.115 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.4 t . . . . . 0 N--CA 1.426 -1.661 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.502 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.43 ' HE3' ' HD3' ' A' ' 41' ' ' PRO . 29.2 mmtm . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.528 0.68 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.468 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 145.01 159.63 8.17 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 33' ' ' ILE . 36.1 mm -77.92 122.16 32.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-N 118.126 0.963 . . . . 0.0 109.502 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.4 p90 -122.31 151.9 40.66 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.363 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.491 HG13 ' HA ' ' A' ' 73' ' ' ILE . 8.7 p -80.82 132.35 31.83 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 O-C-N 124.769 1.293 . . . . 0.0 110.69 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 p -106.75 -27.25 10.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.435 0.636 . . . . 0.0 110.686 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -138.13 131.46 30.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.05 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 71' ' ' LEU . 64.8 t -118.9 140.6 42.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 174.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.71 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.5 t -63.66 116.91 6.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 pt-20 -77.27 2.99 14.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.837 0.827 . . . . 0.0 112.024 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.63 29.94 0.94 Allowed Glycine 0 C--N 1.267 -3.265 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.426 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -128.14 -177.88 15.08 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.075 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.55 -29.01 70.3 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 124.366 3.377 . . . . 0.0 112.791 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -57.77 -59.19 5.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.477 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.71 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.6 pt-20 -74.06 -31.88 63.05 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.387 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 64' ' ' GLY . 26.3 mm -55.11 -41.37 59.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 O-C-N 123.737 0.648 . . . . 0.0 110.471 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -76.05 -55.92 5.15 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.319 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.54 28.69 0.04 OUTLIER Glycine 0 C--N 1.317 -0.501 0 C-N-CA 119.768 -1.206 . . . . 0.0 113.239 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' HB2' HG11 ' A' ' 16' ' ' VAL . 2.5 tp -94.55 117.56 30.32 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -115.39 143.81 44.73 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HA ' HG13 ' A' ' 57' ' ' VAL . 65.6 mt -54.89 129.67 16.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.004 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.02 -3.95 45.03 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.706 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 84.0 m-20 -80.94 130.23 34.92 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.909 0.355 . . . . 0.0 110.571 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.46 116.11 22.92 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.523 HG13 HG12 ' A' ' 109' ' ' VAL . 3.0 mp -86.27 124.34 40.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.592 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 30.5 mmt -102.27 -19.88 14.86 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.313 0.577 . . . . 0.0 111.116 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 7.8 tp-100 -148.47 134.84 19.52 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.91 -171.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.638 HG22 HD22 ' A' ' 107' ' ' LEU . 54.8 t -142.62 108.84 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.0 0.52 . . . . 0.0 111.974 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.446 ' HB3' ' NH2' ' A' ' 96' ' ' ARG . 45.9 t30 55.18 39.43 31.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.297 1.439 . . . . 0.0 112.715 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.32 4.79 83.34 Favored Glycine 0 C--N 1.294 -1.771 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.23 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.496 ' NE1' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -116.7 148.32 41.17 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.629 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.94 122.76 28.69 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.404 ' HG2' ' HB ' ' A' ' 55' ' ' ILE . 40.2 ttm -108.98 -0.92 19.34 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.044 0.926 . . . . 0.0 110.515 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.592 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 3.8 t -58.79 -34.63 71.69 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.657 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.1 ttt -140.72 95.36 2.85 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.444 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 9.7 p -160.1 151.15 5.77 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.449 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 38' ' ' ASP . 10.4 p -71.41 158.33 36.5 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.658 ' HE2' ' HE ' ' A' ' 94' ' ' ARG . 22.2 t60 -56.11 -43.6 78.3 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.124 175.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.15 -49.54 76.8 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.96 0.788 . . . . 0.0 111.399 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -31.77 68.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.44 ' O ' HD12 ' A' ' 97' ' ' LEU . . . -75.21 -40.62 59.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.658 ' HE ' ' HE2' ' A' ' 90' ' ' HIS . 15.9 mmt180 -53.04 -47.34 68.47 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.681 0.613 . . . . 0.0 111.023 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 63.1 tttm -86.24 39.14 0.8 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.666 1.222 . . . . 0.0 108.921 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.51 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 30.7 tpt180 -145.76 -45.99 0.21 Allowed 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.147 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.508 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -92.45 -26.95 17.75 Favored 'General case' 0 C--O 1.208 -1.104 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.326 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.0 t -117.43 14.79 14.7 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.521 ' HD2' ' HG2' ' A' ' 102' ' ' GLU . 13.6 ptpt -74.08 171.06 14.22 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -113.8 -0.36 14.23 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.034 0.445 . . . . 0.0 111.897 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 69.8 m -76.72 -28.46 55.82 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 33.9 mm-40 -81.84 179.19 7.92 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.117 0.484 . . . . 0.0 110.696 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.576 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 7.6 pt-20 -146.42 -70.14 0.25 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 44.0 t -105.99 126.63 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 30.6 m -128.49 134.68 64.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 123.626 0.579 . . . . 0.0 111.014 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -103.56 116.52 32.52 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.638 HD22 HG22 ' A' ' 80' ' ' VAL . 5.9 mt -114.39 161.43 17.95 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -134.77 121.61 20.95 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 77' ' ' ILE . 32.7 m -113.39 156.27 14.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.662 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.5 p . . . . . 1 N--CA 1.371 -4.414 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.424 -1.774 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.0 p -93.33 126.31 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 154.41 47.83 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.98 -174.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 3.1 ppt_? -97.06 145.57 25.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.568 HG21 ' HB2' ' A' ' 71' ' ' LEU . 7.9 p -133.97 149.03 30.13 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.94 103.06 5.87 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.548 0.689 . . . . 0.0 111.291 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -91.72 126.79 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.482 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 3.8 m-70 -96.26 150.51 20.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HB2' HD21 ' A' ' 27' ' ' LEU . 21.5 pttm -43.37 121.72 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.475 HD22 ' HD2' ' A' ' 65' ' ' PRO . 52.6 tp -122.59 123.91 42.28 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.566 176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.9 126.84 33.83 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.432 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 21.8 mt-30 -128.4 111.4 13.28 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 175.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.55 -105.81 1.69 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -122.73 15.24 10.17 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.39 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.81 171.16 7.66 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.9 tm? -122.84 109.42 14.16 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.05 164.35 19.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 105' ' ' VAL . 9.2 mp -88.08 3.69 48.1 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.056 0.931 . . . . 0.0 109.62 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 87.64 -42.2 3.11 Favored Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.676 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -90.4 166.48 13.26 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.3 m -120.5 167.82 11.98 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.404 1.481 . . . . 0.0 108.894 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 55' ' ' ILE . 11.4 pt -127.4 167.13 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 110.988 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.95 -27.1 5.0 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.99 157.97 10.17 Favored Glycine 0 C--O 1.196 -2.274 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.856 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.61 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -106.02 -115.9 4.1 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.577 0.81 . . . . 0.0 113.486 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.618 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.74 -26.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -173.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.73 -18.39 65.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.752 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.495 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 6.4 mm100 -98.58 164.83 12.09 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.806 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 5.3 t70 -119.8 118.91 31.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 10.2 Cg_endo -54.0 -26.04 39.02 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.732 2.955 . . . . 0.0 113.731 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 t -66.32 -26.79 67.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -121.05 4.37 10.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.26 0.553 . . . . 0.0 111.431 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 5.9 m120 -90.62 149.57 40.9 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 -50.52 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 123.439 2.759 . . . . 0.0 113.131 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.12 -3.48 19.88 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.692 0.758 . . . . 0.0 111.52 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 6.1 t . . . . . 0 C--N 1.291 -1.976 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.758 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.618 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 56.4 mttm . . . . . 0 N--CA 1.447 -0.611 0 CA-C-O 121.362 0.601 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.4 156.17 7.19 Favored Glycine 0 C--O 1.191 -2.548 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 33' ' ' ILE . 18.5 mm -74.41 129.21 36.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 118.207 1.003 . . . . 0.0 110.332 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -130.71 154.06 48.35 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.197 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 71' ' ' LEU . 90.8 t -77.22 135.54 26.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 124.591 1.182 . . . . 0.0 110.369 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 p -111.02 -19.93 12.59 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.22 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -152.73 138.19 17.65 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 71' ' ' LEU . 15.5 m -106.22 -173.3 0.42 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.046 0 CA-C-N 119.252 0.933 . . . . 0.0 108.632 172.161 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.616 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.8 t -87.74 118.0 26.95 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.26 -14.59 27.39 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.69 33.41 0.63 Allowed Glycine 0 C--N 1.286 -2.219 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -118.92 -169.76 14.51 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.521 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.475 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.9 Cg_endo -63.93 -29.6 67.13 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.761 2.974 . . . . 0.0 112.373 -170.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.03 -64.87 0.73 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.611 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.2 pt-20 -72.19 -31.89 66.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.506 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 mm -57.08 -39.86 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.335 0.397 . . . . 0.0 110.997 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.91 16.02 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.851 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.59 17.75 0.2 Allowed Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.402 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.688 HD11 HG21 ' A' ' 57' ' ' VAL . 5.5 tp -89.46 124.05 34.13 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -115.37 157.99 23.09 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 122.197 0.998 . . . . 0.0 111.175 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.5 mt -61.84 128.3 23.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.914 172.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.97 4.8 56.63 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -82.55 121.82 27.29 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.204 0.526 . . . . 0.0 111.661 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -83.56 99.98 10.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.876 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 57' ' ' VAL . 9.5 mt -79.28 128.24 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 -174.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.451 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 1.1 mmt -112.17 -18.91 12.45 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.453 HE22 ' C ' ' A' ' 82' ' ' GLY . 0.9 OUTLIER -148.47 137.97 22.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.627 HG22 HD22 ' A' ' 107' ' ' LEU . 37.8 t -139.73 120.88 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.2 t30 50.44 40.13 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.24 1.416 . . . . 0.0 112.471 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.453 ' C ' HE22 ' A' ' 79' ' ' GLN . . . 62.98 16.21 57.03 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 114.226 -1.352 . . . . 0.0 114.783 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . 0.307 0.0 OUTLIER -91.17 -82.89 0.28 Allowed 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 118.742 -0.646 . . . . 0.0 112.255 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.4 t70 168.41 127.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.507 ' HG3' ' HB ' ' A' ' 55' ' ' ILE . 47.3 tpp -128.3 1.0 5.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 122.709 1.242 . . . . 0.0 109.907 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.451 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 5.2 t -80.73 -29.5 36.34 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.629 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.6 ttp -133.01 75.25 1.61 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.78 -0.575 . . . . 0.0 110.409 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -151.52 150.51 13.13 Favored 'Isoleucine or valine' 0 C--O 1.259 1.574 0 CA-C-O 121.252 0.549 . . . . 0.0 110.232 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.512 HG23 HD11 ' A' ' 37' ' ' ILE . 1.9 p -73.29 157.85 36.25 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.999 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -56.74 -43.11 80.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.655 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.88 -50.72 72.94 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 124.357 1.063 . . . . 0.0 111.996 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -39.4 76.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.958 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.071 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.437 ' CZ ' HG21 ' A' ' 98' ' ' THR . 15.6 mmm180 -55.53 -38.7 69.59 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.238 0.542 . . . . 0.0 110.469 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -86.98 24.44 1.52 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.515 0.674 . . . . 0.0 109.215 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.554 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 19.1 mmt180 -137.23 -48.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.751 0.82 . . . . 0.0 110.984 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -96.76 -20.49 18.18 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.502 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.1 t -117.94 12.7 13.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.854 -1.538 . . . . 0.0 110.586 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.8 ptpt -68.49 -173.63 0.45 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -133.4 6.55 3.83 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.587 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.414 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 10.4 m -80.24 -40.48 26.93 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.131 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.06 152.28 22.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.563 ' HG3' HG12 ' A' ' 104' ' ' VAL . 9.7 pt-20 -104.06 -63.42 1.2 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.932 0.396 . . . . 0.0 110.678 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.563 HG12 ' HG3' ' A' ' 103' ' ' GLU . 2.0 p -118.81 132.5 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 CA-C-O 121.323 0.582 . . . . 0.0 110.929 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 29' ' ' LEU . 19.6 m -135.51 155.17 36.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.507 -174.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 3.3 mpt_? -107.2 126.29 52.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.627 HD22 HG22 ' A' ' 80' ' ' VAL . 5.2 mt -119.91 146.84 45.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.17 122.56 46.44 Favored 'General case' 0 C--N 1.265 -3.09 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 77' ' ' ILE . 11.1 m -123.25 152.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.661 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p . . . . . 0 C--N 1.28 -2.442 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.924 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 110' ' ' THR . 21.9 t -95.48 117.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.52 156.02 43.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -173.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -94.52 151.79 19.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.945 0.402 . . . . 0.0 111.057 -174.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 71' ' ' LEU . 3.1 t -131.51 151.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 174.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.416 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 39.7 tt0 -147.11 104.16 3.65 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.546 0.688 . . . . 0.0 109.784 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -88.08 127.12 41.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.093 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -108.81 111.64 23.48 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.852 0.72 . . . . 0.0 110.918 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 13.9 ptpt 25.81 97.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 165.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.576 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 41.9 tp -112.25 118.88 36.52 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.617 -0.677 . . . . 0.0 109.765 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -102.55 102.92 13.22 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.361 0.6 . . . . 0.0 110.019 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.447 ' HG2' ' HG ' ' A' ' 21' ' ' LEU . 12.0 mm100 -108.7 112.65 25.06 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.96 -103.51 0.65 Allowed Glycine 0 C--N 1.303 -1.263 0 O-C-N 124.262 0.976 . . . . 0.0 112.272 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -118.45 20.49 13.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 123.319 0.648 . . . . 0.0 110.538 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.52 177.12 7.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.449 0.642 . . . . 0.0 110.175 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -124.77 121.38 34.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -128.55 164.37 30.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.49 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.1 mp -93.75 0.92 56.59 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.724 0.774 . . . . 0.0 110.13 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.78 -35.68 3.9 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 115.152 0.821 . . . . 0.0 115.152 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.416 ' CD1' HD23 ' A' ' 71' ' ' LEU . 50.9 p90 -102.95 165.47 11.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 23.0 m -133.26 168.36 18.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.305 1.442 . . . . 0.0 110.24 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.667 HG21 HD21 ' A' ' 97' ' ' LEU . 6.4 pt -126.75 172.73 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-O 120.525 0.203 . . . . 0.0 111.488 -168.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.32 -5.6 12.8 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.638 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 107.57 -178.98 21.92 Favored Glycine 1 N--CA 1.393 -4.181 0 CA-C-N 114.546 -0.827 . . . . 0.0 111.904 -177.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.617 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -131.58 -79.09 0.17 Allowed Glycine 0 N--CA 1.405 -3.411 0 O-C-N 124.886 0.991 . . . . 0.0 114.293 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.519 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -101.57 -25.85 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.63 ' HB2' HG22 ' A' ' 89' ' ' THR . 10.7 t70 -71.99 -20.69 61.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.35 1.071 . . . . 0.0 109.636 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.586 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -105.88 142.71 35.14 Favored 'General case' 0 N--CA 1.393 -3.319 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.786 -173.761 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.9 t70 -88.53 125.61 62.78 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.9 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.2 Cg_endo -56.28 -31.3 83.97 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.93 2.42 . . . . 0.0 113.486 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -68.89 -29.34 67.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.249 0.547 . . . . 0.0 111.075 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.556 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.4 pt20 -109.42 8.0 25.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.673 0.749 . . . . 0.0 111.293 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 0.9 OUTLIER -99.54 149.31 35.76 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.788 -177.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.65 -52.75 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.115 2.544 . . . . 0.0 113.156 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -107.87 21.93 16.69 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.1 t . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.363 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 83.9 mttt . . . . . 0 C--O 1.24 0.564 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.5 139.91 4.86 Favored Glycine 0 C--O 1.183 -3.084 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.639 HD12 HD12 ' A' ' 33' ' ' ILE . 28.7 mm -55.08 130.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -170.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.564 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -125.7 149.86 48.14 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.188 177.402 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.734 HG23 HD11 ' A' ' 77' ' ' ILE . 95.9 t -83.22 132.99 30.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 124.36 1.037 . . . . 0.0 110.805 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.0 p -112.66 -20.26 11.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.34 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 4.3 mmm180 -140.43 132.84 28.46 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.455 HG13 ' CB ' ' A' ' 66' ' ' ALA . 53.4 t -127.22 142.8 42.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.683 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.4 m -62.1 105.3 0.57 Allowed 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 123.892 0.745 . . . . 0.0 112.363 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.41 -28.28 0.34 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 129.168 2.987 . . . . 0.0 113.545 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.2 29.52 2.05 Favored Glycine 0 C--N 1.296 -1.643 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -113.06 -175.47 19.36 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.051 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 45.7 Cg_endo -64.6 -27.0 61.28 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.01 3.14 . . . . 0.0 111.767 -171.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.455 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -58.15 -59.89 4.6 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.842 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.5 pt-20 -82.63 -20.7 35.82 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.746 -1.582 . . . . 0.0 113.107 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 64' ' ' GLY . 24.5 mm -61.12 -35.59 66.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -80.68 -54.7 5.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.373 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 151.71 25.63 0.05 OUTLIER Glycine 0 C--O 1.225 -0.422 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.608 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.743 ' HB2' HG11 ' A' ' 16' ' ' VAL . 5.2 tp -95.95 125.41 40.48 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.464 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.7 mm100 -113.66 165.18 12.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 122.043 0.925 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.3 mt -75.37 125.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.4 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.19 0.62 41.22 Favored Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.197 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 72' ' ' GLN . 14.0 m-20 -79.97 123.86 28.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 35.1 mtmt -93.04 125.36 37.59 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.734 HD11 HG23 ' A' ' 57' ' ' VAL . 2.5 mp -96.45 131.81 42.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -171.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.0 mmt -107.12 -25.92 11.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.123 0.487 . . . . 0.0 110.649 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 7.3 tp-100 -140.82 128.67 21.78 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.594 HG22 HD22 ' A' ' 107' ' ' LEU . 53.3 t -140.78 113.92 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 C-N-CA 123.382 0.673 . . . . 0.0 110.159 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.6 t30 55.69 43.54 27.86 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.234 1.014 . . . . 0.0 112.564 171.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.19 -4.18 55.61 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.962 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.484 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -104.33 146.92 28.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -81.36 112.88 19.05 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.837 0.827 . . . . 0.0 111.056 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.626 ' HE3' HD23 ' A' ' 97' ' ' LEU . 61.7 tpp -89.05 -8.2 54.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.531 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -70.42 137.3 50.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.6 ttt 53.98 75.06 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.871 0.868 . . . . 0.0 112.849 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.79 149.95 12.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.63 HG22 ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -70.39 154.99 41.29 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 123.269 0.628 . . . . 0.0 112.204 -178.157 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -56.8 -44.28 81.77 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.715 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.14 -52.59 64.68 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.869 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -66.33 -32.12 73.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.942 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.621 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -78.21 -37.26 45.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.843 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.473 ' CZ ' HG21 ' A' ' 98' ' ' THR . 16.6 mmm180 -53.98 -44.11 70.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.407 0.622 . . . . 0.0 110.546 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -85.14 32.56 0.54 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.878 0.847 . . . . 0.0 110.473 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.594 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.3 tpp180 -143.21 -43.3 0.29 Allowed 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.604 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -101.69 -20.94 14.78 Favored 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.473 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 13.7 t -116.44 15.38 15.71 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.683 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.1 ptpt -62.61 158.67 17.67 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.074 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -114.06 6.28 16.36 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.647 0.737 . . . . 0.0 110.531 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.8 m -79.4 -34.39 41.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.339 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.6 144.19 31.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.471 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -100.55 -53.43 3.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.192 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.0 p -121.04 128.58 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.705 0.764 . . . . 0.0 112.565 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.415 HG21 HD23 ' A' ' 29' ' ' LEU . 26.6 m -126.99 146.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.741 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -100.46 115.22 29.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 HG22 ' A' ' 80' ' ' VAL . 12.5 mt -114.52 159.95 19.79 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.2 mp -137.56 123.57 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.59 159.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.538 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.57 HG22 HG22 ' A' ' 13' ' ' VAL . 76.2 p . . . . . 0 N--CA 1.425 -1.713 0 CA-C-O 121.298 0.57 . . . . 0.0 111.495 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.3 141.02 19.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.4 148.96 31.85 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.49 28.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.672 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -126.24 152.89 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.43 101.4 4.1 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.41 0.624 . . . . 0.0 109.88 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -85.54 122.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.317 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.459 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 5.1 m-70 -94.46 145.84 24.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 124.123 0.889 . . . . 0.0 109.549 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -31.64 113.18 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 115.035 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.499 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.1 tp -120.51 117.73 28.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.879 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -96.27 116.97 29.87 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -109.77 106.86 16.64 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.62 -105.31 1.27 Allowed Glycine 0 N--CA 1.432 -1.604 0 O-C-N 123.842 0.714 . . . . 0.0 111.319 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -109.6 -3.58 16.79 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.94 167.81 9.96 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -172.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.92 122.26 44.79 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -133.79 155.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 105' ' ' VAL . 8.6 mp -82.27 1.36 37.08 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.107 0.956 . . . . 0.0 109.792 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 89.35 -43.58 3.04 Favored Glycine 0 N--CA 1.42 -2.381 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.708 176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 41.5 p90 -91.35 164.7 13.75 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 87.2 p -113.83 179.93 3.82 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.344 1.057 . . . . 0.0 109.676 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.667 HG21 HD21 ' A' ' 97' ' ' LEU . 6.6 pt -138.32 166.73 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.19 -23.01 6.25 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.56 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 126.9 171.24 13.03 Favored Glycine 0 CA--C 1.476 -2.382 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.16 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.533 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.92 -117.52 2.63 Favored Glycine 0 C--O 1.208 -1.482 0 O-C-N 124.445 0.732 . . . . 0.0 112.841 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.479 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -65.33 -25.68 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.7 t70 -68.99 -16.77 63.81 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.329 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.543 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.1 mm100 -98.94 163.3 12.65 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.893 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.47 107.52 22.45 Favored Pre-proline 0 CA--C 1.489 -1.376 0 C-N-CA 124.507 1.123 . . . . 0.0 111.787 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.526 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 25.9 Cg_endo -64.16 -20.9 67.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.589 2.192 . . . . 0.0 110.442 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.41 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 2.7 m -63.52 -32.44 73.9 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 113.921 -1.491 . . . . 0.0 110.222 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.41 ' HG3' ' HB2' ' A' ' 42' ' ' SER . 48.7 mt-30 -122.8 4.98 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.792 0.806 . . . . 0.0 112.876 -170.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -95.38 144.81 28.43 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.09 -40.23 11.98 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.794 2.996 . . . . 0.0 113.756 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 41.3 m-85 -119.59 21.29 12.13 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.969 0.89 . . . . 0.0 108.991 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 5.6 t . . . . . 0 N--CA 1.423 -1.787 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.649 177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.3 mtmm . . . . . 0 N--CA 1.422 -1.843 0 CA-C-O 121.562 0.696 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.9 163.31 11.03 Favored Glycine 0 C--O 1.181 -3.174 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -175.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.662 HD12 HD12 ' A' ' 33' ' ' ILE . 36.4 mm -72.0 127.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 118.767 1.283 . . . . 0.0 110.634 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 2.3 p90 -127.64 151.77 48.52 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.667 HG21 HD11 ' A' ' 71' ' ' LEU . 85.9 t -79.89 133.34 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 124.426 1.079 . . . . 0.0 110.369 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.424 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 9.3 p -106.11 -22.38 12.88 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.285 0.564 . . . . 0.0 110.75 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.7 mmt180 -155.13 140.25 17.47 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.193 1.397 . . . . 0.0 107.73 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.44 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 20.6 m -106.88 -176.41 0.57 Allowed 'Isoleucine or valine' 1 N--CA 1.346 -5.657 0 CA-C-N 118.985 0.811 . . . . 0.0 109.714 173.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.489 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 2.8 t -75.82 114.78 14.81 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 173.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.82 -30.26 44.38 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.939 0.775 . . . . 0.0 112.614 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.39 48.13 0.55 Allowed Glycine 0 CA--C 1.484 -1.884 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.467 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -129.3 -165.64 11.74 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.634 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.499 ' HD2' HD22 ' A' ' 21' ' ' LEU . 42.4 Cg_endo -64.9 -28.45 58.49 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.4 2.733 . . . . 0.0 112.177 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.39 -62.37 1.82 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.66 -30.43 67.04 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.173 0.296 . . . . 0.0 111.418 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.0 mm -64.73 -39.07 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.357 0.598 . . . . 0.0 111.299 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.89 -47.65 16.1 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.61 14.14 0.24 Allowed Glycine 0 C--N 1.311 -0.832 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.846 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB2' HG11 ' A' ' 16' ' ' VAL . 8.1 tp -86.44 124.43 32.76 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -116.87 159.29 22.61 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 122.146 0.974 . . . . 0.0 111.029 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.97 125.44 21.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.902 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.83 35.11 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.206 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.43 124.11 23.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-O 120.817 0.341 . . . . 0.0 110.544 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -86.63 119.36 26.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.583 HD11 HG23 ' A' ' 57' ' ' VAL . 3.7 mp -85.54 122.85 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.469 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 25.5 mmt -101.8 -13.25 17.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.44 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -161.53 132.46 5.23 Favored 'General case' 0 C--O 1.2 -1.551 0 O-C-N 121.989 -0.445 . . . . 0.0 110.007 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 107' ' ' LEU . 50.5 t -131.92 125.5 55.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.601 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.0 t30 49.3 43.26 22.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.79 1.236 . . . . 0.0 112.269 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.72 12.57 48.03 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 114.15 -1.386 . . . . 0.0 114.977 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.443 ' HZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -97.12 -8.64 29.69 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.139 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 71.77 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.861 0.864 . . . . 0.0 110.637 -173.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.441 ' HE2' HD23 ' A' ' 97' ' ' LEU . 7.4 tpt -120.73 -0.92 10.08 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.563 0.697 . . . . 0.0 109.689 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.469 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 9.7 t -66.63 -15.98 63.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.842 -174.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.5 ttt -150.28 93.94 2.06 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.042 0.448 . . . . 0.0 110.394 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG21 ' HZ2' ' A' ' 83' ' ' TRP . 7.3 p -154.96 149.51 12.24 Favored 'Isoleucine or valine' 0 C--O 1.259 1.561 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 38' ' ' ASP . 9.3 p -72.33 155.75 39.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 122.632 0.373 . . . . 0.0 110.652 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.737 ' HE2' ' HE ' ' A' ' 94' ' ' ARG . 17.7 t60 -53.58 -44.25 69.19 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.859 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.59 -43.96 92.18 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.126 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -35.23 68.18 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.209 0.528 . . . . 0.0 111.423 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.591 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -68.59 -42.88 77.57 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.432 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.737 ' HE ' ' HE2' ' A' ' 90' ' ' HIS . 18.5 mmt180 -55.7 -38.61 69.93 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.619 0.723 . . . . 0.0 109.092 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' HE3' ' A' ' 99' ' ' LYS . 47.2 tttp -81.15 18.29 1.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.972 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 34.1 mtt-85 -137.74 -37.19 0.61 Allowed 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -102.12 -23.13 14.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.473 ' N ' HD12 ' A' ' 97' ' ' LEU . 13.9 t -111.66 12.0 21.13 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.398 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.3 ptpt -69.97 176.95 3.4 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.527 169.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -119.88 -0.13 10.72 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.552 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.8 m -82.81 -36.95 25.13 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.81 115.19 27.19 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.643 0.735 . . . . 0.0 110.491 -174.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.601 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -75.16 -68.11 0.59 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.725 -173.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.1 p -121.28 125.5 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.421 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.467 HG21 HD21 ' A' ' 29' ' ' LEU . 25.4 m -131.44 147.13 32.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.909 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -97.93 116.72 30.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.054 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 80' ' ' VAL . 11.9 mt -112.76 152.41 29.15 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.97 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.9 mp -126.38 126.0 43.14 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 122.661 0.384 . . . . 0.0 110.146 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 m -122.05 149.64 25.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 p . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.585 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.465 0.298 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 110' ' ' THR . 11.7 t -97.19 137.0 26.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.48 151.18 47.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 5.0 ppt_? -96.24 155.1 16.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.036 0.446 . . . . 0.0 111.111 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -133.71 154.5 38.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -150.53 105.63 3.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.125 0.488 . . . . 0.0 109.781 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -90.94 127.61 43.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.393 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -96.24 134.44 39.34 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HB2' HD21 ' A' ' 27' ' ' LEU . 23.3 pttm -29.34 121.8 0.15 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.438 HD22 ' HD2' ' A' ' 65' ' ' PRO . 42.7 tp -120.79 125.85 48.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.899 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -91.15 125.79 36.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -130.37 105.67 8.04 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.29 -115.82 6.67 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.16 -0.82 49.54 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.469 0.308 . . . . 0.0 110.297 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.78 174.81 5.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.869 0.842 . . . . 0.0 111.08 -169.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -126.51 113.0 16.22 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.65 164.21 25.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 97' ' ' LEU . 49.4 mt -91.93 8.51 37.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.854 0.835 . . . . 0.0 109.984 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.0 -46.92 2.68 Favored Glycine 0 N--CA 1.416 -2.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.53 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 30.6 p90 -93.4 172.39 8.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.3 m -136.44 169.28 17.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.12 1.768 . . . . 0.0 110.222 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 55' ' ' ILE . 5.5 pt -124.81 172.54 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 C-N-CA 122.608 0.363 . . . . 0.0 111.477 -170.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.17 -12.37 8.33 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.626 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.534 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 114.33 170.49 16.85 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 119.537 -1.316 . . . . 0.0 113.066 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -123.68 -114.71 2.14 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 124.083 0.52 . . . . 0.0 112.109 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -29.31 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.6 t70 -66.34 -17.87 65.02 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.852 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.604 ' HB2' HD21 ' A' ' 44' ' ' ASN . 5.8 mm100 -101.24 153.54 19.53 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.452 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.0 t70 -99.98 115.69 65.31 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 4.6 Cg_endo -51.37 -30.01 32.68 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.773 2.982 . . . . 0.0 113.018 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.2 t -66.17 -25.99 67.2 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.331 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.9 pt20 -121.85 15.68 10.92 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.583 0.706 . . . . 0.0 111.032 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 87.7 m-20 -93.49 155.3 40.89 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.57 -55.91 0.08 OUTLIER 'Trans proline' 0 C--O 1.198 -1.524 0 C-N-CA 122.746 2.298 . . . . 0.0 113.003 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.4 ' CZ ' HG22 ' A' ' 73' ' ' ILE . 74.7 m-85 -105.8 27.7 8.24 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.88 0.848 . . . . 0.0 110.602 -175.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.683 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.3 t . . . . . 0 C--O 1.204 -1.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HE3' ' CD ' ' A' ' 41' ' ' PRO . 34.4 mmtm . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 121.327 0.584 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.68 140.86 7.69 Favored Glycine 0 C--O 1.186 -2.892 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.673 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 27.9 mm -60.73 128.83 22.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.248 0.547 . . . . 0.0 111.012 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.3 151.86 48.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.748 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.585 HG23 HD11 ' A' ' 77' ' ' ILE . 97.8 t -79.23 134.23 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 123.959 0.787 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -110.92 -21.93 11.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -148.73 135.63 19.9 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.443 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG11 ' O ' ' A' ' 71' ' ' LEU . 27.5 m -117.63 173.15 4.72 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.9 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 172.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB3' ' HA3' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -72.16 126.24 29.29 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -73.24 -19.16 61.13 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.771 0.67 . . . . 0.0 110.548 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.34 43.8 0.91 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . -129.29 -170.82 12.83 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.314 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HB2' HG23 ' A' ' 18' ' ' ILE . 37.5 Cg_endo -63.95 -31.6 66.6 Favored 'Trans proline' 0 N--CA 1.474 0.327 0 C-N-CA 123.742 2.961 . . . . 0.0 112.297 -172.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.83 -63.52 1.15 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.103 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.7 -28.04 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.003 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.16 -49.76 79.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.339 0.4 . . . . 0.0 110.364 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -52.13 43.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.269 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.96 22.8 0.08 OUTLIER Glycine 0 C--N 1.305 -1.151 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.724 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HG11 ' A' ' 16' ' ' VAL . 4.2 tp -90.19 106.97 18.84 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.3 mm100 -124.49 124.13 41.62 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.4 HG22 ' CZ ' ' A' ' 46' ' ' PHE . 67.1 mt -35.98 122.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 125.777 1.923 . . . . 0.0 112.801 -175.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.06 14.7 23.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.443 ' OD1' ' HB ' ' A' ' 57' ' ' VAL . 5.6 p-10 -87.32 139.0 31.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -104.5 107.43 18.36 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.604 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 9.6 mt -74.78 142.77 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.05 -172.134 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 27.8 mmt -122.15 -20.19 6.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.619 0.723 . . . . 0.0 109.891 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.579 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -144.44 134.82 24.47 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.468 HG22 HD22 ' A' ' 107' ' ' LEU . 62.6 t -140.51 120.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 81' ' ' ASN . 2.1 t-20 53.75 39.55 30.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.867 0.867 . . . . 0.0 111.891 170.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.579 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 57.8 21.89 45.49 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.455 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -102.77 -0.13 31.96 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.362 3.8 p30 49.83 99.28 0.01 OUTLIER 'General case' 0 C--N 1.342 0.273 0 CA-C-O 123.462 1.601 . . . . 0.0 113.635 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.673 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 ttp -97.95 -10.04 25.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.303 -169.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.507 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 6.2 t -33.19 -36.31 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 126.445 1.898 . . . . 0.0 115.727 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.9 ttm -139.26 93.63 2.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.92 151.89 10.04 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 38' ' ' ASP . 14.0 p -73.64 157.34 36.8 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.372 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.413 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 8.8 t60 -54.58 -46.31 73.71 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.967 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.55 -44.83 95.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.281 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -37.61 68.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.872 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' O ' HD22 ' A' ' 97' ' ' LEU . . . -66.79 -39.93 87.95 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.761 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -52.61 -34.98 53.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.638 0.775 . . . . 0.0 111.943 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -88.29 13.5 11.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.351 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.56 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 15.3 tpt180 -133.21 -39.66 0.93 Allowed 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.482 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.567 HD11 ' CG2' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -103.05 -11.88 17.81 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.964 -176.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -125.93 14.23 7.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.978 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 13.4 ptpt -67.13 -168.94 0.08 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.27 170.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.408 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 11.6 ptm180 -132.52 3.22 3.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.12 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.41 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 34.9 m -73.27 -40.3 64.71 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.437 -177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.16 134.32 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 103' ' ' GLU . 1.1 pm0 -81.45 -61.04 2.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.594 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -120.34 129.18 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 C-N-CA 123.049 0.54 . . . . 0.0 110.842 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.78 146.53 30.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.595 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -98.93 117.69 34.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD22 HG22 ' A' ' 80' ' ' VAL . 19.0 mt -112.09 155.35 24.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.875 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 107' ' ' LEU . 4.7 mp -133.42 126.3 30.91 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 17.0 m -123.45 158.93 28.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 123.682 0.614 . . . . 0.0 109.84 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 13' ' ' VAL . 37.9 p . . . . . 0 N--CA 1.41 -2.453 0 CA-C-O 121.25 0.548 . . . . 0.0 110.249 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.7 t . . . . . 0 N--CA 1.426 -1.635 0 CA-C-O 121.062 0.458 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 8.6 p -112.14 126.53 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.608 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.65 152.52 49.4 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -93.81 150.44 20.38 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.682 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -125.71 156.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -141.86 105.72 4.73 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.618 0.723 . . . . 0.0 110.761 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.481 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.7 mp -96.99 128.2 48.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.189 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -97.67 137.54 36.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 27' ' ' LEU . 21.5 pttp -36.09 121.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.457 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.5 tp -124.52 128.54 49.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.649 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -96.09 132.9 41.0 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.153 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -123.68 108.06 12.15 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.33 -103.86 1.25 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -119.92 12.7 12.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.26 167.44 14.87 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.6 tm? -113.73 118.41 34.25 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.48 154.14 36.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.64 HD13 HG21 ' A' ' 105' ' ' VAL . 63.8 mt -79.36 2.31 22.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.8 0.809 . . . . 0.0 109.596 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 95.64 -44.73 2.06 Favored Glycine 0 N--CA 1.408 -3.176 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.921 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 37.7 p90 -90.65 164.56 14.12 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 m -115.01 164.84 13.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 125.027 1.331 . . . . 0.0 109.135 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 55' ' ' ILE . 6.5 pt -126.06 166.62 21.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.0 -31.03 3.46 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.38 154.02 9.13 Favored Glycine 0 C--O 1.2 -1.996 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.298 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.521 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -102.57 -117.67 4.33 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.335 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.47 HD11 HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER -63.88 -23.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.312 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.499 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.5 t70 -68.94 -20.47 64.2 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.761 0.791 . . . . 0.0 109.887 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.654 ' HB2' HD21 ' A' ' 44' ' ' ASN . 6.0 mm100 -100.97 156.96 17.1 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 5.0 t70 -101.32 114.66 65.71 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.17 -25.66 23.95 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 123.859 3.04 . . . . 0.0 113.682 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 m -76.02 -8.59 57.33 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.235 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 3.5 pt20 -135.22 13.09 3.56 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.905 0.859 . . . . 0.0 110.348 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.699 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 95.5 m-20 -97.86 150.43 36.75 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.495 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.09 -45.7 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.037 0 C-N-CA 122.993 2.462 . . . . 0.0 114.31 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -114.02 9.53 17.36 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 121.354 -0.842 . . . . 0.0 110.931 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.699 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 9.6 t . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 138.48 157.99 7.59 Favored Glycine 0 C--O 1.204 -1.765 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 33' ' ' ILE . 30.7 mm -80.95 118.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 117.685 0.743 . . . . 0.0 109.555 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -120.71 155.69 33.36 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.072 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.416 HG21 HG12 ' A' ' 60' ' ' VAL . 7.6 p -81.58 131.56 33.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 O-C-N 124.733 1.271 . . . . 0.0 110.36 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 p -106.57 -19.04 13.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.556 0.693 . . . . 0.0 111.319 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -154.73 135.92 13.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 30.3 m -100.57 -177.44 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.351 -5.416 0 CA-C-N 119.592 1.087 . . . . 0.0 108.186 173.606 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.498 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 5.2 t -76.26 122.41 24.36 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.67 -18.5 31.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.275 0.984 . . . . 0.0 113.09 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.56 46.32 0.23 Allowed Glycine 0 CA--C 1.482 -1.975 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -132.78 -168.34 11.95 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.967 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HD2' HD22 ' A' ' 21' ' ' LEU . 32.9 Cg_endo -61.45 -31.88 88.32 Favored 'Trans proline' 0 C--O 1.216 -0.576 0 C-N-CA 123.987 3.125 . . . . 0.0 112.552 -169.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB3' ' H ' ' A' ' 61' ' ' SER . . . -56.63 -60.26 3.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.31 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -71.17 -30.14 66.07 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.245 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 64' ' ' GLY . 32.4 mm -62.6 -41.1 90.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 122.983 0.513 . . . . 0.0 111.147 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.94 -56.78 4.21 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.498 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.14 22.53 0.05 OUTLIER Glycine 0 C--N 1.314 -0.64 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.029 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HB2' HG11 ' A' ' 16' ' ' VAL . 3.2 tp -87.94 119.61 28.46 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -115.27 140.98 48.64 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.62 0.575 . . . . 0.0 109.494 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.8 mt -49.52 126.53 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 123.316 0.385 . . . . 0.0 111.521 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.71 50.79 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.104 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -80.62 131.91 35.55 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -94.3 108.2 20.11 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.5 HG13 HG12 ' A' ' 109' ' ' VAL . 3.3 mp -78.9 125.72 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.4 mmt -112.84 -8.82 13.71 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.85 0.357 . . . . 0.0 111.821 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -156.55 136.13 12.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.303 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 107' ' ' LEU . 39.2 t -142.61 115.04 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.546 1.138 . . . . 0.0 109.972 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 t30 50.5 57.8 6.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.622 1.169 . . . . 0.0 111.784 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.61 -17.89 1.93 Allowed Glycine 0 C--N 1.289 -2.082 0 CA-C-N 114.029 -1.441 . . . . 0.0 115.293 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.88 157.01 17.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.87 134.33 34.54 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.417 0.627 . . . . 0.0 109.897 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.528 ' HE3' HD23 ' A' ' 97' ' ' LEU . 63.4 tpp -113.15 1.59 15.33 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.235 1.017 . . . . 0.0 108.881 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.561 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.6 t -61.16 -35.7 77.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.133 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.4 ttm -139.47 91.25 2.47 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.519 HG11 ' SD ' ' A' ' 85' ' ' MET . 9.3 p -157.13 151.05 8.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.422 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.499 HG22 ' HB2' ' A' ' 38' ' ' ASP . 2.3 p -71.13 157.19 38.61 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.51 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.467 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 13.0 t60 -53.92 -45.19 71.12 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.189 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.65 -48.36 81.21 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.733 0.645 . . . . 0.0 111.537 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.49 -30.38 67.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.409 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.641 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.86 -42.86 66.4 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 176.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.429 ' C ' ' H ' ' A' ' 96' ' ' ARG . 11.1 mmm180 -56.08 -42.8 77.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.537 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -80.32 27.33 0.34 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 109.123 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.679 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 tpt180 -139.77 -43.27 0.44 Allowed 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -100.03 -28.85 12.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.457 ' N ' HD12 ' A' ' 97' ' ' LEU . 14.9 t -108.19 15.88 23.75 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.945 -1.502 . . . . 0.0 109.614 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.679 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.3 ptpt -65.78 176.2 1.66 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.535 170.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -127.41 12.29 6.97 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.698 0.761 . . . . 0.0 111.261 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 m -94.64 -32.71 13.27 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.95 0.881 . . . . 0.0 111.731 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.576 ' CB ' ' HD2' ' A' ' 99' ' ' LYS . 14.7 tt0 -108.79 119.28 39.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.496 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -80.52 -71.54 0.46 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.135 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.443 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 31.3 t -98.88 136.07 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.64 HG21 HD13 ' A' ' 29' ' ' LEU . 19.6 m -129.62 152.78 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 CA-C-O 121.32 0.581 . . . . 0.0 111.778 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -127.14 112.32 15.02 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.33 162.58 16.92 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.703 -171.778 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.7 mp -130.95 127.39 38.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.5 HG12 HG13 ' A' ' 77' ' ' ILE . 21.7 m -119.14 150.27 21.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.411 HG22 ' HB ' ' A' ' 13' ' ' VAL . 75.1 p . . . . . 0 N--CA 1.42 -1.958 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.657 HG22 HG22 ' A' ' 110' ' ' THR . 15.5 t -97.04 127.5 49.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 150.88 50.08 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -97.14 143.85 27.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -176.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 8.5 p -132.75 154.29 39.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -137.14 108.54 6.89 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.284 0.564 . . . . 0.0 111.689 -174.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.483 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -98.83 133.31 41.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.777 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -99.32 147.71 24.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 41.9 pttt -38.32 116.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 52.3 tp -117.6 125.45 50.81 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.124 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -95.48 126.28 40.66 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 23' ' ' GLN . 8.9 mm100 -122.93 99.6 6.47 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.74 -104.12 1.65 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.0 -1.32 15.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.12 171.22 7.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.316 0.579 . . . . 0.0 109.979 -172.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.7 tm? -122.07 108.42 13.34 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 1.3 mt -121.51 156.04 25.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 105' ' ' VAL . 68.6 mt -84.03 3.35 34.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.628 0.728 . . . . 0.0 109.871 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -34.43 3.97 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.519 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -99.07 170.99 8.31 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.343 0.571 . . . . 0.0 111.55 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.52 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 82.4 p -124.13 -173.7 2.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.09 0.556 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.575 HD12 HD12 ' A' ' 55' ' ' ILE . 8.4 pt -135.42 164.98 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.73 -17.39 7.49 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.578 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 121.6 166.34 12.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.261 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.688 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -115.95 -108.16 2.61 Favored Glycine 0 N--CA 1.409 -3.148 0 O-C-N 124.459 0.741 . . . . 0.0 113.322 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -80.83 -21.14 11.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.194 0.521 . . . . 0.0 111.43 -174.468 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.729 ' HB3' HG22 ' A' ' 89' ' ' THR . 7.3 p-10 -86.39 3.85 41.91 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 110.309 -174.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.52 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 18.0 mm100 -99.34 178.06 5.0 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.474 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -132.12 121.6 17.82 Favored Pre-proline 0 CA--C 1.479 -1.786 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.4 -24.76 44.82 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.477 2.118 . . . . 0.0 113.496 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m -66.73 -30.08 70.21 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.859 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -123.13 21.05 9.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.283 0.563 . . . . 0.0 111.221 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 39' ' ' GLN . 5.8 m120 -115.08 143.76 30.82 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.62 -50.97 1.07 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.667 2.911 . . . . 0.0 114.008 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -104.8 17.78 23.52 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.497 0.665 . . . . 0.0 110.469 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 5.4 t . . . . . 0 N--CA 1.418 -2.05 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HD2' ' HA ' ' A' ' 37' ' ' ILE . 8.6 mtmp? . . . . . 0 CA--C 1.547 0.864 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' C ' ' HA2' ' A' ' 36' ' ' GLY . . . 129.21 146.85 6.2 Favored Glycine 0 C--O 1.177 -3.416 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.688 HD13 ' N ' ' A' ' 36' ' ' GLY . 31.6 mm -58.81 117.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 118.811 1.305 . . . . 0.0 112.402 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -119.25 153.94 34.22 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.106 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.402 HG13 ' H ' ' A' ' 74' ' ' GLY . 7.5 p -80.28 135.39 25.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 124.567 1.167 . . . . 0.0 110.207 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 p -109.65 -23.57 11.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.268 0.556 . . . . 0.0 111.863 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 40.7 mtt-85 -142.56 138.22 30.68 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.446 HG13 ' CB ' ' A' ' 66' ' ' ALA . 54.3 t -124.87 135.76 62.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.617 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.2 t -54.44 118.76 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 124.469 1.106 . . . . 0.0 109.801 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.74 -5.85 9.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.598 1.559 . . . . 0.0 112.659 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.28 38.47 0.33 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -124.01 -174.08 14.05 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.37 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.425 ' HB2' HG23 ' A' ' 18' ' ' ILE . 29.8 Cg_endo -62.92 -29.89 76.5 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 124.018 3.145 . . . . 0.0 111.934 -172.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.446 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -57.94 -60.91 2.99 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.626 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.5 pt-20 -75.61 -23.94 56.47 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.9 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.2 mm -59.24 -43.69 90.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -50.72 19.24 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.024 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.85 21.81 0.24 Allowed Glycine 0 C--N 1.321 -0.277 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.884 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' O ' HG11 ' A' ' 60' ' ' VAL . 2.1 tp -80.13 126.63 31.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -116.66 147.18 42.18 Favored 'General case' 0 C--O 1.205 -1.247 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.6 mt -61.59 132.35 27.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.808 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.402 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 100.41 -0.34 55.72 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 73.1 m-20 -75.86 119.94 20.54 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -83.47 114.53 21.54 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 109' ' ' VAL . 12.1 mt -86.63 123.79 39.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.835 -173.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.45 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 31.3 mmt -107.66 -17.91 13.97 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.228 0.537 . . . . 0.0 110.192 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.431 ' CB ' ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -147.13 137.69 23.55 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 107' ' ' LEU . 18.4 t -139.89 115.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 123.276 0.63 . . . . 0.0 109.326 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASN . . . . . 0.455 ' ND2' ' HG2' ' A' ' 102' ' ' GLU . 31.4 t30 53.12 35.76 20.57 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.802 1.241 . . . . 0.0 111.313 173.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.428 ' C ' HE22 ' A' ' 79' ' ' GLN . . . 73.73 7.35 74.56 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 114.584 -1.189 . . . . 0.0 115.443 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.576 ' CZ2' ' HG3' ' A' ' 96' ' ' ARG 0.325 0.1 OUTLIER -81.39 -86.12 0.09 Allowed 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 118.21 1.005 . . . . 0.0 112.762 -179.965 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 162.99 111.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 126.404 1.881 . . . . 0.0 107.161 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.443 ' HE3' HG21 ' A' ' 55' ' ' ILE . 4.1 tpt -113.0 -1.88 14.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.884 -174.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.45 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 9.9 t -72.41 -33.97 67.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.933 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.546 ' SD ' HG21 ' A' ' 37' ' ' ILE . 16.4 tpt -128.54 85.83 2.38 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.505 HG13 HG13 ' A' ' 55' ' ' ILE . 7.2 p -161.06 147.53 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.891 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 38' ' ' ASP . 8.7 p -69.8 159.55 33.38 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.995 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.474 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 7.9 t60 -57.64 -41.74 82.03 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.616 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.45 -51.14 70.76 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.486 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.2 mp0 -72.06 -34.67 68.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.17 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -33.06 65.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -52.74 -48.72 66.53 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 95' ' ' LYS . 39.6 pttt -83.72 26.68 0.68 Allowed 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.649 0.737 . . . . 0.0 110.885 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 24.3 mmt180 -131.56 -29.03 1.79 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.004 176.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -106.72 -27.6 10.69 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.288 174.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.409 ' N ' HD13 ' A' ' 97' ' ' LEU . 8.7 t -112.47 16.8 19.72 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.754 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.3 ptpt -64.8 165.08 11.11 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.172 168.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -122.91 4.74 9.38 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.946 0.879 . . . . 0.0 109.374 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -45.44 94.78 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.744 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.455 ' HG2' ' ND2' ' A' ' 81' ' ' ASN . 2.0 mp0 -107.69 179.91 4.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.412 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 8.3 pt-20 -132.35 -62.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.4 t -95.99 126.16 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.586 HG21 HD13 ' A' ' 29' ' ' LEU . 28.0 m -127.04 153.02 35.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.088 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 92.5 mtt180 -124.47 116.52 22.64 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.87 147.57 40.92 Favored 'General case' 0 N--CA 1.395 -3.218 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -174.442 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.431 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 6.9 mp -111.98 121.5 45.17 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 35.5 m -117.2 147.35 20.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.002 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.657 HG22 HG22 ' A' ' 13' ' ' VAL . 47.1 p . . . . . 0 N--CA 1.411 -2.42 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.764 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 HG22 ' A' ' 110' ' ' THR . 25.2 t -84.32 119.8 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.27 152.81 49.29 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.34 146.2 24.95 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.898 -174.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -125.87 158.01 35.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.445 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 36.3 tt0 -146.7 103.78 3.68 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.531 0.681 . . . . 0.0 110.777 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.58 126.57 44.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.978 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.497 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 2.8 m-70 -96.94 161.95 13.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 124.232 0.957 . . . . 0.0 109.902 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HG3' HD11 ' A' ' 27' ' ' LEU . 39.6 ttmt -40.68 125.88 2.31 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.237 1.415 . . . . 0.0 113.705 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD22 ' HD2' ' A' ' 65' ' ' PRO . 42.8 tp -139.71 131.43 27.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.037 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -99.96 137.07 38.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -128.49 104.21 7.56 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.96 -108.55 2.52 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -111.85 9.59 20.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.267 0.556 . . . . 0.0 110.679 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.65 172.03 7.28 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' A' ' 20' ' ' LYS . 14.3 tp -122.77 115.74 22.53 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.17 153.62 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.574 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.3 mp -78.59 0.16 27.41 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.667 0.746 . . . . 0.0 111.423 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.54 -37.81 3.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.927 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 34.3 p90 -100.64 178.21 4.78 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -143.57 168.04 20.8 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 124.274 1.03 . . . . 0.0 110.053 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD21 ' A' ' 97' ' ' LEU . 11.1 pt -127.43 167.7 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 117.944 0.338 . . . . 0.0 111.87 -171.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.07 -29.89 4.13 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 127.24 161.82 10.96 Favored Glycine 0 N--CA 1.42 -2.406 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.376 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.605 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -108.19 -119.41 4.34 Favored Glycine 0 N--CA 1.428 -1.899 0 O-C-N 124.16 0.565 . . . . 0.0 112.652 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -24.27 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.153 0.502 . . . . 0.0 111.759 -175.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.538 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.8 t70 -66.63 -13.03 60.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.773 1.229 . . . . 0.0 111.014 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.529 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.8 mm100 -104.61 169.63 8.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.899 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.503 ' HB3' ' CD ' ' A' ' 43' ' ' GLN . 12.3 t70 -114.19 128.08 26.17 Favored Pre-proline 0 CA--C 1.486 -1.502 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.0 Cg_endo -57.08 -32.11 92.27 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.023 1.815 . . . . 0.0 113.731 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.2 t -65.75 -32.18 73.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.503 ' CD ' ' HB3' ' A' ' 40' ' ' ASP . 1.9 pt20 -105.94 13.69 29.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.534 0.683 . . . . 0.0 110.784 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.522 ' ND2' ' HB3' ' A' ' 39' ' ' GLN . 13.0 m-80 -112.26 146.05 34.1 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -64.94 -53.47 0.89 Allowed 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 123.271 2.647 . . . . 0.0 113.349 -171.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.413 ' CZ ' HG22 ' A' ' 73' ' ' ILE . 58.2 m-85 -101.24 0.86 38.19 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.602 0.715 . . . . 0.0 110.624 -176.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 6.2 t . . . . . 0 N--CA 1.415 -2.193 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.69 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 58.9 mtmt . . . . . 0 N--CA 1.431 -1.42 0 CA-C-O 121.811 0.815 . . . . 0.0 112.388 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.2 153.1 5.79 Favored Glycine 0 C--O 1.185 -2.935 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.637 HD12 HD12 ' A' ' 33' ' ' ILE . 29.1 mm -64.25 127.94 25.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 118.708 1.254 . . . . 0.0 111.584 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -129.88 155.5 45.92 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.85 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.771 HG21 HD11 ' A' ' 71' ' ' LEU . 95.2 t -85.02 130.45 36.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 O-C-N 124.441 1.088 . . . . 0.0 111.028 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -107.35 -20.02 13.4 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 41.2 ttt-85 -142.74 143.29 32.18 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.437 HG13 ' CB ' ' A' ' 66' ' ' ALA . 45.9 t -128.38 144.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t -59.32 126.5 27.9 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.68 -26.48 68.68 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.626 1.17 . . . . 0.0 110.834 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.97 52.44 0.53 Allowed Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.766 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.41 -172.51 12.97 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.878 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.547 ' HD2' HD22 ' A' ' 21' ' ' LEU . 36.9 Cg_endo -64.52 -28.12 61.84 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 124.326 3.35 . . . . 0.0 111.619 -173.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -60.44 -58.86 6.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.958 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -69.17 -31.27 69.79 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.535 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.8 mm -59.79 -49.45 83.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.043 0.449 . . . . 0.0 110.546 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -71.43 -47.86 53.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.891 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.61 22.6 0.18 Allowed Glycine 0 C--N 1.302 -1.308 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.647 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.771 HD11 HG21 ' A' ' 57' ' ' VAL . 2.4 tp -85.88 122.92 30.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.9 mm100 -115.43 154.09 29.89 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 121.779 0.8 . . . . 0.0 109.098 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.413 HG22 ' CZ ' ' A' ' 46' ' ' PHE . 49.5 mt -65.33 124.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.147 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -15.36 23.54 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 64.6 m-20 -67.63 130.75 44.0 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.056 0.455 . . . . 0.0 110.533 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -92.37 127.15 37.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.734 HD11 HG23 ' A' ' 57' ' ' VAL . 2.9 mp -94.92 127.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -175.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.419 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 28.8 mmt -103.53 -20.55 13.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.987 0.423 . . . . 0.0 110.689 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 6.5 tp-100 -152.48 129.55 11.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.066 -172.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.473 HG13 HD12 ' A' ' 107' ' ' LEU . 38.8 t -137.16 115.71 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.822 0.849 . . . . 0.0 110.329 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 46.0 t30 53.04 41.75 32.18 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.243 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.68 90.14 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.112 -0.949 . . . . 0.0 115.062 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.417 ' CZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -114.0 150.09 34.39 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.16 136.81 36.58 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.781 0.718 . . . . 0.0 109.884 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.509 ' HE3' ' HB1' ' A' ' 93' ' ' ALA . 7.5 tpt -116.63 -7.06 11.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.229 -175.477 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.419 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 8.1 t -58.63 -34.91 71.7 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.084 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.0 ttp -137.99 91.07 2.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.417 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 7.2 p -154.24 151.55 10.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.029 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 38' ' ' ASP . 11.8 p -75.39 159.59 31.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.493 0.187 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.515 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 11.4 t60 -55.45 -42.77 74.7 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.562 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 39.2 t70 -59.3 -54.0 51.86 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.756 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -30.17 69.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.866 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 85' ' ' MET . . . -71.76 -44.59 63.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.164 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.92 -43.28 86.16 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.673 0.749 . . . . 0.0 109.471 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HE3' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.4 40.34 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.405 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.412 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 11.2 tpt180 -150.02 -45.63 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.243 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -99.16 -26.15 14.29 Favored 'General case' 0 C--O 1.196 -1.722 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.466 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.4 t -111.91 17.09 20.04 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 118.22 -1.392 . . . . 0.0 109.601 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 16.0 ptpt -72.14 161.49 30.81 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -114.43 9.69 16.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.752 0.787 . . . . 0.0 110.373 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.519 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 36.5 m -80.57 -30.44 37.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.851 -177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -110.11 156.73 20.19 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 6.7 pt-20 -110.51 -67.71 0.98 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.865 0.364 . . . . 0.0 111.869 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -103.96 125.11 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-O 122.106 0.955 . . . . 0.0 112.578 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.48 HG23 HD21 ' A' ' 107' ' ' LEU . 15.6 m -126.18 168.48 19.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.453 -175.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.448 ' HD2' ' C ' ' A' ' 105' ' ' VAL . 5.1 mpt_? -127.06 116.29 20.49 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -118.9 153.34 34.72 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.1 mp -125.4 123.6 39.67 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 77' ' ' ILE . 30.2 m -124.09 155.44 31.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.6 -176.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.571 HG22 HG22 ' A' ' 13' ' ' VAL . 11.4 p . . . . . 0 N--CA 1.383 -3.821 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.24 127.35 53.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.97 154.72 49.02 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.372 -176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -95.12 145.47 24.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.093 0.473 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 107' ' ' LEU . 9.6 p -129.95 150.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.81 107.34 6.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 122.138 0.971 . . . . 0.0 111.036 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -96.49 125.78 49.32 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.114 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.441 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 3.4 m-70 -94.68 165.5 12.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.545 ' HB2' HD21 ' A' ' 27' ' ' LEU . 18.5 ptpt -48.65 129.49 16.55 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 176.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 42.6 tp -120.68 122.65 40.92 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 111.98 22.88 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -119.05 102.86 9.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.33 -109.03 2.47 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.28 16.73 21.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.308 0.575 . . . . 0.0 110.822 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.04 167.98 10.67 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.3 tm? -127.24 105.88 8.85 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 102.472 -3.158 . . . . 0.0 102.472 174.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -122.16 163.93 19.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.046 -174.642 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.4 mp -89.93 0.57 57.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.135 0.969 . . . . 0.0 110.245 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 61' ' ' SER . . . 91.46 -41.31 2.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.239 -0.892 . . . . 0.0 115.095 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 42.3 p90 -96.18 170.58 9.16 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 117.448 0.624 . . . . 0.0 112.615 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.7 m -130.44 165.84 21.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.259 1.023 . . . . 0.0 109.702 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.688 HD12 HD12 ' A' ' 55' ' ' ILE . 7.7 pt -124.74 168.95 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 120.461 0.172 . . . . 0.0 110.673 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.45 -23.98 6.08 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.608 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 125.01 172.29 13.46 Favored Glycine 0 N--CA 1.414 -2.805 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.366 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.55 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.56 -113.71 2.47 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 124.525 0.779 . . . . 0.0 112.5 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.564 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -69.61 -24.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.013 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB2' HG22 ' A' ' 89' ' ' THR . 27.3 t70 -70.62 -12.53 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.98 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.542 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 5.4 mm100 -106.23 157.92 17.23 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.504 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 8.0 t70 -97.38 123.43 52.59 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -61.86 -26.49 79.3 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.426 2.084 . . . . 0.0 113.523 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -72.35 -23.21 61.1 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 1.4 pt20 -122.12 20.49 10.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.415 0.626 . . . . 0.0 111.006 -178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -111.82 140.88 23.8 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.36 -39.99 34.24 Favored 'Trans proline' 0 C--O 1.222 -0.284 0 C-N-CA 123.663 2.909 . . . . 0.0 113.632 -170.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CD1' ' HA2' ' A' ' 74' ' ' GLY . 53.5 m-85 -119.72 22.19 11.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.762 0.792 . . . . 0.0 109.693 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 4.6 t . . . . . 0 N--CA 1.433 -1.281 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 36.4 mtmm . . . . . 0 N--CA 1.432 -1.344 0 CA-C-O 121.586 0.708 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.525 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 139.87 169.08 11.53 Favored Glycine 0 CA--C 1.472 -2.626 0 N-CA-C 106.218 -2.753 . . . . 0.0 106.218 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.688 HD12 HD12 ' A' ' 33' ' ' ILE . 24.2 mm -76.69 131.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 118.779 1.29 . . . . 0.0 109.839 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.2 p90 -128.61 149.01 50.82 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 71' ' ' LEU . 95.6 t -78.48 130.88 35.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 124.459 1.1 . . . . 0.0 111.657 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -106.88 -20.4 13.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.103 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 6.9 ttm180 -144.31 143.44 30.99 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.452 HG13 ' CB ' ' A' ' 66' ' ' ALA . 38.4 t -126.53 136.79 59.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.605 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.4 t -55.14 119.76 5.97 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.545 1.153 . . . . 0.0 110.062 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.62 2.59 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 111.471 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.19 41.49 0.27 Allowed Glycine 0 C--N 1.273 -2.954 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.73 -173.09 12.83 Favored Glycine 0 N--CA 1.414 -2.821 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.784 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.2 Cg_endo -65.78 -28.23 51.54 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 124.847 3.698 . . . . 0.0 112.237 -173.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.452 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -58.74 -59.17 5.84 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 61' ' ' SER . 5.5 pt-20 -72.32 -27.86 62.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.577 178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -61.19 -40.95 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.013 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.79 -47.64 18.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.02 16.89 0.41 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.422 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.787 HD11 HG21 ' A' ' 57' ' ' VAL . 1.8 tp -74.57 127.79 33.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.418 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.8 mm100 -113.73 148.49 36.35 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.3 0.571 . . . . 0.0 110.179 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.49 123.3 19.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 46' ' ' PHE . . . 112.99 -15.18 23.59 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.784 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -63.78 127.2 30.31 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.684 0.284 . . . . 0.0 111.021 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.7 123.29 33.6 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.699 HD11 HG23 ' A' ' 57' ' ' VAL . 3.7 mp -90.58 126.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -112.26 -7.7 14.0 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.034 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.635 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -159.96 136.5 9.01 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.587 HG22 HD22 ' A' ' 107' ' ' LEU . 34.0 t -142.49 119.7 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.749 1.219 . . . . 0.0 109.168 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.3 t30 46.08 57.84 4.91 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 124.533 1.133 . . . . 0.0 112.176 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.1 -17.47 2.96 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 113.644 -1.616 . . . . 0.0 115.37 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.401 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -92.49 156.92 16.84 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -94.91 127.32 40.86 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.488 ' SD ' HD23 ' A' ' 97' ' ' LEU . 29.1 ttm -105.82 3.54 28.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.313 1.054 . . . . 0.0 110.695 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.482 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.6 t -61.14 -23.04 65.25 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.374 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.564 ' SD ' HG21 ' A' ' 37' ' ' ILE . 52.0 tpp -140.94 90.14 2.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.406 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 8.9 p -160.33 150.03 5.82 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 38' ' ' ASP . 17.9 p -76.23 159.98 30.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.061 0.458 . . . . 0.0 110.414 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -54.58 -41.43 69.84 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.379 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.92 -47.59 85.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.752 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.14 -37.35 69.44 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.431 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.662 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.85 -45.49 85.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.749 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.416 ' HG2' HD11 ' A' ' 33' ' ' ILE . 12.0 mmm180 -53.63 -39.05 64.65 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 122.828 0.451 . . . . 0.0 111.488 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.73 24.41 0.88 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.947 0.403 . . . . 0.0 111.153 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.586 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 20.6 ttm180 -145.22 -37.98 0.27 Allowed 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -97.51 -17.05 19.83 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.471 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.1 t -122.7 14.18 10.09 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.846 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.2 ptpt -62.28 161.6 11.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.921 173.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -124.94 19.07 8.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.016 0.912 . . . . 0.0 110.338 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.412 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 47.4 m -84.15 -27.51 28.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.073 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -125.02 159.86 30.35 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.379 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -97.64 -70.47 0.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -109.69 128.55 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 m -132.67 148.81 31.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.171 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -100.28 124.61 45.94 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 80' ' ' VAL . 3.9 mt -119.71 154.3 34.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.5 mp -120.08 125.57 48.63 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-O 121.015 0.436 . . . . 0.0 110.389 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.1 m -119.8 150.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.223 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 N--CA 1.423 -1.812 0 CA-C-O 121.469 0.652 . . . . 0.0 111.429 -178.364 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -107.61 138.5 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 153.34 51.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 139.8 38.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 107' ' ' LEU . 8.5 p -128.66 158.31 41.06 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.21 101.99 4.4 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.386 0.612 . . . . 0.0 110.245 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -93.52 127.87 45.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.027 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 2.9 m-70 -93.07 156.79 16.65 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HB2' HD21 ' A' ' 27' ' ' LEU . 24.0 pttm -49.54 125.89 12.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 45.2 tp -119.05 119.01 32.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.203 175.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -101.67 118.65 37.38 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.415 HE21 HD21 ' A' ' 21' ' ' LEU . 48.0 mt-30 -121.8 105.23 10.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 -112.46 5.03 Favored Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.869 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.24 3.09 51.51 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.137 0.494 . . . . 0.0 109.721 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.64 161.69 20.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-O 122.128 0.966 . . . . 0.0 110.59 -171.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.8 tm? -122.75 113.97 19.92 Favored 'General case' 0 C--N 1.256 -3.459 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 171.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -126.38 157.92 36.63 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.919 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 98' ' ' THR . 3.2 mm? -94.65 6.34 49.17 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 123.337 1.541 . . . . 0.0 108.588 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 92.37 -46.9 2.59 Favored Glycine 0 C--N 1.294 -1.764 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.161 172.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.418 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 49.4 p90 -89.13 166.36 13.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -175.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 55.2 m -120.65 168.13 11.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.702 1.201 . . . . 0.0 109.73 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 55' ' ' ILE . 5.9 pt -125.77 164.39 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 120.857 0.36 . . . . 0.0 110.298 -177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.73 -20.99 7.75 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.304 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.632 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 123.17 171.37 13.64 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.558 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -122.15 -117.44 2.44 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 124.388 0.699 . . . . 0.0 112.6 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -22.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' HG22 ' A' ' 89' ' ' THR . 23.1 t70 -74.94 -15.01 60.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.26 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.632 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 5.0 mm100 -100.17 167.37 10.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 2.3 t70 -108.0 111.95 61.88 Favored Pre-proline 0 CA--C 1.497 -1.08 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 10.2 Cg_endo -54.31 -24.69 35.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.582 2.855 . . . . 0.0 113.314 -175.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -66.15 -33.45 75.79 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.217 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.41 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 1.6 pt20 -112.49 15.39 20.18 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.933 0.873 . . . . 0.0 110.632 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 8.3 m120 -102.11 142.0 23.69 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.998 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.55 -45.02 7.48 Favored 'Trans proline' 0 C--O 1.221 -0.36 0 C-N-CA 123.507 2.805 . . . . 0.0 113.171 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 67.8 m-85 -113.2 17.95 18.28 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.659 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 1.8 t . . . . . 0 C--N 1.285 -2.222 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm . . . . . 0 N--CA 1.432 -1.369 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.471 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 96.98 154.18 29.88 Favored Glycine 0 C--O 1.178 -3.355 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 33' ' ' ILE . 21.4 mm -76.95 126.25 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 118.26 1.03 . . . . 0.0 110.779 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.08 148.96 44.22 Favored 'General case' 0 CA--C 1.486 -1.498 0 O-C-N 122.107 -0.37 . . . . 0.0 111.353 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.684 HG21 HD11 ' A' ' 71' ' ' LEU . 95.8 t -74.46 130.92 35.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 124.423 1.077 . . . . 0.0 110.273 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.516 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.3 p -105.99 -22.21 12.95 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.353 0.596 . . . . 0.0 110.466 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -154.59 142.07 19.71 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 21.0 m -109.12 -179.91 0.9 Allowed 'Isoleucine or valine' 1 N--CA 1.352 -5.368 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.621 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 30.3 t -79.55 126.82 31.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.22 -16.19 1.17 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.645 1.578 . . . . 0.0 114.321 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.91 43.46 0.2 Allowed Glycine 0 CA--C 1.483 -1.943 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.29 -168.31 13.69 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.725 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.502 ' HB2' HG23 ' A' ' 18' ' ' ILE . 33.8 Cg_endo -64.06 -30.66 66.1 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 123.433 2.755 . . . . 0.0 111.939 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.26 -64.77 0.74 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.4 pt-20 -70.9 -31.89 68.67 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.557 -0.857 . . . . 0.0 112.146 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.6 mm -59.77 -40.11 81.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.0 -38.64 27.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.95 17.62 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.712 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.684 HD11 HG21 ' A' ' 57' ' ' VAL . 4.9 tp -83.18 127.24 33.44 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.539 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 23.8 mm-40 -115.5 151.29 35.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 111.08 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.85 130.23 33.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.006 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.02 4.3 55.5 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.172 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 13.4 m-20 -102.27 128.76 48.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.151 0.5 . . . . 0.0 111.873 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -79.72 119.28 22.43 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.242 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.437 HD11 ' CG2' ' A' ' 57' ' ' VAL . 19.5 mt -84.62 121.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.308 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.3 mmt -111.56 -6.85 14.35 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.649 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.524 ' CB ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.21 134.65 13.43 Favored 'General case' 0 C--O 1.203 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.779 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.632 HG22 HD22 ' A' ' 107' ' ' LEU . 46.4 t -136.96 122.81 27.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.5 t30 72.58 -34.99 0.31 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 127.338 2.255 . . . . 0.0 113.004 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 134.95 15.32 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.487 ' HE1' ' HB2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -99.49 -15.69 18.6 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -175.101 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.55 109.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.326 1.451 . . . . 0.0 111.568 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.533 ' SD ' HD13 ' A' ' 97' ' ' LEU . 32.0 ttm -111.87 7.6 20.13 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.765 0.793 . . . . 0.0 111.366 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 5.2 t -56.1 -27.41 53.7 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 ttm -143.82 96.1 2.84 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.474 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.0 p -157.09 151.76 8.24 Favored 'Isoleucine or valine' 0 C--O 1.257 1.479 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.485 HG22 ' HB2' ' A' ' 38' ' ' ASP . 23.7 p -74.33 155.57 38.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -51.41 -43.81 62.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -61.89 -46.71 88.19 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.989 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -31.25 57.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.179 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 -42.11 68.24 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -51.14 -43.25 61.17 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -92.81 50.87 1.62 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.343 1.068 . . . . 0.0 109.568 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -157.85 -50.57 0.07 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.238 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.533 HD13 ' SD ' ' A' ' 85' ' ' MET . 0.8 OUTLIER -93.95 -20.48 19.96 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.331 -1.348 . . . . 0.0 112.969 -174.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.467 ' HA ' HD23 ' A' ' 29' ' ' LEU . 10.7 t -123.08 13.43 9.72 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.809 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 16.2 ptpt -71.58 173.69 7.7 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 175.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.408 ' CB ' ' HB3' ' A' ' 27' ' ' LEU . 12.3 ptt180 -107.88 -0.48 21.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 25.8 t -78.02 -23.03 48.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.671 0.748 . . . . 0.0 109.443 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.03 160.09 19.41 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.328 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.58 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -120.58 -77.94 0.59 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.552 174.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.58 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -110.61 133.24 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 C-N-CA 123.534 0.734 . . . . 0.0 109.206 176.507 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 107' ' ' LEU . 14.6 m -126.73 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.366 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.66 108.01 19.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.58 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 80' ' ' VAL . 5.6 mt -116.17 149.16 39.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.427 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 7.8 mp -122.37 129.15 51.83 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 23.6 m -121.36 148.6 24.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 O-C-N 123.997 0.811 . . . . 0.0 110.481 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.418 -2.032 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.897 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.55 144.65 14.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.39 149.74 36.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 3.2 ppt_? -93.5 145.42 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.848 0.356 . . . . 0.0 110.584 -176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -120.67 153.37 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -139.42 104.43 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.0 mp -94.6 133.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.743 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -104.32 128.86 52.19 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.974 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HB2' HD11 ' A' ' 27' ' ' LEU . 39.8 pttt -20.62 103.96 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.577 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.6 tp -102.4 123.83 46.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.981 0.419 . . . . 0.0 110.31 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -92.57 118.12 30.67 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.419 ' NE2' HD12 ' A' ' 28' ' ' ILE . 16.7 mt-30 -126.86 109.02 11.53 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.423 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.95 -98.89 0.65 Allowed Glycine 0 C--N 1.307 -1.03 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.994 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -116.65 5.32 13.21 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.35 160.44 39.82 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.713 0.768 . . . . 0.0 110.816 -169.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 20' ' ' LYS . 26.4 tp -104.84 127.45 52.65 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.419 HD12 ' NE2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -133.88 169.32 21.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.652 -178.464 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 105' ' ' VAL . 47.1 mt -92.75 -1.85 56.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.86 -36.6 3.8 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.56 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -100.56 167.63 10.23 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.807 -0.819 . . . . 0.0 112.913 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.9 m -129.25 168.35 16.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.292 1.437 . . . . 0.0 109.339 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.637 HG21 HD21 ' A' ' 97' ' ' LEU . 6.5 pt -124.06 169.88 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.02 0.438 . . . . 0.0 111.355 -172.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.99 -21.24 5.71 Favored Glycine 0 CA--C 1.479 -2.2 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.548 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 121.85 170.9 13.92 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.757 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.633 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -124.24 -105.26 1.64 Allowed Glycine 0 N--CA 1.408 -3.201 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.705 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -23.85 13.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.528 0.68 . . . . 0.0 110.947 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.769 ' HB3' HG22 ' A' ' 89' ' ' THR . 14.7 p-10 -86.11 3.65 41.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.183 -174.166 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.518 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 12.3 mm100 -107.55 156.12 19.35 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.089 173.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -99.34 118.65 62.01 Favored Pre-proline 0 CA--C 1.496 -1.11 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.6 Cg_endo -55.89 -25.2 51.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.16 2.573 . . . . 0.0 113.484 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 -17.16 62.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -132.85 28.8 4.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.126 0.489 . . . . 0.0 111.437 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.646 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 93.0 m-20 -106.25 147.0 34.08 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 122.175 -0.328 . . . . 0.0 111.067 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.55 -50.91 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.949 2.433 . . . . 0.0 112.613 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.41 4.88 28.93 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 0.0 111.447 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 2.2 t . . . . . 0 C--N 1.305 -1.36 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.578 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.482 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 37.6 mtmm . . . . . 0 N--CA 1.445 -0.722 0 CA-C-O 121.381 0.61 . . . . 0.0 112.335 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.05 138.38 4.87 Favored Glycine 0 C--O 1.191 -2.576 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 36' ' ' GLY . 24.5 mm -50.48 124.81 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.622 1.169 . . . . 0.0 112.546 -174.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -126.59 156.54 40.74 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.287 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 71' ' ' LEU . 81.7 t -82.24 137.26 21.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 O-C-N 124.591 1.182 . . . . 0.0 110.43 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 p -110.89 -22.46 11.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.479 0.657 . . . . 0.0 111.172 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 19.3 mmt180 -143.68 135.92 26.83 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.527 ' CG2' HG11 ' A' ' 57' ' ' VAL . 71.9 t -128.22 139.72 51.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.639 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.7 m -57.55 112.54 1.46 Allowed 'General case' 0 N--CA 1.42 -1.961 0 O-C-N 124.103 0.877 . . . . 0.0 111.281 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.82 -11.81 49.26 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.051 0.844 . . . . 0.0 112.752 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 22.91 2.71 Favored Glycine 0 C--N 1.285 -2.252 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . -111.93 -179.95 19.75 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.32 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.577 ' HD2' HD22 ' A' ' 21' ' ' LEU . 38.6 Cg_endo -63.75 -27.54 68.21 Favored 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 124.537 3.491 . . . . 0.0 111.764 -171.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -56.86 -60.53 3.43 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.0 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.2 pt-20 -87.1 -17.27 33.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.754 -1.578 . . . . 0.0 112.761 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.418 ' HB ' ' HA ' ' A' ' 65' ' ' PRO . 12.9 mm -60.68 -34.3 58.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.69 3.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.431 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 155.67 22.71 0.04 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 119.558 -1.306 . . . . 0.0 114.121 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.746 HD11 HG21 ' A' ' 57' ' ' VAL . 4.0 tp -88.95 121.3 31.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.152 0.501 . . . . 0.0 110.844 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -110.55 164.48 12.67 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-O 121.859 0.837 . . . . 0.0 108.789 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.62 133.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.641 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.46 14.02 74.79 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 116.415 -0.357 . . . . 0.0 112.386 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 12.9 m-20 -71.0 1.4 5.72 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 21.5 mmmt 48.23 87.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 57' ' ' VAL . 11.4 mt -83.15 123.83 39.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.1 mmt -106.63 -19.66 13.59 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.197 0.522 . . . . 0.0 109.868 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 6.4 tp-100 -154.0 131.35 11.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.172 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.59 HG22 HD22 ' A' ' 107' ' ' LEU . 60.7 t -134.57 113.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 C-N-CA 123.732 0.813 . . . . 0.0 110.215 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 32.9 t30 50.58 29.09 3.83 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.612 1.565 . . . . 0.0 113.381 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.36 64.22 Favored Glycine 0 C--O 1.217 -0.95 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.523 ' CZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -107.75 -2.83 19.67 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -175.197 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.28 129.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 119.536 1.062 . . . . 0.0 111.779 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.509 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 26.5 ttm -129.77 1.29 4.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.998 0.904 . . . . 0.0 111.382 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -72.62 -19.17 61.51 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.834 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.0 ttp -139.29 89.15 2.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.523 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 10.0 p -161.29 143.01 3.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 38' ' ' ASP . 11.4 p -69.82 154.59 41.76 Favored 'General case' 0 N--CA 1.425 -1.721 0 O-C-N 123.539 0.524 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.52 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 8.8 t60 -53.85 -43.44 69.52 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.544 173.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.13 -44.05 95.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.895 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.18 -33.02 50.38 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.824 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.631 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.18 -40.08 71.44 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.04 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.559 ' CZ ' HG21 ' A' ' 98' ' ' THR . 13.7 mmm180 -53.79 -46.21 70.96 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 123.567 0.542 . . . . 0.0 110.434 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -86.7 36.84 0.72 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.855 0.836 . . . . 0.0 110.736 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.554 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.5 tpt180 -141.43 -46.92 0.38 Allowed 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.858 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.637 HD21 HG21 ' A' ' 33' ' ' ILE . 1.4 pp -96.05 -26.16 15.63 Favored 'General case' 0 C--O 1.203 -1.361 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.559 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 15.3 t -110.81 10.94 22.52 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.543 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.2 ptpt -68.84 162.36 26.62 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -115.46 8.43 15.24 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.086 0.47 . . . . 0.0 111.953 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -79.54 -30.57 41.83 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.287 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -112.73 171.87 7.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.022 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.8 pt-20 -130.43 -71.56 0.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.5 t -91.63 129.83 41.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 122.03 -0.418 . . . . 0.0 109.962 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.525 HG21 HD13 ' A' ' 29' ' ' LEU . 15.9 m -126.05 150.5 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.9 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 -109.32 101.65 10.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.59 HD22 HG22 ' A' ' 80' ' ' VAL . 21.0 mt -102.55 149.66 24.19 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.4 mp -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.266 -3.035 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 35.9 m -117.42 159.1 17.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.548 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.278 -2.516 0 CA-C-O 121.331 0.586 . . . . 0.0 110.144 -178.392 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 110' ' ' THR . 17.9 t -83.45 115.18 25.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.4 153.37 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -94.27 145.25 24.87 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.141 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.66 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.4 t -121.68 156.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 38.8 tt0 -143.92 104.69 4.19 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.98 0.895 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -99.13 129.38 49.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.877 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -100.23 144.63 29.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 22.3 pttm -40.39 127.2 2.34 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.5 tp -124.81 126.03 44.96 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.83 174.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -91.83 116.3 28.79 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.465 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 20.0 mt-30 -111.08 101.27 9.82 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.75 -117.49 8.19 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.52 9.26 42.81 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.99 166.89 13.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.124 0.488 . . . . 0.0 109.733 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.6 tm? -117.68 107.73 14.56 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.8 163.31 27.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.0 mp -87.06 7.23 28.72 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.681 0.753 . . . . 0.0 110.598 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA2' ' OE1' ' A' ' 23' ' ' GLN . . . 90.44 -41.12 2.96 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.64 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 38.9 p90 -97.51 175.65 6.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.4 m -140.66 168.92 18.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.493 1.117 . . . . 0.0 109.314 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 55' ' ' ILE . 8.7 pt -125.8 167.02 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 117.916 0.326 . . . . 0.0 111.282 -173.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.49 -28.47 4.84 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.557 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 127.46 165.79 11.96 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.052 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -113.75 -116.16 3.26 Favored Glycine 0 N--CA 1.423 -2.175 0 O-C-N 124.238 0.611 . . . . 0.0 112.173 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.611 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.04 -23.71 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB2' HG22 ' A' ' 89' ' ' THR . 24.7 t70 -67.93 -15.71 63.74 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.812 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.557 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 3.7 mm100 -108.87 150.19 28.04 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.549 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.3 t70 -93.11 122.65 62.97 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.68 -24.94 65.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.706 2.271 . . . . 0.0 113.41 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -70.81 -25.4 62.84 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.343 0.592 . . . . 0.0 110.128 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.549 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.1 pt20 -121.24 12.24 10.96 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.059 -176.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.447 HD21 ' HB2' ' A' ' 39' ' ' GLN . 94.2 m-20 -88.7 147.3 39.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.2 -47.94 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.398 2.066 . . . . 0.0 113.74 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -113.67 24.11 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.866 0.841 . . . . 0.0 110.356 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.528 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.307 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.611 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 71.9 mttt . . . . . 0 C--O 1.226 -0.159 0 CA-C-O 120.76 0.314 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.29 157.7 7.52 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 33' ' ' ILE . 22.3 mm -76.71 131.84 34.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 118.066 0.933 . . . . 0.0 110.057 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.496 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 4.7 p90 -133.84 156.78 47.44 Favored 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.523 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 73' ' ' ILE . 8.2 p -84.24 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 O-C-N 125.035 1.46 . . . . 0.0 110.966 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.3 p -110.45 -23.29 11.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 29.8 ttm180 -136.29 146.41 46.63 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 66' ' ' ALA . 18.1 t -135.91 150.99 28.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 66' ' ' ALA . 18.7 p -52.91 127.66 24.4 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 124.047 0.842 . . . . 0.0 109.644 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.61 -19.65 66.0 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 124.048 0.842 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.88 50.23 0.2 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.486 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -129.49 -165.57 11.7 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.464 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HD2' HD22 ' A' ' 21' ' ' LEU . 34.8 Cg_endo -63.4 -34.33 66.45 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.488 2.792 . . . . 0.0 113.21 -169.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -60.27 -56.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.562 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.72 -27.7 61.33 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.564 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.6 mm -58.61 -44.36 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -76.34 -55.65 5.36 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.834 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.47 33.81 0.05 OUTLIER Glycine 0 CA--C 1.499 -0.916 0 C-N-CA 119.479 -1.343 . . . . 0.0 113.018 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.66 ' HB2' HG11 ' A' ' 16' ' ' VAL . 2.1 tp -92.17 115.75 28.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -111.3 141.48 44.78 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.474 ' HA ' HG13 ' A' ' 57' ' ' VAL . 70.7 mt -56.59 126.76 14.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 123.603 0.565 . . . . 0.0 109.92 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.79 -3.25 34.01 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.341 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 8.5 m-20 -86.2 131.88 34.13 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 120.986 0.422 . . . . 0.0 111.436 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 47.5 mtpt -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.443 HG13 HG12 ' A' ' 109' ' ' VAL . 3.2 mp -92.22 122.3 43.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -174.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.463 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.4 mmt -105.8 -15.78 14.85 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.347 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -153.56 136.52 15.45 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.519 HG22 HD22 ' A' ' 107' ' ' LEU . 72.6 t -140.85 118.47 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.795 0.838 . . . . 0.0 110.919 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.2 t30 61.98 14.48 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.271 1.429 . . . . 0.0 113.157 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.61 -15.88 19.43 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.958 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.64 149.91 21.91 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -97.08 113.59 25.17 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.543 ' HG3' HG11 ' A' ' 88' ' ' VAL . 21.3 ttm -77.84 -60.3 2.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.118 -174.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 87' ' ' MET 0.279 9.8 t 23.26 -76.5 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 127.603 2.361 . . . . 0.0 116.775 -176.541 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.513 ' H ' HG23 ' A' ' 86' ' ' THR . 27.7 ttt -113.97 93.66 4.47 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG11 ' HG3' ' A' ' 85' ' ' MET . 9.5 p -148.7 153.25 11.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.346 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 38' ' ' ASP . 4.7 p -70.28 152.9 43.67 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.514 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 9.5 t60 -50.75 -46.22 59.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.008 176.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 38.6 t70 -57.83 -48.95 78.28 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.535 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -35.9 70.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.67 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -66.09 -40.99 91.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.451 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 8.4 mmm180 -55.36 -38.79 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.802 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 38.6 mttm -83.3 30.74 0.46 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.42 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.7 tpm_? -148.66 -43.7 0.15 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.507 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.1 pp -102.05 -16.16 16.52 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.433 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.0 t -121.62 10.66 10.42 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.848 174.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.564 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 15.8 ptpt -68.59 171.41 7.63 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 173.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 18.7 ptt180 -123.99 13.01 9.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.211 0.529 . . . . 0.0 111.317 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.564 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 31.3 t -76.83 -41.1 45.53 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.243 0.544 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.26 167.09 10.37 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.6 pt-20 -120.34 -64.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 12.5 t -91.54 123.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.464 HG21 HD23 ' A' ' 29' ' ' LEU . 25.2 m -125.28 136.73 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.236 0.541 . . . . 0.0 112.056 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -95.9 110.24 22.47 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 172.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 80' ' ' VAL . 14.8 mt -109.23 156.2 20.19 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.4 mp -130.03 123.02 29.52 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -117.36 157.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.584 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.743 HG22 HG22 ' A' ' 13' ' ' VAL . 39.9 p . . . . . 0 N--CA 1.402 -2.86 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.139 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.37 135.3 33.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.97 154.77 39.86 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.62 150.2 20.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.635 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -135.61 162.81 36.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.007 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -154.24 114.23 3.85 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.258 0.551 . . . . 0.0 110.818 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -97.38 134.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.31 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -105.04 134.28 48.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HD3' ' HB2' ' A' ' 103' ' ' GLU . 43.7 pttt -28.12 118.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.438 HD22 ' CD ' ' A' ' 65' ' ' PRO . 45.9 tp -121.8 130.45 53.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.141 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.85 127.85 44.07 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -121.01 92.87 3.86 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.99 -111.83 3.36 Favored Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -109.88 15.98 22.29 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.332 0.587 . . . . 0.0 110.255 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.412 ' HA ' ' NH2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -125.83 163.92 21.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -117.56 112.55 20.73 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.87 160.79 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.619 HD13 HG21 ' A' ' 105' ' ' VAL . 54.0 mt -86.48 0.41 54.27 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.56 -37.68 3.34 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.319 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -95.84 171.47 8.62 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.8 m -130.68 169.5 15.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.679 1.192 . . . . 0.0 109.975 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 55' ' ' ILE . 6.8 pt -128.49 165.33 28.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 117.701 0.228 . . . . 0.0 110.671 -172.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.44 -31.4 3.76 Favored Glycine 0 CA--C 1.488 -1.616 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 124.11 154.74 8.98 Favored Glycine 0 C--O 1.199 -2.077 0 C-N-CA 119.416 -1.373 . . . . 0.0 113.187 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -102.18 -119.17 4.51 Favored Glycine 0 N--CA 1.424 -2.115 0 O-C-N 124.157 0.563 . . . . 0.0 112.85 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.645 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.71 -22.6 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.164 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HB2' HG22 ' A' ' 89' ' ' THR . 31.7 t70 -70.9 -18.05 62.69 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.819 0.818 . . . . 0.0 110.163 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.565 ' HB2' HD21 ' A' ' 44' ' ' ASN . 4.2 mm100 -105.87 147.07 29.13 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 4.8 t70 -94.12 127.15 46.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -175.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -20.86 44.46 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.37 2.714 . . . . 0.0 113.322 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 m -76.91 -16.07 59.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.75 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 pt20 -132.14 19.76 4.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.965 0.888 . . . . 0.0 109.946 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 93.3 m-20 -104.55 144.29 28.41 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.171 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.51 -51.74 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.692 2.261 . . . . 0.0 113.668 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -112.12 22.46 14.77 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.329 0.585 . . . . 0.0 110.639 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 8.5 t . . . . . 0 C--N 1.304 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.645 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 68.8 mttt . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 121.057 0.456 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.75 156.27 10.57 Favored Glycine 0 C--O 1.201 -1.963 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 33' ' ' ILE . 30.4 mm -78.27 126.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 117.813 0.806 . . . . 0.0 108.874 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.9 p90 -129.52 160.0 34.56 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.787 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 71' ' ' LEU . 58.8 t -87.47 128.46 39.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 124.73 1.269 . . . . 0.0 110.917 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 p -104.8 -20.43 13.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.441 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 135.94 23.41 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 HG11 ' A' ' 57' ' ' VAL . 64.6 t -123.59 148.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.48 ' OG ' ' HB3' ' A' ' 66' ' ' ALA . 37.7 p -51.82 126.33 17.7 Favored 'General case' 0 N--CA 1.401 -2.901 0 O-C-N 124.328 1.017 . . . . 0.0 108.563 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -71.32 -28.21 63.93 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-O 121.596 0.712 . . . . 0.0 109.868 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.52 55.57 0.5 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.606 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -139.28 -169.41 11.57 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' CD ' HD22 ' A' ' 21' ' ' LEU . 38.4 Cg_endo -65.61 -30.71 51.19 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 123.677 2.918 . . . . 0.0 113.047 -171.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.48 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -61.96 -53.8 50.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.914 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.3 pp20? -69.84 -30.62 68.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.551 0.215 . . . . 0.0 111.28 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.26 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.638 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.23 -48.14 45.07 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.03 21.51 0.41 Allowed Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.069 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.758 HD11 HG21 ' A' ' 57' ' ' VAL . 3.4 tp -83.03 125.46 31.47 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.461 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.4 mm100 -116.8 158.08 24.5 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.715 0.769 . . . . 0.0 109.614 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.38 135.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.898 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.82 -10.95 57.54 Favored Glycine 0 C--O 1.245 0.796 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 87.5 m-20 -74.99 114.69 13.76 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 18.7 ptpt -91.62 122.31 34.08 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.483 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.563 HD11 HG23 ' A' ' 57' ' ' VAL . 2.9 mp -86.53 134.14 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.194 -172.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.617 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -114.83 -14.07 11.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.565 0.697 . . . . 0.0 110.869 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 6.9 tp-100 -147.06 129.76 16.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.564 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 107' ' ' LEU . 46.2 t -135.38 116.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t30 37.6 59.15 1.28 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.269 1.827 . . . . 0.0 113.465 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.24 4.82 38.63 Favored Glycine 0 C--N 1.3 -1.461 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.431 ' CD1' ' HB ' ' A' ' 80' ' ' VAL 0.385 0.0 OUTLIER -90.27 -100.02 0.1 Allowed 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 118.635 1.218 . . . . 0.0 112.603 178.52 . . . . . . . . 4 4 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 173.66 116.96 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.431 ' HE2' HD23 ' A' ' 97' ' ' LEU . 3.7 tpt -115.14 -2.77 12.66 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.015 -175.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.617 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.5 t -64.87 -28.3 69.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.541 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttm -146.72 87.53 1.71 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.38 0.609 . . . . 0.0 109.579 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG13 HG13 ' A' ' 55' ' ' ILE . 7.5 p -149.37 149.63 14.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.913 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 38' ' ' ASP . 4.3 p -71.22 155.86 40.23 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 123.3 0.64 . . . . 0.0 110.428 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.441 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 10.5 t60 -55.6 -43.83 76.4 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.787 176.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.16 -48.89 79.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.684 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -32.52 70.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.11 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.73 -42.64 73.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.05 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 11.2 mmm180 -60.6 -37.03 80.02 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.83 0.824 . . . . 0.0 108.849 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.91 21.16 1.07 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.052 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.527 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 17.7 mmt180 -134.69 -42.53 0.76 Allowed 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.316 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.625 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -100.62 -28.82 12.66 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.463 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.3 t -106.97 14.8 26.06 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.872 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 14.4 ptpt -73.67 175.48 7.12 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.466 169.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.412 ' NH2' ' HA ' ' A' ' 26' ' ' ASN . 14.3 ptp180 -122.81 6.88 9.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.423 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 22.3 t -75.26 -38.45 60.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.497 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -87.97 174.15 8.48 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.529 178.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.551 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 8.6 pt-20 -137.77 -58.72 0.67 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.587 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 59.0 t -104.07 127.2 58.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.619 HG21 HD13 ' A' ' 29' ' ' LEU . 15.0 m -122.16 148.62 25.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.385 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -119.23 103.96 9.98 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.591 HD12 HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -110.17 151.85 26.78 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.963 -171.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.3 mp -125.31 119.37 28.2 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.516 HG12 HG13 ' A' ' 77' ' ' ILE . 27.1 m -112.58 147.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.184 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.7 p . . . . . 0 N--CA 1.408 -2.57 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.842 178.055 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.427 -1.602 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.517 HG22 HG22 ' A' ' 110' ' ' THR . 12.7 t -80.45 126.35 39.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.74 153.1 41.33 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.425 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -90.12 148.17 23.16 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -128.29 152.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.129 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -135.24 104.36 5.87 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.075 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.7 mp -92.8 129.74 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.942 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -99.35 144.8 28.05 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.62 ' HB2' HD21 ' A' ' 27' ' ' LEU . 20.0 pttm -35.26 127.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.401 HD22 ' HD2' ' A' ' 65' ' ' PRO . 44.0 tp -125.14 118.26 25.71 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.227 174.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -88.38 111.86 22.23 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.729 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -117.99 110.38 17.62 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.93 -109.73 3.04 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -113.95 13.31 18.26 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -112.57 171.64 7.4 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.873 0.844 . . . . 0.0 109.837 -174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.3 tm? -126.53 111.82 14.82 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 172.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.97 164.5 23.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.486 HD13 HG21 ' A' ' 105' ' ' VAL . 38.1 mt -87.66 -4.24 58.94 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.964 0.888 . . . . 0.0 108.629 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 92.67 -46.02 2.53 Favored Glycine 0 N--CA 1.424 -2.154 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.949 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -84.33 166.46 17.41 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.193 0.521 . . . . 0.0 112.218 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 29.2 m -122.36 166.85 14.05 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.656 1.182 . . . . 0.0 109.961 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 55' ' ' ILE . 3.7 pt -125.14 164.4 24.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.07 -16.23 7.39 Favored Glycine 0 CA--C 1.487 -1.685 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.328 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 125.04 169.35 12.93 Favored Glycine 0 CA--C 1.473 -2.54 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.168 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -122.2 -116.3 2.36 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.367 0.686 . . . . 0.0 111.57 175.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.45 -15.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.151 0.977 . . . . 0.0 110.777 -177.467 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.444 ' HB2' HG22 ' A' ' 89' ' ' THR . 15.2 t0 -70.95 -19.91 62.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.085 -177.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.586 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 5.1 mm100 -113.37 155.25 25.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 10.0 t70 -98.32 129.37 30.73 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 118.612 0.642 . . . . 0.0 109.431 -176.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.53 -21.3 45.35 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 122.768 2.312 . . . . 0.0 113.198 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -77.36 -11.13 59.8 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.015 0.436 . . . . 0.0 110.625 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 2.6 pt20 -130.15 11.58 5.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.415 0.626 . . . . 0.0 110.75 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 97.4 m-20 -99.91 143.32 26.27 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.76 -52.98 0.47 Allowed 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.201 2.601 . . . . 0.0 113.118 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.38 18.11 20.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.575 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.0 t . . . . . 0 C--N 1.31 -1.133 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 53.4 mttt . . . . . 0 C--O 1.224 -0.241 0 CA-C-O 121.206 0.526 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.56 153.36 5.85 Favored Glycine 0 C--O 1.18 -3.273 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 33' ' ' ILE . 30.5 mm -68.27 125.33 25.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 118.009 0.904 . . . . 0.0 109.774 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 2.3 p90 -124.98 155.9 38.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.188 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.674 HG21 HD11 ' A' ' 71' ' ' LEU . 87.7 t -81.46 129.92 36.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 124.455 1.097 . . . . 0.0 110.619 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -106.08 -19.7 13.64 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.279 0.561 . . . . 0.0 111.068 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -154.46 138.97 16.84 Favored 'General case' 0 C--O 1.204 -1.309 0 C-N-CA 124.124 0.97 . . . . 0.0 108.519 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.519 HG11 ' O ' ' A' ' 71' ' ' LEU . 18.9 m -109.87 174.83 1.75 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.194 0 CA-C-N 119.688 1.131 . . . . 0.0 109.222 172.025 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.624 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.3 t -77.93 116.23 18.26 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -52.85 -16.34 0.99 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.997 1.719 . . . . 0.0 114.68 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.35 30.41 0.42 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.17 -171.46 19.33 Favored Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD2' HD22 ' A' ' 21' ' ' LEU . 37.7 Cg_endo -63.8 -27.07 67.71 Favored 'Trans proline' 0 C--O 1.208 -0.986 0 C-N-CA 123.468 2.778 . . . . 0.0 111.634 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.51 -66.71 0.42 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.796 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.7 pt-20 -75.43 -22.74 57.12 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.592 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -62.93 -41.03 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.03 -45.51 26.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.074 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.1 2.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 119.644 -1.265 . . . . 0.0 114.08 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.674 HD11 HG21 ' A' ' 57' ' ' VAL . 7.6 tp -74.8 126.51 31.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 122.767 -0.255 . . . . 0.0 110.638 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -120.3 160.82 22.24 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.134 0.896 . . . . 0.0 109.936 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.98 128.72 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.491 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.12 -9.47 54.51 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.341 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 74.1 m-20 -77.78 119.13 20.85 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 37.6 ttpt -88.9 124.12 33.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 109' ' ' VAL . 3.0 mp -88.29 135.96 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -174.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.1 mmt -107.77 -26.1 10.95 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.389 0.614 . . . . 0.0 109.839 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -151.63 133.73 15.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.741 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.619 HG22 HD22 ' A' ' 107' ' ' LEU . 49.9 t -136.98 117.57 17.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 C-N-CA 123.663 0.785 . . . . 0.0 110.037 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.2 t30 49.6 49.98 19.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.153 0.981 . . . . 0.0 111.625 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.93 8.06 60.39 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.442 ' CD2' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -115.26 158.87 21.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 117.681 0.74 . . . . 0.0 110.346 176.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 123.299 0.64 . . . . 0.0 110.509 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.508 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 20.2 ttm -117.47 -4.5 11.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.92 0.867 . . . . 0.0 110.737 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t -68.11 -25.46 65.32 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.779 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 ttt -135.95 85.51 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.91 0.386 . . . . 0.0 110.519 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 11.2 p -154.79 148.4 12.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.445 ' OG1' ' HB2' ' A' ' 92' ' ' GLN . 7.9 p -73.05 156.54 38.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.434 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 10.1 t60 -55.42 -47.33 76.11 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.556 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 33.8 t70 -58.93 -47.46 84.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.331 -176.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.445 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -72.1 -39.46 68.91 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.202 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.94 -41.7 99.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.303 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.486 ' CZ ' HG21 ' A' ' 98' ' ' THR . 18.2 mmm180 -58.16 -26.03 62.22 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.485 0.659 . . . . 0.0 112.119 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 45.1 mmtm -95.0 8.19 43.68 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 24.7 ttm180 -136.79 -30.96 0.87 Allowed 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.686 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.409 HD23 ' H ' ' A' ' 98' ' ' THR . 1.2 pt? -92.98 -40.6 10.47 Favored 'General case' 0 C--O 1.19 -2.062 0 C-N-CA 116.646 -2.021 . . . . 0.0 111.132 174.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.486 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 8.8 t -102.15 14.71 31.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 109.406 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.8 ptpt -66.49 -176.06 0.42 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.951 170.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -122.07 -3.74 9.06 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -67.24 -40.41 86.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 175.51 5.62 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.943 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -134.79 -62.26 0.74 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.53 112.46 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 29' ' ' LEU . 28.0 m -110.41 131.86 60.33 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.206 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -99.8 107.49 19.55 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.619 HD22 HG22 ' A' ' 80' ' ' VAL . 13.9 mt -108.65 151.42 26.17 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.5 mp -122.34 118.62 28.89 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.529 HG12 HG13 ' A' ' 77' ' ' ILE . 31.7 m -117.85 165.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.09 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.517 HG22 HG22 ' A' ' 13' ' ' VAL . 23.8 p . . . . . 0 N--CA 1.407 -2.584 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.307 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.427 -1.614 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 110' ' ' THR . 25.3 t -108.77 125.98 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.43 151.17 46.04 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.317 -176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 149.52 23.2 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.78 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -129.65 157.77 42.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.416 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 33.3 tt0 -144.92 107.84 4.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.334 0.587 . . . . 0.0 110.771 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -97.46 132.17 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -98.45 152.65 19.28 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 123.819 0.699 . . . . 0.0 110.232 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . 23.4 ttmm -40.93 113.17 0.36 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 125.508 1.523 . . . . 0.0 114.48 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.571 HD22 ' HD2' ' A' ' 65' ' ' PRO . 26.7 tp -127.94 137.43 52.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.065 0.546 . . . . 0.0 111.513 177.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -104.62 131.44 52.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -122.47 107.36 11.95 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.15 -113.56 5.24 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -108.79 16.91 22.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.752 0.787 . . . . 0.0 110.539 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -120.63 176.72 5.37 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 1.3 tm? -128.13 112.09 14.18 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mt -129.22 159.01 41.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 105' ' ' VAL . 61.0 mt -79.61 2.69 21.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.759 0.79 . . . . 0.0 109.844 175.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.28 4.57 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.917 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -98.76 167.33 10.84 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.7 m -121.49 164.15 17.66 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.441 1.096 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 55' ' ' ILE . 6.2 pt -124.34 163.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -173.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.21 -24.36 6.56 Favored Glycine 0 CA--C 1.484 -1.886 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.462 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 124.75 167.67 12.67 Favored Glycine 0 N--CA 1.407 -3.25 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.848 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.555 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -113.8 -121.79 3.73 Favored Glycine 0 N--CA 1.427 -1.904 0 O-C-N 124.507 0.769 . . . . 0.0 112.591 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -67.26 -19.51 25.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.593 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.453 ' HB2' HG22 ' A' ' 89' ' ' THR . 25.2 t70 -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.036 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.497 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.2 mm100 -96.01 -173.9 2.96 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 7.0 t70 -132.98 124.96 18.86 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.943 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 10.0 Cg_endo -57.63 -26.69 73.82 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.074 2.516 . . . . 0.0 113.132 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -68.87 -32.64 72.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.228 0.537 . . . . 0.0 110.373 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.9 pt20 -112.74 8.51 18.93 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.522 0.677 . . . . 0.0 110.729 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.13 142.19 24.14 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.85 -51.57 0.64 Allowed 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 123.378 2.719 . . . . 0.0 112.843 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -109.18 26.5 10.56 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.029 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 13.8 t . . . . . 0 C--N 1.301 -1.512 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.0 mtmm . . . . . 0 N--CA 1.427 -1.601 0 CA-C-O 121.843 0.83 . . . . 0.0 111.997 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 144.71 167.36 12.06 Favored Glycine 0 C--O 1.17 -3.877 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 33' ' ' ILE . 35.5 mm -73.9 115.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 120.26 2.03 . . . . 0.0 110.433 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 0.4 OUTLIER -114.9 151.73 33.5 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.059 178.867 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.799 HG21 HD11 ' A' ' 71' ' ' LEU . 87.6 t -82.77 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.31 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p -106.66 -15.04 14.87 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.625 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -152.23 145.32 24.56 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' A' ' 57' ' ' VAL . 39.5 t -133.79 148.72 30.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 13.3 p -52.95 128.54 27.52 Favored 'General case' 0 N--CA 1.406 -2.648 0 O-C-N 124.289 0.993 . . . . 0.0 109.635 176.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.92 -13.6 61.69 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 123.629 0.581 . . . . 0.0 111.553 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.46 41.53 0.31 Allowed Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -120.46 -169.49 13.96 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.194 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.571 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.2 Cg_endo -64.18 -32.28 63.2 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 123.614 2.876 . . . . 0.0 112.391 -171.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -59.08 -57.22 14.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.202 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 61' ' ' SER . 4.5 pt-20 -75.88 -24.45 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.48 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 64' ' ' GLY . 21.2 mm -63.61 -39.74 86.46 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 121.206 0.527 . . . . 0.0 109.903 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -75.7 -56.87 4.27 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.842 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.13 24.74 0.05 OUTLIER Glycine 0 C--O 1.224 -0.501 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.292 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.799 HD11 HG21 ' A' ' 57' ' ' VAL . 4.6 tp -91.96 124.65 36.23 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.447 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.7 mm100 -116.61 157.34 25.49 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.0 137.15 25.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.865 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.34 -0.25 59.93 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.941 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.13 123.24 24.88 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 120.773 0.321 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -89.0 110.81 21.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.492 HD11 ' CG2' ' A' ' 57' ' ' VAL . 12.3 mt -82.94 129.03 38.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.352 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . 0.429 ' HA ' ' HB ' ' A' ' 86' ' ' THR . 21.1 mmt -105.63 -26.26 11.92 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.478 0.656 . . . . 0.0 110.589 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 5.5 tp-100 -152.46 133.11 13.92 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.88 -169.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.608 HG22 HD12 ' A' ' 107' ' ' LEU . 55.0 t -136.53 111.86 11.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 C-N-CA 124.27 1.028 . . . . 0.0 111.431 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 31.4 t30 52.25 34.93 15.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.724 1.61 . . . . 0.0 112.92 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.65 -9.4 68.8 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.435 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.44 150.09 24.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.707 0.403 . . . . 0.0 110.207 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.91 132.76 41.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 123.839 0.855 . . . . 0.0 110.343 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.454 ' SD ' HG21 ' A' ' 80' ' ' VAL . 24.5 ttm -123.28 -0.48 8.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.211 1.005 . . . . 0.0 110.943 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 78' ' ' MET . 2.1 t -70.16 -25.06 63.27 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.259 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.9 ttt -141.41 86.29 2.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.245 0.545 . . . . 0.0 109.903 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.36 151.95 11.29 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 38' ' ' ASP . 17.8 p -75.0 157.11 35.46 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.176 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.469 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 10.9 t60 -53.84 -45.44 70.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.72 -51.22 69.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.435 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -30.3 63.6 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.072 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -76.66 -36.0 57.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.141 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.4 ' HG2' HD11 ' A' ' 33' ' ' ILE . 12.1 mmm180 -51.49 -45.65 62.9 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.931 0.77 . . . . 0.0 111.424 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.357 0.0 OUTLIER -93.06 59.71 3.16 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-O 122.904 1.335 . . . . 0.0 110.813 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tpt180 -154.38 -48.1 0.09 Allowed 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 112.151 -2.295 . . . . 0.0 106.698 171.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.4 pp -94.88 -25.46 16.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.443 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.7 t -114.23 14.06 18.04 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.476 174.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 17.5 ptpt -77.23 168.05 20.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.432 172.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 9.7 ptp85 -113.74 0.39 14.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.822 -175.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . 0.528 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 40.9 m -76.1 -34.02 59.5 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.804 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . 0.433 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 10.2 pt-20 -111.78 172.18 7.05 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.695 -178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.0 pm0 -132.85 -87.35 0.44 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 17.9 t -73.37 114.11 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-O 121.625 0.726 . . . . 0.0 109.816 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 29' ' ' LEU . 11.4 m -110.36 153.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.761 -177.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -120.94 100.28 6.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD12 HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -109.28 160.65 15.95 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.548 -171.465 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.7 mp -132.34 122.58 25.31 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.44 156.99 23.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.027 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.648 HG22 HG22 ' A' ' 13' ' ' VAL . 66.3 p . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 121.27 0.557 . . . . 0.0 110.696 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.856 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m -84.68 98.7 10.36 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.501 0.667 . . . . 0.0 110.355 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.465 ' CE1' ' HD2' ' A' ' 5' ' ' PRO . 10.3 t80 -84.27 127.24 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.61 HG23 ' HD3' ' A' ' 5' ' ' PRO 0.328 7.9 tp -92.26 -43.96 0.35 Allowed Pre-proline 0 CA--C 1.575 1.919 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.61 ' HD3' HG23 ' A' ' 4' ' ' ILE . 7.5 Cg_exo -65.46 -177.3 0.65 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 CA-C-N 121.442 1.551 . . . . 0.0 113.932 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' H ' HG11 ' A' ' 13' ' ' VAL . . . -119.98 39.0 2.59 Favored Glycine 0 C--N 1.288 -2.133 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.474 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -94.43 126.6 47.43 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 61.8 Cg_endo -82.8 -87.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.067 0 C-N-CA 122.419 2.079 . . . . 0.0 111.275 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 m -142.92 -51.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 122.526 0.331 . . . . 0.0 111.751 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -90.24 -44.86 9.45 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.657 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . -88.41 144.79 26.16 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.26 128.77 73.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.459 HG11 ' H ' ' A' ' 6' ' ' GLY . 13.4 p -91.06 129.16 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.28 151.54 51.33 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.741 -175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.95 152.18 18.57 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.742 0.306 . . . . 0.0 110.548 -172.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -129.58 154.61 40.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -141.12 102.12 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.306 0.574 . . . . 0.0 110.35 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.42 127.01 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -99.63 148.67 24.08 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HB2' HD11 ' A' ' 27' ' ' LEU . 22.5 pttm -39.18 123.36 1.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.577 HD22 ' HD2' ' A' ' 65' ' ' PRO . 49.4 tp -117.67 122.08 42.58 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.559 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -92.81 109.71 21.15 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HG3' HD12 ' A' ' 28' ' ' ILE . 16.1 mm100 -107.41 109.14 20.79 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.57 -110.77 3.69 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.72 17.74 12.71 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.194 0.521 . . . . 0.0 111.479 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.67 166.81 12.29 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 20' ' ' LYS . 58.4 tp -112.85 126.59 55.61 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 23' ' ' GLN . 0.9 OUTLIER -136.82 163.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.9 mp -88.4 2.3 52.94 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.051 0.929 . . . . 0.0 109.419 175.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . 94.9 -47.26 2.04 Favored Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 115.264 -0.88 . . . . 0.0 114.362 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 39.9 p90 -90.63 166.11 13.35 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.8 m -123.96 163.62 20.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.508 1.523 . . . . 0.0 109.497 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 55' ' ' ILE . 7.9 pt -125.17 166.15 21.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 122.75 0.42 . . . . 0.0 110.615 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.24 -22.42 6.83 Favored Glycine 0 CA--C 1.487 -1.675 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.311 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.543 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 123.58 163.54 11.78 Favored Glycine 0 C--O 1.196 -2.238 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.613 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.546 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -112.88 -117.3 3.45 Favored Glycine 0 N--CA 1.432 -1.588 0 O-C-N 124.583 0.814 . . . . 0.0 112.345 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.646 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.05 -17.58 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 122.101 0.953 . . . . 0.0 112.869 -174.828 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.61 ' HB2' HG22 ' A' ' 89' ' ' THR . 19.5 t70 -75.2 -9.19 58.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.421 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.513 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.0 mm100 -107.55 162.86 13.57 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.097 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 2.8 m-20 -105.21 108.63 61.82 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.484 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -58.44 -19.79 45.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 123.794 2.996 . . . . 0.0 113.402 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -75.34 -5.58 45.51 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.586 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -148.15 29.29 0.89 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.523 0.329 . . . . 0.0 111.155 176.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 7.4 m120 -107.22 145.5 31.32 Favored Pre-proline 0 CA--C 1.495 -1.14 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.36 -40.83 10.09 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 C-N-CA 123.204 2.603 . . . . 0.0 113.057 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.63 4.41 10.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.262 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 1.1 t -104.22 1.23 30.33 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.242 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.06 -20.4 65.82 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.365 1.078 . . . . 0.0 108.508 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 50' ' ' LYS . 3.0 t70 -69.53 -60.79 2.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.208 175.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.53 ' HG2' ' OD2' ' A' ' 49' ' ' ASP . 45.7 mmtm -122.5 130.32 52.92 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.521 0.677 . . . . 0.0 110.973 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 p -83.67 -0.19 49.65 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.079 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.45 -5.61 56.85 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 123.022 1.392 . . . . 0.0 110.154 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.646 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 53.1 mttp 49.93 -176.63 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 111.354 -2.657 . . . . 0.0 113.535 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.93 159.41 8.28 Favored Glycine 0 C--O 1.191 -2.555 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 33' ' ' ILE . 20.1 mm -77.88 128.11 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 117.657 0.728 . . . . 0.0 109.538 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 3.1 p90 -131.09 157.77 42.18 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.951 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 71' ' ' LEU . 94.5 t -80.57 134.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 O-C-N 124.748 1.28 . . . . 0.0 110.469 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 p -106.15 -23.03 12.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.618 0.723 . . . . 0.0 110.519 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -155.19 142.51 19.47 Favored 'General case' 0 CA--C 1.473 -1.992 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 16.3 m -107.73 -172.03 0.4 Allowed 'Isoleucine or valine' 1 N--CA 1.339 -6.02 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 22.5 p -64.51 131.32 46.77 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.59 -21.42 26.68 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 123.181 0.592 . . . . 0.0 112.146 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.99 52.72 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.6 -161.23 10.45 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-N 114.905 -0.648 . . . . 0.0 112.771 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.577 ' HD2' HD22 ' A' ' 21' ' ' LEU . 38.2 Cg_endo -63.27 -32.68 72.94 Favored 'Trans proline' 0 C--O 1.211 -0.872 0 C-N-CA 123.541 2.827 . . . . 0.0 112.543 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.403 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -59.06 -61.1 2.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -70.79 -30.67 67.2 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.329 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 mm -63.69 -42.69 96.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.783 0.325 . . . . 0.0 111.316 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.74 -55.2 5.7 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.169 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.98 29.4 0.05 OUTLIER Glycine 0 C--N 1.312 -0.78 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.056 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.802 ' HB2' HG11 ' A' ' 16' ' ' VAL . 6.5 tp -100.33 120.93 40.69 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.471 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 14.4 mm100 -116.33 153.31 32.21 Favored 'General case' 0 N--CA 1.425 -1.693 0 O-C-N 123.964 0.79 . . . . 0.0 110.959 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.43 131.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.68 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.96 -27.45 20.34 Favored Glycine 0 C--O 1.252 1.244 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.956 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 111' ' ' ARG . 53.2 m-20 -72.53 125.28 27.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.762 0.792 . . . . 0.0 111.02 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 63.2 mttp -82.87 128.82 34.78 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.139 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.555 HD11 HG23 ' A' ' 57' ' ' VAL . 2.8 mp -92.72 124.57 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.3 mmt -109.41 -11.44 14.83 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.533 0.683 . . . . 0.0 110.918 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.686 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -148.43 124.74 10.88 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.557 HG22 HD22 ' A' ' 107' ' ' LEU . 44.6 t -136.68 118.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 53.07 39.16 29.08 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.607 1.163 . . . . 0.0 112.997 170.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.466 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 65.08 27.42 72.28 Favored Glycine 0 N--CA 1.462 0.408 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.715 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -10.04 13.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 55.69 111.47 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.468 1.107 . . . . 0.0 113.717 -169.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.613 ' SD ' HG11 ' A' ' 88' ' ' VAL . 62.7 tpp -95.92 1.52 52.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.201 1.001 . . . . 0.0 109.353 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -71.33 135.55 47.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttp 55.48 74.61 0.36 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.327 1.051 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG11 ' SD ' ' A' ' 85' ' ' MET . 11.3 p -149.9 150.16 13.95 Favored 'Isoleucine or valine' 0 C--O 1.261 1.691 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.61 HG22 ' HB2' ' A' ' 38' ' ' ASP . 15.6 p -73.31 157.66 36.59 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.494 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 13.7 t60 -53.58 -42.93 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.336 175.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.75 -46.66 84.32 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.789 0.681 . . . . 0.0 110.825 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -32.89 67.42 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.816 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.657 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.88 -45.13 75.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.314 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.471 ' CZ ' HG21 ' A' ' 98' ' ' THR . 13.5 mmm180 -55.18 -40.76 71.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.661 0.743 . . . . 0.0 110.291 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -85.93 32.69 0.6 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.893 -176.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.1 tpt180 -148.88 -48.66 0.15 Allowed 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.014 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -92.32 -20.72 20.81 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.484 ' N ' HD12 ' A' ' 97' ' ' LEU . 14.6 t -118.21 10.12 12.79 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 117.666 -1.613 . . . . 0.0 110.837 175.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -66.28 154.96 38.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -103.67 6.24 36.88 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.0 t -79.28 -37.93 36.64 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -92.96 147.9 22.45 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 11.7 pt-20 -101.48 -63.9 1.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.794 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -117.85 133.26 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-O 122.002 0.905 . . . . 0.0 112.347 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.401 ' CG2' HD21 ' A' ' 107' ' ' LEU . 15.3 m -129.65 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.631 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -100.57 112.82 25.25 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.557 HD22 HG22 ' A' ' 80' ' ' VAL . 14.8 mt -112.86 162.9 15.27 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.686 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.1 mp -139.74 123.66 17.61 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 123.421 0.689 . . . . 0.0 109.273 174.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.502 HG12 HG13 ' A' ' 77' ' ' ILE . 34.7 m -115.71 151.49 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 CA-C-O 121.16 0.505 . . . . 0.0 110.101 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.6 p -102.71 122.63 44.84 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.59 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 68.7 mtp180 -69.08 114.23 7.16 Favored 'General case' 0 N--CA 1.42 -1.929 0 O-C-N 123.968 0.793 . . . . 0.0 110.143 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.458 ' C ' ' H ' ' A' ' 114' ' ' LEU . 27.9 mm-40 -108.79 3.99 23.15 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.8 p -77.24 34.84 0.16 Allowed 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 125.821 1.648 . . . . 0.0 110.518 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 112' ' ' GLN . 6.9 mp -88.43 -173.48 4.2 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 125.29 1.436 . . . . 0.0 112.245 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 117' ' ' ALA . 26.6 mm-40 -129.99 163.51 26.3 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 172.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp 74.91 -29.92 0.2 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 124.753 1.221 . . . . 0.0 110.632 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' A' ' 115' ' ' GLN . . . -101.43 166.55 10.67 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 172.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.5 t 70.8 89.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.132 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -54.27 140.79 31.93 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.512 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLN . . . . . 0.443 ' HB2' ' OXT' ' A' ' 124' ' ' SER . 4.3 pt20 -44.97 -38.12 4.49 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -171.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.3 m 56.32 26.9 11.12 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.471 0.708 . . . . 0.0 111.167 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 92.6 mmm 64.12 6.62 2.99 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.252 1.421 . . . . 0.0 112.98 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.0 -29.4 15.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.419 0.628 . . . . 0.0 109.636 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.443 ' OXT' ' HB2' ' A' ' 120' ' ' GLN . 60.1 m . . . . . 0 N--CA 1.42 -1.952 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.122 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m -87.15 156.95 19.48 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -144.99 123.0 12.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mm -121.62 103.65 40.59 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -83.09 -179.98 4.77 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.455 2.103 . . . . 0.0 112.208 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.4 40.26 2.97 Favored Glycine 0 C--N 1.306 -1.13 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.759 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.87 138.63 27.72 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.87 -90.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.032 1.821 . . . . 0.0 113.239 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -141.13 -42.04 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-O 121.088 0.47 . . . . 0.0 111.795 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -109.78 -37.0 5.77 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.85 149.55 26.49 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.16 124.89 44.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.024 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.33 146.3 14.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -153.78 155.15 35.31 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 122.195 -0.316 . . . . 0.0 110.451 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.64 142.65 27.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.463 HG21 ' HB2' ' A' ' 71' ' ' LEU . 8.1 p -134.68 154.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 42.2 tt0 -144.99 107.72 4.46 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.485 0.659 . . . . 0.0 111.26 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 29' ' ' LEU . 2.0 mp -97.26 126.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.15 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 4.7 m-70 -93.25 145.24 24.58 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.814 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.61 ' HB2' HD11 ' A' ' 27' ' ' LEU . 20.2 pttp -37.6 115.95 0.45 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.695 1.198 . . . . 0.0 113.805 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.02 123.85 44.45 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.303 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.51 126.94 35.79 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.193 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 63.0 mt-30 -120.67 106.32 11.61 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.39 -100.52 1.07 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -125.56 14.89 8.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.269 0.557 . . . . 0.0 110.348 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HA ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.5 169.46 11.39 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 20' ' ' LYS . 14.3 tp -116.45 119.17 34.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.15 163.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 18' ' ' ILE . 2.9 mm? -95.83 9.35 40.81 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-O 123.446 1.593 . . . . 0.0 108.659 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.98 -48.69 3.69 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.603 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.35 170.65 11.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.098 0.475 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 48.8 m -132.85 163.49 28.97 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 123.66 0.784 . . . . 0.0 110.485 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 55' ' ' ILE . 6.1 pt -121.18 166.96 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 122.777 0.431 . . . . 0.0 110.42 -174.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.33 -21.58 6.87 Favored Glycine 0 CA--C 1.486 -1.741 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.595 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.593 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 124.54 169.51 13.04 Favored Glycine 0 N--CA 1.416 -2.672 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.909 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.53 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.4 -117.95 2.7 Favored Glycine 0 C--O 1.209 -1.435 0 O-C-N 124.158 0.563 . . . . 0.0 112.24 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER -67.15 -19.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.051 0.453 . . . . 0.0 111.757 -176.152 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.568 ' HB2' HG22 ' A' ' 89' ' ' THR . 35.8 t70 -76.17 -8.8 57.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.226 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.548 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.2 mm100 -107.11 165.8 11.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.459 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.5 t70 -107.83 119.99 48.53 Favored Pre-proline 0 C--N 1.315 -0.905 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.244 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD3' ' HE3' ' A' ' 53' ' ' LYS . 6.7 Cg_endo -56.07 -29.0 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.335 2.69 . . . . 0.0 113.379 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -67.87 -26.45 66.03 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.5 pt20 -117.43 9.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.0 111.747 -176.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 5.9 m-80 -101.36 150.9 37.59 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 56.4 Cg_endo -69.14 -49.88 0.6 Allowed 'Trans proline' 0 C--O 1.217 -0.549 0 C-N-CA 123.207 2.605 . . . . 0.0 113.49 -175.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.44 7.64 24.98 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.735 0.779 . . . . 0.0 110.333 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 9.2 t -106.43 -11.11 16.04 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.716 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 9.4 pt-20 -69.15 -9.7 54.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.284 1.04 . . . . 0.0 110.048 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.76 -51.05 54.02 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 126.395 1.878 . . . . 0.0 111.468 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -152.25 -161.14 1.25 Allowed 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.3 p -102.14 6.25 40.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.281 172.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.31 128.62 36.19 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.928 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.465 ' HE3' ' HD3' ' A' ' 41' ' ' PRO . 30.5 mmtm -97.14 172.16 8.0 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.442 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.51 154.54 6.21 Favored Glycine 0 C--O 1.174 -3.649 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 33' ' ' ILE . 29.5 mm -73.49 120.15 21.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 118.112 0.956 . . . . 0.0 109.776 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.8 p90 -117.42 151.25 37.44 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.53 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.783 HG21 HD11 ' A' ' 71' ' ' LEU . 93.7 t -82.12 130.3 36.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 124.02 0.825 . . . . 0.0 109.853 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -103.13 -27.19 12.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.58 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 85.4 mtt180 -144.12 138.44 28.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.082 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 66' ' ' ALA . 4.9 t -116.28 144.71 23.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.8 t -45.52 113.69 0.63 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.927 1.392 . . . . 0.0 109.102 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.46 -17.69 14.59 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.513 1.525 . . . . 0.0 114.421 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.3 46.52 0.19 Allowed Glycine 0 CA--C 1.469 -2.806 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -131.65 -165.71 11.46 Favored Glycine 0 N--CA 1.413 -2.899 0 CA-C-N 114.172 -1.014 . . . . 0.0 112.721 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.454 ' CG ' HG23 ' A' ' 18' ' ' ILE . 41.9 Cg_endo -65.2 -29.6 55.47 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 123.706 2.937 . . . . 0.0 112.4 -170.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -60.73 -59.14 5.86 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.433 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.0 pt-20 -67.8 -32.62 73.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.649 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 64' ' ' GLY . 23.1 mm -58.55 -47.26 88.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.015 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -72.96 -40.89 64.97 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.494 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.1 20.62 0.82 Allowed Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.153 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.783 HD11 HG21 ' A' ' 57' ' ' VAL . 1.9 tp -79.58 125.81 30.08 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.439 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.9 mm100 -114.27 150.88 33.73 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.839 0.828 . . . . 0.0 109.733 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.4 mt -68.63 132.68 32.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.9 175.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.31 58.57 Favored Glycine 0 C--O 1.248 0.984 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.429 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 15.4 m-20 -84.74 126.22 33.22 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -86.88 117.35 25.55 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.517 HD11 HG23 ' A' ' 57' ' ' VAL . 10.7 mt -83.15 141.48 14.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.651 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.3 mmt -119.96 -20.6 7.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.438 0.637 . . . . 0.0 109.351 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.538 HE22 ' H ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -143.59 138.61 29.18 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.528 HG13 HD12 ' A' ' 107' ' ' LEU . 34.4 t -142.37 119.68 7.14 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 124.045 0.938 . . . . 0.0 108.752 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.3 t-20 43.86 57.22 4.21 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.736 1.614 . . . . 0.0 112.127 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' H ' HE22 ' A' ' 79' ' ' GLN . . . 47.44 30.15 5.88 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 117.07 1.588 . . . . 0.0 117.07 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.448 ' HE1' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -109.72 -12.47 14.62 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -175.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.95 93.55 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 127.258 2.223 . . . . 0.0 107.973 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.615 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 4.3 ttp -89.02 -12.51 41.17 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -170.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.1 t -53.93 127.84 27.84 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 120.93 0.395 . . . . 0.0 110.357 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.3 ttm 63.4 90.27 0.08 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.446 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' A' ' 85' ' ' MET . 14.8 p -158.49 155.64 4.41 Favored 'Isoleucine or valine' 0 C--O 1.263 1.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.568 HG22 ' HB2' ' A' ' 38' ' ' ASP . 9.4 p -75.09 159.72 31.34 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 120.98 0.419 . . . . 0.0 110.167 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.47 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 14.1 t60 -55.33 -46.9 76.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.634 174.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.8 -50.56 72.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.987 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.4 67.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.957 -176.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.69 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -73.81 -42.54 60.8 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.498 ' CZ ' HG21 ' A' ' 98' ' ' THR . 12.9 mmm180 -50.19 -44.17 52.85 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 123.92 0.888 . . . . 0.0 111.031 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -84.26 29.25 0.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.056 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.506 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 5.3 tpt180 -142.91 -42.61 0.31 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.84 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -95.27 -17.52 21.61 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.498 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 11.9 t -124.75 13.78 8.62 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.692 174.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.6 ptpt -70.17 178.29 2.87 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.315 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.447 ' NH1' ' HA ' ' A' ' 26' ' ' ASN . 13.9 ptm180 -131.65 6.08 4.36 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.556 -176.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.446 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 20.2 m -74.93 -41.77 59.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.37 0.605 . . . . 0.0 109.497 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.31 139.73 32.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.411 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.96 -63.81 1.24 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.0 t -98.8 122.38 50.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 120.81 0.338 . . . . 0.0 110.141 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.499 HG23 HD21 ' A' ' 107' ' ' LEU . 33.4 m -113.96 145.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -125.64 115.98 20.98 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -117.61 153.15 33.77 Favored 'General case' 0 N--CA 1.397 -3.123 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -172.216 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.3 mp -118.0 121.18 39.96 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -116.8 154.08 18.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.7 p -124.8 130.83 53.15 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.778 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.43 ' HB3' ' OD1' ' A' ' 75' ' ' ASP 0.314 0.0 OUTLIER -100.52 98.94 9.48 Favored 'General case' 0 N--CA 1.41 -2.439 0 C-N-CA 119.041 -1.063 . . . . 0.0 112.013 179.917 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 8.8 mm100 -84.54 -49.85 8.24 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.425 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.6 m -86.21 15.69 5.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.54 -172.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -109.45 87.99 2.63 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -96.87 -39.41 9.42 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.968 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 53.96 78.67 0.15 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 125.014 1.326 . . . . 0.0 113.057 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.37 -60.01 2.08 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.3 t 49.82 68.34 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 124.521 1.128 . . . . 0.0 111.299 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -103.92 -14.5 15.96 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.611 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -131.2 91.92 3.11 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.6 t -85.13 -36.96 20.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.076 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptp -172.73 169.39 4.95 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.241 0.543 . . . . 0.0 110.839 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.3 tp -114.56 163.41 15.43 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.421 -1.876 0 CA-C-O 119.169 -0.443 . . . . 0.0 110.047 177.597 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.287 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -77.73 -60.58 2.31 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -81.21 160.79 24.21 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.152 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.12 107.77 54.12 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' HB2' HG11 ' A' ' 13' ' ' VAL . 56.3 Cg_endo -76.03 176.77 9.6 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.446 2.097 . . . . 0.0 112.967 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 43.55 3.25 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -74.4 130.5 82.0 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' O ' HG13 ' A' ' 9' ' ' VAL . 18.8 Cg_endo -63.72 -68.74 0.04 OUTLIER 'Trans proline' 0 C--O 1.21 -0.891 0 C-N-CA 122.083 1.855 . . . . 0.0 111.281 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 169.24 -49.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 127.964 2.505 . . . . 0.0 108.887 178.085 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -79.96 -23.91 41.34 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.37 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.78 164.7 16.2 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.214 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -104.13 158.43 5.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 5' ' ' PRO . 12.5 p -112.28 147.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.59 152.08 43.72 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -94.43 149.26 21.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.887 0.375 . . . . 0.0 110.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 71' ' ' LEU . 9.8 p -136.66 159.16 37.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.49 106.47 4.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.43 0.633 . . . . 0.0 111.326 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -93.95 128.61 45.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.736 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 4.0 m-70 -96.65 151.98 19.09 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 11.0 ptpp? -43.34 128.38 4.8 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.556 HD22 ' HD2' ' A' ' 65' ' ' PRO . 51.2 tp -122.48 123.85 42.23 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.189 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -88.5 116.38 26.7 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -113.3 103.33 11.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.19 -102.47 0.94 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.86 6.19 10.43 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.268 0.556 . . . . 0.0 111.317 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.85 163.11 12.98 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -117.89 108.92 15.9 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.48 163.55 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' HG21 ' A' ' 18' ' ' ILE . 10.9 mp -92.62 9.96 32.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.95 0.881 . . . . 0.0 110.984 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.23 -41.69 3.07 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.68 -0.691 . . . . 0.0 114.341 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 71' ' ' LEU . 49.3 p90 -99.0 172.54 7.33 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.7 m -136.26 170.44 16.02 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.306 1.042 . . . . 0.0 109.364 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 55' ' ' ILE . 7.0 pt -127.93 167.22 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 117.868 0.304 . . . . 0.0 111.169 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.39 -27.68 4.64 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.18 165.25 12.29 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.344 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.548 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -117.85 -110.17 2.5 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.203 0.59 . . . . 0.0 113.13 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.607 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.76 -26.19 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -173.45 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' HB2' HG22 ' A' ' 89' ' ' THR . 15.2 t70 -66.32 -19.82 65.92 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.685 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 7.1 mm100 -96.38 -177.76 4.07 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 3.9 t70 -132.39 120.49 16.95 Favored Pre-proline 0 CA--C 1.498 -1.029 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.12 -23.25 35.17 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.197 2.598 . . . . 0.0 113.771 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -69.9 -28.87 65.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 3.3 pt20 -116.03 7.48 14.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.552 0.691 . . . . 0.0 110.725 -175.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 7.4 m120 -98.89 146.5 31.76 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 72.0 Cg_endo -72.32 -44.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.948 3.098 . . . . 0.0 114.458 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -109.1 12.09 25.31 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.674 0.75 . . . . 0.0 110.427 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.5 t -119.81 3.81 11.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.49 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 8.8 pt-20 -77.22 -28.31 53.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.616 0.722 . . . . 0.0 110.469 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.54 -46.25 33.19 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.179 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -132.5 135.12 45.8 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.8 p -80.29 6.3 12.36 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.297 0.57 . . . . 0.0 112.22 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.47 108.59 5.63 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.771 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.607 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 67.1 mttt -74.63 172.02 12.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.799 0.809 . . . . 0.0 113.144 -175.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.91 159.88 8.09 Favored Glycine 0 C--O 1.192 -2.528 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 33' ' ' ILE . 29.0 mm -74.56 120.19 23.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 117.868 0.834 . . . . 0.0 110.296 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -120.6 157.77 28.8 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.927 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.712 HG21 HD11 ' A' ' 71' ' ' LEU . 98.5 t -84.23 132.57 31.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 O-C-N 124.713 1.258 . . . . 0.0 110.71 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -108.26 -19.66 13.4 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.462 0.649 . . . . 0.0 111.362 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -142.09 142.17 32.79 Favored 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.465 HG13 ' CB ' ' A' ' 66' ' ' ALA . 25.5 t -140.4 132.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.568 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -49.82 126.97 15.14 Favored 'General case' 0 N--CA 1.413 -2.301 0 O-C-N 124.372 1.045 . . . . 0.0 112.521 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.69 -16.17 64.03 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.06 0.944 . . . . 0.0 111.802 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.96 46.7 0.39 Allowed Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.16 -174.87 14.06 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.701 -0.749 . . . . 0.0 111.499 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.556 ' HD2' HD22 ' A' ' 21' ' ' LEU . 35.0 Cg_endo -62.54 -29.1 78.01 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 C-N-CA 124.106 3.204 . . . . 0.0 111.965 -171.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.465 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -59.7 -61.96 2.23 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.752 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 61' ' ' SER . 2.4 pt-20 -70.09 -31.2 68.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.763 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.44 -41.39 84.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.33 -44.25 30.19 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.588 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.78 27.35 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.245 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.712 HD11 HG21 ' A' ' 57' ' ' VAL . 5.1 tp -89.45 123.69 33.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.463 ' N ' HD12 ' A' ' 71' ' ' LEU . 28.0 mm-40 -110.2 162.92 14.12 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 122.301 1.048 . . . . 0.0 110.62 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.63 134.61 29.48 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.88 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.21 18.72 71.11 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.051 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.511 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 3.6 m-20 -77.01 -2.08 32.09 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 43.07 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 57' ' ' VAL . 9.9 mt -84.51 124.93 40.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.519 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.833 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 18.2 mmt -112.18 -10.63 13.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.257 0.551 . . . . 0.0 110.527 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.644 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 5.7 tp-100 -156.47 127.33 6.83 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.731 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.554 HG13 HD12 ' A' ' 107' ' ' LEU . 22.3 t -132.79 121.59 44.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.213 0 C-N-CA 124.175 0.99 . . . . 0.0 109.212 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.85 30.83 12.06 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.44 6.11 86.32 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 115.835 -0.62 . . . . 0.0 114.49 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.509 ' CZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -99.1 -2.47 36.93 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.16 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 68.69 127.04 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 124.386 1.074 . . . . 0.0 111.222 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.442 ' HE3' ' HB1' ' A' ' 93' ' ' ALA . 8.1 tpt -123.58 -4.38 8.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 110.348 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.833 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 5.0 t -68.36 -16.19 63.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.778 -177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.66 98.39 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.509 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 9.2 p -163.93 146.58 2.73 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.504 HG22 ' HB2' ' A' ' 38' ' ' ASP . 3.1 p -73.19 155.46 39.58 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.463 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.48 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 11.1 t60 -53.5 -45.4 69.66 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.975 0.797 . . . . 0.0 109.393 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.87 -42.47 97.51 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.386 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.87 -32.31 61.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.618 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.543 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.12 -43.56 74.17 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.102 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.44 ' HG2' HD11 ' A' ' 33' ' ' ILE . 9.6 mmm180 -55.75 -40.31 72.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.009 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.14 29.53 0.41 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.146 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.6 tpt180 -142.11 -43.45 0.34 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.989 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -101.31 -20.46 15.2 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.452 ' N ' HD12 ' A' ' 97' ' ' LEU . 10.3 t -115.55 11.74 15.96 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.014 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -63.04 143.65 57.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -103.27 6.83 38.32 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.835 0.826 . . . . 0.0 110.453 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.795 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.94 165.71 12.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 8.8 pt-20 -118.53 -63.57 1.39 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.517 HG12 ' HG3' ' A' ' 103' ' ' GLU . 2.7 p -121.49 131.06 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-O 121.687 0.756 . . . . 0.0 112.679 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.427 HG23 HD21 ' A' ' 107' ' ' LEU . 14.9 m -134.49 171.87 17.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.645 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.445 ' C ' HD13 ' A' ' 107' ' ' LEU . 8.8 mmt180 -123.33 114.43 20.18 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.554 HD12 HG13 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -116.97 148.24 41.59 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -176.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.2 mp -116.02 121.91 43.65 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-O 121.349 0.595 . . . . 0.0 109.5 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 27.6 m -117.49 150.2 19.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.293 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 33.6 p -107.84 124.66 50.42 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 121.625 0.726 . . . . 0.0 110.342 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -74.29 84.62 1.91 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.151 0.977 . . . . 0.0 113.407 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -81.84 -36.42 28.31 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.286 31.3 p 58.54 69.48 0.73 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.344 -1.753 . . . . 0.0 112.859 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.28 -38.71 71.81 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.441 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -106.82 127.26 53.25 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.45 83.64 4.58 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.207 1.003 . . . . 0.0 110.625 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.22 147.91 23.27 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.475 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.0 t -103.54 45.47 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 123.302 1.525 . . . . 0.0 108.29 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -87.87 -31.97 19.23 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.604 -1.634 . . . . 0.0 106.83 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -107.24 134.78 49.83 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.27 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 t -73.52 117.07 14.85 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.1 mtt -66.86 -19.85 65.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.61 -173.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.33 -71.17 0.62 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--N 1.314 -0.964 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.098 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.587 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -79.88 -62.45 1.68 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -164.84 126.82 2.17 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.6 109.45 50.74 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.56 157.37 52.75 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.464 2.109 . . . . 0.0 112.436 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.73 43.09 2.1 Favored Glycine 0 C--N 1.302 -1.308 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.235 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' HA ' HG23 ' A' ' 13' ' ' VAL . 51.6 tt0 -77.0 121.37 84.63 Favored Pre-proline 0 N--CA 1.431 -1.377 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.66 -98.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.332 2.022 . . . . 0.0 110.503 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 m -149.18 -43.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 C-N-CA 123.058 0.543 . . . . 0.0 111.35 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 t -81.91 -23.51 36.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.044 0.449 . . . . 0.0 111.319 -175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.26 143.62 46.43 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.8 t -104.7 106.46 20.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 123.411 0.444 . . . . 0.0 110.661 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 110' ' ' THR . 41.6 t -91.5 120.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.01 156.73 47.53 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.458 0.474 . . . . 0.0 110.046 -174.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -103.32 144.71 30.99 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.405 HG21 ' HB2' ' A' ' 71' ' ' LEU . 10.0 p -126.78 156.15 37.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.95 104.07 5.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.667 0.746 . . . . 0.0 111.271 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.504 HD13 HD23 ' A' ' 107' ' ' LEU . 1.5 mp -92.31 129.02 43.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.053 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -93.15 159.97 15.05 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.741 0.651 . . . . 0.0 109.359 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HB2' HD21 ' A' ' 27' ' ' LEU . 17.3 pttp -50.72 124.79 11.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.513 HD22 ' HD2' ' A' ' 65' ' ' PRO . 48.1 tp -128.67 131.72 48.03 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.382 0.673 . . . . 0.0 110.27 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -131.2 106.02 8.05 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.95 -109.17 2.71 Favored Glycine 0 N--CA 1.428 -1.868 0 O-C-N 124.051 0.844 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -116.54 17.74 15.27 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.99 172.59 11.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.1 tm? -120.0 115.34 23.56 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.3 mt -129.49 163.77 33.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -175.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 105' ' ' VAL . 7.5 mp -82.28 2.76 30.48 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.991 0.901 . . . . 0.0 109.892 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 89.56 -44.89 3.06 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.816 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 57' ' ' VAL . 45.6 p90 -89.17 164.69 14.89 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 85.0 p -114.74 -173.2 2.26 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.048 0.939 . . . . 0.0 109.616 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 55' ' ' ILE . 7.3 pt -138.16 164.78 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.275 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.14 -33.79 2.68 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 121.32 151.62 8.59 Favored Glycine 0 C--O 1.2 -2.022 0 C-N-CA 118.581 -1.771 . . . . 0.0 113.798 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA2' ' H ' ' A' ' 54' ' ' GLY . . . -105.66 -115.64 4.09 Favored Glycine 0 C--O 1.205 -1.682 0 C-N-CA 121.071 -0.585 . . . . 0.0 114.16 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.524 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.09 -9.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.039 0.923 . . . . 0.0 112.203 -175.097 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.612 ' HB2' HG22 ' A' ' 89' ' ' THR . 24.0 t70 -81.67 -13.36 57.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.579 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.502 ' OE1' ' HB2' ' A' ' 90' ' ' HIS . 5.6 mm100 -113.8 -178.12 3.3 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 13.3 t70 -122.16 124.63 26.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.6 Cg_endo -56.44 -28.48 73.44 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.537 -176.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -76.32 -19.86 57.84 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.51 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.3 pt20 -120.89 12.64 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.844 0.83 . . . . 0.0 110.104 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.484 HD21 ' HB3' ' A' ' 39' ' ' GLN . 0.8 OUTLIER -103.0 144.03 27.79 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.048 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.54 -49.41 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.936 2.424 . . . . 0.0 113.526 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 63.8 m-85 -111.89 16.32 20.42 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.411 1.101 . . . . 0.0 109.982 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 8.0 t -111.21 -12.41 14.12 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.74 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.6 -9.38 58.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.727 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -53.38 -42.9 67.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.478 0.656 . . . . 0.0 109.806 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -137.24 -120.93 0.14 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 t -145.66 24.99 1.35 Allowed 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -81.3 100.53 9.24 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 113.006 -1.906 . . . . 0.0 108.815 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.524 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 47.2 mttp -83.06 173.07 12.07 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.065 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.479 ' H ' ' HA2' ' A' ' 36' ' ' GLY . . . 141.94 166.51 10.92 Favored Glycine 0 CA--C 1.475 -2.417 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 33' ' ' ILE . 32.7 mm -81.08 132.53 31.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 18.3 p90 -141.76 161.3 38.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.683 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.485 HG11 HG12 ' A' ' 60' ' ' VAL . 59.6 t -84.92 130.6 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.355 0 O-C-N 124.717 1.26 . . . . 0.0 110.447 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.7 p -102.24 -23.08 14.05 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.878 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 27.1 mmt180 -149.28 129.6 13.77 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 123.97 0.908 . . . . 0.0 109.202 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.485 HG12 HG11 ' A' ' 57' ' ' VAL . 30.0 m -104.37 177.29 0.89 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.033 0 CA-C-N 119.217 0.917 . . . . 0.0 109.3 174.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.539 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.2 t -79.7 116.21 19.75 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.73 -2.21 2.36 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.382 1.473 . . . . 0.0 114.336 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.5 33.76 0.16 Allowed Glycine 0 C--N 1.273 -2.921 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -121.51 -168.49 13.44 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.43 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.513 ' HD2' HD22 ' A' ' 21' ' ' LEU . 42.0 Cg_endo -64.96 -28.8 57.83 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 123.323 2.682 . . . . 0.0 111.661 -170.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.67 -64.27 0.99 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.124 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.3 pt-20 -71.48 -29.95 65.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.54 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.7 mm -56.2 -47.31 81.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 O-C-N 123.287 0.367 . . . . 0.0 110.73 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.44 -47.55 32.94 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.28 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.31 14.94 0.44 Allowed Glycine 0 C--N 1.312 -0.772 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.63 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.425 HD11 HG21 ' A' ' 57' ' ' VAL . 2.1 tp -79.63 118.52 21.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -119.35 140.09 50.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.59 139.97 10.8 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 O-C-N 124.64 1.213 . . . . 0.0 110.303 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.48 34.67 19.14 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 119.601 -1.285 . . . . 0.0 111.436 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.566 ' OD2' HG13 ' A' ' 77' ' ' ILE . 10.0 p-10 -94.47 -161.4 0.85 Allowed 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 113.54 -1.33 . . . . 0.0 107.875 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 73.8 mmtt -150.36 96.42 2.4 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.566 HG13 ' OD2' ' A' ' 75' ' ' ASP . 22.8 mt -73.12 113.31 10.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.282 1.039 . . . . 0.0 110.459 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 15.8 mmt -105.06 -10.21 17.33 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.182 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -163.14 134.13 4.76 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 121.861 -0.525 . . . . 0.0 110.023 -178.654 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.556 HG13 HD12 ' A' ' 107' ' ' LEU . 22.8 t -134.31 115.4 20.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.3 t30 48.07 55.79 8.21 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 124.509 1.124 . . . . 0.0 112.395 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 62.0 2.35 3.72 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-N 113.662 -1.608 . . . . 0.0 116.582 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -87.33 -14.17 41.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t0 65.15 120.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.06 1.744 . . . . 0.0 111.602 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.479 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 41.7 ttm -119.36 8.54 11.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.209 1.004 . . . . 0.0 110.926 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.437 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 10.5 t -46.12 -28.43 1.21 Allowed 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 125.793 1.637 . . . . 0.0 114.743 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 ttp -159.86 92.39 1.02 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.1 p -148.5 151.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.612 HG22 ' HB2' ' A' ' 38' ' ' ASP . 18.4 p -70.28 157.06 38.39 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.308 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.502 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 10.4 t60 -57.59 -43.56 84.72 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -58.9 -47.3 85.49 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.954 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -36.8 64.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.631 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' HG13 ' A' ' 55' ' ' ILE . . . -65.14 -40.67 94.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.711 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.424 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 7.9 mmm180 -53.45 -39.77 64.7 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.597 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -81.19 13.93 2.61 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.383 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 22.9 tpt180 -131.37 -35.8 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.865 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -98.86 -27.78 13.76 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.619 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.402 ' N ' HD13 ' A' ' 97' ' ' LEU . 9.0 t -113.53 13.05 18.73 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.048 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HD2' ' HG2' ' A' ' 102' ' ' GLU . 14.4 ptpt -67.64 157.36 34.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 165.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 13.6 ptt180 -112.91 8.92 18.77 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.418 -173.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -81.18 -31.28 34.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.623 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 18.6 mm-40 -87.15 146.12 26.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -94.18 -75.41 0.51 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.566 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.491 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 2.0 p -109.73 133.86 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-O 121.141 0.496 . . . . 0.0 110.012 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 29' ' ' LEU . 16.7 m -132.3 162.99 38.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.511 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.438 ' C ' HD13 ' A' ' 107' ' ' LEU . 97.7 mtt180 -123.91 117.57 25.12 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.556 HD12 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -119.61 152.34 37.21 Favored 'General case' 0 N--CA 1.397 -3.122 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -175.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.9 mp -116.92 131.07 57.05 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 75' ' ' ASP . 20.8 m -131.91 153.96 39.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 123.976 0.797 . . . . 0.0 109.889 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.609 HG22 HG22 ' A' ' 13' ' ' VAL . 36.9 p -110.1 145.34 37.31 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 173.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -97.85 110.06 22.7 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -105.48 15.03 27.77 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.1 p -77.28 13.08 1.25 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.007 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.1 tp 68.5 141.22 0.04 OUTLIER 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.564 1.546 . . . . 0.0 112.616 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -81.14 132.7 35.37 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -83.71 145.51 28.71 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -167.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 66.82 -75.7 0.06 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.159 1.784 . . . . 0.0 112.919 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.3 t 54.91 71.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 122.479 1.133 . . . . 0.0 110.812 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -117.19 5.45 12.71 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.845 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -77.53 3.13 14.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.441 -1.709 . . . . 0.0 110.115 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -72.74 -19.19 61.43 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.313 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.0 mmm -92.71 92.46 7.98 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.709 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.1 mt -113.53 -23.47 9.78 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.955 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.434 -1.248 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.237 178.327 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.626 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 m 74.47 -31.53 0.22 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -79.04 -56.51 4.32 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 63.8 mt 61.31 92.8 0.06 OUTLIER Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 124.307 1.043 . . . . 0.0 111.007 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.16 153.64 36.54 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 121.901 1.734 . . . . 0.0 112.156 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.88 42.7 1.98 Allowed Glycine 0 C--N 1.292 -1.866 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -93.58 138.95 22.71 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 123.538 0.735 . . . . 0.0 110.478 -173.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -84.03 -107.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.837 0 C-N-CA 122.03 1.82 . . . . 0.0 108.93 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.92 -48.94 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 t -76.79 -20.62 56.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 110.998 -174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HB2' HE21 ' A' ' 115' ' ' GLN . . . -126.92 145.18 50.77 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.091 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t -95.11 138.02 21.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.847 175.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 7.6 p -114.05 142.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.84 153.85 42.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -99.27 138.47 36.32 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.455 HG12 ' HB2' ' A' ' 107' ' ' LEU . 7.4 p -122.6 157.13 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.6 106.27 5.36 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.478 0.656 . . . . 0.0 110.959 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -93.59 127.44 45.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.914 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.454 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 5.1 m-70 -95.92 160.09 14.64 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 124.159 0.912 . . . . 0.0 109.311 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 17.6 ptpt -43.13 110.15 0.18 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 33.2 tp -107.96 115.4 30.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.73 103.0 12.55 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.61 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -104.24 108.57 20.01 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.35 -106.34 1.31 Allowed Glycine 0 C--N 1.311 -0.825 0 O-C-N 123.635 0.584 . . . . 0.0 112.846 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.09 6.63 20.98 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.771 0.319 . . . . 0.0 111.47 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.69 170.82 8.3 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.544 0.688 . . . . 0.0 109.294 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.44 121.73 35.69 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.515 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -129.5 155.81 41.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 40.6 mt -86.25 5.0 36.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.777 0.798 . . . . 0.0 109.331 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . 90.36 -46.97 3.04 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 114.388 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 57' ' ' VAL . 46.1 p90 -86.93 161.6 18.16 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 43.6 m -115.62 165.9 12.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.116 1.366 . . . . 0.0 108.705 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.684 HG21 HD21 ' A' ' 97' ' ' LEU . 8.9 pt -126.18 165.35 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.678 0.217 . . . . 0.0 110.491 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.11 -32.61 3.45 Favored Glycine 0 CA--C 1.484 -1.893 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.44 154.02 8.87 Favored Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.325 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.58 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -100.32 -122.83 4.97 Favored Glycine 0 N--CA 1.418 -2.506 0 O-C-N 124.298 0.646 . . . . 0.0 113.478 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -22.93 31.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 89' ' ' THR . 16.8 t70 -66.99 -19.4 65.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.818 0.818 . . . . 0.0 110.424 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.581 ' HB3' HD21 ' A' ' 44' ' ' ASN . 5.1 mm100 -96.26 -169.55 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.068 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 8.9 t70 -136.17 125.5 15.85 Favored Pre-proline 0 CA--C 1.493 -1.216 0 CA-C-O 118.855 -0.593 . . . . 0.0 109.809 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 20.9 Cg_endo -58.9 -24.5 72.92 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.739 2.293 . . . . 0.0 113.683 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.1 t -73.25 -32.46 64.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.216 0.531 . . . . 0.0 109.829 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.426 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 8.3 pm0 -111.93 16.33 20.38 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.01 0.434 . . . . 0.0 111.246 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.581 HD21 ' HB3' ' A' ' 39' ' ' GLN . 3.6 m120 -102.4 140.12 20.84 Favored Pre-proline 0 CA--C 1.485 -1.538 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.412 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.03 -46.15 2.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.434 2.09 . . . . 0.0 113.38 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -120.61 31.52 6.41 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.595 ' HA ' ' NZ ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -128.92 6.94 5.53 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.011 177.007 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -87.56 2.45 50.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.539 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.73 -46.42 74.25 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.328 1.451 . . . . 0.0 108.858 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HB2' ' H ' ' A' ' 52' ' ' ASP . 34.1 mmtp -144.22 -159.34 0.98 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -176.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.1 p -93.2 7.42 44.37 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 50' ' ' LYS . 30.2 t70 -82.67 112.7 19.78 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.72 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 55.8 mtmt -95.63 173.45 7.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.544 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.406 ' C ' ' HA2' ' A' ' 36' ' ' GLY . . . 153.65 156.54 7.67 Favored Glycine 0 C--O 1.183 -3.067 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -176.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.612 HD12 HD12 ' A' ' 33' ' ' ILE . 31.4 mm -71.91 129.06 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.215 1.008 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.43 160.59 38.29 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.57 HG21 HD11 ' A' ' 71' ' ' LEU . 87.1 t -86.01 132.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 O-C-N 125.205 1.566 . . . . 0.0 109.872 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 p -104.54 -27.14 12.06 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.798 0.808 . . . . 0.0 111.026 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -144.42 133.28 22.52 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG12 HG11 ' A' ' 57' ' ' VAL . 33.8 m -97.72 -175.5 0.37 Allowed 'Isoleucine or valine' 1 N--CA 1.347 -5.602 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.443 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.465 ' OG ' ' HA3' ' A' ' 30' ' ' GLY . 0.9 OUTLIER -68.09 126.37 29.29 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.34 -25.14 1.45 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.838 1.255 . . . . 0.0 112.981 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.71 57.96 0.1 Allowed Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -139.83 -168.69 11.4 Favored Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.594 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.412 ' HB2' HG23 ' A' ' 18' ' ' ILE . 28.7 Cg_endo -59.95 -34.49 95.12 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 124.35 3.367 . . . . 0.0 113.095 -170.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 61' ' ' SER . . . -57.53 -57.76 11.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -75.48 -21.51 58.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.933 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 64' ' ' GLY . 28.1 mm -67.56 -42.07 86.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.467 0.651 . . . . 0.0 109.651 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.46 -42.82 21.95 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.297 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.29 20.75 0.89 Allowed Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.398 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.57 HD11 HG21 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -75.94 117.21 17.42 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.092 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.573 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 13.0 mm100 -111.9 135.7 52.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.242 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.1 mt -53.69 143.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 124.199 1.0 . . . . 0.0 111.246 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.64 36.66 58.3 Favored Glycine 0 N--CA 1.48 1.576 0 CA-C-O 122.725 1.181 . . . . 0.0 111.485 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.668 ' HB2' ' HB ' ' A' ' 109' ' ' VAL . 22.2 p-10 -84.92 -52.44 6.0 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 126.183 1.793 . . . . 0.0 114.492 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.595 ' NZ ' ' HA ' ' A' ' 47' ' ' SER . 55.7 mttm 70.46 100.77 0.06 Allowed 'General case' 0 C--O 1.249 1.043 0 C-N-CA 124.624 1.17 . . . . 0.0 108.01 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 57' ' ' VAL . 11.0 mt -83.87 130.47 35.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.006 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.4 mmt -109.97 -22.83 11.64 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.376 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.1 OUTLIER -143.25 134.19 25.5 Favored 'General case' 0 C--O 1.199 -1.58 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -175.702 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.594 HG22 HD22 ' A' ' 107' ' ' LEU . 40.2 t -140.19 115.11 7.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 48.14 50.15 16.54 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 125.668 1.587 . . . . 0.0 112.806 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 66.31 -11.84 0.5 Allowed Glycine 0 CA--C 1.565 3.17 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -21.67 58.27 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.235 1.018 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t0 72.92 113.93 0.06 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 125.301 1.44 . . . . 0.0 109.137 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 tpt -94.2 -8.45 39.28 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.997 -167.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -49.89 125.56 12.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.763 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.9 ttt 53.89 80.87 0.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.91 1.284 . . . . 0.0 113.373 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.404 HG13 HG13 ' A' ' 55' ' ' ILE . 8.4 p -145.15 147.9 18.33 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 38' ' ' ASP . 5.7 p -69.33 156.83 38.14 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.987 0.515 . . . . 0.0 110.992 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.508 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 9.5 t60 -56.48 -41.44 76.59 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.58 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 23.2 t70 -60.16 -53.73 54.3 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 124.045 0.84 . . . . 0.0 111.183 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -31.02 70.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.156 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.687 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.64 -48.23 67.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.462 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.519 ' CZ ' HG21 ' A' ' 98' ' ' THR . 20.3 mmm180 -56.62 -44.13 80.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.801 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 30.0 mmtp -80.83 28.4 0.35 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.385 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -144.61 -45.85 0.24 Allowed 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.4 pp -92.43 -35.2 13.8 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.1 t -103.08 9.2 38.59 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.334 -1.346 . . . . 0.0 109.235 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -62.91 148.86 46.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -96.0 15.09 21.55 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.832 0.825 . . . . 0.0 110.974 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.493 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 67.7 m -93.66 -25.96 17.26 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.947 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -77.12 -178.62 5.12 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.774 0.797 . . . . 0.0 113.086 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 10.1 pt-20 -146.64 -73.27 0.22 Allowed 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.019 169.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.6 p -119.51 134.37 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' CG2' HD21 ' A' ' 107' ' ' LEU . 16.8 m -140.01 149.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.088 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.559 HH21 ' NE2' ' A' ' 79' ' ' GLN . 57.7 ttp180 -104.39 127.29 52.04 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 HG22 ' A' ' 80' ' ' VAL . 3.3 mt -122.46 147.51 46.25 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.9 mp -113.54 124.13 51.64 Favored 'General case' 0 CA--C 1.452 -2.801 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.042 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.668 ' HB ' ' HB2' ' A' ' 75' ' ' ASP . 35.8 m -124.79 153.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.543 -177.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 39.0 p -106.44 168.7 8.98 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -114.03 102.41 10.15 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.423 ' HG3' ' HE2' ' A' ' 76' ' ' LYS . 22.5 mm-40 -84.06 -55.69 4.07 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.771 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 t 51.2 35.11 12.61 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 124.633 1.208 . . . . 0.0 109.788 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.1 mp 61.26 90.64 0.07 Allowed 'General case' 0 C--N 1.354 0.763 0 CA-C-O 122.031 0.92 . . . . 0.0 109.95 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.454 HE21 ' HB2' ' A' ' 11' ' ' ALA . 99.2 mt-30 -63.89 -22.11 66.77 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.4 mptt 71.03 178.0 0.26 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.802 0.689 . . . . 0.0 109.635 -168.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.48 141.97 50.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.047 0.451 . . . . 0.0 109.818 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.68 47.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 123.701 1.715 . . . . 0.0 108.636 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -107.51 140.81 39.92 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.933 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 56.24 33.52 22.33 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.819 1.248 . . . . 0.0 111.932 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.5 p 52.47 83.63 0.06 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.527 1.531 . . . . 0.0 112.915 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.7 mmm -88.95 92.66 9.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.583 0.706 . . . . 0.0 112.28 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.76 -72.34 0.66 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.421 -1.888 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.169 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.733 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 p -127.26 164.44 21.71 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -89.75 163.46 15.07 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 tp -118.82 107.92 41.68 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -69.38 171.59 13.78 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.21 1.94 . . . . 0.0 111.543 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.77 42.1 3.05 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 49.2 tt0 -74.72 122.38 87.37 Favored Pre-proline 0 N--CA 1.436 -1.129 0 C-N-CA 123.254 0.621 . . . . 0.0 110.594 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 74.3 Cg_endo -78.2 -92.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.341 2.027 . . . . 0.0 110.364 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.9 m -138.72 -55.55 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t -81.65 -25.4 35.63 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.981 0.896 . . . . 0.0 110.567 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.642 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -101.15 125.68 47.79 Favored 'General case' 0 CA--C 1.466 -2.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.64 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 110' ' ' THR . 59.4 t -98.59 105.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 12.3 p -99.65 133.65 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.5 154.08 40.31 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.872 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.69 148.29 22.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.94 0.4 . . . . 0.0 109.961 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.641 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -129.14 157.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 38.1 tt0 -150.31 106.38 3.45 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.579 0.704 . . . . 0.0 109.809 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -94.69 130.14 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.3 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -101.57 141.16 34.85 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.916 0.76 . . . . 0.0 109.111 176.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HE2' ' HB2' ' A' ' 103' ' ' GLU . 18.0 ptpt -29.59 112.24 0.07 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.98 1.712 . . . . 0.0 115.401 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 38.0 tp -113.67 121.02 42.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.1 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -97.91 112.47 24.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -114.34 106.22 14.07 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.14 -108.69 2.28 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 123.732 0.645 . . . . 0.0 112.425 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.74 16.67 18.48 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.42 168.98 13.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.82 118.5 28.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -126.89 158.13 37.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.085 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.454 ' CD2' HG21 ' A' ' 105' ' ' VAL . 9.2 mp -86.43 -1.53 57.65 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.763 0.792 . . . . 0.0 109.744 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.98 3.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.38 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -96.5 171.61 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.582 0.691 . . . . 0.0 112.19 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 m -138.71 169.17 18.28 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.863 1.265 . . . . 0.0 110.404 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 55' ' ' ILE . 7.1 pt -126.82 169.45 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.129 -0.357 . . . . 0.0 110.762 -170.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.92 -24.76 5.65 Favored Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 120.4 163.2 12.05 Favored Glycine 0 C--O 1.195 -2.331 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.632 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.52 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -114.97 -115.03 3.02 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.888 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.81 -24.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.251 0.548 . . . . 0.0 111.996 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.537 ' HB2' HG22 ' A' ' 89' ' ' THR . 32.8 t70 -72.54 -17.75 61.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.89 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.563 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.2 mm100 -104.18 166.75 10.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -106.43 121.23 45.97 Favored Pre-proline 0 CA--C 1.492 -1.256 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.257 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HD3' ' HE3' ' A' ' 53' ' ' LYS . 10.1 Cg_endo -57.2 -30.02 85.73 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.88 2.387 . . . . 0.0 113.298 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.9 m -65.75 -27.24 68.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.999 0.428 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -116.42 11.91 15.06 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.391 0.615 . . . . 0.0 110.465 -175.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -103.97 146.04 31.78 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.44 -44.13 6.96 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 123.68 2.92 . . . . 0.0 113.753 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.46 14.45 21.45 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.215 0.531 . . . . 0.0 110.115 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.4 t -122.24 -3.57 8.97 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.502 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.48 -2.72 14.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -71.17 -51.6 23.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.007 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -152.13 -168.08 2.96 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 123.919 0.888 . . . . 0.0 109.518 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 p -87.28 23.11 1.93 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.6 0.714 . . . . 0.0 110.613 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.98 105.74 8.24 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.031 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.43 ' HE3' ' HD3' ' A' ' 41' ' ' PRO . 29.2 mmtm -91.4 166.04 13.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.283 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.468 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 145.01 159.63 8.17 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 33' ' ' ILE . 36.1 mm -77.92 122.16 32.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-N 118.126 0.963 . . . . 0.0 109.502 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.4 p90 -122.31 151.9 40.66 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.363 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.491 HG13 ' HA ' ' A' ' 73' ' ' ILE . 8.7 p -80.82 132.35 31.83 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 O-C-N 124.769 1.293 . . . . 0.0 110.69 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 p -106.75 -27.25 10.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.435 0.636 . . . . 0.0 110.686 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -138.13 131.46 30.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.05 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 71' ' ' LEU . 64.8 t -118.9 140.6 42.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 174.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.71 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.5 t -63.66 116.91 6.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 pt-20 -77.27 2.99 14.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.837 0.827 . . . . 0.0 112.024 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.63 29.94 0.94 Allowed Glycine 0 C--N 1.267 -3.265 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.426 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -128.14 -177.88 15.08 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.075 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.55 -29.01 70.3 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 124.366 3.377 . . . . 0.0 112.791 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -57.77 -59.19 5.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.477 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.71 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.6 pt-20 -74.06 -31.88 63.05 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.387 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 64' ' ' GLY . 26.3 mm -55.11 -41.37 59.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 O-C-N 123.737 0.648 . . . . 0.0 110.471 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -76.05 -55.92 5.15 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.319 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.54 28.69 0.04 OUTLIER Glycine 0 C--N 1.317 -0.501 0 C-N-CA 119.768 -1.206 . . . . 0.0 113.239 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' HB2' HG11 ' A' ' 16' ' ' VAL . 2.5 tp -94.55 117.56 30.32 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -115.39 143.81 44.73 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HA ' HG13 ' A' ' 57' ' ' VAL . 65.6 mt -54.89 129.67 16.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.004 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.02 -3.95 45.03 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.706 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 84.0 m-20 -80.94 130.23 34.92 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.909 0.355 . . . . 0.0 110.571 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.46 116.11 22.92 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.523 HG13 HG12 ' A' ' 109' ' ' VAL . 3.0 mp -86.27 124.34 40.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.592 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 30.5 mmt -102.27 -19.88 14.86 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.313 0.577 . . . . 0.0 111.116 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 7.8 tp-100 -148.47 134.84 19.52 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.91 -171.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.638 HG22 HD22 ' A' ' 107' ' ' LEU . 54.8 t -142.62 108.84 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.0 0.52 . . . . 0.0 111.974 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.446 ' HB3' ' NH2' ' A' ' 96' ' ' ARG . 45.9 t30 55.18 39.43 31.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.297 1.439 . . . . 0.0 112.715 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.32 4.79 83.34 Favored Glycine 0 C--N 1.294 -1.771 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.23 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.496 ' NE1' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -116.7 148.32 41.17 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.629 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.94 122.76 28.69 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.404 ' HG2' ' HB ' ' A' ' 55' ' ' ILE . 40.2 ttm -108.98 -0.92 19.34 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.044 0.926 . . . . 0.0 110.515 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.592 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 3.8 t -58.79 -34.63 71.69 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.657 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.1 ttt -140.72 95.36 2.85 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.444 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 9.7 p -160.1 151.15 5.77 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.449 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 38' ' ' ASP . 10.4 p -71.41 158.33 36.5 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.658 ' HE2' ' HE ' ' A' ' 94' ' ' ARG . 22.2 t60 -56.11 -43.6 78.3 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.124 175.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.15 -49.54 76.8 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.96 0.788 . . . . 0.0 111.399 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -31.77 68.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.44 ' O ' HD12 ' A' ' 97' ' ' LEU . . . -75.21 -40.62 59.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.658 ' HE ' ' HE2' ' A' ' 90' ' ' HIS . 15.9 mmt180 -53.04 -47.34 68.47 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.681 0.613 . . . . 0.0 111.023 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 63.1 tttm -86.24 39.14 0.8 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.666 1.222 . . . . 0.0 108.921 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.51 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 30.7 tpt180 -145.76 -45.99 0.21 Allowed 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.147 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.508 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -92.45 -26.95 17.75 Favored 'General case' 0 C--O 1.208 -1.104 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.326 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.0 t -117.43 14.79 14.7 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.521 ' HD2' ' HG2' ' A' ' 102' ' ' GLU . 13.6 ptpt -74.08 171.06 14.22 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -113.8 -0.36 14.23 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.034 0.445 . . . . 0.0 111.897 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 69.8 m -76.72 -28.46 55.82 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 33.9 mm-40 -81.84 179.19 7.92 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.117 0.484 . . . . 0.0 110.696 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.576 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 7.6 pt-20 -146.42 -70.14 0.25 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 44.0 t -105.99 126.63 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 30.6 m -128.49 134.68 64.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 123.626 0.579 . . . . 0.0 111.014 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -103.56 116.52 32.52 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.638 HD22 HG22 ' A' ' 80' ' ' VAL . 5.9 mt -114.39 161.43 17.95 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -134.77 121.61 20.95 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 77' ' ' ILE . 32.7 m -113.39 156.27 14.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.662 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.5 p -131.1 133.03 45.25 Favored 'General case' 1 N--CA 1.371 -4.414 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -78.24 -62.38 1.7 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.014 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 60.93 68.53 0.74 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.26 -178.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 t -151.71 28.38 0.62 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.628 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.02 6.57 45.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.79 133.56 54.36 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.56 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.31 133.79 34.14 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.023 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.14 134.63 33.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.84 47.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-O 122.57 1.176 . . . . 0.0 110.491 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -139.47 120.7 14.82 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.876 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -88.33 -6.62 57.63 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.0 m 70.83 82.92 0.15 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.496 1.518 . . . . 0.0 111.708 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 168.74 -65.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.002 1.721 . . . . 0.0 107.698 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.2 tp 57.96 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.326 1.45 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.213 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.452 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 m -79.76 -27.83 40.44 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 122.147 0.975 . . . . 0.0 110.542 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -109.21 -158.29 0.64 Allowed 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.407 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -65.53 -61.16 6.24 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 118.498 0.59 . . . . 0.0 111.216 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HB3' ' CG1' ' A' ' 13' ' ' VAL . 6.2 Cg_endo -61.63 175.3 1.74 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 N-CA-C 116.02 1.508 . . . . 0.0 116.02 172.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.97 14.9 6.26 Favored Glycine 0 C--N 1.304 -1.199 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 175.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -123.3 137.95 29.21 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -82.58 -104.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.571 0 C-N-CA 122.528 2.152 . . . . 0.0 116.558 -169.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.16 -34.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -74.0 -18.17 60.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.831 1.3 . . . . 0.0 108.442 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HB1' ' NE2' ' A' ' 112' ' ' GLN . . . -146.48 139.19 25.31 Favored 'General case' 0 N--CA 1.388 -3.569 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -137.33 145.87 28.82 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 5' ' ' PRO . 14.0 p -93.33 126.31 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.52 154.41 47.83 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.98 -174.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 3.1 ppt_? -97.06 145.57 25.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.568 HG21 ' HB2' ' A' ' 71' ' ' LEU . 7.9 p -133.97 149.03 30.13 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.94 103.06 5.87 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.548 0.689 . . . . 0.0 111.291 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -91.72 126.79 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.482 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 3.8 m-70 -96.26 150.51 20.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HB2' HD21 ' A' ' 27' ' ' LEU . 21.5 pttm -43.37 121.72 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.475 HD22 ' HD2' ' A' ' 65' ' ' PRO . 52.6 tp -122.59 123.91 42.28 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.566 176.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.9 126.84 33.83 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.432 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 21.8 mt-30 -128.4 111.4 13.28 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 175.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.55 -105.81 1.69 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -122.73 15.24 10.17 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.39 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.81 171.16 7.66 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.9 tm? -122.84 109.42 14.16 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.05 164.35 19.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 105' ' ' VAL . 9.2 mp -88.08 3.69 48.1 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.056 0.931 . . . . 0.0 109.62 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 87.64 -42.2 3.11 Favored Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.676 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -90.4 166.48 13.26 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -175.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.3 m -120.5 167.82 11.98 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.404 1.481 . . . . 0.0 108.894 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 55' ' ' ILE . 11.4 pt -127.4 167.13 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 110.988 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.95 -27.1 5.0 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.99 157.97 10.17 Favored Glycine 0 C--O 1.196 -2.274 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.856 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.61 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -106.02 -115.9 4.1 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.577 0.81 . . . . 0.0 113.486 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.618 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.74 -26.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -173.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.73 -18.39 65.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.752 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.495 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 6.4 mm100 -98.58 164.83 12.09 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.806 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 5.3 t70 -119.8 118.91 31.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 10.2 Cg_endo -54.0 -26.04 39.02 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.732 2.955 . . . . 0.0 113.731 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 t -66.32 -26.79 67.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -121.05 4.37 10.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.26 0.553 . . . . 0.0 111.431 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 5.9 m120 -90.62 149.57 40.9 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 -50.52 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 123.439 2.759 . . . . 0.0 113.131 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.12 -3.48 19.88 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.692 0.758 . . . . 0.0 111.52 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 6.1 t -97.36 1.0 48.85 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.758 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.17 -23.72 47.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.19 -58.08 3.31 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.015 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -110.39 125.32 53.09 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.811 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -89.7 6.78 39.94 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.628 0.728 . . . . 0.0 112.249 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.58 119.89 25.72 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.618 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 56.4 mttm -70.98 168.01 17.93 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.362 0.601 . . . . 0.0 111.138 -174.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.4 156.17 7.19 Favored Glycine 0 C--O 1.191 -2.548 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 33' ' ' ILE . 18.5 mm -74.41 129.21 36.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 118.207 1.003 . . . . 0.0 110.332 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -130.71 154.06 48.35 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.197 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 71' ' ' LEU . 90.8 t -77.22 135.54 26.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 124.591 1.182 . . . . 0.0 110.369 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 p -111.02 -19.93 12.59 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.22 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -152.73 138.19 17.65 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 71' ' ' LEU . 15.5 m -106.22 -173.3 0.42 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.046 0 CA-C-N 119.252 0.933 . . . . 0.0 108.632 172.161 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.616 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.8 t -87.74 118.0 26.95 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.26 -14.59 27.39 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.69 33.41 0.63 Allowed Glycine 0 C--N 1.286 -2.219 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -118.92 -169.76 14.51 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.521 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.475 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.9 Cg_endo -63.93 -29.6 67.13 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.761 2.974 . . . . 0.0 112.373 -170.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.03 -64.87 0.73 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.611 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.2 pt-20 -72.19 -31.89 66.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.506 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 mm -57.08 -39.86 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.335 0.397 . . . . 0.0 110.997 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.91 16.02 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.851 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.59 17.75 0.2 Allowed Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.402 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.688 HD11 HG21 ' A' ' 57' ' ' VAL . 5.5 tp -89.46 124.05 34.13 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -115.37 157.99 23.09 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 122.197 0.998 . . . . 0.0 111.175 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.5 mt -61.84 128.3 23.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.914 172.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.97 4.8 56.63 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -82.55 121.82 27.29 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.204 0.526 . . . . 0.0 111.661 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -83.56 99.98 10.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.876 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 57' ' ' VAL . 9.5 mt -79.28 128.24 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 -174.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.555 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 1.1 mmt -112.17 -18.91 12.45 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.453 HE22 ' C ' ' A' ' 82' ' ' GLY . 0.9 OUTLIER -148.47 137.97 22.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.627 HG22 HD22 ' A' ' 107' ' ' LEU . 37.8 t -139.73 120.88 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 10.2 t30 50.44 40.13 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.24 1.416 . . . . 0.0 112.471 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.453 ' C ' HE22 ' A' ' 79' ' ' GLN . . . 62.98 16.21 57.03 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 114.226 -1.352 . . . . 0.0 114.783 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . 0.307 0.0 OUTLIER -91.17 -82.89 0.28 Allowed 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 118.742 -0.646 . . . . 0.0 112.255 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.4 t70 168.41 127.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.507 ' HG3' ' HB ' ' A' ' 55' ' ' ILE . 47.3 tpp -128.3 1.0 5.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 122.709 1.242 . . . . 0.0 109.907 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 t -80.73 -29.5 36.34 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.629 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.6 ttp -133.01 75.25 1.61 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.78 -0.575 . . . . 0.0 110.409 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -151.52 150.51 13.13 Favored 'Isoleucine or valine' 0 C--O 1.259 1.574 0 CA-C-O 121.252 0.549 . . . . 0.0 110.232 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.512 HG23 HD11 ' A' ' 37' ' ' ILE . 1.9 p -73.29 157.85 36.25 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.999 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.3 t60 -56.74 -43.11 80.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.655 174.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.88 -50.72 72.94 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 124.357 1.063 . . . . 0.0 111.996 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -39.4 76.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.958 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.071 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.437 ' CZ ' HG21 ' A' ' 98' ' ' THR . 15.6 mmm180 -55.53 -38.7 69.59 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.238 0.542 . . . . 0.0 110.469 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -86.98 24.44 1.52 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.515 0.674 . . . . 0.0 109.215 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.554 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 19.1 mmt180 -137.23 -48.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.751 0.82 . . . . 0.0 110.984 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -96.76 -20.49 18.18 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.502 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.1 t -117.94 12.7 13.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.854 -1.538 . . . . 0.0 110.586 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.8 ptpt -68.49 -173.63 0.45 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -133.4 6.55 3.83 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.587 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.414 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 10.4 m -80.24 -40.48 26.93 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.131 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.06 152.28 22.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.563 ' HG3' HG12 ' A' ' 104' ' ' VAL . 9.7 pt-20 -104.06 -63.42 1.2 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.932 0.396 . . . . 0.0 110.678 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.563 HG12 ' HG3' ' A' ' 103' ' ' GLU . 2.0 p -118.81 132.5 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 CA-C-O 121.323 0.582 . . . . 0.0 110.929 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 29' ' ' LEU . 19.6 m -135.51 155.17 36.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.507 -174.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 3.3 mpt_? -107.2 126.29 52.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.627 HD22 HG22 ' A' ' 80' ' ' VAL . 5.2 mt -119.91 146.84 45.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.17 122.56 46.44 Favored 'General case' 0 C--N 1.265 -3.09 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.436 HG12 HG12 ' A' ' 77' ' ' ILE . 11.1 m -123.25 152.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.661 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p -106.9 129.05 54.79 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 114' ' ' LEU . 95.4 mtt180 -87.88 93.54 9.5 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.424 0.63 . . . . 0.0 109.74 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.415 ' NE2' ' HB1' ' A' ' 11' ' ' ALA . 25.2 mm-40 -100.41 -33.4 10.38 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.75 -176.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 t -101.69 2.14 38.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.013 0.911 . . . . 0.0 111.005 -173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 111' ' ' ARG . 42.5 tp -147.35 106.02 3.82 Favored 'General case' 0 C--N 1.274 -2.681 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.087 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -88.89 -78.24 0.35 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.552 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 49.89 39.94 19.61 Favored 'General case' 0 C--O 1.26 1.632 0 C-N-CA 123.75 0.82 . . . . 0.0 108.987 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.66 140.66 56.24 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 113.765 -1.561 . . . . 0.0 112.342 -173.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.255 9.8 p 46.43 38.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.111 1.764 . . . . 0.0 112.302 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -138.8 -62.92 0.54 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.554 -1.657 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -75.62 -19.86 58.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.896 0.855 . . . . 0.0 109.963 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.8 t -156.46 134.4 11.13 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.36 170.08 8.36 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 47.5 tp -87.25 86.13 7.24 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.51 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.887 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -86.96 0.36 55.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.114 0.483 . . . . 0.0 110.39 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.424 ' OH ' ' HA ' ' A' ' 14' ' ' GLN . 24.5 p90 -146.35 178.26 8.39 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.04 98.02 49.32 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -75.02 169.61 22.24 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.093 1.862 . . . . 0.0 112.433 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.56 59.48 0.61 Allowed Glycine 0 C--N 1.3 -1.427 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 21.5 tt0 -79.95 132.11 61.43 Favored Pre-proline 0 C--N 1.318 -0.802 0 C-N-CA 123.073 0.549 . . . . 0.0 111.531 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.53 -72.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 121.255 1.303 . . . . 0.0 108.999 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 m -153.19 -60.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.571 1.149 . . . . 0.0 110.577 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 115' ' ' GLN . 11.7 t -83.0 -46.43 12.87 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -174.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -70.06 137.27 51.1 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 120.876 0.37 . . . . 0.0 110.392 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.47 120.54 58.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 110' ' ' THR . 21.9 t -95.48 117.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HA ' ' OH ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -128.52 156.02 43.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -173.539 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -94.52 151.79 19.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.945 0.402 . . . . 0.0 111.057 -174.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 71' ' ' LEU . 3.1 t -131.51 151.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 174.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.416 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 39.7 tt0 -147.11 104.16 3.65 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.546 0.688 . . . . 0.0 109.784 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -88.08 127.12 41.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.093 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -108.81 111.64 23.48 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.852 0.72 . . . . 0.0 110.918 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 13.9 ptpt 25.81 97.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 165.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.576 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 41.9 tp -112.25 118.88 36.52 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.617 -0.677 . . . . 0.0 109.765 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -102.55 102.92 13.22 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.361 0.6 . . . . 0.0 110.019 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.447 ' HG2' ' HG ' ' A' ' 21' ' ' LEU . 12.0 mm100 -108.7 112.65 25.06 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.96 -103.51 0.65 Allowed Glycine 0 C--N 1.303 -1.263 0 O-C-N 124.262 0.976 . . . . 0.0 112.272 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -118.45 20.49 13.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 123.319 0.648 . . . . 0.0 110.538 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.52 177.12 7.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.449 0.642 . . . . 0.0 110.175 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -124.77 121.38 34.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -128.55 164.37 30.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.49 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.1 mp -93.75 0.92 56.59 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.724 0.774 . . . . 0.0 110.13 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.78 -35.68 3.9 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 115.152 0.821 . . . . 0.0 115.152 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.416 ' CD1' HD23 ' A' ' 71' ' ' LEU . 50.9 p90 -102.95 165.47 11.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 23.0 m -133.26 168.36 18.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.305 1.442 . . . . 0.0 110.24 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.667 HG21 HD21 ' A' ' 97' ' ' LEU . 6.4 pt -126.75 172.73 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-O 120.525 0.203 . . . . 0.0 111.488 -168.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.32 -5.6 12.8 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.638 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 107.57 -178.98 21.92 Favored Glycine 1 N--CA 1.393 -4.181 0 CA-C-N 114.546 -0.827 . . . . 0.0 111.904 -177.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.617 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -131.58 -79.09 0.17 Allowed Glycine 0 N--CA 1.405 -3.411 0 O-C-N 124.886 0.991 . . . . 0.0 114.293 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.519 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -101.57 -25.85 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.63 ' HB2' HG22 ' A' ' 89' ' ' THR . 10.7 t70 -71.99 -20.69 61.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.35 1.071 . . . . 0.0 109.636 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.586 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -105.88 142.71 35.14 Favored 'General case' 0 N--CA 1.393 -3.319 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.786 -173.761 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.9 t70 -88.53 125.61 62.78 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.9 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.2 Cg_endo -56.28 -31.3 83.97 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.93 2.42 . . . . 0.0 113.486 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -68.89 -29.34 67.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.249 0.547 . . . . 0.0 111.075 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.556 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.4 pt20 -109.42 8.0 25.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.673 0.749 . . . . 0.0 111.293 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 0.9 OUTLIER -99.54 149.31 35.76 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.788 -177.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.65 -52.75 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.115 2.544 . . . . 0.0 113.156 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -107.87 21.93 16.69 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.1 t -125.54 -3.05 7.33 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.363 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.82 -35.59 38.18 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.328 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.96 -57.36 5.11 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.669 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -110.92 109.56 19.76 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.5 p -87.31 7.61 27.94 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 124.273 0.983 . . . . 0.0 113.057 -167.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -72.59 115.21 11.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 83.9 mttt -62.09 167.92 3.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.5 139.91 4.86 Favored Glycine 0 C--O 1.183 -3.084 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.639 HD12 HD12 ' A' ' 33' ' ' ILE . 28.7 mm -55.08 130.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -170.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.564 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -125.7 149.86 48.14 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.188 177.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.734 HG23 HD11 ' A' ' 77' ' ' ILE . 95.9 t -83.22 132.99 30.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 124.36 1.037 . . . . 0.0 110.805 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.0 p -112.66 -20.26 11.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.34 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 4.3 mmm180 -140.43 132.84 28.46 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.455 HG13 ' CB ' ' A' ' 66' ' ' ALA . 53.4 t -127.22 142.8 42.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.683 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.4 m -62.1 105.3 0.57 Allowed 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 123.892 0.745 . . . . 0.0 112.363 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.41 -28.28 0.34 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 129.168 2.987 . . . . 0.0 113.545 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.2 29.52 2.05 Favored Glycine 0 C--N 1.296 -1.643 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -113.06 -175.47 19.36 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.051 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 45.7 Cg_endo -64.6 -27.0 61.28 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.01 3.14 . . . . 0.0 111.767 -171.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.455 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -58.15 -59.89 4.6 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.842 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.5 pt-20 -82.63 -20.7 35.82 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.746 -1.582 . . . . 0.0 113.107 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 64' ' ' GLY . 24.5 mm -61.12 -35.59 66.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -80.68 -54.7 5.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.373 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 151.71 25.63 0.05 OUTLIER Glycine 0 C--O 1.225 -0.422 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.608 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.743 ' HB2' HG11 ' A' ' 16' ' ' VAL . 5.2 tp -95.95 125.41 40.48 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.464 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.7 mm100 -113.66 165.18 12.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 122.043 0.925 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.3 mt -75.37 125.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.4 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.19 0.62 41.22 Favored Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.197 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 72' ' ' GLN . 14.0 m-20 -79.97 123.86 28.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 35.1 mtmt -93.04 125.36 37.59 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.734 HD11 HG23 ' A' ' 57' ' ' VAL . 2.5 mp -96.45 131.81 42.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -171.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.0 mmt -107.12 -25.92 11.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.123 0.487 . . . . 0.0 110.649 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 7.3 tp-100 -140.82 128.67 21.78 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.594 HG22 HD22 ' A' ' 107' ' ' LEU . 53.3 t -140.78 113.92 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 C-N-CA 123.382 0.673 . . . . 0.0 110.159 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 55.6 t30 55.69 43.54 27.86 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.234 1.014 . . . . 0.0 112.564 171.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.19 -4.18 55.61 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.962 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.484 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -104.33 146.92 28.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -81.36 112.88 19.05 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.837 0.827 . . . . 0.0 111.056 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.626 ' HE3' HD23 ' A' ' 97' ' ' LEU . 61.7 tpp -89.05 -8.2 54.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.531 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -70.42 137.3 50.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.6 ttt 53.98 75.06 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.871 0.868 . . . . 0.0 112.849 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.79 149.95 12.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.63 HG22 ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -70.39 154.99 41.29 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 123.269 0.628 . . . . 0.0 112.204 -178.157 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -56.8 -44.28 81.77 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.715 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.14 -52.59 64.68 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.869 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mp0 -66.33 -32.12 73.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.942 -177.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.621 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -78.21 -37.26 45.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.843 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.473 ' CZ ' HG21 ' A' ' 98' ' ' THR . 16.6 mmm180 -53.98 -44.11 70.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.407 0.622 . . . . 0.0 110.546 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -85.14 32.56 0.54 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.878 0.847 . . . . 0.0 110.473 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.594 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.3 tpp180 -143.21 -43.3 0.29 Allowed 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.604 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -101.69 -20.94 14.78 Favored 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.473 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 13.7 t -116.44 15.38 15.71 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.683 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.1 ptpt -62.61 158.67 17.67 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.074 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -114.06 6.28 16.36 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.647 0.737 . . . . 0.0 110.531 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.8 m -79.4 -34.39 41.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.339 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.6 144.19 31.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.471 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -100.55 -53.43 3.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.192 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.0 p -121.04 128.58 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.705 0.764 . . . . 0.0 112.565 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.415 HG21 HD23 ' A' ' 29' ' ' LEU . 26.6 m -126.99 146.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.741 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -100.46 115.22 29.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 HG22 ' A' ' 80' ' ' VAL . 12.5 mt -114.52 159.95 19.79 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.2 mp -137.56 123.57 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.59 159.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.538 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.57 HG22 HG22 ' A' ' 13' ' ' VAL . 76.2 p -112.74 136.58 52.18 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.298 0.57 . . . . 0.0 111.495 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -80.53 97.29 7.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.466 ' HG3' ' HE2' ' A' ' 76' ' ' LYS . 29.9 mm-40 -94.39 -13.59 26.15 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.522 0.677 . . . . 0.0 110.596 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.9 p -86.33 22.65 1.76 Allowed 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.205 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.5 tp -139.36 81.67 1.85 Allowed 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.265 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.473 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 9.6 pt20 -148.54 -40.02 0.16 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.519 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.483 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 8.7 mtmp? 78.42 -178.44 0.11 Allowed 'General case' 0 C--O 1.251 1.134 0 C-N-CA 126.463 1.905 . . . . 0.0 110.261 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -124.75 175.31 7.32 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t -139.56 73.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.47 89.08 5.03 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.278 1.037 . . . . 0.0 109.931 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.4 pp0? -68.65 -18.9 64.37 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.987 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.9 m -69.05 -57.81 4.93 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.364 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.9 tpt 68.61 -12.8 0.34 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.239 1.415 . . . . 0.0 112.991 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.95 1.62 50.58 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 121.644 -0.66 . . . . 0.0 110.657 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.1 t . . . . . 0 N--CA 1.424 -1.742 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.221 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.276 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -122.21 -3.1 9.01 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.1 t80 68.02 -69.11 0.15 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 124.819 1.247 . . . . 0.0 111.475 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.3 mt 64.18 99.84 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.563 1.145 . . . . 0.0 110.503 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -70.25 152.66 66.9 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.663 1.575 . . . . 0.0 111.69 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.39 40.79 2.96 Favored Glycine 0 C--N 1.298 -1.565 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.63 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -82.91 128.16 66.74 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 66.3 Cg_endo -80.71 -88.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.145 1.897 . . . . 0.0 110.897 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.08 -58.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 123.129 0.572 . . . . 0.0 110.626 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -89.67 -51.12 5.68 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 120.769 0.319 . . . . 0.0 111.74 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . -67.83 141.56 56.43 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.198 -174.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.03 132.44 55.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.261 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.3 141.02 19.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.4 148.96 31.85 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.49 28.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.672 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -126.24 152.89 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.43 101.4 4.1 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.41 0.624 . . . . 0.0 109.88 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -85.54 122.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.317 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.459 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 5.1 m-70 -94.46 145.84 24.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 124.123 0.889 . . . . 0.0 109.549 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -31.64 113.18 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 115.035 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.499 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.1 tp -120.51 117.73 28.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.879 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -96.27 116.97 29.87 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -109.77 106.86 16.64 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.62 -105.31 1.27 Allowed Glycine 0 N--CA 1.432 -1.604 0 O-C-N 123.842 0.714 . . . . 0.0 111.319 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -109.6 -3.58 16.79 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.94 167.81 9.96 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -172.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.92 122.26 44.79 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -133.79 155.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 105' ' ' VAL . 8.6 mp -82.27 1.36 37.08 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.107 0.956 . . . . 0.0 109.792 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 89.35 -43.58 3.04 Favored Glycine 0 N--CA 1.42 -2.381 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.708 176.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 41.5 p90 -91.35 164.7 13.75 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 87.2 p -113.83 179.93 3.82 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.344 1.057 . . . . 0.0 109.676 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.667 HG21 HD21 ' A' ' 97' ' ' LEU . 6.6 pt -138.32 166.73 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.19 -23.01 6.25 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.56 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 126.9 171.24 13.03 Favored Glycine 0 CA--C 1.476 -2.382 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.16 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.533 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.92 -117.52 2.63 Favored Glycine 0 C--O 1.208 -1.482 0 O-C-N 124.445 0.732 . . . . 0.0 112.841 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.479 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -65.33 -25.68 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.7 t70 -68.99 -16.77 63.81 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.329 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.543 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.1 mm100 -98.94 163.3 12.65 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.893 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.47 107.52 22.45 Favored Pre-proline 0 CA--C 1.489 -1.376 0 C-N-CA 124.507 1.123 . . . . 0.0 111.787 175.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.526 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 25.9 Cg_endo -64.16 -20.9 67.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.589 2.192 . . . . 0.0 110.442 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.41 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 2.7 m -63.52 -32.44 73.9 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 113.921 -1.491 . . . . 0.0 110.222 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.41 ' HG3' ' HB2' ' A' ' 42' ' ' SER . 48.7 mt-30 -122.8 4.98 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.792 0.806 . . . . 0.0 112.876 -170.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -95.38 144.81 28.43 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.09 -40.23 11.98 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.794 2.996 . . . . 0.0 113.756 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 41.3 m-85 -119.59 21.29 12.13 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.969 0.89 . . . . 0.0 108.991 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 5.6 t -128.22 5.1 5.8 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.649 177.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.7 -1.07 53.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.928 0.871 . . . . 0.0 110.937 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -77.85 -42.0 35.06 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.853 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -141.72 -170.58 3.15 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.5 p -99.06 -3.86 33.77 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.31 110.96 5.56 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.157 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.3 mtmm -96.02 174.12 7.08 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.112 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.9 163.31 11.03 Favored Glycine 0 C--O 1.181 -3.174 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -175.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.662 HD12 HD12 ' A' ' 33' ' ' ILE . 36.4 mm -72.0 127.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 118.767 1.283 . . . . 0.0 110.634 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 2.3 p90 -127.64 151.77 48.52 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.667 HG21 HD11 ' A' ' 71' ' ' LEU . 85.9 t -79.89 133.34 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 124.426 1.079 . . . . 0.0 110.369 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.424 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 9.3 p -106.11 -22.38 12.88 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.285 0.564 . . . . 0.0 110.75 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.7 mmt180 -155.13 140.25 17.47 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.193 1.397 . . . . 0.0 107.73 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.44 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 20.6 m -106.88 -176.41 0.57 Allowed 'Isoleucine or valine' 1 N--CA 1.346 -5.657 0 CA-C-N 118.985 0.811 . . . . 0.0 109.714 173.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.489 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 2.8 t -75.82 114.78 14.81 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 173.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.82 -30.26 44.38 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.939 0.775 . . . . 0.0 112.614 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.39 48.13 0.55 Allowed Glycine 0 CA--C 1.484 -1.884 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.467 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -129.3 -165.64 11.74 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.634 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.499 ' HD2' HD22 ' A' ' 21' ' ' LEU . 42.4 Cg_endo -64.9 -28.45 58.49 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.4 2.733 . . . . 0.0 112.177 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.39 -62.37 1.82 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.66 -30.43 67.04 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.173 0.296 . . . . 0.0 111.418 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.493 ' HA ' HD21 ' A' ' 123' ' ' LEU . 26.0 mm -64.73 -39.07 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.357 0.598 . . . . 0.0 111.299 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.89 -47.65 16.1 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.61 14.14 0.24 Allowed Glycine 0 C--N 1.311 -0.832 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.846 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB2' HG11 ' A' ' 16' ' ' VAL . 8.1 tp -86.44 124.43 32.76 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.452 ' HG3' HG11 ' A' ' 118' ' ' VAL . 13.9 mm100 -116.87 159.29 22.61 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 122.146 0.974 . . . . 0.0 111.029 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.97 125.44 21.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.902 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.83 35.11 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.206 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.43 124.11 23.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-O 120.817 0.341 . . . . 0.0 110.544 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -86.63 119.36 26.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.583 HD11 HG23 ' A' ' 57' ' ' VAL . 3.7 mp -85.54 122.85 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.469 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 25.5 mmt -101.8 -13.25 17.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.44 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -161.53 132.46 5.23 Favored 'General case' 0 C--O 1.2 -1.551 0 O-C-N 121.989 -0.445 . . . . 0.0 110.007 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 107' ' ' LEU . 50.5 t -131.92 125.5 55.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.601 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 8.0 t30 49.3 43.26 22.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.79 1.236 . . . . 0.0 112.269 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 63.72 12.57 48.03 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 114.15 -1.386 . . . . 0.0 114.977 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.443 ' HZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -97.12 -8.64 29.69 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.139 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 71.77 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.861 0.864 . . . . 0.0 110.637 -173.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.441 ' HE2' HD23 ' A' ' 97' ' ' LEU . 7.4 tpt -120.73 -0.92 10.08 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.563 0.697 . . . . 0.0 109.689 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.469 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 9.7 t -66.63 -15.98 63.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.842 -174.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.5 ttt -150.28 93.94 2.06 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.042 0.448 . . . . 0.0 110.394 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG21 ' HZ2' ' A' ' 83' ' ' TRP . 7.3 p -154.96 149.51 12.24 Favored 'Isoleucine or valine' 0 C--O 1.259 1.561 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 38' ' ' ASP . 9.3 p -72.33 155.75 39.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 122.632 0.373 . . . . 0.0 110.652 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.737 ' HE2' ' HE ' ' A' ' 94' ' ' ARG . 17.7 t60 -53.58 -44.25 69.19 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.859 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.59 -43.96 92.18 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.126 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -35.23 68.18 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.209 0.528 . . . . 0.0 111.423 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.591 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -68.59 -42.88 77.57 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.432 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.737 ' HE ' ' HE2' ' A' ' 90' ' ' HIS . 18.5 mmt180 -55.7 -38.61 69.93 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.619 0.723 . . . . 0.0 109.092 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' HE3' ' A' ' 99' ' ' LYS . 47.2 tttp -81.15 18.29 1.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.972 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 34.1 mtt-85 -137.74 -37.19 0.61 Allowed 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -102.12 -23.13 14.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.473 ' N ' HD12 ' A' ' 97' ' ' LEU . 13.9 t -111.66 12.0 21.13 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.398 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.3 ptpt -69.97 176.95 3.4 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.527 169.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -119.88 -0.13 10.72 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.552 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.8 m -82.81 -36.95 25.13 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.81 115.19 27.19 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.643 0.735 . . . . 0.0 110.491 -174.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.601 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -75.16 -68.11 0.59 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.725 -173.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.1 p -121.28 125.5 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.421 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.467 HG21 HD21 ' A' ' 29' ' ' LEU . 25.4 m -131.44 147.13 32.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.909 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -97.93 116.72 30.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.054 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 80' ' ' VAL . 11.9 mt -112.76 152.41 29.15 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.97 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.9 mp -126.38 126.0 43.14 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 122.661 0.384 . . . . 0.0 110.146 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 m -122.05 149.64 25.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 p -119.23 133.07 55.96 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -93.93 87.06 5.24 Favored 'General case' 0 N--CA 1.416 -2.174 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.288 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -84.48 -47.95 10.1 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.466 -1.697 . . . . 0.0 106.949 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 m -91.1 6.23 45.78 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.36 -170.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.8 mt -140.04 75.54 1.51 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.3 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 116' ' ' LYS . 12.1 pt20 -93.9 132.47 38.3 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 174.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 115' ' ' GLN . 62.0 tttp 76.12 150.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.264 0.977 . . . . 0.0 109.54 -173.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 75.72 158.77 0.21 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.596 1.158 . . . . 0.0 112.781 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 72' ' ' GLN . 31.0 t 69.26 70.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.593 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.69 109.88 19.66 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 172.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -70.25 98.4 1.36 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.604 0.716 . . . . 0.0 110.29 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.4 m -144.04 -6.39 0.76 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.552 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 21.6 mmt -102.19 -38.09 7.84 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 68' ' ' ILE . 51.7 tp -76.31 106.48 7.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.84 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--N 1.29 -1.999 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.672 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.052 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 m -128.67 102.01 6.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -121.53 121.21 36.97 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.193 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.8 tt -108.13 111.57 61.85 Favored Pre-proline 0 C--N 1.296 -1.749 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -74.14 164.65 33.81 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.159 1.906 . . . . 0.0 112.64 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.2 50.68 0.99 Allowed Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' HB2' HG23 ' A' ' 13' ' ' VAL . 51.4 tt0 -67.78 123.76 87.74 Favored Pre-proline 0 C--O 1.243 0.731 0 CA-C-O 120.946 0.403 . . . . 0.0 111.835 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -87.69 -106.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 122.94 2.427 . . . . 0.0 112.058 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 m -141.21 -38.85 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.202 0.525 . . . . 0.0 111.5 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -76.23 -12.97 60.18 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.776 0.83 . . . . 0.0 111.067 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.55 148.27 52.33 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.753 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t -126.75 139.8 50.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 110' ' ' THR . 11.7 t -97.19 137.0 26.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.48 151.18 47.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 5.0 ppt_? -96.24 155.1 16.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.036 0.446 . . . . 0.0 111.111 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -133.71 154.5 38.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -150.53 105.63 3.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.125 0.488 . . . . 0.0 109.781 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -90.94 127.61 43.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.393 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -96.24 134.44 39.34 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HB2' HD21 ' A' ' 27' ' ' LEU . 23.3 pttm -29.34 121.8 0.15 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.438 HD22 ' HD2' ' A' ' 65' ' ' PRO . 42.7 tp -120.79 125.85 48.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.899 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -91.15 125.79 36.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 29.6 mt-30 -130.37 105.67 8.04 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.29 -115.82 6.67 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.16 -0.82 49.54 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.469 0.308 . . . . 0.0 110.297 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.78 174.81 5.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.869 0.842 . . . . 0.0 111.08 -169.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -126.51 113.0 16.22 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -125.65 164.21 25.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 97' ' ' LEU . 49.4 mt -91.93 8.51 37.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.854 0.835 . . . . 0.0 109.984 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.0 -46.92 2.68 Favored Glycine 0 N--CA 1.416 -2.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.53 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 30.6 p90 -93.4 172.39 8.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.3 m -136.44 169.28 17.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.12 1.768 . . . . 0.0 110.222 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 55' ' ' ILE . 5.5 pt -124.81 172.54 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 C-N-CA 122.608 0.363 . . . . 0.0 111.477 -170.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.17 -12.37 8.33 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.626 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 114.33 170.49 16.85 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 119.537 -1.316 . . . . 0.0 113.066 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -123.68 -114.71 2.14 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 124.083 0.52 . . . . 0.0 112.109 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -29.31 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.6 t70 -66.34 -17.87 65.02 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.852 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.604 ' HB2' HD21 ' A' ' 44' ' ' ASN . 5.8 mm100 -101.24 153.54 19.53 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.0 t70 -99.98 115.69 65.31 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 4.6 Cg_endo -51.37 -30.01 32.68 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.773 2.982 . . . . 0.0 113.018 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.2 t -66.17 -25.99 67.2 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.331 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.9 pt20 -121.85 15.68 10.92 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.583 0.706 . . . . 0.0 111.032 -177.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 87.7 m-20 -93.49 155.3 40.89 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 56.7 Cg_endo -74.57 -55.91 0.08 OUTLIER 'Trans proline' 0 C--O 1.198 -1.524 0 C-N-CA 122.746 2.298 . . . . 0.0 113.003 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.4 ' CZ ' HG22 ' A' ' 73' ' ' ILE . 74.7 m-85 -105.8 27.7 8.24 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.88 0.848 . . . . 0.0 110.602 -175.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.683 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.3 t -138.74 21.74 2.68 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 8.4 pt-20 -89.0 -26.11 21.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.795 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.414 ' OD2' ' HG2' ' A' ' 50' ' ' LYS . 8.2 p-10 -77.71 -30.13 51.65 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.417 0.627 . . . . 0.0 110.917 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.414 ' HG2' ' OD2' ' A' ' 49' ' ' ASP . 59.3 pttt -154.31 163.95 39.35 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.532 176.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -81.34 19.89 0.92 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.748 1.219 . . . . 0.0 112.298 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.48 110.13 11.99 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.703 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HE3' ' CD ' ' A' ' 41' ' ' PRO . 34.4 mmtm -78.8 -169.11 1.63 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.949 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.68 140.86 7.69 Favored Glycine 0 C--O 1.186 -2.892 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.673 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 27.9 mm -60.73 128.83 22.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.248 0.547 . . . . 0.0 111.012 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.3 151.86 48.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.748 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.585 HG23 HD11 ' A' ' 77' ' ' ILE . 97.8 t -79.23 134.23 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 123.959 0.787 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -110.92 -21.93 11.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -148.73 135.63 19.9 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.443 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG11 ' O ' ' A' ' 71' ' ' LEU . 27.5 m -117.63 173.15 4.72 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.9 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 172.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB3' ' HA3' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -72.16 126.24 29.29 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -73.24 -19.16 61.13 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.771 0.67 . . . . 0.0 110.548 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.34 43.8 0.91 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . -129.29 -170.82 12.83 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.314 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HB2' HG23 ' A' ' 18' ' ' ILE . 37.5 Cg_endo -63.95 -31.6 66.6 Favored 'Trans proline' 0 N--CA 1.474 0.327 0 C-N-CA 123.742 2.961 . . . . 0.0 112.297 -172.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.83 -63.52 1.15 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.103 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.7 -28.04 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.003 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.16 -49.76 79.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.339 0.4 . . . . 0.0 110.364 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -52.13 43.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.269 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.96 22.8 0.08 OUTLIER Glycine 0 C--N 1.305 -1.151 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.724 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HG11 ' A' ' 16' ' ' VAL . 4.2 tp -90.19 106.97 18.84 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.563 ' HB2' ' NH2' ' A' ' 111' ' ' ARG . 12.3 mm100 -124.49 124.13 41.62 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.4 HG22 ' CZ ' ' A' ' 46' ' ' PHE . 67.1 mt -35.98 122.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 125.777 1.923 . . . . 0.0 112.801 -175.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.06 14.7 23.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' OD1' ' HB ' ' A' ' 57' ' ' VAL . 5.6 p-10 -87.32 139.0 31.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HB3' ' HZ3' ' A' ' 76' ' ' LYS . 7.5 mtpm? -104.5 107.43 18.36 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.604 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 9.6 mt -74.78 142.77 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.05 -172.134 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 27.8 mmt -122.15 -20.19 6.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.619 0.723 . . . . 0.0 109.891 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.579 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -144.44 134.82 24.47 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.468 HG22 HD22 ' A' ' 107' ' ' LEU . 62.6 t -140.51 120.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 81' ' ' ASN . 2.1 t-20 53.75 39.55 30.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.867 0.867 . . . . 0.0 111.891 170.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.579 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 57.8 21.89 45.49 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.455 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -102.77 -0.13 31.96 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.362 3.8 p30 49.83 99.28 0.01 OUTLIER 'General case' 0 C--N 1.342 0.273 0 CA-C-O 123.462 1.601 . . . . 0.0 113.635 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.673 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 ttp -97.95 -10.04 25.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.303 -169.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.507 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 6.2 t -33.19 -36.31 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 126.445 1.898 . . . . 0.0 115.727 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.9 ttm -139.26 93.63 2.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.92 151.89 10.04 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 38' ' ' ASP . 14.0 p -73.64 157.34 36.8 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.372 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.413 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 8.8 t60 -54.58 -46.31 73.71 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.967 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.55 -44.83 95.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.281 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -37.61 68.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.872 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' O ' HD22 ' A' ' 97' ' ' LEU . . . -66.79 -39.93 87.95 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.761 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -52.61 -34.98 53.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.638 0.775 . . . . 0.0 111.943 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -88.29 13.5 11.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.351 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.56 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 15.3 tpt180 -133.21 -39.66 0.93 Allowed 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.482 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.567 HD11 ' CG2' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -103.05 -11.88 17.81 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.964 -176.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -125.93 14.23 7.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.978 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 13.4 ptpt -67.13 -168.94 0.08 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.27 170.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 11.6 ptm180 -132.52 3.22 3.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.12 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.41 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 34.9 m -73.27 -40.3 64.71 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.437 -177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.16 134.32 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 103' ' ' GLU . 1.1 pm0 -81.45 -61.04 2.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.594 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -120.34 129.18 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 C-N-CA 123.049 0.54 . . . . 0.0 110.842 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.78 146.53 30.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.595 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -98.93 117.69 34.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD22 HG22 ' A' ' 80' ' ' VAL . 19.0 mt -112.09 155.35 24.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.875 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 107' ' ' LEU . 4.7 mp -133.42 126.3 30.91 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 17.0 m -123.45 158.93 28.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 123.682 0.614 . . . . 0.0 109.84 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 13' ' ' VAL . 37.9 p -112.27 137.43 50.4 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-O 121.25 0.548 . . . . 0.0 110.249 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.563 ' NH2' ' HB2' ' A' ' 72' ' ' GLN . 18.5 mmt180 -100.11 116.24 31.68 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -96.02 14.92 22.1 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 m -72.83 14.7 0.25 Allowed 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 124.681 1.192 . . . . 0.0 112.822 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -117.56 18.38 14.26 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.908 0.861 . . . . 0.0 109.024 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -79.55 150.19 31.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.992 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.402 ' HG2' ' O ' ' A' ' 117' ' ' ALA . 80.8 tttt -155.3 138.98 16.07 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 116' ' ' LYS . . . -71.55 142.84 50.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.175 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t 65.31 71.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.453 1.12 . . . . 0.0 110.357 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -152.31 -63.09 0.17 Allowed 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 176.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 53.27 99.53 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 m -67.68 -30.38 69.9 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 tpt -165.78 -64.73 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.385 -1.734 . . . . 0.0 106.327 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.5 mt -115.1 -33.39 5.39 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.307 -1.259 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.663 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.764 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 p -149.68 162.12 40.86 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.872 0.336 . . . . 0.0 110.427 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -93.17 108.68 20.24 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.9 mm -102.47 105.62 44.68 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.71 171.78 14.84 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.467 2.111 . . . . 0.0 113.898 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.72 39.29 3.11 Favored Glycine 0 C--N 1.32 -0.334 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.425 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 53.7 tt0 -78.42 128.7 77.02 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.48 -64.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.538 1.492 . . . . 0.0 109.929 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -160.48 -41.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 125.047 1.339 . . . . 0.0 109.439 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 t -116.26 -51.46 2.62 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -175.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -61.71 132.75 54.23 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 118.027 0.376 . . . . 0.0 110.463 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.7 t -101.62 128.86 53.62 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.069 -173.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 8.6 p -112.14 126.53 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.608 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -137.65 152.52 49.4 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -176.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -93.81 150.44 20.38 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.682 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -125.71 156.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -141.86 105.72 4.73 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.618 0.723 . . . . 0.0 110.761 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.481 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.7 mp -96.99 128.2 48.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.189 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -97.67 137.54 36.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 27' ' ' LEU . 21.5 pttp -36.09 121.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.457 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.5 tp -124.52 128.54 49.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.649 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -96.09 132.9 41.0 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.153 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.9 mt-30 -123.68 108.06 12.15 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.33 -103.86 1.25 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -119.92 12.7 12.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.26 167.44 14.87 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.6 tm? -113.73 118.41 34.25 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.48 154.14 36.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.64 HD13 HG21 ' A' ' 105' ' ' VAL . 63.8 mt -79.36 2.31 22.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.8 0.809 . . . . 0.0 109.596 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 95.64 -44.73 2.06 Favored Glycine 0 N--CA 1.408 -3.176 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.921 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 37.7 p90 -90.65 164.56 14.12 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 m -115.01 164.84 13.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 125.027 1.331 . . . . 0.0 109.135 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 55' ' ' ILE . 6.5 pt -126.06 166.62 21.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.0 -31.03 3.46 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.38 154.02 9.13 Favored Glycine 0 C--O 1.2 -1.996 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.298 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.521 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -102.57 -117.67 4.33 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.335 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.47 HD11 HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER -63.88 -23.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.312 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.499 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.5 t70 -68.94 -20.47 64.2 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.761 0.791 . . . . 0.0 109.887 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.654 ' HB2' HD21 ' A' ' 44' ' ' ASN . 6.0 mm100 -100.97 156.96 17.1 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 5.0 t70 -101.32 114.66 65.71 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.17 -25.66 23.95 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 123.859 3.04 . . . . 0.0 113.682 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 m -76.02 -8.59 57.33 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.235 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 3.5 pt20 -135.22 13.09 3.56 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.905 0.859 . . . . 0.0 110.348 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.699 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 95.5 m-20 -97.86 150.43 36.75 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.495 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.09 -45.7 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.037 0 C-N-CA 122.993 2.462 . . . . 0.0 114.31 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -114.02 9.53 17.36 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 121.354 -0.842 . . . . 0.0 110.931 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.699 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 9.6 t -104.95 -4.8 21.67 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.55 2.83 31.15 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.929 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -58.32 -37.39 74.99 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.541 1.136 . . . . 0.0 108.367 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -154.02 -111.85 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.222 168.669 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.0 p -134.41 19.29 3.65 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -87.13 135.84 33.15 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.2 -171.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -94.44 176.3 6.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.467 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 138.48 157.99 7.59 Favored Glycine 0 C--O 1.204 -1.765 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 33' ' ' ILE . 30.7 mm -80.95 118.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 117.685 0.743 . . . . 0.0 109.555 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -120.71 155.69 33.36 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.072 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.416 HG21 HG12 ' A' ' 60' ' ' VAL . 7.6 p -81.58 131.56 33.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 O-C-N 124.733 1.271 . . . . 0.0 110.36 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 p -106.57 -19.04 13.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.556 0.693 . . . . 0.0 111.319 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -154.73 135.92 13.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 30.3 m -100.57 -177.44 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.351 -5.416 0 CA-C-N 119.592 1.087 . . . . 0.0 108.186 173.606 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.498 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 5.2 t -76.26 122.41 24.36 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.67 -18.5 31.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.275 0.984 . . . . 0.0 113.09 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.56 46.32 0.23 Allowed Glycine 0 CA--C 1.482 -1.975 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -132.78 -168.34 11.95 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.967 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HD2' HD22 ' A' ' 21' ' ' LEU . 32.9 Cg_endo -61.45 -31.88 88.32 Favored 'Trans proline' 0 C--O 1.216 -0.576 0 C-N-CA 123.987 3.125 . . . . 0.0 112.552 -169.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB3' ' H ' ' A' ' 61' ' ' SER . . . -56.63 -60.26 3.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.31 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -71.17 -30.14 66.07 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.245 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 64' ' ' GLY . 32.4 mm -62.6 -41.1 90.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 122.983 0.513 . . . . 0.0 111.147 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.94 -56.78 4.21 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.498 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.14 22.53 0.05 OUTLIER Glycine 0 C--N 1.314 -0.64 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.029 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HB2' HG11 ' A' ' 16' ' ' VAL . 3.2 tp -87.94 119.61 28.46 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -115.27 140.98 48.64 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.62 0.575 . . . . 0.0 109.494 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.8 mt -49.52 126.53 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 123.316 0.385 . . . . 0.0 111.521 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.71 50.79 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.104 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -80.62 131.91 35.55 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -94.3 108.2 20.11 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.5 HG13 HG12 ' A' ' 109' ' ' VAL . 3.3 mp -78.9 125.72 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.4 mmt -112.84 -8.82 13.71 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.85 0.357 . . . . 0.0 111.821 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -156.55 136.13 12.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.303 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 107' ' ' LEU . 39.2 t -142.61 115.04 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.546 1.138 . . . . 0.0 109.972 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 3.0 t30 50.5 57.8 6.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.622 1.169 . . . . 0.0 111.784 176.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.61 -17.89 1.93 Allowed Glycine 0 C--N 1.289 -2.082 0 CA-C-N 114.029 -1.441 . . . . 0.0 115.293 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.88 157.01 17.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.87 134.33 34.54 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.417 0.627 . . . . 0.0 109.897 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.528 ' HE3' HD23 ' A' ' 97' ' ' LEU . 63.4 tpp -113.15 1.59 15.33 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.235 1.017 . . . . 0.0 108.881 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.561 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.6 t -61.16 -35.7 77.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.133 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.4 ttm -139.47 91.25 2.47 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.519 HG11 ' SD ' ' A' ' 85' ' ' MET . 9.3 p -157.13 151.05 8.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.422 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.499 HG22 ' HB2' ' A' ' 38' ' ' ASP . 2.3 p -71.13 157.19 38.61 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.51 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.467 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 13.0 t60 -53.92 -45.19 71.12 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.189 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.65 -48.36 81.21 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.733 0.645 . . . . 0.0 111.537 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.49 -30.38 67.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.409 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.641 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.86 -42.86 66.4 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 176.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.429 ' C ' ' H ' ' A' ' 96' ' ' ARG . 11.1 mmm180 -56.08 -42.8 77.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.537 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -80.32 27.33 0.34 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 109.123 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.679 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 tpt180 -139.77 -43.27 0.44 Allowed 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -100.03 -28.85 12.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.457 ' N ' HD12 ' A' ' 97' ' ' LEU . 14.9 t -108.19 15.88 23.75 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.945 -1.502 . . . . 0.0 109.614 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.679 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.3 ptpt -65.78 176.2 1.66 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.535 170.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -127.41 12.29 6.97 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.698 0.761 . . . . 0.0 111.261 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 m -94.64 -32.71 13.27 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.95 0.881 . . . . 0.0 111.731 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' CB ' ' HD2' ' A' ' 99' ' ' LYS . 14.7 tt0 -108.79 119.28 39.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.496 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -80.52 -71.54 0.46 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.135 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.443 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 31.3 t -98.88 136.07 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.64 HG21 HD13 ' A' ' 29' ' ' LEU . 19.6 m -129.62 152.78 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 CA-C-O 121.32 0.581 . . . . 0.0 111.778 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -127.14 112.32 15.02 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.33 162.58 16.92 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.703 -171.778 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.7 mp -130.95 127.39 38.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.5 HG12 HG13 ' A' ' 77' ' ' ILE . 21.7 m -119.14 150.27 21.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.411 HG22 ' HB ' ' A' ' 13' ' ' VAL . 75.1 p -118.93 146.98 44.51 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -114.67 96.43 5.73 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -85.02 -11.19 55.98 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.905 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.4 p -81.71 5.51 18.2 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.421 1.105 . . . . 0.0 110.579 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 59.4 tp -109.06 85.08 2.03 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.309 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -95.58 -73.5 0.59 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.87 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm 57.98 19.04 5.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.754 0.822 . . . . 0.0 110.984 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.09 -179.09 7.71 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.8 p -163.51 95.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-O 122.321 1.058 . . . . 0.0 109.69 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -51.31 118.69 3.44 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.378 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -112.11 16.22 20.26 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.239 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.0 m 68.59 16.62 9.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 110.344 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 56.9 ttp -177.73 95.0 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 126.047 1.739 . . . . 0.0 106.794 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.4 tp -111.02 87.35 2.52 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.416 -2.172 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -177.12 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.4 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 p -115.02 104.03 11.49 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 117.346 0.573 . . . . 0.0 109.847 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.498 ' HE1' ' C ' ' A' ' 5' ' ' PRO . 11.7 t80 -80.62 120.21 24.26 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.462 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 44.8 mm -83.35 -58.25 0.41 Allowed Pre-proline 0 CA--C 1.568 1.666 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.498 ' C ' ' HE1' ' A' ' 3' ' ' TYR . 51.3 Cg_endo -70.32 -158.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.558 2.172 . . . . 0.0 116.358 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.53 50.64 0.34 Allowed Glycine 0 CA--C 1.493 -1.332 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -77.36 127.13 83.79 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.627 -0.786 . . . . 0.0 113.062 -174.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.21 -106.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 123.025 2.483 . . . . 0.0 109.793 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.79 -50.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 121.961 -0.462 . . . . 0.0 111.701 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -73.89 -24.0 59.65 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.782 0.801 . . . . 0.0 110.675 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.87 142.44 46.93 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.976 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.44 130.91 71.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.657 HG22 HG22 ' A' ' 110' ' ' THR . 15.5 t -97.04 127.5 49.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 150.88 50.08 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -97.14 143.85 27.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -176.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 8.5 p -132.75 154.29 39.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -137.14 108.54 6.89 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.284 0.564 . . . . 0.0 111.689 -174.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.483 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -98.83 133.31 41.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.777 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.4 m-70 -99.32 147.71 24.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 41.9 pttt -38.32 116.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 52.3 tp -117.6 125.45 50.81 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.124 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -95.48 126.28 40.66 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 23' ' ' GLN . 8.9 mm100 -122.93 99.6 6.47 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.74 -104.12 1.65 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.0 -1.32 15.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.12 171.22 7.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.316 0.579 . . . . 0.0 109.979 -172.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.7 tm? -122.07 108.42 13.34 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 1.3 mt -121.51 156.04 25.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 105' ' ' VAL . 68.6 mt -84.03 3.35 34.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.628 0.728 . . . . 0.0 109.871 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -34.43 3.97 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.519 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -99.07 170.99 8.31 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.343 0.571 . . . . 0.0 111.55 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.52 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 82.4 p -124.13 -173.7 2.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.09 0.556 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.575 HD12 HD12 ' A' ' 55' ' ' ILE . 8.4 pt -135.42 164.98 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.73 -17.39 7.49 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.578 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 121.6 166.34 12.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.261 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.688 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -115.95 -108.16 2.61 Favored Glycine 0 N--CA 1.409 -3.148 0 O-C-N 124.459 0.741 . . . . 0.0 113.322 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -80.83 -21.14 11.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.194 0.521 . . . . 0.0 111.43 -174.468 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.729 ' HB3' HG22 ' A' ' 89' ' ' THR . 7.3 p-10 -86.39 3.85 41.91 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 110.309 -174.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.52 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 18.0 mm100 -99.34 178.06 5.0 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.474 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -132.12 121.6 17.82 Favored Pre-proline 0 CA--C 1.479 -1.786 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.4 -24.76 44.82 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.477 2.118 . . . . 0.0 113.496 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m -66.73 -30.08 70.21 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.859 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -123.13 21.05 9.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.283 0.563 . . . . 0.0 111.221 -175.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 39' ' ' GLN . 5.8 m120 -115.08 143.76 30.82 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.62 -50.97 1.07 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.667 2.911 . . . . 0.0 114.008 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -104.8 17.78 23.52 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.497 0.665 . . . . 0.0 110.469 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 5.4 t -123.66 2.89 8.92 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -86.32 -14.23 44.23 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.46 -53.85 12.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.392 0.615 . . . . 0.0 109.582 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -138.42 154.36 48.89 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.024 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.1 p -78.92 21.62 0.42 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 124.957 1.303 . . . . 0.0 113.438 -167.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -87.77 111.96 21.92 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.205 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HD2' ' HA ' ' A' ' 37' ' ' ILE . 8.6 mtmp? -92.03 -176.98 4.57 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' C ' ' HA2' ' A' ' 36' ' ' GLY . . . 129.21 146.85 6.2 Favored Glycine 0 C--O 1.177 -3.416 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.688 HD13 ' N ' ' A' ' 36' ' ' GLY . 31.6 mm -58.81 117.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 118.811 1.305 . . . . 0.0 112.402 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -119.25 153.94 34.22 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.106 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.402 HG13 ' H ' ' A' ' 74' ' ' GLY . 7.5 p -80.28 135.39 25.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 124.567 1.167 . . . . 0.0 110.207 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 p -109.65 -23.57 11.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.268 0.556 . . . . 0.0 111.863 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 40.7 mtt-85 -142.56 138.22 30.68 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.446 HG13 ' CB ' ' A' ' 66' ' ' ALA . 54.3 t -124.87 135.76 62.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.617 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.2 t -54.44 118.76 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 124.469 1.106 . . . . 0.0 109.801 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.74 -5.85 9.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.598 1.559 . . . . 0.0 112.659 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.28 38.47 0.33 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -124.01 -174.08 14.05 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.37 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.425 ' HB2' HG23 ' A' ' 18' ' ' ILE . 29.8 Cg_endo -62.92 -29.89 76.5 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 124.018 3.145 . . . . 0.0 111.934 -172.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.446 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -57.94 -60.91 2.99 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.626 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.5 pt-20 -75.61 -23.94 56.47 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.9 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.2 mm -59.24 -43.69 90.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -50.72 19.24 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.024 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.85 21.81 0.24 Allowed Glycine 0 C--N 1.321 -0.277 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.884 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' O ' HG11 ' A' ' 60' ' ' VAL . 2.1 tp -80.13 126.63 31.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -116.66 147.18 42.18 Favored 'General case' 0 C--O 1.205 -1.247 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.6 mt -61.59 132.35 27.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.808 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.402 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 100.41 -0.34 55.72 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 73.1 m-20 -75.86 119.94 20.54 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -83.47 114.53 21.54 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 109' ' ' VAL . 12.1 mt -86.63 123.79 39.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.835 -173.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.45 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 31.3 mmt -107.66 -17.91 13.97 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.228 0.537 . . . . 0.0 110.192 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.431 ' CB ' ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -147.13 137.69 23.55 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 107' ' ' LEU . 18.4 t -139.89 115.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 123.276 0.63 . . . . 0.0 109.326 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASN . . . . . 0.455 ' ND2' ' HG2' ' A' ' 102' ' ' GLU . 31.4 t30 53.12 35.76 20.57 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.802 1.241 . . . . 0.0 111.313 173.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.428 ' C ' HE22 ' A' ' 79' ' ' GLN . . . 73.73 7.35 74.56 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 114.584 -1.189 . . . . 0.0 115.443 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.576 ' CZ2' ' HG3' ' A' ' 96' ' ' ARG 0.325 0.1 OUTLIER -81.39 -86.12 0.09 Allowed 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 118.21 1.005 . . . . 0.0 112.762 -179.965 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 162.99 111.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 126.404 1.881 . . . . 0.0 107.161 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.443 ' HE3' HG21 ' A' ' 55' ' ' ILE . 4.1 tpt -113.0 -1.88 14.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.884 -174.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.45 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 9.9 t -72.41 -33.97 67.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.933 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.546 ' SD ' HG21 ' A' ' 37' ' ' ILE . 16.4 tpt -128.54 85.83 2.38 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.505 HG13 HG13 ' A' ' 55' ' ' ILE . 7.2 p -161.06 147.53 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.891 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 38' ' ' ASP . 8.7 p -69.8 159.55 33.38 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.995 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.474 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 7.9 t60 -57.64 -41.74 82.03 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.616 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.45 -51.14 70.76 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.486 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.538 ' O ' ' HG2' ' A' ' 96' ' ' ARG . 2.2 mp0 -72.06 -34.67 68.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.17 -178.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -33.06 65.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -52.74 -48.72 66.53 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 95' ' ' LYS . 39.6 pttt -83.72 26.68 0.68 Allowed 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.649 0.737 . . . . 0.0 110.885 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 24.3 mmt180 -131.56 -29.03 1.79 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.004 176.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -106.72 -27.6 10.69 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.288 174.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.409 ' N ' HD13 ' A' ' 97' ' ' LEU . 8.7 t -112.47 16.8 19.72 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.754 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.3 ptpt -64.8 165.08 11.11 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.172 168.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -122.91 4.74 9.38 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.946 0.879 . . . . 0.0 109.374 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -45.44 94.78 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.744 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.455 ' HG2' ' ND2' ' A' ' 81' ' ' ASN . 2.0 mp0 -107.69 179.91 4.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.412 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 8.3 pt-20 -132.35 -62.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 28.4 t -95.99 126.16 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.586 HG21 HD13 ' A' ' 29' ' ' LEU . 28.0 m -127.04 153.02 35.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.088 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 92.5 mtt180 -124.47 116.52 22.64 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.87 147.57 40.92 Favored 'General case' 0 N--CA 1.395 -3.218 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -174.442 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.431 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 6.9 mp -111.98 121.5 45.17 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 35.5 m -117.2 147.35 20.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.002 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.657 HG22 HG22 ' A' ' 13' ' ' VAL . 47.1 p -117.81 127.18 53.64 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.764 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 114' ' ' LEU . 85.6 mtt180 -97.5 97.24 8.92 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.521 0.677 . . . . 0.0 110.595 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -80.99 -44.56 17.95 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.802 -1.544 . . . . 0.0 111.195 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.6 t -141.98 20.12 2.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 3.7 mm? -129.0 40.9 3.56 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -75.99 -22.19 56.1 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.11 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 71.06 177.37 0.27 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.13 1.372 . . . . 0.0 111.01 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.75 164.98 33.81 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t 64.04 75.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-O 122.551 1.167 . . . . 0.0 109.714 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -87.25 2.53 49.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.79 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -75.68 71.06 2.54 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.958 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 t -130.86 8.41 4.84 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -160.42 178.82 9.19 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 tp 57.53 71.61 0.57 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.559 1.143 . . . . 0.0 111.249 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.3 m . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.717 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.967 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -104.36 -30.61 9.99 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 117.116 0.458 . . . . 0.0 110.368 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.8 t80 68.29 91.47 0.09 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.148 0.975 . . . . 0.0 112.264 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 mm -114.22 93.38 30.67 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -69.63 167.3 24.67 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.109 1.873 . . . . 0.0 112.748 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.23 50.69 4.41 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 50.9 tt0 -63.63 124.63 85.34 Favored Pre-proline 0 N--CA 1.438 -1.034 0 C-N-CA 123.302 0.641 . . . . 0.0 110.975 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' O ' HG13 ' A' ' 9' ' ' VAL . 18.6 Cg_endo -64.66 -63.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.154 1.903 . . . . 0.0 110.218 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 8' ' ' PRO . 1.2 m 157.59 -42.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 129.121 2.969 . . . . 0.0 109.014 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 113' ' ' SER . 13.9 t -78.74 -15.15 58.8 Favored 'General case' 0 C--O 1.208 -1.103 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.49 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -132.58 136.56 46.64 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.58 117.66 42.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 HG22 ' A' ' 110' ' ' THR . 25.2 t -84.32 119.8 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.27 152.81 49.29 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.34 146.2 24.95 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.898 -174.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -125.87 158.01 35.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.445 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 36.3 tt0 -146.7 103.78 3.68 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.531 0.681 . . . . 0.0 110.777 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.58 126.57 44.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.978 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.497 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 2.8 m-70 -96.94 161.95 13.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 124.232 0.957 . . . . 0.0 109.902 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HG3' HD11 ' A' ' 27' ' ' LEU . 39.6 ttmt -40.68 125.88 2.31 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.237 1.415 . . . . 0.0 113.705 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD22 ' HD2' ' A' ' 65' ' ' PRO . 42.8 tp -139.71 131.43 27.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.037 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -99.96 137.07 38.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -128.49 104.21 7.56 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 174.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.96 -108.55 2.52 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -111.85 9.59 20.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.267 0.556 . . . . 0.0 110.679 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.65 172.03 7.28 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' A' ' 20' ' ' LYS . 14.3 tp -122.77 115.74 22.53 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.17 153.62 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.574 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.3 mp -78.59 0.16 27.41 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.667 0.746 . . . . 0.0 111.423 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.54 -37.81 3.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.927 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 34.3 p90 -100.64 178.21 4.78 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -143.57 168.04 20.8 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 124.274 1.03 . . . . 0.0 110.053 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD21 ' A' ' 97' ' ' LEU . 11.1 pt -127.43 167.7 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 117.944 0.338 . . . . 0.0 111.87 -171.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.07 -29.89 4.13 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 127.24 161.82 10.96 Favored Glycine 0 N--CA 1.42 -2.406 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.376 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.605 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -108.19 -119.41 4.34 Favored Glycine 0 N--CA 1.428 -1.899 0 O-C-N 124.16 0.565 . . . . 0.0 112.652 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -24.27 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.153 0.502 . . . . 0.0 111.759 -175.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.8 t70 -66.63 -13.03 60.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.773 1.229 . . . . 0.0 111.014 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.529 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.8 mm100 -104.61 169.63 8.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.899 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.503 ' HB3' ' CD ' ' A' ' 43' ' ' GLN . 12.3 t70 -114.19 128.08 26.17 Favored Pre-proline 0 CA--C 1.486 -1.502 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.0 Cg_endo -57.08 -32.11 92.27 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.023 1.815 . . . . 0.0 113.731 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.2 t -65.75 -32.18 73.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.503 ' CD ' ' HB3' ' A' ' 40' ' ' ASP . 1.9 pt20 -105.94 13.69 29.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.534 0.683 . . . . 0.0 110.784 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.522 ' ND2' ' HB3' ' A' ' 39' ' ' GLN . 13.0 m-80 -112.26 146.05 34.1 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 46.5 Cg_endo -64.94 -53.47 0.89 Allowed 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 123.271 2.647 . . . . 0.0 113.349 -171.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.413 ' CZ ' HG22 ' A' ' 73' ' ' ILE . 58.2 m-85 -101.24 0.86 38.19 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.602 0.715 . . . . 0.0 110.624 -176.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 6.2 t -102.47 -10.76 19.1 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.69 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 10.7 pt-20 -71.5 -30.04 65.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.295 1.045 . . . . 0.0 108.828 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -82.89 -38.43 22.9 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.768 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -128.42 117.1 20.79 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.6 p -83.71 8.2 15.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -172.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.72 105.74 13.99 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 58.9 mtmt -74.55 159.99 31.47 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.811 0.815 . . . . 0.0 112.388 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.2 153.1 5.79 Favored Glycine 0 C--O 1.185 -2.935 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.637 HD12 HD12 ' A' ' 33' ' ' ILE . 29.1 mm -64.25 127.94 25.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 118.708 1.254 . . . . 0.0 111.584 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -129.88 155.5 45.92 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.85 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.771 HG21 HD11 ' A' ' 71' ' ' LEU . 95.2 t -85.02 130.45 36.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 O-C-N 124.441 1.088 . . . . 0.0 111.028 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -107.35 -20.02 13.4 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 41.2 ttt-85 -142.74 143.29 32.18 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.437 HG13 ' CB ' ' A' ' 66' ' ' ALA . 45.9 t -128.38 144.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t -59.32 126.5 27.9 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.68 -26.48 68.68 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.626 1.17 . . . . 0.0 110.834 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.97 52.44 0.53 Allowed Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.766 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.41 -172.51 12.97 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.878 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.547 ' HD2' HD22 ' A' ' 21' ' ' LEU . 36.9 Cg_endo -64.52 -28.12 61.84 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 124.326 3.35 . . . . 0.0 111.619 -173.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.437 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -60.44 -58.86 6.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.958 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -69.17 -31.27 69.79 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.535 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.8 mm -59.79 -49.45 83.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.043 0.449 . . . . 0.0 110.546 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -71.43 -47.86 53.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.891 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.61 22.6 0.18 Allowed Glycine 0 C--N 1.302 -1.308 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.647 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.771 HD11 HG21 ' A' ' 57' ' ' VAL . 2.4 tp -85.88 122.92 30.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.9 mm100 -115.43 154.09 29.89 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 121.779 0.8 . . . . 0.0 109.098 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.413 HG22 ' CZ ' ' A' ' 46' ' ' PHE . 49.5 mt -65.33 124.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.147 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -15.36 23.54 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 64.6 m-20 -67.63 130.75 44.0 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.056 0.455 . . . . 0.0 110.533 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -92.37 127.15 37.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.734 HD11 HG23 ' A' ' 57' ' ' VAL . 2.9 mp -94.92 127.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -175.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.419 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 28.8 mmt -103.53 -20.55 13.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.987 0.423 . . . . 0.0 110.689 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 6.5 tp-100 -152.48 129.55 11.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.066 -172.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.473 HG13 HD12 ' A' ' 107' ' ' LEU . 38.8 t -137.16 115.71 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.822 0.849 . . . . 0.0 110.329 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 46.0 t30 53.04 41.75 32.18 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.243 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.68 90.14 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.112 -0.949 . . . . 0.0 115.062 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.417 ' CZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -114.0 150.09 34.39 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.16 136.81 36.58 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.781 0.718 . . . . 0.0 109.884 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.509 ' HE3' ' HB1' ' A' ' 93' ' ' ALA . 7.5 tpt -116.63 -7.06 11.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.229 -175.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.419 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 8.1 t -58.63 -34.91 71.7 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.084 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.0 ttp -137.99 91.07 2.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.417 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 7.2 p -154.24 151.55 10.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.029 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 38' ' ' ASP . 11.8 p -75.39 159.59 31.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.493 0.187 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.515 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 11.4 t60 -55.45 -42.77 74.7 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.562 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 39.2 t70 -59.3 -54.0 51.86 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.756 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -30.17 69.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.866 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 85' ' ' MET . . . -71.76 -44.59 63.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.164 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.92 -43.28 86.16 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.673 0.749 . . . . 0.0 109.471 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HE3' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.4 40.34 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.405 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.412 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 11.2 tpt180 -150.02 -45.63 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.243 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -99.16 -26.15 14.29 Favored 'General case' 0 C--O 1.196 -1.722 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.466 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.4 t -111.91 17.09 20.04 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 118.22 -1.392 . . . . 0.0 109.601 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 16.0 ptpt -72.14 161.49 30.81 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -114.43 9.69 16.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.752 0.787 . . . . 0.0 110.373 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.519 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 36.5 m -80.57 -30.44 37.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.851 -177.137 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -110.11 156.73 20.19 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 6.7 pt-20 -110.51 -67.71 0.98 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.865 0.364 . . . . 0.0 111.869 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -103.96 125.11 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-O 122.106 0.955 . . . . 0.0 112.578 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.48 HG23 HD21 ' A' ' 107' ' ' LEU . 15.6 m -126.18 168.48 19.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.453 -175.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.448 ' HD2' ' C ' ' A' ' 105' ' ' VAL . 5.1 mpt_? -127.06 116.29 20.49 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -118.9 153.34 34.72 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.1 mp -125.4 123.6 39.67 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 77' ' ' ILE . 30.2 m -124.09 155.44 31.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.6 -176.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.571 HG22 HG22 ' A' ' 13' ' ' VAL . 11.4 p -98.69 124.32 43.44 Favored 'General case' 0 N--CA 1.383 -3.821 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -65.58 -15.68 62.96 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.645 1.578 . . . . 0.0 111.693 -168.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 64.62 72.9 0.44 Allowed 'General case' 0 CA--C 1.457 -2.618 0 CA-C-O 123.373 1.559 . . . . 0.0 112.211 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 10' ' ' THR . 3.0 m -92.52 -3.24 55.41 Favored 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 111.805 -2.452 . . . . 0.0 108.306 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.6 tp -90.15 92.88 9.14 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -122.15 -170.95 2.16 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.709 -174.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -88.55 168.41 12.6 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.25 149.16 21.43 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.81 60.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 123.526 1.631 . . . . 0.0 109.076 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -76.86 -29.53 55.89 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.543 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -68.6 149.69 48.87 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.047 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.1 m -138.17 107.9 6.26 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 74.5 mtm -85.12 103.57 14.23 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.327 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -106.04 89.35 3.04 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 C--N 1.314 -0.954 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.62 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.898 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 m -75.76 114.02 13.89 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -58.26 -57.32 13.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.399 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm 54.1 92.31 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 123.701 0.8 . . . . 0.0 110.949 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.25 150.97 81.65 Favored 'Trans proline' 0 CA--C 1.506 -0.902 0 C-N-CA 122.288 1.992 . . . . 0.0 113.475 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.58 36.86 3.63 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -138.74 146.99 52.71 Favored Pre-proline 0 N--CA 1.413 -2.306 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.01 -99.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 121.676 1.584 . . . . 0.0 115.289 -170.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.24 -51.89 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 121.532 0.682 . . . . 0.0 110.99 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -74.69 -13.35 60.61 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.699 -175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.98 139.33 50.36 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.948 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t -114.37 127.6 71.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.225 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.24 127.35 53.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.97 154.72 49.02 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.372 -176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -95.12 145.47 24.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.093 0.473 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 107' ' ' LEU . 9.6 p -129.95 150.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.81 107.34 6.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 122.138 0.971 . . . . 0.0 111.036 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -96.49 125.78 49.32 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.114 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.441 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 3.4 m-70 -94.68 165.5 12.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.545 ' HB2' HD21 ' A' ' 27' ' ' LEU . 18.5 ptpt -48.65 129.49 16.55 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 176.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 42.6 tp -120.68 122.65 40.92 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 111.98 22.88 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -119.05 102.86 9.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.33 -109.03 2.47 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.28 16.73 21.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.308 0.575 . . . . 0.0 110.822 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.04 167.98 10.67 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.3 tm? -127.24 105.88 8.85 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 102.472 -3.158 . . . . 0.0 102.472 174.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -122.16 163.93 19.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.046 -174.642 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.4 mp -89.93 0.57 57.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.135 0.969 . . . . 0.0 110.245 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 61' ' ' SER . . . 91.46 -41.31 2.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.239 -0.892 . . . . 0.0 115.095 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 42.3 p90 -96.18 170.58 9.16 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 117.448 0.624 . . . . 0.0 112.615 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.7 m -130.44 165.84 21.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.259 1.023 . . . . 0.0 109.702 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.688 HD12 HD12 ' A' ' 55' ' ' ILE . 7.7 pt -124.74 168.95 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 120.461 0.172 . . . . 0.0 110.673 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.45 -23.98 6.08 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.608 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 125.01 172.29 13.46 Favored Glycine 0 N--CA 1.414 -2.805 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.366 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.55 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.56 -113.71 2.47 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 124.525 0.779 . . . . 0.0 112.5 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.564 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -69.61 -24.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.013 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB2' HG22 ' A' ' 89' ' ' THR . 27.3 t70 -70.62 -12.53 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.98 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.542 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 5.4 mm100 -106.23 157.92 17.23 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.504 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 8.0 t70 -97.38 123.43 52.59 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -61.86 -26.49 79.3 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.426 2.084 . . . . 0.0 113.523 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -72.35 -23.21 61.1 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 1.4 pt20 -122.12 20.49 10.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.415 0.626 . . . . 0.0 111.006 -178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -111.82 140.88 23.8 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.36 -39.99 34.24 Favored 'Trans proline' 0 C--O 1.222 -0.284 0 C-N-CA 123.663 2.909 . . . . 0.0 113.632 -170.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CD1' ' HA2' ' A' ' 74' ' ' GLY . 53.5 m-85 -119.72 22.19 11.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.762 0.792 . . . . 0.0 109.693 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 4.6 t -125.77 1.0 7.43 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -81.78 -6.66 59.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.012 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -69.4 -42.65 74.8 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.36 -177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -166.25 171.16 12.47 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 123.667 0.787 . . . . 0.0 109.073 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 p -79.44 19.52 0.61 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.802 0.81 . . . . 0.0 112.823 -173.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.23 99.52 12.29 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.154 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 36.4 mtmm -87.11 -179.48 6.47 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.56 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.525 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 139.87 169.08 11.53 Favored Glycine 0 CA--C 1.472 -2.626 0 N-CA-C 106.218 -2.753 . . . . 0.0 106.218 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.688 HD12 HD12 ' A' ' 33' ' ' ILE . 24.2 mm -76.69 131.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 118.779 1.29 . . . . 0.0 109.839 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.2 p90 -128.61 149.01 50.82 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 71' ' ' LEU . 95.6 t -78.48 130.88 35.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 124.459 1.1 . . . . 0.0 111.657 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -106.88 -20.4 13.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.103 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 6.9 ttm180 -144.31 143.44 30.99 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.452 HG13 ' CB ' ' A' ' 66' ' ' ALA . 38.4 t -126.53 136.79 59.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.605 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.4 t -55.14 119.76 5.97 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.545 1.153 . . . . 0.0 110.062 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.62 2.59 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 111.471 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.19 41.49 0.27 Allowed Glycine 0 C--N 1.273 -2.954 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.73 -173.09 12.83 Favored Glycine 0 N--CA 1.414 -2.821 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.784 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.2 Cg_endo -65.78 -28.23 51.54 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 124.847 3.698 . . . . 0.0 112.237 -173.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.452 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -58.74 -59.17 5.84 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 61' ' ' SER . 5.5 pt-20 -72.32 -27.86 62.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.577 178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -61.19 -40.95 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.013 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.79 -47.64 18.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.02 16.89 0.41 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.422 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.787 HD11 HG21 ' A' ' 57' ' ' VAL . 1.8 tp -74.57 127.79 33.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.418 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.8 mm100 -113.73 148.49 36.35 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.3 0.571 . . . . 0.0 110.179 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.49 123.3 19.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 46' ' ' PHE . . . 112.99 -15.18 23.59 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.784 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -63.78 127.2 30.31 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.684 0.284 . . . . 0.0 111.021 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.7 123.29 33.6 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.699 HD11 HG23 ' A' ' 57' ' ' VAL . 3.7 mp -90.58 126.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -112.26 -7.7 14.0 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.034 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.635 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -159.96 136.5 9.01 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.587 HG22 HD22 ' A' ' 107' ' ' LEU . 34.0 t -142.49 119.7 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.749 1.219 . . . . 0.0 109.168 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.3 t30 46.08 57.84 4.91 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 124.533 1.133 . . . . 0.0 112.176 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 75.1 -17.47 2.96 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 113.644 -1.616 . . . . 0.0 115.37 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.401 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -92.49 156.92 16.84 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -94.91 127.32 40.86 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.488 ' SD ' HD23 ' A' ' 97' ' ' LEU . 29.1 ttm -105.82 3.54 28.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.313 1.054 . . . . 0.0 110.695 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.482 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.6 t -61.14 -23.04 65.25 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.374 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.564 ' SD ' HG21 ' A' ' 37' ' ' ILE . 52.0 tpp -140.94 90.14 2.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.406 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 8.9 p -160.33 150.03 5.82 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 38' ' ' ASP . 17.9 p -76.23 159.98 30.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.061 0.458 . . . . 0.0 110.414 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t60 -54.58 -41.43 69.84 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.379 175.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.92 -47.59 85.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.752 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.14 -37.35 69.44 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.431 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.662 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.85 -45.49 85.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.749 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.416 ' HG2' HD11 ' A' ' 33' ' ' ILE . 12.0 mmm180 -53.63 -39.05 64.65 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 122.828 0.451 . . . . 0.0 111.488 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.73 24.41 0.88 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.947 0.403 . . . . 0.0 111.153 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.586 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 20.6 ttm180 -145.22 -37.98 0.27 Allowed 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -97.51 -17.05 19.83 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.471 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.1 t -122.7 14.18 10.09 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.846 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.2 ptpt -62.28 161.6 11.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.921 173.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -124.94 19.07 8.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.016 0.912 . . . . 0.0 110.338 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.412 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 47.4 m -84.15 -27.51 28.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.073 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -125.02 159.86 30.35 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.379 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -97.64 -70.47 0.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -109.69 128.55 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 m -132.67 148.81 31.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.171 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -100.28 124.61 45.94 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 80' ' ' VAL . 3.9 mt -119.71 154.3 34.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.5 mp -120.08 125.57 48.63 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-O 121.015 0.436 . . . . 0.0 110.389 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 22.1 m -119.8 150.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.223 -177.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.8 p -114.12 128.96 56.61 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.469 0.652 . . . . 0.0 111.429 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -94.35 100.41 12.44 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -80.92 -39.25 26.54 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m 51.18 27.34 3.4 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.967 1.707 . . . . 0.0 114.215 173.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 mt 47.63 91.09 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -97.67 -60.73 1.51 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -137.57 114.97 11.07 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.221 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.19 170.11 9.62 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.9 t 58.93 66.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 122.796 1.284 . . . . 0.0 110.229 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -138.77 102.79 4.66 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -115.35 110.99 20.18 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.077 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.4 m 62.25 22.86 13.46 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.514 1.126 . . . . 0.0 112.54 176.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 55.1 ttm -127.71 140.62 51.96 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -90.9 163.89 14.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.42 -1.954 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -177.874 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.005 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -117.07 111.27 19.29 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -82.11 -65.79 0.97 Allowed 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.507 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp 61.88 100.04 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.244 1.018 . . . . 0.0 111.782 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.17 -169.74 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.979 2.453 . . . . 0.0 111.802 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.14 50.35 0.37 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -93.8 121.64 64.0 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.665 -0.268 . . . . 0.0 111.415 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' O ' HG13 ' A' ' 9' ' ' VAL . 24.2 Cg_endo -69.19 -70.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.318 2.012 . . . . 0.0 110.671 174.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 178.42 -50.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 127.326 2.251 . . . . 0.0 109.99 177.021 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -78.92 -32.43 45.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.954 0.883 . . . . 0.0 110.372 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.32 142.28 40.45 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.28 136.67 55.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -107.61 138.5 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -135.32 153.34 51.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 139.8 38.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 107' ' ' LEU . 8.5 p -128.66 158.31 41.06 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.21 101.99 4.4 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.386 0.612 . . . . 0.0 110.245 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -93.52 127.87 45.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.027 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 2.9 m-70 -93.07 156.79 16.65 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HB2' HD21 ' A' ' 27' ' ' LEU . 24.0 pttm -49.54 125.89 12.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 45.2 tp -119.05 119.01 32.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.203 175.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -101.67 118.65 37.38 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.415 HE21 HD21 ' A' ' 21' ' ' LEU . 48.0 mt-30 -121.8 105.23 10.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 -112.46 5.03 Favored Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.869 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.24 3.09 51.51 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.137 0.494 . . . . 0.0 109.721 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.64 161.69 20.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-O 122.128 0.966 . . . . 0.0 110.59 -171.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.8 tm? -122.75 113.97 19.92 Favored 'General case' 0 C--N 1.256 -3.459 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 171.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -126.38 157.92 36.63 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.919 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 98' ' ' THR . 3.2 mm? -94.65 6.34 49.17 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 123.337 1.541 . . . . 0.0 108.588 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 92.37 -46.9 2.59 Favored Glycine 0 C--N 1.294 -1.764 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.161 172.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.418 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 49.4 p90 -89.13 166.36 13.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -175.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 55.2 m -120.65 168.13 11.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.702 1.201 . . . . 0.0 109.73 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 55' ' ' ILE . 5.9 pt -125.77 164.39 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 120.857 0.36 . . . . 0.0 110.298 -177.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.73 -20.99 7.75 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.304 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.632 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 123.17 171.37 13.64 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.558 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -122.15 -117.44 2.44 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 124.388 0.699 . . . . 0.0 112.6 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -22.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' HG22 ' A' ' 89' ' ' THR . 23.1 t70 -74.94 -15.01 60.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.26 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.632 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 5.0 mm100 -100.17 167.37 10.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 2.3 t70 -108.0 111.95 61.88 Favored Pre-proline 0 CA--C 1.497 -1.08 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 10.2 Cg_endo -54.31 -24.69 35.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.582 2.855 . . . . 0.0 113.314 -175.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -66.15 -33.45 75.79 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.217 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.41 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 1.6 pt20 -112.49 15.39 20.18 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.933 0.873 . . . . 0.0 110.632 -176.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 8.3 m120 -102.11 142.0 23.69 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.998 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.55 -45.02 7.48 Favored 'Trans proline' 0 C--O 1.221 -0.36 0 C-N-CA 123.507 2.805 . . . . 0.0 113.171 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 67.8 m-85 -113.2 17.95 18.28 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.659 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 1.8 t -123.03 -10.78 8.14 Favored 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.98 -11.07 60.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.023 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.02 -30.52 71.08 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.155 0.982 . . . . 0.0 109.92 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -134.96 -170.38 2.56 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.017 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -116.8 8.47 13.66 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -80.04 146.29 32.04 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.543 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -95.76 -146.48 0.28 Allowed 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 123.105 0.562 . . . . 0.0 109.513 -176.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.471 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 96.98 154.18 29.88 Favored Glycine 0 C--O 1.178 -3.355 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 33' ' ' ILE . 21.4 mm -76.95 126.25 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 118.26 1.03 . . . . 0.0 110.779 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.08 148.96 44.22 Favored 'General case' 0 CA--C 1.486 -1.498 0 O-C-N 122.107 -0.37 . . . . 0.0 111.353 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.684 HG21 HD11 ' A' ' 71' ' ' LEU . 95.8 t -74.46 130.92 35.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 124.423 1.077 . . . . 0.0 110.273 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.516 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.3 p -105.99 -22.21 12.95 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.353 0.596 . . . . 0.0 110.466 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -154.59 142.07 19.71 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 21.0 m -109.12 -179.91 0.9 Allowed 'Isoleucine or valine' 1 N--CA 1.352 -5.368 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 30.3 t -79.55 126.82 31.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.22 -16.19 1.17 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.645 1.578 . . . . 0.0 114.321 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.91 43.46 0.2 Allowed Glycine 0 CA--C 1.483 -1.943 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.29 -168.31 13.69 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.725 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.502 ' HB2' HG23 ' A' ' 18' ' ' ILE . 33.8 Cg_endo -64.06 -30.66 66.1 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 123.433 2.755 . . . . 0.0 111.939 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.26 -64.77 0.74 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.4 pt-20 -70.9 -31.89 68.67 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.557 -0.857 . . . . 0.0 112.146 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.6 mm -59.77 -40.11 81.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.0 -38.64 27.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.95 17.62 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.712 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.684 HD11 HG21 ' A' ' 57' ' ' VAL . 4.9 tp -83.18 127.24 33.44 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.539 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 23.8 mm-40 -115.5 151.29 35.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 111.08 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.85 130.23 33.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.006 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.02 4.3 55.5 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.172 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 13.4 m-20 -102.27 128.76 48.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.151 0.5 . . . . 0.0 111.873 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -79.72 119.28 22.43 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.242 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.437 HD11 ' CG2' ' A' ' 57' ' ' VAL . 19.5 mt -84.62 121.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.308 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.3 mmt -111.56 -6.85 14.35 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.649 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.524 ' CB ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.21 134.65 13.43 Favored 'General case' 0 C--O 1.203 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.632 HG22 HD22 ' A' ' 107' ' ' LEU . 46.4 t -136.96 122.81 27.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 63.5 t30 72.58 -34.99 0.31 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 127.338 2.255 . . . . 0.0 113.004 174.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 134.95 15.32 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.487 ' HE1' ' HB2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -99.49 -15.69 18.6 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -175.101 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.55 109.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.326 1.451 . . . . 0.0 111.568 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.533 ' SD ' HD13 ' A' ' 97' ' ' LEU . 32.0 ttm -111.87 7.6 20.13 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.765 0.793 . . . . 0.0 111.366 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 5.2 t -56.1 -27.41 53.7 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 ttm -143.82 96.1 2.84 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.474 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.0 p -157.09 151.76 8.24 Favored 'Isoleucine or valine' 0 C--O 1.257 1.479 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.485 HG22 ' HB2' ' A' ' 38' ' ' ASP . 23.7 p -74.33 155.57 38.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -51.41 -43.81 62.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -61.89 -46.71 88.19 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.989 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -31.25 57.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.179 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 -42.11 68.24 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -51.14 -43.25 61.17 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -92.81 50.87 1.62 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.343 1.068 . . . . 0.0 109.568 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -157.85 -50.57 0.07 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.238 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.533 HD13 ' SD ' ' A' ' 85' ' ' MET . 0.8 OUTLIER -93.95 -20.48 19.96 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.331 -1.348 . . . . 0.0 112.969 -174.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.467 ' HA ' HD23 ' A' ' 29' ' ' LEU . 10.7 t -123.08 13.43 9.72 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.809 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 16.2 ptpt -71.58 173.69 7.7 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 175.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' CB ' ' HB3' ' A' ' 27' ' ' LEU . 12.3 ptt180 -107.88 -0.48 21.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 25.8 t -78.02 -23.03 48.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.671 0.748 . . . . 0.0 109.443 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.03 160.09 19.41 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.328 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.58 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -120.58 -77.94 0.59 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.552 174.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.58 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -110.61 133.24 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 C-N-CA 123.534 0.734 . . . . 0.0 109.206 176.507 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 107' ' ' LEU . 14.6 m -126.73 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.66 108.01 19.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.58 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 80' ' ' VAL . 5.6 mt -116.17 149.16 39.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.427 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 7.8 mp -122.37 129.15 51.83 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.438 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 23.6 m -121.36 148.6 24.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 O-C-N 123.997 0.811 . . . . 0.0 110.481 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 p -112.36 127.5 56.03 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -90.71 115.71 28.01 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -174.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -97.12 -44.56 6.91 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.957 -174.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.6 m -85.56 18.38 2.82 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.539 0.685 . . . . 0.0 111.85 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 49.3 tp -80.82 -40.58 24.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.765 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -151.53 178.44 9.31 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -86.54 144.76 27.07 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.09 -179.14 5.61 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.813 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t 66.82 84.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 122.272 1.034 . . . . 0.0 109.676 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -109.97 -25.26 10.36 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.672 -1.149 . . . . 0.0 113.293 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -133.99 137.06 44.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.7 m -96.17 109.2 21.7 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.1 mtt -64.85 -64.77 0.79 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.52 -67.65 0.91 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.165 0.507 . . . . 0.0 109.73 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.264 1.851 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.008 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.146 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 66.14 27.98 10.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.217 1.007 . . . . 0.0 111.285 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -94.62 -12.35 27.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.01 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.0 mt 70.65 98.92 0.04 OUTLIER Pre-proline 0 C--O 1.241 0.652 0 C-N-CA 123.742 0.817 . . . . 0.0 110.311 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.04 172.44 16.26 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.756 2.304 . . . . 0.0 113.044 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.2 52.96 0.67 Allowed Glycine 0 N--CA 1.435 -1.389 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -77.59 130.51 73.7 Favored Pre-proline 0 CA--C 1.506 -0.715 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -71.73 -73.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 121.344 1.363 . . . . 0.0 110.4 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 m -154.98 -53.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 124.45 1.1 . . . . 0.0 109.774 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -99.9 -42.59 6.73 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -75.59 140.49 42.68 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.426 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.3 t -86.15 115.57 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.55 144.65 14.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.39 149.74 36.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 3.2 ppt_? -93.5 145.42 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.848 0.356 . . . . 0.0 110.584 -176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -120.67 153.37 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -139.42 104.43 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.0 mp -94.6 133.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.743 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -104.32 128.86 52.19 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.974 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HB2' HD11 ' A' ' 27' ' ' LEU . 39.8 pttt -20.62 103.96 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.577 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.6 tp -102.4 123.83 46.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.981 0.419 . . . . 0.0 110.31 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -92.57 118.12 30.67 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' NE2' HD12 ' A' ' 28' ' ' ILE . 16.7 mt-30 -126.86 109.02 11.53 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.423 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.95 -98.89 0.65 Allowed Glycine 0 C--N 1.307 -1.03 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.994 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -116.65 5.32 13.21 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.35 160.44 39.82 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.713 0.768 . . . . 0.0 110.816 -169.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 20' ' ' LYS . 26.4 tp -104.84 127.45 52.65 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.419 HD12 ' NE2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -133.88 169.32 21.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.652 -178.464 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 105' ' ' VAL . 47.1 mt -92.75 -1.85 56.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.86 -36.6 3.8 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.56 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -100.56 167.63 10.23 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.807 -0.819 . . . . 0.0 112.913 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.9 m -129.25 168.35 16.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.292 1.437 . . . . 0.0 109.339 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.637 HG21 HD21 ' A' ' 97' ' ' LEU . 6.5 pt -124.06 169.88 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.02 0.438 . . . . 0.0 111.355 -172.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.99 -21.24 5.71 Favored Glycine 0 CA--C 1.479 -2.2 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.548 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 121.85 170.9 13.92 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.757 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.633 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -124.24 -105.26 1.64 Allowed Glycine 0 N--CA 1.408 -3.201 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.705 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -23.85 13.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.528 0.68 . . . . 0.0 110.947 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.769 ' HB3' HG22 ' A' ' 89' ' ' THR . 14.7 p-10 -86.11 3.65 41.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.183 -174.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.518 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 12.3 mm100 -107.55 156.12 19.35 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.089 173.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -99.34 118.65 62.01 Favored Pre-proline 0 CA--C 1.496 -1.11 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.6 Cg_endo -55.89 -25.2 51.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.16 2.573 . . . . 0.0 113.484 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 -17.16 62.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -132.85 28.8 4.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.126 0.489 . . . . 0.0 111.437 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.646 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 93.0 m-20 -106.25 147.0 34.08 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 122.175 -0.328 . . . . 0.0 111.067 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.55 -50.91 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.949 2.433 . . . . 0.0 112.613 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.41 4.88 28.93 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 0.0 111.447 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 2.2 t -114.35 1.96 14.58 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.578 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.13 -22.4 45.17 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.43 -37.96 24.7 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.679 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -137.99 130.79 29.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.9 p -83.99 2.42 39.02 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.387 0.613 . . . . 0.0 112.488 -172.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.21 114.15 14.57 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.482 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 37.6 mtmm -82.4 -178.27 6.99 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.381 0.61 . . . . 0.0 112.335 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.05 138.38 4.87 Favored Glycine 0 C--O 1.191 -2.576 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 36' ' ' GLY . 24.5 mm -50.48 124.81 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.622 1.169 . . . . 0.0 112.546 -174.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -126.59 156.54 40.74 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.287 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 71' ' ' LEU . 81.7 t -82.24 137.26 21.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 O-C-N 124.591 1.182 . . . . 0.0 110.43 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 p -110.89 -22.46 11.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.479 0.657 . . . . 0.0 111.172 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 19.3 mmt180 -143.68 135.92 26.83 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.527 ' CG2' HG11 ' A' ' 57' ' ' VAL . 71.9 t -128.22 139.72 51.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.639 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.7 m -57.55 112.54 1.46 Allowed 'General case' 0 N--CA 1.42 -1.961 0 O-C-N 124.103 0.877 . . . . 0.0 111.281 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.82 -11.81 49.26 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.051 0.844 . . . . 0.0 112.752 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 22.91 2.71 Favored Glycine 0 C--N 1.285 -2.252 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . -111.93 -179.95 19.75 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.32 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.577 ' HD2' HD22 ' A' ' 21' ' ' LEU . 38.6 Cg_endo -63.75 -27.54 68.21 Favored 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 124.537 3.491 . . . . 0.0 111.764 -171.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -56.86 -60.53 3.43 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.0 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.2 pt-20 -87.1 -17.27 33.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.754 -1.578 . . . . 0.0 112.761 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.418 ' HB ' ' HA ' ' A' ' 65' ' ' PRO . 12.9 mm -60.68 -34.3 58.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.69 3.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.431 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 155.67 22.71 0.04 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 119.558 -1.306 . . . . 0.0 114.121 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.746 HD11 HG21 ' A' ' 57' ' ' VAL . 4.0 tp -88.95 121.3 31.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.152 0.501 . . . . 0.0 110.844 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -110.55 164.48 12.67 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-O 121.859 0.837 . . . . 0.0 108.789 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.62 133.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.641 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.46 14.02 74.79 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 116.415 -0.357 . . . . 0.0 112.386 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 12.9 m-20 -71.0 1.4 5.72 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 21.5 mmmt 48.23 87.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 57' ' ' VAL . 11.4 mt -83.15 123.83 39.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.1 mmt -106.63 -19.66 13.59 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.197 0.522 . . . . 0.0 109.868 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 6.4 tp-100 -154.0 131.35 11.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.172 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.59 HG22 HD22 ' A' ' 107' ' ' LEU . 60.7 t -134.57 113.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 C-N-CA 123.732 0.813 . . . . 0.0 110.215 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 32.9 t30 50.58 29.09 3.83 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.612 1.565 . . . . 0.0 113.381 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 92.05 7.36 64.22 Favored Glycine 0 C--O 1.217 -0.95 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 178.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.523 ' CZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -107.75 -2.83 19.67 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -175.197 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.28 129.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 119.536 1.062 . . . . 0.0 111.779 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.509 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 26.5 ttm -129.77 1.29 4.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.998 0.904 . . . . 0.0 111.382 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -72.62 -19.17 61.51 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.834 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.0 ttp -139.29 89.15 2.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.523 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 10.0 p -161.29 143.01 3.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 38' ' ' ASP . 11.4 p -69.82 154.59 41.76 Favored 'General case' 0 N--CA 1.425 -1.721 0 O-C-N 123.539 0.524 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.52 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 8.8 t60 -53.85 -43.44 69.52 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.544 173.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.13 -44.05 95.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.895 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.18 -33.02 50.38 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.824 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.631 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.18 -40.08 71.44 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.04 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.559 ' CZ ' HG21 ' A' ' 98' ' ' THR . 13.7 mmm180 -53.79 -46.21 70.96 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 123.567 0.542 . . . . 0.0 110.434 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -86.7 36.84 0.72 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.855 0.836 . . . . 0.0 110.736 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.554 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.5 tpt180 -141.43 -46.92 0.38 Allowed 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.858 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.637 HD21 HG21 ' A' ' 33' ' ' ILE . 1.4 pp -96.05 -26.16 15.63 Favored 'General case' 0 C--O 1.203 -1.361 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.559 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 15.3 t -110.81 10.94 22.52 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.543 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.2 ptpt -68.84 162.36 26.62 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -115.46 8.43 15.24 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.086 0.47 . . . . 0.0 111.953 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -79.54 -30.57 41.83 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.287 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -112.73 171.87 7.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.022 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.8 pt-20 -130.43 -71.56 0.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.5 t -91.63 129.83 41.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 122.03 -0.418 . . . . 0.0 109.962 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.525 HG21 HD13 ' A' ' 29' ' ' LEU . 15.9 m -126.05 150.5 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.9 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 -109.32 101.65 10.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.59 HD22 HG22 ' A' ' 80' ' ' VAL . 21.0 mt -102.55 149.66 24.19 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.4 mp -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.266 -3.035 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 35.9 m -117.42 159.1 17.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.548 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.489 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 18.8 p -117.17 129.93 56.27 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-O 121.331 0.586 . . . . 0.0 110.144 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.5 mtp85 -78.57 -6.43 55.52 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -166.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 114' ' ' LEU . 25.4 mm-40 62.96 8.58 3.25 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.283 1.433 . . . . 0.0 113.727 174.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 p -75.85 24.49 0.12 Allowed 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 125.591 1.557 . . . . 0.0 111.516 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 112' ' ' GLN . 2.1 pp -84.79 -6.5 59.35 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.53 1.132 . . . . 0.0 112.575 -175.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -159.41 -46.71 0.05 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.504 0.669 . . . . 0.0 109.604 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -101.19 56.35 0.85 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.292 -175.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -120.13 -61.54 1.58 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.6 t -111.9 56.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -159.28 92.16 1.05 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.174 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -130.15 39.64 3.64 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.4 p -63.34 -172.08 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.849 1.66 . . . . 0.0 113.483 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.9 tpt 78.6 -45.13 0.39 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.178 1.391 . . . . 0.0 110.729 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.23 113.98 6.32 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.664 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.394 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.017 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t 74.25 161.94 0.25 Allowed 'General case' 0 C--O 1.25 1.097 0 C-N-CA 124.213 1.005 . . . . 0.0 111.214 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -85.33 115.72 23.25 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.27 108.89 56.85 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.97 172.46 14.59 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.492 2.128 . . . . 0.0 112.457 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.18 45.12 3.15 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 176.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' HA ' HG23 ' A' ' 13' ' ' VAL . 50.8 tt0 -70.57 130.38 89.03 Favored Pre-proline 0 N--CA 1.436 -1.127 0 C-N-CA 123.034 0.533 . . . . 0.0 110.479 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.67 -95.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.27 1.98 . . . . 0.0 111.55 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 m -155.84 -46.31 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.428 1.091 . . . . 0.0 110.873 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 t -78.9 -23.0 45.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.565 0.698 . . . . 0.0 111.233 -174.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.53 136.27 54.85 Favored 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.07 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 59.3 t -96.77 104.92 16.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 110' ' ' THR . 17.9 t -83.45 115.18 25.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.4 153.37 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -94.27 145.25 24.87 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.141 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.66 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.4 t -121.68 156.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 38.8 tt0 -143.92 104.69 4.19 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.98 0.895 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -99.13 129.38 49.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.877 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -100.23 144.63 29.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 22.3 pttm -40.39 127.2 2.34 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.5 tp -124.81 126.03 44.96 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.83 174.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -91.83 116.3 28.79 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.465 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 20.0 mt-30 -111.08 101.27 9.82 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.75 -117.49 8.19 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.52 9.26 42.81 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.99 166.89 13.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.124 0.488 . . . . 0.0 109.733 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.6 tm? -117.68 107.73 14.56 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.8 163.31 27.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.0 mp -87.06 7.23 28.72 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.681 0.753 . . . . 0.0 110.598 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA2' ' OE1' ' A' ' 23' ' ' GLN . . . 90.44 -41.12 2.96 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.64 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 38.9 p90 -97.51 175.65 6.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.4 m -140.66 168.92 18.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.493 1.117 . . . . 0.0 109.314 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 55' ' ' ILE . 8.7 pt -125.8 167.02 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 117.916 0.326 . . . . 0.0 111.282 -173.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.49 -28.47 4.84 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.557 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 127.46 165.79 11.96 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.052 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -113.75 -116.16 3.26 Favored Glycine 0 N--CA 1.423 -2.175 0 O-C-N 124.238 0.611 . . . . 0.0 112.173 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.611 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.04 -23.71 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB2' HG22 ' A' ' 89' ' ' THR . 24.7 t70 -67.93 -15.71 63.74 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.812 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.557 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 3.7 mm100 -108.87 150.19 28.04 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.549 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.3 t70 -93.11 122.65 62.97 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.68 -24.94 65.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.706 2.271 . . . . 0.0 113.41 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -70.81 -25.4 62.84 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.343 0.592 . . . . 0.0 110.128 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.549 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.1 pt20 -121.24 12.24 10.96 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.059 -176.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.447 HD21 ' HB2' ' A' ' 39' ' ' GLN . 94.2 m-20 -88.7 147.3 39.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.2 -47.94 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.398 2.066 . . . . 0.0 113.74 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -113.67 24.11 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.866 0.841 . . . . 0.0 110.356 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.16 15.83 3.49 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.307 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.4 3.78 54.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.835 0.35 . . . . 0.0 111.782 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -61.08 -58.86 6.63 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.202 1.001 . . . . 0.0 108.72 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -140.81 -177.86 5.27 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 p -84.84 23.56 1.17 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.894 0.854 . . . . 0.0 112.133 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -87.62 117.03 26.15 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.806 -176.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.611 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 71.9 mttt -88.72 178.15 6.55 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.373 0.669 . . . . 0.0 110.911 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.29 157.7 7.52 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 33' ' ' ILE . 22.3 mm -76.71 131.84 34.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 118.066 0.933 . . . . 0.0 110.057 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.496 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 4.7 p90 -133.84 156.78 47.44 Favored 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.523 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 73' ' ' ILE . 8.2 p -84.24 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 O-C-N 125.035 1.46 . . . . 0.0 110.966 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.3 p -110.45 -23.29 11.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 29.8 ttm180 -136.29 146.41 46.63 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 66' ' ' ALA . 18.1 t -135.91 150.99 28.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 66' ' ' ALA . 18.7 p -52.91 127.66 24.4 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 124.047 0.842 . . . . 0.0 109.644 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.61 -19.65 66.0 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 124.048 0.842 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.88 50.23 0.2 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.486 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -129.49 -165.57 11.7 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.464 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HD2' HD22 ' A' ' 21' ' ' LEU . 34.8 Cg_endo -63.4 -34.33 66.45 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.488 2.792 . . . . 0.0 113.21 -169.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -60.27 -56.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.562 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.72 -27.7 61.33 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.564 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.6 mm -58.61 -44.36 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -76.34 -55.65 5.36 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.834 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.47 33.81 0.05 OUTLIER Glycine 0 CA--C 1.499 -0.916 0 C-N-CA 119.479 -1.343 . . . . 0.0 113.018 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.66 ' HB2' HG11 ' A' ' 16' ' ' VAL . 2.1 tp -92.17 115.75 28.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -111.3 141.48 44.78 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.474 ' HA ' HG13 ' A' ' 57' ' ' VAL . 70.7 mt -56.59 126.76 14.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 123.603 0.565 . . . . 0.0 109.92 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.79 -3.25 34.01 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.341 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 8.5 m-20 -86.2 131.88 34.13 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 120.986 0.422 . . . . 0.0 111.436 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 47.5 mtpt -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.443 HG13 HG12 ' A' ' 109' ' ' VAL . 3.2 mp -92.22 122.3 43.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -174.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.463 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.4 mmt -105.8 -15.78 14.85 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.347 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -153.56 136.52 15.45 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.519 HG22 HD22 ' A' ' 107' ' ' LEU . 72.6 t -140.85 118.47 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.795 0.838 . . . . 0.0 110.919 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 38.2 t30 61.98 14.48 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.271 1.429 . . . . 0.0 113.157 171.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 114.61 -15.88 19.43 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.958 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.64 149.91 21.91 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -97.08 113.59 25.17 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.543 ' HG3' HG11 ' A' ' 88' ' ' VAL . 21.3 ttm -77.84 -60.3 2.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.118 -174.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 87' ' ' MET 0.279 9.8 t 23.26 -76.5 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 127.603 2.361 . . . . 0.0 116.775 -176.541 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.513 ' H ' HG23 ' A' ' 86' ' ' THR . 27.7 ttt -113.97 93.66 4.47 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG11 ' HG3' ' A' ' 85' ' ' MET . 9.5 p -148.7 153.25 11.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.346 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 38' ' ' ASP . 4.7 p -70.28 152.9 43.67 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.514 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 9.5 t60 -50.75 -46.22 59.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.008 176.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 38.6 t70 -57.83 -48.95 78.28 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.535 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -35.9 70.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.67 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -66.09 -40.99 91.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.451 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 8.4 mmm180 -55.36 -38.79 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.802 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 38.6 mttm -83.3 30.74 0.46 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.42 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.7 tpm_? -148.66 -43.7 0.15 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.507 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.1 pp -102.05 -16.16 16.52 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.433 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.0 t -121.62 10.66 10.42 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.848 174.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.564 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 15.8 ptpt -68.59 171.41 7.63 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 173.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 18.7 ptt180 -123.99 13.01 9.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.211 0.529 . . . . 0.0 111.317 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.564 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 31.3 t -76.83 -41.1 45.53 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.243 0.544 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.26 167.09 10.37 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.6 pt-20 -120.34 -64.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 12.5 t -91.54 123.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.464 HG21 HD23 ' A' ' 29' ' ' LEU . 25.2 m -125.28 136.73 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.236 0.541 . . . . 0.0 112.056 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -95.9 110.24 22.47 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 172.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 80' ' ' VAL . 14.8 mt -109.23 156.2 20.19 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.4 mp -130.03 123.02 29.52 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -117.36 157.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.584 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.743 HG22 HG22 ' A' ' 13' ' ' VAL . 39.9 p -115.28 118.62 33.78 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.139 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.486 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 2.1 mmp_? -73.51 112.52 9.67 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -85.3 -46.62 10.82 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.868 -175.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 m 51.15 41.18 27.39 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.181 0.925 . . . . 0.0 110.194 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.1 tp 70.98 84.9 0.13 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 108.281 -172.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -69.34 155.09 41.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.447 -174.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -116.53 147.16 42.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -113.56 -166.87 1.13 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.194 0.521 . . . . 0.0 111.146 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.9 m -86.1 69.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-O 123.484 1.611 . . . . 0.0 108.901 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 91.42 -79.46 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 110.282 -3.144 . . . . 0.0 109.398 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -163.69 97.34 0.86 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.8 m 65.3 118.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.397 1.079 . . . . 0.0 113.819 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 22.5 ptp -90.0 -2.25 58.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.982 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.14 127.72 33.28 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.812 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.435 -1.18 0 C-N-CA 124.46 1.104 . . . . 0.0 108.707 178.696 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.821 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -164.67 118.82 1.35 Allowed 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -145.49 114.13 6.79 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.5 mt -106.1 115.58 60.94 Favored Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.85 -175.67 2.79 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.302 2.001 . . . . 0.0 111.986 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.76 58.01 0.6 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.86 120.33 77.36 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.65 -88.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 123.517 2.811 . . . . 0.0 113.148 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 m -147.06 -47.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.368 0.667 . . . . 0.0 111.29 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -98.1 -7.6 29.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.52 143.24 33.3 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.313 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t -112.21 115.7 50.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.37 135.3 33.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.97 154.77 39.86 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.62 150.2 20.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.635 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -135.61 162.81 36.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.007 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -154.24 114.23 3.85 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.258 0.551 . . . . 0.0 110.818 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -97.38 134.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.31 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -105.04 134.28 48.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HD3' ' HB2' ' A' ' 103' ' ' GLU . 43.7 pttt -28.12 118.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.438 HD22 ' CD ' ' A' ' 65' ' ' PRO . 45.9 tp -121.8 130.45 53.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.141 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.85 127.85 44.07 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -121.01 92.87 3.86 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.99 -111.83 3.36 Favored Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -109.88 15.98 22.29 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.332 0.587 . . . . 0.0 110.255 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.412 ' HA ' ' NH2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -125.83 163.92 21.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -117.56 112.55 20.73 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.87 160.79 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.619 HD13 HG21 ' A' ' 105' ' ' VAL . 54.0 mt -86.48 0.41 54.27 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.56 -37.68 3.34 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.319 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -95.84 171.47 8.62 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.8 m -130.68 169.5 15.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.679 1.192 . . . . 0.0 109.975 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 55' ' ' ILE . 6.8 pt -128.49 165.33 28.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 117.701 0.228 . . . . 0.0 110.671 -172.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.44 -31.4 3.76 Favored Glycine 0 CA--C 1.488 -1.616 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 124.11 154.74 8.98 Favored Glycine 0 C--O 1.199 -2.077 0 C-N-CA 119.416 -1.373 . . . . 0.0 113.187 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -102.18 -119.17 4.51 Favored Glycine 0 N--CA 1.424 -2.115 0 O-C-N 124.157 0.563 . . . . 0.0 112.85 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.645 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.71 -22.6 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.164 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HB2' HG22 ' A' ' 89' ' ' THR . 31.7 t70 -70.9 -18.05 62.69 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.819 0.818 . . . . 0.0 110.163 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.565 ' HB2' HD21 ' A' ' 44' ' ' ASN . 4.2 mm100 -105.87 147.07 29.13 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 4.8 t70 -94.12 127.15 46.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -175.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -20.86 44.46 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.37 2.714 . . . . 0.0 113.322 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 m -76.91 -16.07 59.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.75 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 3.2 pt20 -132.14 19.76 4.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.965 0.888 . . . . 0.0 109.946 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 93.3 m-20 -104.55 144.29 28.41 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.171 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.51 -51.74 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.692 2.261 . . . . 0.0 113.668 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -112.12 22.46 14.77 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.329 0.585 . . . . 0.0 110.639 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 8.5 t -117.58 2.06 12.32 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.81 14.2 5.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.976 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 12.4 m-20 -61.55 -36.34 80.33 Favored 'General case' 0 C--O 1.186 -2.277 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.229 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 1.2 mptt -166.1 -144.7 0.07 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 101.215 -3.624 . . . . 0.0 101.215 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.7 p -92.26 28.62 1.87 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -86.74 101.66 13.52 Favored 'General case' 0 C--O 1.251 1.137 0 C-N-CA 126.113 1.765 . . . . 0.0 112.18 -172.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.645 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 68.8 mttt -81.41 -160.07 0.31 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.089 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.75 156.27 10.57 Favored Glycine 0 C--O 1.201 -1.963 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 33' ' ' ILE . 30.4 mm -78.27 126.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 117.813 0.806 . . . . 0.0 108.874 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.9 p90 -129.52 160.0 34.56 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.787 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 71' ' ' LEU . 58.8 t -87.47 128.46 39.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 124.73 1.269 . . . . 0.0 110.917 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 p -104.8 -20.43 13.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.441 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 135.94 23.41 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 HG11 ' A' ' 57' ' ' VAL . 64.6 t -123.59 148.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.48 ' OG ' ' HB3' ' A' ' 66' ' ' ALA . 37.7 p -51.82 126.33 17.7 Favored 'General case' 0 N--CA 1.401 -2.901 0 O-C-N 124.328 1.017 . . . . 0.0 108.563 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -71.32 -28.21 63.93 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-O 121.596 0.712 . . . . 0.0 109.868 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.52 55.57 0.5 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.606 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -139.28 -169.41 11.57 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' CD ' HD22 ' A' ' 21' ' ' LEU . 38.4 Cg_endo -65.61 -30.71 51.19 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 123.677 2.918 . . . . 0.0 113.047 -171.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.48 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -61.96 -53.8 50.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.914 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.3 pp20? -69.84 -30.62 68.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.551 0.215 . . . . 0.0 111.28 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.26 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.638 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.23 -48.14 45.07 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.03 21.51 0.41 Allowed Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.069 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.758 HD11 HG21 ' A' ' 57' ' ' VAL . 3.4 tp -83.03 125.46 31.47 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.461 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.4 mm100 -116.8 158.08 24.5 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.715 0.769 . . . . 0.0 109.614 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.38 135.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.898 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.82 -10.95 57.54 Favored Glycine 0 C--O 1.245 0.796 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 87.5 m-20 -74.99 114.69 13.76 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 18.7 ptpt -91.62 122.31 34.08 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.483 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.563 HD11 HG23 ' A' ' 57' ' ' VAL . 2.9 mp -86.53 134.14 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.194 -172.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.617 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -114.83 -14.07 11.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.565 0.697 . . . . 0.0 110.869 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 6.9 tp-100 -147.06 129.76 16.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.564 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 107' ' ' LEU . 46.2 t -135.38 116.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t30 37.6 59.15 1.28 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.269 1.827 . . . . 0.0 113.465 176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.24 4.82 38.63 Favored Glycine 0 C--N 1.3 -1.461 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.431 ' CD1' ' HB ' ' A' ' 80' ' ' VAL 0.385 0.0 OUTLIER -90.27 -100.02 0.1 Allowed 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 118.635 1.218 . . . . 0.0 112.603 178.52 . . . . . . . . 4 4 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 173.66 116.96 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.431 ' HE2' HD23 ' A' ' 97' ' ' LEU . 3.7 tpt -115.14 -2.77 12.66 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.015 -175.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.617 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.5 t -64.87 -28.3 69.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.541 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttm -146.72 87.53 1.71 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.38 0.609 . . . . 0.0 109.579 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG13 HG13 ' A' ' 55' ' ' ILE . 7.5 p -149.37 149.63 14.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.913 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 38' ' ' ASP . 4.3 p -71.22 155.86 40.23 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 123.3 0.64 . . . . 0.0 110.428 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.441 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 10.5 t60 -55.6 -43.83 76.4 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.787 176.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.16 -48.89 79.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.684 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -32.52 70.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.11 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.73 -42.64 73.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.05 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 11.2 mmm180 -60.6 -37.03 80.02 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.83 0.824 . . . . 0.0 108.849 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.91 21.16 1.07 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.052 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.527 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 17.7 mmt180 -134.69 -42.53 0.76 Allowed 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.316 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.625 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -100.62 -28.82 12.66 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.463 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.3 t -106.97 14.8 26.06 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.872 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 14.4 ptpt -73.67 175.48 7.12 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.466 169.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.412 ' NH2' ' HA ' ' A' ' 26' ' ' ASN . 14.3 ptp180 -122.81 6.88 9.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.423 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 22.3 t -75.26 -38.45 60.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.497 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -87.97 174.15 8.48 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.529 178.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.551 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 8.6 pt-20 -137.77 -58.72 0.67 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.587 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 59.0 t -104.07 127.2 58.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.619 HG21 HD13 ' A' ' 29' ' ' LEU . 15.0 m -122.16 148.62 25.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.385 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -119.23 103.96 9.98 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.591 HD12 HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -110.17 151.85 26.78 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.963 -171.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.3 mp -125.31 119.37 28.2 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.516 HG12 HG13 ' A' ' 77' ' ' ILE . 27.1 m -112.58 147.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.184 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.7 p -116.09 128.73 55.91 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.842 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -104.9 108.9 20.65 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -82.79 -54.93 4.73 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.5 m 48.86 37.68 10.51 Favored 'General case' 0 C--O 1.248 1.006 0 O-C-N 124.309 1.006 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 49' ' ' ASP . 32.0 tp -72.25 147.62 46.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.29 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' A' ' 116' ' ' LYS . 11.4 pt20 -48.41 -61.05 2.21 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.298 1.439 . . . . 0.0 114.115 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' A' ' 115' ' ' GLN . 33.7 mmtp -145.62 176.38 9.66 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -176.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.42 -84.73 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.627 1.205 . . . . 0.0 113.138 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p -163.95 78.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-O 122.391 1.091 . . . . 0.0 113.401 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -3.17 9.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.463 1.125 . . . . 0.0 108.207 169.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.18 150.55 51.09 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 175.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.1 m 61.09 35.34 18.74 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.613 0.721 . . . . 0.0 109.979 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.5 mtp -68.77 116.07 8.84 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.164 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.96 -43.71 70.97 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.9 m . . . . . 0 N--CA 1.421 -1.923 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.465 177.17 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.87 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -86.6 97.34 10.48 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 117.037 0.419 . . . . 0.0 111.156 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -139.01 132.33 30.01 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.465 HD12 ' HD2' ' A' ' 5' ' ' PRO . 6.4 tp -123.84 115.87 27.8 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HD2' HD12 ' A' ' 4' ' ' ILE . 15.5 Cg_endo -65.49 167.75 16.21 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.73 2.287 . . . . 0.0 114.242 -177.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.78 54.33 1.67 Allowed Glycine 0 N--CA 1.426 -2.002 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.554 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -61.17 129.2 90.47 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 123.021 0.529 . . . . 0.0 110.467 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 58.7 Cg_endo -79.69 -84.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.04 1.827 . . . . 0.0 111.705 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.01 -52.28 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 120.735 0.303 . . . . 0.0 111.236 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 t -99.13 -48.3 4.9 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . -69.08 135.85 51.41 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.5 0.666 . . . . 0.0 111.371 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.17 106.01 19.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.517 HG22 HG22 ' A' ' 110' ' ' THR . 12.7 t -80.45 126.35 39.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.74 153.1 41.33 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.425 -175.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -90.12 148.17 23.16 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -128.29 152.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.129 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -135.24 104.36 5.87 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.075 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.7 mp -92.8 129.74 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.942 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -99.35 144.8 28.05 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.62 ' HB2' HD21 ' A' ' 27' ' ' LEU . 20.0 pttm -35.26 127.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.401 HD22 ' HD2' ' A' ' 65' ' ' PRO . 44.0 tp -125.14 118.26 25.71 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.227 174.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -88.38 111.86 22.23 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.729 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -117.99 110.38 17.62 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.93 -109.73 3.04 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -113.95 13.31 18.26 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -112.57 171.64 7.4 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.873 0.844 . . . . 0.0 109.837 -174.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.3 tm? -126.53 111.82 14.82 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 172.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.97 164.5 23.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.486 HD13 HG21 ' A' ' 105' ' ' VAL . 38.1 mt -87.66 -4.24 58.94 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.964 0.888 . . . . 0.0 108.629 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 92.67 -46.02 2.53 Favored Glycine 0 N--CA 1.424 -2.154 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.949 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -84.33 166.46 17.41 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.193 0.521 . . . . 0.0 112.218 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 29.2 m -122.36 166.85 14.05 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.656 1.182 . . . . 0.0 109.961 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 55' ' ' ILE . 3.7 pt -125.14 164.4 24.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.07 -16.23 7.39 Favored Glycine 0 CA--C 1.487 -1.685 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.328 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 125.04 169.35 12.93 Favored Glycine 0 CA--C 1.473 -2.54 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.168 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -122.2 -116.3 2.36 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.367 0.686 . . . . 0.0 111.57 175.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.45 -15.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.151 0.977 . . . . 0.0 110.777 -177.467 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.444 ' HB2' HG22 ' A' ' 89' ' ' THR . 15.2 t0 -70.95 -19.91 62.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.085 -177.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.586 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 5.1 mm100 -113.37 155.25 25.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 10.0 t70 -98.32 129.37 30.73 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 118.612 0.642 . . . . 0.0 109.431 -176.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.53 -21.3 45.35 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 122.768 2.312 . . . . 0.0 113.198 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -77.36 -11.13 59.8 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.015 0.436 . . . . 0.0 110.625 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 2.6 pt20 -130.15 11.58 5.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.415 0.626 . . . . 0.0 110.75 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 97.4 m-20 -99.91 143.32 26.27 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.76 -52.98 0.47 Allowed 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.201 2.601 . . . . 0.0 113.118 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.38 18.11 20.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.575 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.0 t -123.25 -2.37 8.58 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -83.55 -4.33 58.45 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.12 -38.59 89.5 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.705 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -145.81 -168.55 3.01 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.0 p -96.48 0.63 50.59 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.55 0.69 . . . . 0.0 109.659 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.09 99.85 4.77 Favored 'General case' 0 C--O 1.256 1.421 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.276 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 53.4 mttt -74.88 178.4 5.57 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.387 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.56 153.36 5.85 Favored Glycine 0 C--O 1.18 -3.273 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 33' ' ' ILE . 30.5 mm -68.27 125.33 25.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 118.009 0.904 . . . . 0.0 109.774 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 2.3 p90 -124.98 155.9 38.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.188 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.674 HG21 HD11 ' A' ' 71' ' ' LEU . 87.7 t -81.46 129.92 36.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 124.455 1.097 . . . . 0.0 110.619 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -106.08 -19.7 13.64 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.279 0.561 . . . . 0.0 111.068 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -154.46 138.97 16.84 Favored 'General case' 0 C--O 1.204 -1.309 0 C-N-CA 124.124 0.97 . . . . 0.0 108.519 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.519 HG11 ' O ' ' A' ' 71' ' ' LEU . 18.9 m -109.87 174.83 1.75 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.194 0 CA-C-N 119.688 1.131 . . . . 0.0 109.222 172.025 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.624 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.3 t -77.93 116.23 18.26 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -52.85 -16.34 0.99 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.997 1.719 . . . . 0.0 114.68 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.35 30.41 0.42 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.17 -171.46 19.33 Favored Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD2' HD22 ' A' ' 21' ' ' LEU . 37.7 Cg_endo -63.8 -27.07 67.71 Favored 'Trans proline' 0 C--O 1.208 -0.986 0 C-N-CA 123.468 2.778 . . . . 0.0 111.634 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.51 -66.71 0.42 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.796 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.7 pt-20 -75.43 -22.74 57.12 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.592 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -62.93 -41.03 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.03 -45.51 26.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.074 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.1 2.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 119.644 -1.265 . . . . 0.0 114.08 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.674 HD11 HG21 ' A' ' 57' ' ' VAL . 7.6 tp -74.8 126.51 31.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 122.767 -0.255 . . . . 0.0 110.638 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -120.3 160.82 22.24 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.134 0.896 . . . . 0.0 109.936 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.98 128.72 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.491 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.12 -9.47 54.51 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.341 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 74.1 m-20 -77.78 119.13 20.85 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 37.6 ttpt -88.9 124.12 33.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 109' ' ' VAL . 3.0 mp -88.29 135.96 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -174.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.1 mmt -107.77 -26.1 10.95 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.389 0.614 . . . . 0.0 109.839 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -151.63 133.73 15.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.741 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.619 HG22 HD22 ' A' ' 107' ' ' LEU . 49.9 t -136.98 117.57 17.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 C-N-CA 123.663 0.785 . . . . 0.0 110.037 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 34.2 t30 49.6 49.98 19.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.153 0.981 . . . . 0.0 111.625 171.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 69.93 8.06 60.39 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.442 ' CD2' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -115.26 158.87 21.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 117.681 0.74 . . . . 0.0 110.346 176.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 123.299 0.64 . . . . 0.0 110.509 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.508 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 20.2 ttm -117.47 -4.5 11.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.92 0.867 . . . . 0.0 110.737 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t -68.11 -25.46 65.32 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.779 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 ttt -135.95 85.51 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.91 0.386 . . . . 0.0 110.519 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 11.2 p -154.79 148.4 12.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.445 ' OG1' ' HB2' ' A' ' 92' ' ' GLN . 7.9 p -73.05 156.54 38.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.434 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 10.1 t60 -55.42 -47.33 76.11 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.556 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 33.8 t70 -58.93 -47.46 84.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.331 -176.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.445 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -72.1 -39.46 68.91 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.202 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.94 -41.7 99.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.303 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.486 ' CZ ' HG21 ' A' ' 98' ' ' THR . 18.2 mmm180 -58.16 -26.03 62.22 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.485 0.659 . . . . 0.0 112.119 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 45.1 mmtm -95.0 8.19 43.68 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 24.7 ttm180 -136.79 -30.96 0.87 Allowed 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.686 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.409 HD23 ' H ' ' A' ' 98' ' ' THR . 1.2 pt? -92.98 -40.6 10.47 Favored 'General case' 0 C--O 1.19 -2.062 0 C-N-CA 116.646 -2.021 . . . . 0.0 111.132 174.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.486 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 8.8 t -102.15 14.71 31.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 109.406 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.8 ptpt -66.49 -176.06 0.42 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.951 170.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -122.07 -3.74 9.06 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -67.24 -40.41 86.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 175.51 5.62 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.943 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -134.79 -62.26 0.74 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 22.2 t -94.53 112.46 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 29' ' ' LEU . 28.0 m -110.41 131.86 60.33 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.206 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -99.8 107.49 19.55 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.619 HD22 HG22 ' A' ' 80' ' ' VAL . 13.9 mt -108.65 151.42 26.17 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.5 mp -122.34 118.62 28.89 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.529 HG12 HG13 ' A' ' 77' ' ' ILE . 31.7 m -117.85 165.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.09 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.517 HG22 HG22 ' A' ' 13' ' ' VAL . 23.8 p -117.67 124.48 48.67 Favored 'General case' 0 N--CA 1.407 -2.584 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.307 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -81.01 125.65 30.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -93.0 -12.94 29.44 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.937 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.9 t 61.53 22.8 13.19 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 124.532 1.133 . . . . 0.0 112.139 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 92.9 mt 63.28 -52.56 0.2 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.933 1.693 . . . . 0.0 113.308 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -119.04 137.23 53.69 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -87.41 -4.71 59.03 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.949 0.404 . . . . 0.0 111.499 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.81 135.87 50.68 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.778 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.5 m -151.1 44.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 125.318 1.447 . . . . 0.0 107.763 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.24 74.72 7.06 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.046 -1.434 . . . . 0.0 112.866 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -139.35 13.04 2.58 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 122.722 1.248 . . . . 0.0 108.188 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 t -125.28 105.27 8.99 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 69.4 mtm -73.63 -59.03 2.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -133.09 -36.0 1.03 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 172.059 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.176 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -147.82 163.19 37.51 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.404 ' CE1' HD21 ' A' ' 108' ' ' LEU . 26.2 p90 -99.09 -2.54 36.82 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.294 16.1 tt 42.09 90.69 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.517 1.927 . . . . 0.0 114.151 -178.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -76.01 -173.72 1.78 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.454 2.103 . . . . 0.0 112.941 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.45 47.63 1.17 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 47.5 tt0 -84.95 127.94 62.51 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 115.089 -0.556 . . . . 0.0 110.444 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -81.08 -87.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.805 1.67 . . . . 0.0 109.707 174.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -140.58 -47.23 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.268 -0.27 . . . . 0.0 111.33 171.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 t -94.28 -29.19 15.19 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -76.9 135.07 38.8 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.37 122.45 58.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 110' ' ' THR . 25.3 t -108.77 125.98 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.43 151.17 46.04 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.317 -176.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 149.52 23.2 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.78 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -129.65 157.77 42.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.416 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 33.3 tt0 -144.92 107.84 4.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.334 0.587 . . . . 0.0 110.771 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -97.46 132.17 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -98.45 152.65 19.28 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 123.819 0.699 . . . . 0.0 110.232 175.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . 23.4 ttmm -40.93 113.17 0.36 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 125.508 1.523 . . . . 0.0 114.48 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.571 HD22 ' HD2' ' A' ' 65' ' ' PRO . 26.7 tp -127.94 137.43 52.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.065 0.546 . . . . 0.0 111.513 177.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -104.62 131.44 52.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -122.47 107.36 11.95 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.15 -113.56 5.24 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -108.79 16.91 22.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.752 0.787 . . . . 0.0 110.539 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -120.63 176.72 5.37 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 1.3 tm? -128.13 112.09 14.18 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mt -129.22 159.01 41.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 105' ' ' VAL . 61.0 mt -79.61 2.69 21.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.759 0.79 . . . . 0.0 109.844 175.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.28 4.57 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.917 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -98.76 167.33 10.84 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.7 m -121.49 164.15 17.66 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.441 1.096 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 55' ' ' ILE . 6.2 pt -124.34 163.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -173.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.21 -24.36 6.56 Favored Glycine 0 CA--C 1.484 -1.886 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.462 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 124.75 167.67 12.67 Favored Glycine 0 N--CA 1.407 -3.25 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.848 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.555 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -113.8 -121.79 3.73 Favored Glycine 0 N--CA 1.427 -1.904 0 O-C-N 124.507 0.769 . . . . 0.0 112.591 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -67.26 -19.51 25.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.593 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.453 ' HB2' HG22 ' A' ' 89' ' ' THR . 25.2 t70 -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.036 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.497 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 7.2 mm100 -96.01 -173.9 2.96 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 7.0 t70 -132.98 124.96 18.86 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.943 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 10.0 Cg_endo -57.63 -26.69 73.82 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.074 2.516 . . . . 0.0 113.132 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -68.87 -32.64 72.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.228 0.537 . . . . 0.0 110.373 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.9 pt20 -112.74 8.51 18.93 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.522 0.677 . . . . 0.0 110.729 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.13 142.19 24.14 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.85 -51.57 0.64 Allowed 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 123.378 2.719 . . . . 0.0 112.843 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -109.18 26.5 10.56 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.029 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 13.8 t -124.31 -6.76 7.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.57 -4.98 45.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.303 -171.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.71 -52.62 17.74 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.934 1.693 . . . . 0.0 109.327 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 37.0 mtmm -148.48 -147.11 0.21 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 p -99.31 21.41 12.03 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.993 1.378 . . . . 0.0 107.887 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.47 ' HB2' ' HE2' ' A' ' 50' ' ' LYS . 50.7 t0 -73.48 106.83 5.43 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 112.352 -2.204 . . . . 0.0 111.417 -173.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.0 mtmm -110.03 171.03 7.69 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.843 0.83 . . . . 0.0 111.997 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 144.71 167.36 12.06 Favored Glycine 0 C--O 1.17 -3.877 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 33' ' ' ILE . 35.5 mm -73.9 115.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 120.26 2.03 . . . . 0.0 110.433 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 0.4 OUTLIER -114.9 151.73 33.5 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.059 178.867 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.799 HG21 HD11 ' A' ' 71' ' ' LEU . 87.6 t -82.77 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.31 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p -106.66 -15.04 14.87 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.625 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -152.23 145.32 24.56 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' A' ' 57' ' ' VAL . 39.5 t -133.79 148.72 30.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 13.3 p -52.95 128.54 27.52 Favored 'General case' 0 N--CA 1.406 -2.648 0 O-C-N 124.289 0.993 . . . . 0.0 109.635 176.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.92 -13.6 61.69 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 123.629 0.581 . . . . 0.0 111.553 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.46 41.53 0.31 Allowed Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -120.46 -169.49 13.96 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.194 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.571 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.2 Cg_endo -64.18 -32.28 63.2 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 123.614 2.876 . . . . 0.0 112.391 -171.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -59.08 -57.22 14.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.202 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 61' ' ' SER . 4.5 pt-20 -75.88 -24.45 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.48 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 64' ' ' GLY . 21.2 mm -63.61 -39.74 86.46 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 121.206 0.527 . . . . 0.0 109.903 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -75.7 -56.87 4.27 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.842 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.13 24.74 0.05 OUTLIER Glycine 0 C--O 1.224 -0.501 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.292 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.799 HD11 HG21 ' A' ' 57' ' ' VAL . 4.6 tp -91.96 124.65 36.23 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.447 ' N ' HD12 ' A' ' 71' ' ' LEU . 12.7 mm100 -116.61 157.34 25.49 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.0 137.15 25.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.865 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.34 -0.25 59.93 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.941 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.13 123.24 24.88 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 120.773 0.321 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -89.0 110.81 21.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.492 HD11 ' CG2' ' A' ' 57' ' ' VAL . 12.3 mt -82.94 129.03 38.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.352 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.429 ' HA ' ' HB ' ' A' ' 86' ' ' THR . 21.1 mmt -105.63 -26.26 11.92 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.478 0.656 . . . . 0.0 110.589 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 5.5 tp-100 -152.46 133.11 13.92 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.88 -169.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.608 HG22 HD12 ' A' ' 107' ' ' LEU . 55.0 t -136.53 111.86 11.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 C-N-CA 124.27 1.028 . . . . 0.0 111.431 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 31.4 t30 52.25 34.93 15.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.724 1.61 . . . . 0.0 112.92 173.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 95.65 -9.4 68.8 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.435 179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -104.44 150.09 24.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.707 0.403 . . . . 0.0 110.207 178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.91 132.76 41.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 123.839 0.855 . . . . 0.0 110.343 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.454 ' SD ' HG21 ' A' ' 80' ' ' VAL . 24.5 ttm -123.28 -0.48 8.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.211 1.005 . . . . 0.0 110.943 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 78' ' ' MET . 2.1 t -70.16 -25.06 63.27 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.259 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.9 ttt -141.41 86.29 2.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.245 0.545 . . . . 0.0 109.903 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.36 151.95 11.29 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 38' ' ' ASP . 17.8 p -75.0 157.11 35.46 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.176 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.469 ' HB2' ' OE1' ' A' ' 39' ' ' GLN . 10.9 t60 -53.84 -45.44 70.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.72 -51.22 69.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.435 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -30.3 63.6 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.072 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -76.66 -36.0 57.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.141 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.4 ' HG2' HD11 ' A' ' 33' ' ' ILE . 12.1 mmm180 -51.49 -45.65 62.9 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.931 0.77 . . . . 0.0 111.424 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.357 0.0 OUTLIER -93.06 59.71 3.16 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-O 122.904 1.335 . . . . 0.0 110.813 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tpt180 -154.38 -48.1 0.09 Allowed 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 112.151 -2.295 . . . . 0.0 106.698 171.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.4 pp -94.88 -25.46 16.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.443 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.7 t -114.23 14.06 18.04 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.476 174.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 17.5 ptpt -77.23 168.05 20.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.432 172.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 9.7 ptp85 -113.74 0.39 14.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.822 -175.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . 0.528 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 40.9 m -76.1 -34.02 59.5 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.804 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.433 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 10.2 pt-20 -111.78 172.18 7.05 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.695 -178.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.0 pm0 -132.85 -87.35 0.44 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 17.9 t -73.37 114.11 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-O 121.625 0.726 . . . . 0.0 109.816 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 29' ' ' LEU . 11.4 m -110.36 153.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.761 -177.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -120.94 100.28 6.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD12 HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -109.28 160.65 15.95 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.548 -171.465 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.7 mp -132.34 122.58 25.31 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.44 156.99 23.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.027 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.648 HG22 HG22 ' A' ' 13' ' ' VAL . 66.3 p -129.98 146.29 51.66 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.27 0.557 . . . . 0.0 110.696 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -100.17 84.91 2.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -89.72 -6.44 56.05 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.823 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -81.46 20.61 0.86 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp 55.34 77.28 0.23 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.488 1.115 . . . . 0.0 112.311 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -134.75 149.83 50.49 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -127.02 92.93 3.63 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -94.52 163.33 13.44 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.672 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.3 t 68.64 78.38 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 124.416 1.072 . . . . 0.0 111.28 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -151.7 89.02 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.301 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -90.82 85.99 6.19 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 m -86.93 -27.3 23.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.027 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.6 mtt 71.05 -70.67 0.15 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.757 1.223 . . . . 0.0 109.871 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.7 tp -92.5 79.61 4.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.262 1.734 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.79 -176.144 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.43 -1.461 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.4 p -91.06 129.16 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.443 HE21 HG22 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -134.28 151.54 51.33 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.741 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.95 152.18 18.57 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.742 0.306 . . . . 0.0 110.548 -172.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -129.58 154.61 40.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -141.12 102.12 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.306 0.574 . . . . 0.0 110.35 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.42 127.01 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -99.63 148.67 24.08 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HB2' HD11 ' A' ' 27' ' ' LEU . 22.5 pttm -39.18 123.36 1.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.577 HD22 ' HD2' ' A' ' 65' ' ' PRO . 49.4 tp -117.67 122.08 42.58 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.559 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -92.81 109.71 21.15 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HG3' HD12 ' A' ' 28' ' ' ILE . 16.1 mm100 -107.41 109.14 20.79 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.57 -110.77 3.69 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.72 17.74 12.71 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.194 0.521 . . . . 0.0 111.479 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.67 166.81 12.29 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 20' ' ' LYS . 58.4 tp -112.85 126.59 55.61 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 23' ' ' GLN . 0.9 OUTLIER -136.82 163.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.9 mp -88.4 2.3 52.94 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.051 0.929 . . . . 0.0 109.419 175.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . 94.9 -47.26 2.04 Favored Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 115.264 -0.88 . . . . 0.0 114.362 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 39.9 p90 -90.63 166.11 13.35 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.8 m -123.96 163.62 20.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.508 1.523 . . . . 0.0 109.497 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 55' ' ' ILE . 7.9 pt -125.17 166.15 21.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 122.75 0.42 . . . . 0.0 110.615 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.24 -22.42 6.83 Favored Glycine 0 CA--C 1.487 -1.675 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.311 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.543 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 123.58 163.54 11.78 Favored Glycine 0 C--O 1.196 -2.238 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.613 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.546 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -112.88 -117.3 3.45 Favored Glycine 0 N--CA 1.432 -1.588 0 O-C-N 124.583 0.814 . . . . 0.0 112.345 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.646 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.05 -17.58 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 122.101 0.953 . . . . 0.0 112.869 -174.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.61 ' HB2' HG22 ' A' ' 89' ' ' THR . 19.5 t70 -75.2 -9.19 58.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.421 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.644 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 24.9 mm-40 -107.55 162.86 13.57 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.097 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 2.8 m-20 -105.21 108.63 61.82 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.484 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -58.44 -19.79 45.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 123.794 2.996 . . . . 0.0 113.402 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -75.34 -5.58 45.51 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.586 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.15 29.29 0.89 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.523 0.329 . . . . 0.0 111.155 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 7.4 m120 -107.22 145.5 31.32 Favored Pre-proline 0 CA--C 1.495 -1.14 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.36 -40.83 10.09 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 C-N-CA 123.204 2.603 . . . . 0.0 113.057 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.63 4.41 10.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.262 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 1.1 t . . . . . 0 C--N 1.303 -1.454 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.242 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.646 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 53.1 mttp . . . . . 0 CA--C 1.552 1.047 0 N-CA-C 113.535 0.939 . . . . 0.0 113.535 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.93 159.41 8.28 Favored Glycine 0 C--O 1.191 -2.555 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 33' ' ' ILE . 20.1 mm -77.88 128.11 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 117.657 0.728 . . . . 0.0 109.538 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 3.1 p90 -131.09 157.77 42.18 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.951 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 71' ' ' LEU . 94.5 t -80.57 134.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 O-C-N 124.748 1.28 . . . . 0.0 110.469 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 p -106.15 -23.03 12.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.618 0.723 . . . . 0.0 110.519 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -155.19 142.51 19.47 Favored 'General case' 0 CA--C 1.473 -1.992 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 16.3 m -107.73 -172.03 0.4 Allowed 'Isoleucine or valine' 1 N--CA 1.339 -6.02 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 22.5 p -64.51 131.32 46.77 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.59 -21.42 26.68 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 123.181 0.592 . . . . 0.0 112.146 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.99 52.72 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.6 -161.23 10.45 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-N 114.905 -0.648 . . . . 0.0 112.771 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.577 ' HD2' HD22 ' A' ' 21' ' ' LEU . 38.2 Cg_endo -63.27 -32.68 72.94 Favored 'Trans proline' 0 C--O 1.211 -0.872 0 C-N-CA 123.541 2.827 . . . . 0.0 112.543 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.403 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -59.06 -61.1 2.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -70.79 -30.67 67.2 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.329 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 mm -63.69 -42.69 96.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.783 0.325 . . . . 0.0 111.316 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.74 -55.2 5.7 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.169 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.98 29.4 0.05 OUTLIER Glycine 0 C--N 1.312 -0.78 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.056 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.802 ' HB2' HG11 ' A' ' 16' ' ' VAL . 6.5 tp -100.33 120.93 40.69 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.471 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 28.7 mm-40 -116.33 153.31 32.21 Favored 'General case' 0 N--CA 1.425 -1.693 0 O-C-N 123.964 0.79 . . . . 0.0 110.959 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.43 131.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.68 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.96 -27.45 20.34 Favored Glycine 0 C--O 1.252 1.244 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.956 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.471 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 53.2 m-20 -72.53 125.28 27.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.762 0.792 . . . . 0.0 111.02 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 63.2 mttp -82.87 128.82 34.78 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.139 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.555 HD11 HG23 ' A' ' 57' ' ' VAL . 2.8 mp -92.72 124.57 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.3 mmt -109.41 -11.44 14.83 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.533 0.683 . . . . 0.0 110.918 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.686 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -148.43 124.74 10.88 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.557 HG22 HD22 ' A' ' 107' ' ' LEU . 44.6 t -136.68 118.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 53.07 39.16 29.08 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.607 1.163 . . . . 0.0 112.997 170.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.466 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 65.08 27.42 72.28 Favored Glycine 0 N--CA 1.462 0.408 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.715 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -10.04 13.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 55.69 111.47 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.468 1.107 . . . . 0.0 113.717 -169.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.613 ' SD ' HG11 ' A' ' 88' ' ' VAL . 62.7 tpp -95.92 1.52 52.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.201 1.001 . . . . 0.0 109.353 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -71.33 135.55 47.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttp 55.48 74.61 0.36 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.327 1.051 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.613 HG11 ' SD ' ' A' ' 85' ' ' MET . 11.3 p -149.9 150.16 13.95 Favored 'Isoleucine or valine' 0 C--O 1.261 1.691 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.61 HG22 ' HB2' ' A' ' 38' ' ' ASP . 15.6 p -73.31 157.66 36.59 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.644 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 13.7 t60 -53.58 -42.93 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.336 175.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.75 -46.66 84.32 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.789 0.681 . . . . 0.0 110.825 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -32.89 67.42 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.816 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.657 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.88 -45.13 75.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.314 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.471 ' CZ ' HG21 ' A' ' 98' ' ' THR . 13.5 mmm180 -55.18 -40.76 71.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.661 0.743 . . . . 0.0 110.291 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -85.93 32.69 0.6 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.893 -176.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.1 tpt180 -148.88 -48.66 0.15 Allowed 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.014 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -92.32 -20.72 20.81 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.484 ' N ' HD12 ' A' ' 97' ' ' LEU . 14.6 t -118.21 10.12 12.79 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 117.666 -1.613 . . . . 0.0 110.837 175.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -66.28 154.96 38.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -103.67 6.24 36.88 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.0 t -79.28 -37.93 36.64 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -92.96 147.9 22.45 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 11.7 pt-20 -101.48 -63.9 1.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.794 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -117.85 133.26 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-O 122.002 0.905 . . . . 0.0 112.347 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.401 ' CG2' HD21 ' A' ' 107' ' ' LEU . 15.3 m -129.65 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.631 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -100.57 112.82 25.25 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.557 HD22 HG22 ' A' ' 80' ' ' VAL . 14.8 mt -112.86 162.9 15.27 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.686 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.1 mp -139.74 123.66 17.61 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 123.421 0.689 . . . . 0.0 109.273 174.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.502 HG12 HG13 ' A' ' 77' ' ' ILE . 34.7 m -115.71 151.49 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 CA-C-O 121.16 0.505 . . . . 0.0 110.101 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.401 -2.913 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 173.96 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.437 -1.09 0 N-CA-C 110.024 -0.362 . . . . 0.0 110.024 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.33 146.3 14.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.656 HE22 ' HB ' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -153.78 155.15 35.31 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 122.195 -0.316 . . . . 0.0 110.451 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.64 142.65 27.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.656 ' HB ' HE22 ' A' ' 14' ' ' GLN . 8.1 p -134.68 154.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 42.2 tt0 -144.99 107.72 4.46 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.485 0.659 . . . . 0.0 111.26 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 29' ' ' LEU . 2.0 mp -97.26 126.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.15 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -93.25 145.24 24.58 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.814 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.61 ' HB2' HD11 ' A' ' 27' ' ' LEU . 20.2 pttp -37.6 115.95 0.45 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.695 1.198 . . . . 0.0 113.805 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.02 123.85 44.45 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.303 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.51 126.94 35.79 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.193 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -120.67 106.32 11.61 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.39 -100.52 1.07 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -125.56 14.89 8.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.269 0.557 . . . . 0.0 110.348 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HA ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.5 169.46 11.39 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 20' ' ' LYS . 14.3 tp -116.45 119.17 34.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.15 163.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 18' ' ' ILE . 2.9 mm? -95.83 9.35 40.81 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-O 123.446 1.593 . . . . 0.0 108.659 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.98 -48.69 3.69 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.603 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.35 170.65 11.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.098 0.475 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 48.8 m -132.85 163.49 28.97 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 123.66 0.784 . . . . 0.0 110.485 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 55' ' ' ILE . 6.1 pt -121.18 166.96 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 122.777 0.431 . . . . 0.0 110.42 -174.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.33 -21.58 6.87 Favored Glycine 0 CA--C 1.486 -1.741 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.595 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.593 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 124.54 169.51 13.04 Favored Glycine 0 N--CA 1.416 -2.672 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.909 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.53 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.4 -117.95 2.7 Favored Glycine 0 C--O 1.209 -1.435 0 O-C-N 124.158 0.563 . . . . 0.0 112.24 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER -67.15 -19.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.051 0.453 . . . . 0.0 111.757 -176.152 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.568 ' HB2' HG22 ' A' ' 89' ' ' THR . 35.8 t70 -76.17 -8.8 57.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.226 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.62 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 26.4 mm-40 -107.11 165.8 11.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.459 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.5 t70 -107.83 119.99 48.53 Favored Pre-proline 0 C--N 1.315 -0.905 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.244 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD3' ' HE3' ' A' ' 53' ' ' LYS . 6.7 Cg_endo -56.07 -29.0 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.335 2.69 . . . . 0.0 113.379 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -67.87 -26.45 66.03 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -117.43 9.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.0 111.747 -176.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 5.9 m-80 -101.36 150.9 37.59 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.14 -49.88 0.6 Allowed 'Trans proline' 0 C--O 1.217 -0.549 0 C-N-CA 123.207 2.605 . . . . 0.0 113.49 -175.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.44 7.64 24.98 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.735 0.779 . . . . 0.0 110.333 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 9.2 t . . . . . 0 N--CA 1.427 -1.622 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.716 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.465 ' HE3' ' HD3' ' A' ' 41' ' ' PRO . 30.5 mmtm . . . . . 0 N--CA 1.429 -1.518 0 CA-C-O 121.382 0.61 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.51 154.54 6.21 Favored Glycine 0 C--O 1.174 -3.649 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 33' ' ' ILE . 29.5 mm -73.49 120.15 21.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 118.112 0.956 . . . . 0.0 109.776 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.8 p90 -117.42 151.25 37.44 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.53 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.783 HG21 HD11 ' A' ' 71' ' ' LEU . 93.7 t -82.12 130.3 36.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 124.02 0.825 . . . . 0.0 109.853 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -103.13 -27.19 12.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.58 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 85.4 mtt180 -144.12 138.44 28.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.082 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 66' ' ' ALA . 4.9 t -116.28 144.71 23.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.8 t -45.52 113.69 0.63 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.927 1.392 . . . . 0.0 109.102 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.46 -17.69 14.59 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.513 1.525 . . . . 0.0 114.421 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.3 46.52 0.19 Allowed Glycine 0 CA--C 1.469 -2.806 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -131.65 -165.71 11.46 Favored Glycine 0 N--CA 1.413 -2.899 0 CA-C-N 114.172 -1.014 . . . . 0.0 112.721 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.454 ' CG ' HG23 ' A' ' 18' ' ' ILE . 41.9 Cg_endo -65.2 -29.6 55.47 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 123.706 2.937 . . . . 0.0 112.4 -170.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.422 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -60.73 -59.14 5.86 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.433 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.0 pt-20 -67.8 -32.62 73.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.649 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 64' ' ' GLY . 23.1 mm -58.55 -47.26 88.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.015 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -72.96 -40.89 64.97 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.494 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.1 20.62 0.82 Allowed Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.153 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.783 HD11 HG21 ' A' ' 57' ' ' VAL . 1.9 tp -79.58 125.81 30.08 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.439 ' N ' HD12 ' A' ' 71' ' ' LEU . 21.3 mm-40 -114.27 150.88 33.73 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.839 0.828 . . . . 0.0 109.733 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.4 mt -68.63 132.68 32.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.9 175.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.31 58.57 Favored Glycine 0 C--O 1.248 0.984 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.429 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 15.4 m-20 -84.74 126.22 33.22 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -86.88 117.35 25.55 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.517 HD11 HG23 ' A' ' 57' ' ' VAL . 10.7 mt -83.15 141.48 14.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.651 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.3 mmt -119.96 -20.6 7.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.438 0.637 . . . . 0.0 109.351 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.538 HE22 ' H ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -143.59 138.61 29.18 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.528 HG13 HD12 ' A' ' 107' ' ' LEU . 34.4 t -142.37 119.68 7.14 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 124.045 0.938 . . . . 0.0 108.752 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.3 t-20 43.86 57.22 4.21 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.736 1.614 . . . . 0.0 112.127 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.538 ' H ' HE22 ' A' ' 79' ' ' GLN . . . 47.44 30.15 5.88 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 117.07 1.588 . . . . 0.0 117.07 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.448 ' HE1' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -109.72 -12.47 14.62 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -175.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.95 93.55 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 127.258 2.223 . . . . 0.0 107.973 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.615 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 4.3 ttp -89.02 -12.51 41.17 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -170.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.1 t -53.93 127.84 27.84 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 120.93 0.395 . . . . 0.0 110.357 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.3 ttm 63.4 90.27 0.08 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.446 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' A' ' 85' ' ' MET . 14.8 p -158.49 155.64 4.41 Favored 'Isoleucine or valine' 0 C--O 1.263 1.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.568 HG22 ' HB2' ' A' ' 38' ' ' ASP . 9.4 p -75.09 159.72 31.34 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 120.98 0.419 . . . . 0.0 110.167 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.62 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 14.1 t60 -55.33 -46.9 76.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.634 174.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.8 -50.56 72.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.987 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.4 67.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.957 -176.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.69 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -73.81 -42.54 60.8 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.498 ' CZ ' HG21 ' A' ' 98' ' ' THR . 12.9 mmm180 -50.19 -44.17 52.85 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 123.92 0.888 . . . . 0.0 111.031 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -84.26 29.25 0.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.056 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.506 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 5.3 tpt180 -142.91 -42.61 0.31 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.84 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -95.27 -17.52 21.61 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.498 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 11.9 t -124.75 13.78 8.62 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.692 174.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.6 ptpt -70.17 178.29 2.87 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.315 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.447 ' NH1' ' HA ' ' A' ' 26' ' ' ASN . 13.9 ptm180 -131.65 6.08 4.36 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.556 -176.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.446 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 20.2 m -74.93 -41.77 59.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.37 0.605 . . . . 0.0 109.497 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.31 139.73 32.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.411 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.96 -63.81 1.24 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.0 t -98.8 122.38 50.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 120.81 0.338 . . . . 0.0 110.141 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.499 HG23 HD21 ' A' ' 107' ' ' LEU . 33.4 m -113.96 145.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -125.64 115.98 20.98 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -117.61 153.15 33.77 Favored 'General case' 0 N--CA 1.397 -3.123 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -172.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.3 mp -118.0 121.18 39.96 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -116.8 154.08 18.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.7 p . . . . . 0 N--CA 1.399 -3.0 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.778 176.844 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.448 -0.561 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.5 p -112.28 147.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.421 HE21 HG22 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -141.59 152.08 43.72 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -94.43 149.26 21.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.887 0.375 . . . . 0.0 110.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 71' ' ' LEU . 9.8 p -136.66 159.16 37.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.49 106.47 4.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.43 0.633 . . . . 0.0 111.326 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -93.95 128.61 45.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.736 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 54.6 m170 -96.65 151.98 19.09 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 11.0 ptpp? -43.34 128.38 4.8 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.556 HD22 ' HD2' ' A' ' 65' ' ' PRO . 51.2 tp -122.48 123.85 42.23 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.189 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -88.5 116.38 26.7 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -113.3 103.33 11.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.19 -102.47 0.94 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.86 6.19 10.43 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.268 0.556 . . . . 0.0 111.317 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.85 163.11 12.98 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -117.89 108.92 15.9 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.48 163.55 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' HG21 ' A' ' 18' ' ' ILE . 10.9 mp -92.62 9.96 32.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.95 0.881 . . . . 0.0 110.984 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.23 -41.69 3.07 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.68 -0.691 . . . . 0.0 114.341 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 71' ' ' LEU . 49.3 p90 -99.0 172.54 7.33 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.7 m -136.26 170.44 16.02 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.306 1.042 . . . . 0.0 109.364 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 55' ' ' ILE . 7.0 pt -127.93 167.22 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 117.868 0.304 . . . . 0.0 111.169 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.39 -27.68 4.64 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.521 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.18 165.25 12.29 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.344 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.548 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -117.85 -110.17 2.5 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.203 0.59 . . . . 0.0 113.13 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.607 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.76 -26.19 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -173.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' HB2' HG22 ' A' ' 89' ' ' THR . 15.2 t70 -66.32 -19.82 65.92 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.685 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.63 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 27.5 mm-40 -96.38 -177.76 4.07 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 3.9 t70 -132.39 120.49 16.95 Favored Pre-proline 0 CA--C 1.498 -1.029 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.12 -23.25 35.17 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.197 2.598 . . . . 0.0 113.771 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -69.9 -28.87 65.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -116.03 7.48 14.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.552 0.691 . . . . 0.0 110.725 -175.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 7.4 m120 -98.89 146.5 31.76 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.32 -44.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.948 3.098 . . . . 0.0 114.458 -175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -109.1 12.09 25.31 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.674 0.75 . . . . 0.0 110.427 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.5 t . . . . . 0 N--CA 1.432 -1.364 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.49 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.607 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 67.1 mttt . . . . . 0 C--O 1.238 0.495 0 CA-C-O 121.799 0.809 . . . . 0.0 113.144 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.91 159.88 8.09 Favored Glycine 0 C--O 1.192 -2.528 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 33' ' ' ILE . 29.0 mm -74.56 120.19 23.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 117.868 0.834 . . . . 0.0 110.296 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -120.6 157.77 28.8 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.927 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.712 HG21 HD11 ' A' ' 71' ' ' LEU . 98.5 t -84.23 132.57 31.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 O-C-N 124.713 1.258 . . . . 0.0 110.71 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -108.26 -19.66 13.4 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.462 0.649 . . . . 0.0 111.362 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -142.09 142.17 32.79 Favored 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.465 HG13 ' CB ' ' A' ' 66' ' ' ALA . 25.5 t -140.4 132.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.568 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -49.82 126.97 15.14 Favored 'General case' 0 N--CA 1.413 -2.301 0 O-C-N 124.372 1.045 . . . . 0.0 112.521 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.69 -16.17 64.03 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.06 0.944 . . . . 0.0 111.802 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.96 46.7 0.39 Allowed Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.16 -174.87 14.06 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.701 -0.749 . . . . 0.0 111.499 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.556 ' HD2' HD22 ' A' ' 21' ' ' LEU . 35.0 Cg_endo -62.54 -29.1 78.01 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 C-N-CA 124.106 3.204 . . . . 0.0 111.965 -171.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.465 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -59.7 -61.96 2.23 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.752 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 61' ' ' SER . 2.4 pt-20 -70.09 -31.2 68.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.763 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.44 -41.39 84.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.33 -44.25 30.19 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.588 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.78 27.35 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.245 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.712 HD11 HG21 ' A' ' 57' ' ' VAL . 5.1 tp -89.45 123.69 33.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.463 ' N ' HD12 ' A' ' 71' ' ' LEU . 28.0 mm-40 -110.2 162.92 14.12 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 122.301 1.048 . . . . 0.0 110.62 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.63 134.61 29.48 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.88 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.21 18.72 71.11 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.051 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.511 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 3.6 m-20 -77.01 -2.08 32.09 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 43.07 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 57' ' ' VAL . 9.9 mt -84.51 124.93 40.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.519 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.833 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 18.2 mmt -112.18 -10.63 13.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.257 0.551 . . . . 0.0 110.527 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.644 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 7.8 tp60 -156.47 127.33 6.83 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.731 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.554 HG13 HD12 ' A' ' 107' ' ' LEU . 22.3 t -132.79 121.59 44.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.213 0 C-N-CA 124.175 0.99 . . . . 0.0 109.212 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.85 30.83 12.06 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.44 6.11 86.32 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 115.835 -0.62 . . . . 0.0 114.49 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.509 ' CZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -99.1 -2.47 36.93 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 68.69 127.04 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 124.386 1.074 . . . . 0.0 111.222 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.442 ' HE3' ' HB1' ' A' ' 93' ' ' ALA . 8.1 tpt -123.58 -4.38 8.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 110.348 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.833 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 5.0 t -68.36 -16.19 63.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.778 -177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.66 98.39 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.509 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 9.2 p -163.93 146.58 2.73 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.504 HG22 ' HB2' ' A' ' 38' ' ' ASP . 3.1 p -73.19 155.46 39.58 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.463 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.63 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 11.1 t60 -53.5 -45.4 69.66 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.975 0.797 . . . . 0.0 109.393 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.87 -42.47 97.51 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.386 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.87 -32.31 61.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.618 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.543 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.12 -43.56 74.17 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.102 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.44 ' HG2' HD11 ' A' ' 33' ' ' ILE . 9.6 mmm180 -55.75 -40.31 72.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.009 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.14 29.53 0.41 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.146 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.6 tpt180 -142.11 -43.45 0.34 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.989 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -101.31 -20.46 15.2 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.452 ' N ' HD12 ' A' ' 97' ' ' LEU . 10.3 t -115.55 11.74 15.96 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.014 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -63.04 143.65 57.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -103.27 6.83 38.32 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.835 0.826 . . . . 0.0 110.453 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.795 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.94 165.71 12.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 8.8 pt-20 -118.53 -63.57 1.39 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.517 HG12 ' HG3' ' A' ' 103' ' ' GLU . 2.7 p -121.49 131.06 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-O 121.687 0.756 . . . . 0.0 112.679 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.427 HG23 HD21 ' A' ' 107' ' ' LEU . 14.9 m -134.49 171.87 17.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.645 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.445 ' C ' HD13 ' A' ' 107' ' ' LEU . 8.8 mmt180 -123.33 114.43 20.18 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.554 HD12 HG13 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -116.97 148.24 41.59 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -176.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.2 mp -116.02 121.91 43.65 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-O 121.349 0.595 . . . . 0.0 109.5 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 27.6 m -117.49 150.2 19.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.293 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 N--CA 1.413 -2.284 0 CA-C-O 121.625 0.726 . . . . 0.0 110.342 -178.222 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.8 t . . . . . 0 N--CA 1.439 -0.994 0 CA-C-O 120.629 0.252 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 110' ' ' THR . 41.6 t -91.5 120.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.5 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -138.01 156.73 47.53 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.458 0.474 . . . . 0.0 110.046 -174.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -103.32 144.71 30.99 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.494 ' HB ' HE22 ' A' ' 14' ' ' GLN . 10.0 p -126.78 156.15 37.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.95 104.07 5.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.667 0.746 . . . . 0.0 111.271 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.504 HD13 HD23 ' A' ' 107' ' ' LEU . 1.5 mp -92.31 129.02 43.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.053 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -93.15 159.97 15.05 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.741 0.651 . . . . 0.0 109.359 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HB2' HD21 ' A' ' 27' ' ' LEU . 17.3 pttp -50.72 124.79 11.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.513 HD22 ' HD2' ' A' ' 65' ' ' PRO . 48.1 tp -128.67 131.72 48.03 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.382 0.673 . . . . 0.0 110.27 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.437 HE21 ' HB ' ' A' ' 28' ' ' ILE . 30.3 mt-30 -131.2 106.02 8.05 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.95 -109.17 2.71 Favored Glycine 0 N--CA 1.428 -1.868 0 O-C-N 124.051 0.844 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -116.54 17.74 15.27 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.99 172.59 11.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.1 tm? -120.0 115.34 23.56 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.437 ' HB ' HE21 ' A' ' 23' ' ' GLN . 1.3 mt -129.49 163.77 33.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -175.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 105' ' ' VAL . 7.5 mp -82.28 2.76 30.48 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.991 0.901 . . . . 0.0 109.892 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 89.56 -44.89 3.06 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.816 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 57' ' ' VAL . 45.6 p90 -89.17 164.69 14.89 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 85.0 p -114.74 -173.2 2.26 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.048 0.939 . . . . 0.0 109.616 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 55' ' ' ILE . 7.3 pt -138.16 164.78 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.275 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.14 -33.79 2.68 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 121.32 151.62 8.59 Favored Glycine 0 C--O 1.2 -2.022 0 C-N-CA 118.581 -1.771 . . . . 0.0 113.798 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA2' ' H ' ' A' ' 54' ' ' GLY . . . -105.66 -115.64 4.09 Favored Glycine 0 C--O 1.205 -1.682 0 C-N-CA 121.071 -0.585 . . . . 0.0 114.16 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.524 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.09 -9.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.039 0.923 . . . . 0.0 112.203 -175.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.612 ' HB2' HG22 ' A' ' 89' ' ' THR . 24.0 t70 -81.67 -13.36 57.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.579 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.652 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 17.6 mm-40 -113.8 -178.12 3.3 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.51 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 13.3 t70 -122.16 124.63 26.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.6 Cg_endo -56.44 -28.48 73.44 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.537 -176.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -76.32 -19.86 57.84 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.51 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -120.89 12.64 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.844 0.83 . . . . 0.0 110.104 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.484 HD21 ' HB3' ' A' ' 39' ' ' GLN . 0.8 OUTLIER -103.0 144.03 27.79 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.048 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.54 -49.41 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.936 2.424 . . . . 0.0 113.526 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 63.8 m-85 -111.89 16.32 20.42 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.411 1.101 . . . . 0.0 109.982 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 8.0 t . . . . . 0 N--CA 1.424 -1.757 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.74 176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.524 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 47.2 mttp . . . . . 0 N--CA 1.427 -1.585 0 CA-C-O 121.102 0.477 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.479 ' H ' ' HA2' ' A' ' 36' ' ' GLY . . . 141.94 166.51 10.92 Favored Glycine 0 CA--C 1.475 -2.417 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 33' ' ' ILE . 32.7 mm -81.08 132.53 31.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 18.3 p90 -141.76 161.3 38.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.683 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.485 HG11 HG12 ' A' ' 60' ' ' VAL . 59.6 t -84.92 130.6 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.355 0 O-C-N 124.717 1.26 . . . . 0.0 110.447 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.7 p -102.24 -23.08 14.05 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.878 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 27.1 mmt180 -149.28 129.6 13.77 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 123.97 0.908 . . . . 0.0 109.202 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.485 HG12 HG11 ' A' ' 57' ' ' VAL . 30.0 m -104.37 177.29 0.89 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.033 0 CA-C-N 119.217 0.917 . . . . 0.0 109.3 174.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.539 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.2 t -79.7 116.21 19.75 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.73 -2.21 2.36 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.382 1.473 . . . . 0.0 114.336 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.5 33.76 0.16 Allowed Glycine 0 C--N 1.273 -2.921 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.469 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -121.51 -168.49 13.44 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.43 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.513 ' HD2' HD22 ' A' ' 21' ' ' LEU . 42.0 Cg_endo -64.96 -28.8 57.83 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 123.323 2.682 . . . . 0.0 111.661 -170.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.67 -64.27 0.99 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.124 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.3 pt-20 -71.48 -29.95 65.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.54 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.7 mm -56.2 -47.31 81.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 O-C-N 123.287 0.367 . . . . 0.0 110.73 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.44 -47.55 32.94 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.28 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.31 14.94 0.44 Allowed Glycine 0 C--N 1.312 -0.772 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.63 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.425 HD11 HG21 ' A' ' 57' ' ' VAL . 2.1 tp -79.63 118.52 21.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -119.35 140.09 50.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.59 139.97 10.8 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 O-C-N 124.64 1.213 . . . . 0.0 110.303 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.48 34.67 19.14 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 119.601 -1.285 . . . . 0.0 111.436 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.566 ' OD2' HG13 ' A' ' 77' ' ' ILE . 10.0 p-10 -94.47 -161.4 0.85 Allowed 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 113.54 -1.33 . . . . 0.0 107.875 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 73.8 mmtt -150.36 96.42 2.4 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.566 HG13 ' OD2' ' A' ' 75' ' ' ASP . 22.8 mt -73.12 113.31 10.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.282 1.039 . . . . 0.0 110.459 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 15.8 mmt -105.06 -10.21 17.33 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.182 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 1.1 tm0? -163.14 134.13 4.76 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 121.861 -0.525 . . . . 0.0 110.023 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.556 HG13 HD12 ' A' ' 107' ' ' LEU . 22.8 t -134.31 115.4 20.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 48.07 55.79 8.21 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 124.509 1.124 . . . . 0.0 112.395 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 62.0 2.35 3.72 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-N 113.662 -1.608 . . . . 0.0 116.582 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -87.33 -14.17 41.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t0 65.15 120.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.06 1.744 . . . . 0.0 111.602 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.479 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 41.7 ttm -119.36 8.54 11.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.209 1.004 . . . . 0.0 110.926 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.437 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 10.5 t -46.12 -28.43 1.21 Allowed 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 125.793 1.637 . . . . 0.0 114.743 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 ttp -159.86 92.39 1.02 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.479 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.1 p -148.5 151.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.612 HG22 ' HB2' ' A' ' 38' ' ' ASP . 18.4 p -70.28 157.06 38.39 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.308 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.652 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.4 t60 -57.59 -43.56 84.72 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -58.9 -47.3 85.49 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.954 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -36.8 64.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.631 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' HG13 ' A' ' 55' ' ' ILE . . . -65.14 -40.67 94.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.711 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.424 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 7.9 mmm180 -53.45 -39.77 64.7 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.597 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -81.19 13.93 2.61 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.383 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 22.9 tpt180 -131.37 -35.8 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.865 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -98.86 -27.78 13.76 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.619 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.402 ' N ' HD13 ' A' ' 97' ' ' LEU . 9.0 t -113.53 13.05 18.73 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.048 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HD2' ' HG2' ' A' ' 102' ' ' GLU . 14.4 ptpt -67.64 157.36 34.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 165.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 13.6 ptt180 -112.91 8.92 18.77 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.418 -173.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -81.18 -31.28 34.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.623 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 18.6 mm-40 -87.15 146.12 26.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -94.18 -75.41 0.51 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.566 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.491 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 2.0 p -109.73 133.86 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-O 121.141 0.496 . . . . 0.0 110.012 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 29' ' ' LEU . 16.7 m -132.3 162.99 38.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.511 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.438 ' C ' HD13 ' A' ' 107' ' ' LEU . 97.7 mtt180 -123.91 117.57 25.12 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.556 HD12 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -119.61 152.34 37.21 Favored 'General case' 0 N--CA 1.397 -3.122 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -175.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.9 mp -116.92 131.07 57.05 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 75' ' ' ASP . 20.8 m -131.91 153.96 39.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 123.976 0.797 . . . . 0.0 109.889 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.609 HG22 HG22 ' A' ' 13' ' ' VAL . 36.9 p . . . . . 0 N--CA 1.419 -1.984 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 173.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t . . . . . 0 N--CA 1.435 -1.214 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 7.6 p -114.05 142.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.624 HE22 ' HB ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -144.84 153.85 42.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -99.27 138.47 36.32 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HE22 ' A' ' 14' ' ' GLN . 7.4 p -122.6 157.13 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.6 106.27 5.36 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.478 0.656 . . . . 0.0 110.959 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -93.59 127.44 45.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.914 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.454 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 43.9 m170 -95.92 160.09 14.64 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 124.159 0.912 . . . . 0.0 109.311 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 17.6 ptpt -43.13 110.15 0.18 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 33.2 tp -107.96 115.4 30.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.73 103.0 12.55 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.61 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -104.24 108.57 20.01 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.35 -106.34 1.31 Allowed Glycine 0 C--N 1.311 -0.825 0 O-C-N 123.635 0.584 . . . . 0.0 112.846 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.09 6.63 20.98 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.771 0.319 . . . . 0.0 111.47 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.69 170.82 8.3 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.544 0.688 . . . . 0.0 109.294 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.44 121.73 35.69 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.515 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -129.5 155.81 41.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 40.6 mt -86.25 5.0 36.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.777 0.798 . . . . 0.0 109.331 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . 90.36 -46.97 3.04 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 114.388 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 57' ' ' VAL . 46.1 p90 -86.93 161.6 18.16 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 43.6 m -115.62 165.9 12.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.116 1.366 . . . . 0.0 108.705 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.684 HG21 HD21 ' A' ' 97' ' ' LEU . 8.9 pt -126.18 165.35 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.678 0.217 . . . . 0.0 110.491 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.11 -32.61 3.45 Favored Glycine 0 CA--C 1.484 -1.893 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.44 154.02 8.87 Favored Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.325 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.58 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -100.32 -122.83 4.97 Favored Glycine 0 N--CA 1.418 -2.506 0 O-C-N 124.298 0.646 . . . . 0.0 113.478 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -22.93 31.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.521 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 16.8 t70 -66.99 -19.4 65.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.818 0.818 . . . . 0.0 110.424 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.658 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 15.5 mm-40 -96.26 -169.55 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.068 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 8.9 t70 -136.17 125.5 15.85 Favored Pre-proline 0 CA--C 1.493 -1.216 0 CA-C-O 118.855 -0.593 . . . . 0.0 109.809 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 20.9 Cg_endo -58.9 -24.5 72.92 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.739 2.293 . . . . 0.0 113.683 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.1 t -73.25 -32.46 64.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.216 0.531 . . . . 0.0 109.829 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.426 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -111.93 16.33 20.38 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.01 0.434 . . . . 0.0 111.246 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.581 HD21 ' HB3' ' A' ' 39' ' ' GLN . 3.6 m120 -102.4 140.12 20.84 Favored Pre-proline 0 CA--C 1.485 -1.538 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.412 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.03 -46.15 2.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.434 2.09 . . . . 0.0 113.38 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -120.61 31.52 6.41 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.595 ' HA ' ' NZ ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER . . . . . 0 C--N 1.312 -1.064 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.011 177.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.5 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 55.8 mtmt . . . . . 0 N--CA 1.431 -1.422 0 CA-C-O 121.001 0.429 . . . . 0.0 110.544 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.406 ' C ' ' HA2' ' A' ' 36' ' ' GLY . . . 153.65 156.54 7.67 Favored Glycine 0 C--O 1.183 -3.067 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -176.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.612 HD12 HD12 ' A' ' 33' ' ' ILE . 31.4 mm -71.91 129.06 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.215 1.008 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.43 160.59 38.29 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.57 HG21 HD11 ' A' ' 71' ' ' LEU . 87.1 t -86.01 132.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 O-C-N 125.205 1.566 . . . . 0.0 109.872 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 p -104.54 -27.14 12.06 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.798 0.808 . . . . 0.0 111.026 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -144.42 133.28 22.52 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.544 HG12 HG11 ' A' ' 57' ' ' VAL . 33.8 m -97.72 -175.5 0.37 Allowed 'Isoleucine or valine' 1 N--CA 1.347 -5.602 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.465 ' OG ' ' HA3' ' A' ' 30' ' ' GLY . 0.9 OUTLIER -68.09 126.37 29.29 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.34 -25.14 1.45 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.838 1.255 . . . . 0.0 112.981 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.71 57.96 0.1 Allowed Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -139.83 -168.69 11.4 Favored Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.594 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.412 ' HB2' HG23 ' A' ' 18' ' ' ILE . 28.7 Cg_endo -59.95 -34.49 95.12 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 124.35 3.367 . . . . 0.0 113.095 -170.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 61' ' ' SER . . . -57.53 -57.76 11.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -75.48 -21.51 58.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.933 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 64' ' ' GLY . 28.1 mm -67.56 -42.07 86.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.467 0.651 . . . . 0.0 109.651 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.46 -42.82 21.95 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.297 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.29 20.75 0.89 Allowed Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.398 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.57 HD11 HG21 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -75.94 117.21 17.42 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.573 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 24.5 mm-40 -111.9 135.7 52.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.242 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.1 mt -53.69 143.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 124.199 1.0 . . . . 0.0 111.246 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.64 36.66 58.3 Favored Glycine 0 N--CA 1.48 1.576 0 CA-C-O 122.725 1.181 . . . . 0.0 111.485 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.668 ' HB2' ' HB ' ' A' ' 109' ' ' VAL . 22.2 p-10 -84.92 -52.44 6.0 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 126.183 1.793 . . . . 0.0 114.492 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.595 ' NZ ' ' HA ' ' A' ' 47' ' ' SER . 55.7 mttm 70.46 100.77 0.06 Allowed 'General case' 0 C--O 1.249 1.043 0 C-N-CA 124.624 1.17 . . . . 0.0 108.01 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 57' ' ' VAL . 11.0 mt -83.87 130.47 35.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.006 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.4 mmt -109.97 -22.83 11.64 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.376 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -143.25 134.19 25.5 Favored 'General case' 0 C--O 1.199 -1.58 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -175.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.594 HG22 HD22 ' A' ' 107' ' ' LEU . 40.2 t -140.19 115.11 7.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 48.14 50.15 16.54 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 125.668 1.587 . . . . 0.0 112.806 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.587 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 66.31 -11.84 0.5 Allowed Glycine 0 CA--C 1.565 3.17 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -21.67 58.27 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.235 1.018 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t0 72.92 113.93 0.06 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 125.301 1.44 . . . . 0.0 109.137 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 tpt -94.2 -8.45 39.28 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.997 -167.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -49.89 125.56 12.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.763 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.9 ttt 53.89 80.87 0.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.91 1.284 . . . . 0.0 113.373 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.404 HG13 HG13 ' A' ' 55' ' ' ILE . 8.4 p -145.15 147.9 18.33 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 38' ' ' ASP . 5.7 p -69.33 156.83 38.14 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.987 0.515 . . . . 0.0 110.992 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.658 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.5 t60 -56.48 -41.44 76.59 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.58 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 23.2 t70 -60.16 -53.73 54.3 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 124.045 0.84 . . . . 0.0 111.183 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -31.02 70.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.156 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.687 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.64 -48.23 67.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.462 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.519 ' CZ ' HG21 ' A' ' 98' ' ' THR . 20.3 mmm180 -56.62 -44.13 80.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.801 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 30.0 mmtp -80.83 28.4 0.35 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.385 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.584 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -144.61 -45.85 0.24 Allowed 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.4 pp -92.43 -35.2 13.8 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.1 t -103.08 9.2 38.59 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.334 -1.346 . . . . 0.0 109.235 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -62.91 148.86 46.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -96.0 15.09 21.55 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.832 0.825 . . . . 0.0 110.974 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.493 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 67.7 m -93.66 -25.96 17.26 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.947 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -77.12 -178.62 5.12 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.774 0.797 . . . . 0.0 113.086 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 10.1 pt-20 -146.64 -73.27 0.22 Allowed 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.019 169.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.6 p -119.51 134.37 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' CG2' HD21 ' A' ' 107' ' ' LEU . 16.8 m -140.01 149.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.088 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -104.39 127.29 52.04 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 HG22 ' A' ' 80' ' ' VAL . 3.3 mt -122.46 147.51 46.25 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.9 mp -113.54 124.13 51.64 Favored 'General case' 0 CA--C 1.452 -2.801 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.668 ' HB ' ' HB2' ' A' ' 75' ' ' ASP . 35.8 m -124.79 153.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.543 -177.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 39.0 p . . . . . 0 C--N 1.276 -2.597 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 176.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 110' ' ' THR . 59.4 t . . . . . 0 N--CA 1.423 -1.785 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 12.3 p -99.65 133.65 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.444 HE21 HG22 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -147.5 154.08 40.31 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.872 -178.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.69 148.29 22.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.94 0.4 . . . . 0.0 109.961 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.641 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -129.14 157.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 38.1 tt0 -150.31 106.38 3.45 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.579 0.704 . . . . 0.0 109.809 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -94.69 130.14 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.3 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.418 ' HD2' HG13 ' A' ' 104' ' ' VAL . 49.3 m170 -101.57 141.16 34.85 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.916 0.76 . . . . 0.0 109.111 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HE2' ' HB2' ' A' ' 103' ' ' GLU . 18.0 ptpt -29.59 112.24 0.07 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.98 1.712 . . . . 0.0 115.401 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 38.0 tp -113.67 121.02 42.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.1 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -97.91 112.47 24.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -114.34 106.22 14.07 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.14 -108.69 2.28 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 123.732 0.645 . . . . 0.0 112.425 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.74 16.67 18.48 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.42 168.98 13.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.82 118.5 28.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -126.89 158.13 37.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.085 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.454 ' CD2' HG21 ' A' ' 105' ' ' VAL . 9.2 mp -86.43 -1.53 57.65 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.763 0.792 . . . . 0.0 109.744 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.98 3.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.38 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -96.5 171.61 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.582 0.691 . . . . 0.0 112.19 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 m -138.71 169.17 18.28 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.863 1.265 . . . . 0.0 110.404 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 55' ' ' ILE . 7.1 pt -126.82 169.45 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.129 -0.357 . . . . 0.0 110.762 -170.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.92 -24.76 5.65 Favored Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 120.4 163.2 12.05 Favored Glycine 0 C--O 1.195 -2.331 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.632 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.52 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -114.97 -115.03 3.02 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.888 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.81 -24.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.251 0.548 . . . . 0.0 111.996 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.537 ' HB2' HG22 ' A' ' 89' ' ' THR . 32.8 t70 -72.54 -17.75 61.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.89 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 28.3 mm-40 -104.18 166.75 10.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -106.43 121.23 45.97 Favored Pre-proline 0 CA--C 1.492 -1.256 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.257 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HD3' ' HE3' ' A' ' 53' ' ' LYS . 10.1 Cg_endo -57.2 -30.02 85.73 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.88 2.387 . . . . 0.0 113.298 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.9 m -65.75 -27.24 68.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.999 0.428 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -116.42 11.91 15.06 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.391 0.615 . . . . 0.0 110.465 -175.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -103.97 146.04 31.78 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.44 -44.13 6.96 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 123.68 2.92 . . . . 0.0 113.753 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.46 14.45 21.45 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.215 0.531 . . . . 0.0 110.115 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.4 t . . . . . 0 N--CA 1.426 -1.661 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.502 -178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.43 ' HE3' ' HD3' ' A' ' 41' ' ' PRO . 29.2 mmtm . . . . . 0 N--CA 1.445 -0.679 0 CA-C-O 121.528 0.68 . . . . 0.0 109.283 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.468 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 145.01 159.63 8.17 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 33' ' ' ILE . 36.1 mm -77.92 122.16 32.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-N 118.126 0.963 . . . . 0.0 109.502 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.4 p90 -122.31 151.9 40.66 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.363 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.491 HG13 ' HA ' ' A' ' 73' ' ' ILE . 8.7 p -80.82 132.35 31.83 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 O-C-N 124.769 1.293 . . . . 0.0 110.69 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 p -106.75 -27.25 10.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.435 0.636 . . . . 0.0 110.686 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -138.13 131.46 30.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.05 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 71' ' ' LEU . 64.8 t -118.9 140.6 42.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 174.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.71 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.5 t -63.66 116.91 6.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 pt-20 -77.27 2.99 14.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.837 0.827 . . . . 0.0 112.024 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.63 29.94 0.94 Allowed Glycine 0 C--N 1.267 -3.265 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.426 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -128.14 -177.88 15.08 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.075 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.55 -29.01 70.3 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 124.366 3.377 . . . . 0.0 112.791 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -57.77 -59.19 5.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.477 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.71 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.6 pt-20 -74.06 -31.88 63.05 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.387 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 64' ' ' GLY . 26.3 mm -55.11 -41.37 59.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 O-C-N 123.737 0.648 . . . . 0.0 110.471 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -76.05 -55.92 5.15 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.319 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.54 28.69 0.04 OUTLIER Glycine 0 C--N 1.317 -0.501 0 C-N-CA 119.768 -1.206 . . . . 0.0 113.239 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.641 ' HB2' HG11 ' A' ' 16' ' ' VAL . 2.5 tp -94.55 117.56 30.32 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -115.39 143.81 44.73 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HA ' HG13 ' A' ' 57' ' ' VAL . 65.6 mt -54.89 129.67 16.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.004 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.02 -3.95 45.03 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.706 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 84.0 m-20 -80.94 130.23 34.92 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.909 0.355 . . . . 0.0 110.571 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.46 116.11 22.92 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.523 HG13 HG12 ' A' ' 109' ' ' VAL . 3.0 mp -86.27 124.34 40.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.592 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 30.5 mmt -102.27 -19.88 14.86 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.313 0.577 . . . . 0.0 111.116 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 50.2 tp60 -148.47 134.84 19.52 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.91 -171.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.638 HG22 HD22 ' A' ' 107' ' ' LEU . 54.8 t -142.62 108.84 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.0 0.52 . . . . 0.0 111.974 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.4 t-20 55.18 39.43 31.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.297 1.439 . . . . 0.0 112.715 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.32 4.79 83.34 Favored Glycine 0 C--N 1.294 -1.771 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.23 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.496 ' NE1' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -116.7 148.32 41.17 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.94 122.76 28.69 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.404 ' HG2' ' HB ' ' A' ' 55' ' ' ILE . 40.2 ttm -108.98 -0.92 19.34 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.044 0.926 . . . . 0.0 110.515 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.592 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 3.8 t -58.79 -34.63 71.69 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.657 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.1 ttt -140.72 95.36 2.85 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.444 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 9.7 p -160.1 151.15 5.77 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.449 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 38' ' ' ASP . 10.4 p -71.41 158.33 36.5 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.658 ' HE2' ' HE ' ' A' ' 94' ' ' ARG . 22.2 t60 -56.11 -43.6 78.3 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.124 175.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.15 -49.54 76.8 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.96 0.788 . . . . 0.0 111.399 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -31.77 68.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.44 ' O ' HD12 ' A' ' 97' ' ' LEU . . . -75.21 -40.62 59.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.658 ' HE ' ' HE2' ' A' ' 90' ' ' HIS . 15.9 mmt180 -53.04 -47.34 68.47 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.681 0.613 . . . . 0.0 111.023 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 63.1 tttm -86.24 39.14 0.8 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.666 1.222 . . . . 0.0 108.921 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.51 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 30.7 tpt180 -145.76 -45.99 0.21 Allowed 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.147 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.508 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -92.45 -26.95 17.75 Favored 'General case' 0 C--O 1.208 -1.104 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.326 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.0 t -117.43 14.79 14.7 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.521 ' HD2' ' HG2' ' A' ' 102' ' ' GLU . 13.6 ptpt -74.08 171.06 14.22 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -113.8 -0.36 14.23 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.034 0.445 . . . . 0.0 111.897 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 69.8 m -76.72 -28.46 55.82 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 33.9 mm-40 -81.84 179.19 7.92 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.117 0.484 . . . . 0.0 110.696 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.576 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 7.6 pt-20 -146.42 -70.14 0.25 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 44.0 t -105.99 126.63 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 30.6 m -128.49 134.68 64.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 123.626 0.579 . . . . 0.0 111.014 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -103.56 116.52 32.52 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.638 HD22 HG22 ' A' ' 80' ' ' VAL . 5.9 mt -114.39 161.43 17.95 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -134.77 121.61 20.95 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 77' ' ' ILE . 32.7 m -113.39 156.27 14.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.662 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.5 p . . . . . 1 N--CA 1.371 -4.414 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 N--CA 1.424 -1.774 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.0 p -93.33 126.31 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.568 HE22 ' HB ' ' A' ' 16' ' ' VAL . 0.2 OUTLIER -130.52 154.41 47.83 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.98 -174.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 3.1 ppt_? -97.06 145.57 25.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.568 ' HB ' HE22 ' A' ' 14' ' ' GLN . 7.9 p -133.97 149.03 30.13 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.94 103.06 5.87 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.548 0.689 . . . . 0.0 111.291 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -91.72 126.79 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.482 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 56.0 m170 -96.26 150.51 20.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HB2' HD21 ' A' ' 27' ' ' LEU . 21.5 pttm -43.37 121.72 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.475 HD22 ' HD2' ' A' ' 65' ' ' PRO . 52.6 tp -122.59 123.91 42.28 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.566 176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.9 126.84 33.83 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.432 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 21.8 mt-30 -128.4 111.4 13.28 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 175.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.55 -105.81 1.69 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -122.73 15.24 10.17 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.39 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.81 171.16 7.66 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.9 tm? -122.84 109.42 14.16 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.05 164.35 19.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 105' ' ' VAL . 9.2 mp -88.08 3.69 48.1 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.056 0.931 . . . . 0.0 109.62 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 87.64 -42.2 3.11 Favored Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.676 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -90.4 166.48 13.26 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.3 m -120.5 167.82 11.98 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.404 1.481 . . . . 0.0 108.894 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 55' ' ' ILE . 11.4 pt -127.4 167.13 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 110.988 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.95 -27.1 5.0 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.99 157.97 10.17 Favored Glycine 0 C--O 1.196 -2.274 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.856 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.61 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -106.02 -115.9 4.1 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.577 0.81 . . . . 0.0 113.486 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.618 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.74 -26.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -173.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.73 -18.39 65.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.752 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.549 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 24.4 mm-40 -98.58 164.83 12.09 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.806 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 5.3 t70 -119.8 118.91 31.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 10.2 Cg_endo -54.0 -26.04 39.02 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.732 2.955 . . . . 0.0 113.731 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 t -66.32 -26.79 67.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.448 HE21 ' HB3' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -121.05 4.37 10.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.26 0.553 . . . . 0.0 111.431 -175.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 5.9 m120 -90.62 149.57 40.9 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 -50.52 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 123.439 2.759 . . . . 0.0 113.131 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.12 -3.48 19.88 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.692 0.758 . . . . 0.0 111.52 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 6.1 t . . . . . 0 C--N 1.291 -1.976 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.758 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.618 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 56.4 mttm . . . . . 0 N--CA 1.447 -0.611 0 CA-C-O 121.362 0.601 . . . . 0.0 111.138 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.4 156.17 7.19 Favored Glycine 0 C--O 1.191 -2.548 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 33' ' ' ILE . 18.5 mm -74.41 129.21 36.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 118.207 1.003 . . . . 0.0 110.332 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -130.71 154.06 48.35 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.197 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 71' ' ' LEU . 90.8 t -77.22 135.54 26.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 124.591 1.182 . . . . 0.0 110.369 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 p -111.02 -19.93 12.59 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.22 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -152.73 138.19 17.65 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 71' ' ' LEU . 15.5 m -106.22 -173.3 0.42 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.046 0 CA-C-N 119.252 0.933 . . . . 0.0 108.632 172.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.616 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.8 t -87.74 118.0 26.95 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.26 -14.59 27.39 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.69 33.41 0.63 Allowed Glycine 0 C--N 1.286 -2.219 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -118.92 -169.76 14.51 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.521 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.475 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.9 Cg_endo -63.93 -29.6 67.13 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.761 2.974 . . . . 0.0 112.373 -170.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.03 -64.87 0.73 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.611 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.2 pt-20 -72.19 -31.89 66.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.506 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 mm -57.08 -39.86 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.335 0.397 . . . . 0.0 110.997 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.91 16.02 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.851 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.59 17.75 0.2 Allowed Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.402 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.688 HD11 HG21 ' A' ' 57' ' ' VAL . 5.5 tp -89.46 124.05 34.13 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -115.37 157.99 23.09 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 122.197 0.998 . . . . 0.0 111.175 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.5 mt -61.84 128.3 23.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.914 172.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.97 4.8 56.63 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -82.55 121.82 27.29 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.204 0.526 . . . . 0.0 111.661 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -83.56 99.98 10.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.876 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 57' ' ' VAL . 9.5 mt -79.28 128.24 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 -174.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.451 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 1.1 mmt -112.17 -18.91 12.45 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.54 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -148.47 137.97 22.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.627 HG22 HD22 ' A' ' 107' ' ' LEU . 37.8 t -139.73 120.88 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 50.44 40.13 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.24 1.416 . . . . 0.0 112.471 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.54 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 62.98 16.21 57.03 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 114.226 -1.352 . . . . 0.0 114.783 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . 0.307 0.0 OUTLIER -91.17 -82.89 0.28 Allowed 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 118.742 -0.646 . . . . 0.0 112.255 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.4 t70 168.41 127.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.507 ' HG3' ' HB ' ' A' ' 55' ' ' ILE . 47.3 tpp -128.3 1.0 5.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 122.709 1.242 . . . . 0.0 109.907 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.451 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 5.2 t -80.73 -29.5 36.34 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.629 -179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.6 ttp -133.01 75.25 1.61 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.78 -0.575 . . . . 0.0 110.409 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -151.52 150.51 13.13 Favored 'Isoleucine or valine' 0 C--O 1.259 1.574 0 CA-C-O 121.252 0.549 . . . . 0.0 110.232 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.512 HG23 HD11 ' A' ' 37' ' ' ILE . 1.9 p -73.29 157.85 36.25 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.999 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.549 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.3 t60 -56.74 -43.11 80.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.655 174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.88 -50.72 72.94 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 124.357 1.063 . . . . 0.0 111.996 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -39.4 76.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.958 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.071 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.437 ' CZ ' HG21 ' A' ' 98' ' ' THR . 15.6 mmm180 -55.53 -38.7 69.59 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.238 0.542 . . . . 0.0 110.469 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -86.98 24.44 1.52 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.515 0.674 . . . . 0.0 109.215 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.554 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 19.1 mmt180 -137.23 -48.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.751 0.82 . . . . 0.0 110.984 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -96.76 -20.49 18.18 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.502 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.1 t -117.94 12.7 13.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.854 -1.538 . . . . 0.0 110.586 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.8 ptpt -68.49 -173.63 0.45 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -133.4 6.55 3.83 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.587 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.414 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 10.4 m -80.24 -40.48 26.93 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.131 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.06 152.28 22.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.563 ' HG3' HG12 ' A' ' 104' ' ' VAL . 9.7 pt-20 -104.06 -63.42 1.2 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.932 0.396 . . . . 0.0 110.678 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.563 HG12 ' HG3' ' A' ' 103' ' ' GLU . 2.0 p -118.81 132.5 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 CA-C-O 121.323 0.582 . . . . 0.0 110.929 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 29' ' ' LEU . 19.6 m -135.51 155.17 36.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.507 -174.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 3.3 mpt_? -107.2 126.29 52.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.627 HD22 HG22 ' A' ' 80' ' ' VAL . 5.2 mt -119.91 146.84 45.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.17 122.56 46.44 Favored 'General case' 0 C--N 1.265 -3.09 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.52 HG22 ' NE2' ' A' ' 14' ' ' GLN . 11.1 m -123.25 152.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.661 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p . . . . . 0 C--N 1.28 -2.442 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.44 -0.972 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 110' ' ' THR . 21.9 t -95.48 117.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.413 HE22 HG22 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -128.52 156.02 43.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -173.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -94.52 151.79 19.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.945 0.402 . . . . 0.0 111.057 -174.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 71' ' ' LEU . 3.1 t -131.51 151.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 174.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.416 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 39.7 tt0 -147.11 104.16 3.65 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.546 0.688 . . . . 0.0 109.784 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -88.08 127.12 41.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.093 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.1 m170 -108.81 111.64 23.48 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.852 0.72 . . . . 0.0 110.918 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 13.9 ptpt 25.81 97.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 165.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.576 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 41.9 tp -112.25 118.88 36.52 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.617 -0.677 . . . . 0.0 109.765 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -102.55 102.92 13.22 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.361 0.6 . . . . 0.0 110.019 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.447 ' HG2' ' HG ' ' A' ' 21' ' ' LEU . 12.0 mm100 -108.7 112.65 25.06 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.96 -103.51 0.65 Allowed Glycine 0 C--N 1.303 -1.263 0 O-C-N 124.262 0.976 . . . . 0.0 112.272 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -118.45 20.49 13.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 123.319 0.648 . . . . 0.0 110.538 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.52 177.12 7.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.449 0.642 . . . . 0.0 110.175 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -124.77 121.38 34.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -128.55 164.37 30.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.49 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.1 mp -93.75 0.92 56.59 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.724 0.774 . . . . 0.0 110.13 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.78 -35.68 3.9 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 115.152 0.821 . . . . 0.0 115.152 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.416 ' CD1' HD23 ' A' ' 71' ' ' LEU . 50.9 p90 -102.95 165.47 11.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 23.0 m -133.26 168.36 18.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.305 1.442 . . . . 0.0 110.24 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.667 HG21 HD21 ' A' ' 97' ' ' LEU . 6.4 pt -126.75 172.73 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-O 120.525 0.203 . . . . 0.0 111.488 -168.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.32 -5.6 12.8 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.638 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 107.57 -178.98 21.92 Favored Glycine 1 N--CA 1.393 -4.181 0 CA-C-N 114.546 -0.827 . . . . 0.0 111.904 -177.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.617 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -131.58 -79.09 0.17 Allowed Glycine 0 N--CA 1.405 -3.411 0 O-C-N 124.886 0.991 . . . . 0.0 114.293 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.519 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -101.57 -25.85 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.63 ' HB2' HG22 ' A' ' 89' ' ' THR . 10.7 t70 -71.99 -20.69 61.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.35 1.071 . . . . 0.0 109.636 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.586 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -105.88 142.71 35.14 Favored 'General case' 0 N--CA 1.393 -3.319 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.786 -173.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.9 t70 -88.53 125.61 62.78 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.9 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.2 Cg_endo -56.28 -31.3 83.97 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.93 2.42 . . . . 0.0 113.486 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -68.89 -29.34 67.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.249 0.547 . . . . 0.0 111.075 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.556 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.4 pt20 -109.42 8.0 25.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.673 0.749 . . . . 0.0 111.293 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 0.9 OUTLIER -99.54 149.31 35.76 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.788 -177.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.65 -52.75 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.115 2.544 . . . . 0.0 113.156 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -107.87 21.93 16.69 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.1 t . . . . . 0 C--N 1.301 -1.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.363 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 83.9 mttt . . . . . 0 C--O 1.24 0.564 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.5 139.91 4.86 Favored Glycine 0 C--O 1.183 -3.084 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.639 HD12 HD12 ' A' ' 33' ' ' ILE . 28.7 mm -55.08 130.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -170.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.564 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -125.7 149.86 48.14 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.188 177.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.734 HG23 HD11 ' A' ' 77' ' ' ILE . 95.9 t -83.22 132.99 30.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 124.36 1.037 . . . . 0.0 110.805 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.0 p -112.66 -20.26 11.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.34 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 4.3 mmm180 -140.43 132.84 28.46 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.455 HG13 ' CB ' ' A' ' 66' ' ' ALA . 53.4 t -127.22 142.8 42.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.683 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.4 m -62.1 105.3 0.57 Allowed 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 123.892 0.745 . . . . 0.0 112.363 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.41 -28.28 0.34 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 129.168 2.987 . . . . 0.0 113.545 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.2 29.52 2.05 Favored Glycine 0 C--N 1.296 -1.643 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.432 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -113.06 -175.47 19.36 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.051 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 45.7 Cg_endo -64.6 -27.0 61.28 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.01 3.14 . . . . 0.0 111.767 -171.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.455 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -58.15 -59.89 4.6 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.842 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.5 pt-20 -82.63 -20.7 35.82 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.746 -1.582 . . . . 0.0 113.107 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 64' ' ' GLY . 24.5 mm -61.12 -35.59 66.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -80.68 -54.7 5.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.373 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 151.71 25.63 0.05 OUTLIER Glycine 0 C--O 1.225 -0.422 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.608 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.743 ' HB2' HG11 ' A' ' 16' ' ' VAL . 5.2 tp -95.95 125.41 40.48 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.464 ' N ' HD12 ' A' ' 71' ' ' LEU . 22.6 mm-40 -113.66 165.18 12.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 122.043 0.925 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.3 mt -75.37 125.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.4 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.19 0.62 41.22 Favored Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.197 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 72' ' ' GLN . 14.0 m-20 -79.97 123.86 28.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 35.1 mtmt -93.04 125.36 37.59 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.734 HD11 HG23 ' A' ' 57' ' ' VAL . 2.5 mp -96.45 131.81 42.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -171.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.0 mmt -107.12 -25.92 11.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.123 0.487 . . . . 0.0 110.649 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 19.6 tp60 -140.82 128.67 21.78 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.594 HG22 HD22 ' A' ' 107' ' ' LEU . 53.3 t -140.78 113.92 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 C-N-CA 123.382 0.673 . . . . 0.0 110.159 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 55.69 43.54 27.86 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.234 1.014 . . . . 0.0 112.564 171.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.19 -4.18 55.61 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.962 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.484 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -104.33 146.92 28.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -81.36 112.88 19.05 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.837 0.827 . . . . 0.0 111.056 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.626 ' HE3' HD23 ' A' ' 97' ' ' LEU . 61.7 tpp -89.05 -8.2 54.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.531 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -70.42 137.3 50.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.6 ttt 53.98 75.06 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.871 0.868 . . . . 0.0 112.849 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.79 149.95 12.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.63 HG22 ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -70.39 154.99 41.29 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 123.269 0.628 . . . . 0.0 112.204 -178.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -56.8 -44.28 81.77 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.715 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.14 -52.59 64.68 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.869 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.33 -32.12 73.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.942 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.621 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -78.21 -37.26 45.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.843 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.473 ' CZ ' HG21 ' A' ' 98' ' ' THR . 16.6 mmm180 -53.98 -44.11 70.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.407 0.622 . . . . 0.0 110.546 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -85.14 32.56 0.54 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.878 0.847 . . . . 0.0 110.473 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.594 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.3 tpp180 -143.21 -43.3 0.29 Allowed 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.604 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -101.69 -20.94 14.78 Favored 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.473 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 13.7 t -116.44 15.38 15.71 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.683 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.1 ptpt -62.61 158.67 17.67 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.074 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -114.06 6.28 16.36 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.647 0.737 . . . . 0.0 110.531 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.8 m -79.4 -34.39 41.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.339 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.6 144.19 31.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.471 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -100.55 -53.43 3.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.192 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.0 p -121.04 128.58 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.705 0.764 . . . . 0.0 112.565 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.415 HG21 HD23 ' A' ' 29' ' ' LEU . 26.6 m -126.99 146.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.741 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -100.46 115.22 29.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 HG22 ' A' ' 80' ' ' VAL . 12.5 mt -114.52 159.95 19.79 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.2 mp -137.56 123.57 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.59 159.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.538 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.57 HG22 HG22 ' A' ' 13' ' ' VAL . 76.2 p . . . . . 0 N--CA 1.425 -1.713 0 CA-C-O 121.298 0.57 . . . . 0.0 111.495 -179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.419 -2.016 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.3 141.02 19.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.451 HE22 HG22 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -147.4 148.96 31.85 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.49 28.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.672 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -126.24 152.89 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.43 101.4 4.1 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.41 0.624 . . . . 0.0 109.88 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -85.54 122.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.317 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.459 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 46.2 m170 -94.46 145.84 24.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 124.123 0.889 . . . . 0.0 109.549 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -31.64 113.18 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 115.035 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.499 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.1 tp -120.51 117.73 28.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.879 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -96.27 116.97 29.87 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.424 HE21 HD23 ' A' ' 21' ' ' LEU . 68.5 mt-30 -109.77 106.86 16.64 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.62 -105.31 1.27 Allowed Glycine 0 N--CA 1.432 -1.604 0 O-C-N 123.842 0.714 . . . . 0.0 111.319 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -109.6 -3.58 16.79 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.94 167.81 9.96 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -172.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.92 122.26 44.79 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -133.79 155.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 105' ' ' VAL . 8.6 mp -82.27 1.36 37.08 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.107 0.956 . . . . 0.0 109.792 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 89.35 -43.58 3.04 Favored Glycine 0 N--CA 1.42 -2.381 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.708 176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 41.5 p90 -91.35 164.7 13.75 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 87.2 p -113.83 179.93 3.82 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.344 1.057 . . . . 0.0 109.676 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.667 HG21 HD21 ' A' ' 97' ' ' LEU . 6.6 pt -138.32 166.73 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.19 -23.01 6.25 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.56 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 126.9 171.24 13.03 Favored Glycine 0 CA--C 1.476 -2.382 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.16 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.533 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.92 -117.52 2.63 Favored Glycine 0 C--O 1.208 -1.482 0 O-C-N 124.445 0.732 . . . . 0.0 112.841 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.479 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -65.33 -25.68 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.7 t70 -68.99 -16.77 63.81 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.329 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 28.4 mm-40 -98.94 163.3 12.65 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.893 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.414 ' HB3' HE21 ' A' ' 43' ' ' GLN . 1.3 m-20 -91.47 107.52 22.45 Favored Pre-proline 0 CA--C 1.489 -1.376 0 C-N-CA 124.507 1.123 . . . . 0.0 111.787 175.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.526 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 25.9 Cg_endo -64.16 -20.9 67.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.589 2.192 . . . . 0.0 110.442 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.41 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 2.7 m -63.52 -32.44 73.9 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 113.921 -1.491 . . . . 0.0 110.222 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.414 HE21 ' HB3' ' A' ' 40' ' ' ASP . 41.2 mt-30 -122.8 4.98 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.792 0.806 . . . . 0.0 112.876 -170.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -95.38 144.81 28.43 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.09 -40.23 11.98 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.794 2.996 . . . . 0.0 113.756 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 41.3 m-85 -119.59 21.29 12.13 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.969 0.89 . . . . 0.0 108.991 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 5.6 t . . . . . 0 N--CA 1.423 -1.787 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.649 177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.3 mtmm . . . . . 0 N--CA 1.422 -1.843 0 CA-C-O 121.562 0.696 . . . . 0.0 111.112 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.9 163.31 11.03 Favored Glycine 0 C--O 1.181 -3.174 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -175.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.662 HD12 HD12 ' A' ' 33' ' ' ILE . 36.4 mm -72.0 127.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 118.767 1.283 . . . . 0.0 110.634 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 2.3 p90 -127.64 151.77 48.52 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.667 HG21 HD11 ' A' ' 71' ' ' LEU . 85.9 t -79.89 133.34 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 124.426 1.079 . . . . 0.0 110.369 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.424 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 9.3 p -106.11 -22.38 12.88 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.285 0.564 . . . . 0.0 110.75 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.7 mmt180 -155.13 140.25 17.47 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.193 1.397 . . . . 0.0 107.73 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.44 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 20.6 m -106.88 -176.41 0.57 Allowed 'Isoleucine or valine' 1 N--CA 1.346 -5.657 0 CA-C-N 118.985 0.811 . . . . 0.0 109.714 173.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.489 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 2.8 t -75.82 114.78 14.81 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 173.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.82 -30.26 44.38 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.939 0.775 . . . . 0.0 112.614 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.39 48.13 0.55 Allowed Glycine 0 CA--C 1.484 -1.884 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.467 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -129.3 -165.64 11.74 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.634 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.499 ' HD2' HD22 ' A' ' 21' ' ' LEU . 42.4 Cg_endo -64.9 -28.45 58.49 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.4 2.733 . . . . 0.0 112.177 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.39 -62.37 1.82 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.66 -30.43 67.04 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.173 0.296 . . . . 0.0 111.418 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.0 mm -64.73 -39.07 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.357 0.598 . . . . 0.0 111.299 178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.89 -47.65 16.1 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.61 14.14 0.24 Allowed Glycine 0 C--N 1.311 -0.832 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.846 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB2' HG11 ' A' ' 16' ' ' VAL . 8.1 tp -86.44 124.43 32.76 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -116.87 159.29 22.61 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 122.146 0.974 . . . . 0.0 111.029 -178.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.97 125.44 21.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.902 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.83 35.11 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.206 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.43 124.11 23.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-O 120.817 0.341 . . . . 0.0 110.544 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -86.63 119.36 26.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.583 HD11 HG23 ' A' ' 57' ' ' VAL . 3.7 mp -85.54 122.85 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.469 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 25.5 mmt -101.8 -13.25 17.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.44 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.528 ' NE2' ' H ' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -161.53 132.46 5.23 Favored 'General case' 0 C--O 1.2 -1.551 0 O-C-N 121.989 -0.445 . . . . 0.0 110.007 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 107' ' ' LEU . 50.5 t -131.92 125.5 55.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.601 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 49.3 43.26 22.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.79 1.236 . . . . 0.0 112.269 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 63.72 12.57 48.03 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 114.15 -1.386 . . . . 0.0 114.977 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.443 ' HZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -97.12 -8.64 29.69 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 71.77 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.861 0.864 . . . . 0.0 110.637 -173.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.441 ' HE2' HD23 ' A' ' 97' ' ' LEU . 7.4 tpt -120.73 -0.92 10.08 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.563 0.697 . . . . 0.0 109.689 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.469 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 9.7 t -66.63 -15.98 63.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.842 -174.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.5 ttt -150.28 93.94 2.06 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.042 0.448 . . . . 0.0 110.394 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG21 ' HZ2' ' A' ' 83' ' ' TRP . 7.3 p -154.96 149.51 12.24 Favored 'Isoleucine or valine' 0 C--O 1.259 1.561 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 38' ' ' ASP . 9.3 p -72.33 155.75 39.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 122.632 0.373 . . . . 0.0 110.652 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.737 ' HE2' ' HE ' ' A' ' 94' ' ' ARG . 17.7 t60 -53.58 -44.25 69.19 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.859 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.59 -43.96 92.18 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.126 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -35.23 68.18 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.209 0.528 . . . . 0.0 111.423 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.591 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -68.59 -42.88 77.57 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.432 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.737 ' HE ' ' HE2' ' A' ' 90' ' ' HIS . 18.5 mmt180 -55.7 -38.61 69.93 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.619 0.723 . . . . 0.0 109.092 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' HE3' ' A' ' 99' ' ' LYS . 47.2 tttp -81.15 18.29 1.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.972 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 34.1 mtt-85 -137.74 -37.19 0.61 Allowed 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -102.12 -23.13 14.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.473 ' N ' HD12 ' A' ' 97' ' ' LEU . 13.9 t -111.66 12.0 21.13 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.398 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.3 ptpt -69.97 176.95 3.4 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.527 169.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -119.88 -0.13 10.72 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.552 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.8 m -82.81 -36.95 25.13 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.81 115.19 27.19 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.643 0.735 . . . . 0.0 110.491 -174.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.601 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -75.16 -68.11 0.59 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.725 -173.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.1 p -121.28 125.5 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.421 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.467 HG21 HD21 ' A' ' 29' ' ' LEU . 25.4 m -131.44 147.13 32.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.909 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -97.93 116.72 30.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.054 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 80' ' ' VAL . 11.9 mt -112.76 152.41 29.15 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.97 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.9 mp -126.38 126.0 43.14 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 122.661 0.384 . . . . 0.0 110.146 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.431 HG22 HE21 ' A' ' 14' ' ' GLN . 20.1 m -122.05 149.64 25.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 p . . . . . 0 N--CA 1.429 -1.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.585 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.465 0.298 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 110' ' ' THR . 11.7 t -97.19 137.0 26.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.429 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -138.48 151.18 47.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 5.0 ppt_? -96.24 155.1 16.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.036 0.446 . . . . 0.0 111.111 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -133.71 154.5 38.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -150.53 105.63 3.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.125 0.488 . . . . 0.0 109.781 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -90.94 127.61 43.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.393 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -96.24 134.44 39.34 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HB2' HD21 ' A' ' 27' ' ' LEU . 23.3 pttm -29.34 121.8 0.15 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.438 HD22 ' HD2' ' A' ' 65' ' ' PRO . 42.7 tp -120.79 125.85 48.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.899 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -91.15 125.79 36.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.419 ' NE2' HD12 ' A' ' 28' ' ' ILE . 33.1 mt-30 -130.37 105.67 8.04 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.29 -115.82 6.67 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.16 -0.82 49.54 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.469 0.308 . . . . 0.0 110.297 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.78 174.81 5.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.869 0.842 . . . . 0.0 111.08 -169.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -126.51 113.0 16.22 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.419 HD12 ' NE2' ' A' ' 23' ' ' GLN . 0.9 OUTLIER -125.65 164.21 25.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 97' ' ' LEU . 49.4 mt -91.93 8.51 37.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.854 0.835 . . . . 0.0 109.984 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.0 -46.92 2.68 Favored Glycine 0 N--CA 1.416 -2.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.53 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 30.6 p90 -93.4 172.39 8.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.3 m -136.44 169.28 17.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.12 1.768 . . . . 0.0 110.222 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 55' ' ' ILE . 5.5 pt -124.81 172.54 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 C-N-CA 122.608 0.363 . . . . 0.0 111.477 -170.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.17 -12.37 8.33 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.626 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.534 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 114.33 170.49 16.85 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 119.537 -1.316 . . . . 0.0 113.066 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.482 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -123.68 -114.71 2.14 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 124.083 0.52 . . . . 0.0 112.109 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -29.31 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.6 t70 -66.34 -17.87 65.02 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.852 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.604 ' HB2' HD21 ' A' ' 44' ' ' ASN . 19.6 mm-40 -101.24 153.54 19.53 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.452 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.0 t70 -99.98 115.69 65.31 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 4.6 Cg_endo -51.37 -30.01 32.68 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.773 2.982 . . . . 0.0 113.018 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.2 t -66.17 -25.99 67.2 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.331 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -121.85 15.68 10.92 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.583 0.706 . . . . 0.0 111.032 -177.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 87.7 m-20 -93.49 155.3 40.89 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -74.57 -55.91 0.08 OUTLIER 'Trans proline' 0 C--O 1.198 -1.524 0 C-N-CA 122.746 2.298 . . . . 0.0 113.003 179.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.4 ' CZ ' HG22 ' A' ' 73' ' ' ILE . 74.7 m-85 -105.8 27.7 8.24 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.88 0.848 . . . . 0.0 110.602 -175.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.683 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.3 t . . . . . 0 C--O 1.204 -1.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HE3' ' CD ' ' A' ' 41' ' ' PRO . 34.4 mmtm . . . . . 0 CA--C 1.53 0.211 0 CA-C-O 121.327 0.584 . . . . 0.0 109.949 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.68 140.86 7.69 Favored Glycine 0 C--O 1.186 -2.892 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.673 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 27.9 mm -60.73 128.83 22.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.248 0.547 . . . . 0.0 111.012 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.3 151.86 48.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.748 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.585 HG23 HD11 ' A' ' 77' ' ' ILE . 97.8 t -79.23 134.23 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 123.959 0.787 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -110.92 -21.93 11.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -148.73 135.63 19.9 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.443 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.521 HG11 ' O ' ' A' ' 71' ' ' LEU . 27.5 m -117.63 173.15 4.72 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.9 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 172.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB3' ' HA3' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -72.16 126.24 29.29 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -73.24 -19.16 61.13 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.771 0.67 . . . . 0.0 110.548 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.34 43.8 0.91 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . -129.29 -170.82 12.83 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.314 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HB2' HG23 ' A' ' 18' ' ' ILE . 37.5 Cg_endo -63.95 -31.6 66.6 Favored 'Trans proline' 0 N--CA 1.474 0.327 0 C-N-CA 123.742 2.961 . . . . 0.0 112.297 -172.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.83 -63.52 1.15 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.103 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.7 -28.04 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.003 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.16 -49.76 79.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.339 0.4 . . . . 0.0 110.364 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -52.13 43.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.269 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.96 22.8 0.08 OUTLIER Glycine 0 C--N 1.305 -1.151 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.724 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HG11 ' A' ' 16' ' ' VAL . 4.2 tp -90.19 106.97 18.84 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.1 mm-40 -124.49 124.13 41.62 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.4 HG22 ' CZ ' ' A' ' 46' ' ' PHE . 67.1 mt -35.98 122.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 125.777 1.923 . . . . 0.0 112.801 -175.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.06 14.7 23.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.443 ' OD1' ' HB ' ' A' ' 57' ' ' VAL . 5.6 p-10 -87.32 139.0 31.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -104.5 107.43 18.36 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.604 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 9.6 mt -74.78 142.77 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.05 -172.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 27.8 mmt -122.15 -20.19 6.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.619 0.723 . . . . 0.0 109.891 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.579 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -144.44 134.82 24.47 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.468 HG22 HD22 ' A' ' 107' ' ' LEU . 62.6 t -140.51 120.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 81' ' ' ASN . 2.1 t-20 53.75 39.55 30.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.867 0.867 . . . . 0.0 111.891 170.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.579 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 57.8 21.89 45.49 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.455 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -102.77 -0.13 31.96 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.362 3.8 p30 49.83 99.28 0.01 OUTLIER 'General case' 0 C--N 1.342 0.273 0 CA-C-O 123.462 1.601 . . . . 0.0 113.635 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.673 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 ttp -97.95 -10.04 25.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.303 -169.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.507 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 6.2 t -33.19 -36.31 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 126.445 1.898 . . . . 0.0 115.727 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.9 ttm -139.26 93.63 2.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.92 151.89 10.04 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 38' ' ' ASP . 14.0 p -73.64 157.34 36.8 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.372 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.563 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 8.8 t60 -54.58 -46.31 73.71 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.967 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.55 -44.83 95.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.281 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -37.61 68.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.872 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.435 ' O ' HD22 ' A' ' 97' ' ' LEU . . . -66.79 -39.93 87.95 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.761 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -52.61 -34.98 53.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.638 0.775 . . . . 0.0 111.943 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -88.29 13.5 11.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.351 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.56 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 15.3 tpt180 -133.21 -39.66 0.93 Allowed 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.482 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.567 HD11 ' CG2' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -103.05 -11.88 17.81 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.964 -176.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -125.93 14.23 7.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.978 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 13.4 ptpt -67.13 -168.94 0.08 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.27 170.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.408 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 11.6 ptm180 -132.52 3.22 3.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.12 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.41 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 34.9 m -73.27 -40.3 64.71 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.437 -177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.16 134.32 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 103' ' ' GLU . 1.1 pm0 -81.45 -61.04 2.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.594 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -120.34 129.18 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 C-N-CA 123.049 0.54 . . . . 0.0 110.842 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.78 146.53 30.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.595 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -98.93 117.69 34.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.468 HD22 HG22 ' A' ' 80' ' ' VAL . 19.0 mt -112.09 155.35 24.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.875 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 107' ' ' LEU . 4.7 mp -133.42 126.3 30.91 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 17.0 m -123.45 158.93 28.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 123.682 0.614 . . . . 0.0 109.84 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 13' ' ' VAL . 37.9 p . . . . . 0 N--CA 1.41 -2.453 0 CA-C-O 121.25 0.548 . . . . 0.0 110.249 178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.7 t . . . . . 0 N--CA 1.426 -1.635 0 CA-C-O 121.062 0.458 . . . . 0.0 111.069 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 8.6 p -112.14 126.53 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.608 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.474 HE22 HG22 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -137.65 152.52 49.4 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -176.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -93.81 150.44 20.38 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.682 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -125.71 156.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -141.86 105.72 4.73 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.618 0.723 . . . . 0.0 110.761 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.481 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.7 mp -96.99 128.2 48.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.189 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.415 ' HD2' HG13 ' A' ' 104' ' ' VAL . 58.5 m170 -97.67 137.54 36.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 27' ' ' LEU . 21.5 pttp -36.09 121.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.466 HD23 HE21 ' A' ' 23' ' ' GLN . 50.5 tp -124.52 128.54 49.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.649 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -96.09 132.9 41.0 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.153 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.544 ' NE2' ' HA2' ' A' ' 30' ' ' GLY . 66.4 mt-30 -123.68 108.06 12.15 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.33 -103.86 1.25 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -119.92 12.7 12.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.26 167.44 14.87 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.6 tm? -113.73 118.41 34.25 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.48 154.14 36.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.64 HD13 HG21 ' A' ' 105' ' ' VAL . 63.8 mt -79.36 2.31 22.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.8 0.809 . . . . 0.0 109.596 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.544 ' HA2' ' NE2' ' A' ' 23' ' ' GLN . . . 95.64 -44.73 2.06 Favored Glycine 0 N--CA 1.408 -3.176 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.921 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 37.7 p90 -90.65 164.56 14.12 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 m -115.01 164.84 13.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 125.027 1.331 . . . . 0.0 109.135 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 55' ' ' ILE . 6.5 pt -126.06 166.62 21.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.0 -31.03 3.46 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.38 154.02 9.13 Favored Glycine 0 C--O 1.2 -1.996 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.298 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.521 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -102.57 -117.67 4.33 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.335 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.47 HD11 HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER -63.88 -23.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.499 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.5 t70 -68.94 -20.47 64.2 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.761 0.791 . . . . 0.0 109.887 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.654 ' HB2' HD21 ' A' ' 44' ' ' ASN . 21.9 mm-40 -100.97 156.96 17.1 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 5.0 t70 -101.32 114.66 65.71 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.17 -25.66 23.95 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 123.859 3.04 . . . . 0.0 113.682 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 m -76.02 -8.59 57.33 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.235 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -135.22 13.09 3.56 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.905 0.859 . . . . 0.0 110.348 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.699 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 95.5 m-20 -97.86 150.43 36.75 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.495 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.09 -45.7 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.037 0 C-N-CA 122.993 2.462 . . . . 0.0 114.31 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -114.02 9.53 17.36 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 121.354 -0.842 . . . . 0.0 110.931 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.699 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 9.6 t . . . . . 0 C--N 1.301 -1.536 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm . . . . . 0 N--CA 1.438 -1.044 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 138.48 157.99 7.59 Favored Glycine 0 C--O 1.204 -1.765 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 33' ' ' ILE . 30.7 mm -80.95 118.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 117.685 0.743 . . . . 0.0 109.555 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -120.71 155.69 33.36 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.072 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.416 HG21 HG12 ' A' ' 60' ' ' VAL . 7.6 p -81.58 131.56 33.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 O-C-N 124.733 1.271 . . . . 0.0 110.36 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 p -106.57 -19.04 13.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.556 0.693 . . . . 0.0 111.319 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -154.73 135.92 13.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 30.3 m -100.57 -177.44 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.351 -5.416 0 CA-C-N 119.592 1.087 . . . . 0.0 108.186 173.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.498 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 5.2 t -76.26 122.41 24.36 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.67 -18.5 31.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.275 0.984 . . . . 0.0 113.09 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.56 46.32 0.23 Allowed Glycine 0 CA--C 1.482 -1.975 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -132.78 -168.34 11.95 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.967 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HD2' HD22 ' A' ' 21' ' ' LEU . 32.9 Cg_endo -61.45 -31.88 88.32 Favored 'Trans proline' 0 C--O 1.216 -0.576 0 C-N-CA 123.987 3.125 . . . . 0.0 112.552 -169.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB3' ' H ' ' A' ' 61' ' ' SER . . . -56.63 -60.26 3.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.31 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -71.17 -30.14 66.07 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.245 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 64' ' ' GLY . 32.4 mm -62.6 -41.1 90.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 122.983 0.513 . . . . 0.0 111.147 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.94 -56.78 4.21 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.498 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.14 22.53 0.05 OUTLIER Glycine 0 C--N 1.314 -0.64 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.029 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HB2' HG11 ' A' ' 16' ' ' VAL . 3.2 tp -87.94 119.61 28.46 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -115.27 140.98 48.64 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.62 0.575 . . . . 0.0 109.494 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.8 mt -49.52 126.53 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 123.316 0.385 . . . . 0.0 111.521 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.71 50.79 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.104 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -80.62 131.91 35.55 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -94.3 108.2 20.11 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.5 HG13 HG12 ' A' ' 109' ' ' VAL . 3.3 mp -78.9 125.72 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.4 mmt -112.84 -8.82 13.71 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.85 0.357 . . . . 0.0 111.821 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -156.55 136.13 12.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 107' ' ' LEU . 39.2 t -142.61 115.04 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.546 1.138 . . . . 0.0 109.972 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.763 HD22 ' HA ' ' A' ' 105' ' ' VAL . 2.8 t-20 50.5 57.8 6.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.622 1.169 . . . . 0.0 111.784 176.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.61 -17.89 1.93 Allowed Glycine 0 C--N 1.289 -2.082 0 CA-C-N 114.029 -1.441 . . . . 0.0 115.293 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.88 157.01 17.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.87 134.33 34.54 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.417 0.627 . . . . 0.0 109.897 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.528 ' HE3' HD23 ' A' ' 97' ' ' LEU . 63.4 tpp -113.15 1.59 15.33 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.235 1.017 . . . . 0.0 108.881 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.561 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.6 t -61.16 -35.7 77.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.133 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.4 ttm -139.47 91.25 2.47 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.519 HG11 ' SD ' ' A' ' 85' ' ' MET . 9.3 p -157.13 151.05 8.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.422 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.499 HG22 ' HB2' ' A' ' 38' ' ' ASP . 2.3 p -71.13 157.19 38.61 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.51 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.615 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 13.0 t60 -53.92 -45.19 71.12 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.189 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.65 -48.36 81.21 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.733 0.645 . . . . 0.0 111.537 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.49 -30.38 67.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.409 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.641 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.86 -42.86 66.4 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 176.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.429 ' C ' ' H ' ' A' ' 96' ' ' ARG . 11.1 mmm180 -56.08 -42.8 77.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.537 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -80.32 27.33 0.34 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 109.123 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.679 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 tpt180 -139.77 -43.27 0.44 Allowed 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -100.03 -28.85 12.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.457 ' N ' HD12 ' A' ' 97' ' ' LEU . 14.9 t -108.19 15.88 23.75 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.945 -1.502 . . . . 0.0 109.614 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.679 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.3 ptpt -65.78 176.2 1.66 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.535 170.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -127.41 12.29 6.97 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.698 0.761 . . . . 0.0 111.261 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 m -94.64 -32.71 13.27 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.95 0.881 . . . . 0.0 111.731 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.576 ' CB ' ' HD2' ' A' ' 99' ' ' LYS . 14.7 tt0 -108.79 119.28 39.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.496 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -80.52 -71.54 0.46 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.443 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 31.3 t -98.88 136.07 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.763 ' HA ' HD22 ' A' ' 81' ' ' ASN . 19.6 m -129.62 152.78 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 CA-C-O 121.32 0.581 . . . . 0.0 111.778 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -127.14 112.32 15.02 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.33 162.58 16.92 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.703 -171.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.7 mp -130.95 127.39 38.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.5 HG12 HG13 ' A' ' 77' ' ' ILE . 21.7 m -119.14 150.27 21.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.411 HG22 ' HB ' ' A' ' 13' ' ' VAL . 75.1 p . . . . . 0 N--CA 1.42 -1.958 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t . . . . . 0 N--CA 1.43 -1.46 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.657 HG22 HG22 ' A' ' 110' ' ' THR . 15.5 t -97.04 127.5 49.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.413 HE21 HG22 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -135.32 150.88 50.08 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -97.14 143.85 27.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -176.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 8.5 p -132.75 154.29 39.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -137.14 108.54 6.89 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.284 0.564 . . . . 0.0 111.689 -174.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.483 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -98.83 133.31 41.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.777 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.425 ' HD2' HG13 ' A' ' 104' ' ' VAL . 53.6 m170 -99.32 147.71 24.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 41.9 pttt -38.32 116.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 52.3 tp -117.6 125.45 50.81 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.124 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -95.48 126.28 40.66 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 23' ' ' GLN . 8.9 mm100 -122.93 99.6 6.47 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.74 -104.12 1.65 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.0 -1.32 15.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.12 171.22 7.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.316 0.579 . . . . 0.0 109.979 -172.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.7 tm? -122.07 108.42 13.34 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 1.3 mt -121.51 156.04 25.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 105' ' ' VAL . 68.6 mt -84.03 3.35 34.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.628 0.728 . . . . 0.0 109.871 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -34.43 3.97 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.519 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -99.07 170.99 8.31 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.343 0.571 . . . . 0.0 111.55 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.52 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 82.4 p -124.13 -173.7 2.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.09 0.556 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.575 HD12 HD12 ' A' ' 55' ' ' ILE . 8.4 pt -135.42 164.98 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.73 -17.39 7.49 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.578 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 121.6 166.34 12.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.261 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.688 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -115.95 -108.16 2.61 Favored Glycine 0 N--CA 1.409 -3.148 0 O-C-N 124.459 0.741 . . . . 0.0 113.322 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -80.83 -21.14 11.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.194 0.521 . . . . 0.0 111.43 -174.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.729 ' HB3' HG22 ' A' ' 89' ' ' THR . 7.3 p-10 -86.39 3.85 41.91 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 110.309 -174.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.547 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 60.6 mm-40 -99.34 178.06 5.0 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.474 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -132.12 121.6 17.82 Favored Pre-proline 0 CA--C 1.479 -1.786 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.4 -24.76 44.82 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.477 2.118 . . . . 0.0 113.496 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m -66.73 -30.08 70.21 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.859 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.415 HE21 ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -123.13 21.05 9.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.283 0.563 . . . . 0.0 111.221 -175.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 39' ' ' GLN . 5.8 m120 -115.08 143.76 30.82 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.62 -50.97 1.07 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.667 2.911 . . . . 0.0 114.008 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -104.8 17.78 23.52 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.497 0.665 . . . . 0.0 110.469 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 5.4 t . . . . . 0 N--CA 1.418 -2.05 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HD2' ' HA ' ' A' ' 37' ' ' ILE . 8.6 mtmp? . . . . . 0 CA--C 1.547 0.864 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.459 ' C ' ' HA2' ' A' ' 36' ' ' GLY . . . 129.21 146.85 6.2 Favored Glycine 0 C--O 1.177 -3.416 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.688 HD13 ' N ' ' A' ' 36' ' ' GLY . 31.6 mm -58.81 117.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 118.811 1.305 . . . . 0.0 112.402 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -119.25 153.94 34.22 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.106 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.402 HG13 ' H ' ' A' ' 74' ' ' GLY . 7.5 p -80.28 135.39 25.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 124.567 1.167 . . . . 0.0 110.207 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 p -109.65 -23.57 11.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.268 0.556 . . . . 0.0 111.863 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 40.7 mtt-85 -142.56 138.22 30.68 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.446 HG13 ' CB ' ' A' ' 66' ' ' ALA . 54.3 t -124.87 135.76 62.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.617 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.2 t -54.44 118.76 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 124.469 1.106 . . . . 0.0 109.801 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.74 -5.85 9.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.598 1.559 . . . . 0.0 112.659 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.28 38.47 0.33 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -124.01 -174.08 14.05 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.37 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.425 ' HB2' HG23 ' A' ' 18' ' ' ILE . 29.8 Cg_endo -62.92 -29.89 76.5 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 124.018 3.145 . . . . 0.0 111.934 -172.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.446 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -57.94 -60.91 2.99 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.626 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.5 pt-20 -75.61 -23.94 56.47 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.9 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.2 mm -59.24 -43.69 90.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -50.72 19.24 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.024 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.85 21.81 0.24 Allowed Glycine 0 C--N 1.321 -0.277 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.884 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.408 ' O ' HG11 ' A' ' 60' ' ' VAL . 2.1 tp -80.13 126.63 31.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -116.66 147.18 42.18 Favored 'General case' 0 C--O 1.205 -1.247 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.6 mt -61.59 132.35 27.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.808 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.402 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 100.41 -0.34 55.72 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 73.1 m-20 -75.86 119.94 20.54 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -83.47 114.53 21.54 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 109' ' ' VAL . 12.1 mt -86.63 123.79 39.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.835 -173.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.45 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 31.3 mmt -107.66 -17.91 13.97 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.228 0.537 . . . . 0.0 110.192 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.539 HE22 ' CA ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -147.13 137.69 23.55 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 107' ' ' LEU . 18.4 t -139.89 115.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 123.276 0.63 . . . . 0.0 109.326 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER 53.12 35.76 20.57 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.802 1.241 . . . . 0.0 111.313 173.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.539 ' CA ' HE22 ' A' ' 79' ' ' GLN . . . 73.73 7.35 74.56 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 114.584 -1.189 . . . . 0.0 115.443 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.576 ' CZ2' ' HG3' ' A' ' 96' ' ' ARG 0.325 0.1 OUTLIER -81.39 -86.12 0.09 Allowed 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 118.21 1.005 . . . . 0.0 112.762 -179.965 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 162.99 111.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 126.404 1.881 . . . . 0.0 107.161 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.443 ' HE3' HG21 ' A' ' 55' ' ' ILE . 4.1 tpt -113.0 -1.88 14.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.884 -174.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.45 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 9.9 t -72.41 -33.97 67.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.933 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.546 ' SD ' HG21 ' A' ' 37' ' ' ILE . 16.4 tpt -128.54 85.83 2.38 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.505 HG13 HG13 ' A' ' 55' ' ' ILE . 7.2 p -161.06 147.53 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.891 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 38' ' ' ASP . 8.7 p -69.8 159.55 33.38 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.995 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.547 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 7.9 t60 -57.64 -41.74 82.03 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.616 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.45 -51.14 70.76 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.486 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.549 ' N ' HE21 ' A' ' 92' ' ' GLN . 0.0 OUTLIER -72.06 -34.67 68.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.17 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -33.06 65.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -52.74 -48.72 66.53 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 95' ' ' LYS . 39.6 pttt -83.72 26.68 0.68 Allowed 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.649 0.737 . . . . 0.0 110.885 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 24.3 mmt180 -131.56 -29.03 1.79 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.004 176.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -106.72 -27.6 10.69 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.288 174.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.409 ' N ' HD13 ' A' ' 97' ' ' LEU . 8.7 t -112.47 16.8 19.72 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.754 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.3 ptpt -64.8 165.08 11.11 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.172 168.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -122.91 4.74 9.38 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.946 0.879 . . . . 0.0 109.374 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -45.44 94.78 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.744 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -107.69 179.91 4.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.412 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 8.3 pt-20 -132.35 -62.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.425 HG13 ' HD2' ' A' ' 19' ' ' HIS . 28.4 t -95.99 126.16 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.586 HG21 HD13 ' A' ' 29' ' ' LEU . 28.0 m -127.04 153.02 35.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.088 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 92.5 mtt180 -124.47 116.52 22.64 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.87 147.57 40.92 Favored 'General case' 0 N--CA 1.395 -3.218 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -174.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.431 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 6.9 mp -111.98 121.5 45.17 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 35.5 m -117.2 147.35 20.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.002 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.657 HG22 HG22 ' A' ' 13' ' ' VAL . 47.1 p . . . . . 0 N--CA 1.411 -2.42 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.764 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 N--CA 1.434 -1.246 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 HG22 ' A' ' 110' ' ' THR . 25.2 t -84.32 119.8 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.443 HE22 HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -130.27 152.81 49.29 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.34 146.2 24.95 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.898 -174.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -125.87 158.01 35.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.445 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 36.3 tt0 -146.7 103.78 3.68 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.531 0.681 . . . . 0.0 110.777 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.58 126.57 44.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.978 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.497 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 55.6 m170 -96.94 161.95 13.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 124.232 0.957 . . . . 0.0 109.902 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HG3' HD11 ' A' ' 27' ' ' LEU . 39.6 ttmt -40.68 125.88 2.31 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.237 1.415 . . . . 0.0 113.705 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.547 HD22 ' HD2' ' A' ' 65' ' ' PRO . 42.8 tp -139.71 131.43 27.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.037 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -99.96 137.07 38.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.407 HE21 HD23 ' A' ' 21' ' ' LEU . 75.1 mt-30 -128.49 104.21 7.56 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.96 -108.55 2.52 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -111.85 9.59 20.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.267 0.556 . . . . 0.0 110.679 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.65 172.03 7.28 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' A' ' 20' ' ' LYS . 14.3 tp -122.77 115.74 22.53 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.17 153.62 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.574 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.3 mp -78.59 0.16 27.41 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.667 0.746 . . . . 0.0 111.423 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.54 -37.81 3.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.927 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 34.3 p90 -100.64 178.21 4.78 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -143.57 168.04 20.8 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 124.274 1.03 . . . . 0.0 110.053 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD21 ' A' ' 97' ' ' LEU . 11.1 pt -127.43 167.7 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 117.944 0.338 . . . . 0.0 111.87 -171.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.07 -29.89 4.13 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 127.24 161.82 10.96 Favored Glycine 0 N--CA 1.42 -2.406 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.376 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.605 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -108.19 -119.41 4.34 Favored Glycine 0 N--CA 1.428 -1.899 0 O-C-N 124.16 0.565 . . . . 0.0 112.652 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -24.27 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.153 0.502 . . . . 0.0 111.759 -175.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.538 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.8 t70 -66.63 -13.03 60.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.773 1.229 . . . . 0.0 111.014 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.665 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 30.0 mm-40 -104.61 169.63 8.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.899 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.503 ' HB3' ' CD ' ' A' ' 43' ' ' GLN . 12.3 t70 -114.19 128.08 26.17 Favored Pre-proline 0 CA--C 1.486 -1.502 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.0 Cg_endo -57.08 -32.11 92.27 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.023 1.815 . . . . 0.0 113.731 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.2 t -65.75 -32.18 73.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.503 ' CD ' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -105.94 13.69 29.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.534 0.683 . . . . 0.0 110.784 -176.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.522 ' ND2' ' HB3' ' A' ' 39' ' ' GLN . 13.0 m-80 -112.26 146.05 34.1 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -64.94 -53.47 0.89 Allowed 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 123.271 2.647 . . . . 0.0 113.349 -171.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.413 ' CZ ' HG22 ' A' ' 73' ' ' ILE . 58.2 m-85 -101.24 0.86 38.19 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.602 0.715 . . . . 0.0 110.624 -176.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 6.2 t . . . . . 0 N--CA 1.415 -2.193 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.69 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 58.9 mtmt . . . . . 0 N--CA 1.431 -1.42 0 CA-C-O 121.811 0.815 . . . . 0.0 112.388 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.2 153.1 5.79 Favored Glycine 0 C--O 1.185 -2.935 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.637 HD12 HD12 ' A' ' 33' ' ' ILE . 29.1 mm -64.25 127.94 25.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 118.708 1.254 . . . . 0.0 111.584 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -129.88 155.5 45.92 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.85 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.771 HG21 HD11 ' A' ' 71' ' ' LEU . 95.2 t -85.02 130.45 36.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 O-C-N 124.441 1.088 . . . . 0.0 111.028 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -107.35 -20.02 13.4 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 41.2 ttt-85 -142.74 143.29 32.18 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.437 HG13 ' CB ' ' A' ' 66' ' ' ALA . 45.9 t -128.38 144.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t -59.32 126.5 27.9 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.68 -26.48 68.68 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.626 1.17 . . . . 0.0 110.834 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.97 52.44 0.53 Allowed Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.766 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.41 -172.51 12.97 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.878 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.547 ' HD2' HD22 ' A' ' 21' ' ' LEU . 36.9 Cg_endo -64.52 -28.12 61.84 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 124.326 3.35 . . . . 0.0 111.619 -173.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -60.44 -58.86 6.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.958 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -69.17 -31.27 69.79 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.535 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.8 mm -59.79 -49.45 83.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.043 0.449 . . . . 0.0 110.546 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -71.43 -47.86 53.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.891 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.61 22.6 0.18 Allowed Glycine 0 C--N 1.302 -1.308 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.647 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.771 HD11 HG21 ' A' ' 57' ' ' VAL . 2.4 tp -85.88 122.92 30.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.421 ' N ' HD12 ' A' ' 71' ' ' LEU . 24.5 mm-40 -115.43 154.09 29.89 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 121.779 0.8 . . . . 0.0 109.098 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.413 HG22 ' CZ ' ' A' ' 46' ' ' PHE . 49.5 mt -65.33 124.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.147 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -15.36 23.54 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 64.6 m-20 -67.63 130.75 44.0 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.056 0.455 . . . . 0.0 110.533 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -92.37 127.15 37.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.734 HD11 HG23 ' A' ' 57' ' ' VAL . 2.9 mp -94.92 127.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -175.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.419 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 28.8 mmt -103.53 -20.55 13.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.987 0.423 . . . . 0.0 110.689 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 14.6 tp60 -152.48 129.55 11.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.066 -172.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.473 HG13 HD12 ' A' ' 107' ' ' LEU . 38.8 t -137.16 115.71 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.822 0.849 . . . . 0.0 110.329 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 53.04 41.75 32.18 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.243 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.68 90.14 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.112 -0.949 . . . . 0.0 115.062 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.503 ' N ' HE22 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -114.0 150.09 34.39 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.16 136.81 36.58 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.781 0.718 . . . . 0.0 109.884 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.509 ' HE3' ' HB1' ' A' ' 93' ' ' ALA . 7.5 tpt -116.63 -7.06 11.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.229 -175.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.419 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 8.1 t -58.63 -34.91 71.7 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.084 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.0 ttp -137.99 91.07 2.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.417 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 7.2 p -154.24 151.55 10.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.029 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 38' ' ' ASP . 11.8 p -75.39 159.59 31.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.493 0.187 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.665 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 11.4 t60 -55.45 -42.77 74.7 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.562 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 39.2 t70 -59.3 -54.0 51.86 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.756 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -30.17 69.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.866 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 85' ' ' MET . . . -71.76 -44.59 63.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.164 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.92 -43.28 86.16 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.673 0.749 . . . . 0.0 109.471 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HE3' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.4 40.34 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.405 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.412 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 11.2 tpt180 -150.02 -45.63 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.243 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -99.16 -26.15 14.29 Favored 'General case' 0 C--O 1.196 -1.722 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.466 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.4 t -111.91 17.09 20.04 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 118.22 -1.392 . . . . 0.0 109.601 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 16.0 ptpt -72.14 161.49 30.81 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -114.43 9.69 16.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.752 0.787 . . . . 0.0 110.373 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.519 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 36.5 m -80.57 -30.44 37.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.851 -177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -110.11 156.73 20.19 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 6.7 pt-20 -110.51 -67.71 0.98 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.865 0.364 . . . . 0.0 111.869 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -103.96 125.11 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-O 122.106 0.955 . . . . 0.0 112.578 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.48 HG23 HD21 ' A' ' 107' ' ' LEU . 15.6 m -126.18 168.48 19.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.453 -175.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.448 ' HD2' ' C ' ' A' ' 105' ' ' VAL . 5.1 mpt_? -127.06 116.29 20.49 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -118.9 153.34 34.72 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.1 mp -125.4 123.6 39.67 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 77' ' ' ILE . 30.2 m -124.09 155.44 31.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.6 -176.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.571 HG22 HG22 ' A' ' 13' ' ' VAL . 11.4 p . . . . . 0 N--CA 1.383 -3.821 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t . . . . . 0 N--CA 1.441 -0.883 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.24 127.35 53.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.472 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -131.97 154.72 49.02 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.372 -176.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -95.12 145.47 24.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.093 0.473 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 107' ' ' LEU . 9.6 p -129.95 150.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.81 107.34 6.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 122.138 0.971 . . . . 0.0 111.036 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -96.49 125.78 49.32 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.114 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.441 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 55.2 m170 -94.68 165.5 12.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.545 ' HB2' HD21 ' A' ' 27' ' ' LEU . 18.5 ptpt -48.65 129.49 16.55 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 176.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 42.6 tp -120.68 122.65 40.92 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 111.98 22.88 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -119.05 102.86 9.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.33 -109.03 2.47 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.28 16.73 21.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.308 0.575 . . . . 0.0 110.822 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.04 167.98 10.67 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.3 tm? -127.24 105.88 8.85 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 102.472 -3.158 . . . . 0.0 102.472 174.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -122.16 163.93 19.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.046 -174.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.4 mp -89.93 0.57 57.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.135 0.969 . . . . 0.0 110.245 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 61' ' ' SER . . . 91.46 -41.31 2.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.239 -0.892 . . . . 0.0 115.095 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 42.3 p90 -96.18 170.58 9.16 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 117.448 0.624 . . . . 0.0 112.615 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.7 m -130.44 165.84 21.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.259 1.023 . . . . 0.0 109.702 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.688 HD12 HD12 ' A' ' 55' ' ' ILE . 7.7 pt -124.74 168.95 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 120.461 0.172 . . . . 0.0 110.673 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.45 -23.98 6.08 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.608 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 125.01 172.29 13.46 Favored Glycine 0 N--CA 1.414 -2.805 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.366 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.55 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.56 -113.71 2.47 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 124.525 0.779 . . . . 0.0 112.5 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.564 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -69.61 -24.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB2' HG22 ' A' ' 89' ' ' THR . 27.3 t70 -70.62 -12.53 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.98 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.542 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 19.0 mm-40 -106.23 157.92 17.23 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.504 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 8.0 t70 -97.38 123.43 52.59 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -61.86 -26.49 79.3 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.426 2.084 . . . . 0.0 113.523 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -72.35 -23.21 61.1 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -122.12 20.49 10.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.415 0.626 . . . . 0.0 111.006 -178.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -111.82 140.88 23.8 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.36 -39.99 34.24 Favored 'Trans proline' 0 C--O 1.222 -0.284 0 C-N-CA 123.663 2.909 . . . . 0.0 113.632 -170.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CD1' ' HA2' ' A' ' 74' ' ' GLY . 53.5 m-85 -119.72 22.19 11.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.762 0.792 . . . . 0.0 109.693 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 4.6 t . . . . . 0 N--CA 1.433 -1.281 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 36.4 mtmm . . . . . 0 N--CA 1.432 -1.344 0 CA-C-O 121.586 0.708 . . . . 0.0 111.56 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.525 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 139.87 169.08 11.53 Favored Glycine 0 CA--C 1.472 -2.626 0 N-CA-C 106.218 -2.753 . . . . 0.0 106.218 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.688 HD12 HD12 ' A' ' 33' ' ' ILE . 24.2 mm -76.69 131.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 118.779 1.29 . . . . 0.0 109.839 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.2 p90 -128.61 149.01 50.82 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 71' ' ' LEU . 95.6 t -78.48 130.88 35.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 124.459 1.1 . . . . 0.0 111.657 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -106.88 -20.4 13.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.103 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 6.9 ttm180 -144.31 143.44 30.99 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.452 HG13 ' CB ' ' A' ' 66' ' ' ALA . 38.4 t -126.53 136.79 59.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.605 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.4 t -55.14 119.76 5.97 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.545 1.153 . . . . 0.0 110.062 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.62 2.59 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 111.471 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.19 41.49 0.27 Allowed Glycine 0 C--N 1.273 -2.954 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.73 -173.09 12.83 Favored Glycine 0 N--CA 1.414 -2.821 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.784 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.2 Cg_endo -65.78 -28.23 51.54 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 124.847 3.698 . . . . 0.0 112.237 -173.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.452 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -58.74 -59.17 5.84 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 61' ' ' SER . 5.5 pt-20 -72.32 -27.86 62.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.577 178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -61.19 -40.95 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.013 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.79 -47.64 18.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.02 16.89 0.41 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.422 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.787 HD11 HG21 ' A' ' 57' ' ' VAL . 1.8 tp -74.57 127.79 33.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.418 ' N ' HD12 ' A' ' 71' ' ' LEU . 22.4 mm-40 -113.73 148.49 36.35 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.3 0.571 . . . . 0.0 110.179 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.49 123.3 19.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 46' ' ' PHE . . . 112.99 -15.18 23.59 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.784 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -63.78 127.2 30.31 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.684 0.284 . . . . 0.0 111.021 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.7 123.29 33.6 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.699 HD11 HG23 ' A' ' 57' ' ' VAL . 3.7 mp -90.58 126.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -112.26 -7.7 14.0 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.034 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.635 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -159.96 136.5 9.01 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.587 HG22 HD22 ' A' ' 107' ' ' LEU . 34.0 t -142.49 119.7 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.749 1.219 . . . . 0.0 109.168 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 46.08 57.84 4.91 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 124.533 1.133 . . . . 0.0 112.176 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.403 ' H ' HE22 ' A' ' 79' ' ' GLN . . . 75.1 -17.47 2.96 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 113.644 -1.616 . . . . 0.0 115.37 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.401 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -92.49 156.92 16.84 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -94.91 127.32 40.86 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.488 ' SD ' HD23 ' A' ' 97' ' ' LEU . 29.1 ttm -105.82 3.54 28.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.313 1.054 . . . . 0.0 110.695 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.482 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.6 t -61.14 -23.04 65.25 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.374 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.564 ' SD ' HG21 ' A' ' 37' ' ' ILE . 52.0 tpp -140.94 90.14 2.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.406 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 8.9 p -160.33 150.03 5.82 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 38' ' ' ASP . 17.9 p -76.23 159.98 30.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.061 0.458 . . . . 0.0 110.414 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.522 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.1 t60 -54.58 -41.43 69.84 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.379 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.92 -47.59 85.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.752 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.14 -37.35 69.44 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.431 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.662 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.85 -45.49 85.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.749 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.416 ' HG2' HD11 ' A' ' 33' ' ' ILE . 12.0 mmm180 -53.63 -39.05 64.65 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 122.828 0.451 . . . . 0.0 111.488 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.73 24.41 0.88 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.947 0.403 . . . . 0.0 111.153 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.586 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 20.6 ttm180 -145.22 -37.98 0.27 Allowed 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -97.51 -17.05 19.83 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.471 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.1 t -122.7 14.18 10.09 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.846 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.2 ptpt -62.28 161.6 11.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.921 173.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -124.94 19.07 8.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.016 0.912 . . . . 0.0 110.338 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.412 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 47.4 m -84.15 -27.51 28.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.073 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -125.02 159.86 30.35 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.379 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -97.64 -70.47 0.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -109.69 128.55 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 m -132.67 148.81 31.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.171 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -100.28 124.61 45.94 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 80' ' ' VAL . 3.9 mt -119.71 154.3 34.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.5 mp -120.08 125.57 48.63 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-O 121.015 0.436 . . . . 0.0 110.389 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.472 HG22 ' NE2' ' A' ' 14' ' ' GLN . 22.1 m -119.8 150.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.223 -177.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.8 p . . . . . 0 N--CA 1.423 -1.812 0 CA-C-O 121.469 0.652 . . . . 0.0 111.429 -178.364 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 N--CA 1.432 -1.371 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -107.61 138.5 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.514 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -135.32 153.34 51.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 139.8 38.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 107' ' ' LEU . 8.5 p -128.66 158.31 41.06 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.21 101.99 4.4 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.386 0.612 . . . . 0.0 110.245 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -93.52 127.87 45.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.027 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 56.4 m170 -93.07 156.79 16.65 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HB2' HD21 ' A' ' 27' ' ' LEU . 24.0 pttm -49.54 125.89 12.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 45.2 tp -119.05 119.01 32.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.203 175.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -101.67 118.65 37.38 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.415 HE21 HD21 ' A' ' 21' ' ' LEU . 48.0 mt-30 -121.8 105.23 10.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 -112.46 5.03 Favored Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.869 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.24 3.09 51.51 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.137 0.494 . . . . 0.0 109.721 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.64 161.69 20.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-O 122.128 0.966 . . . . 0.0 110.59 -171.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.8 tm? -122.75 113.97 19.92 Favored 'General case' 0 C--N 1.256 -3.459 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 171.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -126.38 157.92 36.63 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.919 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 98' ' ' THR . 3.2 mm? -94.65 6.34 49.17 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 123.337 1.541 . . . . 0.0 108.588 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 92.37 -46.9 2.59 Favored Glycine 0 C--N 1.294 -1.764 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.161 172.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.418 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 49.4 p90 -89.13 166.36 13.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -175.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 55.2 m -120.65 168.13 11.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.702 1.201 . . . . 0.0 109.73 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 55' ' ' ILE . 5.9 pt -125.77 164.39 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 120.857 0.36 . . . . 0.0 110.298 -177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.73 -20.99 7.75 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.304 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.632 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 123.17 171.37 13.64 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.558 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -122.15 -117.44 2.44 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 124.388 0.699 . . . . 0.0 112.6 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -22.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' HG22 ' A' ' 89' ' ' THR . 23.1 t70 -74.94 -15.01 60.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.26 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.632 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 6.6 mm-40 -100.17 167.37 10.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 2.3 t70 -108.0 111.95 61.88 Favored Pre-proline 0 CA--C 1.497 -1.08 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 10.2 Cg_endo -54.31 -24.69 35.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.582 2.855 . . . . 0.0 113.314 -175.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -66.15 -33.45 75.79 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.217 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.428 HE21 ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -112.49 15.39 20.18 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.933 0.873 . . . . 0.0 110.632 -176.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 8.3 m120 -102.11 142.0 23.69 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.998 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.55 -45.02 7.48 Favored 'Trans proline' 0 C--O 1.221 -0.36 0 C-N-CA 123.507 2.805 . . . . 0.0 113.171 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 67.8 m-85 -113.2 17.95 18.28 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.659 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 1.8 t . . . . . 0 C--N 1.285 -2.222 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm . . . . . 0 N--CA 1.432 -1.369 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.471 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 96.98 154.18 29.88 Favored Glycine 0 C--O 1.178 -3.355 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 33' ' ' ILE . 21.4 mm -76.95 126.25 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 118.26 1.03 . . . . 0.0 110.779 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.08 148.96 44.22 Favored 'General case' 0 CA--C 1.486 -1.498 0 O-C-N 122.107 -0.37 . . . . 0.0 111.353 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.684 HG21 HD11 ' A' ' 71' ' ' LEU . 95.8 t -74.46 130.92 35.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 124.423 1.077 . . . . 0.0 110.273 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.516 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.3 p -105.99 -22.21 12.95 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.353 0.596 . . . . 0.0 110.466 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -154.59 142.07 19.71 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 21.0 m -109.12 -179.91 0.9 Allowed 'Isoleucine or valine' 1 N--CA 1.352 -5.368 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 30.3 t -79.55 126.82 31.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.22 -16.19 1.17 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.645 1.578 . . . . 0.0 114.321 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.91 43.46 0.2 Allowed Glycine 0 CA--C 1.483 -1.943 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.29 -168.31 13.69 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.725 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.502 ' HB2' HG23 ' A' ' 18' ' ' ILE . 33.8 Cg_endo -64.06 -30.66 66.1 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 123.433 2.755 . . . . 0.0 111.939 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.26 -64.77 0.74 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.4 pt-20 -70.9 -31.89 68.67 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.557 -0.857 . . . . 0.0 112.146 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.6 mm -59.77 -40.11 81.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.0 -38.64 27.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.95 17.62 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.712 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.684 HD11 HG21 ' A' ' 57' ' ' VAL . 4.9 tp -83.18 127.24 33.44 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.539 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 23.8 mm-40 -115.5 151.29 35.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 111.08 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.85 130.23 33.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.006 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.02 4.3 55.5 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.172 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.539 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 13.4 m-20 -102.27 128.76 48.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.151 0.5 . . . . 0.0 111.873 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -79.72 119.28 22.43 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.242 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.437 HD11 ' CG2' ' A' ' 57' ' ' VAL . 19.5 mt -84.62 121.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.308 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.3 mmt -111.56 -6.85 14.35 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.649 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.524 ' CB ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.21 134.65 13.43 Favored 'General case' 0 C--O 1.203 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.632 HG22 HD22 ' A' ' 107' ' ' LEU . 46.4 t -136.96 122.81 27.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.41 ' HA ' HD22 ' A' ' 81' ' ' ASN . 3.1 t-20 72.58 -34.99 0.31 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 127.338 2.255 . . . . 0.0 113.004 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.492 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 134.95 15.32 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.487 ' HE1' ' HB2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -99.49 -15.69 18.6 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -175.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.55 109.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.326 1.451 . . . . 0.0 111.568 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.533 ' SD ' HD13 ' A' ' 97' ' ' LEU . 32.0 ttm -111.87 7.6 20.13 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.765 0.793 . . . . 0.0 111.366 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 5.2 t -56.1 -27.41 53.7 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 ttm -143.82 96.1 2.84 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.474 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.0 p -157.09 151.76 8.24 Favored 'Isoleucine or valine' 0 C--O 1.257 1.479 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.485 HG22 ' HB2' ' A' ' 38' ' ' ASP . 23.7 p -74.33 155.57 38.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -51.41 -43.81 62.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -61.89 -46.71 88.19 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.989 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -31.25 57.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.179 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 -42.11 68.24 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -51.14 -43.25 61.17 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -92.81 50.87 1.62 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.343 1.068 . . . . 0.0 109.568 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -157.85 -50.57 0.07 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.238 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.533 HD13 ' SD ' ' A' ' 85' ' ' MET . 0.8 OUTLIER -93.95 -20.48 19.96 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.331 -1.348 . . . . 0.0 112.969 -174.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.467 ' HA ' HD23 ' A' ' 29' ' ' LEU . 10.7 t -123.08 13.43 9.72 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.809 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 16.2 ptpt -71.58 173.69 7.7 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 175.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.408 ' CB ' ' HB3' ' A' ' 27' ' ' LEU . 12.3 ptt180 -107.88 -0.48 21.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 25.8 t -78.02 -23.03 48.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.671 0.748 . . . . 0.0 109.443 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.03 160.09 19.41 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.328 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.58 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -120.58 -77.94 0.59 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.552 174.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.58 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -110.61 133.24 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 C-N-CA 123.534 0.734 . . . . 0.0 109.206 176.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 107' ' ' LEU . 14.6 m -126.73 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.66 108.01 19.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.58 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 80' ' ' VAL . 5.6 mt -116.17 149.16 39.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.427 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 7.8 mp -122.37 129.15 51.83 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.514 HG22 ' NE2' ' A' ' 14' ' ' GLN . 23.6 m -121.36 148.6 24.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 O-C-N 123.997 0.811 . . . . 0.0 110.481 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 p . . . . . 0 N--CA 1.418 -2.032 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.897 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.3 t . . . . . 0 N--CA 1.43 -1.47 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.55 144.65 14.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.472 HE22 HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -144.39 149.74 36.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 3.2 ppt_? -93.5 145.42 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.848 0.356 . . . . 0.0 110.584 -176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -120.67 153.37 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -139.42 104.43 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.0 mp -94.6 133.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.743 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -104.32 128.86 52.19 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.974 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HB2' HD11 ' A' ' 27' ' ' LEU . 39.8 pttt -20.62 103.96 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.577 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.6 tp -102.4 123.83 46.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.981 0.419 . . . . 0.0 110.31 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -92.57 118.12 30.67 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.419 ' NE2' HD12 ' A' ' 28' ' ' ILE . 16.7 mt-30 -126.86 109.02 11.53 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.95 -98.89 0.65 Allowed Glycine 0 C--N 1.307 -1.03 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.994 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -116.65 5.32 13.21 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.35 160.44 39.82 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.713 0.768 . . . . 0.0 110.816 -169.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 20' ' ' LYS . 26.4 tp -104.84 127.45 52.65 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.419 HD12 ' NE2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -133.88 169.32 21.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.652 -178.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 105' ' ' VAL . 47.1 mt -92.75 -1.85 56.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.86 -36.6 3.8 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.56 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -100.56 167.63 10.23 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.807 -0.819 . . . . 0.0 112.913 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.9 m -129.25 168.35 16.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.292 1.437 . . . . 0.0 109.339 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.637 HG21 HD21 ' A' ' 97' ' ' LEU . 6.5 pt -124.06 169.88 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.02 0.438 . . . . 0.0 111.355 -172.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.99 -21.24 5.71 Favored Glycine 0 CA--C 1.479 -2.2 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.548 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 121.85 170.9 13.92 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.757 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.633 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -124.24 -105.26 1.64 Allowed Glycine 0 N--CA 1.408 -3.201 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.705 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -23.85 13.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.528 0.68 . . . . 0.0 110.947 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.769 ' HB3' HG22 ' A' ' 89' ' ' THR . 14.7 p-10 -86.11 3.65 41.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.183 -174.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.518 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 44.2 mm-40 -107.55 156.12 19.35 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.089 173.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -99.34 118.65 62.01 Favored Pre-proline 0 CA--C 1.496 -1.11 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.6 Cg_endo -55.89 -25.2 51.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.16 2.573 . . . . 0.0 113.484 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 -17.16 62.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.85 28.8 4.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.126 0.489 . . . . 0.0 111.437 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.646 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 93.0 m-20 -106.25 147.0 34.08 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 122.175 -0.328 . . . . 0.0 111.067 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.55 -50.91 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.949 2.433 . . . . 0.0 112.613 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.41 4.88 28.93 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 0.0 111.447 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 2.2 t . . . . . 0 C--N 1.305 -1.36 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.578 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.482 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 37.6 mtmm . . . . . 0 N--CA 1.445 -0.722 0 CA-C-O 121.381 0.61 . . . . 0.0 112.335 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.05 138.38 4.87 Favored Glycine 0 C--O 1.191 -2.576 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 36' ' ' GLY . 24.5 mm -50.48 124.81 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.622 1.169 . . . . 0.0 112.546 -174.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -126.59 156.54 40.74 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.287 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 71' ' ' LEU . 81.7 t -82.24 137.26 21.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 O-C-N 124.591 1.182 . . . . 0.0 110.43 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 p -110.89 -22.46 11.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.479 0.657 . . . . 0.0 111.172 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 19.3 mmt180 -143.68 135.92 26.83 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.527 ' CG2' HG11 ' A' ' 57' ' ' VAL . 71.9 t -128.22 139.72 51.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.639 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.7 m -57.55 112.54 1.46 Allowed 'General case' 0 N--CA 1.42 -1.961 0 O-C-N 124.103 0.877 . . . . 0.0 111.281 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.82 -11.81 49.26 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.051 0.844 . . . . 0.0 112.752 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 22.91 2.71 Favored Glycine 0 C--N 1.285 -2.252 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . -111.93 -179.95 19.75 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.32 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.577 ' HD2' HD22 ' A' ' 21' ' ' LEU . 38.6 Cg_endo -63.75 -27.54 68.21 Favored 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 124.537 3.491 . . . . 0.0 111.764 -171.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -56.86 -60.53 3.43 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.0 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.2 pt-20 -87.1 -17.27 33.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.754 -1.578 . . . . 0.0 112.761 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.418 ' HB ' ' HA ' ' A' ' 65' ' ' PRO . 12.9 mm -60.68 -34.3 58.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.69 3.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.431 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 155.67 22.71 0.04 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 119.558 -1.306 . . . . 0.0 114.121 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.746 HD11 HG21 ' A' ' 57' ' ' VAL . 4.0 tp -88.95 121.3 31.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.152 0.501 . . . . 0.0 110.844 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -110.55 164.48 12.67 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-O 121.859 0.837 . . . . 0.0 108.789 177.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.62 133.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.641 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.46 14.02 74.79 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 116.415 -0.357 . . . . 0.0 112.386 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.559 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 12.9 m-20 -71.0 1.4 5.72 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 21.5 mmmt 48.23 87.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 57' ' ' VAL . 11.4 mt -83.15 123.83 39.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.1 mmt -106.63 -19.66 13.59 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.197 0.522 . . . . 0.0 109.868 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 16.4 tp60 -154.0 131.35 11.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.172 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.59 HG22 HD22 ' A' ' 107' ' ' LEU . 60.7 t -134.57 113.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 C-N-CA 123.732 0.813 . . . . 0.0 110.215 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 50.58 29.09 3.83 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.612 1.565 . . . . 0.0 113.381 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.441 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 92.05 7.36 64.22 Favored Glycine 0 C--O 1.217 -0.95 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.523 ' CZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -107.75 -2.83 19.67 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -175.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.28 129.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 119.536 1.062 . . . . 0.0 111.779 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.509 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 26.5 ttm -129.77 1.29 4.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.998 0.904 . . . . 0.0 111.382 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -72.62 -19.17 61.51 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.834 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.0 ttp -139.29 89.15 2.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.523 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 10.0 p -161.29 143.01 3.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 38' ' ' ASP . 11.4 p -69.82 154.59 41.76 Favored 'General case' 0 N--CA 1.425 -1.721 0 O-C-N 123.539 0.524 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.52 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 8.8 t60 -53.85 -43.44 69.52 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.544 173.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.13 -44.05 95.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.895 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.18 -33.02 50.38 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.824 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.631 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.18 -40.08 71.44 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.04 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.559 ' CZ ' HG21 ' A' ' 98' ' ' THR . 13.7 mmm180 -53.79 -46.21 70.96 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 123.567 0.542 . . . . 0.0 110.434 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -86.7 36.84 0.72 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.855 0.836 . . . . 0.0 110.736 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.554 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.5 tpt180 -141.43 -46.92 0.38 Allowed 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.858 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.637 HD21 HG21 ' A' ' 33' ' ' ILE . 1.4 pp -96.05 -26.16 15.63 Favored 'General case' 0 C--O 1.203 -1.361 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.559 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 15.3 t -110.81 10.94 22.52 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.543 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.2 ptpt -68.84 162.36 26.62 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -115.46 8.43 15.24 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.086 0.47 . . . . 0.0 111.953 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -79.54 -30.57 41.83 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.287 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -112.73 171.87 7.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.022 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.8 pt-20 -130.43 -71.56 0.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.5 t -91.63 129.83 41.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 122.03 -0.418 . . . . 0.0 109.962 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.525 HG21 HD13 ' A' ' 29' ' ' LEU . 15.9 m -126.05 150.5 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.9 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 -109.32 101.65 10.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.59 HD22 HG22 ' A' ' 80' ' ' VAL . 21.0 mt -102.55 149.66 24.19 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.4 mp -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.266 -3.035 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 35.9 m -117.42 159.1 17.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.548 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 18.8 p . . . . . 0 C--N 1.278 -2.516 0 CA-C-O 121.331 0.586 . . . . 0.0 110.144 -178.392 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 N--CA 1.44 -0.957 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 110' ' ' THR . 17.9 t -83.45 115.18 25.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.431 HE22 HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -128.4 153.37 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -94.27 145.25 24.87 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.141 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.66 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.4 t -121.68 156.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.439 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 38.8 tt0 -143.92 104.69 4.19 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.98 0.895 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -99.13 129.38 49.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.877 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.431 ' HD2' HG13 ' A' ' 104' ' ' VAL . 40.2 m170 -100.23 144.63 29.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 22.3 pttm -40.39 127.2 2.34 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.5 tp -124.81 126.03 44.96 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.83 174.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -91.83 116.3 28.79 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.465 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 20.0 mt-30 -111.08 101.27 9.82 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.75 -117.49 8.19 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.52 9.26 42.81 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.99 166.89 13.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.124 0.488 . . . . 0.0 109.733 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.6 tm? -117.68 107.73 14.56 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.8 163.31 27.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.0 mp -87.06 7.23 28.72 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.681 0.753 . . . . 0.0 110.598 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA2' ' OE1' ' A' ' 23' ' ' GLN . . . 90.44 -41.12 2.96 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.64 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 38.9 p90 -97.51 175.65 6.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.4 m -140.66 168.92 18.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.493 1.117 . . . . 0.0 109.314 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 55' ' ' ILE . 8.7 pt -125.8 167.02 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 117.916 0.326 . . . . 0.0 111.282 -173.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.49 -28.47 4.84 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.557 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 127.46 165.79 11.96 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.052 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -113.75 -116.16 3.26 Favored Glycine 0 N--CA 1.423 -2.175 0 O-C-N 124.238 0.611 . . . . 0.0 112.173 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.611 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.04 -23.71 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB2' HG22 ' A' ' 89' ' ' THR . 24.7 t70 -67.93 -15.71 63.74 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.812 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 9.8 mm-40 -108.87 150.19 28.04 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.549 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.3 t70 -93.11 122.65 62.97 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.68 -24.94 65.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.706 2.271 . . . . 0.0 113.41 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -70.81 -25.4 62.84 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.343 0.592 . . . . 0.0 110.128 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.549 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -121.24 12.24 10.96 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.059 -176.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.447 HD21 ' HB2' ' A' ' 39' ' ' GLN . 94.2 m-20 -88.7 147.3 39.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.2 -47.94 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.398 2.066 . . . . 0.0 113.74 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -113.67 24.11 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.866 0.841 . . . . 0.0 110.356 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.528 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.307 178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.611 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 71.9 mttt . . . . . 0 C--O 1.226 -0.159 0 CA-C-O 120.76 0.314 . . . . 0.0 110.911 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.29 157.7 7.52 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 33' ' ' ILE . 22.3 mm -76.71 131.84 34.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 118.066 0.933 . . . . 0.0 110.057 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.496 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 4.7 p90 -133.84 156.78 47.44 Favored 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.523 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 73' ' ' ILE . 8.2 p -84.24 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 O-C-N 125.035 1.46 . . . . 0.0 110.966 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.3 p -110.45 -23.29 11.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 29.8 ttm180 -136.29 146.41 46.63 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 66' ' ' ALA . 18.1 t -135.91 150.99 28.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 66' ' ' ALA . 18.7 p -52.91 127.66 24.4 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 124.047 0.842 . . . . 0.0 109.644 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.61 -19.65 66.0 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 124.048 0.842 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.88 50.23 0.2 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.486 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -129.49 -165.57 11.7 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.464 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HD2' HD22 ' A' ' 21' ' ' LEU . 34.8 Cg_endo -63.4 -34.33 66.45 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.488 2.792 . . . . 0.0 113.21 -169.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -60.27 -56.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.562 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.72 -27.7 61.33 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.564 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.6 mm -58.61 -44.36 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -76.34 -55.65 5.36 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.834 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.47 33.81 0.05 OUTLIER Glycine 0 CA--C 1.499 -0.916 0 C-N-CA 119.479 -1.343 . . . . 0.0 113.018 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.66 ' HB2' HG11 ' A' ' 16' ' ' VAL . 2.1 tp -92.17 115.75 28.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -111.3 141.48 44.78 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.474 ' HA ' HG13 ' A' ' 57' ' ' VAL . 70.7 mt -56.59 126.76 14.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 123.603 0.565 . . . . 0.0 109.92 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.79 -3.25 34.01 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.341 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 8.5 m-20 -86.2 131.88 34.13 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 120.986 0.422 . . . . 0.0 111.436 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 47.5 mtpt -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.443 HG13 HG12 ' A' ' 109' ' ' VAL . 3.2 mp -92.22 122.3 43.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -174.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.463 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.4 mmt -105.8 -15.78 14.85 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.347 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -153.56 136.52 15.45 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.519 HG22 HD22 ' A' ' 107' ' ' LEU . 72.6 t -140.85 118.47 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.795 0.838 . . . . 0.0 110.919 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.412 HD22 ' HA ' ' A' ' 81' ' ' ASN . 1.1 t-20 61.98 14.48 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.271 1.429 . . . . 0.0 113.157 171.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.468 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 114.61 -15.88 19.43 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.958 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.64 149.91 21.91 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -97.08 113.59 25.17 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.543 ' HG3' HG11 ' A' ' 88' ' ' VAL . 21.3 ttm -77.84 -60.3 2.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.118 -174.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 87' ' ' MET 0.279 9.8 t 23.26 -76.5 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 127.603 2.361 . . . . 0.0 116.775 -176.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.513 ' H ' HG23 ' A' ' 86' ' ' THR . 27.7 ttt -113.97 93.66 4.47 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.543 HG11 ' HG3' ' A' ' 85' ' ' MET . 9.5 p -148.7 153.25 11.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.346 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 38' ' ' ASP . 4.7 p -70.28 152.9 43.67 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.568 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.5 t60 -50.75 -46.22 59.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.008 176.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 38.6 t70 -57.83 -48.95 78.28 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.535 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -35.9 70.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.67 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -66.09 -40.99 91.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.451 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 8.4 mmm180 -55.36 -38.79 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.802 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 38.6 mttm -83.3 30.74 0.46 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.42 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.7 tpm_? -148.66 -43.7 0.15 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.507 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.1 pp -102.05 -16.16 16.52 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.433 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.0 t -121.62 10.66 10.42 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.848 174.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.564 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 15.8 ptpt -68.59 171.41 7.63 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 173.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 18.7 ptt180 -123.99 13.01 9.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.211 0.529 . . . . 0.0 111.317 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.564 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 31.3 t -76.83 -41.1 45.53 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.243 0.544 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.26 167.09 10.37 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.6 pt-20 -120.34 -64.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 12.5 t -91.54 123.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.464 HG21 HD23 ' A' ' 29' ' ' LEU . 25.2 m -125.28 136.73 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.236 0.541 . . . . 0.0 112.056 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -95.9 110.24 22.47 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 172.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 80' ' ' VAL . 14.8 mt -109.23 156.2 20.19 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.4 mp -130.03 123.02 29.52 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -117.36 157.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.584 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.743 HG22 HG22 ' A' ' 13' ' ' VAL . 39.9 p . . . . . 0 N--CA 1.402 -2.86 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.139 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t . . . . . 0 N--CA 1.442 -0.858 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.37 135.3 33.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.459 HE21 HG22 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -148.97 154.77 39.86 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -178.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.62 150.2 20.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.635 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -135.61 162.81 36.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -154.24 114.23 3.85 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.258 0.551 . . . . 0.0 110.818 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -97.38 134.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.31 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.418 ' HD2' HG13 ' A' ' 104' ' ' VAL . 42.5 m170 -105.04 134.28 48.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HD3' ' HB2' ' A' ' 103' ' ' GLU . 43.7 pttt -28.12 118.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.438 HD22 ' CD ' ' A' ' 65' ' ' PRO . 45.9 tp -121.8 130.45 53.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.141 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.85 127.85 44.07 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -121.01 92.87 3.86 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.99 -111.83 3.36 Favored Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -109.88 15.98 22.29 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.332 0.587 . . . . 0.0 110.255 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.412 ' HA ' ' NH2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -125.83 163.92 21.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -117.56 112.55 20.73 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.87 160.79 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.619 HD13 HG21 ' A' ' 105' ' ' VAL . 54.0 mt -86.48 0.41 54.27 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.56 -37.68 3.34 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.319 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -95.84 171.47 8.62 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.8 m -130.68 169.5 15.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.679 1.192 . . . . 0.0 109.975 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 55' ' ' ILE . 6.8 pt -128.49 165.33 28.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 117.701 0.228 . . . . 0.0 110.671 -172.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.44 -31.4 3.76 Favored Glycine 0 CA--C 1.488 -1.616 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.53 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 124.11 154.74 8.98 Favored Glycine 0 C--O 1.199 -2.077 0 C-N-CA 119.416 -1.373 . . . . 0.0 113.187 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -102.18 -119.17 4.51 Favored Glycine 0 N--CA 1.424 -2.115 0 O-C-N 124.157 0.563 . . . . 0.0 112.85 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.645 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.71 -22.6 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HB2' HG22 ' A' ' 89' ' ' THR . 31.7 t70 -70.9 -18.05 62.69 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.819 0.818 . . . . 0.0 110.163 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 11.0 mm-40 -105.87 147.07 29.13 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 4.8 t70 -94.12 127.15 46.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -175.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -20.86 44.46 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.37 2.714 . . . . 0.0 113.322 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 m -76.91 -16.07 59.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.75 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -132.14 19.76 4.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.965 0.888 . . . . 0.0 109.946 -177.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 93.3 m-20 -104.55 144.29 28.41 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.171 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.51 -51.74 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.692 2.261 . . . . 0.0 113.668 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -112.12 22.46 14.77 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.329 0.585 . . . . 0.0 110.639 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 8.5 t . . . . . 0 C--N 1.304 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.645 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 68.8 mttt . . . . . 0 CA--C 1.544 0.742 0 CA-C-O 121.057 0.456 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.75 156.27 10.57 Favored Glycine 0 C--O 1.201 -1.963 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 33' ' ' ILE . 30.4 mm -78.27 126.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 117.813 0.806 . . . . 0.0 108.874 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.9 p90 -129.52 160.0 34.56 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.787 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 71' ' ' LEU . 58.8 t -87.47 128.46 39.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 124.73 1.269 . . . . 0.0 110.917 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 p -104.8 -20.43 13.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.441 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 135.94 23.41 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 HG11 ' A' ' 57' ' ' VAL . 64.6 t -123.59 148.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.48 ' OG ' ' HB3' ' A' ' 66' ' ' ALA . 37.7 p -51.82 126.33 17.7 Favored 'General case' 0 N--CA 1.401 -2.901 0 O-C-N 124.328 1.017 . . . . 0.0 108.563 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -71.32 -28.21 63.93 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-O 121.596 0.712 . . . . 0.0 109.868 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.52 55.57 0.5 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.606 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -139.28 -169.41 11.57 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' CD ' HD22 ' A' ' 21' ' ' LEU . 38.4 Cg_endo -65.61 -30.71 51.19 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 123.677 2.918 . . . . 0.0 113.047 -171.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.48 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -61.96 -53.8 50.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.914 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.3 pp20? -69.84 -30.62 68.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.551 0.215 . . . . 0.0 111.28 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.26 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.638 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.23 -48.14 45.07 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.03 21.51 0.41 Allowed Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.069 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.758 HD11 HG21 ' A' ' 57' ' ' VAL . 3.4 tp -83.03 125.46 31.47 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.461 ' N ' HD12 ' A' ' 71' ' ' LEU . 20.9 mm-40 -116.8 158.08 24.5 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.715 0.769 . . . . 0.0 109.614 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.38 135.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.898 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.82 -10.95 57.54 Favored Glycine 0 C--O 1.245 0.796 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 87.5 m-20 -74.99 114.69 13.76 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 18.7 ptpt -91.62 122.31 34.08 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.483 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.563 HD11 HG23 ' A' ' 57' ' ' VAL . 2.9 mp -86.53 134.14 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.194 -172.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.617 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -114.83 -14.07 11.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.565 0.697 . . . . 0.0 110.869 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 23.0 tp60 -147.06 129.76 16.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.564 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 107' ' ' LEU . 46.2 t -135.38 116.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 105' ' ' VAL . 5.3 t-20 37.6 59.15 1.28 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.269 1.827 . . . . 0.0 113.465 176.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.24 4.82 38.63 Favored Glycine 0 C--N 1.3 -1.461 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.431 ' CD1' ' HB ' ' A' ' 80' ' ' VAL 0.385 0.0 OUTLIER -90.27 -100.02 0.1 Allowed 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 118.635 1.218 . . . . 0.0 112.603 178.52 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 173.66 116.96 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.431 ' HE2' HD23 ' A' ' 97' ' ' LEU . 3.7 tpt -115.14 -2.77 12.66 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.015 -175.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.617 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.5 t -64.87 -28.3 69.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.541 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttm -146.72 87.53 1.71 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.38 0.609 . . . . 0.0 109.579 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.43 HG13 HG13 ' A' ' 55' ' ' ILE . 7.5 p -149.37 149.63 14.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.913 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 38' ' ' ASP . 4.3 p -71.22 155.86 40.23 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 123.3 0.64 . . . . 0.0 110.428 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.569 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.5 t60 -55.6 -43.83 76.4 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.787 176.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.16 -48.89 79.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.684 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -32.52 70.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.11 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.73 -42.64 73.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.05 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 11.2 mmm180 -60.6 -37.03 80.02 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.83 0.824 . . . . 0.0 108.849 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.91 21.16 1.07 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.052 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.527 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 17.7 mmt180 -134.69 -42.53 0.76 Allowed 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.316 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.625 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -100.62 -28.82 12.66 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.463 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.3 t -106.97 14.8 26.06 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.872 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 14.4 ptpt -73.67 175.48 7.12 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.466 169.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.412 ' NH2' ' HA ' ' A' ' 26' ' ' ASN . 14.3 ptp180 -122.81 6.88 9.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.423 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 22.3 t -75.26 -38.45 60.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.497 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -87.97 174.15 8.48 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.529 178.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.551 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 8.6 pt-20 -137.77 -58.72 0.67 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.587 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 59.0 t -104.07 127.2 58.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.619 HG21 HD13 ' A' ' 29' ' ' LEU . 15.0 m -122.16 148.62 25.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.385 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -119.23 103.96 9.98 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.591 HD12 HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -110.17 151.85 26.78 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.963 -171.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.3 mp -125.31 119.37 28.2 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.516 HG12 HG13 ' A' ' 77' ' ' ILE . 27.1 m -112.58 147.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.184 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.7 p . . . . . 0 N--CA 1.408 -2.57 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.842 178.055 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t . . . . . 0 N--CA 1.427 -1.602 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.517 HG22 HG22 ' A' ' 110' ' ' THR . 12.7 t -80.45 126.35 39.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.454 HE21 HG22 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -144.74 153.1 41.33 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.425 -175.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -90.12 148.17 23.16 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -128.29 152.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -135.24 104.36 5.87 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.075 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.7 mp -92.8 129.74 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.942 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.504 ' HD2' HG13 ' A' ' 104' ' ' VAL . 61.4 m170 -99.35 144.8 28.05 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.62 ' HB2' HD21 ' A' ' 27' ' ' LEU . 20.0 pttm -35.26 127.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.401 HD22 ' HD2' ' A' ' 65' ' ' PRO . 44.0 tp -125.14 118.26 25.71 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.227 174.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -88.38 111.86 22.23 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.729 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -117.99 110.38 17.62 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.93 -109.73 3.04 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -113.95 13.31 18.26 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -112.57 171.64 7.4 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.873 0.844 . . . . 0.0 109.837 -174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.3 tm? -126.53 111.82 14.82 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 172.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.97 164.5 23.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.486 HD13 HG21 ' A' ' 105' ' ' VAL . 38.1 mt -87.66 -4.24 58.94 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.964 0.888 . . . . 0.0 108.629 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 92.67 -46.02 2.53 Favored Glycine 0 N--CA 1.424 -2.154 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.949 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -84.33 166.46 17.41 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.193 0.521 . . . . 0.0 112.218 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 29.2 m -122.36 166.85 14.05 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.656 1.182 . . . . 0.0 109.961 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 55' ' ' ILE . 3.7 pt -125.14 164.4 24.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.07 -16.23 7.39 Favored Glycine 0 CA--C 1.487 -1.685 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.328 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 125.04 169.35 12.93 Favored Glycine 0 CA--C 1.473 -2.54 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.168 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -122.2 -116.3 2.36 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.367 0.686 . . . . 0.0 111.57 175.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.45 -15.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.151 0.977 . . . . 0.0 110.777 -177.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.513 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 15.2 t0 -70.95 -19.91 62.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.085 -177.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.586 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 16.4 mm-40 -113.37 155.25 25.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 10.0 t70 -98.32 129.37 30.73 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 118.612 0.642 . . . . 0.0 109.431 -176.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.53 -21.3 45.35 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 122.768 2.312 . . . . 0.0 113.198 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -77.36 -11.13 59.8 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.015 0.436 . . . . 0.0 110.625 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -130.15 11.58 5.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.415 0.626 . . . . 0.0 110.75 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 97.4 m-20 -99.91 143.32 26.27 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.76 -52.98 0.47 Allowed 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.201 2.601 . . . . 0.0 113.118 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.38 18.11 20.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.575 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.0 t . . . . . 0 C--N 1.31 -1.133 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 53.4 mttt . . . . . 0 C--O 1.224 -0.241 0 CA-C-O 121.206 0.526 . . . . 0.0 111.387 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.56 153.36 5.85 Favored Glycine 0 C--O 1.18 -3.273 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 33' ' ' ILE . 30.5 mm -68.27 125.33 25.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 118.009 0.904 . . . . 0.0 109.774 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 2.3 p90 -124.98 155.9 38.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.188 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.674 HG21 HD11 ' A' ' 71' ' ' LEU . 87.7 t -81.46 129.92 36.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 124.455 1.097 . . . . 0.0 110.619 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -106.08 -19.7 13.64 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.279 0.561 . . . . 0.0 111.068 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -154.46 138.97 16.84 Favored 'General case' 0 C--O 1.204 -1.309 0 C-N-CA 124.124 0.97 . . . . 0.0 108.519 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.519 HG11 ' O ' ' A' ' 71' ' ' LEU . 18.9 m -109.87 174.83 1.75 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.194 0 CA-C-N 119.688 1.131 . . . . 0.0 109.222 172.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.624 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.3 t -77.93 116.23 18.26 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -52.85 -16.34 0.99 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.997 1.719 . . . . 0.0 114.68 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.35 30.41 0.42 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.17 -171.46 19.33 Favored Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD2' HD22 ' A' ' 21' ' ' LEU . 37.7 Cg_endo -63.8 -27.07 67.71 Favored 'Trans proline' 0 C--O 1.208 -0.986 0 C-N-CA 123.468 2.778 . . . . 0.0 111.634 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.51 -66.71 0.42 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.796 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.7 pt-20 -75.43 -22.74 57.12 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.592 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -62.93 -41.03 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.03 -45.51 26.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.074 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.1 2.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 119.644 -1.265 . . . . 0.0 114.08 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.674 HD11 HG21 ' A' ' 57' ' ' VAL . 7.6 tp -74.8 126.51 31.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 122.767 -0.255 . . . . 0.0 110.638 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -120.3 160.82 22.24 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.134 0.896 . . . . 0.0 109.936 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.98 128.72 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.491 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.12 -9.47 54.51 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.341 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 74.1 m-20 -77.78 119.13 20.85 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 37.6 ttpt -88.9 124.12 33.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 109' ' ' VAL . 3.0 mp -88.29 135.96 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -174.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.1 mmt -107.77 -26.1 10.95 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.389 0.614 . . . . 0.0 109.839 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -151.63 133.73 15.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.619 HG22 HD22 ' A' ' 107' ' ' LEU . 49.9 t -136.98 117.57 17.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 C-N-CA 123.663 0.785 . . . . 0.0 110.037 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.406 HD22 ' HA ' ' A' ' 81' ' ' ASN . 1.1 t-20 49.6 49.98 19.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.153 0.981 . . . . 0.0 111.625 171.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.528 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 69.93 8.06 60.39 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.442 ' CD2' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -115.26 158.87 21.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 117.681 0.74 . . . . 0.0 110.346 176.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 123.299 0.64 . . . . 0.0 110.509 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.508 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 20.2 ttm -117.47 -4.5 11.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.92 0.867 . . . . 0.0 110.737 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t -68.11 -25.46 65.32 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.779 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 ttt -135.95 85.51 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.91 0.386 . . . . 0.0 110.519 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 11.2 p -154.79 148.4 12.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.445 ' OG1' ' HB2' ' A' ' 92' ' ' GLN . 7.9 p -73.05 156.54 38.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.583 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.1 t60 -55.42 -47.33 76.11 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.556 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 33.8 t70 -58.93 -47.46 84.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.331 -176.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.445 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -72.1 -39.46 68.91 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.202 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.94 -41.7 99.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.303 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.486 ' CZ ' HG21 ' A' ' 98' ' ' THR . 18.2 mmm180 -58.16 -26.03 62.22 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.485 0.659 . . . . 0.0 112.119 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 45.1 mmtm -95.0 8.19 43.68 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 24.7 ttm180 -136.79 -30.96 0.87 Allowed 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.686 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.409 HD23 ' H ' ' A' ' 98' ' ' THR . 1.2 pt? -92.98 -40.6 10.47 Favored 'General case' 0 C--O 1.19 -2.062 0 C-N-CA 116.646 -2.021 . . . . 0.0 111.132 174.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.486 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 8.8 t -102.15 14.71 31.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 109.406 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.8 ptpt -66.49 -176.06 0.42 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.951 170.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -122.07 -3.74 9.06 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -67.24 -40.41 86.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 175.51 5.62 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.943 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -134.79 -62.26 0.74 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.504 HG13 ' HD2' ' A' ' 19' ' ' HIS . 22.2 t -94.53 112.46 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 29' ' ' LEU . 28.0 m -110.41 131.86 60.33 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.206 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -99.8 107.49 19.55 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.619 HD22 HG22 ' A' ' 80' ' ' VAL . 13.9 mt -108.65 151.42 26.17 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.5 mp -122.34 118.62 28.89 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.529 HG12 HG13 ' A' ' 77' ' ' ILE . 31.7 m -117.85 165.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.09 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.517 HG22 HG22 ' A' ' 13' ' ' VAL . 23.8 p . . . . . 0 N--CA 1.407 -2.584 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.307 177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.5 t . . . . . 0 N--CA 1.427 -1.614 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 110' ' ' THR . 25.3 t -108.77 125.98 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.438 HE22 HG22 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -139.43 151.17 46.04 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.317 -176.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 149.52 23.2 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.78 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -129.65 157.77 42.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.416 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 33.3 tt0 -144.92 107.84 4.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.334 0.587 . . . . 0.0 110.771 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -97.46 132.17 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.42 ' HD2' HG13 ' A' ' 104' ' ' VAL . 37.5 m170 -98.45 152.65 19.28 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 123.819 0.699 . . . . 0.0 110.232 175.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . 23.4 ttmm -40.93 113.17 0.36 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 125.508 1.523 . . . . 0.0 114.48 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.571 HD22 ' HD2' ' A' ' 65' ' ' PRO . 26.7 tp -127.94 137.43 52.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.065 0.546 . . . . 0.0 111.513 177.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -104.62 131.44 52.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -122.47 107.36 11.95 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.15 -113.56 5.24 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -108.79 16.91 22.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.752 0.787 . . . . 0.0 110.539 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -120.63 176.72 5.37 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 1.3 tm? -128.13 112.09 14.18 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mt -129.22 159.01 41.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 105' ' ' VAL . 61.0 mt -79.61 2.69 21.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.759 0.79 . . . . 0.0 109.844 175.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.28 4.57 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.917 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -98.76 167.33 10.84 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.7 m -121.49 164.15 17.66 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.441 1.096 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 55' ' ' ILE . 6.2 pt -124.34 163.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -173.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.21 -24.36 6.56 Favored Glycine 0 CA--C 1.484 -1.886 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.462 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.552 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 124.75 167.67 12.67 Favored Glycine 0 N--CA 1.407 -3.25 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.848 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.555 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -113.8 -121.79 3.73 Favored Glycine 0 N--CA 1.427 -1.904 0 O-C-N 124.507 0.769 . . . . 0.0 112.591 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -67.26 -19.51 25.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.453 ' HB2' HG22 ' A' ' 89' ' ' THR . 25.2 t70 -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.036 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 27.0 mm-40 -96.01 -173.9 2.96 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 7.0 t70 -132.98 124.96 18.86 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.943 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 10.0 Cg_endo -57.63 -26.69 73.82 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.074 2.516 . . . . 0.0 113.132 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -68.87 -32.64 72.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.228 0.537 . . . . 0.0 110.373 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -112.74 8.51 18.93 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.522 0.677 . . . . 0.0 110.729 -176.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.13 142.19 24.14 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.85 -51.57 0.64 Allowed 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 123.378 2.719 . . . . 0.0 112.843 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -109.18 26.5 10.56 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.029 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 13.8 t . . . . . 0 C--N 1.301 -1.512 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.0 mtmm . . . . . 0 N--CA 1.427 -1.601 0 CA-C-O 121.843 0.83 . . . . 0.0 111.997 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.413 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 144.71 167.36 12.06 Favored Glycine 0 C--O 1.17 -3.877 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 33' ' ' ILE . 35.5 mm -73.9 115.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 120.26 2.03 . . . . 0.0 110.433 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 0.4 OUTLIER -114.9 151.73 33.5 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.059 178.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.799 HG21 HD11 ' A' ' 71' ' ' LEU . 87.6 t -82.77 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.31 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p -106.66 -15.04 14.87 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.625 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -152.23 145.32 24.56 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' A' ' 57' ' ' VAL . 39.5 t -133.79 148.72 30.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 13.3 p -52.95 128.54 27.52 Favored 'General case' 0 N--CA 1.406 -2.648 0 O-C-N 124.289 0.993 . . . . 0.0 109.635 176.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.92 -13.6 61.69 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 123.629 0.581 . . . . 0.0 111.553 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.46 41.53 0.31 Allowed Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -120.46 -169.49 13.96 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.194 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.571 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.2 Cg_endo -64.18 -32.28 63.2 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 123.614 2.876 . . . . 0.0 112.391 -171.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -59.08 -57.22 14.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.202 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 61' ' ' SER . 4.5 pt-20 -75.88 -24.45 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.48 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 64' ' ' GLY . 21.2 mm -63.61 -39.74 86.46 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 121.206 0.527 . . . . 0.0 109.903 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -75.7 -56.87 4.27 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.842 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.13 24.74 0.05 OUTLIER Glycine 0 C--O 1.224 -0.501 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.292 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.799 HD11 HG21 ' A' ' 57' ' ' VAL . 4.6 tp -91.96 124.65 36.23 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.447 ' N ' HD12 ' A' ' 71' ' ' LEU . 20.8 mm-40 -116.61 157.34 25.49 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.0 137.15 25.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.865 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.34 -0.25 59.93 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.941 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.13 123.24 24.88 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 120.773 0.321 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -89.0 110.81 21.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.492 HD11 ' CG2' ' A' ' 57' ' ' VAL . 12.3 mt -82.94 129.03 38.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.352 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . 0.429 ' HA ' ' HB ' ' A' ' 86' ' ' THR . 21.1 mmt -105.63 -26.26 11.92 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.478 0.656 . . . . 0.0 110.589 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 11.9 tp60 -152.46 133.11 13.92 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.88 -169.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.608 HG22 HD12 ' A' ' 107' ' ' LEU . 55.0 t -136.53 111.86 11.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 C-N-CA 124.27 1.028 . . . . 0.0 111.431 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.2 t-20 52.25 34.93 15.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.724 1.61 . . . . 0.0 112.92 173.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . 0.401 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 95.65 -9.4 68.8 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.435 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.447 ' N ' HE22 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -104.44 150.09 24.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.707 0.403 . . . . 0.0 110.207 178.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.91 132.76 41.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 123.839 0.855 . . . . 0.0 110.343 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.454 ' SD ' HG21 ' A' ' 80' ' ' VAL . 24.5 ttm -123.28 -0.48 8.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.211 1.005 . . . . 0.0 110.943 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 78' ' ' MET . 2.1 t -70.16 -25.06 63.27 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.259 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.9 ttt -141.41 86.29 2.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.245 0.545 . . . . 0.0 109.903 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.36 151.95 11.29 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 38' ' ' ASP . 17.8 p -75.0 157.11 35.46 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.176 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.612 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.9 t60 -53.84 -45.44 70.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.72 -51.22 69.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.435 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -30.3 63.6 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.072 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -76.66 -36.0 57.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.141 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.4 ' HG2' HD11 ' A' ' 33' ' ' ILE . 12.1 mmm180 -51.49 -45.65 62.9 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.931 0.77 . . . . 0.0 111.424 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.357 0.0 OUTLIER -93.06 59.71 3.16 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-O 122.904 1.335 . . . . 0.0 110.813 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tpt180 -154.38 -48.1 0.09 Allowed 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 112.151 -2.295 . . . . 0.0 106.698 171.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.4 pp -94.88 -25.46 16.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.443 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.7 t -114.23 14.06 18.04 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.476 174.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 17.5 ptpt -77.23 168.05 20.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.432 172.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 9.7 ptp85 -113.74 0.39 14.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.822 -175.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . 0.528 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 40.9 m -76.1 -34.02 59.5 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.804 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . 0.433 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 10.2 pt-20 -111.78 172.18 7.05 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.695 -178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.0 pm0 -132.85 -87.35 0.44 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 17.9 t -73.37 114.11 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-O 121.625 0.726 . . . . 0.0 109.816 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 29' ' ' LEU . 11.4 m -110.36 153.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.761 -177.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -120.94 100.28 6.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.608 HD12 HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -109.28 160.65 15.95 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.548 -171.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.7 mp -132.34 122.58 25.31 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.44 156.99 23.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.027 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.648 HG22 HG22 ' A' ' 13' ' ' VAL . 66.3 p . . . . . 0 C--N 1.307 -1.281 0 CA-C-O 121.27 0.557 . . . . 0.0 110.696 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.856 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.2 m -84.68 98.7 10.36 Favored 'General case' 0 N--CA 1.43 -1.443 0 CA-C-O 121.501 0.667 . . . . 0.0 110.355 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.465 ' CE1' ' HD2' ' A' ' 5' ' ' PRO . 10.3 t80 -84.27 127.24 33.84 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.61 HG23 ' HD3' ' A' ' 5' ' ' PRO 0.328 7.9 tp -92.26 -43.96 0.35 Allowed Pre-proline 0 CA--C 1.575 1.919 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -177.6 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.61 ' HD3' HG23 ' A' ' 4' ' ' ILE . 7.5 Cg_exo -65.46 -177.3 0.65 Allowed 'Trans proline' 0 C--N 1.383 2.382 0 CA-C-N 121.442 1.551 . . . . 0.0 113.932 175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.459 ' H ' HG11 ' A' ' 13' ' ' VAL . . . -119.98 39.0 2.59 Favored Glycine 0 C--N 1.288 -2.133 0 CA-C-N 115.403 -0.817 . . . . 0.0 112.474 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -94.43 126.6 47.43 Favored Pre-proline 0 C--N 1.307 -1.242 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 61.8 Cg_endo -82.8 -87.8 0.0 OUTLIER 'Trans proline' 0 N--CA 1.433 -2.067 0 C-N-CA 122.419 2.079 . . . . 0.0 111.275 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.7 m -142.92 -51.47 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 122.526 0.331 . . . . 0.0 111.751 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.9 t -90.24 -44.86 9.45 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.104 -0.638 . . . . 0.0 111.657 -173.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.515 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . -88.41 144.79 26.16 Favored 'General case' 0 N--CA 1.433 -1.303 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 58.5 t -116.26 128.77 73.48 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.459 HG11 ' H ' ' A' ' 6' ' ' GLY . 13.4 p -91.06 129.16 42.26 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.811 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 175.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.443 HE21 HG22 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -134.28 151.54 51.33 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.741 -175.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.95 152.18 18.57 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 120.742 0.306 . . . . 0.0 110.548 -172.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.802 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -129.58 154.61 40.47 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 176.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -141.12 102.12 4.18 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 121.306 0.574 . . . . 0.0 110.35 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.505 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.42 127.01 44.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -99.63 148.67 24.08 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 173.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.571 ' HB2' HD11 ' A' ' 27' ' ' LEU . 22.5 pttm -39.18 123.36 1.36 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 115.548 1.685 . . . . 0.0 115.548 -178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.577 HD22 ' HD2' ' A' ' 65' ' ' PRO . 49.4 tp -117.67 122.08 42.58 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.559 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -92.81 109.71 21.15 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.403 ' HG3' HD12 ' A' ' 28' ' ' ILE . 16.1 mm100 -107.41 109.14 20.79 Favored 'General case' 0 CA--C 1.473 -1.984 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 65.57 -110.77 3.69 Favored Glycine 0 N--CA 1.428 -1.899 0 N-CA-C 110.046 -1.221 . . . . 0.0 110.046 -177.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -119.72 17.74 12.71 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-O 121.194 0.521 . . . . 0.0 111.479 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.67 166.81 12.29 Favored 'General case' 0 CA--C 1.49 -1.344 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.571 HD11 ' HB2' ' A' ' 20' ' ' LYS . 58.4 tp -112.85 126.59 55.61 Favored 'General case' 0 N--CA 1.408 -2.528 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 173.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.403 HD12 ' HG3' ' A' ' 23' ' ' GLN . 0.9 OUTLIER -136.82 163.17 33.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 -179.398 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.407 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.9 mp -88.4 2.3 52.94 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-O 122.051 0.929 . . . . 0.0 109.419 175.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . 94.9 -47.26 2.04 Favored Glycine 0 N--CA 1.424 -2.133 0 CA-C-N 115.264 -0.88 . . . . 0.0 114.362 175.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 39.9 p90 -90.63 166.11 13.35 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 67.8 m -123.96 163.62 20.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 125.508 1.523 . . . . 0.0 109.497 177.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 55' ' ' ILE . 7.9 pt -125.17 166.15 21.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 C-N-CA 122.75 0.42 . . . . 0.0 110.615 -174.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.24 -22.42 6.83 Favored Glycine 0 CA--C 1.487 -1.675 0 C-N-CA 120.208 -0.996 . . . . 0.0 111.311 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.543 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 123.58 163.54 11.78 Favored Glycine 0 C--O 1.196 -2.238 0 C-N-CA 119.617 -1.278 . . . . 0.0 112.613 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.546 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -112.88 -117.3 3.45 Favored Glycine 0 N--CA 1.432 -1.588 0 O-C-N 124.583 0.814 . . . . 0.0 112.345 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.646 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.05 -17.58 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 122.101 0.953 . . . . 0.0 112.869 -174.828 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.61 ' HB2' HG22 ' A' ' 89' ' ' THR . 19.5 t70 -75.2 -9.19 58.32 Favored 'General case' 0 C--N 1.288 -2.069 0 CA-C-N 113.611 -1.631 . . . . 0.0 110.421 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.644 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 24.9 mm-40 -107.55 162.86 13.57 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.097 -179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 2.8 m-20 -105.21 108.63 61.82 Favored Pre-proline 0 C--N 1.312 -1.043 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.484 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -58.44 -19.79 45.59 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 123.794 2.996 . . . . 0.0 113.402 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 37.4 t -75.34 -5.58 45.51 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.586 178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.15 29.29 0.89 Allowed 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.523 0.329 . . . . 0.0 111.155 176.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 7.4 m120 -107.22 145.5 31.32 Favored Pre-proline 0 CA--C 1.495 -1.14 0 O-C-N 121.918 -0.489 . . . . 0.0 112.163 -178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -67.36 -40.83 10.09 Favored 'Trans proline' 0 C--O 1.218 -0.5 0 C-N-CA 123.204 2.603 . . . . 0.0 113.057 -176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -120.63 4.41 10.62 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 119.696 -0.802 . . . . 0.0 111.262 -177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 1.1 t -104.22 1.23 30.33 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.612 -0.835 . . . . 0.0 109.242 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.06 -20.4 65.82 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 122.365 1.078 . . . . 0.0 108.508 173.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.53 ' OD2' ' HG2' ' A' ' 50' ' ' LYS . 3.0 t70 -69.53 -60.79 2.1 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 113.28 -1.782 . . . . 0.0 111.208 175.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.53 ' HG2' ' OD2' ' A' ' 49' ' ' ASP . 45.7 mmtm -122.5 130.32 52.92 Favored 'General case' 0 CA--C 1.5 -0.958 0 CA-C-O 121.521 0.677 . . . . 0.0 110.973 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.9 p -83.67 -0.19 49.65 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.079 177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -80.45 -5.61 56.85 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-O 123.022 1.392 . . . . 0.0 110.154 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.646 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 53.1 mttp 49.93 -176.63 0.02 OUTLIER 'General case' 0 C--N 1.288 -2.1 0 CA-C-N 111.354 -2.657 . . . . 0.0 113.535 -177.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.93 159.41 8.28 Favored Glycine 0 C--O 1.191 -2.555 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.701 HD12 HD12 ' A' ' 33' ' ' ILE . 20.1 mm -77.88 128.11 38.27 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 CA-C-N 117.657 0.728 . . . . 0.0 109.538 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.456 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 3.1 p90 -131.09 157.77 42.18 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.951 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.637 HG21 HD11 ' A' ' 71' ' ' LEU . 94.5 t -80.57 134.14 27.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.905 0 O-C-N 124.748 1.28 . . . . 0.0 110.469 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.9 p -106.15 -23.03 12.7 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.618 0.723 . . . . 0.0 110.519 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 19.4 mmt180 -155.19 142.51 19.47 Favored 'General case' 0 CA--C 1.473 -1.992 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 177.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 16.3 m -107.73 -172.03 0.4 Allowed 'Isoleucine or valine' 1 N--CA 1.339 -6.02 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 176.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.403 ' HB3' ' HA3' ' A' ' 30' ' ' GLY . 22.5 p -64.51 131.32 46.77 Favored 'General case' 0 N--CA 1.389 -3.48 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.59 -21.42 26.68 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 123.181 0.592 . . . . 0.0 112.146 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 178.99 52.72 0.08 OUTLIER Glycine 0 N--CA 1.429 -1.815 0 N-CA-C 108.555 -1.818 . . . . 0.0 108.555 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -129.6 -161.23 10.45 Favored Glycine 0 N--CA 1.429 -1.785 0 CA-C-N 114.905 -0.648 . . . . 0.0 112.771 -173.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.577 ' HD2' HD22 ' A' ' 21' ' ' LEU . 38.2 Cg_endo -63.27 -32.68 72.94 Favored 'Trans proline' 0 C--O 1.211 -0.872 0 C-N-CA 123.541 2.827 . . . . 0.0 112.543 -170.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.403 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -59.06 -61.1 2.89 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.893 179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -70.79 -30.67 67.2 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 119.338 -0.945 . . . . 0.0 112.329 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.9 mm -63.69 -42.69 96.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 120.783 0.325 . . . . 0.0 111.316 178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.74 -55.2 5.7 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 120.897 -0.321 . . . . 0.0 111.169 -178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.98 29.4 0.05 OUTLIER Glycine 0 C--N 1.312 -0.78 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.056 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.802 ' HB2' HG11 ' A' ' 16' ' ' VAL . 6.5 tp -100.33 120.93 40.69 Favored 'General case' 0 CA--C 1.486 -1.51 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.471 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 28.7 mm-40 -116.33 153.31 32.21 Favored 'General case' 0 N--CA 1.425 -1.693 0 O-C-N 123.964 0.79 . . . . 0.0 110.959 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 67.4 mt -59.43 131.23 23.8 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 114.475 -1.239 . . . . 0.0 110.68 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.96 -27.45 20.34 Favored Glycine 0 C--O 1.252 1.244 0 C-N-CA 121.349 -0.453 . . . . 0.0 112.956 177.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.59 ' OD1' ' HA ' ' A' ' 111' ' ' ARG . 53.2 m-20 -72.53 125.28 27.05 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-O 121.762 0.792 . . . . 0.0 111.02 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.456 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 63.2 mttp -82.87 128.82 34.78 Favored 'General case' 0 CA--C 1.489 -1.402 0 CA-C-N 114.222 -1.354 . . . . 0.0 110.139 -175.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.555 HD11 HG23 ' A' ' 57' ' ' VAL . 2.8 mp -92.72 124.57 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.153 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 -177.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 25.3 mmt -109.41 -11.44 14.83 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-O 121.533 0.683 . . . . 0.0 110.918 -178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.686 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.4 OUTLIER -148.43 124.74 10.88 Favored 'General case' 0 N--CA 1.431 -1.388 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.557 HG22 HD22 ' A' ' 107' ' ' LEU . 44.6 t -136.68 118.5 19.47 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.049 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 53.07 39.16 29.08 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 124.607 1.163 . . . . 0.0 112.997 170.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.466 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 65.08 27.42 72.28 Favored Glycine 0 N--CA 1.462 0.408 0 CA-C-N 116.324 -0.398 . . . . 0.0 113.715 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -113.85 -10.04 13.02 Favored 'General case' 0 C--N 1.286 -2.163 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -177.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 55.69 111.47 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 124.468 1.107 . . . . 0.0 113.717 -169.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.613 ' SD ' HG11 ' A' ' 88' ' ' VAL . 62.7 tpp -95.92 1.52 52.97 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.201 1.001 . . . . 0.0 109.353 -176.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 14.7 t -71.33 135.55 47.42 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttp 55.48 74.61 0.36 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.327 1.051 . . . . 0.0 112.552 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.613 HG11 ' SD ' ' A' ' 85' ' ' MET . 11.3 p -149.9 150.16 13.95 Favored 'Isoleucine or valine' 0 C--O 1.261 1.691 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.61 HG22 ' HB2' ' A' ' 38' ' ' ASP . 15.6 p -73.31 157.66 36.59 Favored 'General case' 0 N--CA 1.416 -2.142 0 CA-C-O 121.032 0.444 . . . . 0.0 110.608 179.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.644 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 13.7 t60 -53.58 -42.93 68.13 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.336 175.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -63.75 -46.66 84.32 Favored 'General case' 0 C--N 1.32 -0.683 0 O-C-N 123.789 0.681 . . . . 0.0 110.825 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -72.1 -32.89 67.42 Favored 'General case' 0 CA--C 1.511 -0.553 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.816 -177.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.657 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.88 -45.13 75.36 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.314 177.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.471 ' CZ ' HG21 ' A' ' 98' ' ' THR . 13.5 mmm180 -55.18 -40.76 71.08 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.661 0.743 . . . . 0.0 110.291 178.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.586 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -85.93 32.69 0.6 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.033 -0.985 . . . . 0.0 108.893 -176.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.1 tpt180 -148.88 -48.66 0.15 Allowed 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.014 176.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.3 pp -92.32 -20.72 20.81 Favored 'General case' 0 C--O 1.204 -1.326 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.484 ' N ' HD12 ' A' ' 97' ' ' LEU . 14.6 t -118.21 10.12 12.79 Favored 'General case' 0 C--N 1.283 -2.308 0 C-N-CA 117.666 -1.613 . . . . 0.0 110.837 175.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.479 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -66.28 154.96 38.55 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 172.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptp180 -103.67 6.24 36.88 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -172.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.0 t -79.28 -37.93 36.64 Favored 'General case' 0 C--N 1.29 -1.984 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.519 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -92.96 147.9 22.45 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 -173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 11.7 pt-20 -101.48 -63.9 1.1 Allowed 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.794 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -117.85 133.26 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.118 0 CA-C-O 122.002 0.905 . . . . 0.0 112.347 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.401 ' CG2' HD21 ' A' ' 107' ' ' LEU . 15.3 m -129.65 146.89 33.47 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.631 -174.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 16.0 mmt180 -100.57 112.82 25.25 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.557 HD22 HG22 ' A' ' 80' ' ' VAL . 14.8 mt -112.86 162.9 15.27 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 110.198 -0.297 . . . . 0.0 110.198 -177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.686 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.1 mp -139.74 123.66 17.61 Favored 'General case' 0 C--O 1.251 1.158 0 C-N-CA 123.421 0.689 . . . . 0.0 109.273 174.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.502 HG12 HG13 ' A' ' 77' ' ' ILE . 34.7 m -115.71 151.49 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.475 -1.937 0 CA-C-O 121.16 0.505 . . . . 0.0 110.101 177.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.6 p -102.71 122.63 44.84 Favored 'General case' 0 N--CA 1.401 -2.913 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 173.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.59 ' HA ' ' OD1' ' A' ' 75' ' ' ASP . 68.7 mtp180 -69.08 114.23 7.16 Favored 'General case' 0 N--CA 1.42 -1.929 0 O-C-N 123.968 0.793 . . . . 0.0 110.143 -176.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.458 ' C ' ' H ' ' A' ' 114' ' ' LEU . 27.9 mm-40 -108.79 3.99 23.15 Favored 'General case' 0 C--N 1.294 -1.84 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 1.8 p -77.24 34.84 0.16 Allowed 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 125.821 1.648 . . . . 0.0 110.518 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 112' ' ' GLN . 6.9 mp -88.43 -173.48 4.2 Favored 'General case' 0 C--N 1.298 -1.631 0 C-N-CA 125.29 1.436 . . . . 0.0 112.245 -177.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.504 ' C ' ' H ' ' A' ' 117' ' ' ALA . 26.6 mm-40 -129.99 163.51 26.3 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 105.912 -1.884 . . . . 0.0 105.912 172.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp 74.91 -29.92 0.2 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 124.753 1.221 . . . . 0.0 110.632 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.504 ' H ' ' C ' ' A' ' 115' ' ' GLN . . . -101.43 166.55 10.67 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 105.729 -1.952 . . . . 0.0 105.729 172.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 44.5 t 70.8 89.17 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.25 1.132 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 11.5 mm100 -54.27 140.79 31.93 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.512 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . 0.443 ' HB2' ' OXT' ' A' ' 124' ' ' SER . 4.3 pt20 -44.97 -38.12 4.49 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 -171.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.3 m 56.32 26.9 11.12 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 123.471 0.708 . . . . 0.0 111.167 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 92.6 mmm 64.12 6.62 2.99 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.252 1.421 . . . . 0.0 112.98 -176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 95.5 mt -94.0 -29.4 15.25 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.419 0.628 . . . . 0.0 109.636 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.443 ' OXT' ' HB2' ' A' ' 120' ' ' GLN . 60.1 m . . . . . 0 N--CA 1.42 -1.952 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 175.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.122 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.3 m -87.15 156.95 19.48 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -144.99 123.0 12.05 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 -178.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 47.3 mm -121.62 103.65 40.59 Favored Pre-proline 0 C--N 1.318 -0.797 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -83.09 -179.98 4.77 Favored 'Trans proline' 0 N--CA 1.447 -1.242 0 C-N-CA 122.455 2.103 . . . . 0.0 112.208 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.4 40.26 2.97 Favored Glycine 0 C--N 1.306 -1.13 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.759 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -89.87 138.63 27.72 Favored Pre-proline 0 C--N 1.309 -1.161 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -78.87 -90.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 122.032 1.821 . . . . 0.0 113.239 -179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -141.13 -42.04 0.22 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-O 121.088 0.47 . . . . 0.0 111.795 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 t -109.78 -37.0 5.77 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.85 149.55 26.49 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.9 t -92.16 124.89 44.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.024 -179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.8 p -109.33 146.3 14.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.656 HE22 ' HB ' ' A' ' 16' ' ' VAL . 0.3 OUTLIER -153.78 155.15 35.31 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 122.195 -0.316 . . . . 0.0 110.451 179.285 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.64 142.65 27.2 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.656 ' HB ' HE22 ' A' ' 14' ' ' GLN . 8.1 p -134.68 154.57 37.15 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 42.2 tt0 -144.99 107.72 4.46 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.485 0.659 . . . . 0.0 111.26 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.479 HG21 ' HB3' ' A' ' 29' ' ' LEU . 2.0 mp -97.26 126.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.478 0 CA-C-N 114.908 -1.042 . . . . 0.0 110.15 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 61.0 m170 -93.25 145.24 24.58 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.814 177.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.61 ' HB2' HD11 ' A' ' 27' ' ' LEU . 20.2 pttp -37.6 115.95 0.45 Allowed 'General case' 0 CA--C 1.555 1.14 0 C-N-CA 124.695 1.198 . . . . 0.0 113.805 176.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.4 tp -120.02 123.85 44.45 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.303 176.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 88.7 mtt180 -89.51 126.94 35.79 Favored 'General case' 0 C--N 1.288 -2.082 0 C-N-CA 120.088 -0.645 . . . . 0.0 110.193 176.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -120.67 106.32 11.61 Favored 'General case' 0 N--CA 1.418 -2.03 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 175.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.39 -100.52 1.07 Allowed Glycine 0 N--CA 1.436 -1.366 0 N-CA-C 111.234 -0.746 . . . . 0.0 111.234 -179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -125.56 14.89 8.19 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.269 0.557 . . . . 0.0 110.348 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.447 ' HA ' ' NH1' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -123.5 169.46 11.39 Favored 'General case' 0 CA--C 1.476 -1.879 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -176.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.61 HD11 ' HB2' ' A' ' 20' ' ' LYS . 14.3 tp -116.45 119.17 34.78 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 105.847 -1.909 . . . . 0.0 105.847 173.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -126.15 163.54 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.896 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.479 ' HB3' HG21 ' A' ' 18' ' ' ILE . 2.9 mm? -95.83 9.35 40.81 Favored 'General case' 0 C--N 1.273 -2.744 0 CA-C-O 123.446 1.593 . . . . 0.0 108.659 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.98 -48.69 3.69 Favored Glycine 0 C--N 1.293 -1.839 0 CA-C-N 112.998 -1.91 . . . . 0.0 114.603 172.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -86.35 170.65 11.84 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.098 0.475 . . . . 0.0 112.259 -175.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.456 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 48.8 m -132.85 163.49 28.97 Favored 'General case' 0 N--CA 1.435 -1.211 0 C-N-CA 123.66 0.784 . . . . 0.0 110.485 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 55' ' ' ILE . 6.1 pt -121.18 166.96 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 C-N-CA 122.777 0.431 . . . . 0.0 110.42 -174.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.33 -21.58 6.87 Favored Glycine 0 CA--C 1.486 -1.741 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.595 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.593 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 124.54 169.51 13.04 Favored Glycine 0 N--CA 1.416 -2.672 0 C-N-CA 120.063 -1.065 . . . . 0.0 111.909 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.53 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.4 -117.95 2.7 Favored Glycine 0 C--O 1.209 -1.435 0 O-C-N 124.158 0.563 . . . . 0.0 112.24 176.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.457 HD11 HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER -67.15 -19.86 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 CA-C-O 121.051 0.453 . . . . 0.0 111.757 -176.152 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.568 ' HB2' HG22 ' A' ' 89' ' ' THR . 35.8 t70 -76.17 -8.8 57.84 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.226 -177.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.62 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 26.4 mm-40 -107.11 165.8 11.09 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.459 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.5 t70 -107.83 119.99 48.53 Favored Pre-proline 0 C--N 1.315 -0.905 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.244 176.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD3' ' HE3' ' A' ' 53' ' ' LYS . 6.7 Cg_endo -56.07 -29.0 72.5 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 123.335 2.69 . . . . 0.0 113.379 -178.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 17.4 t -67.87 -26.45 66.03 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.968 -177.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.459 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -117.43 9.26 13.24 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.0 111.747 -176.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.487 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 5.9 m-80 -101.36 150.9 37.59 Favored Pre-proline 0 C--N 1.29 -2.019 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -178.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.464 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 56.4 Cg_endo -69.14 -49.88 0.6 Allowed 'Trans proline' 0 C--O 1.217 -0.549 0 C-N-CA 123.207 2.605 . . . . 0.0 113.49 -175.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -109.44 7.64 24.98 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.735 0.779 . . . . 0.0 110.333 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.487 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 9.2 t -106.43 -11.11 16.04 Favored 'General case' 0 N--CA 1.427 -1.622 0 CA-C-N 115.032 -0.986 . . . . 0.0 108.716 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 9.4 pt-20 -69.15 -9.7 54.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-O 122.284 1.04 . . . . 0.0 110.048 -179.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -50.76 -51.05 54.02 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 126.395 1.878 . . . . 0.0 111.468 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -152.25 -161.14 1.25 Allowed 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -177.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 32.3 p -102.14 6.25 40.74 Favored 'General case' 0 C--N 1.307 -1.267 0 C-N-CA 119.381 -0.928 . . . . 0.0 109.281 172.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -72.31 128.62 36.19 Favored 'General case' 0 C--O 1.243 0.762 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.928 178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.465 ' HE3' ' HD3' ' A' ' 41' ' ' PRO . 30.5 mmtm -97.14 172.16 8.0 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.442 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.51 154.54 6.21 Favored Glycine 0 C--O 1.174 -3.649 0 N-CA-C 108.751 -1.74 . . . . 0.0 108.751 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 33' ' ' ILE . 29.5 mm -73.49 120.15 21.87 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 CA-C-N 118.112 0.956 . . . . 0.0 109.776 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.441 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.8 p90 -117.42 151.25 37.44 Favored 'General case' 0 C--N 1.288 -2.074 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.53 178.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.783 HG21 HD11 ' A' ' 71' ' ' LEU . 93.7 t -82.12 130.3 36.02 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.931 0 O-C-N 124.02 0.825 . . . . 0.0 109.853 178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.9 p -103.13 -27.19 12.7 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.256 0.55 . . . . 0.0 110.58 -178.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.456 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 85.4 mtt180 -144.12 138.44 28.21 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.082 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.422 HG13 ' CB ' ' A' ' 66' ' ' ALA . 4.9 t -116.28 144.71 23.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.008 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.482 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.8 t -45.52 113.69 0.63 Allowed 'General case' 0 N--CA 1.444 -0.769 0 O-C-N 124.927 1.392 . . . . 0.0 109.102 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -57.46 -17.69 14.59 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 125.513 1.525 . . . . 0.0 114.421 -175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -171.3 46.52 0.19 Allowed Glycine 0 CA--C 1.469 -2.806 0 N-CA-C 107.531 -2.227 . . . . 0.0 107.531 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.48 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -131.65 -165.71 11.46 Favored Glycine 0 N--CA 1.413 -2.899 0 CA-C-N 114.172 -1.014 . . . . 0.0 112.721 -174.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.454 ' CG ' HG23 ' A' ' 18' ' ' ILE . 41.9 Cg_endo -65.2 -29.6 55.47 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 C-N-CA 123.706 2.937 . . . . 0.0 112.4 -170.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.422 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -60.73 -59.14 5.86 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.433 -179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.0 pt-20 -67.8 -32.62 73.32 Favored 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 119.584 -0.846 . . . . 0.0 111.649 178.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 64' ' ' GLY . 23.1 mm -58.55 -47.26 88.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.093 0.473 . . . . 0.0 111.015 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.41 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -72.96 -40.89 64.97 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.494 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.1 20.62 0.82 Allowed Glycine 0 C--O 1.237 0.312 0 C-N-CA 120.012 -1.09 . . . . 0.0 113.153 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.783 HD11 HG21 ' A' ' 57' ' ' VAL . 1.9 tp -79.58 125.81 30.08 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.439 ' N ' HD12 ' A' ' 71' ' ' LEU . 21.3 mm-40 -114.27 150.88 33.73 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 121.839 0.828 . . . . 0.0 109.733 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 59.4 mt -68.63 132.68 32.73 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.533 0 CA-C-N 115.025 -0.989 . . . . 0.0 108.9 175.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 95.51 8.31 58.57 Favored Glycine 0 C--O 1.248 0.984 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.429 -178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.502 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 15.4 m-20 -84.74 126.22 33.22 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 178.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 mttp -86.88 117.35 25.55 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.517 HD11 HG23 ' A' ' 57' ' ' VAL . 10.7 mt -83.15 141.48 14.84 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.651 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -175.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.3 mmt -119.96 -20.6 7.44 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 121.438 0.637 . . . . 0.0 109.351 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.538 HE22 ' H ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -143.59 138.61 29.18 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -176.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.528 HG13 HD12 ' A' ' 107' ' ' LEU . 34.4 t -142.37 119.68 7.14 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.41 0 C-N-CA 124.045 0.938 . . . . 0.0 108.752 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.3 t-20 43.86 57.22 4.21 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.736 1.614 . . . . 0.0 112.127 171.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.538 ' H ' HE22 ' A' ' 79' ' ' GLN . . . 47.44 30.15 5.88 Favored Glycine 0 CA--C 1.541 1.664 0 N-CA-C 117.07 1.588 . . . . 0.0 117.07 -176.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.448 ' HE1' ' HG3' ' A' ' 85' ' ' MET . 0.1 OUTLIER -109.72 -12.47 14.62 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 -175.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.2 t70 64.95 93.55 0.06 Allowed 'General case' 0 CA--C 1.498 -1.046 0 C-N-CA 127.258 2.223 . . . . 0.0 107.973 -176.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.615 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 4.3 ttp -89.02 -12.51 41.17 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 -170.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 11.1 t -53.93 127.84 27.84 Favored 'General case' 0 C--O 1.256 1.397 0 CA-C-O 120.93 0.395 . . . . 0.0 110.357 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 45.3 ttm 63.4 90.27 0.08 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.446 -176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.478 HG11 ' HG2' ' A' ' 85' ' ' MET . 14.8 p -158.49 155.64 4.41 Favored 'Isoleucine or valine' 0 C--O 1.263 1.774 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.568 HG22 ' HB2' ' A' ' 38' ' ' ASP . 9.4 p -75.09 159.72 31.34 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-O 120.98 0.419 . . . . 0.0 110.167 176.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.62 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 14.1 t60 -55.33 -46.9 76.35 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.634 174.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -57.8 -50.56 72.87 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.191 -0.913 . . . . 0.0 111.987 -177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.97 -31.4 67.94 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.957 -176.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.69 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -73.81 -42.54 60.8 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.844 177.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.498 ' CZ ' HG21 ' A' ' 98' ' ' THR . 12.9 mmm180 -50.19 -44.17 52.85 Favored 'General case' 0 CA--C 1.508 -0.664 0 C-N-CA 123.92 0.888 . . . . 0.0 111.031 179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -84.26 29.25 0.58 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.056 -176.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.506 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 5.3 tpt180 -142.91 -42.61 0.31 Allowed 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.84 173.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.69 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -95.27 -17.52 21.61 Favored 'General case' 0 C--O 1.21 -1.001 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -178.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.498 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 11.9 t -124.75 13.78 8.62 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.692 174.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.506 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.6 ptpt -70.17 178.29 2.87 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.315 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.447 ' NH1' ' HA ' ' A' ' 26' ' ' ASN . 13.9 ptm180 -131.65 6.08 4.36 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.556 -176.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.446 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 20.2 m -74.93 -41.77 59.0 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.37 0.605 . . . . 0.0 109.497 178.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.31 139.73 32.83 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.411 179.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -87.96 -63.81 1.24 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 42.0 t -98.8 122.38 50.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-O 120.81 0.338 . . . . 0.0 110.141 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.499 HG23 HD21 ' A' ' 107' ' ' LEU . 33.4 m -113.96 145.11 20.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 177.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 64.3 mtt85 -125.64 115.98 20.98 Favored 'General case' 0 C--N 1.284 -2.254 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.528 HD12 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -117.61 153.15 33.77 Favored 'General case' 0 N--CA 1.397 -3.123 0 N-CA-C 107.999 -1.112 . . . . 0.0 107.999 -172.216 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.3 mp -118.0 121.18 39.96 Favored 'General case' 0 C--N 1.276 -2.598 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 174.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -116.8 154.08 18.45 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.413 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.941 -176.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 36.7 p -124.8 130.83 53.15 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-N 114.758 -1.11 . . . . 0.0 108.778 176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.43 ' HB3' ' OD1' ' A' ' 75' ' ' ASP 0.314 0.0 OUTLIER -100.52 98.94 9.48 Favored 'General case' 0 N--CA 1.41 -2.439 0 C-N-CA 119.041 -1.063 . . . . 0.0 112.013 179.917 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 19.6 mm-40 -84.54 -49.85 8.24 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 113.541 -1.663 . . . . 0.0 109.425 -175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.6 m -86.21 15.69 5.0 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.54 -172.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 32.6 tp -109.45 87.99 2.63 Favored 'General case' 0 C--N 1.288 -2.102 0 N-CA-C 108.428 -0.952 . . . . 0.0 108.428 -178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 -96.87 -39.41 9.42 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.968 -178.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 mtpp 53.96 78.67 0.15 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 125.014 1.326 . . . . 0.0 113.057 -177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.37 -60.01 2.08 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 25.3 t 49.82 68.34 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.631 0 C-N-CA 124.521 1.128 . . . . 0.0 111.299 178.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -103.92 -14.5 15.96 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.611 178.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 53.0 tp60 -131.2 91.92 3.11 Favored 'General case' 0 N--CA 1.423 -1.784 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 173.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.6 t -85.13 -36.96 20.77 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.076 -176.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 23.7 ptp -172.73 169.39 4.95 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.241 0.543 . . . . 0.0 110.839 -179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 57.3 tp -114.56 163.41 15.43 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.421 -1.876 0 CA-C-O 119.169 -0.443 . . . . 0.0 110.047 177.597 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.287 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.9 p -77.73 -60.58 2.31 Favored 'General case' 0 N--CA 1.432 -1.339 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -81.21 160.79 24.21 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-N 114.315 -1.311 . . . . 0.0 108.152 174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 65.4 mt -102.12 107.77 54.12 Favored Pre-proline 0 C--N 1.294 -1.832 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.457 ' HB2' HG11 ' A' ' 13' ' ' VAL . 56.3 Cg_endo -76.03 176.77 9.6 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.446 2.097 . . . . 0.0 112.967 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -86.27 43.55 3.25 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 -74.4 130.5 82.0 Favored Pre-proline 0 C--N 1.311 -1.067 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 177.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' O ' HG13 ' A' ' 9' ' ' VAL . 18.8 Cg_endo -63.72 -68.74 0.04 OUTLIER 'Trans proline' 0 C--O 1.21 -0.891 0 C-N-CA 122.083 1.855 . . . . 0.0 111.281 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.559 HG13 ' O ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 169.24 -49.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 127.964 2.505 . . . . 0.0 108.887 178.085 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.7 t -79.96 -23.91 41.34 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 114.795 -1.093 . . . . 0.0 111.37 -173.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -120.78 164.7 16.2 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.214 -176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.7 p -104.13 158.43 5.28 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -177.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG11 ' HB2' ' A' ' 5' ' ' PRO . 12.5 p -112.28 147.21 16.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 178.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.421 HE21 HG22 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -141.59 152.08 43.72 Favored 'General case' 0 C--O 1.249 1.078 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 179.253 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -94.43 149.26 21.42 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 120.887 0.375 . . . . 0.0 110.789 -177.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 71' ' ' LEU . 9.8 p -136.66 159.16 37.65 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -144.49 106.47 4.32 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-O 121.43 0.633 . . . . 0.0 111.326 -177.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -93.95 128.61 45.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.736 178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 54.6 m170 -96.65 151.98 19.09 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 174.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.559 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 11.0 ptpp? -43.34 128.38 4.8 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.556 HD22 ' HD2' ' A' ' 65' ' ' PRO . 51.2 tp -122.48 123.85 42.23 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.189 175.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.6 mpt_? -88.5 116.38 26.7 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 176.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -113.3 103.33 11.21 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 175.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.19 -102.47 0.94 Allowed Glycine 0 N--CA 1.434 -1.478 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -120.86 6.19 10.43 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.268 0.556 . . . . 0.0 111.317 177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -105.85 163.11 12.98 Favored 'General case' 0 CA--C 1.476 -1.888 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.534 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -117.89 108.92 15.9 Favored 'General case' 0 C--N 1.263 -3.175 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.48 163.55 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.731 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 -175.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.416 ' CB ' HG21 ' A' ' 18' ' ' ILE . 10.9 mp -92.62 9.96 32.51 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.95 0.881 . . . . 0.0 110.984 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.23 -41.69 3.07 Favored Glycine 0 N--CA 1.422 -2.272 0 CA-C-N 115.68 -0.691 . . . . 0.0 114.341 176.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.421 ' CD1' HD23 ' A' ' 71' ' ' LEU . 49.3 p90 -99.0 172.54 7.33 Favored 'General case' 0 C--N 1.289 -2.038 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 53.7 m -136.26 170.44 16.02 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 124.306 1.042 . . . . 0.0 109.364 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 55' ' ' ILE . 7.0 pt -127.93 167.22 23.37 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.712 0 CA-C-N 117.868 0.304 . . . . 0.0 111.169 -173.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.39 -27.68 4.64 Favored Glycine 0 CA--C 1.485 -1.803 0 N-CA-C 110.575 -1.01 . . . . 0.0 110.575 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.521 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.18 165.25 12.29 Favored Glycine 0 N--CA 1.412 -2.955 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.344 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.548 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -117.85 -110.17 2.5 Favored Glycine 0 N--CA 1.428 -1.865 0 O-C-N 124.203 0.59 . . . . 0.0 113.13 178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.607 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.76 -26.19 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -173.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' HB2' HG22 ' A' ' 89' ' ' THR . 15.2 t70 -66.32 -19.82 65.92 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.685 178.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.63 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 27.5 mm-40 -96.38 -177.76 4.07 Favored 'General case' 0 C--O 1.242 0.683 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -175.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 3.9 t70 -132.39 120.49 16.95 Favored Pre-proline 0 CA--C 1.498 -1.029 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -55.12 -23.25 35.17 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 123.197 2.598 . . . . 0.0 113.771 -175.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.8 m -69.9 -28.87 65.97 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.836 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -116.03 7.48 14.32 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.552 0.691 . . . . 0.0 110.725 -175.534 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.515 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 7.4 m120 -98.89 146.5 31.76 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 113.497 0.925 . . . . 0.0 113.497 -176.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.43 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 72.0 Cg_endo -72.32 -44.69 0.75 Allowed 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.948 3.098 . . . . 0.0 114.458 -175.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -109.1 12.09 25.31 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-O 121.674 0.75 . . . . 0.0 110.427 -176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.515 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.5 t -119.81 3.81 11.05 Favored 'General case' 0 N--CA 1.432 -1.364 0 CA-C-N 114.862 -1.063 . . . . 0.0 108.49 179.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 8.8 pt-20 -77.22 -28.31 53.71 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.616 0.722 . . . . 0.0 110.469 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -75.54 -46.25 33.19 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.179 -178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -132.5 135.12 45.8 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.8 p -80.29 6.3 12.36 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.297 0.57 . . . . 0.0 112.22 -173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -72.47 108.59 5.63 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.997 -1.002 . . . . 0.0 109.771 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.607 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 67.1 mttt -74.63 172.02 12.82 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-O 121.799 0.809 . . . . 0.0 113.144 -175.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 140.91 159.88 8.09 Favored Glycine 0 C--O 1.192 -2.528 0 N-CA-C 108.216 -1.954 . . . . 0.0 108.216 -178.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 33' ' ' ILE . 29.0 mm -74.56 120.19 23.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.278 0 CA-C-N 117.868 0.834 . . . . 0.0 110.296 -179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -120.6 157.77 28.8 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.927 177.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.712 HG21 HD11 ' A' ' 71' ' ' LEU . 98.5 t -84.23 132.57 31.25 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.367 0 O-C-N 124.713 1.258 . . . . 0.0 110.71 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 23.1 p -108.26 -19.66 13.4 Favored 'General case' 0 C--N 1.305 -1.366 0 CA-C-O 121.462 0.649 . . . . 0.0 111.362 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 -142.09 142.17 32.79 Favored 'General case' 0 C--O 1.197 -1.689 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.465 HG13 ' CB ' ' A' ' 66' ' ' ALA . 25.5 t -140.4 132.08 31.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.568 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.8 m -49.82 126.97 15.14 Favored 'General case' 0 N--CA 1.413 -2.301 0 O-C-N 124.372 1.045 . . . . 0.0 112.521 178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -66.69 -16.17 64.03 Favored 'General case' 0 C--O 1.212 -0.903 0 C-N-CA 124.06 0.944 . . . . 0.0 111.802 -178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.96 46.7 0.39 Allowed Glycine 0 N--CA 1.423 -2.207 0 N-CA-C 109.256 -1.537 . . . . 0.0 109.256 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -125.16 -174.87 14.06 Favored Glycine 0 N--CA 1.421 -2.352 0 CA-C-N 114.701 -0.749 . . . . 0.0 111.499 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.556 ' HD2' HD22 ' A' ' 21' ' ' LEU . 35.0 Cg_endo -62.54 -29.1 78.01 Favored 'Trans proline' 0 CA--C 1.51 -0.702 0 C-N-CA 124.106 3.204 . . . . 0.0 111.965 -171.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.465 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -59.7 -61.96 2.23 Favored 'General case' 0 N--CA 1.42 -1.941 0 CA-C-N 114.646 -1.161 . . . . 0.0 110.752 -179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 61' ' ' SER . 2.4 pt-20 -70.09 -31.2 68.65 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.043 -0.663 . . . . 0.0 111.763 178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.9 mm -59.44 -41.39 84.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.543 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.776 178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.33 -44.25 30.19 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.588 176.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 134.78 27.35 0.49 Allowed Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.245 178.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.712 HD11 HG21 ' A' ' 57' ' ' VAL . 5.1 tp -89.45 123.69 33.8 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 176.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.463 ' N ' HD12 ' A' ' 71' ' ' LEU . 28.0 mm-40 -110.2 162.92 14.12 Favored 'General case' 0 N--CA 1.427 -1.613 0 CA-C-O 122.301 1.048 . . . . 0.0 110.62 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.6 mt -72.63 134.61 29.48 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.572 0 CA-C-N 114.628 -1.169 . . . . 0.0 109.88 175.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 80.21 18.72 71.11 Favored Glycine 0 C--O 1.223 -0.578 0 CA-C-N 116.198 -0.455 . . . . 0.0 112.051 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.511 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 3.6 m-20 -77.01 -2.08 32.09 Favored 'General case' 0 C--O 1.205 -1.282 0 N-CA-C 115.582 1.697 . . . . 0.0 115.582 -174.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt 43.07 95.51 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.469 HD11 HG23 ' A' ' 57' ' ' VAL . 9.9 mt -84.51 124.93 40.23 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.519 -174.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.833 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 18.2 mmt -112.18 -10.63 13.84 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.257 0.551 . . . . 0.0 110.527 -176.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.644 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 7.8 tp60 -156.47 127.33 6.83 Favored 'General case' 0 C--O 1.195 -1.764 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.731 -176.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.554 HG13 HD12 ' A' ' 107' ' ' LEU . 22.3 t -132.79 121.59 44.9 Favored 'Isoleucine or valine' 0 C--O 1.206 -1.213 0 C-N-CA 124.175 0.99 . . . . 0.0 109.212 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 53.85 30.83 12.06 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 124.217 1.007 . . . . 0.0 112.845 168.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.44 6.11 86.32 Favored Glycine 0 CA--C 1.545 1.965 0 CA-C-N 115.835 -0.62 . . . . 0.0 114.49 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.509 ' CZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -99.1 -2.47 36.93 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -173.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.7 t70 68.69 127.04 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 124.386 1.074 . . . . 0.0 111.222 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.442 ' HE3' ' HB1' ' A' ' 93' ' ' ALA . 8.1 tpt -123.58 -4.38 8.24 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.641 0.734 . . . . 0.0 110.348 -175.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.833 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 5.0 t -68.36 -16.19 63.84 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.778 -177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.66 98.39 3.18 Favored 'General case' 0 C--N 1.311 -1.076 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 175.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.509 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 9.2 p -163.93 146.58 2.73 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 178.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.504 HG22 ' HB2' ' A' ' 38' ' ' ASP . 3.1 p -73.19 155.46 39.58 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.463 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.63 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 11.1 t60 -53.5 -45.4 69.66 Favored 'General case' 0 C--N 1.314 -0.977 0 O-C-N 123.975 0.797 . . . . 0.0 109.393 176.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -63.87 -42.47 97.51 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.386 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.87 -32.31 61.85 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.618 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.543 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.12 -43.56 74.17 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.102 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.44 ' HG2' HD11 ' A' ' 33' ' ' ILE . 9.6 mmm180 -55.75 -40.31 72.37 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.009 178.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -82.14 29.53 0.41 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.056 -0.974 . . . . 0.0 110.146 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.528 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.6 tpt180 -142.11 -43.45 0.34 Allowed 'General case' 0 N--CA 1.425 -1.692 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.989 177.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -101.31 -20.46 15.2 Favored 'General case' 0 C--O 1.204 -1.322 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.452 ' N ' HD12 ' A' ' 97' ' ' LEU . 10.3 t -115.55 11.74 15.96 Favored 'General case' 0 C--N 1.286 -2.189 0 C-N-CA 118.152 -1.419 . . . . 0.0 110.014 173.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -63.04 143.65 57.59 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 171.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 16.0 ptp180 -103.27 6.83 38.32 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.835 0.826 . . . . 0.0 110.453 -173.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.5 m -84.4 -36.55 22.35 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.795 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -92.94 165.71 12.74 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 -178.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 8.8 pt-20 -118.53 -63.57 1.39 Allowed 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.517 HG12 ' HG3' ' A' ' 103' ' ' GLU . 2.7 p -121.49 131.06 73.97 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.741 0 CA-C-O 121.687 0.756 . . . . 0.0 112.679 -176.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.427 HG23 HD21 ' A' ' 107' ' ' LEU . 14.9 m -134.49 171.87 17.1 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.645 -175.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.445 ' C ' HD13 ' A' ' 107' ' ' LEU . 8.8 mmt180 -123.33 114.43 20.18 Favored 'General case' 0 CA--C 1.478 -1.805 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.554 HD12 HG13 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -116.97 148.24 41.59 Favored 'General case' 0 N--CA 1.4 -2.928 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 -176.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.644 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.2 mp -116.02 121.91 43.65 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-O 121.349 0.595 . . . . 0.0 109.5 176.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 27.6 m -117.49 150.2 19.62 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.556 0 CA-C-N 114.233 -1.349 . . . . 0.0 110.293 -177.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 33.6 p -107.84 124.66 50.42 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 121.625 0.726 . . . . 0.0 110.342 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.9 mmt85 -74.29 84.62 1.91 Allowed 'General case' 0 C--N 1.293 -1.868 0 CA-C-O 122.151 0.977 . . . . 0.0 113.407 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -81.84 -36.42 28.31 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . 0.286 31.3 p 58.54 69.48 0.73 Allowed 'General case' 0 N--CA 1.437 -1.121 0 CA-C-N 113.344 -1.753 . . . . 0.0 112.859 -177.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -71.28 -38.71 71.81 Favored 'General case' 0 CA--C 1.499 -1.002 0 CA-C-N 115.021 -0.991 . . . . 0.0 108.441 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -106.82 127.26 53.25 Favored 'General case' 0 N--CA 1.425 -1.69 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 172.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -93.45 83.64 4.58 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-O 122.207 1.003 . . . . 0.0 110.625 -178.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -96.22 147.91 23.27 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.374 -1.284 . . . . 0.0 110.475 -177.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 13.0 t -103.54 45.47 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 123.302 1.525 . . . . 0.0 108.29 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -87.87 -31.97 19.23 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 113.604 -1.634 . . . . 0.0 106.83 174.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 48.9 tp60 -107.24 134.78 49.83 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 113.77 -1.559 . . . . 0.0 107.27 175.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 t -73.52 117.07 14.85 Favored 'General case' 0 N--CA 1.417 -2.101 0 N-CA-C 106.732 -1.581 . . . . 0.0 106.732 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.1 mtt -66.86 -19.85 65.81 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.61 -173.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 tt -89.33 -71.17 0.62 Allowed 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 75.6 m . . . . . 0 C--N 1.314 -0.964 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 179.098 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.587 0 N-CA-C 110.713 -0.955 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -79.88 -62.45 1.68 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.7 t80 -164.84 126.82 2.17 Favored 'General case' 0 N--CA 1.425 -1.701 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -113.6 109.45 50.74 Favored Pre-proline 0 C--N 1.295 -1.767 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.56 157.37 52.75 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.464 2.109 . . . . 0.0 112.436 -177.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -77.73 43.09 2.1 Favored Glycine 0 C--N 1.302 -1.308 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.235 177.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.408 ' HA ' HG23 ' A' ' 13' ' ' VAL . 7.7 tt0 -77.0 121.37 84.63 Favored Pre-proline 0 N--CA 1.431 -1.377 0 N-CA-C 109.33 -0.618 . . . . 0.0 109.33 178.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -74.66 -98.49 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.387 0 C-N-CA 122.332 2.022 . . . . 0.0 110.503 178.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.6 m -149.18 -43.73 0.08 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.537 0 C-N-CA 123.058 0.543 . . . . 0.0 111.35 175.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.6 t -81.91 -23.51 36.19 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.044 0.449 . . . . 0.0 111.319 -175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -118.26 143.62 46.43 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 52.8 t -104.7 106.46 20.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 O-C-N 123.411 0.444 . . . . 0.0 110.661 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.609 HG22 HG22 ' A' ' 110' ' ' THR . 41.6 t -91.5 120.49 40.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.5 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.3 OUTLIER -138.01 156.73 47.53 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 123.458 0.474 . . . . 0.0 110.046 -174.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 6.0 ppt_? -103.32 144.71 30.99 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.494 ' HB ' HE22 ' A' ' 14' ' ' GLN . 10.0 p -126.78 156.15 37.77 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.139 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.95 104.07 5.35 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 121.667 0.746 . . . . 0.0 111.271 -178.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.504 HD13 HD23 ' A' ' 107' ' ' LEU . 1.5 mp -92.31 129.02 43.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.053 -179.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -93.15 159.97 15.05 Favored 'General case' 0 C--N 1.309 -1.18 0 O-C-N 123.741 0.651 . . . . 0.0 109.359 176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.421 ' HB2' HD21 ' A' ' 27' ' ' LEU . 17.3 pttp -50.72 124.79 11.69 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.513 HD22 ' HD2' ' A' ' 65' ' ' PRO . 48.1 tp -128.67 131.72 48.03 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 123.382 0.673 . . . . 0.0 110.27 176.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -92.46 130.02 38.24 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.437 HE21 ' HB ' ' A' ' 28' ' ' ILE . 30.3 mt-30 -131.2 106.02 8.05 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 73.95 -109.17 2.71 Favored Glycine 0 N--CA 1.428 -1.868 0 O-C-N 124.051 0.844 . . . . 0.0 111.099 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -116.54 17.74 15.27 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.282 0.563 . . . . 0.0 109.826 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.99 172.59 11.22 Favored 'General case' 0 CA--C 1.494 -1.192 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HB3' ' HB2' ' A' ' 100' ' ' ARG . 2.1 tm? -120.0 115.34 23.56 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 102.946 -2.983 . . . . 0.0 102.946 175.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.437 ' HB ' HE21 ' A' ' 23' ' ' GLN . 1.3 mt -129.49 163.77 33.84 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -175.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.451 HD21 HG21 ' A' ' 105' ' ' VAL . 7.5 mp -82.28 2.76 30.48 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.991 0.901 . . . . 0.0 109.892 177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 89.56 -44.89 3.06 Favored Glycine 0 N--CA 1.435 -1.396 0 CA-C-N 115.061 -0.972 . . . . 0.0 113.816 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 57' ' ' VAL . 45.6 p90 -89.17 164.69 14.89 Favored 'General case' 0 CA--C 1.556 1.179 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 85.0 p -114.74 -173.2 2.26 Favored 'General case' 0 C--O 1.224 -0.246 0 C-N-CA 124.048 0.939 . . . . 0.0 109.616 178.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 55' ' ' ILE . 7.3 pt -138.16 164.78 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 C-N-CA 120.775 -0.37 . . . . 0.0 110.275 178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.14 -33.79 2.68 Favored Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 121.32 151.62 8.59 Favored Glycine 0 C--O 1.2 -2.022 0 C-N-CA 118.581 -1.771 . . . . 0.0 113.798 179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA2' ' H ' ' A' ' 54' ' ' GLY . . . -105.66 -115.64 4.09 Favored Glycine 0 C--O 1.205 -1.682 0 C-N-CA 121.071 -0.585 . . . . 0.0 114.16 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.524 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -71.09 -9.84 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 CA-C-O 122.039 0.923 . . . . 0.0 112.203 -175.097 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.612 ' HB2' HG22 ' A' ' 89' ' ' THR . 24.0 t70 -81.67 -13.36 57.99 Favored 'General case' 0 C--N 1.285 -2.214 0 CA-C-N 114.271 -1.331 . . . . 0.0 108.579 178.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.652 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 17.6 mm-40 -113.8 -178.12 3.3 Favored 'General case' 0 C--O 1.252 1.197 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.51 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 13.3 t70 -122.16 124.63 26.85 Favored Pre-proline 0 C--N 1.304 -1.372 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.437 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.6 Cg_endo -56.44 -28.48 73.44 Favored 'Trans proline' 0 C--O 1.221 -0.355 0 C-N-CA 123.305 2.67 . . . . 0.0 113.537 -176.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.7 t -76.32 -19.86 57.84 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.192 0.52 . . . . 0.0 110.383 -174.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.51 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -120.89 12.64 11.3 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.844 0.83 . . . . 0.0 110.104 -179.591 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.484 HD21 ' HB3' ' A' ' 39' ' ' GLN . 0.8 OUTLIER -103.0 144.03 27.79 Favored Pre-proline 0 C--N 1.306 -1.295 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.048 179.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -67.54 -49.41 1.21 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.936 2.424 . . . . 0.0 113.526 -173.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' HB2' ' CD1' ' A' ' 56' ' ' TYR . 63.8 m-85 -111.89 16.32 20.42 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.411 1.101 . . . . 0.0 109.982 -175.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 8.0 t -111.21 -12.41 14.12 Favored 'General case' 0 N--CA 1.424 -1.757 0 CA-C-N 115.318 -0.855 . . . . 0.0 108.74 176.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.6 -9.38 58.92 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.575 -0.739 . . . . 0.0 111.727 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -53.38 -42.9 67.37 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 121.478 0.656 . . . . 0.0 109.806 178.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -137.24 -120.93 0.14 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 174.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.5 t -145.66 24.99 1.35 Allowed 'General case' 0 N--CA 1.411 -2.415 0 N-CA-C 104.727 -2.323 . . . . 0.0 104.727 172.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 36.8 p-10 -81.3 100.53 9.24 Favored 'General case' 0 N--CA 1.425 -1.693 0 CA-C-N 113.006 -1.906 . . . . 0.0 108.815 -179.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.524 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 47.2 mttp -83.06 173.07 12.07 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 114.343 -1.298 . . . . 0.0 110.065 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.479 ' H ' ' HA2' ' A' ' 36' ' ' GLY . . . 141.94 166.51 10.92 Favored Glycine 0 CA--C 1.475 -2.417 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.609 HD12 HD12 ' A' ' 33' ' ' ILE . 32.7 mm -81.08 132.53 31.34 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.412 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.424 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 18.3 p90 -141.76 161.3 38.28 Favored 'General case' 0 C--N 1.29 -1.996 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.683 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.485 HG11 HG12 ' A' ' 60' ' ' VAL . 59.6 t -84.92 130.6 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.355 0 O-C-N 124.717 1.26 . . . . 0.0 110.447 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.7 p -102.24 -23.08 14.05 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.878 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 27.1 mmt180 -149.28 129.6 13.77 Favored 'General case' 0 C--O 1.206 -1.204 0 C-N-CA 123.97 0.908 . . . . 0.0 109.202 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.485 HG12 HG11 ' A' ' 57' ' ' VAL . 30.0 m -104.37 177.29 0.89 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.033 0 CA-C-N 119.217 0.917 . . . . 0.0 109.3 174.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.539 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.2 t -79.7 116.21 19.75 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 177.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.73 -2.21 2.36 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 125.382 1.473 . . . . 0.0 114.336 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -170.5 33.76 0.16 Allowed Glycine 0 C--N 1.273 -2.921 0 N-CA-C 108.453 -1.859 . . . . 0.0 108.453 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.469 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -121.51 -168.49 13.44 Favored Glycine 0 N--CA 1.421 -2.35 0 C-N-CA 120.356 -0.926 . . . . 0.0 112.43 -174.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.513 ' HD2' HD22 ' A' ' 21' ' ' LEU . 42.0 Cg_endo -64.96 -28.8 57.83 Favored 'Trans proline' 0 CA--C 1.507 -0.84 0 C-N-CA 123.323 2.682 . . . . 0.0 111.661 -170.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -58.67 -64.27 0.99 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.124 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.3 pt-20 -71.48 -29.95 65.42 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 118.767 -1.173 . . . . 0.0 111.54 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 14.7 mm -56.2 -47.31 81.0 Favored 'Isoleucine or valine' 0 C--N 1.349 0.549 0 O-C-N 123.287 0.367 . . . . 0.0 110.73 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -74.44 -47.55 32.94 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.28 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.31 14.94 0.44 Allowed Glycine 0 C--N 1.312 -0.772 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.63 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.425 HD11 HG21 ' A' ' 57' ' ' VAL . 2.1 tp -79.63 118.52 21.54 Favored 'General case' 0 N--CA 1.433 -1.283 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.6 mm-40 -119.35 140.09 50.91 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 -174.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.59 139.97 10.8 Favored 'Isoleucine or valine' 0 C--O 1.259 1.556 0 O-C-N 124.64 1.213 . . . . 0.0 110.303 179.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.48 34.67 19.14 Favored Glycine 0 CA--C 1.49 -1.505 0 C-N-CA 119.601 -1.285 . . . . 0.0 111.436 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.566 ' OD2' HG13 ' A' ' 77' ' ' ILE . 10.0 p-10 -94.47 -161.4 0.85 Allowed 'General case' 0 C--N 1.268 -2.952 0 CA-C-N 113.54 -1.33 . . . . 0.0 107.875 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 109' ' ' VAL . 73.8 mmtt -150.36 96.42 2.4 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.566 HG13 ' OD2' ' A' ' 75' ' ' ASP . 22.8 mt -73.12 113.31 10.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 122.282 1.039 . . . . 0.0 110.459 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 15.8 mmt -105.06 -10.21 17.33 Favored 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 114.53 -1.214 . . . . 0.0 110.182 -176.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 1.1 tm0? -163.14 134.13 4.76 Favored 'General case' 0 C--O 1.196 -1.753 0 O-C-N 121.861 -0.525 . . . . 0.0 110.023 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.556 HG13 HD12 ' A' ' 107' ' ' LEU . 22.8 t -134.31 115.4 20.4 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 48.07 55.79 8.21 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 124.509 1.124 . . . . 0.0 112.395 176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 62.0 2.35 3.72 Favored Glycine 0 CA--C 1.541 1.689 0 CA-C-N 113.662 -1.608 . . . . 0.0 116.582 178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -87.33 -14.17 41.54 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 7.3 t0 65.15 120.26 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 126.06 1.744 . . . . 0.0 111.602 -176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.479 ' HG3' ' CG1' ' A' ' 88' ' ' VAL . 41.7 ttm -119.36 8.54 11.42 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-O 122.209 1.004 . . . . 0.0 110.926 -174.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.437 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 10.5 t -46.12 -28.43 1.21 Allowed 'General case' 0 CA--C 1.573 1.855 0 C-N-CA 125.793 1.637 . . . . 0.0 114.743 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 59.6 ttp -159.86 92.39 1.02 Allowed 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.479 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.1 p -148.5 151.1 13.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.612 HG22 ' HB2' ' A' ' 38' ' ' ASP . 18.4 p -70.28 157.06 38.39 Favored 'General case' 0 N--CA 1.416 -2.157 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.308 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.652 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.4 t60 -57.59 -43.56 84.72 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 176.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -58.9 -47.3 85.49 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 114.559 -1.201 . . . . 0.0 110.954 -177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.1 -36.8 64.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.631 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.419 ' HB2' HG13 ' A' ' 55' ' ' ILE . . . -65.14 -40.67 94.74 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.711 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.424 ' HA ' ' CD1' ' A' ' 97' ' ' LEU . 7.9 mmm180 -53.45 -39.77 64.7 Favored 'General case' 0 C--O 1.221 -0.447 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.597 179.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.8 mmmp? -81.19 13.93 2.61 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.383 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 22.9 tpt180 -131.37 -35.8 1.31 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-N 116.683 -0.235 . . . . 0.0 110.865 -177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -98.86 -27.78 13.76 Favored 'General case' 0 C--O 1.213 -0.853 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.619 179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.402 ' N ' HD13 ' A' ' 97' ' ' LEU . 9.0 t -113.53 13.05 18.73 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 118.229 -1.388 . . . . 0.0 110.048 -178.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.623 ' HD2' ' HG2' ' A' ' 102' ' ' GLU . 14.4 ptpt -67.64 157.36 34.68 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 165.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 13.6 ptt180 -112.91 8.92 18.77 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 120.257 -0.577 . . . . 0.0 111.418 -173.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 69.4 m -81.18 -31.28 34.08 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.623 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 18.6 mm-40 -87.15 146.12 26.16 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.491 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -94.18 -75.41 0.51 Allowed 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.566 175.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.491 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 2.0 p -109.73 133.86 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.718 0 CA-C-O 121.141 0.496 . . . . 0.0 110.012 176.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.451 HG21 HD21 ' A' ' 29' ' ' LEU . 16.7 m -132.3 162.99 38.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.511 -173.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.438 ' C ' HD13 ' A' ' 107' ' ' LEU . 97.7 mtt180 -123.91 117.57 25.12 Favored 'General case' 0 CA--C 1.48 -1.724 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.556 HD12 HG13 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -119.61 152.34 37.21 Favored 'General case' 0 N--CA 1.397 -3.122 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 -175.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.9 mp -116.92 131.07 57.05 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.528 ' HB ' ' HB2' ' A' ' 75' ' ' ASP . 20.8 m -131.91 153.96 39.45 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 O-C-N 123.976 0.797 . . . . 0.0 109.889 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.609 HG22 HG22 ' A' ' 13' ' ' VAL . 36.9 p -110.1 145.34 37.31 Favored 'General case' 0 N--CA 1.419 -1.984 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 173.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.0 mmm180 -97.85 110.06 22.7 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -105.48 15.03 27.77 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 3.1 p -77.28 13.08 1.25 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.295 -1.775 . . . . 0.0 113.007 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 41.1 tp 68.5 141.22 0.04 OUTLIER 'General case' 0 C--O 1.241 0.615 0 C-N-CA 125.564 1.546 . . . . 0.0 112.616 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 84.7 mt-30 -81.14 132.7 35.37 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -83.71 145.51 28.71 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 113.986 1.106 . . . . 0.0 113.986 -167.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 66.82 -75.7 0.06 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 126.159 1.784 . . . . 0.0 112.919 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 42.3 t 54.91 71.12 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 122.479 1.133 . . . . 0.0 110.812 -176.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -117.19 5.45 12.71 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.246 -1.343 . . . . 0.0 107.845 175.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -77.53 3.13 14.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 113.441 -1.709 . . . . 0.0 110.115 178.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -72.74 -19.19 61.43 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.313 177.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 95.0 mmm -92.71 92.46 7.98 Favored 'General case' 0 C--O 1.249 1.051 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.709 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 94.1 mt -113.53 -23.47 9.78 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.955 178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.1 m . . . . . 0 N--CA 1.434 -1.248 0 CA-C-O 118.667 -0.682 . . . . 0.0 109.237 178.327 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.626 0 N-CA-C 110.591 -1.003 . . . . 0.0 110.591 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.7 m 74.47 -31.53 0.22 Allowed 'General case' 0 CA--C 1.549 0.922 0 N-CA-C 114.8 1.407 . . . . 0.0 114.8 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -79.04 -56.51 4.32 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 63.8 mt 61.31 92.8 0.06 OUTLIER Pre-proline 0 C--O 1.246 0.908 0 C-N-CA 124.307 1.043 . . . . 0.0 111.007 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.16 153.64 36.54 Favored 'Trans proline' 0 N--CA 1.44 -1.626 0 C-N-CA 121.901 1.734 . . . . 0.0 112.156 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.88 42.7 1.98 Allowed Glycine 0 C--N 1.292 -1.866 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -93.58 138.95 22.71 Favored Pre-proline 0 C--N 1.312 -1.042 0 C-N-CA 123.538 0.735 . . . . 0.0 110.478 -173.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -84.03 -107.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.837 0 C-N-CA 122.03 1.82 . . . . 0.0 108.93 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.92 -48.94 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 6.0 t -76.79 -20.62 56.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.282 0.563 . . . . 0.0 110.998 -174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.454 ' HB2' HE21 ' A' ' 115' ' ' GLN . . . -126.92 145.18 50.77 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.091 -176.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 88.3 t -95.11 138.02 21.96 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.373 -0.831 . . . . 0.0 108.847 175.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.409 ' HA ' ' HA ' ' A' ' 110' ' ' THR . 7.6 p -114.05 142.42 26.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 174.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.624 HE22 ' HB ' ' A' ' 16' ' ' VAL . 0.5 OUTLIER -144.84 153.85 42.05 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -179.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 5.4 ppt_? -99.27 138.47 36.32 Favored 'General case' 0 N--CA 1.432 -1.334 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.624 ' HB ' HE22 ' A' ' 14' ' ' GLN . 7.4 p -122.6 157.13 27.68 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -139.6 106.27 5.36 Favored 'General case' 0 N--CA 1.428 -1.536 0 CA-C-O 121.478 0.656 . . . . 0.0 110.959 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.662 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -93.59 127.44 45.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.868 0 CA-C-N 115.003 -0.999 . . . . 0.0 108.914 179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.454 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 43.9 m170 -95.92 160.09 14.64 Favored 'General case' 0 C--N 1.311 -1.101 0 O-C-N 124.159 0.912 . . . . 0.0 109.311 177.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 17.6 ptpt -43.13 110.15 0.18 Allowed 'General case' 0 N--CA 1.482 1.141 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 33.2 tp -107.96 115.4 30.06 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 173.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.73 103.0 12.55 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.61 -174.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -104.24 108.57 20.01 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 179.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.35 -106.34 1.31 Allowed Glycine 0 C--N 1.311 -0.825 0 O-C-N 123.635 0.584 . . . . 0.0 112.846 177.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.09 6.63 20.98 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 120.771 0.319 . . . . 0.0 111.47 -179.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -116.69 170.82 8.3 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.544 0.688 . . . . 0.0 109.294 -174.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -124.44 121.73 35.69 Favored 'General case' 0 C--N 1.279 -2.48 0 N-CA-C 103.65 -2.722 . . . . 0.0 103.65 172.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.515 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -129.5 155.81 41.52 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.998 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 -178.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 97' ' ' LEU . 40.6 mt -86.25 5.0 36.4 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 121.777 0.798 . . . . 0.0 109.331 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . 90.36 -46.97 3.04 Favored Glycine 0 N--CA 1.419 -2.486 0 CA-C-N 115.844 -0.616 . . . . 0.0 114.388 176.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.463 ' CD1' HG22 ' A' ' 57' ' ' VAL . 46.1 p90 -86.93 161.6 18.16 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -175.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 43.6 m -115.62 165.9 12.52 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 125.116 1.366 . . . . 0.0 108.705 178.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.684 HG21 HD21 ' A' ' 97' ' ' LEU . 8.9 pt -126.18 165.35 24.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 117.678 0.217 . . . . 0.0 110.491 -175.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.11 -32.61 3.45 Favored Glycine 0 CA--C 1.484 -1.893 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 123.44 154.02 8.87 Favored Glycine 0 N--CA 1.422 -2.268 0 C-N-CA 119.21 -1.471 . . . . 0.0 113.325 178.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.58 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -100.32 -122.83 4.97 Favored Glycine 0 N--CA 1.418 -2.506 0 O-C-N 124.298 0.646 . . . . 0.0 113.478 -179.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.93 -22.93 31.31 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 113.094 0.776 . . . . 0.0 113.094 -174.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.521 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 16.8 t70 -66.99 -19.4 65.71 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.818 0.818 . . . . 0.0 110.424 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.658 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 15.5 mm-40 -96.26 -169.55 1.94 Allowed 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.068 -175.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.426 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 8.9 t70 -136.17 125.5 15.85 Favored Pre-proline 0 CA--C 1.493 -1.216 0 CA-C-O 118.855 -0.593 . . . . 0.0 109.809 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.5 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 20.9 Cg_endo -58.9 -24.5 72.92 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.739 2.293 . . . . 0.0 113.683 -175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 28.1 t -73.25 -32.46 64.72 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.216 0.531 . . . . 0.0 109.829 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.426 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -111.93 16.33 20.38 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.01 0.434 . . . . 0.0 111.246 -179.204 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.581 HD21 ' HB3' ' A' ' 39' ' ' GLN . 3.6 m120 -102.4 140.12 20.84 Favored Pre-proline 0 CA--C 1.485 -1.538 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.412 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -68.03 -46.15 2.52 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 122.434 2.09 . . . . 0.0 113.38 -175.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -120.61 31.52 6.41 Favored 'General case' 0 C--N 1.312 -1.04 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -175.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.595 ' HA ' ' NZ ' ' A' ' 76' ' ' LYS . 0.9 OUTLIER -128.92 6.94 5.53 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 118.833 -1.147 . . . . 0.0 111.011 177.007 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -87.56 2.45 50.76 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.539 -175.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -54.73 -46.42 74.25 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 125.328 1.451 . . . . 0.0 108.858 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.403 ' HB2' ' H ' ' A' ' 52' ' ' ASP . 34.1 mmtp -144.22 -159.34 0.98 Allowed 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 105.354 -2.091 . . . . 0.0 105.354 -176.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 25.1 p -93.2 7.42 44.37 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 170.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 50' ' ' LYS . 30.2 t70 -82.67 112.7 19.78 Favored 'General case' 0 C--O 1.254 1.329 0 CA-C-N 113.772 -1.558 . . . . 0.0 111.72 -173.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.5 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 55.8 mtmt -95.63 173.45 7.48 Favored 'General case' 0 N--CA 1.431 -1.422 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.544 177.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.406 ' C ' ' HA2' ' A' ' 36' ' ' GLY . . . 153.65 156.54 7.67 Favored Glycine 0 C--O 1.183 -3.067 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -176.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.612 HD12 HD12 ' A' ' 33' ' ' ILE . 31.4 mm -71.91 129.06 35.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 118.215 1.008 . . . . 0.0 109.966 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -136.43 160.59 38.29 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.57 HG21 HD11 ' A' ' 71' ' ' LEU . 87.1 t -86.01 132.48 31.97 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 O-C-N 125.205 1.566 . . . . 0.0 109.872 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 p -104.54 -27.14 12.06 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 121.798 0.808 . . . . 0.0 111.026 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 90.2 mtt180 -144.42 133.28 22.52 Favored 'General case' 0 CA--C 1.474 -1.947 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.544 HG12 HG11 ' A' ' 57' ' ' VAL . 33.8 m -97.72 -175.5 0.37 Allowed 'Isoleucine or valine' 1 N--CA 1.347 -5.602 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 173.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.465 ' OG ' ' HA3' ' A' ' 30' ' ' GLY . 0.9 OUTLIER -68.09 126.37 29.29 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -48.34 -25.14 1.45 Allowed 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.838 1.255 . . . . 0.0 112.981 177.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -176.71 57.96 0.1 Allowed Glycine 0 N--CA 1.417 -2.609 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.501 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -139.83 -168.69 11.4 Favored Glycine 0 N--CA 1.417 -2.621 0 C-N-CA 120.207 -0.997 . . . . 0.0 113.594 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.412 ' HB2' HG23 ' A' ' 18' ' ' ILE . 28.7 Cg_endo -59.95 -34.49 95.12 Favored 'Trans proline' 0 CA--C 1.514 -0.512 0 C-N-CA 124.35 3.367 . . . . 0.0 113.095 -170.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.452 ' HB3' ' H ' ' A' ' 61' ' ' SER . . . -57.53 -57.76 11.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.337 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -75.48 -21.51 58.0 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.205 -0.998 . . . . 0.0 112.933 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 64' ' ' GLY . 28.1 mm -67.56 -42.07 86.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.467 0.651 . . . . 0.0 109.651 175.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -80.46 -42.82 21.95 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.297 -178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.29 20.75 0.89 Allowed Glycine 0 C--N 1.305 -1.16 0 C-N-CA 119.357 -1.401 . . . . 0.0 113.398 177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.57 HD11 HG21 ' A' ' 57' ' ' VAL . 0.5 OUTLIER -75.94 117.21 17.42 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 175.092 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.573 ' O ' ' HB3' ' A' ' 75' ' ' ASP . 24.5 mm-40 -111.9 135.7 52.17 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.242 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.1 mt -53.69 143.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 124.199 1.0 . . . . 0.0 111.246 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.64 36.66 58.3 Favored Glycine 0 N--CA 1.48 1.576 0 CA-C-O 122.725 1.181 . . . . 0.0 111.485 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.668 ' HB2' ' HB ' ' A' ' 109' ' ' VAL . 22.2 p-10 -84.92 -52.44 6.0 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 126.183 1.793 . . . . 0.0 114.492 -176.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.595 ' NZ ' ' HA ' ' A' ' 47' ' ' SER . 55.7 mttm 70.46 100.77 0.06 Allowed 'General case' 0 C--O 1.249 1.043 0 C-N-CA 124.624 1.17 . . . . 0.0 108.01 -169.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.413 HD11 HG23 ' A' ' 57' ' ' VAL . 11.0 mt -83.87 130.47 35.82 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.144 0 CA-C-N 114.589 -1.187 . . . . 0.0 110.006 -175.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.4 mmt -109.97 -22.83 11.64 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.376 -176.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.613 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -143.25 134.19 25.5 Favored 'General case' 0 C--O 1.199 -1.58 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -175.702 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.594 HG22 HD22 ' A' ' 107' ' ' LEU . 40.2 t -140.19 115.11 7.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.275 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 176.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 48.14 50.15 16.54 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 125.668 1.587 . . . . 0.0 112.806 173.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.587 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 66.31 -11.84 0.5 Allowed Glycine 0 CA--C 1.565 3.17 0 N-CA-C 115.793 1.077 . . . . 0.0 115.793 -177.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.31 -21.67 58.27 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 118.235 1.018 . . . . 0.0 112.097 -174.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 31.0 t0 72.92 113.93 0.06 Allowed 'General case' 0 C--O 1.219 -0.504 0 C-N-CA 125.301 1.44 . . . . 0.0 109.137 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 10.1 tpt -94.2 -8.45 39.28 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.997 -167.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 12.4 t -49.89 125.56 12.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.763 176.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 20.9 ttt 53.89 80.87 0.1 Allowed 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 124.91 1.284 . . . . 0.0 113.373 175.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.404 HG13 HG13 ' A' ' 55' ' ' ILE . 8.4 p -145.15 147.9 18.33 Favored 'Isoleucine or valine' 0 C--O 1.258 1.512 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.4 HG22 ' HB2' ' A' ' 38' ' ' ASP . 5.7 p -69.33 156.83 38.14 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 122.987 0.515 . . . . 0.0 110.992 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.658 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.5 t60 -56.48 -41.44 76.59 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.58 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 23.2 t70 -60.16 -53.73 54.3 Favored 'General case' 0 C--N 1.314 -0.939 0 O-C-N 124.045 0.84 . . . . 0.0 111.183 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -68.25 -31.02 70.21 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.156 -176.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.687 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -67.64 -48.23 67.29 Favored 'General case' 0 N--CA 1.43 -1.471 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.462 176.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.519 ' CZ ' HG21 ' A' ' 98' ' ' THR . 20.3 mmm180 -56.62 -44.13 80.9 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.892 -0.595 . . . . 0.0 109.801 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 30.0 mmtp -80.83 28.4 0.35 Allowed 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.385 -177.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.584 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -144.61 -45.85 0.24 Allowed 'General case' 0 N--CA 1.426 -1.653 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.616 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 2.4 pp -92.43 -35.2 13.8 Favored 'General case' 0 C--O 1.201 -1.459 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.555 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.1 t -103.08 9.2 38.59 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.334 -1.346 . . . . 0.0 109.235 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.584 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.6 ptpt -62.91 148.86 46.09 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 172.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 37.2 ptt180 -96.0 15.09 21.55 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.832 0.825 . . . . 0.0 110.974 -172.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.493 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 67.7 m -93.66 -25.96 17.26 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.947 -176.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 27.4 mm-40 -77.12 -178.62 5.12 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.774 0.797 . . . . 0.0 113.086 -176.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.551 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 10.1 pt-20 -146.64 -73.27 0.22 Allowed 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 114.603 -1.18 . . . . 0.0 109.019 169.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.662 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.6 p -119.51 134.37 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.473 0 CA-C-O 121.315 0.579 . . . . 0.0 110.516 178.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' CG2' HD21 ' A' ' 107' ' ' LEU . 16.8 m -140.01 149.83 21.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.088 -173.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -104.39 127.29 52.04 Favored 'General case' 0 CA--C 1.486 -1.49 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 174.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 HG22 ' A' ' 80' ' ' VAL . 3.3 mt -122.46 147.51 46.25 Favored 'General case' 0 C--N 1.277 -2.545 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.613 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.9 mp -113.54 124.13 51.64 Favored 'General case' 0 CA--C 1.452 -2.801 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.042 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.668 ' HB ' ' HB2' ' A' ' 75' ' ' ASP . 35.8 m -124.79 153.3 31.65 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.821 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.543 -177.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 39.0 p -106.44 168.7 8.98 Favored 'General case' 0 C--N 1.276 -2.597 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.914 176.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 28.1 mmm180 -114.03 102.41 10.15 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 171.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.423 ' HG3' ' HE2' ' A' ' 76' ' ' LYS . 22.5 mm-40 -84.06 -55.69 4.07 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.771 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 10.7 t 51.2 35.11 12.61 Favored 'General case' 0 CA--C 1.548 0.891 0 O-C-N 124.633 1.208 . . . . 0.0 109.788 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.1 mp 61.26 90.64 0.07 Allowed 'General case' 0 C--N 1.354 0.763 0 CA-C-O 122.031 0.92 . . . . 0.0 109.95 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.454 HE21 ' HB2' ' A' ' 11' ' ' ALA . 99.2 mt-30 -63.89 -22.11 66.77 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 -171.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.4 mptt 71.03 178.0 0.26 Allowed 'General case' 0 N--CA 1.483 1.197 0 O-C-N 123.802 0.689 . . . . 0.0 109.635 -168.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -71.48 141.97 50.19 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.047 0.451 . . . . 0.0 109.818 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.0 p -93.68 47.74 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 123.701 1.715 . . . . 0.0 108.636 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -107.51 140.81 39.92 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 113.095 -1.866 . . . . 0.0 107.933 -178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 56.24 33.52 22.33 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 124.819 1.248 . . . . 0.0 111.932 -176.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 44.5 p 52.47 83.63 0.06 Allowed 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 125.527 1.531 . . . . 0.0 112.915 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 82.7 mmm -88.95 92.66 9.31 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-O 121.583 0.706 . . . . 0.0 112.28 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -98.76 -72.34 0.66 Allowed 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 172.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 11.7 t . . . . . 0 N--CA 1.421 -1.888 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 176.169 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.733 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.5 p -127.26 164.44 21.71 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -89.75 163.46 15.07 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 tp -118.82 107.92 41.68 Favored Pre-proline 0 C--N 1.3 -1.572 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -69.38 171.59 13.78 Favored 'Trans proline' 0 C--O 1.241 0.63 0 C-N-CA 122.21 1.94 . . . . 0.0 111.543 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -88.77 42.1 3.05 Favored Glycine 0 C--N 1.308 -0.975 0 N-CA-C 111.026 -0.83 . . . . 0.0 111.026 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 49.2 tt0 -74.72 122.38 87.37 Favored Pre-proline 0 N--CA 1.436 -1.129 0 C-N-CA 123.254 0.621 . . . . 0.0 110.594 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 74.3 Cg_endo -78.2 -92.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.467 0 C-N-CA 122.341 2.027 . . . . 0.0 110.364 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.9 m -138.72 -55.55 0.37 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.639 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 172.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.6 t -81.65 -25.4 35.63 Favored 'General case' 0 C--O 1.25 1.08 0 CA-C-O 121.981 0.896 . . . . 0.0 110.567 -174.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.642 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -101.15 125.68 47.79 Favored 'General case' 0 CA--C 1.466 -2.279 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.64 -177.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 110' ' ' THR . 59.4 t -98.59 105.49 17.41 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 174.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 12.3 p -99.65 133.65 41.74 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.229 -177.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.444 HE21 HG22 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -147.5 154.08 40.31 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.872 -178.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -92.69 148.29 22.18 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.94 0.4 . . . . 0.0 109.961 -173.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.641 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -129.14 157.22 42.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.542 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 38.1 tt0 -150.31 106.38 3.45 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-O 121.579 0.704 . . . . 0.0 109.809 178.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.9 mp -94.69 130.14 43.92 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.3 -178.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.418 ' HD2' HG13 ' A' ' 104' ' ' VAL . 49.3 m170 -101.57 141.16 34.85 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.916 0.76 . . . . 0.0 109.111 176.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.576 ' HE2' ' HB2' ' A' ' 103' ' ' GLU . 18.0 ptpt -29.59 112.24 0.07 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 125.98 1.712 . . . . 0.0 115.401 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 38.0 tp -113.67 121.02 42.87 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.1 176.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 mpt_? -97.91 112.47 24.38 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -114.34 106.22 14.07 Favored 'General case' 0 N--CA 1.424 -1.751 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.14 -108.69 2.28 Favored Glycine 0 N--CA 1.444 -0.818 0 O-C-N 123.732 0.645 . . . . 0.0 112.425 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -113.74 16.67 18.48 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 120.979 0.419 . . . . 0.0 110.533 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -126.42 168.98 13.46 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -122.82 118.5 28.1 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 103.077 -2.934 . . . . 0.0 103.077 174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.7 OUTLIER -126.89 158.13 37.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.085 -176.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.454 ' CD2' HG21 ' A' ' 105' ' ' VAL . 9.2 mp -86.43 -1.53 57.65 Favored 'General case' 0 C--N 1.301 -1.543 0 CA-C-O 121.763 0.792 . . . . 0.0 109.744 174.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.57 -38.98 3.13 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-N 115.46 -0.791 . . . . 0.0 114.38 176.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 30.9 p90 -96.5 171.61 8.45 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 117.582 0.691 . . . . 0.0 112.19 -177.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.1 m -138.71 169.17 18.28 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 124.863 1.265 . . . . 0.0 110.404 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 55' ' ' ILE . 7.1 pt -126.82 169.45 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 122.129 -0.357 . . . . 0.0 110.762 -170.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.92 -24.76 5.65 Favored Glycine 0 CA--C 1.489 -1.539 0 N-CA-C 110.996 -0.842 . . . . 0.0 110.996 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.563 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 120.4 163.2 12.05 Favored Glycine 0 C--O 1.195 -2.331 0 C-N-CA 120.073 -1.061 . . . . 0.0 112.632 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.52 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -114.97 -115.03 3.02 Favored Glycine 0 N--CA 1.429 -1.828 0 C-N-CA 121.373 -0.441 . . . . 0.0 112.888 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.81 -24.23 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-O 121.251 0.548 . . . . 0.0 111.996 -176.224 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.537 ' HB2' HG22 ' A' ' 89' ' ' THR . 32.8 t70 -72.54 -17.75 61.69 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.89 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.585 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 28.3 mm-40 -104.18 166.75 10.21 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -177.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -106.43 121.23 45.97 Favored Pre-proline 0 CA--C 1.492 -1.256 0 C-N-CA 119.111 -1.036 . . . . 0.0 109.257 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.43 ' HD3' ' HE3' ' A' ' 53' ' ' LYS . 10.1 Cg_endo -57.2 -30.02 85.73 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 122.88 2.387 . . . . 0.0 113.298 -178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.9 m -65.75 -27.24 68.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.999 0.428 . . . . 0.0 111.639 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -116.42 11.91 15.06 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.391 0.615 . . . . 0.0 110.465 -175.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -103.97 146.04 31.78 Favored Pre-proline 0 C--N 1.299 -1.622 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -66.44 -44.13 6.96 Favored 'Trans proline' 0 N--CA 1.473 0.296 0 C-N-CA 123.68 2.92 . . . . 0.0 113.753 -171.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.46 14.45 21.45 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 121.215 0.531 . . . . 0.0 110.115 -175.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.4 t -122.24 -3.57 8.97 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.502 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -70.48 -2.72 14.8 Favored 'General case' 0 N--CA 1.474 0.736 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -174.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -71.17 -51.6 23.91 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.007 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 44.6 mttp -152.13 -168.08 2.96 Favored 'General case' 0 C--O 1.21 -0.979 0 C-N-CA 123.919 0.888 . . . . 0.0 109.518 -176.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.8 p -87.28 23.11 1.93 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-O 121.6 0.714 . . . . 0.0 110.613 -178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -76.98 105.74 8.24 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.031 -176.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.43 ' HE3' ' HD3' ' A' ' 41' ' ' PRO . 29.2 mmtm -91.4 166.04 13.09 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.283 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.468 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 145.01 159.63 8.17 Favored Glycine 0 CA--C 1.476 -2.371 0 N-CA-C 108.026 -2.029 . . . . 0.0 108.026 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.667 HD12 HD12 ' A' ' 33' ' ' ILE . 36.1 mm -77.92 122.16 32.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.511 0 CA-C-N 118.126 0.963 . . . . 0.0 109.502 178.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.4 p90 -122.31 151.9 40.66 Favored 'General case' 0 C--N 1.289 -2.025 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.363 177.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.491 HG13 ' HA ' ' A' ' 73' ' ' ILE . 8.7 p -80.82 132.35 31.83 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.714 0 O-C-N 124.769 1.293 . . . . 0.0 110.69 -178.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 18.3 p -106.75 -27.25 10.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.435 0.636 . . . . 0.0 110.686 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -138.13 131.46 30.5 Favored 'General case' 0 N--CA 1.432 -1.334 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.05 177.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 71' ' ' LEU . 64.8 t -118.9 140.6 42.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 174.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.71 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.5 t -63.66 116.91 6.13 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.477 ' HA ' ' OE1' ' A' ' 67' ' ' GLU . 13.3 pt-20 -77.27 2.99 14.0 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.837 0.827 . . . . 0.0 112.024 -177.081 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.63 29.94 0.94 Allowed Glycine 0 C--N 1.267 -3.265 0 N-CA-C 109.147 -1.581 . . . . 0.0 109.147 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.426 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -128.14 -177.88 15.08 Favored Glycine 0 N--CA 1.419 -2.476 0 C-N-CA 120.672 -0.775 . . . . 0.0 113.075 -176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -63.55 -29.01 70.3 Favored 'Trans proline' 0 CA--C 1.507 -0.853 0 C-N-CA 124.366 3.377 . . . . 0.0 112.791 -171.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -57.77 -59.19 5.6 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.914 -1.039 . . . . 0.0 111.477 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.71 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.6 pt-20 -74.06 -31.88 63.05 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.387 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 64' ' ' GLY . 26.3 mm -55.11 -41.37 59.4 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 O-C-N 123.737 0.648 . . . . 0.0 110.471 177.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.45 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -76.05 -55.92 5.15 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.319 177.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 153.54 28.69 0.04 OUTLIER Glycine 0 C--N 1.317 -0.501 0 C-N-CA 119.768 -1.206 . . . . 0.0 113.239 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.641 ' HB2' HG11 ' A' ' 16' ' ' VAL . 2.5 tp -94.55 117.56 30.32 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -115.39 143.81 44.73 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.491 ' HA ' HG13 ' A' ' 57' ' ' VAL . 65.6 mt -54.89 129.67 16.34 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.004 178.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.02 -3.95 45.03 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.706 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.456 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 84.0 m-20 -80.94 130.23 34.92 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.909 0.355 . . . . 0.0 110.571 -179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -84.46 116.11 22.92 Favored 'General case' 0 C--O 1.246 0.909 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 175.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.523 HG13 HG12 ' A' ' 109' ' ' VAL . 3.0 mp -86.27 124.34 40.25 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -177.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.592 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 30.5 mmt -102.27 -19.88 14.86 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.313 0.577 . . . . 0.0 111.116 -178.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.59 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 50.2 tp60 -148.47 134.84 19.52 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.91 -171.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.638 HG22 HD22 ' A' ' 107' ' ' LEU . 54.8 t -142.62 108.84 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.503 0 C-N-CA 123.0 0.52 . . . . 0.0 111.974 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.493 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.4 t-20 55.18 39.43 31.42 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.297 1.439 . . . . 0.0 112.715 172.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 86.32 4.79 83.34 Favored Glycine 0 C--N 1.294 -1.771 0 CA-C-N 115.603 -0.726 . . . . 0.0 114.23 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.496 ' NE1' ' HG2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -116.7 148.32 41.17 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 176.629 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -82.94 122.76 28.69 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 120.682 0.277 . . . . 0.0 110.99 -176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.404 ' HG2' ' HB ' ' A' ' 55' ' ' ILE . 40.2 ttm -108.98 -0.92 19.34 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 122.044 0.926 . . . . 0.0 110.515 177.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.592 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 3.8 t -58.79 -34.63 71.69 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 115.35 -0.841 . . . . 0.0 112.657 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 28.1 ttt -140.72 95.36 2.85 Favored 'General case' 0 C--N 1.31 -1.134 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.444 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 9.7 p -160.1 151.15 5.77 Favored 'Isoleucine or valine' 0 C--O 1.255 1.373 0 CA-C-N 115.503 -0.772 . . . . 0.0 109.449 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 38' ' ' ASP . 10.4 p -71.41 158.33 36.5 Favored 'General case' 0 N--CA 1.42 -1.963 0 C-N-CA 123.119 0.568 . . . . 0.0 111.165 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.658 ' HE2' ' HE ' ' A' ' 94' ' ' ARG . 22.2 t60 -56.11 -43.6 78.3 Favored 'General case' 0 C--O 1.2 -1.535 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.124 175.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -61.15 -49.54 76.8 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 123.96 0.788 . . . . 0.0 111.399 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -31.77 68.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.576 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.44 ' O ' HD12 ' A' ' 97' ' ' LEU . . . -75.21 -40.62 59.04 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.984 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.658 ' HE ' ' HE2' ' A' ' 90' ' ' HIS . 15.9 mmt180 -53.04 -47.34 68.47 Favored 'General case' 0 CA--C 1.502 -0.901 0 O-C-N 123.681 0.613 . . . . 0.0 111.023 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.4 ' O ' ' HE2' ' A' ' 99' ' ' LYS . 63.1 tttm -86.24 39.14 0.8 Allowed 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.666 1.222 . . . . 0.0 108.921 -176.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.51 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 30.7 tpt180 -145.76 -45.99 0.21 Allowed 'General case' 0 N--CA 1.415 -2.195 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.147 177.047 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.508 ' CD1' ' HA ' ' A' ' 94' ' ' ARG . 0.0 OUTLIER -92.45 -26.95 17.75 Favored 'General case' 0 C--O 1.208 -1.104 0 C-N-CA 118.923 -1.111 . . . . 0.0 112.326 179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.0 t -117.43 14.79 14.7 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.49 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.521 ' HD2' ' HG2' ' A' ' 102' ' ' GLU . 13.6 ptpt -74.08 171.06 14.22 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 171.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -113.8 -0.36 14.23 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-O 121.034 0.445 . . . . 0.0 111.897 -175.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.491 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 69.8 m -76.72 -28.46 55.82 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.521 ' HG2' ' HD2' ' A' ' 99' ' ' LYS . 33.9 mm-40 -81.84 179.19 7.92 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.117 0.484 . . . . 0.0 110.696 -178.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.576 ' HB2' ' HE2' ' A' ' 20' ' ' LYS . 7.6 pt-20 -146.42 -70.14 0.25 Allowed 'General case' 0 N--CA 1.435 -1.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.618 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 44.0 t -105.99 126.63 61.45 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.416 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 17' ' ' GLU . 30.6 m -128.49 134.68 64.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.957 0 O-C-N 123.626 0.579 . . . . 0.0 111.014 -177.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -103.56 116.52 32.52 Favored 'General case' 0 CA--C 1.485 -1.548 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.638 HD22 HG22 ' A' ' 80' ' ' VAL . 5.9 mt -114.39 161.43 17.95 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.338 -0.846 . . . . 0.0 108.717 -174.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 0.9 OUTLIER -134.77 121.61 20.95 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 173.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.523 HG12 HG13 ' A' ' 77' ' ' ILE . 32.7 m -113.39 156.27 14.4 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.662 -178.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 12' ' ' VAL . 9.5 p -131.1 133.03 45.25 Favored 'General case' 1 N--CA 1.371 -4.414 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 178.405 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -78.24 -62.38 1.7 Allowed 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.908 -0.717 . . . . 0.0 110.014 -176.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 60.93 68.53 0.74 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.26 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 12.3 t -151.71 28.38 0.62 Allowed 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 113.781 -1.554 . . . . 0.0 107.628 -177.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 25.4 tp -100.02 6.57 45.06 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 -179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -56.79 133.56 54.36 Favored 'General case' 0 C--O 1.244 0.806 0 CA-C-N 114.16 -1.382 . . . . 0.0 111.56 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -85.31 133.79 34.14 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.54 -0.755 . . . . 0.0 109.023 178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -88.14 134.63 33.72 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 176.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 17.2 m -131.84 47.41 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 CA-C-O 122.57 1.176 . . . . 0.0 110.491 -174.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -139.47 120.7 14.82 Favored 'General case' 0 C--N 1.29 -2.003 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.876 178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -88.33 -6.62 57.63 Favored 'General case' 0 C--N 1.308 -1.228 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 47.0 m 70.83 82.92 0.15 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 125.496 1.518 . . . . 0.0 111.708 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER 168.74 -65.54 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.002 1.721 . . . . 0.0 107.698 176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 50.2 tp 57.96 -83.95 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 125.326 1.45 . . . . 0.0 113.047 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 65.1 m . . . . . 0 N--CA 1.43 -1.438 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 -177.213 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.452 0 N-CA-C 111.077 -0.809 . . . . 0.0 111.077 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.1 m -79.76 -27.83 40.44 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 122.147 0.975 . . . . 0.0 110.542 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -109.21 -158.29 0.64 Allowed 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.407 -177.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 48.9 mm -65.53 -61.16 6.24 Favored Pre-proline 0 CA--C 1.562 1.431 0 CA-C-N 118.498 0.59 . . . . 0.0 111.216 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.431 ' HB3' ' CG1' ' A' ' 13' ' ' VAL . 6.2 Cg_endo -61.63 175.3 1.74 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 N-CA-C 116.02 1.508 . . . . 0.0 116.02 172.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -127.97 14.9 6.26 Favored Glycine 0 C--N 1.304 -1.199 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 175.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -123.3 137.95 29.21 Favored Pre-proline 0 C--N 1.309 -1.184 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -82.58 -104.7 0.0 OUTLIER 'Trans proline' 0 CA--C 1.555 1.571 0 C-N-CA 122.528 2.152 . . . . 0.0 116.558 -169.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.2 m -134.16 -34.13 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -174.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.3 t -74.0 -18.17 60.89 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 122.831 1.3 . . . . 0.0 108.442 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.415 ' HB1' ' NE2' ' A' ' 112' ' ' GLN . . . -146.48 139.19 25.31 Favored 'General case' 0 N--CA 1.388 -3.569 0 N-CA-C 103.118 -2.919 . . . . 0.0 103.118 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.2 p -137.33 145.87 28.82 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.252 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 5' ' ' PRO . 14.0 p -93.33 126.31 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.159 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 174.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.568 HE22 ' HB ' ' A' ' 16' ' ' VAL . 0.2 OUTLIER -130.52 154.41 47.83 Favored 'General case' 0 C--N 1.271 -2.81 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.98 -174.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.428 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 3.1 ppt_? -97.06 145.57 25.84 Favored 'General case' 0 N--CA 1.424 -1.756 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.568 ' HB ' HE22 ' A' ' 14' ' ' GLN . 7.9 p -133.97 149.03 30.13 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.787 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -132.94 103.06 5.87 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-O 121.548 0.689 . . . . 0.0 111.291 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -91.72 126.79 44.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.933 0 CA-C-N 114.781 -1.099 . . . . 0.0 109.482 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.422 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 56.0 m170 -96.26 150.51 20.47 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 176.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.566 ' HB2' HD21 ' A' ' 27' ' ' LEU . 21.5 pttm -43.37 121.72 2.33 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.475 HD22 ' HD2' ' A' ' 65' ' ' PRO . 52.6 tp -122.59 123.91 42.28 Favored 'General case' 0 N--CA 1.44 -0.925 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.566 176.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -84.9 126.84 33.83 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 175.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.432 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 21.8 mt-30 -128.4 111.4 13.28 Favored 'General case' 0 CA--C 1.487 -1.474 0 N-CA-C 106.392 -1.707 . . . . 0.0 106.392 175.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.55 -105.81 1.69 Allowed Glycine 0 C--N 1.299 -1.483 0 N-CA-C 109.316 -1.514 . . . . 0.0 109.316 -176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -122.73 15.24 10.17 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 120.831 0.348 . . . . 0.0 110.39 174.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -111.81 171.16 7.66 Favored 'General case' 0 CA--C 1.471 -2.084 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.566 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.9 tm? -122.84 109.42 14.16 Favored 'General case' 0 C--N 1.267 -3.013 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -122.05 164.35 19.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.438 HD21 HG21 ' A' ' 105' ' ' VAL . 9.2 mp -88.08 3.69 48.1 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 122.056 0.931 . . . . 0.0 109.62 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 87.64 -42.2 3.11 Favored Glycine 0 N--CA 1.424 -2.142 0 CA-C-N 115.094 -0.957 . . . . 0.0 114.676 175.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -90.4 166.48 13.26 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -175.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 20.3 m -120.5 167.82 11.98 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 125.404 1.481 . . . . 0.0 108.894 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 55' ' ' ILE . 11.4 pt -127.4 167.13 22.85 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.574 0 CA-C-O 120.664 0.269 . . . . 0.0 110.988 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.95 -27.1 5.0 Favored Glycine 0 N--CA 1.432 -1.581 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.495 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.99 157.97 10.17 Favored Glycine 0 C--O 1.196 -2.274 0 C-N-CA 119.904 -1.141 . . . . 0.0 113.856 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.61 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -106.02 -115.9 4.1 Favored Glycine 0 N--CA 1.433 -1.564 0 O-C-N 124.577 0.81 . . . . 0.0 113.486 179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.618 ' HA ' ' CD ' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.74 -26.06 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -173.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -66.73 -18.39 65.35 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.752 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.549 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 24.4 mm-40 -98.58 164.83 12.09 Favored 'General case' 0 C--O 1.25 1.124 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.806 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.406 ' HA ' ' HD2' ' A' ' 41' ' ' PRO . 5.3 t70 -119.8 118.91 31.6 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 40' ' ' ASP . 10.2 Cg_endo -54.0 -26.04 39.02 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 123.732 2.955 . . . . 0.0 113.731 -179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 38.0 t -66.32 -26.79 67.47 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.464 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.448 HE21 ' HB3' ' A' ' 43' ' ' GLN . 0.1 OUTLIER -121.05 4.37 10.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.26 0.553 . . . . 0.0 111.431 -175.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.571 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 5.9 m120 -90.62 149.57 40.9 Favored Pre-proline 0 C--N 1.3 -1.582 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.1 -50.52 0.42 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 123.439 2.759 . . . . 0.0 113.131 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -107.12 -3.48 19.88 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-O 121.692 0.758 . . . . 0.0 111.52 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.571 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 6.1 t -97.36 1.0 48.85 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.208 -0.906 . . . . 0.0 108.758 -178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -78.17 -23.72 47.54 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 176.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -80.19 -58.08 3.31 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.015 -178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HE3' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -110.39 125.32 53.09 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 174.811 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.5 p -89.7 6.78 39.94 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-O 121.628 0.728 . . . . 0.0 112.249 -173.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -84.58 119.89 25.72 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 174.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.618 ' CD ' ' HA ' ' A' ' 37' ' ' ILE . 56.4 mttm -70.98 168.01 17.93 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.362 0.601 . . . . 0.0 111.138 -174.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 150.4 156.17 7.19 Favored Glycine 0 C--O 1.191 -2.548 0 N-CA-C 107.863 -2.095 . . . . 0.0 107.863 -176.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.711 HD12 HD12 ' A' ' 33' ' ' ILE . 18.5 mm -74.41 129.21 36.72 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 118.207 1.003 . . . . 0.0 110.332 -178.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -130.71 154.06 48.35 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.197 178.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.688 HG21 HD11 ' A' ' 71' ' ' LEU . 90.8 t -77.22 135.54 26.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.943 0 O-C-N 124.591 1.182 . . . . 0.0 110.369 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.3 p -111.02 -19.93 12.59 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.368 0.604 . . . . 0.0 111.22 178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 20.4 mtm180 -152.73 138.19 17.65 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.43 HG11 ' O ' ' A' ' 71' ' ' LEU . 15.5 m -106.22 -173.3 0.42 Allowed 'Isoleucine or valine' 1 N--CA 1.358 -5.046 0 CA-C-N 119.252 0.933 . . . . 0.0 108.632 172.161 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.616 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.8 t -87.74 118.0 26.95 Favored 'General case' 0 N--CA 1.407 -2.616 0 N-CA-C 105.13 -2.174 . . . . 0.0 105.13 174.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -61.26 -14.59 27.39 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -172.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.69 33.41 0.63 Allowed Glycine 0 C--N 1.286 -2.219 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 176.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.477 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -118.92 -169.76 14.51 Favored Glycine 0 N--CA 1.426 -2.016 0 C-N-CA 120.943 -0.646 . . . . 0.0 113.521 -174.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.475 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.9 Cg_endo -63.93 -29.6 67.13 Favored 'Trans proline' 0 CA--C 1.508 -0.823 0 C-N-CA 123.761 2.974 . . . . 0.0 112.373 -170.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.03 -64.87 0.73 Allowed 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.331 -0.849 . . . . 0.0 110.611 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.616 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.2 pt-20 -72.19 -31.89 66.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.506 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.0 mm -57.08 -39.86 69.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 O-C-N 123.335 0.397 . . . . 0.0 110.997 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.69 -47.91 16.02 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.851 179.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.59 17.75 0.2 Allowed Glycine 0 C--N 1.311 -0.838 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.402 -179.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.688 HD11 HG21 ' A' ' 57' ' ' VAL . 5.5 tp -89.46 124.05 34.13 Favored 'General case' 0 CA--C 1.492 -1.279 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -115.37 157.99 23.09 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 122.197 0.998 . . . . 0.0 111.175 -178.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 48.5 mt -61.84 128.3 23.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.914 172.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 98.97 4.8 56.63 Favored Glycine 0 N--CA 1.435 -1.372 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.303 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -82.55 121.82 27.29 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.204 0.526 . . . . 0.0 111.661 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -83.56 99.98 10.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 CA-C-N 114.308 -1.315 . . . . 0.0 108.876 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.494 HD11 HG23 ' A' ' 57' ' ' VAL . 9.5 mt -79.28 128.24 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.346 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.715 -174.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.555 ' HE2' ' HA ' ' A' ' 78' ' ' MET . 1.1 mmt -112.17 -18.91 12.45 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -176.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.54 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -148.47 137.97 22.05 Favored 'General case' 0 N--CA 1.427 -1.623 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -174.867 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.627 HG22 HD22 ' A' ' 107' ' ' LEU . 37.8 t -139.73 120.88 15.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 177.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 50.44 40.13 22.37 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 125.24 1.416 . . . . 0.0 112.471 175.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.54 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 62.98 16.21 57.03 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 114.226 -1.352 . . . . 0.0 114.783 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . 0.307 0.0 OUTLIER -91.17 -82.89 0.28 Allowed 'General case' 0 CA--C 1.571 1.77 0 CA-C-O 118.742 -0.646 . . . . 0.0 112.255 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.4 t70 168.41 127.93 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.507 ' HG3' ' HB ' ' A' ' 55' ' ' ILE . 47.3 tpp -128.3 1.0 5.73 Favored 'General case' 0 C--N 1.286 -2.184 0 CA-C-O 122.709 1.242 . . . . 0.0 109.907 177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.2 t -80.73 -29.5 36.34 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.337 -1.301 . . . . 0.0 111.629 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 58.6 ttp -133.01 75.25 1.61 Allowed 'General case' 0 C--N 1.314 -0.961 0 O-C-N 121.78 -0.575 . . . . 0.0 110.409 179.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 9.1 p -151.52 150.51 13.13 Favored 'Isoleucine or valine' 0 C--O 1.259 1.574 0 CA-C-O 121.252 0.549 . . . . 0.0 110.232 -176.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.512 HG23 HD11 ' A' ' 37' ' ' ILE . 1.9 p -73.29 157.85 36.25 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.999 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.549 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.3 t60 -56.74 -43.11 80.38 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.655 174.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -58.88 -50.72 72.94 Favored 'General case' 0 C--N 1.313 -0.994 0 C-N-CA 124.357 1.063 . . . . 0.0 111.996 -177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -69.85 -39.4 76.43 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.958 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.67 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -63.05 -43.23 99.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.071 178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.437 ' CZ ' HG21 ' A' ' 98' ' ' THR . 15.6 mmm180 -55.53 -38.7 69.59 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-O 121.238 0.542 . . . . 0.0 110.469 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptp -86.98 24.44 1.52 Allowed 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.515 0.674 . . . . 0.0 109.215 -176.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.554 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 19.1 mmt180 -137.23 -48.03 0.59 Allowed 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 123.751 0.82 . . . . 0.0 110.984 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.6 pp -96.76 -20.49 18.18 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.502 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.1 t -117.94 12.7 13.81 Favored 'General case' 0 C--N 1.288 -2.091 0 C-N-CA 117.854 -1.538 . . . . 0.0 110.586 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.8 ptpt -68.49 -173.63 0.45 Allowed 'General case' 0 CA--C 1.55 0.943 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -133.4 6.55 3.83 Favored 'General case' 0 C--N 1.312 -1.058 0 C-N-CA 120.23 -0.588 . . . . 0.0 111.587 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.414 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 10.4 m -80.24 -40.48 26.93 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.131 -176.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -88.06 152.28 22.14 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.563 ' HG3' HG12 ' A' ' 104' ' ' VAL . 9.7 pt-20 -104.06 -63.42 1.2 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 120.932 0.396 . . . . 0.0 110.678 177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.563 HG12 ' HG3' ' A' ' 103' ' ' GLU . 2.0 p -118.81 132.5 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.282 0 CA-C-O 121.323 0.582 . . . . 0.0 110.929 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.438 HG21 HD21 ' A' ' 29' ' ' LEU . 19.6 m -135.51 155.17 36.34 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.507 -174.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.516 ' N ' ' HD2' ' A' ' 106' ' ' ARG . 3.3 mpt_? -107.2 126.29 52.21 Favored 'General case' 0 CA--C 1.491 -1.327 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 175.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.627 HD22 HG22 ' A' ' 80' ' ' VAL . 5.2 mt -119.91 146.84 45.41 Favored 'General case' 0 N--CA 1.415 -2.181 0 N-CA-C 106.403 -1.702 . . . . 0.0 106.403 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.0 mp -115.17 122.56 46.44 Favored 'General case' 0 C--N 1.265 -3.09 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.52 HG22 ' NE2' ' A' ' 14' ' ' GLN . 11.1 m -123.25 152.44 28.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.661 -177.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 25.1 p -106.9 129.05 54.79 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.423 ' HB3' ' O ' ' A' ' 114' ' ' LEU . 95.4 mtt180 -87.88 93.54 9.5 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 121.424 0.63 . . . . 0.0 109.74 -177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.415 ' NE2' ' HB1' ' A' ' 11' ' ' ALA . 25.2 mm-40 -100.41 -33.4 10.38 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.75 -176.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 44.8 t -101.69 2.14 38.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.013 0.911 . . . . 0.0 111.005 -173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.423 ' O ' ' HB3' ' A' ' 111' ' ' ARG . 42.5 tp -147.35 106.02 3.82 Favored 'General case' 0 C--N 1.274 -2.681 0 CA-C-N 114.812 -1.085 . . . . 0.0 109.087 177.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -88.89 -78.24 0.35 Allowed 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 114.824 -1.08 . . . . 0.0 110.552 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp 49.89 39.94 19.61 Favored 'General case' 0 C--O 1.26 1.632 0 C-N-CA 123.75 0.82 . . . . 0.0 108.987 -175.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -59.66 140.66 56.24 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 113.765 -1.561 . . . . 0.0 112.342 -173.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . 0.255 9.8 p 46.43 38.55 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.111 1.764 . . . . 0.0 112.302 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 8.9 tt0 -138.8 -62.92 0.54 Allowed 'General case' 0 C--N 1.297 -1.681 0 CA-C-N 113.554 -1.657 . . . . 0.0 109.792 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -75.62 -19.86 58.92 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 121.896 0.855 . . . . 0.0 109.963 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 28.8 t -156.46 134.4 11.13 Favored 'General case' 0 N--CA 1.41 -2.432 0 N-CA-C 105.194 -2.151 . . . . 0.0 105.194 175.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.36 170.08 8.36 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.37 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 47.5 tp -87.25 86.13 7.24 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m . . . . . 0 C--N 1.303 -1.415 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -179.51 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.887 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -86.96 0.36 55.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.114 0.483 . . . . 0.0 110.39 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.424 ' OH ' ' HA ' ' A' ' 14' ' ' GLN . 24.5 p90 -146.35 178.26 8.39 Favored 'General case' 0 N--CA 1.411 -2.383 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.4 mp -115.04 98.02 49.32 Favored Pre-proline 0 C--N 1.301 -1.535 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -75.02 169.61 22.24 Favored 'Trans proline' 0 C--O 1.243 0.759 0 C-N-CA 122.093 1.862 . . . . 0.0 112.433 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.56 59.48 0.61 Allowed Glycine 0 C--N 1.3 -1.427 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.548 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 27.3 tt0 -79.95 132.11 61.43 Favored Pre-proline 0 C--N 1.318 -0.802 0 C-N-CA 123.073 0.549 . . . . 0.0 111.531 -179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -74.53 -72.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.665 0 C-N-CA 121.255 1.303 . . . . 0.0 108.999 173.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.3 m -153.19 -60.32 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 C-N-CA 124.571 1.149 . . . . 0.0 110.577 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.473 ' OG1' ' HA ' ' A' ' 115' ' ' GLN . 11.7 t -83.0 -46.43 12.87 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -174.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.548 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -70.06 137.27 51.1 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 120.876 0.37 . . . . 0.0 110.392 -178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 57.9 t -107.47 120.54 58.98 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.089 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 110' ' ' THR . 21.9 t -95.48 117.83 40.34 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.142 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 176.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.424 ' HA ' ' OH ' ' A' ' 3' ' ' TYR . 0.0 OUTLIER -128.52 156.02 43.95 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.55 -173.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -94.52 151.79 19.07 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.945 0.402 . . . . 0.0 111.057 -174.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 71' ' ' LEU . 3.1 t -131.51 151.88 36.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 174.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.416 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 39.7 tt0 -147.11 104.16 3.65 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.546 0.688 . . . . 0.0 109.784 179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.632 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -88.08 127.12 41.39 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 CA-C-N 115.006 -0.997 . . . . 0.0 110.093 -177.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 53.1 m170 -108.81 111.64 23.48 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.852 0.72 . . . . 0.0 110.918 177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.554 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 13.9 ptpt 25.81 97.77 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 117.331 2.345 . . . . 0.0 117.331 165.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.576 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 41.9 tp -112.25 118.88 36.52 Favored 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.617 -0.677 . . . . 0.0 109.765 176.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -102.55 102.92 13.22 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.361 0.6 . . . . 0.0 110.019 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.447 ' HG2' ' HG ' ' A' ' 21' ' ' LEU . 12.0 mm100 -108.7 112.65 25.06 Favored 'General case' 0 CA--C 1.478 -1.802 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 62.96 -103.51 0.65 Allowed Glycine 0 C--N 1.303 -1.263 0 O-C-N 124.262 0.976 . . . . 0.0 112.272 177.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -118.45 20.49 13.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 123.319 0.648 . . . . 0.0 110.538 -177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.52 177.12 7.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-O 121.449 0.642 . . . . 0.0 110.175 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -124.77 121.38 34.45 Favored 'General case' 0 N--CA 1.416 -2.13 0 N-CA-C 102.262 -3.236 . . . . 0.0 102.262 171.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.576 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -128.55 164.37 30.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.21 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.49 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.1 mp -93.75 0.92 56.59 Favored 'General case' 0 C--N 1.294 -1.829 0 CA-C-O 121.724 0.774 . . . . 0.0 110.13 176.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.78 -35.68 3.9 Favored Glycine 0 N--CA 1.42 -2.374 0 N-CA-C 115.152 0.821 . . . . 0.0 115.152 176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.416 ' CD1' HD23 ' A' ' 71' ' ' LEU . 50.9 p90 -102.95 165.47 11.01 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 -176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.51 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 23.0 m -133.26 168.36 18.71 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 125.305 1.442 . . . . 0.0 110.24 177.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.667 HG21 HD21 ' A' ' 97' ' ' LEU . 6.4 pt -126.75 172.73 13.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 CA-C-O 120.525 0.203 . . . . 0.0 111.488 -168.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -118.32 -5.6 12.8 Favored Glycine 0 CA--C 1.488 -1.603 0 N-CA-C 110.106 -1.198 . . . . 0.0 110.106 179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.638 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 107.57 -178.98 21.92 Favored Glycine 1 N--CA 1.393 -4.181 0 CA-C-N 114.546 -0.827 . . . . 0.0 111.904 -177.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.617 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -131.58 -79.09 0.17 Allowed Glycine 0 N--CA 1.405 -3.411 0 O-C-N 124.886 0.991 . . . . 0.0 114.293 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.519 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -101.57 -25.85 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -173.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.63 ' HB2' HG22 ' A' ' 89' ' ' THR . 10.7 t70 -71.99 -20.69 61.68 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.35 1.071 . . . . 0.0 109.636 -176.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.586 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 0.0 OUTLIER -105.88 142.71 35.14 Favored 'General case' 0 N--CA 1.393 -3.319 0 CA-C-N 113.395 -1.73 . . . . 0.0 107.786 -173.761 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.556 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.9 t70 -88.53 125.61 62.78 Favored Pre-proline 0 C--N 1.308 -1.212 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.9 -172.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 11.2 Cg_endo -56.28 -31.3 83.97 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.93 2.42 . . . . 0.0 113.486 -178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.1 m -68.89 -29.34 67.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.249 0.547 . . . . 0.0 111.075 -174.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.556 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 2.4 pt20 -109.42 8.0 25.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.673 0.749 . . . . 0.0 111.293 -176.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.423 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 0.9 OUTLIER -99.54 149.31 35.76 Favored Pre-proline 0 C--N 1.3 -1.56 0 CA-C-N 114.969 -1.014 . . . . 0.0 112.788 -177.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.65 -52.75 0.68 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 123.115 2.544 . . . . 0.0 113.156 -176.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -107.87 21.93 16.69 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -173.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.448 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 6.1 t -125.54 -3.05 7.33 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.363 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.82 -35.59 38.18 Favored 'General case' 0 C--N 1.316 -0.864 0 C-N-CA 119.765 -0.774 . . . . 0.0 112.328 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -69.96 -57.36 5.11 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.089 -0.959 . . . . 0.0 110.669 178.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.2 mmmt -110.92 109.56 19.76 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 174.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 27.5 p -87.31 7.61 27.94 Favored 'General case' 0 C--N 1.287 -2.11 0 O-C-N 124.273 0.983 . . . . 0.0 113.057 -167.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -72.59 115.21 11.59 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 174.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 83.9 mttt -62.09 167.92 3.64 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -176.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.5 139.91 4.86 Favored Glycine 0 C--O 1.183 -3.084 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -176.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.639 HD12 HD12 ' A' ' 33' ' ' ILE . 28.7 mm -55.08 130.16 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -170.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.564 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 0.4 OUTLIER -125.7 149.86 48.14 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.188 177.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.734 HG23 HD11 ' A' ' 77' ' ' ILE . 95.9 t -83.22 132.99 30.1 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 O-C-N 124.36 1.037 . . . . 0.0 110.805 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.0 p -112.66 -20.26 11.75 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.34 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.51 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 4.3 mmm180 -140.43 132.84 28.46 Favored 'General case' 0 C--O 1.201 -1.484 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.455 HG13 ' CB ' ' A' ' 66' ' ' ALA . 53.4 t -127.22 142.8 42.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 176.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.683 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 3.4 m -62.1 105.3 0.57 Allowed 'General case' 0 N--CA 1.406 -2.634 0 O-C-N 123.892 0.745 . . . . 0.0 112.363 175.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -43.41 -28.28 0.34 Allowed 'General case' 0 C--N 1.296 -1.73 0 C-N-CA 129.168 2.987 . . . . 0.0 113.545 175.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -143.2 29.52 2.05 Favored Glycine 0 C--N 1.296 -1.643 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 177.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.432 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -113.06 -175.47 19.36 Favored Glycine 0 N--CA 1.424 -2.129 0 C-N-CA 120.324 -0.941 . . . . 0.0 112.051 -176.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.468 ' HG3' ' HB2' ' A' ' 21' ' ' LEU . 45.7 Cg_endo -64.6 -27.0 61.28 Favored 'Trans proline' 0 CA--C 1.5 -1.207 0 C-N-CA 124.01 3.14 . . . . 0.0 111.767 -171.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.455 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -58.15 -59.89 4.6 Favored 'General case' 0 N--CA 1.418 -2.039 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.842 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.683 ' HG2' ' O ' ' A' ' 61' ' ' SER . 6.5 pt-20 -82.63 -20.7 35.82 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 117.746 -1.582 . . . . 0.0 113.107 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.432 HG12 ' O ' ' A' ' 64' ' ' GLY . 24.5 mm -61.12 -35.59 66.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 173.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -80.68 -54.7 5.4 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.373 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 151.71 25.63 0.05 OUTLIER Glycine 0 C--O 1.225 -0.422 0 C-N-CA 119.858 -1.163 . . . . 0.0 113.608 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.743 ' HB2' HG11 ' A' ' 16' ' ' VAL . 5.2 tp -95.95 125.41 40.48 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 177.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.464 ' N ' HD12 ' A' ' 71' ' ' LEU . 22.6 mm-40 -113.66 165.18 12.78 Favored 'General case' 0 N--CA 1.427 -1.615 0 CA-C-O 122.043 0.925 . . . . 0.0 110.155 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.3 mt -75.37 125.38 34.89 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.921 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.4 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 105.19 0.62 41.22 Favored Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.197 -178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 72' ' ' GLN . 14.0 m-20 -79.97 123.86 28.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 35.1 mtmt -93.04 125.36 37.59 Favored 'General case' 0 N--CA 1.437 -1.125 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.734 HD11 HG23 ' A' ' 57' ' ' VAL . 2.5 mp -96.45 131.81 42.32 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.975 -171.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 9.0 mmt -107.12 -25.92 11.34 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 121.123 0.487 . . . . 0.0 110.649 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.597 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 19.6 tp60 -140.82 128.67 21.78 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -173.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.594 HG22 HD22 ' A' ' 107' ' ' LEU . 53.3 t -140.78 113.92 5.0 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.7 0 C-N-CA 123.382 0.673 . . . . 0.0 110.159 -178.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 55.69 43.54 27.86 Favored 'General case' 0 C--N 1.31 -1.146 0 C-N-CA 124.234 1.014 . . . . 0.0 112.564 171.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 77.19 -4.18 55.61 Favored Glycine 0 CA--C 1.53 1.026 0 CA-C-N 115.498 -0.774 . . . . 0.0 113.962 -179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.484 ' HE1' ' HE2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -104.33 146.92 28.12 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 178.798 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -81.36 112.88 19.05 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-O 121.837 0.827 . . . . 0.0 111.056 -179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.626 ' HE3' HD23 ' A' ' 97' ' ' LEU . 61.7 tpp -89.05 -8.2 54.42 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 115.025 -0.989 . . . . 0.0 110.531 -177.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 13.0 t -70.42 137.3 50.28 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 27.6 ttt 53.98 75.06 0.29 Allowed 'General case' 0 CA--C 1.557 1.213 0 C-N-CA 123.871 0.868 . . . . 0.0 112.849 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.79 149.95 12.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.017 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.63 HG22 ' HB2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -70.39 154.99 41.29 Favored 'General case' 0 N--CA 1.406 -2.652 0 C-N-CA 123.269 0.628 . . . . 0.0 112.204 -178.157 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -56.8 -44.28 81.77 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.419 -1.264 . . . . 0.0 108.715 175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -60.14 -52.59 64.68 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.869 -179.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -66.33 -32.12 73.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.344 -0.843 . . . . 0.0 111.942 -177.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.621 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -78.21 -37.26 45.9 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.843 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.473 ' CZ ' HG21 ' A' ' 98' ' ' THR . 16.6 mmm180 -53.98 -44.11 70.54 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.407 0.622 . . . . 0.0 110.546 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -85.14 32.56 0.54 Allowed 'General case' 0 C--N 1.285 -2.231 0 CA-C-O 121.878 0.847 . . . . 0.0 110.473 -178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.594 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 8.3 tpp180 -143.21 -43.3 0.29 Allowed 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.98 -1.009 . . . . 0.0 109.604 -179.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -101.69 -20.94 14.78 Favored 'General case' 0 C--O 1.198 -1.647 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.473 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 13.7 t -116.44 15.38 15.71 Favored 'General case' 0 C--N 1.284 -2.274 0 C-N-CA 117.965 -1.494 . . . . 0.0 109.683 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.594 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.1 ptpt -62.61 158.67 17.67 Favored 'General case' 0 C--N 1.358 0.942 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.074 169.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -114.06 6.28 16.36 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-O 121.647 0.737 . . . . 0.0 110.531 -176.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 19.8 m -79.4 -34.39 41.86 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.339 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -103.6 144.19 31.76 Favored 'General case' 0 N--CA 1.43 -1.455 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.471 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.554 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -100.55 -53.43 3.09 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.162 -0.472 . . . . 0.0 112.192 -176.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.632 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.0 p -121.04 128.58 76.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.468 0 CA-C-O 121.705 0.764 . . . . 0.0 112.565 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.415 HG21 HD23 ' A' ' 29' ' ' LEU . 26.6 m -126.99 146.84 32.21 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 CA-C-N 114.354 -1.293 . . . . 0.0 110.741 -174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 49.2 mtp180 -100.46 115.22 29.56 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 174.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.594 HD22 HG22 ' A' ' 80' ' ' VAL . 12.5 mt -114.52 159.95 19.79 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.2 mp -137.56 123.57 20.26 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 173.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 31.8 m -121.59 159.65 23.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.538 -177.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.57 HG22 HG22 ' A' ' 13' ' ' VAL . 76.2 p -112.74 136.58 52.18 Favored 'General case' 0 N--CA 1.425 -1.713 0 CA-C-O 121.298 0.57 . . . . 0.0 111.495 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.8 mmt180 -80.53 97.29 7.09 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 176.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.466 ' HG3' ' HE2' ' A' ' 76' ' ' LYS . 29.9 mm-40 -94.39 -13.59 26.15 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.522 0.677 . . . . 0.0 110.596 -177.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.9 p -86.33 22.65 1.76 Allowed 'General case' 0 N--CA 1.427 -1.601 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.205 177.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 55.5 tp -139.36 81.67 1.85 Allowed 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.265 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.473 ' HA ' ' OG1' ' A' ' 10' ' ' THR . 9.6 pt20 -148.54 -40.02 0.16 Allowed 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 114.989 -1.005 . . . . 0.0 109.519 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.483 ' NZ ' ' HB2' ' A' ' 116' ' ' LYS . 8.7 mtmp? 78.42 -178.44 0.11 Allowed 'General case' 0 C--O 1.251 1.134 0 C-N-CA 126.463 1.905 . . . . 0.0 110.261 178.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -124.75 175.31 7.32 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t -139.56 73.0 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -79.47 89.08 5.03 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 122.278 1.037 . . . . 0.0 109.931 177.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.65 -18.9 64.37 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.291 -1.322 . . . . 0.0 112.987 -176.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.9 m -69.05 -57.81 4.93 Favored 'General case' 0 N--CA 1.429 -1.499 0 CA-C-N 115.778 -0.647 . . . . 0.0 109.364 178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 15.9 tpt 68.61 -12.8 0.34 Allowed 'General case' 0 CA--C 1.553 1.082 0 C-N-CA 125.239 1.415 . . . . 0.0 112.991 175.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 71.7 mt -96.95 1.62 50.58 Favored 'General case' 0 C--N 1.317 -0.845 0 O-C-N 121.644 -0.66 . . . . 0.0 110.657 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 18.1 t . . . . . 0 N--CA 1.424 -1.742 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 178.221 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.494 -1.276 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 t -122.21 -3.1 9.01 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.1 t80 68.02 -69.11 0.15 Allowed 'General case' 0 C--N 1.345 0.378 0 C-N-CA 124.819 1.247 . . . . 0.0 111.475 -175.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.3 mt 64.18 99.84 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 C-N-CA 124.563 1.145 . . . . 0.0 110.503 -178.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -70.25 152.66 66.9 Favored 'Trans proline' 0 N--CA 1.447 -1.256 0 C-N-CA 121.663 1.575 . . . . 0.0 111.69 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.39 40.79 2.96 Favored Glycine 0 C--N 1.298 -1.565 0 CA-C-N 115.523 -0.762 . . . . 0.0 113.63 -177.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -82.91 128.16 66.74 Favored Pre-proline 0 N--CA 1.443 -0.782 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 177.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 66.3 Cg_endo -80.71 -88.81 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.145 1.897 . . . . 0.0 110.897 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.8 m -137.08 -58.89 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 C-N-CA 123.129 0.572 . . . . 0.0 110.626 176.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.5 t -89.67 -51.12 5.68 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-O 120.769 0.319 . . . . 0.0 111.74 -177.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.502 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . -67.83 141.56 56.43 Favored 'General case' 0 N--CA 1.435 -1.197 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.198 -174.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.6 p -108.03 132.44 55.73 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.261 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.7 p -102.3 141.02 19.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 175.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.451 HE22 HG22 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -147.4 148.96 31.85 Favored 'General case' 0 C--N 1.289 -2.054 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -99.15 144.49 28.22 Favored 'General case' 0 C--N 1.292 -1.894 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -174.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.672 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.4 OUTLIER -126.24 152.89 34.09 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -140.43 101.4 4.1 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.41 0.624 . . . . 0.0 109.88 176.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.506 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -85.54 122.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 114.72 -1.127 . . . . 0.0 109.317 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.459 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 46.2 m170 -94.46 145.84 24.5 Favored 'General case' 0 C--N 1.294 -1.814 0 O-C-N 124.123 0.889 . . . . 0.0 109.549 179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.601 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 0.0 OUTLIER -31.64 113.18 0.11 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 126.107 1.763 . . . . 0.0 115.035 179.571 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.499 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.1 tp -120.51 117.73 28.39 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.879 176.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -96.27 116.97 29.87 Favored 'General case' 0 C--N 1.279 -2.465 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.424 HE21 HD23 ' A' ' 21' ' ' LEU . 68.5 mt-30 -109.77 106.86 16.64 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.62 -105.31 1.27 Allowed Glycine 0 N--CA 1.432 -1.604 0 O-C-N 123.842 0.714 . . . . 0.0 111.319 -177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -109.6 -3.58 16.79 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.94 167.81 9.96 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -172.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -115.92 122.26 44.79 Favored 'General case' 0 C--N 1.278 -2.543 0 N-CA-C 103.708 -2.701 . . . . 0.0 103.708 175.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.425 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.5 OUTLIER -133.79 155.53 40.07 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 179.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 105' ' ' VAL . 8.6 mp -82.27 1.36 37.08 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.107 0.956 . . . . 0.0 109.792 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 89.35 -43.58 3.04 Favored Glycine 0 N--CA 1.42 -2.381 0 CA-C-N 115.061 -0.972 . . . . 0.0 114.708 176.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.44 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 41.5 p90 -91.35 164.7 13.75 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -174.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.543 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 87.2 p -113.83 179.93 3.82 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.344 1.057 . . . . 0.0 109.676 178.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.667 HG21 HD21 ' A' ' 97' ' ' LEU . 6.6 pt -138.32 166.73 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -110.19 -23.01 6.25 Favored Glycine 0 CA--C 1.491 -1.468 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.56 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 126.9 171.24 13.03 Favored Glycine 0 CA--C 1.476 -2.382 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.16 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.533 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.92 -117.52 2.63 Favored Glycine 0 C--O 1.208 -1.482 0 O-C-N 124.445 0.732 . . . . 0.0 112.841 177.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.479 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -65.33 -25.68 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 N-CA-C 112.545 0.572 . . . . 0.0 112.545 -175.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.7 t70 -68.99 -16.77 63.81 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.329 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.559 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 28.4 mm-40 -98.94 163.3 12.65 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.893 -175.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.414 ' HB3' HE21 ' A' ' 43' ' ' GLN . 1.3 m-20 -91.47 107.52 22.45 Favored Pre-proline 0 CA--C 1.489 -1.376 0 C-N-CA 124.507 1.123 . . . . 0.0 111.787 175.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.526 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 25.9 Cg_endo -64.16 -20.9 67.74 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.589 2.192 . . . . 0.0 110.442 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.41 ' HB2' ' HG3' ' A' ' 43' ' ' GLN . 2.7 m -63.52 -32.44 73.9 Favored 'General case' 0 N--CA 1.415 -2.218 0 CA-C-N 113.921 -1.491 . . . . 0.0 110.222 176.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.414 HE21 ' HB3' ' A' ' 40' ' ' ASP . 41.2 mt-30 -122.8 4.98 9.43 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.792 0.806 . . . . 0.0 112.876 -170.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -95.38 144.81 28.43 Favored Pre-proline 0 C--N 1.292 -1.908 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -176.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -67.09 -40.23 11.98 Favored 'Trans proline' 0 N--CA 1.473 0.315 0 C-N-CA 123.794 2.996 . . . . 0.0 113.756 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.424 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 41.3 m-85 -119.59 21.29 12.13 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 121.969 0.89 . . . . 0.0 108.991 -175.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 5.6 t -128.22 5.1 5.8 Favored 'General case' 0 N--CA 1.423 -1.787 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.649 177.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -83.7 -1.07 53.3 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.928 0.871 . . . . 0.0 110.937 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -77.85 -42.0 35.06 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.853 -177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -141.72 -170.58 3.15 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 22.5 p -99.06 -3.86 33.77 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 172.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -70.31 110.96 5.56 Favored 'General case' 0 C--O 1.247 0.941 0 CA-C-N 114.323 -1.308 . . . . 0.0 110.157 179.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.3 mtmm -96.02 174.12 7.08 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.347 -1.297 . . . . 0.0 111.112 -177.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 149.9 163.31 11.03 Favored Glycine 0 C--O 1.181 -3.174 0 N-CA-C 106.875 -2.49 . . . . 0.0 106.875 -175.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.662 HD12 HD12 ' A' ' 33' ' ' ILE . 36.4 mm -72.0 127.29 33.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.225 0 CA-C-N 118.767 1.283 . . . . 0.0 110.634 -178.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.411 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 2.3 p90 -127.64 151.77 48.52 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 178.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.667 HG21 HD11 ' A' ' 71' ' ' LEU . 85.9 t -79.89 133.34 29.91 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 O-C-N 124.426 1.079 . . . . 0.0 110.369 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.424 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 9.3 p -106.11 -22.38 12.88 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-O 121.285 0.564 . . . . 0.0 110.75 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.543 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 22.7 mmt180 -155.13 140.25 17.47 Favored 'General case' 0 CA--C 1.492 -1.257 0 C-N-CA 125.193 1.397 . . . . 0.0 107.73 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.44 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 20.6 m -106.88 -176.41 0.57 Allowed 'Isoleucine or valine' 1 N--CA 1.346 -5.657 0 CA-C-N 118.985 0.811 . . . . 0.0 109.714 173.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.489 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 2.8 t -75.82 114.78 14.81 Favored 'General case' 0 N--CA 1.407 -2.578 0 N-CA-C 104.85 -2.278 . . . . 0.0 104.85 173.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -53.82 -30.26 44.38 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 123.939 0.775 . . . . 0.0 112.614 -174.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -152.39 48.13 0.55 Allowed Glycine 0 CA--C 1.484 -1.884 0 N-CA-C 108.669 -1.773 . . . . 0.0 108.669 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.467 ' HA3' ' OG ' ' A' ' 61' ' ' SER . . . -129.3 -165.64 11.74 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.634 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.499 ' HD2' HD22 ' A' ' 21' ' ' LEU . 42.4 Cg_endo -64.9 -28.45 58.49 Favored 'Trans proline' 0 CA--C 1.505 -0.965 0 C-N-CA 123.4 2.733 . . . . 0.0 112.177 -170.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.39 -62.37 1.82 Allowed 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.635 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -70.66 -30.43 67.04 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 123.173 0.296 . . . . 0.0 111.418 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.493 ' HA ' HD21 ' A' ' 123' ' ' LEU . 26.0 mm -64.73 -39.07 84.36 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 CA-C-O 121.357 0.598 . . . . 0.0 111.299 178.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -78.89 -47.65 16.1 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.755 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 144.61 14.14 0.24 Allowed Glycine 0 C--N 1.311 -0.832 0 C-N-CA 120.095 -1.05 . . . . 0.0 113.846 177.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.672 ' HB2' HG11 ' A' ' 16' ' ' VAL . 8.1 tp -86.44 124.43 32.76 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.452 ' HG3' HG11 ' A' ' 118' ' ' VAL . 25.9 mm-40 -116.87 159.29 22.61 Favored 'General case' 0 N--CA 1.424 -1.766 0 CA-C-O 122.146 0.974 . . . . 0.0 111.029 -178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 54.3 mt -64.97 125.44 21.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.32 0 CA-C-N 113.992 -1.458 . . . . 0.0 108.902 173.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 108.73 -13.83 35.11 Favored Glycine 0 C--N 1.311 -0.835 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.206 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -71.43 124.11 23.87 Favored 'General case' 0 C--O 1.249 1.063 0 CA-C-O 120.817 0.341 . . . . 0.0 110.544 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -86.63 119.36 26.78 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 174.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.583 HD11 HG23 ' A' ' 57' ' ' VAL . 3.7 mp -85.54 122.85 38.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -177.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.469 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 25.5 mmt -101.8 -13.25 17.78 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.44 -176.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.528 ' NE2' ' H ' ' A' ' 82' ' ' GLY . 1.0 OUTLIER -161.53 132.46 5.23 Favored 'General case' 0 C--O 1.2 -1.551 0 O-C-N 121.989 -0.445 . . . . 0.0 110.007 -177.253 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.6 HG22 HD22 ' A' ' 107' ' ' LEU . 50.5 t -131.92 125.5 55.25 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.601 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 49.3 43.26 22.95 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 124.79 1.236 . . . . 0.0 112.269 174.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.528 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 63.72 12.57 48.03 Favored Glycine 0 CA--C 1.537 1.408 0 CA-C-N 114.15 -1.386 . . . . 0.0 114.977 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.443 ' HZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -97.12 -8.64 29.69 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.139 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.1 t70 71.77 121.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 123.861 0.864 . . . . 0.0 110.637 -173.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.441 ' HE2' HD23 ' A' ' 97' ' ' LEU . 7.4 tpt -120.73 -0.92 10.08 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.563 0.697 . . . . 0.0 109.689 -176.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.469 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 9.7 t -66.63 -15.98 63.86 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.387 -0.824 . . . . 0.0 112.842 -174.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.5 ttt -150.28 93.94 2.06 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.042 0.448 . . . . 0.0 110.394 175.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG21 ' HZ2' ' A' ' 83' ' ' TRP . 7.3 p -154.96 149.51 12.24 Favored 'Isoleucine or valine' 0 C--O 1.259 1.561 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 38' ' ' ASP . 9.3 p -72.33 155.75 39.84 Favored 'General case' 0 N--CA 1.422 -1.832 0 C-N-CA 122.632 0.373 . . . . 0.0 110.652 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.737 ' HE2' ' HE ' ' A' ' 94' ' ' ARG . 17.7 t60 -53.58 -44.25 69.19 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.431 -0.804 . . . . 0.0 109.859 175.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -64.59 -43.96 92.18 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 115.707 -0.678 . . . . 0.0 111.126 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.47 -35.23 68.18 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.209 0.528 . . . . 0.0 111.423 179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.591 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -68.59 -42.88 77.57 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.432 177.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.737 ' HE ' ' HE2' ' A' ' 90' ' ' HIS . 18.5 mmt180 -55.7 -38.61 69.93 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-O 121.619 0.723 . . . . 0.0 109.092 177.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' O ' ' HE3' ' A' ' 99' ' ' LYS . 47.2 tttp -81.15 18.29 1.1 Allowed 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.972 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.578 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 34.1 mtt-85 -137.74 -37.19 0.61 Allowed 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 176.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.667 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -102.12 -23.13 14.09 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.473 ' N ' HD12 ' A' ' 97' ' ' LEU . 13.9 t -111.66 12.0 21.13 Favored 'General case' 0 C--N 1.287 -2.119 0 C-N-CA 117.939 -1.505 . . . . 0.0 110.398 176.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.578 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 15.3 ptpt -69.97 176.95 3.4 Favored 'General case' 0 CA--C 1.549 0.913 0 CA-C-N 114.859 -1.064 . . . . 0.0 108.527 169.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 8.1 ptm180 -119.88 -0.13 10.72 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 120.206 -0.598 . . . . 0.0 112.552 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 51.8 m -82.81 -36.95 25.13 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -176.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -94.81 115.19 27.19 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.643 0.735 . . . . 0.0 110.491 -174.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.601 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 0.9 OUTLIER -75.16 -68.11 0.59 Allowed 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 114.143 -1.39 . . . . 0.0 113.725 -173.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.1 p -121.28 125.5 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.421 0 CA-C-O 121.211 0.529 . . . . 0.0 110.329 178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.467 HG21 HD21 ' A' ' 29' ' ' LEU . 25.4 m -131.44 147.13 32.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 CA-C-N 114.871 -1.059 . . . . 0.0 110.909 -175.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -97.93 116.72 30.71 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.054 178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.6 HD22 HG22 ' A' ' 80' ' ' VAL . 11.9 mt -112.76 152.41 29.15 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 115.169 -0.923 . . . . 0.0 108.97 -175.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.9 mp -126.38 126.0 43.14 Favored 'General case' 0 C--N 1.286 -2.19 0 C-N-CA 122.661 0.384 . . . . 0.0 110.146 174.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.431 HG22 HE21 ' A' ' 14' ' ' GLN . 20.1 m -122.05 149.64 25.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.502 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 54.6 p -119.23 133.07 55.96 Favored 'General case' 0 N--CA 1.429 -1.508 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 176.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 66.1 mtt180 -93.93 87.06 5.24 Favored 'General case' 0 N--CA 1.416 -2.174 0 C-N-CA 119.397 -0.921 . . . . 0.0 112.288 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.1 mm-40 -84.48 -47.95 10.1 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 113.466 -1.697 . . . . 0.0 106.949 175.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 2.0 m -91.1 6.23 45.78 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.054 -1.43 . . . . 0.0 111.36 -170.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 95.8 mt -140.04 75.54 1.51 Allowed 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.3 -177.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.43 ' O ' ' HB3' ' A' ' 116' ' ' LYS . 12.1 pt20 -93.9 132.47 38.3 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 174.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.43 ' HB3' ' O ' ' A' ' 115' ' ' GLN . 62.0 tttp 76.12 150.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 O-C-N 124.264 0.977 . . . . 0.0 109.54 -173.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . 75.72 158.77 0.21 Allowed 'General case' 0 C--O 1.242 0.658 0 C-N-CA 124.596 1.158 . . . . 0.0 112.781 178.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.452 HG11 ' HG3' ' A' ' 72' ' ' GLN . 31.0 t 69.26 70.5 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 113.867 -1.515 . . . . 0.0 111.593 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -112.69 109.88 19.66 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 104.477 -2.416 . . . . 0.0 104.477 172.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -70.25 98.4 1.36 Allowed 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.604 0.716 . . . . 0.0 110.29 -176.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.4 m -144.04 -6.39 0.76 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.552 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 21.6 mmt -102.19 -38.09 7.84 Favored 'General case' 0 CA--C 1.51 -0.59 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 68' ' ' ILE . 51.7 tp -76.31 106.48 7.96 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.186 -0.916 . . . . 0.0 110.84 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.3 m . . . . . 0 C--N 1.29 -1.999 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.672 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.497 -1.052 0 N-CA-C 110.49 -1.044 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.8 m -128.67 102.01 6.39 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -121.53 121.21 36.97 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.193 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.8 tt -108.13 111.57 61.85 Favored Pre-proline 0 C--N 1.296 -1.749 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -74.14 164.65 33.81 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.159 1.906 . . . . 0.0 112.64 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.2 50.68 0.99 Allowed Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 177.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.427 ' HB2' HG23 ' A' ' 13' ' ' VAL . 51.4 tt0 -67.78 123.76 87.74 Favored Pre-proline 0 C--O 1.243 0.731 0 CA-C-O 120.946 0.403 . . . . 0.0 111.835 -178.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -87.69 -106.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.44 -1.666 0 C-N-CA 122.94 2.427 . . . . 0.0 112.058 177.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.4 m -141.21 -38.85 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.202 0.525 . . . . 0.0 111.5 -177.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.2 t -76.23 -12.97 60.18 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 123.776 0.83 . . . . 0.0 111.067 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -130.55 148.27 52.33 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.753 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 98.9 t -126.75 139.8 50.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 110' ' ' THR . 11.7 t -97.19 137.0 26.06 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.429 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.0 OUTLIER -138.48 151.18 47.16 Favored 'General case' 0 C--N 1.313 -0.992 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 178.245 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 5.0 ppt_? -96.24 155.1 16.9 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 121.036 0.446 . . . . 0.0 111.111 -174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.61 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -133.71 154.5 38.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.349 -1.723 . . . . 0.0 106.349 176.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -150.53 105.63 3.33 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-O 121.125 0.488 . . . . 0.0 109.781 177.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -90.94 127.61 43.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.393 -178.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 40.9 m170 -96.24 134.44 39.34 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.463 ' HB2' HD21 ' A' ' 27' ' ' LEU . 23.3 pttm -29.34 121.8 0.15 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -177.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.438 HD22 ' HD2' ' A' ' 65' ' ' PRO . 42.7 tp -120.79 125.85 48.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.899 177.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -91.15 125.79 36.04 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' NE2' HD12 ' A' ' 28' ' ' ILE . 33.1 mt-30 -130.37 105.67 8.04 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.29 -115.82 6.67 Favored Glycine 0 N--CA 1.432 -1.589 0 N-CA-C 111.226 -0.749 . . . . 0.0 111.226 -179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -96.16 -0.82 49.54 Favored 'General case' 0 C--N 1.293 -1.876 0 C-N-CA 122.469 0.308 . . . . 0.0 110.297 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -115.78 174.81 5.83 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-O 121.869 0.842 . . . . 0.0 111.08 -169.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.463 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.0 tm? -126.51 113.0 16.22 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 102.459 -3.163 . . . . 0.0 102.459 173.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.419 HD12 ' NE2' ' A' ' 23' ' ' GLN . 0.9 OUTLIER -125.65 164.21 25.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -175.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 97' ' ' LEU . 49.4 mt -91.93 8.51 37.15 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.854 0.835 . . . . 0.0 109.984 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.0 -46.92 2.68 Favored Glycine 0 N--CA 1.416 -2.635 0 CA-C-N 115.532 -0.758 . . . . 0.0 114.53 176.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 30.6 p90 -93.4 172.39 8.31 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 114.684 1.364 . . . . 0.0 114.684 -172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 58.3 m -136.44 169.28 17.94 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 126.12 1.768 . . . . 0.0 110.222 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 55' ' ' ILE . 5.5 pt -124.81 172.54 12.27 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 C-N-CA 122.608 0.363 . . . . 0.0 111.477 -170.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -117.17 -12.37 8.33 Favored Glycine 0 N--CA 1.435 -1.431 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.626 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.534 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 114.33 170.49 16.85 Favored Glycine 0 N--CA 1.424 -2.147 0 C-N-CA 119.537 -1.316 . . . . 0.0 113.066 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.482 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -123.68 -114.71 2.14 Favored Glycine 0 C--O 1.211 -1.339 0 O-C-N 124.083 0.52 . . . . 0.0 112.109 176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -29.31 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.431 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.6 t70 -66.34 -17.87 65.02 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.852 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.604 ' HB2' HD21 ' A' ' 44' ' ' ASN . 19.6 mm-40 -101.24 153.54 19.53 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 106.831 -1.544 . . . . 0.0 106.831 -178.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 6.0 t70 -99.98 115.69 65.31 Favored Pre-proline 0 C--N 1.305 -1.326 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -176.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' CD ' ' HE3' ' A' ' 53' ' ' LYS . 4.6 Cg_endo -51.37 -30.01 32.68 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 123.773 2.982 . . . . 0.0 113.018 -178.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 7.2 t -66.17 -25.99 67.2 Favored 'General case' 0 CA--C 1.556 1.209 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.331 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.452 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -121.85 15.68 10.92 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.583 0.706 . . . . 0.0 111.032 -177.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.683 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 87.7 m-20 -93.49 155.3 40.89 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -179.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 56.7 Cg_endo -74.57 -55.91 0.08 OUTLIER 'Trans proline' 0 C--O 1.198 -1.524 0 C-N-CA 122.746 2.298 . . . . 0.0 113.003 179.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.4 ' CZ ' HG22 ' A' ' 73' ' ' ILE . 74.7 m-85 -105.8 27.7 8.24 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 121.88 0.848 . . . . 0.0 110.602 -175.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.683 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.3 t -138.74 21.74 2.68 Favored 'General case' 0 C--O 1.204 -1.319 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 8.4 pt-20 -89.0 -26.11 21.64 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.795 -175.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.414 ' OD2' ' HG2' ' A' ' 50' ' ' LYS . 8.2 p-10 -77.71 -30.13 51.65 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 121.417 0.627 . . . . 0.0 110.917 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.414 ' HG2' ' OD2' ' A' ' 49' ' ' ASP . 59.3 pttt -154.31 163.95 39.35 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.532 176.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.1 p -81.34 19.89 0.92 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 124.748 1.219 . . . . 0.0 112.298 -174.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -77.48 110.13 11.99 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 114.672 -1.149 . . . . 0.0 109.703 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.406 ' HE3' ' CD ' ' A' ' 41' ' ' PRO . 34.4 mmtm -78.8 -169.11 1.63 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.949 -177.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 113.68 140.86 7.69 Favored Glycine 0 C--O 1.186 -2.892 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.673 ' HB ' ' CE ' ' A' ' 85' ' ' MET . 27.9 mm -60.73 128.83 22.55 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.248 0.547 . . . . 0.0 111.012 -179.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.3 151.86 48.81 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 115.439 -0.801 . . . . 0.0 109.748 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.585 HG23 HD11 ' A' ' 77' ' ' ILE . 97.8 t -79.23 134.23 28.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 123.959 0.787 . . . . 0.0 111.09 179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 17.3 p -110.92 -21.93 11.77 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.08 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 68.6 mtm180 -148.73 135.63 19.9 Favored 'General case' 0 CA--C 1.494 -1.176 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.443 178.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.521 HG11 ' O ' ' A' ' 71' ' ' LEU . 27.5 m -117.63 173.15 4.72 Favored 'Isoleucine or valine' 1 N--CA 1.361 -4.9 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 172.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.411 ' HB3' ' HA3' ' A' ' 64' ' ' GLY . 1.0 OUTLIER -72.16 126.24 29.29 Favored 'General case' 0 N--CA 1.403 -2.801 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 169.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -73.24 -19.16 61.13 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 123.771 0.67 . . . . 0.0 110.548 -176.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -145.34 43.8 0.91 Allowed Glycine 0 N--CA 1.422 -2.299 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.411 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . -129.29 -170.82 12.83 Favored Glycine 0 N--CA 1.424 -2.155 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.314 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.449 ' HB2' HG23 ' A' ' 18' ' ' ILE . 37.5 Cg_endo -63.95 -31.6 66.6 Favored 'Trans proline' 0 N--CA 1.474 0.327 0 C-N-CA 123.742 2.961 . . . . 0.0 112.297 -172.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.83 -63.52 1.15 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.103 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -68.7 -28.04 66.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.333 -0.394 . . . . 0.0 112.003 -177.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 20.8 mm -64.16 -49.76 79.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 O-C-N 123.339 0.4 . . . . 0.0 110.364 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -52.13 43.91 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.269 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.96 22.8 0.08 OUTLIER Glycine 0 C--N 1.305 -1.151 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.724 177.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.61 ' HB2' HG11 ' A' ' 16' ' ' VAL . 4.2 tp -90.19 106.97 18.84 Favored 'General case' 0 N--CA 1.434 -1.263 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.563 ' HB2' ' NH2' ' A' ' 111' ' ' ARG . 22.1 mm-40 -124.49 124.13 41.62 Favored 'General case' 0 CA--C 1.499 -0.993 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -174.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.4 HG22 ' CZ ' ' A' ' 46' ' ' PHE . 67.1 mt -35.98 122.26 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 O-C-N 125.777 1.923 . . . . 0.0 112.801 -175.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 104.06 14.7 23.94 Favored Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.346 179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.443 ' OD1' ' HB ' ' A' ' 57' ' ' VAL . 5.6 p-10 -87.32 139.0 31.0 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 174.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.464 ' HB3' ' HZ3' ' A' ' 76' ' ' LYS . 7.5 mtpm? -104.5 107.43 18.36 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.604 ' HB ' ' HE1' ' A' ' 85' ' ' MET . 9.6 mt -74.78 142.77 14.2 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.825 0 CA-C-N 114.964 -1.017 . . . . 0.0 110.05 -172.134 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.507 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 27.8 mmt -122.15 -20.19 6.31 Favored 'General case' 0 C--N 1.313 -0.978 0 CA-C-O 121.619 0.723 . . . . 0.0 109.891 176.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.579 HE22 ' N ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -144.44 134.82 24.47 Favored 'General case' 0 C--N 1.309 -1.156 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -173.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.468 HG22 HD22 ' A' ' 107' ' ' LEU . 62.6 t -140.51 120.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 177.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.4 HD22 ' HA ' ' A' ' 81' ' ' ASN . 2.1 t-20 53.75 39.55 30.41 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 123.867 0.867 . . . . 0.0 111.891 170.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.579 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 57.8 21.89 45.49 Favored Glycine 0 CA--C 1.537 1.407 0 N-CA-C 116.147 1.219 . . . . 0.0 116.147 -176.354 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.455 ' HD1' ' O ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -102.77 -0.13 31.96 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . 0.362 3.8 p30 49.83 99.28 0.01 OUTLIER 'General case' 0 C--N 1.342 0.273 0 CA-C-O 123.462 1.601 . . . . 0.0 113.635 -173.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.673 ' CE ' ' HB ' ' A' ' 55' ' ' ILE . 3.3 ttp -97.95 -10.04 25.18 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 113.68 -1.6 . . . . 0.0 111.303 -169.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.507 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 6.2 t -33.19 -36.31 0.03 OUTLIER 'General case' 0 CA--C 1.574 1.875 0 C-N-CA 126.445 1.898 . . . . 0.0 115.727 -177.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.9 ttm -139.26 93.63 2.71 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 -176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 14.5 p -154.92 151.89 10.04 Favored 'Isoleucine or valine' 0 C--O 1.255 1.372 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.431 HG22 ' HB2' ' A' ' 38' ' ' ASP . 14.0 p -73.64 157.34 36.8 Favored 'General case' 0 N--CA 1.416 -2.15 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.372 178.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.563 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 8.8 t60 -54.58 -46.31 73.71 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.001 -1.0 . . . . 0.0 108.967 174.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -62.55 -44.83 95.36 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.281 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -72.62 -37.61 68.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.872 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.435 ' O ' HD22 ' A' ' 97' ' ' LEU . . . -66.79 -39.93 87.95 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.761 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.1 mmm180 -52.61 -34.98 53.46 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 123.638 0.775 . . . . 0.0 111.943 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.7 tptt -88.29 13.5 11.45 Favored 'General case' 0 C--N 1.275 -2.671 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.351 -174.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.56 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 15.3 tpt180 -133.21 -39.66 0.93 Allowed 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.482 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.567 HD11 ' CG2' ' A' ' 33' ' ' ILE . 0.6 OUTLIER -103.05 -11.88 17.81 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 118.675 -1.21 . . . . 0.0 112.964 -176.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 8.8 t -125.93 14.23 7.95 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.978 173.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.56 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 13.4 ptpt -67.13 -168.94 0.08 Allowed 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.27 170.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 11.6 ptm180 -132.52 3.22 3.87 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 120.088 -0.645 . . . . 0.0 112.12 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.41 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 34.9 m -73.27 -40.3 64.71 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 120.873 0.368 . . . . 0.0 111.437 -177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -94.16 134.32 36.73 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.418 ' H ' ' CD ' ' A' ' 103' ' ' GLU . 1.1 pm0 -81.45 -61.04 2.05 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.594 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -120.34 129.18 75.83 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.931 0 C-N-CA 123.049 0.54 . . . . 0.0 110.842 177.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 26.8 m -124.78 146.53 30.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.595 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -98.93 117.69 34.0 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 175.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.468 HD22 HG22 ' A' ' 80' ' ' VAL . 19.0 mt -112.09 155.35 24.01 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.875 -176.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.443 HD12 ' O ' ' A' ' 107' ' ' LEU . 4.7 mp -133.42 126.3 30.91 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 173.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 77' ' ' ILE . 17.0 m -123.45 158.93 28.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 O-C-N 123.682 0.614 . . . . 0.0 109.84 -177.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 13' ' ' VAL . 37.9 p -112.27 137.43 50.4 Favored 'General case' 0 N--CA 1.41 -2.453 0 CA-C-O 121.25 0.548 . . . . 0.0 110.249 178.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.563 ' NH2' ' HB2' ' A' ' 72' ' ' GLN . 18.5 mmt180 -100.11 116.24 31.68 Favored 'General case' 0 CA--C 1.479 -1.768 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 22.7 mm-40 -96.02 14.92 22.1 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 9.5 m -72.83 14.7 0.25 Allowed 'General case' 0 C--N 1.313 -0.991 0 C-N-CA 124.681 1.192 . . . . 0.0 112.822 -175.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 6.3 mp -117.56 18.38 14.26 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-O 121.908 0.861 . . . . 0.0 109.024 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 3.6 pt20 -79.55 150.19 31.19 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.992 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HB3' HE21 ' A' ' 119' ' ' GLN . 80.8 tttt -155.3 138.98 16.07 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.402 ' O ' ' HG2' ' A' ' 116' ' ' LYS . . . -71.55 142.84 50.06 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 175.175 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 38.6 t 65.31 71.13 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 122.453 1.12 . . . . 0.0 110.357 -175.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.409 HE21 ' HB3' ' A' ' 116' ' ' LYS . 8.4 tt0 -152.31 -63.09 0.17 Allowed 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 176.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 11.1 mp0 53.27 99.53 0.01 OUTLIER 'General case' 0 N--CA 1.422 -1.849 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 174.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 8.6 m -67.68 -30.38 69.9 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 173.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 13.6 tpt -165.78 -64.73 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 113.385 -1.734 . . . . 0.0 106.327 175.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 97.5 mt -115.1 -33.39 5.39 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 174.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.8 m . . . . . 0 C--N 1.307 -1.259 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.663 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.764 0 N-CA-C 110.659 -0.977 . . . . 0.0 110.659 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.2 p -149.68 162.12 40.86 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 116.872 0.336 . . . . 0.0 110.427 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -93.17 108.68 20.24 Favored 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 50.9 mm -102.47 105.62 44.68 Favored Pre-proline 0 C--N 1.302 -1.487 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -70.71 171.78 14.84 Favored 'Trans proline' 0 C--O 1.252 1.22 0 C-N-CA 122.467 2.111 . . . . 0.0 113.898 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.72 39.29 3.11 Favored Glycine 0 C--N 1.32 -0.334 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.425 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.524 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 8.3 tt0 -78.42 128.7 77.02 Favored Pre-proline 0 C--N 1.309 -1.162 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 178.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -64.48 -64.82 0.06 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.538 1.492 . . . . 0.0 109.929 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.2 m -160.48 -41.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 125.047 1.339 . . . . 0.0 109.439 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.6 t -116.26 -51.46 2.62 Favored 'General case' 0 CA--C 1.558 1.266 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -175.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.524 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -61.71 132.75 54.23 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 118.027 0.376 . . . . 0.0 110.463 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.7 t -101.62 128.86 53.62 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.208 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.069 -173.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 109' ' ' VAL . 8.6 p -112.14 126.53 69.54 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.608 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 172.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.474 HE22 HG22 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -137.65 152.52 49.4 Favored 'General case' 0 C--N 1.279 -2.484 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 -176.32 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.6 ppt_? -93.81 150.44 20.38 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.066 0.46 . . . . 0.0 110.902 -175.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.682 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.5 t -125.71 156.57 35.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 176.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -141.86 105.72 4.73 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.618 0.723 . . . . 0.0 110.761 179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.481 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.7 mp -96.99 128.2 48.42 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.189 -178.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.415 ' HD2' HG13 ' A' ' 104' ' ' VAL . 58.5 m170 -97.67 137.54 36.42 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 176.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.401 ' HB2' HD21 ' A' ' 27' ' ' LEU . 21.5 pttp -36.09 121.33 0.67 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 -177.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.466 HD23 HE21 ' A' ' 23' ' ' GLN . 50.5 tp -124.52 128.54 49.11 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.649 177.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 64.2 mtt-85 -96.09 132.9 41.0 Favored 'General case' 0 C--N 1.29 -1.99 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.153 172.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.544 ' NE2' ' HA2' ' A' ' 30' ' ' GLY . 66.4 mt-30 -123.68 108.06 12.15 Favored 'General case' 0 N--CA 1.418 -2.072 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 70.33 -103.86 1.25 Allowed Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -119.92 12.7 12.1 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.292 0.568 . . . . 0.0 109.789 -177.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -125.26 167.44 14.87 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.401 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.6 tm? -113.73 118.41 34.25 Favored 'General case' 0 C--N 1.28 -2.442 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 173.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -134.48 154.14 36.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -177.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.64 HD13 HG21 ' A' ' 105' ' ' VAL . 63.8 mt -79.36 2.31 22.07 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.8 0.809 . . . . 0.0 109.596 174.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.544 ' HA2' ' NE2' ' A' ' 23' ' ' GLN . . . 95.64 -44.73 2.06 Favored Glycine 0 N--CA 1.408 -3.176 0 CA-C-N 115.637 -0.711 . . . . 0.0 113.921 177.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.437 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 37.7 p90 -90.65 164.56 14.12 Favored 'General case' 0 CA--C 1.556 1.204 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -174.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.0 m -115.01 164.84 13.59 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 125.027 1.331 . . . . 0.0 109.135 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 55' ' ' ILE . 6.5 pt -126.06 166.62 21.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.0 -31.03 3.46 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 121.38 154.02 9.13 Favored Glycine 0 C--O 1.2 -1.996 0 C-N-CA 119.365 -1.398 . . . . 0.0 113.298 -179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.521 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -102.57 -117.67 4.33 Favored Glycine 0 N--CA 1.429 -1.768 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.335 -179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.47 HD11 HG23 ' A' ' 89' ' ' THR . 0.2 OUTLIER -63.88 -23.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -175.312 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.499 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.5 t70 -68.94 -20.47 64.2 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 121.761 0.791 . . . . 0.0 109.887 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.654 ' HB2' HD21 ' A' ' 44' ' ' ASN . 21.9 mm-40 -100.97 156.96 17.1 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 5.0 t70 -101.32 114.66 65.71 Favored Pre-proline 0 C--N 1.312 -1.036 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -177.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -52.17 -25.66 23.95 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 123.859 3.04 . . . . 0.0 113.682 -176.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 m -76.02 -8.59 57.33 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.235 -178.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -135.22 13.09 3.56 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-O 121.905 0.859 . . . . 0.0 110.348 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.699 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 95.5 m-20 -97.86 150.43 36.75 Favored Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.495 -179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -75.09 -45.7 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.037 0 C-N-CA 122.993 2.462 . . . . 0.0 114.31 -177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -114.02 9.53 17.36 Favored 'General case' 0 CA--C 1.508 -0.653 0 O-C-N 121.354 -0.842 . . . . 0.0 110.931 -176.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.699 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 9.6 t -104.95 -4.8 21.67 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -82.55 2.83 31.15 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.929 -176.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -58.32 -37.39 74.99 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 124.541 1.136 . . . . 0.0 108.367 177.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . 0.265 0.0 OUTLIER -154.02 -111.85 0.04 OUTLIER 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 114.385 -1.28 . . . . 0.0 110.222 168.669 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 39.0 p -134.41 19.29 3.65 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -87.13 135.84 33.15 Favored 'General case' 0 N--CA 1.42 -1.934 0 CA-C-N 114.418 -1.264 . . . . 0.0 111.2 -171.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.2 mmtm -94.44 176.3 6.35 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.467 -177.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.421 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 138.48 157.99 7.59 Favored Glycine 0 C--O 1.204 -1.765 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 176.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 33' ' ' ILE . 30.7 mm -80.95 118.37 28.6 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.406 0 CA-C-N 117.685 0.743 . . . . 0.0 109.555 178.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -120.71 155.69 33.36 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.072 179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.416 HG21 HG12 ' A' ' 60' ' ' VAL . 7.6 p -81.58 131.56 33.57 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.306 0 O-C-N 124.733 1.271 . . . . 0.0 110.36 -179.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.0 p -106.57 -19.04 13.79 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-O 121.556 0.693 . . . . 0.0 111.319 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -154.73 135.92 13.97 Favored 'General case' 0 CA--C 1.482 -1.671 0 N-CA-C 106.857 -1.535 . . . . 0.0 106.857 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 30.3 m -100.57 -177.44 0.47 Allowed 'Isoleucine or valine' 1 N--CA 1.351 -5.416 0 CA-C-N 119.592 1.087 . . . . 0.0 108.186 173.606 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.498 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 5.2 t -76.26 122.41 24.36 Favored 'General case' 0 N--CA 1.409 -2.519 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 176.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -58.67 -18.5 31.35 Favored 'General case' 0 N--CA 1.475 0.815 0 O-C-N 124.275 0.984 . . . . 0.0 113.09 -175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -168.56 46.32 0.23 Allowed Glycine 0 CA--C 1.482 -1.975 0 N-CA-C 108.462 -1.855 . . . . 0.0 108.462 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.493 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -132.78 -168.34 11.95 Favored Glycine 0 N--CA 1.42 -2.399 0 CA-C-N 114.514 -0.843 . . . . 0.0 112.967 -174.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.457 ' HD2' HD22 ' A' ' 21' ' ' LEU . 32.9 Cg_endo -61.45 -31.88 88.32 Favored 'Trans proline' 0 C--O 1.216 -0.576 0 C-N-CA 123.987 3.125 . . . . 0.0 112.552 -169.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' HB3' ' H ' ' A' ' 61' ' ' SER . . . -56.63 -60.26 3.8 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.31 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.427 ' HG2' ' O ' ' A' ' 61' ' ' SER . 0.5 OUTLIER -71.17 -30.14 66.07 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 120.024 -0.67 . . . . 0.0 111.245 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 64' ' ' GLY . 32.4 mm -62.6 -41.1 90.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 C-N-CA 122.983 0.513 . . . . 0.0 111.147 179.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.94 -56.78 4.21 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.498 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.14 22.53 0.05 OUTLIER Glycine 0 C--N 1.314 -0.64 0 C-N-CA 119.501 -1.333 . . . . 0.0 114.029 178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.682 ' HB2' HG11 ' A' ' 16' ' ' VAL . 3.2 tp -87.94 119.61 28.46 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 177.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 22.3 mm-40 -115.27 140.98 48.64 Favored 'General case' 0 C--O 1.211 -0.954 0 O-C-N 123.62 0.575 . . . . 0.0 109.494 -177.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.8 mt -49.52 126.53 4.21 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 O-C-N 123.316 0.385 . . . . 0.0 111.521 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 102.18 -0.71 50.79 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.366 -0.921 . . . . 0.0 112.104 -179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -80.62 131.91 35.55 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -94.3 108.2 20.11 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.5 HG13 HG12 ' A' ' 109' ' ' VAL . 3.3 mp -78.9 125.72 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -175.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.561 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.4 mmt -112.84 -8.82 13.71 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 120.85 0.357 . . . . 0.0 111.821 -177.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.656 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -156.55 136.13 12.36 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -177.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.566 HG22 HD12 ' A' ' 107' ' ' LEU . 39.2 t -142.61 115.04 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 124.546 1.138 . . . . 0.0 109.972 -176.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.763 HD22 ' HA ' ' A' ' 105' ' ' VAL . 2.8 t-20 50.5 57.8 6.21 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.622 1.169 . . . . 0.0 111.784 176.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 73.61 -17.89 1.93 Allowed Glycine 0 C--N 1.289 -2.082 0 CA-C-N 114.029 -1.441 . . . . 0.0 115.293 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.88 157.01 17.58 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -90.87 134.33 34.54 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 121.417 0.627 . . . . 0.0 109.897 178.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.528 ' HE3' HD23 ' A' ' 97' ' ' LEU . 63.4 tpp -113.15 1.59 15.33 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 122.235 1.017 . . . . 0.0 108.881 -178.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.561 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.6 t -61.16 -35.7 77.83 Favored 'General case' 0 CA--C 1.55 0.976 0 CA-C-N 114.78 -1.1 . . . . 0.0 113.133 -176.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 53.4 ttm -139.47 91.25 2.47 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.519 HG11 ' SD ' ' A' ' 85' ' ' MET . 9.3 p -157.13 151.05 8.83 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.736 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.422 -178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.499 HG22 ' HB2' ' A' ' 38' ' ' ASP . 2.3 p -71.13 157.19 38.61 Favored 'General case' 0 N--CA 1.417 -2.086 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.51 178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.615 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 13.0 t60 -53.92 -45.19 71.12 Favored 'General case' 0 C--O 1.202 -1.406 0 CA-C-N 114.959 -1.018 . . . . 0.0 109.189 176.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -61.65 -48.36 81.21 Favored 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.733 0.645 . . . . 0.0 111.537 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -70.49 -30.38 67.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.409 -177.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.641 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.86 -42.86 66.4 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.304 176.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.429 ' C ' ' H ' ' A' ' 96' ' ' ARG . 11.1 mmm180 -56.08 -42.8 77.25 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.537 176.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -80.32 27.33 0.34 Allowed 'General case' 0 C--N 1.3 -1.566 0 C-N-CA 124.305 1.042 . . . . 0.0 109.123 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.679 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 4.8 tpt180 -139.77 -43.27 0.44 Allowed 'General case' 0 N--CA 1.418 -2.063 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 177.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -100.03 -28.85 12.86 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.457 ' N ' HD12 ' A' ' 97' ' ' LEU . 14.9 t -108.19 15.88 23.75 Favored 'General case' 0 C--N 1.28 -2.455 0 C-N-CA 117.945 -1.502 . . . . 0.0 109.614 175.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.679 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.3 ptpt -65.78 176.2 1.66 Allowed 'General case' 0 CA--C 1.563 1.454 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.535 170.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -127.41 12.29 6.97 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.698 0.761 . . . . 0.0 111.261 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 22.8 m -94.64 -32.71 13.27 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.95 0.881 . . . . 0.0 111.731 -176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.576 ' CB ' ' HD2' ' A' ' 99' ' ' LYS . 14.7 tt0 -108.79 119.28 39.06 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.496 -172.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.451 ' H ' ' CD ' ' A' ' 103' ' ' GLU . 0.7 OUTLIER -80.52 -71.54 0.46 Allowed 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -173.135 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.443 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 31.3 t -98.88 136.07 31.38 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.719 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.763 ' HA ' HD22 ' A' ' 81' ' ' ASN . 19.6 m -129.62 152.78 37.82 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.317 0 CA-C-O 121.32 0.581 . . . . 0.0 111.778 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 -127.14 112.32 15.02 Favored 'General case' 0 CA--C 1.48 -1.73 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.566 HD12 HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.33 162.58 16.92 Favored 'General case' 0 C--N 1.278 -2.505 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.703 -171.778 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.7 mp -130.95 127.39 38.33 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.5 HG12 HG13 ' A' ' 77' ' ' ILE . 21.7 m -119.14 150.27 21.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.884 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.369 -178.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.411 HG22 ' HB ' ' A' ' 13' ' ' VAL . 75.1 p -118.93 146.98 44.51 Favored 'General case' 0 N--CA 1.42 -1.958 0 N-CA-C 109.03 -0.729 . . . . 0.0 109.03 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 77.0 mtt180 -114.67 96.43 5.73 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -85.02 -11.19 55.98 Favored 'General case' 0 CA--C 1.504 -0.807 0 CA-C-N 114.019 -1.446 . . . . 0.0 110.905 -173.086 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 8.4 p -81.71 5.51 18.2 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 122.421 1.105 . . . . 0.0 110.579 177.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 59.4 tp -109.06 85.08 2.03 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 113.877 -1.51 . . . . 0.0 107.309 176.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -95.58 -73.5 0.59 Allowed 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.87 -177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 49.1 mmtm 57.98 19.04 5.54 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.754 0.822 . . . . 0.0 110.984 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -159.09 -179.09 7.71 Favored 'General case' 0 N--CA 1.436 -1.134 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -174.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.8 p -163.51 95.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-O 122.321 1.058 . . . . 0.0 109.69 -178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -51.31 118.69 3.44 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-N 112.849 -1.978 . . . . 0.0 110.378 173.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -112.11 16.22 20.26 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.239 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 46.0 m 68.59 16.62 9.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 110.344 -176.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 56.9 ttp -177.73 95.0 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 126.047 1.739 . . . . 0.0 106.794 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 33.4 tp -111.02 87.35 2.52 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.416 -2.172 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 -177.12 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.492 -1.4 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.5 p -115.02 104.03 11.49 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 117.346 0.573 . . . . 0.0 109.847 179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.498 ' HE1' ' C ' ' A' ' 5' ' ' PRO . 11.7 t80 -80.62 120.21 24.26 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 177.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.462 ' HB ' ' HD3' ' A' ' 5' ' ' PRO . 44.8 mm -83.35 -58.25 0.41 Allowed Pre-proline 0 CA--C 1.568 1.666 0 N-CA-C 112.547 0.573 . . . . 0.0 112.547 -176.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.498 ' C ' ' HE1' ' A' ' 3' ' ' TYR . 51.3 Cg_endo -70.32 -158.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.383 2.352 0 C-N-CA 122.558 2.172 . . . . 0.0 116.358 -178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -161.53 50.64 0.34 Allowed Glycine 0 CA--C 1.493 -1.332 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 176.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -77.36 127.13 83.79 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-N 114.627 -0.786 . . . . 0.0 113.062 -174.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -84.21 -106.87 0.0 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.554 0 C-N-CA 123.025 2.483 . . . . 0.0 109.793 172.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.2 m -141.79 -50.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 O-C-N 121.961 -0.462 . . . . 0.0 111.701 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.8 t -73.89 -24.0 59.65 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-O 121.782 0.801 . . . . 0.0 110.675 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -116.87 142.44 46.93 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.976 -176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.44 130.91 71.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.657 HG22 HG22 ' A' ' 110' ' ' THR . 15.5 t -97.04 127.5 49.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 106.382 -1.711 . . . . 0.0 106.382 177.237 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.413 HE21 HG22 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -135.32 150.88 50.08 Favored 'General case' 0 C--N 1.287 -2.109 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 -179.532 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -97.14 143.85 27.55 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -176.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 106' ' ' ARG . 8.5 p -132.75 154.29 39.53 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.194 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -137.14 108.54 6.89 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-O 121.284 0.564 . . . . 0.0 111.689 -174.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.483 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -98.83 133.31 41.86 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.777 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.425 ' HD2' HG13 ' A' ' 104' ' ' VAL . 53.6 m170 -99.32 147.71 24.92 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.541 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 41.9 pttt -38.32 116.45 0.53 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 177.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 52.3 tp -117.6 125.45 50.81 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.124 174.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 79.2 mtm180 -95.48 126.28 40.66 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.423 HE21 ' HB3' ' A' ' 23' ' ' GLN . 8.9 mm100 -122.93 99.6 6.47 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 74.74 -104.12 1.65 Allowed Glycine 0 N--CA 1.437 -1.285 0 N-CA-C 110.929 -0.869 . . . . 0.0 110.929 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -112.0 -1.32 15.44 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-O 120.758 0.313 . . . . 0.0 110.738 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -109.12 171.22 7.56 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.316 0.579 . . . . 0.0 109.979 -172.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.472 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.7 tm? -122.07 108.42 13.34 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 103.997 -2.594 . . . . 0.0 103.997 177.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.404 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 1.3 mt -121.51 156.04 25.54 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.586 HD13 HG21 ' A' ' 105' ' ' VAL . 68.6 mt -84.03 3.35 34.85 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-O 121.628 0.728 . . . . 0.0 109.871 176.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.23 -34.43 3.97 Favored Glycine 0 N--CA 1.438 -1.222 0 C-N-CA 121.067 -0.587 . . . . 0.0 113.519 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -99.07 170.99 8.31 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-N 117.343 0.571 . . . . 0.0 111.55 -178.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.52 ' OG ' ' HB2' ' A' ' 59' ' ' ARG . 82.4 p -124.13 -173.7 2.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 123.09 0.556 . . . . 0.0 110.254 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.575 HD12 HD12 ' A' ' 55' ' ' ILE . 8.4 pt -135.42 164.98 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.73 -17.39 7.49 Favored Glycine 0 CA--C 1.478 -2.255 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.578 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 121.6 166.34 12.86 Favored Glycine 0 N--CA 1.414 -2.772 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.261 178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.688 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -115.95 -108.16 2.61 Favored Glycine 0 N--CA 1.409 -3.148 0 O-C-N 124.459 0.741 . . . . 0.0 113.322 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.546 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -80.83 -21.14 11.24 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 CA-C-O 121.194 0.521 . . . . 0.0 111.43 -174.468 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.729 ' HB3' HG22 ' A' ' 89' ' ' THR . 7.3 p-10 -86.39 3.85 41.91 Favored 'General case' 0 N--CA 1.425 -1.715 0 CA-C-O 122.668 1.223 . . . . 0.0 110.309 -174.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.547 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 60.6 mm-40 -99.34 178.06 5.0 Favored 'General case' 0 C--N 1.29 -1.989 0 CA-C-N 113.581 -1.645 . . . . 0.0 108.474 175.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -132.12 121.6 17.82 Favored Pre-proline 0 CA--C 1.479 -1.786 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 178.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.4 -24.76 44.82 Favored 'Trans proline' 0 C--N 1.324 -0.713 0 C-N-CA 122.477 2.118 . . . . 0.0 113.496 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.2 m -66.73 -30.08 70.21 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.859 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.415 HE21 ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -123.13 21.05 9.79 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 121.283 0.563 . . . . 0.0 111.221 -175.339 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.52 ' OD1' ' HB3' ' A' ' 39' ' ' GLN . 5.8 m120 -115.08 143.76 30.82 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -179.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -66.62 -50.97 1.07 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.667 2.911 . . . . 0.0 114.008 -172.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -104.8 17.78 23.52 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.497 0.665 . . . . 0.0 110.469 -177.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.4 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 5.4 t -123.66 2.89 8.92 Favored 'General case' 0 N--CA 1.418 -2.05 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -86.32 -14.23 44.23 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 113.134 0.79 . . . . 0.0 113.134 -175.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -71.46 -53.85 12.58 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.392 0.615 . . . . 0.0 109.582 177.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm -138.42 154.36 48.89 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 114.621 -1.172 . . . . 0.0 108.024 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.1 p -78.92 21.62 0.42 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 124.957 1.303 . . . . 0.0 113.438 -167.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -87.77 111.96 21.92 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.205 -177.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.47 ' HD2' ' HA ' ' A' ' 37' ' ' ILE . 8.6 mtmp? -92.03 -176.98 4.57 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 113.683 0.994 . . . . 0.0 113.683 -177.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.459 ' C ' ' HA2' ' A' ' 36' ' ' GLY . . . 129.21 146.85 6.2 Favored Glycine 0 C--O 1.177 -3.416 0 N-CA-C 107.005 -2.438 . . . . 0.0 107.005 -178.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.688 HD13 ' N ' ' A' ' 36' ' ' GLY . 31.6 mm -58.81 117.94 2.17 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 CA-C-N 118.811 1.305 . . . . 0.0 112.402 -175.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.0 p90 -119.25 153.94 34.22 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.106 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.402 HG13 ' H ' ' A' ' 74' ' ' GLY . 7.5 p -80.28 135.39 25.45 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.013 0 O-C-N 124.567 1.167 . . . . 0.0 110.207 178.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.1 p -109.65 -23.57 11.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-O 121.268 0.556 . . . . 0.0 111.863 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.52 ' HB2' ' OG ' ' A' ' 32' ' ' SER . 40.7 mtt-85 -142.56 138.22 30.68 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.706 177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.446 HG13 ' CB ' ' A' ' 66' ' ' ALA . 54.3 t -124.87 135.76 62.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 176.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.617 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.2 t -54.44 118.76 4.41 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 124.469 1.106 . . . . 0.0 109.801 -179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -65.74 -5.85 9.93 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.598 1.559 . . . . 0.0 112.659 -177.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -163.28 38.47 0.33 Allowed Glycine 0 N--CA 1.429 -1.823 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.424 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -124.01 -174.08 14.05 Favored Glycine 0 N--CA 1.425 -2.036 0 C-N-CA 120.43 -0.89 . . . . 0.0 112.37 -177.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.425 ' HB2' HG23 ' A' ' 18' ' ' ILE . 29.8 Cg_endo -62.92 -29.89 76.5 Favored 'Trans proline' 0 CA--C 1.506 -0.88 0 C-N-CA 124.018 3.145 . . . . 0.0 111.934 -172.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.446 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -57.94 -60.91 2.99 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.626 -178.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.617 ' HG2' ' O ' ' A' ' 61' ' ' SER . 3.5 pt-20 -75.61 -23.94 56.47 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 119.299 -0.96 . . . . 0.0 111.9 179.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.424 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.2 mm -59.24 -43.69 90.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 174.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.78 -50.72 19.24 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.024 176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.85 21.81 0.24 Allowed Glycine 0 C--N 1.321 -0.277 0 C-N-CA 119.644 -1.265 . . . . 0.0 113.884 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.408 ' O ' HG11 ' A' ' 60' ' ' VAL . 2.1 tp -80.13 126.63 31.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 176.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 18.3 mm-40 -116.66 147.18 42.18 Favored 'General case' 0 C--O 1.205 -1.247 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -177.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 58.6 mt -61.59 132.35 27.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.938 0 CA-C-N 116.54 -0.3 . . . . 0.0 110.808 177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.402 ' H ' HG13 ' A' ' 57' ' ' VAL . . . 100.41 -0.34 55.72 Favored Glycine 0 C--O 1.243 0.676 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -178.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.536 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 73.1 m-20 -75.86 119.94 20.54 Favored 'General case' 0 C--O 1.249 1.052 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -83.47 114.53 21.54 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.417 HG12 HG12 ' A' ' 109' ' ' VAL . 12.1 mt -86.63 123.79 39.98 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.835 -173.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.45 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 31.3 mmt -107.66 -17.91 13.97 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 121.228 0.537 . . . . 0.0 110.192 -176.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.539 HE22 ' CA ' ' A' ' 82' ' ' GLY . 0.0 OUTLIER -147.13 137.69 23.55 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 -176.491 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.553 HG22 HD12 ' A' ' 107' ' ' LEU . 18.4 t -139.89 115.12 7.72 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 C-N-CA 123.276 0.63 . . . . 0.0 109.326 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.498 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.0 OUTLIER 53.12 35.76 20.57 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.802 1.241 . . . . 0.0 111.313 173.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.539 ' CA ' HE22 ' A' ' 79' ' ' GLN . . . 73.73 7.35 74.56 Favored Glycine 0 CA--C 1.534 1.244 0 CA-C-N 114.584 -1.189 . . . . 0.0 115.443 -178.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.576 ' CZ2' ' HG3' ' A' ' 96' ' ' ARG 0.325 0.1 OUTLIER -81.39 -86.12 0.09 Allowed 'General case' 0 CA--C 1.585 2.305 0 CA-C-N 118.21 1.005 . . . . 0.0 112.762 -179.965 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 23.7 t70 162.99 111.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 C-N-CA 126.404 1.881 . . . . 0.0 107.161 176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.443 ' HE3' HG21 ' A' ' 55' ' ' ILE . 4.1 tpt -113.0 -1.88 14.38 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.063 -1.055 . . . . 0.0 109.884 -174.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.45 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 9.9 t -72.41 -33.97 67.53 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.933 -175.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.546 ' SD ' HG21 ' A' ' 37' ' ' ILE . 16.4 tpt -128.54 85.83 2.38 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -178.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.505 HG13 HG13 ' A' ' 55' ' ' ILE . 7.2 p -161.06 147.53 5.13 Favored 'Isoleucine or valine' 0 C--O 1.248 0.986 0 C-N-CA 120.254 -0.578 . . . . 0.0 109.891 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.729 HG22 ' HB3' ' A' ' 38' ' ' ASP . 8.7 p -69.8 159.55 33.38 Favored 'General case' 0 CA--C 1.478 -1.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.995 177.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.547 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 7.9 t60 -57.64 -41.74 82.03 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.791 -1.095 . . . . 0.0 108.616 172.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -60.45 -51.14 70.76 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.486 -177.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.549 ' N ' HE21 ' A' ' 92' ' ' GLN . 0.0 OUTLIER -72.06 -34.67 68.93 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.17 -178.486 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.25 -33.06 65.08 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 12.8 mmm180 -52.74 -48.72 66.53 Favored 'General case' 0 C--O 1.215 -0.761 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 174.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.416 ' HG2' ' H ' ' A' ' 95' ' ' LYS . 39.6 pttt -83.72 26.68 0.68 Allowed 'General case' 0 C--N 1.285 -2.228 0 CA-C-O 121.649 0.737 . . . . 0.0 110.885 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.576 ' HG3' ' CZ2' ' A' ' 83' ' ' TRP . 24.3 mmt180 -131.56 -29.03 1.79 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.004 176.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.513 ' O ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -106.72 -27.6 10.69 Favored 'General case' 0 C--O 1.199 -1.585 0 C-N-CA 119.392 -0.923 . . . . 0.0 111.288 174.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.409 ' N ' HD13 ' A' ' 97' ' ' LEU . 8.7 t -112.47 16.8 19.72 Favored 'General case' 0 C--N 1.3 -1.573 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.754 179.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.3 ptpt -64.8 165.08 11.11 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.405 -1.271 . . . . 0.0 109.172 168.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -122.91 4.74 9.38 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 121.946 0.879 . . . . 0.0 109.374 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 5.0 m -60.99 -45.44 94.78 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 113.709 -1.587 . . . . 0.0 109.744 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -107.69 179.91 4.1 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.412 -177.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.541 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 8.3 pt-20 -132.35 -62.16 0.84 Allowed 'General case' 0 C--N 1.313 -0.994 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.425 HG13 ' HD2' ' A' ' 19' ' ' HIS . 28.4 t -95.99 126.16 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.641 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 177.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.586 HG21 HD13 ' A' ' 29' ' ' LEU . 28.0 m -127.04 153.02 35.72 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.766 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.088 -177.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 92.5 mtt180 -124.47 116.52 22.64 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 106.014 -1.847 . . . . 0.0 106.014 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.553 HD12 HG22 ' A' ' 80' ' ' VAL . 0.1 OUTLIER -115.87 147.57 40.92 Favored 'General case' 0 N--CA 1.395 -3.218 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -174.442 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.431 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 6.9 mp -111.98 121.5 45.17 Favored 'General case' 0 C--N 1.27 -2.881 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 177.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.536 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 35.5 m -117.2 147.35 20.65 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.002 -176.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.657 HG22 HG22 ' A' ' 13' ' ' VAL . 47.1 p -117.81 127.18 53.64 Favored 'General case' 0 N--CA 1.411 -2.42 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.764 -179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HD3' ' O ' ' A' ' 114' ' ' LEU . 85.6 mtt180 -97.5 97.24 8.92 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-O 121.521 0.677 . . . . 0.0 110.595 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.8 mm-40 -80.99 -44.56 17.95 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 113.802 -1.544 . . . . 0.0 111.195 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 32.6 t -141.98 20.12 2.12 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -178.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.425 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 3.7 mm? -129.0 40.9 3.56 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 106.668 -1.604 . . . . 0.0 106.668 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -75.99 -22.19 56.1 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 114.937 -1.029 . . . . 0.0 110.11 -176.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.2 mptp? 71.06 177.37 0.27 Allowed 'General case' 0 C--O 1.237 0.412 0 C-N-CA 125.13 1.372 . . . . 0.0 111.01 -176.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -149.75 164.98 33.81 Favored 'General case' 0 C--N 1.293 -1.884 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 48.0 t 64.04 75.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 CA-C-O 122.551 1.167 . . . . 0.0 109.714 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -87.25 2.53 49.81 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.79 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -75.68 71.06 2.54 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.958 178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 22.1 t -130.86 8.41 4.84 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 177.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -160.42 178.82 9.19 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -176.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 41.9 tp 57.53 71.61 0.57 Allowed 'General case' 0 C--O 1.246 0.902 0 C-N-CA 124.559 1.143 . . . . 0.0 111.249 179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.3 m . . . . . 0 C--N 1.296 -1.734 0 N-CA-C 106.954 -1.499 . . . . 0.0 106.954 179.717 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -0.967 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -104.36 -30.61 9.99 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 117.116 0.458 . . . . 0.0 110.368 178.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 24.8 t80 68.29 91.47 0.09 Allowed 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.148 0.975 . . . . 0.0 112.264 -178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 41.2 mm -114.22 93.38 30.67 Favored Pre-proline 0 C--N 1.301 -1.543 0 N-CA-C 106.421 -1.696 . . . . 0.0 106.421 175.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -69.63 167.3 24.67 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.109 1.873 . . . . 0.0 112.748 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.23 50.69 4.41 Favored Glycine 0 N--CA 1.436 -1.306 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 7.7 tt0 -63.63 124.63 85.34 Favored Pre-proline 0 N--CA 1.438 -1.034 0 C-N-CA 123.302 0.641 . . . . 0.0 110.975 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.504 ' O ' HG13 ' A' ' 9' ' ' VAL . 18.6 Cg_endo -64.66 -63.25 0.08 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.033 0 C-N-CA 122.154 1.903 . . . . 0.0 110.218 177.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 8' ' ' PRO . 1.2 m 157.59 -42.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 129.121 2.969 . . . . 0.0 109.014 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 113' ' ' SER . 13.9 t -78.74 -15.15 58.8 Favored 'General case' 0 C--O 1.208 -1.103 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.49 -176.306 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.416 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -132.58 136.56 46.64 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 175.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -97.58 117.66 42.69 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.294 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.571 HG22 HG22 ' A' ' 110' ' ' THR . 25.2 t -84.32 119.8 33.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 106.107 -1.812 . . . . 0.0 106.107 175.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.443 HE22 HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -130.27 152.81 49.29 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -177.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -96.34 146.2 24.95 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.898 -174.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.4 t -125.87 158.01 35.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 177.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.445 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 36.3 tt0 -146.7 103.78 3.68 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 121.531 0.681 . . . . 0.0 110.777 179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.547 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.7 mp -91.58 126.57 44.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.978 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.497 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 55.6 m170 -96.94 161.95 13.61 Favored 'General case' 0 C--N 1.313 -0.993 0 O-C-N 124.232 0.957 . . . . 0.0 109.902 176.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.508 ' HG3' HD11 ' A' ' 27' ' ' LEU . 39.6 ttmt -40.68 125.88 2.31 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.237 1.415 . . . . 0.0 113.705 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.547 HD22 ' HD2' ' A' ' 65' ' ' PRO . 42.8 tp -139.71 131.43 27.38 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.037 173.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 35.8 mtm180 -99.96 137.07 38.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 176.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.407 HE21 HD23 ' A' ' 21' ' ' LEU . 75.1 mt-30 -128.49 104.21 7.56 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 174.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.96 -108.55 2.52 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.746 -0.942 . . . . 0.0 110.746 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -111.85 9.59 20.69 Favored 'General case' 0 C--N 1.304 -1.411 0 CA-C-O 121.267 0.556 . . . . 0.0 110.679 179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -114.65 172.03 7.28 Favored 'General case' 0 CA--C 1.482 -1.664 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -175.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.508 HD11 ' HG3' ' A' ' 20' ' ' LYS . 14.3 tp -122.77 115.74 22.53 Favored 'General case' 0 C--N 1.272 -2.799 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 172.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.17 153.62 31.97 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.054 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.574 -176.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.449 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.3 mp -78.59 0.16 27.41 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.667 0.746 . . . . 0.0 111.423 -178.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.54 -37.81 3.31 Favored Glycine 0 N--CA 1.43 -1.743 0 C-N-CA 120.225 -0.988 . . . . 0.0 114.927 175.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 34.3 p90 -100.64 178.21 4.78 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 -176.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 62.3 m -143.57 168.04 20.8 Favored 'General case' 0 N--CA 1.439 -1.023 0 C-N-CA 124.274 1.03 . . . . 0.0 110.053 -178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.651 HG21 HD21 ' A' ' 97' ' ' LEU . 11.1 pt -127.43 167.7 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.375 0 CA-C-N 117.944 0.338 . . . . 0.0 111.87 -171.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.07 -29.89 4.13 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 110.463 -1.055 . . . . 0.0 110.463 -179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.529 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 127.24 161.82 10.96 Favored Glycine 0 N--CA 1.42 -2.406 0 C-N-CA 119.742 -1.218 . . . . 0.0 113.376 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.605 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -108.19 -119.41 4.34 Favored Glycine 0 N--CA 1.428 -1.899 0 O-C-N 124.16 0.565 . . . . 0.0 112.652 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.76 -24.27 30.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 121.153 0.502 . . . . 0.0 111.759 -175.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' HB2' HG22 ' A' ' 89' ' ' THR . 18.8 t70 -66.63 -13.03 60.62 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.773 1.229 . . . . 0.0 111.014 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.665 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 30.0 mm-40 -104.61 169.63 8.35 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.899 -176.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.503 ' HB3' ' CD ' ' A' ' 43' ' ' GLN . 12.3 t70 -114.19 128.08 26.17 Favored Pre-proline 0 CA--C 1.486 -1.502 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 173.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.44 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.0 Cg_endo -57.08 -32.11 92.27 Favored 'Trans proline' 0 N--CA 1.443 -1.497 0 C-N-CA 122.023 1.815 . . . . 0.0 113.731 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.2 t -65.75 -32.18 73.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.143 0.497 . . . . 0.0 111.147 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.503 ' CD ' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -105.94 13.69 29.01 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.534 0.683 . . . . 0.0 110.784 -176.219 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.522 ' ND2' ' HB3' ' A' ' 39' ' ' GLN . 13.0 m-80 -112.26 146.05 34.1 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -179.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.441 ' O ' ' HG2' ' A' ' 48' ' ' GLU . 46.5 Cg_endo -64.94 -53.47 0.89 Allowed 'Trans proline' 0 C--O 1.218 -0.521 0 C-N-CA 123.271 2.647 . . . . 0.0 113.349 -171.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.413 ' CZ ' HG22 ' A' ' 73' ' ' ILE . 58.2 m-85 -101.24 0.86 38.19 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.602 0.715 . . . . 0.0 110.624 -176.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.436 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 6.2 t -102.47 -10.76 19.1 Favored 'General case' 0 N--CA 1.415 -2.193 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.69 -179.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 45' ' ' PRO . 10.7 pt-20 -71.5 -30.04 65.5 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 122.295 1.045 . . . . 0.0 108.828 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -82.89 -38.43 22.9 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 113.672 -1.604 . . . . 0.0 109.768 -178.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 28.8 mttm -128.42 117.1 20.79 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 14.6 p -83.71 8.2 15.26 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -172.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -82.72 105.74 13.99 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.44 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 58.9 mtmt -74.55 159.99 31.47 Favored 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.811 0.815 . . . . 0.0 112.388 -178.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 146.2 153.1 5.79 Favored Glycine 0 C--O 1.185 -2.935 0 N-CA-C 106.834 -2.506 . . . . 0.0 106.834 -174.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.637 HD12 HD12 ' A' ' 33' ' ' ILE . 29.1 mm -64.25 127.94 25.79 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 CA-C-N 118.708 1.254 . . . . 0.0 111.584 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -129.88 155.5 45.92 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.239 -0.892 . . . . 0.0 108.85 176.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.771 HG21 HD11 ' A' ' 71' ' ' LEU . 95.2 t -85.02 130.45 36.07 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.122 0 O-C-N 124.441 1.088 . . . . 0.0 111.028 -178.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -107.35 -20.02 13.4 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.262 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 41.2 ttt-85 -142.74 143.29 32.18 Favored 'General case' 0 CA--C 1.477 -1.836 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 177.003 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.437 HG13 ' CB ' ' A' ' 66' ' ' ALA . 45.9 t -128.38 144.88 36.49 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.581 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 174.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.2 t -59.32 126.5 27.9 Favored 'General case' 0 N--CA 1.421 -1.901 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -62.68 -26.48 68.68 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 124.626 1.17 . . . . 0.0 110.834 178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.97 52.44 0.53 Allowed Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.026 -0.988 . . . . 0.0 110.766 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.41 -172.51 12.97 Favored Glycine 0 N--CA 1.422 -2.247 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.878 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.547 ' HD2' HD22 ' A' ' 21' ' ' LEU . 36.9 Cg_endo -64.52 -28.12 61.84 Favored 'Trans proline' 0 CA--C 1.509 -0.726 0 C-N-CA 124.326 3.35 . . . . 0.0 111.619 -173.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.437 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -60.44 -58.86 6.68 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.958 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -69.17 -31.27 69.79 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 121.096 -0.241 . . . . 0.0 111.535 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 15.8 mm -59.79 -49.45 83.8 Favored 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-O 121.043 0.449 . . . . 0.0 110.546 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -71.43 -47.86 53.2 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.891 -177.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 143.61 22.6 0.18 Allowed Glycine 0 C--N 1.302 -1.308 0 C-N-CA 119.5 -1.333 . . . . 0.0 113.647 175.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.771 HD11 HG21 ' A' ' 57' ' ' VAL . 2.4 tp -85.88 122.92 30.63 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 178.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.421 ' N ' HD12 ' A' ' 71' ' ' LEU . 24.5 mm-40 -115.43 154.09 29.89 Favored 'General case' 0 N--CA 1.426 -1.626 0 CA-C-O 121.779 0.8 . . . . 0.0 109.098 179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.413 HG22 ' CZ ' ' A' ' 46' ' ' PHE . 49.5 mt -65.33 124.14 19.66 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.699 0 CA-C-N 115.058 -0.973 . . . . 0.0 110.147 177.055 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 112.98 -15.36 23.54 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.705 -0.558 . . . . 0.0 111.705 -179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.418 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 64.6 m-20 -67.63 130.75 44.0 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-O 121.056 0.455 . . . . 0.0 110.533 178.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -92.37 127.15 37.75 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 177.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.734 HD11 HG23 ' A' ' 57' ' ' VAL . 2.9 mp -94.92 127.69 46.69 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -175.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.419 ' HE2' ' HA ' ' A' ' 86' ' ' THR . 28.8 mmt -103.53 -20.55 13.99 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.987 0.423 . . . . 0.0 110.689 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.662 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 14.6 tp60 -152.48 129.55 11.11 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.066 -172.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.473 HG13 HD12 ' A' ' 107' ' ' LEU . 38.8 t -137.16 115.71 14.51 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 123.822 0.849 . . . . 0.0 110.329 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 53.04 41.75 32.18 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 124.212 1.005 . . . . 0.0 112.243 170.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 80.57 3.68 90.14 Favored Glycine 0 CA--C 1.534 1.259 0 CA-C-N 115.112 -0.949 . . . . 0.0 115.062 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.503 ' N ' HE22 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -114.0 150.09 34.39 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -80.16 136.81 36.58 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-N 118.781 0.718 . . . . 0.0 109.884 -176.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.509 ' HE3' ' HB1' ' A' ' 93' ' ' ALA . 7.5 tpt -116.63 -7.06 11.61 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.229 -175.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.419 ' HA ' ' HE2' ' A' ' 78' ' ' MET . 8.1 t -58.63 -34.91 71.7 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.804 -1.089 . . . . 0.0 112.084 -178.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 55.0 ttp -137.99 91.07 2.54 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.417 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 7.2 p -154.24 151.55 10.86 Favored 'Isoleucine or valine' 0 C--O 1.256 1.43 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.029 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.538 HG22 ' HB2' ' A' ' 38' ' ' ASP . 11.8 p -75.39 159.59 31.23 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-O 120.493 0.187 . . . . 0.0 110.795 179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.665 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 11.4 t60 -55.45 -42.77 74.7 Favored 'General case' 0 C--O 1.21 -0.984 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 175.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.562 ' O ' ' HE3' ' A' ' 95' ' ' LYS . 39.2 t70 -59.3 -54.0 51.86 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.054 -0.976 . . . . 0.0 111.756 -178.297 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.23 -30.17 69.17 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.866 -176.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.509 ' HB1' ' HE3' ' A' ' 85' ' ' MET . . . -71.76 -44.59 63.79 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.164 178.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 8.7 mmm180 -57.92 -43.28 86.16 Favored 'General case' 0 CA--C 1.506 -0.714 0 CA-C-O 121.673 0.749 . . . . 0.0 109.471 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.562 ' HE3' ' O ' ' A' ' 91' ' ' ASP . 0.0 OUTLIER -86.4 40.34 0.88 Allowed 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.713 -1.13 . . . . 0.0 109.405 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.412 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 11.2 tpt180 -150.02 -45.63 0.13 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 114.533 -1.212 . . . . 0.0 109.243 174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.651 HD21 HG21 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -99.16 -26.15 14.29 Favored 'General case' 0 C--O 1.196 -1.722 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 179.726 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.466 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.4 t -111.91 17.09 20.04 Favored 'General case' 0 C--N 1.28 -2.439 0 C-N-CA 118.22 -1.392 . . . . 0.0 109.601 176.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.519 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 16.0 ptpt -72.14 161.49 30.81 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 168.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.7 ptm180 -114.43 9.69 16.85 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.752 0.787 . . . . 0.0 110.373 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.519 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 36.5 m -80.57 -30.44 37.0 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.74 -1.118 . . . . 0.0 111.851 -177.137 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -110.11 156.73 20.19 Favored 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.432 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 6.7 pt-20 -110.51 -67.71 0.98 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.865 0.364 . . . . 0.0 111.869 -179.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 1.6 p -103.96 125.11 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-O 122.106 0.955 . . . . 0.0 112.578 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.48 HG23 HD21 ' A' ' 107' ' ' LEU . 15.6 m -126.18 168.48 19.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 114.304 -1.316 . . . . 0.0 110.453 -175.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.448 ' HD2' ' C ' ' A' ' 105' ' ' VAL . 5.1 mpt_? -127.06 116.29 20.49 Favored 'General case' 0 CA--C 1.485 -1.528 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.48 HD21 HG23 ' A' ' 105' ' ' VAL . 0.2 OUTLIER -118.9 153.34 34.72 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -174.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.662 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 5.1 mp -125.4 123.6 39.67 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 176.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.54 HG12 HG13 ' A' ' 77' ' ' ILE . 30.2 m -124.09 155.44 31.31 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.128 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.6 -176.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.571 HG22 HG22 ' A' ' 13' ' ' VAL . 11.4 p -98.69 124.32 43.44 Favored 'General case' 0 N--CA 1.383 -3.821 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.1 tpm_? -65.58 -15.68 62.96 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.645 1.578 . . . . 0.0 111.693 -168.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 64.62 72.9 0.44 Allowed 'General case' 0 CA--C 1.457 -2.618 0 CA-C-O 123.373 1.559 . . . . 0.0 112.211 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 10' ' ' THR . 3.0 m -92.52 -3.24 55.41 Favored 'General case' 0 C--N 1.259 -3.328 0 CA-C-N 111.805 -2.452 . . . . 0.0 108.306 179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 64.6 tp -90.15 92.88 9.14 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 105.472 -2.047 . . . . 0.0 105.472 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 71.4 mt-30 -122.15 -170.95 2.16 Favored 'General case' 0 C--N 1.284 -2.28 0 CA-C-N 114.592 -1.186 . . . . 0.0 109.709 -174.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 16.4 mtpp -88.55 168.41 12.6 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -175.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -93.25 149.16 21.43 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 9.0 p -121.81 60.69 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-O 123.526 1.631 . . . . 0.0 109.076 179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -76.86 -29.53 55.89 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 113.308 -1.769 . . . . 0.0 108.543 179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -68.6 149.69 48.87 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.047 178.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 25.1 m -138.17 107.9 6.26 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 178.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 74.5 mtm -85.12 103.57 14.23 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.327 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.4 tt -106.04 89.35 3.04 Favored 'General case' 0 N--CA 1.428 -1.546 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 24.8 t . . . . . 0 C--N 1.314 -0.954 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 176.62 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.898 0 N-CA-C 110.045 -1.222 . . . . 0.0 110.045 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.7 m -75.76 114.02 13.89 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -58.26 -57.32 13.4 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.399 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 46.2 mm 54.1 92.31 0.06 OUTLIER Pre-proline 0 N--CA 1.484 1.262 0 C-N-CA 123.701 0.8 . . . . 0.0 110.949 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -67.25 150.97 81.65 Favored 'Trans proline' 0 CA--C 1.506 -0.902 0 C-N-CA 122.288 1.992 . . . . 0.0 113.475 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.58 36.86 3.63 Favored Glycine 0 N--CA 1.426 -1.972 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 175.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -138.74 146.99 52.71 Favored Pre-proline 0 N--CA 1.413 -2.306 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -77.01 -99.76 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 121.676 1.584 . . . . 0.0 115.289 -170.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -133.24 -51.89 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 CA-C-O 121.532 0.682 . . . . 0.0 110.99 -175.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 4.1 t -74.69 -13.35 60.61 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.699 -175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.98 139.33 50.36 Favored 'General case' 0 N--CA 1.42 -1.948 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.948 178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 49.5 t -114.37 127.6 71.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.225 -175.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.24 127.35 53.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 175.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.472 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.4 OUTLIER -131.97 154.72 49.02 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.372 -176.045 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 ppt_? -95.12 145.47 24.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-O 121.093 0.473 . . . . 0.0 110.035 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.486 HG12 ' HB2' ' A' ' 107' ' ' LEU . 9.6 p -129.95 150.47 34.65 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -136.81 107.34 6.51 Favored 'General case' 0 C--N 1.283 -2.309 0 CA-C-O 122.138 0.971 . . . . 0.0 111.036 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -96.49 125.78 49.32 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.713 0 CA-C-N 114.391 -1.277 . . . . 0.0 109.114 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.441 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 55.2 m170 -94.68 165.5 12.47 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 175.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.545 ' HB2' HD21 ' A' ' 27' ' ' LEU . 18.5 ptpt -48.65 129.49 16.55 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 176.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 42.6 tp -120.68 122.65 40.92 Favored 'General case' 0 C--N 1.311 -1.081 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 173.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.15 111.98 22.88 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -119.05 102.86 9.05 Favored 'General case' 0 CA--C 1.478 -1.803 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 63.33 -109.03 2.47 Favored Glycine 0 C--N 1.311 -0.826 0 N-CA-C 110.889 -0.885 . . . . 0.0 110.889 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -110.28 16.73 21.52 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.308 0.575 . . . . 0.0 110.822 178.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -117.04 167.98 10.67 Favored 'General case' 0 CA--C 1.475 -1.922 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.545 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.3 tm? -127.24 105.88 8.85 Favored 'General case' 0 C--N 1.261 -3.246 0 N-CA-C 102.472 -3.158 . . . . 0.0 102.472 174.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.498 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.4 OUTLIER -122.16 163.93 19.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.046 -174.642 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.46 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.4 mp -89.93 0.57 57.0 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 122.135 0.969 . . . . 0.0 110.245 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' CA ' ' HB2' ' A' ' 61' ' ' SER . . . 91.46 -41.31 2.87 Favored Glycine 0 N--CA 1.427 -1.913 0 CA-C-N 115.239 -0.892 . . . . 0.0 115.095 174.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 42.3 p90 -96.18 170.58 9.16 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 117.448 0.624 . . . . 0.0 112.615 -176.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 64.7 m -130.44 165.84 21.76 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.259 1.023 . . . . 0.0 109.702 179.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.688 HD12 HD12 ' A' ' 55' ' ' ILE . 7.7 pt -124.74 168.95 16.72 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 120.461 0.172 . . . . 0.0 110.673 -174.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -109.45 -23.98 6.08 Favored Glycine 0 CA--C 1.484 -1.904 0 N-CA-C 110.849 -0.9 . . . . 0.0 110.849 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.608 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 125.01 172.29 13.46 Favored Glycine 0 N--CA 1.414 -2.805 0 C-N-CA 120.279 -0.962 . . . . 0.0 111.366 -178.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.55 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -119.56 -113.71 2.47 Favored Glycine 0 N--CA 1.429 -1.789 0 O-C-N 124.525 0.779 . . . . 0.0 112.5 177.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.564 HG21 ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -69.61 -24.07 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -176.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.512 ' HB2' HG22 ' A' ' 89' ' ' THR . 27.3 t70 -70.62 -12.53 61.62 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.98 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.542 ' HG3' ' HA3' ' A' ' 35' ' ' GLY . 19.0 mm-40 -106.23 157.92 17.23 Favored 'General case' 0 C--O 1.24 0.579 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.504 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 8.0 t70 -97.38 123.43 52.59 Favored Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.54 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 19.5 Cg_endo -61.86 -26.49 79.3 Favored 'Trans proline' 0 C--N 1.326 -0.635 0 C-N-CA 122.426 2.084 . . . . 0.0 113.523 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -72.35 -23.21 61.1 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.968 0.413 . . . . 0.0 111.006 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.504 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -122.12 20.49 10.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.415 0.626 . . . . 0.0 111.006 -178.013 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -111.82 140.88 23.8 Favored Pre-proline 0 C--N 1.302 -1.465 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -63.36 -39.99 34.24 Favored 'Trans proline' 0 C--O 1.222 -0.284 0 C-N-CA 123.663 2.909 . . . . 0.0 113.632 -170.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.445 ' CD1' ' HA2' ' A' ' 74' ' ' GLY . 53.5 m-85 -119.72 22.19 11.7 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.762 0.792 . . . . 0.0 109.693 -176.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.517 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 4.6 t -125.77 1.0 7.43 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -81.78 -6.66 59.25 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.012 -176.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -69.4 -42.65 74.8 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.36 -177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 22.0 pttp -166.25 171.16 12.47 Favored 'General case' 0 C--N 1.31 -1.151 0 C-N-CA 123.667 0.787 . . . . 0.0 109.073 176.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.9 p -79.44 19.52 0.61 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.802 0.81 . . . . 0.0 112.823 -173.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -92.23 99.52 12.29 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.685 -1.143 . . . . 0.0 108.154 -179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.54 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 36.4 mtmm -87.11 -179.48 6.47 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.56 -175.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.525 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 139.87 169.08 11.53 Favored Glycine 0 CA--C 1.472 -2.626 0 N-CA-C 106.218 -2.753 . . . . 0.0 106.218 -174.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.688 HD12 HD12 ' A' ' 33' ' ' ILE . 24.2 mm -76.69 131.09 35.52 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.669 0 CA-C-N 118.779 1.29 . . . . 0.0 109.839 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.517 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 1.2 p90 -128.61 149.01 50.82 Favored 'General case' 0 CA--C 1.488 -1.416 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.787 HG21 HD11 ' A' ' 71' ' ' LEU . 95.6 t -78.48 130.88 35.58 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 O-C-N 124.459 1.1 . . . . 0.0 111.657 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 16.6 p -106.88 -20.4 13.34 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.103 178.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 6.9 ttm180 -144.31 143.44 30.99 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.452 HG13 ' CB ' ' A' ' 66' ' ' ALA . 38.4 t -126.53 136.79 59.76 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.494 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 173.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.605 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 8.4 t -55.14 119.76 5.97 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.545 1.153 . . . . 0.0 110.062 -178.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -77.62 2.59 16.14 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 124.431 1.092 . . . . 0.0 111.471 -176.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -166.19 41.49 0.27 Allowed Glycine 0 C--N 1.273 -2.954 0 N-CA-C 108.561 -1.816 . . . . 0.0 108.561 -178.444 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -138.73 -173.09 12.83 Favored Glycine 0 N--CA 1.414 -2.821 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.784 -179.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.488 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.2 Cg_endo -65.78 -28.23 51.54 Favored 'Trans proline' 0 CA--C 1.508 -0.779 0 C-N-CA 124.847 3.698 . . . . 0.0 112.237 -173.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.452 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -58.74 -59.17 5.84 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.194 -178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' A' ' 61' ' ' SER . 5.5 pt-20 -72.32 -27.86 62.7 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 119.653 -0.819 . . . . 0.0 111.577 178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -61.19 -40.95 87.64 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 111.013 176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.79 -47.64 18.46 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.91 0.386 . . . . 0.0 111.143 177.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.02 16.89 0.41 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 119.978 -1.106 . . . . 0.0 113.422 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.787 HD11 HG21 ' A' ' 57' ' ' VAL . 1.8 tp -74.57 127.79 33.95 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 178.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.418 ' N ' HD12 ' A' ' 71' ' ' LEU . 22.4 mm-40 -113.73 148.49 36.35 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-O 121.3 0.571 . . . . 0.0 110.179 -178.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.4 mt -66.49 123.3 19.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 174.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.445 ' HA2' ' CD1' ' A' ' 46' ' ' PHE . . . 112.99 -15.18 23.59 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.784 -177.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -63.78 127.2 30.31 Favored 'General case' 0 CA--C 1.495 -1.142 0 O-C-N 123.684 0.284 . . . . 0.0 111.021 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -89.7 123.29 33.6 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 174.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.699 HD11 HG23 ' A' ' 57' ' ' VAL . 3.7 mp -90.58 126.55 43.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -177.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -112.26 -7.7 14.0 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 120.42 -0.512 . . . . 0.0 112.034 -177.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.635 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -159.96 136.5 9.01 Favored 'General case' 0 C--O 1.202 -1.429 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -178.49 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.587 HG22 HD22 ' A' ' 107' ' ' LEU . 34.0 t -142.49 119.7 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 C-N-CA 124.749 1.219 . . . . 0.0 109.168 -176.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 46.08 57.84 4.91 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 124.533 1.133 . . . . 0.0 112.176 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.403 ' H ' HE22 ' A' ' 79' ' ' GLN . . . 75.1 -17.47 2.96 Favored Glycine 0 CA--C 1.54 1.618 0 CA-C-N 113.644 -1.616 . . . . 0.0 115.37 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.401 ' CD1' ' HB ' ' A' ' 80' ' ' VAL . 0.0 OUTLIER -92.49 156.92 16.84 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -179.489 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -94.91 127.32 40.86 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.093 0.473 . . . . 0.0 110.677 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.488 ' SD ' HD23 ' A' ' 97' ' ' LEU . 29.1 ttm -105.82 3.54 28.83 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.313 1.054 . . . . 0.0 110.695 -178.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.482 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 12.6 t -61.14 -23.04 65.25 Favored 'General case' 0 CA--C 1.565 1.535 0 CA-C-N 114.92 -1.037 . . . . 0.0 112.374 179.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.564 ' SD ' HG21 ' A' ' 37' ' ' ILE . 52.0 tpp -140.94 90.14 2.31 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.406 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 8.9 p -160.33 150.03 5.82 Favored 'Isoleucine or valine' 0 C--O 1.256 1.439 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 38' ' ' ASP . 17.9 p -76.23 159.98 30.12 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.061 0.458 . . . . 0.0 110.414 177.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.522 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.1 t60 -54.58 -41.43 69.84 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.379 175.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -60.92 -47.59 85.71 Favored 'General case' 0 C--N 1.315 -0.935 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.752 -177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -72.14 -37.35 69.44 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.376 0.608 . . . . 0.0 110.431 -178.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.662 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -64.85 -45.49 85.88 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.749 179.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.416 ' HG2' HD11 ' A' ' 33' ' ' ILE . 12.0 mmm180 -53.63 -39.05 64.65 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 122.828 0.451 . . . . 0.0 111.488 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.0 mtmm -83.73 24.41 0.88 Allowed 'General case' 0 C--N 1.301 -1.533 0 CA-C-O 120.947 0.403 . . . . 0.0 111.153 -177.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.586 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 20.6 ttm180 -145.22 -37.98 0.27 Allowed 'General case' 0 N--CA 1.421 -1.921 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.187 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.662 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.5 pp -97.51 -17.05 19.83 Favored 'General case' 0 C--O 1.203 -1.354 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 176.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.471 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.1 t -122.7 14.18 10.09 Favored 'General case' 0 C--N 1.288 -2.075 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.846 171.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 16.2 ptpt -62.28 161.6 11.13 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.921 173.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -124.94 19.07 8.48 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.016 0.912 . . . . 0.0 110.338 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.412 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 47.4 m -84.15 -27.51 28.06 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.659 -1.155 . . . . 0.0 111.073 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -125.02 159.86 30.35 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.379 -178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -97.64 -70.47 0.72 Allowed 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 2.4 p -109.69 128.55 65.68 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.294 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 24.1 m -132.67 148.81 31.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.171 -177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.3 mtm180 -100.28 124.61 45.94 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 175.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.587 HD22 HG22 ' A' ' 80' ' ' VAL . 3.9 mt -119.71 154.3 34.32 Favored 'General case' 0 N--CA 1.431 -1.424 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 6.5 mp -120.08 125.57 48.63 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-O 121.015 0.436 . . . . 0.0 110.389 177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.472 HG22 ' NE2' ' A' ' 14' ' ' GLN . 22.1 m -119.8 150.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-N 115.124 -0.944 . . . . 0.0 110.223 -177.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 68.8 p -114.12 128.96 56.61 Favored 'General case' 0 N--CA 1.423 -1.812 0 CA-C-O 121.469 0.652 . . . . 0.0 111.429 -178.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 25.4 mmm180 -94.35 100.41 12.44 Favored 'General case' 0 C--N 1.31 -1.143 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 25.4 mm-40 -80.92 -39.25 26.54 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -177.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.3 m 51.18 27.34 3.4 Favored 'General case' 0 CA--C 1.557 1.244 0 C-N-CA 125.967 1.707 . . . . 0.0 114.215 173.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 24.5 mt 47.63 91.09 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -97.67 -60.73 1.51 Allowed 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -137.57 114.97 11.07 Favored 'General case' 0 N--CA 1.431 -1.401 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.221 178.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -95.19 170.11 9.62 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 176.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.9 t 58.93 66.54 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 122.796 1.284 . . . . 0.0 110.229 -178.112 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -138.77 102.79 4.66 Favored 'General case' 0 C--N 1.289 -2.036 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -115.35 110.99 20.18 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.077 -174.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 41.4 m 62.25 22.86 13.46 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.514 1.126 . . . . 0.0 112.54 176.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 55.1 ttm -127.71 140.62 51.96 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 85.5 mt -90.9 163.89 14.22 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 177.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 9.6 t . . . . . 0 N--CA 1.42 -1.954 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -177.874 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.005 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.3 m -117.07 111.27 19.29 Favored 'General case' 0 N--CA 1.425 -1.707 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -82.11 -65.79 0.97 Allowed 'General case' 0 N--CA 1.433 -1.323 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.507 -178.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.1 mp 61.88 100.04 0.04 OUTLIER Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 124.244 1.018 . . . . 0.0 111.782 -176.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -84.17 -169.74 0.72 Allowed 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.979 2.453 . . . . 0.0 111.802 177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.14 50.35 0.37 Allowed Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.452 -1.059 . . . . 0.0 110.452 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -93.8 121.64 64.0 Favored Pre-proline 0 C--N 1.307 -1.277 0 CA-C-N 115.665 -0.268 . . . . 0.0 111.415 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' O ' HG13 ' A' ' 9' ' ' VAL . 24.2 Cg_endo -69.19 -70.67 0.02 OUTLIER 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 122.318 2.012 . . . . 0.0 110.671 174.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 8' ' ' PRO . 0.3 OUTLIER 178.42 -50.64 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 127.326 2.251 . . . . 0.0 109.99 177.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 9.3 t -78.92 -32.43 45.61 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.954 0.883 . . . . 0.0 110.372 -176.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.32 142.28 40.45 Favored 'General case' 0 N--CA 1.413 -2.294 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.7 p -119.28 136.67 55.71 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.387 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 177.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.8 p -107.61 138.5 33.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -179.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.514 ' NE2' HG22 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -135.32 153.34 51.89 Favored 'General case' 0 C--N 1.289 -2.047 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -103.17 139.8 38.19 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 -177.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.529 ' CG1' ' HB2' ' A' ' 107' ' ' LEU . 8.5 p -128.66 158.31 41.06 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.143 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -139.21 101.99 4.4 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-O 121.386 0.612 . . . . 0.0 110.245 -177.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -93.52 127.87 45.3 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.284 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.027 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 104' ' ' VAL . 56.4 m170 -93.07 156.79 16.65 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' HB2' HD21 ' A' ' 27' ' ' LEU . 24.0 pttm -49.54 125.89 12.28 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' O ' ' A' ' 28' ' ' ILE . 45.2 tp -119.05 119.01 32.98 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.203 175.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.4 mtt180 -101.67 118.65 37.38 Favored 'General case' 0 C--N 1.287 -2.12 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -178.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.415 HE21 HD21 ' A' ' 21' ' ' LEU . 48.0 mt-30 -121.8 105.23 10.18 Favored 'General case' 0 N--CA 1.425 -1.725 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 64.97 -112.46 5.03 Favored Glycine 0 C--N 1.304 -1.233 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.869 176.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -97.24 3.09 51.51 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.137 0.494 . . . . 0.0 109.721 -177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -119.64 161.69 20.25 Favored 'General case' 0 CA--C 1.475 -1.934 0 CA-C-O 122.128 0.966 . . . . 0.0 110.59 -171.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.8 tm? -122.75 113.97 19.92 Favored 'General case' 0 C--N 1.256 -3.459 0 N-CA-C 102.463 -3.162 . . . . 0.0 102.463 171.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.46 ' O ' ' HB3' ' A' ' 21' ' ' LEU . 0.2 OUTLIER -126.38 157.92 36.63 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.919 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 -177.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.467 HD23 ' HA ' ' A' ' 98' ' ' THR . 3.2 mm? -94.65 6.34 49.17 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 123.337 1.541 . . . . 0.0 108.588 178.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.402 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 92.37 -46.9 2.59 Favored Glycine 0 C--N 1.294 -1.764 0 CA-C-N 113.115 -1.857 . . . . 0.0 115.161 172.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.418 ' CB ' ' HA ' ' A' ' 60' ' ' VAL . 49.4 p90 -89.13 166.36 13.9 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 112.597 0.591 . . . . 0.0 112.597 -175.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 55.2 m -120.65 168.13 11.71 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 124.702 1.201 . . . . 0.0 109.73 178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 55' ' ' ILE . 5.9 pt -125.77 164.39 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-O 120.857 0.36 . . . . 0.0 110.298 -177.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.73 -20.99 7.75 Favored Glycine 0 N--CA 1.429 -1.786 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.304 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.632 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 123.17 171.37 13.64 Favored Glycine 0 N--CA 1.409 -3.132 0 N-CA-C 111.3 -0.72 . . . . 0.0 111.3 -177.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.558 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -122.15 -117.44 2.44 Favored Glycine 0 N--CA 1.43 -1.762 0 O-C-N 124.388 0.699 . . . . 0.0 112.6 176.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -67.19 -22.2 28.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -174.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' HB2' HG22 ' A' ' 89' ' ' THR . 23.1 t70 -74.94 -15.01 60.7 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.26 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.632 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 6.6 mm-40 -100.17 167.37 10.49 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 2.3 t70 -108.0 111.95 61.88 Favored Pre-proline 0 CA--C 1.497 -1.08 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.4 ' HA ' ' HB3' ' A' ' 47' ' ' SER . 10.2 Cg_endo -54.31 -24.69 35.62 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.582 2.855 . . . . 0.0 113.314 -175.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.3 m -66.15 -33.45 75.79 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.217 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.428 HE21 ' HB3' ' A' ' 43' ' ' GLN . 0.0 OUTLIER -112.49 15.39 20.18 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 121.933 0.873 . . . . 0.0 110.632 -176.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.474 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 8.3 m120 -102.11 142.0 23.69 Favored Pre-proline 0 C--N 1.29 -1.988 0 CA-C-N 114.532 -1.213 . . . . 0.0 112.998 -178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.55 -45.02 7.48 Favored 'Trans proline' 0 C--O 1.221 -0.36 0 C-N-CA 123.507 2.805 . . . . 0.0 113.171 -174.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.516 ' CE2' ' HA ' ' A' ' 58' ' ' THR . 67.8 m-85 -113.2 17.95 18.28 Favored 'General case' 0 CA--C 1.485 -1.554 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.659 -173.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.474 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 1.8 t -123.03 -10.78 8.14 Favored 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.853 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -70.98 -11.07 60.76 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.023 -175.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -66.02 -30.52 71.08 Favored 'General case' 0 C--O 1.241 0.62 0 C-N-CA 124.155 0.982 . . . . 0.0 109.92 178.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -134.96 -170.38 2.56 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.111 -1.404 . . . . 0.0 108.017 -177.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.0 p -116.8 8.47 13.66 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 169.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -80.04 146.29 32.04 Favored 'General case' 0 N--CA 1.441 -0.917 0 CA-C-N 114.119 -1.401 . . . . 0.0 108.543 -177.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 36.1 mmtm -95.76 -146.48 0.28 Allowed 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 123.105 0.562 . . . . 0.0 109.513 -176.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.471 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 96.98 154.18 29.88 Favored Glycine 0 C--O 1.178 -3.355 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 177.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.726 HD12 HD12 ' A' ' 33' ' ' ILE . 21.4 mm -76.95 126.25 37.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 118.26 1.03 . . . . 0.0 110.779 -176.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -122.08 148.96 44.22 Favored 'General case' 0 CA--C 1.486 -1.498 0 O-C-N 122.107 -0.37 . . . . 0.0 111.353 -178.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.684 HG21 HD11 ' A' ' 71' ' ' LEU . 95.8 t -74.46 130.92 35.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 124.423 1.077 . . . . 0.0 110.273 178.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.516 ' HA ' ' CE2' ' A' ' 46' ' ' PHE . 3.3 p -105.99 -22.21 12.95 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-O 121.353 0.596 . . . . 0.0 110.466 178.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 21.2 mtm180 -154.59 142.07 19.71 Favored 'General case' 0 CA--C 1.476 -1.89 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.418 ' HA ' ' CB ' ' A' ' 31' ' ' PHE . 21.0 m -109.12 -179.91 0.9 Allowed 'Isoleucine or valine' 1 N--CA 1.352 -5.368 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 169.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 30.3 t -79.55 126.82 31.37 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -53.22 -16.19 1.17 Allowed 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 125.645 1.578 . . . . 0.0 114.321 -177.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.91 43.46 0.2 Allowed Glycine 0 CA--C 1.483 -1.943 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 178.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.29 -168.31 13.69 Favored Glycine 0 N--CA 1.424 -2.149 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.725 -175.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.502 ' HB2' HG23 ' A' ' 18' ' ' ILE . 33.8 Cg_endo -64.06 -30.66 66.1 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 123.433 2.755 . . . . 0.0 111.939 -171.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.26 -64.77 0.74 Allowed 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.09 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.4 pt-20 -70.9 -31.89 68.67 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 119.557 -0.857 . . . . 0.0 112.146 -179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 18.6 mm -59.77 -40.11 81.62 Favored 'Isoleucine or valine' 0 C--O 1.241 0.636 0 CA-C-O 121.037 0.446 . . . . 0.0 111.351 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.0 -38.64 27.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.277 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 133.95 17.62 1.02 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 119.895 -1.145 . . . . 0.0 113.712 178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.684 HD11 HG21 ' A' ' 57' ' ' VAL . 4.9 tp -83.18 127.24 33.44 Favored 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.033 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.539 ' HB2' ' OD2' ' A' ' 75' ' ' ASP . 23.8 mm-40 -115.5 151.29 35.09 Favored 'General case' 0 N--CA 1.424 -1.736 0 CA-C-O 121.733 0.778 . . . . 0.0 111.08 -175.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 55.9 mt -68.85 130.23 33.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.006 175.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 100.02 4.3 55.5 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.273 -0.965 . . . . 0.0 113.172 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.539 ' OD2' ' HB2' ' A' ' 72' ' ' GLN . 13.4 m-20 -102.27 128.76 48.68 Favored 'General case' 0 N--CA 1.431 -1.418 0 CA-C-O 121.151 0.5 . . . . 0.0 111.873 -178.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.1 mttm -79.72 119.28 22.43 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.242 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.437 HD11 ' CG2' ' A' ' 57' ' ' VAL . 19.5 mt -84.62 121.76 37.18 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 CA-C-N 115.144 -0.934 . . . . 0.0 109.308 -178.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.3 mmt -111.56 -6.85 14.35 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.649 -177.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.524 ' CB ' ' HB2' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.21 134.65 13.43 Favored 'General case' 0 C--O 1.203 -1.391 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -178.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.632 HG22 HD22 ' A' ' 107' ' ' LEU . 46.4 t -136.96 122.81 27.29 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.41 ' HA ' HD22 ' A' ' 81' ' ' ASN . 3.1 t-20 72.58 -34.99 0.31 Allowed 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 127.338 2.255 . . . . 0.0 113.004 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.492 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 134.95 15.32 1.05 Allowed Glycine 0 C--N 1.292 -1.897 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -172.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.487 ' HE1' ' HB2' ' A' ' 85' ' ' MET . 0.0 OUTLIER -99.49 -15.69 18.6 Favored 'General case' 0 CA--C 1.564 1.502 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 -175.101 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 30.8 t70 70.55 109.42 0.06 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.326 1.451 . . . . 0.0 111.568 -174.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.533 ' SD ' HD13 ' A' ' 97' ' ' LEU . 32.0 ttm -111.87 7.6 20.13 Favored 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 121.765 0.793 . . . . 0.0 111.366 -175.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 5.2 t -56.1 -27.41 53.7 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -177.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 56.4 ttm -143.82 96.1 2.84 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.474 ' CG1' ' HG3' ' A' ' 85' ' ' MET . 10.0 p -157.09 151.76 8.24 Favored 'Isoleucine or valine' 0 C--O 1.257 1.479 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 -179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.485 HG22 ' HB2' ' A' ' 38' ' ' ASP . 23.7 p -74.33 155.57 38.03 Favored 'General case' 0 N--CA 1.429 -1.487 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -51.41 -43.81 62.07 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 174.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -61.89 -46.71 88.19 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.989 -176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -76.69 -31.25 57.13 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 116.126 -0.488 . . . . 0.0 112.179 -178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.56 -42.11 68.24 Favored 'General case' 0 CA--C 1.494 -1.174 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.043 -179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 10.7 mmm180 -51.14 -43.25 61.17 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 124.108 0.88 . . . . 0.0 111.199 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.0 pttm -92.81 50.87 1.62 Allowed 'General case' 0 C--N 1.275 -2.64 0 CA-C-O 122.343 1.068 . . . . 0.0 109.568 -178.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 19.0 tpp180 -157.85 -50.57 0.07 Allowed 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.238 172.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.533 HD13 ' SD ' ' A' ' 85' ' ' MET . 0.8 OUTLIER -93.95 -20.48 19.96 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 118.331 -1.348 . . . . 0.0 112.969 -174.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.467 ' HA ' HD23 ' A' ' 29' ' ' LEU . 10.7 t -123.08 13.43 9.72 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 119.511 -0.876 . . . . 0.0 110.809 176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.462 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 16.2 ptpt -71.58 173.69 7.7 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.649 175.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' CB ' ' HB3' ' A' ' 27' ' ' LEU . 12.3 ptt180 -107.88 -0.48 21.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -174.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.462 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 25.8 t -78.02 -23.03 48.39 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.671 0.748 . . . . 0.0 109.443 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -86.03 160.09 19.41 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.854 -1.067 . . . . 0.0 110.328 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.58 ' HG2' ' H ' ' A' ' 104' ' ' VAL . 1.4 pm0 -120.58 -77.94 0.59 Allowed 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.552 174.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.58 ' H ' ' HG2' ' A' ' 103' ' ' GLU . 1.0 OUTLIER -110.61 133.24 56.72 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.542 0 C-N-CA 123.534 0.734 . . . . 0.0 109.206 176.507 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 107' ' ' LEU . 14.6 m -126.73 136.65 60.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 -174.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 88.4 mtm180 -89.66 108.01 19.42 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.58 175.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.632 HD22 HG22 ' A' ' 80' ' ' VAL . 5.6 mt -116.17 149.16 39.52 Favored 'General case' 0 N--CA 1.432 -1.372 0 C-N-CA 118.98 -1.088 . . . . 0.0 108.427 -175.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 79' ' ' GLN . 7.8 mp -122.37 129.15 51.83 Favored 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 177.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.514 HG22 ' NE2' ' A' ' 14' ' ' GLN . 23.6 m -121.36 148.6 24.64 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.286 0 O-C-N 123.997 0.811 . . . . 0.0 110.481 178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 p -112.36 127.5 56.03 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 20.5 mtp180 -90.71 115.71 28.01 Favored 'General case' 0 C--N 1.284 -2.262 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -174.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 28.9 mm-40 -97.12 -44.56 6.91 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.957 -174.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 45.6 m -85.56 18.38 2.82 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.539 0.685 . . . . 0.0 111.85 -176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 49.3 tp -80.82 -40.58 24.69 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.765 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -151.53 178.44 9.31 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -176.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -86.54 144.76 27.07 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -169.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -90.09 -179.14 5.61 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 114.351 -1.295 . . . . 0.0 109.813 177.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.0 t 66.82 84.52 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 CA-C-O 122.272 1.034 . . . . 0.0 109.676 -179.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -109.97 -25.26 10.36 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 114.672 -1.149 . . . . 0.0 113.293 -176.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -133.99 137.06 44.55 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 -176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.7 m -96.17 109.2 21.7 Favored 'General case' 0 N--CA 1.436 -1.163 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 170.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 65.1 mtt -64.85 -64.77 0.79 Allowed 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -173.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -105.52 -67.65 0.91 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.165 0.507 . . . . 0.0 109.73 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 27.7 m . . . . . 0 C--O 1.264 1.851 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.008 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.146 0 N-CA-C 110.466 -1.053 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.8 m 66.14 27.98 10.31 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.217 1.007 . . . . 0.0 111.285 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -94.62 -12.35 27.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.057 -0.974 . . . . 0.0 112.01 -177.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.0 mt 70.65 98.92 0.04 OUTLIER Pre-proline 0 C--O 1.241 0.652 0 C-N-CA 123.742 0.817 . . . . 0.0 110.311 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -76.04 172.44 16.26 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.756 2.304 . . . . 0.0 113.044 -177.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -118.2 52.96 0.67 Allowed Glycine 0 N--CA 1.435 -1.389 0 N-CA-C 110.076 -1.21 . . . . 0.0 110.076 177.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 -77.59 130.51 73.7 Favored Pre-proline 0 CA--C 1.506 -0.715 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -71.73 -73.38 0.02 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.693 0 C-N-CA 121.344 1.363 . . . . 0.0 110.4 179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.7 m -154.98 -53.76 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 124.45 1.1 . . . . 0.0 109.774 176.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 10.0 t -99.9 -42.59 6.73 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 -172.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' HB1' ' HB ' ' A' ' 110' ' ' THR . . . -75.59 140.49 42.68 Favored 'General case' 0 CA--C 1.494 -1.196 0 C-N-CA 120.28 -0.568 . . . . 0.0 112.426 -175.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.3 t -86.15 115.57 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.47 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 176.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 9.9 p -104.55 144.65 14.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.94 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -175.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.472 HE22 HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -144.39 149.74 36.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.651 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.41 ' HA ' ' O ' ' A' ' 107' ' ' LEU . 3.2 ppt_? -93.5 145.42 24.52 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 120.848 0.356 . . . . 0.0 110.584 -176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.625 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.6 t -120.67 153.37 23.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -139.42 104.43 4.96 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.381 0.61 . . . . 0.0 110.325 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 2.0 mp -94.6 133.14 36.56 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.999 0 CA-C-N 115.342 -0.845 . . . . 0.0 109.743 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.0 m170 -104.32 128.86 52.19 Favored 'General case' 0 N--CA 1.428 -1.551 0 CA-C-N 115.359 -0.837 . . . . 0.0 108.974 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.623 ' HB2' HD11 ' A' ' 27' ' ' LEU . 39.8 pttt -20.62 103.96 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 116.248 1.944 . . . . 0.0 116.248 176.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.577 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.6 tp -102.4 123.83 46.87 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.981 0.419 . . . . 0.0 110.31 178.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.423 ' HD3' ' N ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER -92.57 118.12 30.67 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 -178.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.419 ' NE2' HD12 ' A' ' 28' ' ' ILE . 16.7 mt-30 -126.86 109.02 11.53 Favored 'General case' 0 C--N 1.312 -1.03 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 177.423 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.95 -98.89 0.65 Allowed Glycine 0 C--N 1.307 -1.03 0 C-N-CA 121.21 -0.519 . . . . 0.0 113.994 174.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -116.65 5.32 13.21 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 121.021 0.439 . . . . 0.0 110.0 -176.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -139.35 160.44 39.82 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-O 121.713 0.768 . . . . 0.0 110.816 -169.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.623 HD11 ' HB2' ' A' ' 20' ' ' LYS . 26.4 tp -104.84 127.45 52.65 Favored 'General case' 0 N--CA 1.406 -2.654 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 173.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.419 HD12 ' NE2' ' A' ' 23' ' ' GLN . 0.5 OUTLIER -133.88 169.32 21.98 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 120.382 -0.527 . . . . 0.0 109.652 -178.464 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.525 HD13 HG21 ' A' ' 105' ' ' VAL . 47.1 mt -92.75 -1.85 56.47 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.464 0.65 . . . . 0.0 109.674 176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.86 -36.6 3.8 Favored Glycine 0 N--CA 1.418 -2.505 0 CA-C-N 116.032 -0.531 . . . . 0.0 113.56 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -100.56 167.63 10.23 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.807 -0.819 . . . . 0.0 112.913 -176.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.447 ' HB2' ' HB2' ' A' ' 59' ' ' ARG . 50.9 m -129.25 168.35 16.33 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.292 1.437 . . . . 0.0 109.339 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.637 HG21 HD21 ' A' ' 97' ' ' LEU . 6.5 pt -124.06 169.88 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-O 121.02 0.438 . . . . 0.0 111.355 -172.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -113.99 -21.24 5.71 Favored Glycine 0 CA--C 1.479 -2.2 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.548 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 121.85 170.9 13.92 Favored Glycine 0 N--CA 1.409 -3.119 0 C-N-CA 120.253 -0.975 . . . . 0.0 110.757 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.633 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -124.24 -105.26 1.64 Allowed Glycine 0 N--CA 1.408 -3.201 0 C-N-CA 120.011 -1.09 . . . . 0.0 113.705 -179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.96 -23.85 13.96 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 CA-C-O 121.528 0.68 . . . . 0.0 110.947 -174.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.769 ' HB3' HG22 ' A' ' 89' ' ' THR . 14.7 p-10 -86.11 3.65 41.69 Favored 'General case' 0 N--CA 1.406 -2.644 0 CA-C-N 114.834 -1.076 . . . . 0.0 111.183 -174.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.518 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 44.2 mm-40 -107.55 156.12 19.35 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-N 113.874 -1.512 . . . . 0.0 107.089 173.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -99.34 118.65 62.01 Favored Pre-proline 0 CA--C 1.496 -1.11 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.482 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 11.6 Cg_endo -55.89 -25.2 51.55 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.16 2.573 . . . . 0.0 113.484 -175.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.5 m -71.86 -17.16 62.15 Favored 'General case' 0 CA--C 1.549 0.94 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.513 -178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.85 28.8 4.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.126 0.489 . . . . 0.0 111.437 179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.646 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 93.0 m-20 -106.25 147.0 34.08 Favored Pre-proline 0 C--N 1.308 -1.205 0 O-C-N 122.175 -0.328 . . . . 0.0 111.067 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -65.55 -50.91 1.6 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.949 2.433 . . . . 0.0 112.613 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -106.41 4.88 28.93 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.102 0.477 . . . . 0.0 111.447 -176.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.646 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 2.2 t -114.35 1.96 14.58 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.578 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -79.13 -22.4 45.17 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -82.43 -37.96 24.7 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 114.13 -1.396 . . . . 0.0 109.679 -177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 54.9 mttp -137.99 130.79 29.81 Favored 'General case' 0 CA--C 1.504 -0.794 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 179.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.9 p -83.99 2.42 39.02 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.387 0.613 . . . . 0.0 112.488 -172.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -76.21 114.15 14.57 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.482 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 37.6 mtmm -82.4 -178.27 6.99 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.381 0.61 . . . . 0.0 112.335 -175.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 126.05 138.38 4.87 Favored Glycine 0 C--O 1.191 -2.576 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.633 HD13 ' N ' ' A' ' 36' ' ' GLY . 24.5 mm -50.48 124.81 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.622 1.169 . . . . 0.0 112.546 -174.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.5 p90 -126.59 156.54 40.74 Favored 'General case' 0 N--CA 1.421 -1.902 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.287 176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.746 HG21 HD11 ' A' ' 71' ' ' LEU . 81.7 t -82.24 137.26 21.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.461 0 O-C-N 124.591 1.182 . . . . 0.0 110.43 -178.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.7 p -110.89 -22.46 11.52 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-O 121.479 0.657 . . . . 0.0 111.172 178.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.447 ' HB2' ' HB2' ' A' ' 32' ' ' SER . 19.3 mmt180 -143.68 135.92 26.83 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.149 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.527 ' CG2' HG11 ' A' ' 57' ' ' VAL . 71.9 t -128.22 139.72 51.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.639 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 2.7 m -57.55 112.54 1.46 Allowed 'General case' 0 N--CA 1.42 -1.961 0 O-C-N 124.103 0.877 . . . . 0.0 111.281 174.117 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -65.82 -11.81 49.26 Favored 'General case' 0 C--N 1.318 -0.779 0 O-C-N 124.051 0.844 . . . . 0.0 112.752 -178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -140.41 22.91 2.71 Favored Glycine 0 C--N 1.285 -2.252 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 61' ' ' SER . . . -111.93 -179.95 19.75 Favored Glycine 0 N--CA 1.417 -2.6 0 C-N-CA 120.507 -0.854 . . . . 0.0 112.32 -176.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.577 ' HD2' HD22 ' A' ' 21' ' ' LEU . 38.6 Cg_endo -63.75 -27.54 68.21 Favored 'Trans proline' 0 CA--C 1.497 -1.33 0 C-N-CA 124.537 3.491 . . . . 0.0 111.764 -171.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' HG13 ' A' ' 60' ' ' VAL . . . -56.86 -60.53 3.43 Favored 'General case' 0 N--CA 1.419 -1.991 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.0 -178.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.2 pt-20 -87.1 -17.27 33.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 117.754 -1.578 . . . . 0.0 112.761 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.418 ' HB ' ' HA ' ' A' ' 65' ' ' PRO . 12.9 mm -60.68 -34.3 58.23 Favored 'Isoleucine or valine' 0 C--O 1.241 0.619 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 171.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.37 -56.69 3.88 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.431 174.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 155.67 22.71 0.04 OUTLIER Glycine 0 CA--C 1.519 0.342 0 C-N-CA 119.558 -1.306 . . . . 0.0 114.121 178.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.746 HD11 HG21 ' A' ' 57' ' ' VAL . 4.0 tp -88.95 121.3 31.18 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.152 0.501 . . . . 0.0 110.844 178.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.487 HE21 ' HA ' ' A' ' 72' ' ' GLN . 0.0 OUTLIER -110.55 164.48 12.67 Favored 'General case' 0 N--CA 1.419 -1.975 0 CA-C-O 121.859 0.837 . . . . 0.0 108.789 177.241 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.62 133.22 32.22 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.641 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 83.46 14.02 74.79 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 116.415 -0.357 . . . . 0.0 112.386 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.559 ' O ' ' HB ' ' A' ' 109' ' ' VAL . 12.9 m-20 -71.0 1.4 5.72 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 117.546 2.425 . . . . 0.0 117.546 -174.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.407 ' HB3' ' HE3' ' A' ' 76' ' ' LYS . 21.5 mmmt 48.23 87.2 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 175.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.449 HD11 HG23 ' A' ' 57' ' ' VAL . 11.4 mt -83.15 123.83 39.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -174.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 8.1 mmt -106.63 -19.66 13.59 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 121.197 0.522 . . . . 0.0 109.868 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 16.4 tp60 -154.0 131.35 11.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.172 -172.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.59 HG22 HD22 ' A' ' 107' ' ' LEU . 60.7 t -134.57 113.96 17.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.684 0 C-N-CA 123.732 0.813 . . . . 0.0 110.215 -179.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 50.58 29.09 3.83 Favored 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 125.612 1.565 . . . . 0.0 113.381 171.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.441 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 92.05 7.36 64.22 Favored Glycine 0 C--O 1.217 -0.95 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 178.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.523 ' CZ2' HG21 ' A' ' 88' ' ' VAL . 0.0 OUTLIER -107.75 -2.83 19.67 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.327 1.973 . . . . 0.0 116.327 -175.197 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.5 t70 67.28 129.96 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 119.536 1.062 . . . . 0.0 111.779 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.509 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 26.5 ttm -129.77 1.29 4.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 121.998 0.904 . . . . 0.0 111.382 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 5.0 t -72.62 -19.17 61.51 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.834 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 60.0 ttp -139.29 89.15 2.32 Favored 'General case' 0 N--CA 1.437 -1.113 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 174.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.523 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 10.0 p -161.29 143.01 3.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.968 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.769 HG22 ' HB3' ' A' ' 38' ' ' ASP . 11.4 p -69.82 154.59 41.76 Favored 'General case' 0 N--CA 1.425 -1.721 0 O-C-N 123.539 0.524 . . . . 0.0 111.213 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.52 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 8.8 t60 -53.85 -43.44 69.52 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.544 173.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -60.13 -44.05 95.22 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.895 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -78.18 -33.02 50.38 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.824 -179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.631 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -71.18 -40.08 71.44 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.04 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.559 ' CZ ' HG21 ' A' ' 98' ' ' THR . 13.7 mmm180 -53.79 -46.21 70.96 Favored 'General case' 0 C--O 1.216 -0.697 0 O-C-N 123.567 0.542 . . . . 0.0 110.434 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 17.3 pttm -86.7 36.84 0.72 Allowed 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.855 0.836 . . . . 0.0 110.736 -178.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.554 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.5 tpt180 -141.43 -46.92 0.38 Allowed 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 114.554 -1.203 . . . . 0.0 108.858 175.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.637 HD21 HG21 ' A' ' 33' ' ' ILE . 1.4 pp -96.05 -26.16 15.63 Favored 'General case' 0 C--O 1.203 -1.361 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.559 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 15.3 t -110.81 10.94 22.52 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 117.503 -1.679 . . . . 0.0 110.543 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.554 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 17.2 ptpt -68.84 162.36 26.62 Favored 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 172.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -115.46 8.43 15.24 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.086 0.47 . . . . 0.0 111.953 178.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 8.6 t -79.54 -30.57 41.83 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-O 120.891 0.377 . . . . 0.0 110.287 -179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -112.73 171.87 7.27 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.022 -177.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.8 pt-20 -130.43 -71.56 0.59 Allowed 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 -172.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 8.5 t -91.63 129.83 41.72 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 122.03 -0.418 . . . . 0.0 109.962 -176.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.525 HG21 HD13 ' A' ' 29' ' ' LEU . 15.9 m -126.05 150.5 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.828 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.9 -179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 36.6 mtm-85 -109.32 101.65 10.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 N-CA-C 105.264 -2.124 . . . . 0.0 105.264 177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.59 HD22 HG22 ' A' ' 80' ' ' VAL . 21.0 mt -102.55 149.66 24.19 Favored 'General case' 0 C--N 1.262 -3.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -176.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 4.4 mp -125.75 116.35 21.48 Favored 'General case' 0 C--N 1.266 -3.035 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 174.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 75' ' ' ASP . 35.9 m -117.42 159.1 17.78 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.423 0 CA-C-N 114.229 -1.351 . . . . 0.0 109.548 -177.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.489 ' HB ' ' HB1' ' A' ' 11' ' ' ALA . 18.8 p -117.17 129.93 56.27 Favored 'General case' 0 C--N 1.278 -2.516 0 CA-C-O 121.331 0.586 . . . . 0.0 110.144 -178.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 57.5 mtp85 -78.57 -6.43 55.52 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 -166.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . 0.454 ' C ' ' H ' ' A' ' 114' ' ' LEU . 25.4 mm-40 62.96 8.58 3.25 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 125.283 1.433 . . . . 0.0 113.727 174.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 5.4 p -75.85 24.49 0.12 Allowed 'General case' 0 C--N 1.281 -2.403 0 C-N-CA 125.591 1.557 . . . . 0.0 111.516 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.454 ' H ' ' C ' ' A' ' 112' ' ' GLN . 2.1 pp -84.79 -6.5 59.35 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 124.53 1.132 . . . . 0.0 112.575 -175.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -159.41 -46.71 0.05 Allowed 'General case' 0 C--N 1.312 -1.037 0 CA-C-O 121.504 0.669 . . . . 0.0 109.604 -178.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -101.19 56.35 0.85 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.422 -0.808 . . . . 0.0 112.292 -175.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -120.13 -61.54 1.58 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 20.6 t -111.9 56.86 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.327 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 178.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -159.28 92.16 1.05 Allowed 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 113.806 -1.543 . . . . 0.0 109.174 177.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -130.15 39.64 3.64 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.348 -1.352 . . . . 0.0 107.348 178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 11.4 p -63.34 -172.08 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.849 1.66 . . . . 0.0 113.483 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 16.9 tpt 78.6 -45.13 0.39 Allowed 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 125.178 1.391 . . . . 0.0 110.729 -179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -68.23 113.98 6.32 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.664 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 41.4 m . . . . . 0 C--N 1.295 -1.799 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 176.394 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -1.017 0 N-CA-C 109.97 -1.252 . . . . 0.0 109.97 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.0 t 74.25 161.94 0.25 Allowed 'General case' 0 C--O 1.25 1.097 0 C-N-CA 124.213 1.005 . . . . 0.0 111.214 179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -85.33 115.72 23.25 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 62.0 mt -111.27 108.89 56.85 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 177.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -71.97 172.46 14.59 Favored 'Trans proline' 0 C--O 1.245 0.867 0 C-N-CA 122.492 2.128 . . . . 0.0 112.457 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.18 45.12 3.15 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 176.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' HA ' HG23 ' A' ' 13' ' ' VAL . 7.8 tt0 -70.57 130.38 89.03 Favored Pre-proline 0 N--CA 1.436 -1.127 0 C-N-CA 123.034 0.533 . . . . 0.0 110.479 178.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -78.67 -95.71 0.01 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.27 1.98 . . . . 0.0 111.55 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 m -155.84 -46.31 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 124.428 1.091 . . . . 0.0 110.873 178.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 13.3 t -78.9 -23.0 45.06 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 121.565 0.698 . . . . 0.0 111.233 -174.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -122.53 136.27 54.85 Favored 'General case' 0 N--CA 1.416 -2.144 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.07 178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.486 ' HB ' ' HB2' ' A' ' 111' ' ' ARG . 59.3 t -96.77 104.92 16.44 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.018 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.743 HG22 HG22 ' A' ' 110' ' ' THR . 17.9 t -83.45 115.18 25.36 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 176.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.431 HE22 HG22 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -128.4 153.37 47.15 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 -177.344 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -94.27 145.25 24.87 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 120.331 -0.548 . . . . 0.0 112.141 -174.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.66 HG11 ' HB2' ' A' ' 71' ' ' LEU . 2.4 t -121.68 156.84 25.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.439 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 38.8 tt0 -143.92 104.69 4.19 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.98 0.895 . . . . 0.0 110.349 -178.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.8 mp -99.13 129.38 49.65 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.877 -179.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.431 ' HD2' HG13 ' A' ' 104' ' ' VAL . 40.2 m170 -100.23 144.63 29.02 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.579 ' HB3' ' HB2' ' A' ' 103' ' ' GLU . 22.3 pttm -40.39 127.2 2.34 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.4 HD22 ' HD2' ' A' ' 65' ' ' PRO . 50.5 tp -124.81 126.03 44.96 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.83 174.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 63.3 mtt85 -91.83 116.3 28.79 Favored 'General case' 0 C--N 1.292 -1.929 0 C-N-CA 120.266 -0.573 . . . . 0.0 110.353 175.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.465 ' OE1' ' HA2' ' A' ' 30' ' ' GLY . 20.0 mt-30 -111.08 101.27 9.82 Favored 'General case' 0 N--CA 1.413 -2.299 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.75 -117.49 8.19 Favored Glycine 0 C--N 1.297 -1.608 0 N-CA-C 110.696 -0.962 . . . . 0.0 110.696 -177.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -100.52 9.26 42.81 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 120.932 0.396 . . . . 0.0 110.585 -176.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.99 166.89 13.21 Favored 'General case' 0 CA--C 1.492 -1.286 0 CA-C-O 121.124 0.488 . . . . 0.0 109.733 -173.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.576 HD21 ' HB2' ' A' ' 20' ' ' LYS . 1.6 tm? -117.68 107.73 14.56 Favored 'General case' 0 C--N 1.281 -2.382 0 N-CA-C 103.35 -2.833 . . . . 0.0 103.35 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.2 mt -125.8 163.31 27.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 97' ' ' LEU . 9.0 mp -87.06 7.23 28.72 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-O 121.681 0.753 . . . . 0.0 110.598 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.465 ' HA2' ' OE1' ' A' ' 23' ' ' GLN . . . 90.44 -41.12 2.96 Favored Glycine 0 N--CA 1.438 -1.192 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.64 177.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 59' ' ' ARG . 38.9 p90 -97.51 175.65 6.15 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -175.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 68.4 m -140.66 168.92 18.64 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.493 1.117 . . . . 0.0 109.314 179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 55' ' ' ILE . 8.7 pt -125.8 167.02 20.81 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.69 0 CA-C-N 117.916 0.326 . . . . 0.0 111.282 -173.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.49 -28.47 4.84 Favored Glycine 0 CA--C 1.482 -2.029 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.557 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 127.46 165.79 11.96 Favored Glycine 0 N--CA 1.418 -2.53 0 C-N-CA 119.498 -1.334 . . . . 0.0 112.052 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.531 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -113.75 -116.16 3.26 Favored Glycine 0 N--CA 1.423 -2.175 0 O-C-N 124.238 0.611 . . . . 0.0 112.173 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.611 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.04 -23.71 25.59 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.815 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -176.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' HB2' HG22 ' A' ' 89' ' ' THR . 24.7 t70 -67.93 -15.71 63.74 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.812 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.568 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 9.8 mm-40 -108.87 150.19 28.04 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.549 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 9.3 t70 -93.11 122.65 62.97 Favored Pre-proline 0 N--CA 1.484 1.274 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 -176.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -57.68 -24.94 65.55 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.706 2.271 . . . . 0.0 113.41 -175.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 m -70.81 -25.4 62.84 Favored 'General case' 0 CA--C 1.549 0.926 0 CA-C-O 121.343 0.592 . . . . 0.0 110.128 -177.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.549 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -121.24 12.24 10.96 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.059 -176.449 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.447 HD21 ' HB2' ' A' ' 39' ' ' GLN . 94.2 m-20 -88.7 147.3 39.0 Favored Pre-proline 0 C--N 1.307 -1.242 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.976 178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -72.2 -47.94 0.38 Allowed 'Trans proline' 0 CA--C 1.535 0.54 0 C-N-CA 122.398 2.066 . . . . 0.0 113.74 -177.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -113.67 24.11 12.46 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.866 0.841 . . . . 0.0 110.356 -176.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -135.16 15.83 3.49 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.307 178.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -91.4 3.78 54.08 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 120.835 0.35 . . . . 0.0 111.782 -177.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -61.08 -58.86 6.63 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 122.202 1.001 . . . . 0.0 108.72 177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -140.81 -177.86 5.27 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 -178.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.3 p -84.84 23.56 1.17 Allowed 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.894 0.854 . . . . 0.0 112.133 -176.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -87.62 117.03 26.15 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.806 -176.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.611 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 71.9 mttt -88.72 178.15 6.55 Favored 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 123.373 0.669 . . . . 0.0 110.911 -178.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.29 157.7 7.52 Favored Glycine 0 C--O 1.197 -2.198 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.685 HD12 HD12 ' A' ' 33' ' ' ILE . 22.3 mm -76.71 131.84 34.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 CA-C-N 118.066 0.933 . . . . 0.0 110.057 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.496 ' HB3' ' HG2' ' A' ' 76' ' ' LYS . 4.7 p90 -133.84 156.78 47.44 Favored 'General case' 0 CA--C 1.47 -2.098 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.523 178.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.474 HG13 ' HA ' ' A' ' 73' ' ' ILE . 8.2 p -84.24 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.674 0 O-C-N 125.035 1.46 . . . . 0.0 110.966 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.3 p -110.45 -23.29 11.23 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.407 0.622 . . . . 0.0 111.699 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 31' ' ' PHE . 29.8 ttm180 -136.29 146.41 46.63 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 179.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 66' ' ' ALA . 18.1 t -135.91 150.99 28.67 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.519 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.416 ' OG ' ' HB3' ' A' ' 66' ' ' ALA . 18.7 p -52.91 127.66 24.4 Favored 'General case' 0 N--CA 1.402 -2.836 0 O-C-N 124.047 0.842 . . . . 0.0 109.644 177.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -65.61 -19.65 66.0 Favored 'General case' 0 C--N 1.291 -1.956 0 O-C-N 124.048 0.842 . . . . 0.0 111.82 -179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -169.88 50.23 0.2 Allowed Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.637 -1.785 . . . . 0.0 108.637 177.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.486 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -129.49 -165.57 11.7 Favored Glycine 0 N--CA 1.434 -1.439 0 CA-C-N 114.975 -0.613 . . . . 0.0 112.464 -175.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HD2' HD22 ' A' ' 21' ' ' LEU . 34.8 Cg_endo -63.4 -34.33 66.45 Favored 'Trans proline' 0 CA--C 1.505 -0.939 0 C-N-CA 123.488 2.792 . . . . 0.0 113.21 -169.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.416 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -60.27 -56.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.553 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.562 -179.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -73.72 -27.7 61.33 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 119.072 -1.051 . . . . 0.0 112.564 178.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 64' ' ' GLY . 19.6 mm -58.61 -44.36 89.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.439 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -76.34 -55.65 5.36 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.834 178.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 148.47 33.81 0.05 OUTLIER Glycine 0 CA--C 1.499 -0.916 0 C-N-CA 119.479 -1.343 . . . . 0.0 113.018 178.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.66 ' HB2' HG11 ' A' ' 16' ' ' VAL . 2.1 tp -92.17 115.75 28.35 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 176.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.3 mm-40 -111.3 141.48 44.78 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.474 ' HA ' HG13 ' A' ' 57' ' ' VAL . 70.7 mt -56.59 126.76 14.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.264 0 O-C-N 123.603 0.565 . . . . 0.0 109.92 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 107.79 -3.25 34.01 Favored Glycine 0 N--CA 1.441 -1.0 0 C-N-CA 120.133 -1.032 . . . . 0.0 112.341 -176.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.457 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 8.5 m-20 -86.2 131.88 34.13 Favored 'General case' 0 CA--C 1.482 -1.64 0 CA-C-O 120.986 0.422 . . . . 0.0 111.436 177.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.496 ' HG2' ' HB3' ' A' ' 56' ' ' TYR . 47.5 mtpt -89.16 126.97 35.69 Favored 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.443 HG13 HG12 ' A' ' 109' ' ' VAL . 3.2 mp -92.22 122.3 43.56 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 -174.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.463 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 25.4 mmt -105.8 -15.78 14.85 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.41 -0.516 . . . . 0.0 112.347 -177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.622 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.9 OUTLIER -153.56 136.52 15.45 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 -177.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.519 HG22 HD22 ' A' ' 107' ' ' LEU . 72.6 t -140.85 118.47 9.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 123.795 0.838 . . . . 0.0 110.919 -176.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.412 HD22 ' HA ' ' A' ' 81' ' ' ASN . 1.1 t-20 61.98 14.48 6.46 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 125.271 1.429 . . . . 0.0 113.157 171.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.468 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 114.61 -15.88 19.43 Favored Glycine 0 C--N 1.304 -1.231 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.958 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -90.64 149.91 21.91 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -97.08 113.59 25.17 Favored 'General case' 0 C--N 1.285 -2.207 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 176.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.543 ' HG3' HG11 ' A' ' 88' ' ' VAL . 21.3 ttm -77.84 -60.3 2.43 Favored 'General case' 0 C--N 1.287 -2.112 0 CA-C-N 114.572 -1.194 . . . . 0.0 111.118 -174.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.513 HG23 ' H ' ' A' ' 87' ' ' MET 0.279 9.8 t 23.26 -76.5 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.954 0 C-N-CA 127.603 2.361 . . . . 0.0 116.775 -176.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.513 ' H ' HG23 ' A' ' 86' ' ' THR . 27.7 ttt -113.97 93.66 4.47 Favored 'General case' 0 N--CA 1.42 -1.941 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -177.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.543 HG11 ' HG3' ' A' ' 85' ' ' MET . 9.5 p -148.7 153.25 11.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 CA-C-N 114.84 -1.073 . . . . 0.0 108.346 -178.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 38' ' ' ASP . 4.7 p -70.28 152.9 43.67 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.568 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 9.5 t60 -50.75 -46.22 59.24 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.008 176.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.555 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 38.6 t70 -57.83 -48.95 78.28 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.535 -177.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -71.69 -35.9 70.42 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.67 -178.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.557 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -66.09 -40.99 91.24 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.451 178.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 8.4 mmm180 -55.36 -38.79 69.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.802 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 91' ' ' ASP . 38.6 mttm -83.3 30.74 0.46 Allowed 'General case' 0 C--N 1.311 -1.1 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -175.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.42 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.7 tpm_? -148.66 -43.7 0.15 Allowed 'General case' 0 N--CA 1.433 -1.284 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.507 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.1 pp -102.05 -16.16 16.52 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.433 ' N ' HD12 ' A' ' 97' ' ' LEU . 15.0 t -121.62 10.66 10.42 Favored 'General case' 0 C--N 1.282 -2.336 0 C-N-CA 117.831 -1.548 . . . . 0.0 110.848 174.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.564 ' HD3' ' HB3' ' A' ' 101' ' ' SER . 15.8 ptpt -68.59 171.41 7.63 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 173.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 27' ' ' LEU . 18.7 ptt180 -123.99 13.01 9.08 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.211 0.529 . . . . 0.0 111.317 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.564 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 31.3 t -76.83 -41.1 45.53 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-O 121.243 0.544 . . . . 0.0 110.333 -179.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -109.26 167.09 10.37 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 -179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.579 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.6 pt-20 -120.34 -64.27 1.27 Allowed 'General case' 0 C--N 1.307 -1.271 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -176.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 12.5 t -91.54 123.69 43.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 N-CA-C 109.368 -0.605 . . . . 0.0 109.368 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.464 HG21 HD23 ' A' ' 29' ' ' LEU . 25.2 m -125.28 136.73 59.93 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 CA-C-O 121.236 0.541 . . . . 0.0 112.056 -176.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 20.9 mmt85 -95.9 110.24 22.47 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 172.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.519 HD22 HG22 ' A' ' 80' ' ' VAL . 14.8 mt -109.23 156.2 20.19 Favored 'General case' 0 C--N 1.282 -2.344 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.622 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 3.4 mp -130.03 123.02 29.52 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 173.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 75' ' ' ASP . 33.5 m -117.36 157.22 18.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.747 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.584 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.743 HG22 HG22 ' A' ' 13' ' ' VAL . 39.9 p -115.28 118.62 33.78 Favored 'General case' 0 N--CA 1.402 -2.86 0 CA-C-N 115.493 -0.776 . . . . 0.0 111.139 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.486 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 2.1 mmp_? -73.51 112.52 9.67 Favored 'General case' 0 CA--C 1.485 -1.52 0 N-CA-C 105.889 -1.893 . . . . 0.0 105.889 176.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -85.3 -46.62 10.82 Favored 'General case' 0 C--N 1.283 -2.306 0 C-N-CA 120.8 -0.36 . . . . 0.0 110.868 -175.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 14.9 m 51.15 41.18 27.39 Favored 'General case' 0 CA--C 1.547 0.844 0 O-C-N 124.181 0.925 . . . . 0.0 110.194 177.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 54.1 tp 70.98 84.9 0.13 Allowed 'General case' 0 C--O 1.239 0.527 0 C-N-CA 124.88 1.272 . . . . 0.0 108.281 -172.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -69.34 155.09 41.0 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.447 -174.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -116.53 147.16 42.06 Favored 'General case' 0 N--CA 1.429 -1.483 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 174.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -113.56 -166.87 1.13 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.194 0.521 . . . . 0.0 111.146 -174.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 15.9 m -86.1 69.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 CA-C-O 123.484 1.611 . . . . 0.0 108.901 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 91.42 -79.46 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 110.282 -3.144 . . . . 0.0 109.398 178.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 59.5 tp60 -163.69 97.34 0.86 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 50.8 m 65.3 118.41 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.397 1.079 . . . . 0.0 113.819 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 22.5 ptp -90.0 -2.25 58.11 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.982 179.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 pp -66.14 127.72 33.28 Favored 'General case' 0 C--O 1.243 0.717 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.812 -178.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.2 p . . . . . 0 N--CA 1.435 -1.18 0 C-N-CA 124.46 1.104 . . . . 0.0 108.707 178.696 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.821 0 N-CA-C 110.318 -1.113 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -164.67 118.82 1.35 Allowed 'General case' 0 N--CA 1.434 -1.229 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -177.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.3 t80 -145.49 114.13 6.79 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.5 mt -106.1 115.58 60.94 Favored Pre-proline 0 C--N 1.287 -2.138 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -80.85 -175.67 2.79 Favored 'Trans proline' 0 N--CA 1.443 -1.484 0 C-N-CA 122.302 2.001 . . . . 0.0 111.986 177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -121.76 58.01 0.6 Allowed Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -81.86 120.33 77.36 Favored Pre-proline 0 C--N 1.311 -1.066 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -77.65 -88.47 0.0 OUTLIER 'Trans proline' 0 CA--C 1.553 1.441 0 C-N-CA 123.517 2.811 . . . . 0.0 113.148 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 m -147.06 -47.99 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 123.368 0.667 . . . . 0.0 111.29 178.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -98.1 -7.6 29.3 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -171.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.52 143.24 33.3 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.313 -177.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.8 t -112.21 115.7 50.56 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.6 p -98.37 135.3 33.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.459 HE21 HG22 ' A' ' 109' ' ' VAL . 0.1 OUTLIER -148.97 154.77 39.86 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 110.497 -0.186 . . . . 0.0 110.497 -178.074 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.62 150.2 20.47 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.635 -176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.2 OUTLIER -135.61 162.81 36.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.007 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -154.24 114.23 3.85 Favored 'General case' 0 N--CA 1.425 -1.677 0 CA-C-O 121.258 0.551 . . . . 0.0 110.818 176.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.452 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.9 mp -97.38 134.53 34.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.752 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.31 -179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.418 ' HD2' HG13 ' A' ' 104' ' ' VAL . 42.5 m170 -105.04 134.28 48.41 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.551 ' HD3' ' HB2' ' A' ' 103' ' ' GLU . 43.7 pttt -28.12 118.37 0.11 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.634 2.087 . . . . 0.0 116.634 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.438 HD22 ' CD ' ' A' ' 65' ' ' PRO . 45.9 tp -121.8 130.45 53.41 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.141 176.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -97.85 127.85 44.07 Favored 'General case' 0 N--CA 1.421 -1.897 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 176.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -121.01 92.87 3.86 Favored 'General case' 0 N--CA 1.412 -2.349 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.99 -111.83 3.36 Favored Glycine 0 N--CA 1.428 -1.856 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -109.88 15.98 22.29 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-O 121.332 0.587 . . . . 0.0 110.255 -178.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.412 ' HA ' ' NH2' ' A' ' 100' ' ' ARG . 0.4 OUTLIER -125.83 163.92 21.84 Favored 'General case' 0 CA--C 1.491 -1.303 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -177.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -117.56 112.55 20.73 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 103.765 -2.68 . . . . 0.0 103.765 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -128.87 160.79 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.619 HD13 HG21 ' A' ' 105' ' ' VAL . 54.0 mt -86.48 0.41 54.27 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.442 0.639 . . . . 0.0 109.804 176.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.56 -37.68 3.34 Favored Glycine 0 N--CA 1.431 -1.664 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.319 178.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -95.84 171.47 8.62 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -177.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 48.8 m -130.68 169.5 15.56 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 124.679 1.192 . . . . 0.0 109.975 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 55' ' ' ILE . 6.8 pt -128.49 165.33 28.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-N 117.701 0.228 . . . . 0.0 110.671 -172.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.44 -31.4 3.76 Favored Glycine 0 CA--C 1.488 -1.616 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.53 ' HA3' ' HG3' ' A' ' 39' ' ' GLN . . . 124.11 154.74 8.98 Favored Glycine 0 C--O 1.199 -2.077 0 C-N-CA 119.416 -1.373 . . . . 0.0 113.187 178.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.575 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -102.18 -119.17 4.51 Favored Glycine 0 N--CA 1.424 -2.115 0 O-C-N 124.157 0.563 . . . . 0.0 112.85 -178.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.645 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -66.71 -22.6 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 -174.164 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.465 ' HB2' HG22 ' A' ' 89' ' ' THR . 31.7 t70 -70.9 -18.05 62.69 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-O 121.819 0.818 . . . . 0.0 110.163 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.569 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 11.0 mm-40 -105.87 147.07 29.13 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 -178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.454 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 4.8 t70 -94.12 127.15 46.01 Favored Pre-proline 0 C--N 1.298 -1.634 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -175.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.68 -20.86 44.46 Favored 'Trans proline' 0 N--CA 1.48 0.721 0 C-N-CA 123.37 2.714 . . . . 0.0 113.322 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.9 m -76.91 -16.07 59.49 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.75 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.454 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -132.14 19.76 4.47 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-O 121.965 0.888 . . . . 0.0 109.946 -177.534 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.588 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 93.3 m-20 -104.55 144.29 28.41 Favored Pre-proline 0 C--N 1.297 -1.69 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.171 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -72.51 -51.74 0.19 Allowed 'Trans proline' 0 CA--C 1.539 0.772 0 C-N-CA 122.692 2.261 . . . . 0.0 113.668 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -112.12 22.46 14.77 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.329 0.585 . . . . 0.0 110.639 -173.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.588 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 8.5 t -117.58 2.06 12.32 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -84.81 14.2 5.04 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.976 -171.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.524 ' O ' ' HG3' ' A' ' 50' ' ' LYS . 12.4 m-20 -61.55 -36.34 80.33 Favored 'General case' 0 C--O 1.186 -2.277 0 CA-C-N 114.803 -1.089 . . . . 0.0 109.229 178.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.524 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 1.2 mptt -166.1 -144.7 0.07 Allowed 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 101.215 -3.624 . . . . 0.0 101.215 177.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 21.7 p -92.26 28.62 1.87 Allowed 'General case' 0 C--N 1.292 -1.913 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 171.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -86.74 101.66 13.52 Favored 'General case' 0 C--O 1.251 1.137 0 C-N-CA 126.113 1.765 . . . . 0.0 112.18 -172.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.645 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 68.8 mttt -81.41 -160.07 0.31 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.089 -179.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 116.75 156.27 10.57 Favored Glycine 0 C--O 1.201 -1.963 0 N-CA-C 109.096 -1.601 . . . . 0.0 109.096 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.665 HD12 HD12 ' A' ' 33' ' ' ILE . 30.4 mm -78.27 126.33 38.39 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.055 0 CA-C-N 117.813 0.806 . . . . 0.0 108.874 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 6.9 p90 -129.52 160.0 34.56 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.787 178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 71' ' ' LEU . 58.8 t -87.47 128.46 39.99 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.594 0 O-C-N 124.73 1.269 . . . . 0.0 110.917 -178.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.3 p -104.8 -20.43 13.6 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.441 178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.1 135.94 23.41 Favored 'General case' 0 C--O 1.2 -1.546 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.456 HG22 HG11 ' A' ' 57' ' ' VAL . 64.6 t -123.59 148.13 27.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.749 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 176.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.48 ' OG ' ' HB3' ' A' ' 66' ' ' ALA . 37.7 p -51.82 126.33 17.7 Favored 'General case' 0 N--CA 1.401 -2.901 0 O-C-N 124.328 1.017 . . . . 0.0 108.563 174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -71.32 -28.21 63.93 Favored 'General case' 0 C--N 1.276 -2.591 0 CA-C-O 121.596 0.712 . . . . 0.0 109.868 176.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -148.52 55.57 0.5 Allowed Glycine 0 N--CA 1.43 -1.732 0 CA-C-N 114.736 -1.12 . . . . 0.0 110.606 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.447 ' O ' ' HG3' ' A' ' 67' ' ' GLU . . . -139.28 -169.41 11.57 Favored Glycine 0 N--CA 1.426 -2.01 0 N-CA-C 111.374 -0.691 . . . . 0.0 111.374 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' CD ' HD22 ' A' ' 21' ' ' LEU . 38.4 Cg_endo -65.61 -30.71 51.19 Favored 'Trans proline' 0 CA--C 1.512 -0.618 0 C-N-CA 123.677 2.918 . . . . 0.0 113.047 -171.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.48 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -61.96 -53.8 50.64 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.914 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 64' ' ' GLY . 2.3 pp20? -69.84 -30.62 68.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.551 0.215 . . . . 0.0 111.28 178.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.0 mm -62.26 -45.26 99.17 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.638 176.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -72.23 -48.14 45.07 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.31 -179.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 139.03 21.51 0.41 Allowed Glycine 0 C--N 1.315 -0.611 0 C-N-CA 120.293 -0.956 . . . . 0.0 113.069 178.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.758 HD11 HG21 ' A' ' 57' ' ' VAL . 3.4 tp -83.03 125.46 31.47 Favored 'General case' 0 N--CA 1.437 -1.1 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 178.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.461 ' N ' HD12 ' A' ' 71' ' ' LEU . 20.9 mm-40 -116.8 158.08 24.5 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.715 0.769 . . . . 0.0 109.614 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.6 mt -67.38 135.0 29.35 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.543 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.898 173.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 101.82 -10.95 57.54 Favored Glycine 0 C--O 1.245 0.796 0 C-N-CA 120.739 -0.743 . . . . 0.0 111.367 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 87.5 m-20 -74.99 114.69 13.76 Favored 'General case' 0 C--O 1.246 0.907 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.447 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 18.7 ptpt -91.62 122.31 34.08 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.483 176.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.563 HD11 HG23 ' A' ' 57' ' ' VAL . 2.9 mp -86.53 134.14 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.194 -172.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.617 ' SD ' ' HA ' ' A' ' 86' ' ' THR . 24.3 mmt -114.83 -14.07 11.96 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.565 0.697 . . . . 0.0 110.869 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.6 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 23.0 tp60 -147.06 129.76 16.07 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.564 -177.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.591 HG22 HD12 ' A' ' 107' ' ' LEU . 46.2 t -135.38 116.08 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.076 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.5 HD22 ' HA ' ' A' ' 105' ' ' VAL . 5.3 t-20 37.6 59.15 1.28 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 126.269 1.827 . . . . 0.0 113.465 176.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 68.24 4.82 38.63 Favored Glycine 0 C--N 1.3 -1.461 0 N-CA-C 116.645 1.418 . . . . 0.0 116.645 177.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.431 ' CD1' ' HB ' ' A' ' 80' ' ' VAL 0.385 0.0 OUTLIER -90.27 -100.02 0.1 Allowed 'General case' 0 CA--C 1.585 2.321 0 CA-C-N 118.635 1.218 . . . . 0.0 112.603 178.52 . . . . . . . . 4 4 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 16.3 t70 173.66 116.96 0.02 OUTLIER 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.431 ' HE2' HD23 ' A' ' 97' ' ' LEU . 3.7 tpt -115.14 -2.77 12.66 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 119.07 -1.052 . . . . 0.0 110.015 -175.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.617 ' HA ' ' SD ' ' A' ' 78' ' ' MET . 11.5 t -64.87 -28.3 69.45 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 114.597 -1.183 . . . . 0.0 112.541 -174.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 49.6 ttm -146.72 87.53 1.71 Allowed 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.38 0.609 . . . . 0.0 109.579 178.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.43 HG13 HG13 ' A' ' 55' ' ' ILE . 7.5 p -149.37 149.63 14.6 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.913 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.465 HG22 ' HB2' ' A' ' 38' ' ' ASP . 4.3 p -71.22 155.86 40.23 Favored 'General case' 0 N--CA 1.421 -1.907 0 C-N-CA 123.3 0.64 . . . . 0.0 110.428 178.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.569 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.5 t60 -55.6 -43.83 76.4 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.787 176.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -61.16 -48.89 79.52 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.684 -177.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -69.99 -32.52 70.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.11 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.521 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -69.73 -42.64 73.71 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.05 178.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.441 ' HG2' ' O ' ' A' ' 90' ' ' HIS . 11.2 mmm180 -60.6 -37.03 80.02 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-O 121.83 0.824 . . . . 0.0 108.849 177.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -82.91 21.16 1.07 Allowed 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 114.653 -1.158 . . . . 0.0 109.052 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.527 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 17.7 mmt180 -134.69 -42.53 0.76 Allowed 'General case' 0 CA--C 1.5 -0.955 0 CA-C-N 115.335 -0.848 . . . . 0.0 112.316 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.625 HD21 HG21 ' A' ' 33' ' ' ILE . 1.3 pp -100.62 -28.82 12.66 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 178.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.463 ' N ' HD12 ' A' ' 97' ' ' LEU . 9.3 t -106.97 14.8 26.06 Favored 'General case' 0 C--N 1.288 -2.083 0 C-N-CA 117.983 -1.487 . . . . 0.0 109.872 177.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.527 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 14.4 ptpt -73.67 175.48 7.12 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.466 169.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.412 ' NH2' ' HA ' ' A' ' 26' ' ' ASN . 14.3 ptp180 -122.81 6.88 9.35 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -178.138 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.423 ' HB3' ' HD3' ' A' ' 99' ' ' LYS . 22.3 t -75.26 -38.45 60.49 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.913 0.387 . . . . 0.0 110.118 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.497 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 0.9 OUTLIER -87.97 174.15 8.48 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.529 178.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.551 ' HB2' ' HD3' ' A' ' 20' ' ' LYS . 8.6 pt-20 -137.77 -58.72 0.67 Allowed 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.587 178.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.42 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 59.0 t -104.07 127.2 58.47 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 176.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.619 HG21 HD13 ' A' ' 29' ' ' LEU . 15.0 m -122.16 148.62 25.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.385 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 mtm-85 -119.23 103.96 9.98 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 -174.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.591 HD12 HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -110.17 151.85 26.78 Favored 'General case' 0 C--N 1.275 -2.663 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.963 -171.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.6 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.3 mp -125.31 119.37 28.2 Favored 'General case' 0 C--N 1.281 -2.389 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.516 HG12 HG13 ' A' ' 77' ' ' ILE . 27.1 m -112.58 147.2 16.46 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.926 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.184 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 45.7 p -116.09 128.73 55.91 Favored 'General case' 0 N--CA 1.408 -2.57 0 CA-C-N 115.321 -0.854 . . . . 0.0 108.842 178.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 84.6 mtt180 -104.9 108.9 20.65 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 31.3 mm-40 -82.79 -54.93 4.73 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -176.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 23.5 m 48.86 37.68 10.51 Favored 'General case' 0 C--O 1.248 1.006 0 O-C-N 124.309 1.006 . . . . 0.0 110.785 -179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 49' ' ' ASP . 32.0 tp -72.25 147.62 46.28 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.29 -176.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.466 ' HG3' ' H ' ' A' ' 116' ' ' LYS . 11.4 pt20 -48.41 -61.05 2.21 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 125.298 1.439 . . . . 0.0 114.115 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' A' ' 115' ' ' GLN . 33.7 mmtp -145.62 176.38 9.66 Favored 'General case' 0 C--N 1.307 -1.276 0 N-CA-C 107.09 -1.448 . . . . 0.0 107.09 -176.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -64.42 -84.73 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 124.627 1.205 . . . . 0.0 113.138 -175.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 7.3 p -163.95 78.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.431 -1.385 0 CA-C-O 122.391 1.091 . . . . 0.0 113.401 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.51 -3.17 9.89 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.463 1.125 . . . . 0.0 108.207 169.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -134.18 150.55 51.09 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 105.069 -2.197 . . . . 0.0 105.069 175.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 68.1 m 61.09 35.34 18.74 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-O 121.613 0.721 . . . . 0.0 109.979 -177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 90.5 mtp -68.77 116.07 8.84 Favored 'General case' 0 C--O 1.245 0.843 0 CA-C-N 114.827 -1.079 . . . . 0.0 111.164 -177.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 5.5 mp -69.96 -43.71 70.97 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 177.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.9 m . . . . . 0 N--CA 1.421 -1.923 0 CA-C-N 113.983 -1.462 . . . . 0.0 107.465 177.17 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.87 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.1 m -86.6 97.34 10.48 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 117.037 0.419 . . . . 0.0 111.156 -176.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -139.01 132.33 30.01 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 175.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.465 HD12 ' HD2' ' A' ' 5' ' ' PRO . 6.4 tp -123.84 115.87 27.8 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 177.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.465 ' HD2' HD12 ' A' ' 4' ' ' ILE . 15.5 Cg_endo -65.49 167.75 16.21 Favored 'Trans proline' 0 C--O 1.241 0.626 0 C-N-CA 122.73 2.287 . . . . 0.0 114.242 -177.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -95.78 54.33 1.67 Allowed Glycine 0 N--CA 1.426 -2.002 0 CA-C-N 114.401 -1.272 . . . . 0.0 111.554 179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.17 129.2 90.47 Favored Pre-proline 0 C--N 1.319 -0.76 0 C-N-CA 123.021 0.529 . . . . 0.0 110.467 174.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 11' ' ' ALA . 58.7 Cg_endo -79.69 -84.33 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.232 0 C-N-CA 122.04 1.827 . . . . 0.0 111.705 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 m -137.01 -52.28 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 120.735 0.303 . . . . 0.0 111.236 176.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.2 t -99.13 -48.3 4.9 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -177.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.471 ' O ' ' HD2' ' A' ' 8' ' ' PRO . . . -69.08 135.85 51.41 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-O 121.5 0.666 . . . . 0.0 111.371 -176.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 47.2 t -103.17 106.01 19.33 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.316 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.517 HG22 HG22 ' A' ' 110' ' ' THR . 12.7 t -80.45 126.35 39.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 174.18 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.454 HE21 HG22 ' A' ' 109' ' ' VAL . 0.2 OUTLIER -144.74 153.1 41.33 Favored 'General case' 0 C--N 1.288 -2.09 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.425 -175.1 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -90.12 148.17 23.16 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.535 HG11 ' HB2' ' A' ' 71' ' ' LEU . 0.3 OUTLIER -128.29 152.24 36.14 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 174.129 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -135.24 104.36 5.87 Favored 'General case' 0 C--N 1.288 -2.071 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.075 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.413 HG21 ' HB3' ' A' ' 29' ' ' LEU . 1.7 mp -92.8 129.74 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.942 -178.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.504 ' HD2' HG13 ' A' ' 104' ' ' VAL . 61.4 m170 -99.35 144.8 28.05 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.62 ' HB2' HD21 ' A' ' 27' ' ' LEU . 20.0 pttm -35.26 127.61 0.57 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 115.439 1.644 . . . . 0.0 115.439 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.401 HD22 ' HD2' ' A' ' 65' ' ' PRO . 44.0 tp -125.14 118.26 25.71 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.227 174.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -88.38 111.86 22.23 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.729 178.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -117.99 110.38 17.62 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 68.93 -109.73 3.04 Favored Glycine 0 C--N 1.305 -1.18 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -113.95 13.31 18.26 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 176.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -112.57 171.64 7.4 Favored 'General case' 0 CA--C 1.479 -1.759 0 CA-C-O 121.873 0.844 . . . . 0.0 109.837 -174.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 20' ' ' LYS . 2.3 tm? -126.53 111.82 14.82 Favored 'General case' 0 C--N 1.27 -2.856 0 N-CA-C 102.169 -3.271 . . . . 0.0 102.169 172.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -124.97 164.5 23.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.486 HD13 HG21 ' A' ' 105' ' ' VAL . 38.1 mt -87.66 -4.24 58.94 Favored 'General case' 0 C--N 1.306 -1.316 0 CA-C-O 121.964 0.888 . . . . 0.0 108.629 174.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 61' ' ' SER . . . 92.67 -46.02 2.53 Favored Glycine 0 N--CA 1.424 -2.154 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.949 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -84.33 166.46 17.41 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.193 0.521 . . . . 0.0 112.218 -177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 57' ' ' VAL . 29.2 m -122.36 166.85 14.05 Favored 'General case' 0 C--N 1.308 -1.237 0 C-N-CA 124.656 1.182 . . . . 0.0 109.961 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 55' ' ' ILE . 3.7 pt -125.14 164.4 24.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -175.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -115.07 -16.23 7.39 Favored Glycine 0 CA--C 1.487 -1.685 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.328 179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.586 ' HA3' ' CG ' ' A' ' 39' ' ' GLN . . . 125.04 169.35 12.93 Favored Glycine 0 CA--C 1.473 -2.54 0 C-N-CA 119.654 -1.26 . . . . 0.0 112.168 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.523 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -122.2 -116.3 2.36 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.367 0.686 . . . . 0.0 111.57 175.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.526 ' HA ' ' HD3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -70.45 -15.31 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 CA-C-O 122.151 0.977 . . . . 0.0 110.777 -177.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.513 ' HB3' ' NE2' ' A' ' 39' ' ' GLN . 15.2 t0 -70.95 -19.91 62.51 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.547 -1.66 . . . . 0.0 108.085 -177.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.586 ' CG ' ' HA3' ' A' ' 35' ' ' GLY . 16.4 mm-40 -113.37 155.25 25.55 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -177.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.512 ' O ' ' HG2' ' A' ' 43' ' ' GLN . 10.0 t70 -98.32 129.37 30.73 Favored Pre-proline 0 C--N 1.303 -1.435 0 CA-C-N 118.612 0.642 . . . . 0.0 109.431 -176.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.53 -21.3 45.35 Favored 'Trans proline' 0 C--O 1.212 -0.786 0 C-N-CA 122.768 2.312 . . . . 0.0 113.198 -177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.8 m -77.36 -11.13 59.8 Favored 'General case' 0 CA--C 1.55 0.957 0 CA-C-O 121.015 0.436 . . . . 0.0 110.625 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -130.15 11.58 5.51 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.415 0.626 . . . . 0.0 110.75 -179.654 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.594 ' HB2' ' HB3' ' A' ' 47' ' ' SER . 97.4 m-20 -99.91 143.32 26.27 Favored Pre-proline 0 C--N 1.301 -1.51 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -67.76 -52.98 0.47 Allowed 'Trans proline' 0 CA--C 1.529 0.243 0 C-N-CA 123.201 2.601 . . . . 0.0 113.118 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -109.38 18.11 20.77 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.575 -172.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.594 ' HB3' ' HB2' ' A' ' 44' ' ' ASN . 4.0 t -123.25 -2.37 8.58 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.065 -0.654 . . . . 0.0 109.985 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -83.55 -4.33 58.45 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -174.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -62.12 -38.59 89.5 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.705 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 41.8 mmtm -145.81 -168.55 3.01 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 12.0 p -96.48 0.63 50.59 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.55 0.69 . . . . 0.0 109.659 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -76.09 99.85 4.77 Favored 'General case' 0 C--O 1.256 1.421 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.276 -176.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.526 ' HD3' ' HA ' ' A' ' 37' ' ' ILE . 53.4 mttt -74.88 178.4 5.57 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.533 -1.212 . . . . 0.0 111.387 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 145.56 153.36 5.85 Favored Glycine 0 C--O 1.18 -3.273 0 N-CA-C 109.364 -1.495 . . . . 0.0 109.364 179.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.672 HD12 HD12 ' A' ' 33' ' ' ILE . 30.5 mm -68.27 125.33 25.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-N 118.009 0.904 . . . . 0.0 109.774 179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 76' ' ' LYS . 2.3 p90 -124.98 155.9 38.91 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.188 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.674 HG21 HD11 ' A' ' 71' ' ' LEU . 87.7 t -81.46 129.92 36.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 O-C-N 124.455 1.097 . . . . 0.0 110.619 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.2 p -106.08 -19.7 13.64 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.279 0.561 . . . . 0.0 111.068 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 55.4 mtm180 -154.46 138.97 16.84 Favored 'General case' 0 C--O 1.204 -1.309 0 C-N-CA 124.124 0.97 . . . . 0.0 108.519 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.519 HG11 ' O ' ' A' ' 71' ' ' LEU . 18.9 m -109.87 174.83 1.75 Allowed 'Isoleucine or valine' 1 N--CA 1.355 -5.194 0 CA-C-N 119.688 1.131 . . . . 0.0 109.222 172.025 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.624 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 9.3 t -77.93 116.23 18.26 Favored 'General case' 0 N--CA 1.413 -2.284 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 177.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -52.85 -16.34 0.99 Allowed 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 125.997 1.719 . . . . 0.0 114.68 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -159.35 30.41 0.42 Allowed Glycine 0 C--N 1.288 -2.123 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 176.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.17 -171.46 19.33 Favored Glycine 0 N--CA 1.422 -2.283 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.456 -173.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD2' HD22 ' A' ' 21' ' ' LEU . 37.7 Cg_endo -63.8 -27.07 67.71 Favored 'Trans proline' 0 C--O 1.208 -0.986 0 C-N-CA 123.468 2.778 . . . . 0.0 111.634 -171.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.51 -66.71 0.42 Allowed 'General case' 0 N--CA 1.435 -1.208 0 CA-C-N 114.979 -1.01 . . . . 0.0 110.796 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.624 ' HG2' ' O ' ' A' ' 61' ' ' SER . 7.7 pt-20 -75.43 -22.74 57.12 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 119.073 -1.051 . . . . 0.0 112.592 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 19.6 mm -62.93 -41.03 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.03 -45.51 26.96 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.074 178.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 147.1 2.24 0.53 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 119.644 -1.265 . . . . 0.0 114.08 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.674 HD11 HG21 ' A' ' 57' ' ' VAL . 7.6 tp -74.8 126.51 31.07 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 122.767 -0.255 . . . . 0.0 110.638 -178.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 -120.3 160.82 22.24 Favored 'General case' 0 N--CA 1.424 -1.728 0 O-C-N 124.134 0.896 . . . . 0.0 109.936 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 46.8 mt -61.98 128.72 24.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.155 0 CA-C-N 114.741 -1.118 . . . . 0.0 109.491 173.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 103.12 -9.47 54.51 Favored Glycine 0 N--CA 1.437 -1.297 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.341 178.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.433 ' HB3' ' HB ' ' A' ' 109' ' ' VAL . 74.1 m-20 -77.78 119.13 20.85 Favored 'General case' 0 C--N 1.308 -1.225 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 176.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 56' ' ' TYR . 37.6 ttpt -88.9 124.12 33.91 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.529 HG13 HG12 ' A' ' 109' ' ' VAL . 3.0 mp -88.29 135.96 24.4 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 -174.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 5.1 mmt -107.77 -26.1 10.95 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-O 121.389 0.614 . . . . 0.0 109.839 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.586 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 0.3 OUTLIER -151.63 133.73 15.12 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -170.741 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.619 HG22 HD22 ' A' ' 107' ' ' LEU . 49.9 t -136.98 117.57 17.21 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.179 0 C-N-CA 123.663 0.785 . . . . 0.0 110.037 -178.041 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.406 HD22 ' HA ' ' A' ' 81' ' ' ASN . 1.1 t-20 49.6 49.98 19.03 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.153 0.981 . . . . 0.0 111.625 171.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.528 ' N ' HE22 ' A' ' 79' ' ' GLN . . . 69.93 8.06 60.39 Favored Glycine 0 CA--C 1.541 1.717 0 N-CA-C 116.187 1.235 . . . . 0.0 116.187 -177.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.442 ' CD2' ' HD2' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -115.26 158.87 21.72 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-N 117.681 0.74 . . . . 0.0 110.346 176.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -86.55 127.06 34.86 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 123.299 0.64 . . . . 0.0 110.509 -175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.508 ' CG ' ' HB ' ' A' ' 55' ' ' ILE . 20.2 ttm -117.47 -4.5 11.29 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.92 0.867 . . . . 0.0 110.737 177.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 9.8 t -68.11 -25.46 65.32 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.779 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 25.5 ttt -135.95 85.51 2.16 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.91 0.386 . . . . 0.0 110.519 175.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG21 ' CZ2' ' A' ' 83' ' ' TRP . 11.2 p -154.79 148.4 12.9 Favored 'Isoleucine or valine' 0 C--O 1.254 1.295 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.445 ' OG1' ' HB2' ' A' ' 92' ' ' GLN . 7.9 p -73.05 156.54 38.66 Favored 'General case' 0 N--CA 1.419 -1.993 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.53 178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.583 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.1 t60 -55.42 -47.33 76.11 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 175.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.556 ' O ' ' HG2' ' A' ' 95' ' ' LYS . 33.8 t70 -58.93 -47.46 84.96 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 114.21 -1.359 . . . . 0.0 111.331 -176.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.445 ' HB2' ' OG1' ' A' ' 89' ' ' THR . 0.5 OUTLIER -72.1 -39.46 68.91 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.202 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.94 -41.7 99.57 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.303 179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.486 ' CZ ' HG21 ' A' ' 98' ' ' THR . 18.2 mmm180 -58.16 -26.03 62.22 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 121.485 0.659 . . . . 0.0 112.119 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 91' ' ' ASP . 45.1 mmtm -95.0 8.19 43.68 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 -175.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 24.7 ttm180 -136.79 -30.96 0.87 Allowed 'General case' 0 N--CA 1.419 -2.008 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.686 -175.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.409 HD23 ' H ' ' A' ' 98' ' ' THR . 1.2 pt? -92.98 -40.6 10.47 Favored 'General case' 0 C--O 1.19 -2.062 0 C-N-CA 116.646 -2.021 . . . . 0.0 111.132 174.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.486 HG21 ' CZ ' ' A' ' 94' ' ' ARG . 8.8 t -102.15 14.71 31.21 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 109.406 -174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.587 ' HE3' ' HA ' ' A' ' 96' ' ' ARG . 12.8 ptpt -66.49 -176.06 0.42 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 114.496 -1.229 . . . . 0.0 109.951 170.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -122.07 -3.74 9.06 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 112.916 0.709 . . . . 0.0 112.916 -176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 32.8 t -67.24 -40.41 86.3 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.95 0.405 . . . . 0.0 111.815 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.75 175.51 5.62 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 116.022 -0.536 . . . . 0.0 109.943 -177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.62 ' HB2' ' HB3' ' A' ' 20' ' ' LYS . 7.9 pt-20 -134.79 -62.26 0.74 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.504 HG13 ' HD2' ' A' ' 19' ' ' HIS . 22.2 t -94.53 112.46 27.21 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.519 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.486 HG21 HD13 ' A' ' 29' ' ' LEU . 28.0 m -110.41 131.86 60.33 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 CA-C-N 115.366 -0.833 . . . . 0.0 111.206 -177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 -99.8 107.49 19.55 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 177.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.619 HD22 HG22 ' A' ' 80' ' ' VAL . 13.9 mt -108.65 151.42 26.17 Favored 'General case' 0 C--N 1.278 -2.507 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 -174.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 2.5 mp -122.34 118.62 28.89 Favored 'General case' 0 C--N 1.279 -2.488 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 172.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.529 HG12 HG13 ' A' ' 77' ' ' ILE . 31.7 m -117.85 165.37 13.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.09 -177.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.517 HG22 HG22 ' A' ' 13' ' ' VAL . 23.8 p -117.67 124.48 48.67 Favored 'General case' 0 N--CA 1.407 -2.584 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.307 177.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -81.01 125.65 30.43 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 105.549 -2.019 . . . . 0.0 105.549 177.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 33.5 mm-40 -93.0 -12.94 29.44 Favored 'General case' 0 C--N 1.285 -2.223 0 C-N-CA 120.598 -0.441 . . . . 0.0 111.937 -174.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 21.9 t 61.53 22.8 13.19 Favored 'General case' 0 C--O 1.247 0.967 0 C-N-CA 124.532 1.133 . . . . 0.0 112.139 174.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 92.9 mt 63.28 -52.56 0.2 Allowed 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.933 1.693 . . . . 0.0 113.308 -177.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -119.04 137.23 53.69 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 178.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -87.41 -4.71 59.03 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 120.949 0.404 . . . . 0.0 111.499 -179.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -127.81 135.87 50.68 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.778 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 6.5 m -151.1 44.23 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 125.318 1.447 . . . . 0.0 107.763 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.24 74.72 7.06 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-N 114.046 -1.434 . . . . 0.0 112.866 -174.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -139.35 13.04 2.58 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 122.722 1.248 . . . . 0.0 108.188 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 t -125.28 105.27 8.99 Favored 'General case' 0 N--CA 1.427 -1.578 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 69.4 mtm -73.63 -59.03 2.9 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 177.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -133.09 -36.0 1.03 Allowed 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 174.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 N--CA 1.426 -1.672 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 172.059 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.495 -1.176 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.1 t -147.82 163.19 37.51 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.404 ' CE1' HD21 ' A' ' 108' ' ' LEU . 26.2 p90 -99.09 -2.54 36.82 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 176.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . 0.294 16.1 tt 42.09 90.69 0.07 OUTLIER Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 126.517 1.927 . . . . 0.0 114.151 -178.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -76.01 -173.72 1.78 Allowed 'Trans proline' 0 C--O 1.243 0.753 0 C-N-CA 122.454 2.103 . . . . 0.0 112.941 -178.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.45 47.63 1.17 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 175.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.435 ' HG3' ' O ' ' A' ' 11' ' ' ALA . 7.4 tt0 -84.95 127.94 62.51 Favored Pre-proline 0 N--CA 1.435 -1.176 0 CA-C-N 115.089 -0.556 . . . . 0.0 110.444 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -81.08 -87.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.437 -1.802 0 C-N-CA 121.805 1.67 . . . . 0.0 109.707 174.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.2 m -140.58 -47.23 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 O-C-N 122.268 -0.27 . . . . 0.0 111.33 171.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.6 t -94.28 -29.19 15.19 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -175.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . -76.9 135.07 38.8 Favored 'General case' 0 CA--C 1.482 -1.652 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.5 t -105.37 122.45 58.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.213 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -175.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.648 HG22 HG22 ' A' ' 110' ' ' THR . 25.3 t -108.77 125.98 65.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 175.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.438 HE22 HG22 ' A' ' 16' ' ' VAL . 0.1 OUTLIER -139.43 151.17 46.04 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.317 -176.644 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.03 149.52 23.2 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.78 -177.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 71' ' ' LEU . 1.8 t -129.65 157.77 42.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.416 ' H ' ' HB1' ' A' ' 69' ' ' ALA . 33.3 tt0 -144.92 107.84 4.5 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-O 121.334 0.587 . . . . 0.0 110.771 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.508 ' O ' ' HA ' ' A' ' 104' ' ' VAL . 1.6 mp -97.46 132.17 42.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.845 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.42 ' HD2' HG13 ' A' ' 104' ' ' VAL . 37.5 m170 -98.45 152.65 19.28 Favored 'General case' 0 C--N 1.312 -1.059 0 O-C-N 123.819 0.699 . . . . 0.0 110.232 175.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 103' ' ' GLU . 23.4 ttmm -40.93 113.17 0.36 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 125.508 1.523 . . . . 0.0 114.48 -178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.571 HD22 ' HD2' ' A' ' 65' ' ' PRO . 26.7 tp -127.94 137.43 52.27 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.065 0.546 . . . . 0.0 111.513 177.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 54.9 mtt180 -104.62 131.44 52.03 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 173.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -122.47 107.36 11.95 Favored 'General case' 0 N--CA 1.418 -2.059 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 175.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 69.15 -113.56 5.24 Favored Glycine 0 N--CA 1.435 -1.402 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -179.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -108.79 16.91 22.39 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-O 121.752 0.787 . . . . 0.0 110.539 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -120.63 176.72 5.37 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.431 ' HB3' ' HA ' ' A' ' 100' ' ' ARG . 1.3 tm? -128.13 112.09 14.18 Favored 'General case' 0 C--N 1.278 -2.515 0 N-CA-C 101.921 -3.363 . . . . 0.0 101.921 175.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mt -129.22 159.01 41.74 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.859 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -175.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.623 HD13 HG21 ' A' ' 105' ' ' VAL . 61.0 mt -79.61 2.69 21.45 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.759 0.79 . . . . 0.0 109.844 175.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.4 -35.28 4.57 Favored Glycine 0 N--CA 1.435 -1.421 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.917 177.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -98.76 167.33 10.84 Favored 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -176.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 31.7 m -121.49 164.15 17.66 Favored 'General case' 0 N--CA 1.438 -1.038 0 C-N-CA 124.441 1.096 . . . . 0.0 109.648 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 55' ' ' ILE . 6.2 pt -124.34 163.09 24.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -173.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -107.21 -24.36 6.56 Favored Glycine 0 CA--C 1.484 -1.886 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.462 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.552 ' C ' HD13 ' A' ' 55' ' ' ILE . . . 124.75 167.67 12.67 Favored Glycine 0 N--CA 1.407 -3.25 0 C-N-CA 119.898 -1.144 . . . . 0.0 110.848 -177.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.555 ' N ' HD13 ' A' ' 55' ' ' ILE . . . -113.8 -121.79 3.73 Favored Glycine 0 N--CA 1.427 -1.904 0 O-C-N 124.507 0.769 . . . . 0.0 112.591 176.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.412 ' HA ' ' HD2' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -67.26 -19.51 25.52 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.265 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -175.593 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.453 ' HB2' HG22 ' A' ' 89' ' ' THR . 25.2 t70 -71.57 -16.98 62.32 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.036 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.612 ' NE2' ' HB2' ' A' ' 90' ' ' HIS . 27.0 mm-40 -96.01 -173.9 2.96 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -175.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 43' ' ' GLN . 7.0 t70 -132.98 124.96 18.86 Favored Pre-proline 0 C--N 1.306 -1.297 0 C-N-CA 119.542 -0.863 . . . . 0.0 108.943 179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HD3' ' HD3' ' A' ' 53' ' ' LYS . 10.0 Cg_endo -57.63 -26.69 73.82 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.074 2.516 . . . . 0.0 113.132 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.6 m -68.87 -32.64 72.45 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.228 0.537 . . . . 0.0 110.373 -179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.433 ' HG2' ' HB3' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -112.74 8.51 18.93 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.522 0.677 . . . . 0.0 110.729 -176.271 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.13 142.19 24.14 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -67.85 -51.57 0.64 Allowed 'Trans proline' 0 C--N 1.331 -0.368 0 C-N-CA 123.378 2.719 . . . . 0.0 112.843 -176.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -109.18 26.5 10.56 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.029 -173.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.511 ' HB2' ' CZ ' ' A' ' 56' ' ' TYR . 13.8 t -124.31 -6.76 7.63 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.57 -4.98 45.72 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-N 115.65 -0.705 . . . . 0.0 112.303 -171.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -47.71 -52.62 17.74 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.934 1.693 . . . . 0.0 109.327 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HE2' ' HB2' ' A' ' 52' ' ' ASP . 37.0 mtmm -148.48 -147.11 0.21 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 103.335 -2.839 . . . . 0.0 103.335 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.0 p -99.31 21.41 12.03 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 122.993 1.378 . . . . 0.0 107.887 171.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.47 ' HB2' ' HE2' ' A' ' 50' ' ' LYS . 50.7 t0 -73.48 106.83 5.43 Favored 'General case' 0 C--O 1.245 0.855 0 CA-C-N 112.352 -2.204 . . . . 0.0 111.417 -173.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.486 ' HD3' ' HD3' ' A' ' 41' ' ' PRO . 35.0 mtmm -110.03 171.03 7.69 Favored 'General case' 0 N--CA 1.427 -1.601 0 CA-C-O 121.843 0.83 . . . . 0.0 111.997 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.413 ' O ' ' HA2' ' A' ' 36' ' ' GLY . . . 144.71 167.36 12.06 Favored Glycine 0 C--O 1.17 -3.877 0 N-CA-C 105.963 -2.855 . . . . 0.0 105.963 -175.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 33' ' ' ILE . 35.5 mm -73.9 115.87 15.54 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.377 0 CA-C-N 120.26 2.03 . . . . 0.0 110.433 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.511 ' CZ ' ' HB2' ' A' ' 47' ' ' SER . 0.4 OUTLIER -114.9 151.73 33.5 Favored 'General case' 0 CA--C 1.477 -1.841 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.059 178.867 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.799 HG21 HD11 ' A' ' 71' ' ' LEU . 87.6 t -82.77 128.79 38.39 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.524 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.31 -178.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 p -106.66 -15.04 14.87 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.625 -179.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 28.7 ttm180 -152.23 145.32 24.56 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.442 ' CG2' HG11 ' A' ' 57' ' ' VAL . 39.5 t -133.79 148.72 30.4 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 176.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.463 ' O ' ' HG2' ' A' ' 67' ' ' GLU . 13.3 p -52.95 128.54 27.52 Favored 'General case' 0 N--CA 1.406 -2.648 0 O-C-N 124.289 0.993 . . . . 0.0 109.635 176.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -71.92 -13.6 61.69 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 123.629 0.581 . . . . 0.0 111.553 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -164.46 41.53 0.31 Allowed Glycine 0 N--CA 1.431 -1.647 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.421 ' O ' HG12 ' A' ' 68' ' ' ILE . . . -120.46 -169.49 13.96 Favored Glycine 0 N--CA 1.437 -1.243 0 CA-C-O 119.706 -0.496 . . . . 0.0 112.194 -178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.571 ' HD2' HD22 ' A' ' 21' ' ' LEU . 39.2 Cg_endo -64.18 -32.28 63.2 Favored 'Trans proline' 0 CA--C 1.511 -0.661 0 C-N-CA 123.614 2.876 . . . . 0.0 112.391 -171.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HB3' ' OG ' ' A' ' 61' ' ' SER . . . -59.08 -57.22 14.02 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.202 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 61' ' ' SER . 4.5 pt-20 -75.88 -24.45 55.67 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.303 -0.959 . . . . 0.0 112.48 178.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 64' ' ' GLY . 21.2 mm -63.61 -39.74 86.46 Favored 'Isoleucine or valine' 0 C--O 1.247 0.969 0 CA-C-O 121.206 0.527 . . . . 0.0 109.903 176.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB1' ' H ' ' A' ' 17' ' ' GLU . . . -75.7 -56.87 4.27 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.842 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 152.13 24.74 0.05 OUTLIER Glycine 0 C--O 1.224 -0.501 0 C-N-CA 119.882 -1.152 . . . . 0.0 113.292 179.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.799 HD11 HG21 ' A' ' 57' ' ' VAL . 4.6 tp -91.96 124.65 36.23 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.447 ' N ' HD12 ' A' ' 71' ' ' LEU . 20.8 mm-40 -116.61 157.34 25.49 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.0 137.15 25.29 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.865 176.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 97.34 -0.25 59.93 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.941 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -75.13 123.24 24.88 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 120.773 0.321 . . . . 0.0 110.651 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -89.0 110.81 21.45 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.492 HD11 ' CG2' ' A' ' 57' ' ' VAL . 12.3 mt -82.94 129.03 38.14 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 CA-C-N 114.693 -1.14 . . . . 0.0 110.352 -173.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.429 ' HA ' ' HB ' ' A' ' 86' ' ' THR . 21.1 mmt -105.63 -26.26 11.92 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.478 0.656 . . . . 0.0 110.589 -177.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . 0.604 ' HB3' ' HB2' ' A' ' 108' ' ' LEU . 11.9 tp60 -152.46 133.11 13.92 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.88 -169.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.608 HG22 HD12 ' A' ' 107' ' ' LEU . 55.0 t -136.53 111.86 11.28 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.645 0 C-N-CA 124.27 1.028 . . . . 0.0 111.431 -178.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . 0.423 ' ND2' ' HA ' ' A' ' 105' ' ' VAL . 1.2 t-20 52.25 34.93 15.66 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 125.724 1.61 . . . . 0.0 112.92 173.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . 0.401 ' H ' ' NE2' ' A' ' 79' ' ' GLN . . . 95.65 -9.4 68.8 Favored Glycine 0 CA--C 1.523 0.556 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.435 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.447 ' N ' HE22 ' A' ' 79' ' ' GLN . 0.0 OUTLIER -104.44 150.09 24.85 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 122.707 0.403 . . . . 0.0 110.207 178.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -74.91 132.76 41.7 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 123.839 0.855 . . . . 0.0 110.343 -175.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.454 ' SD ' HG21 ' A' ' 80' ' ' VAL . 24.5 ttm -123.28 -0.48 8.81 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 122.211 1.005 . . . . 0.0 110.943 174.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 78' ' ' MET . 2.1 t -70.16 -25.06 63.27 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.259 -178.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 26.9 ttt -141.41 86.29 2.01 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.245 0.545 . . . . 0.0 109.903 175.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 10.0 p -152.36 151.95 11.29 Favored 'Isoleucine or valine' 0 C--O 1.255 1.378 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.453 HG22 ' HB2' ' A' ' 38' ' ' ASP . 17.8 p -75.0 157.11 35.46 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.176 179.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.612 ' HB2' ' NE2' ' A' ' 39' ' ' GLN . 10.9 t60 -53.84 -45.44 70.92 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 174.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -56.72 -51.22 69.67 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 113.958 -1.474 . . . . 0.0 111.435 -177.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -30.3 63.6 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.908 -0.587 . . . . 0.0 112.072 -177.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.569 ' O ' ' HG ' ' A' ' 97' ' ' LEU . . . -76.66 -36.0 57.6 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.141 -178.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.4 ' HG2' HD11 ' A' ' 33' ' ' ILE . 12.1 mmm180 -51.49 -45.65 62.9 Favored 'General case' 0 CA--C 1.509 -0.616 0 O-C-N 123.931 0.77 . . . . 0.0 111.424 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . 0.357 0.0 OUTLIER -93.06 59.71 3.16 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-O 122.904 1.335 . . . . 0.0 110.813 179.299 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 7.0 tpt180 -154.38 -48.1 0.09 Allowed 'General case' 0 C--N 1.278 -2.518 0 CA-C-N 112.151 -2.295 . . . . 0.0 106.698 171.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 93' ' ' ALA . 1.4 pp -94.88 -25.46 16.57 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -178.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.443 ' N ' HD12 ' A' ' 97' ' ' LEU . 12.7 t -114.23 14.06 18.04 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 118.482 -1.287 . . . . 0.0 110.476 174.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.528 ' HD3' ' HB2' ' A' ' 101' ' ' SER . 17.5 ptpt -77.23 168.05 20.7 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 119.151 -1.02 . . . . 0.0 108.432 172.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.431 ' HA ' ' HB3' ' A' ' 27' ' ' LEU . 9.7 ptp85 -113.74 0.39 14.51 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.16 -0.616 . . . . 0.0 111.822 -175.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . 0.528 ' HB2' ' HD3' ' A' ' 99' ' ' LYS . 40.9 m -76.1 -34.02 59.5 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-N 115.573 -0.74 . . . . 0.0 112.804 -175.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.433 ' OE2' ' HD2' ' A' ' 99' ' ' LYS . 10.2 pt-20 -111.78 172.18 7.05 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 116.706 -0.225 . . . . 0.0 110.695 -178.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 20' ' ' LYS . 2.0 pm0 -132.85 -87.35 0.44 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 -175.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 17.9 t -73.37 114.11 12.32 Favored 'Isoleucine or valine' 0 CA--C 1.487 -1.444 0 CA-C-O 121.625 0.726 . . . . 0.0 109.816 -176.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.623 HG21 HD13 ' A' ' 29' ' ' LEU . 11.4 m -110.36 153.1 12.21 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.177 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.761 -177.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 11.9 mmm180 -120.94 100.28 6.99 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 106.042 -1.836 . . . . 0.0 106.042 -174.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.608 HD12 HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -109.28 160.65 15.95 Favored 'General case' 0 C--N 1.283 -2.296 0 C-N-CA 120.694 -0.402 . . . . 0.0 110.548 -171.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.604 ' HB2' ' HB3' ' A' ' 79' ' ' GLN . 1.7 mp -132.34 122.58 25.31 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 33.7 m -120.44 156.99 23.4 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.027 -178.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.648 HG22 HG22 ' A' ' 13' ' ' VAL . 66.3 p -129.98 146.29 51.66 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.27 0.557 . . . . 0.0 110.696 -178.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 31.1 mmm180 -100.17 84.91 2.91 Favored 'General case' 0 N--CA 1.423 -1.803 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 176.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -89.72 -6.44 56.05 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.823 -175.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' SER . . . . . . . . . . . . . 13.6 m -81.46 20.61 0.86 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.892 -178.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 9.0 mp 55.34 77.28 0.23 Allowed 'General case' 0 C--O 1.236 0.39 0 C-N-CA 124.488 1.115 . . . . 0.0 112.311 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -134.75 149.83 50.49 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp -127.02 92.93 3.63 Favored 'General case' 0 C--N 1.268 -2.936 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 -179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -94.52 163.33 13.44 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.672 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 61.3 t 68.64 78.38 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 O-C-N 124.416 1.072 . . . . 0.0 111.28 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -151.7 89.02 1.44 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 114.556 -1.202 . . . . 0.0 109.301 175.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -90.82 85.99 6.19 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.2 m -86.93 -27.3 23.42 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.027 -176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' MET . . . . . . . . . . . . . 66.6 mtt 71.05 -70.67 0.15 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.757 1.223 . . . . 0.0 109.871 -173.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 51.7 tp -92.5 79.61 4.9 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 4.9 m . . . . . 0 C--O 1.262 1.734 0 CA-C-N 114.436 -1.256 . . . . 0.0 109.79 -176.144 . . . . . . . . 0 0 . 1 stop_ save_